Name,Synonym,CAS,SMILES,CID
Lapatinib ditosylate monohydrate,Lapatinib ditoluenesulfonate monohydrate; Lapatinib tosilate; Lapatinib tosilate hydrate; Tykerb; Tyverb,388082-78-8,n1cnc(c2cc(ccc12)c1oc(cc1)CNCCS(=O)(=O)C)Nc1cc(c(cc1)OCc1cc(ccc1)F)Cl.c1(ccc(cc1)C)S(=O)(=O)O.O.c1(ccc(cc1)C)S(=O)(=O)O,
Capsaicin,8-Methyl-N-vanillyl-trans-6-nonenamide; (E)-Capsaicin; Qutenza; Vanilloid; Zostrix,404-86-4,c1(cc(c(cc1)O)OC)CNC(=O)CCCC/C=C/C(C)C,
Sunitinib,SU 11248,557795-19-4,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C/2\C(=O)Nc3c2cc(F)cc3)c1C,
Ellipticine,NSC 71795; Elliptisine,519-23-3,Cc1c2[nH]c3ccccc3c2c(C)c2cnccc12,
Irinotecan Hydrochloride,Camptothecin 11 hydrochloride; CPT-11 hydrochloride,100286-90-6,Cl.CCc1c2cc(OC(=O)N3CCC(CC3)N3CCCCC3)ccc2nc2c1Cn1c2cc2c(COC(=O)[C@]2(O)CC)c1=O,
Sodium butanoate,Butanoic acid sodium salt; Sodium Butyrate,156-54-7,[Na+].CCCC(=O)[O-],
Dasatinib monohydrate,BMS-354825 Monohydrate,863127-77-9,n1cc(sc1Nc1nc(nc(N2CCN(CC2)CCO)c1)C)C(=O)Nc1c(cccc1C)Cl.O,
Ibandronic acid,Bonviva; Bondronat; Boniva,114084-78-5,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,
Imatinib Mesylate,STI-571; CGP-57148B; ST-1571 Mesylate,220127-57-1,CS(O)(=O)=O.CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,
SCR7 pyrazine,SCR7,14892-97-8,O=c1[nH]c(=S)[nH]c2c1nc(c1ccccc1)c(n2)c1ccccc1,
BMH-21,BMH21; BMH 21; BMH-21,896705-16-1,CN(C)CCNC(=O)c1cccn2c1nc1cc3ccccc3cc1c2=O,
7ACC2,,1472624-85-3,CN(Cc1ccccc1)c1cc2c(cc1)cc(C(=O)O)c(=O)o2,
GSK503,,1346572-63-1,CC(C)n1cc(C)c2c(cc(cc12)c1cnc(cc1)N1CCN(C)CC1)C(=O)NCc1c(C)cc(C)[nH]c1=O,
CID 2011756,CID2011756; CID 2011756; CID-2011756,638156-11-3,Clc1cccc(c1)-c1ccc(o1)C(=O)Nc1ccc(CN2CCOCC2)cc1,
Ansamitocin P 3',Ansamitocin P-3'; Maytansinol butyrate; Ansamitocin P 3'; Antibiotic C 15003P3',66547-09-9,CCCC(=O)O[C@H]1CC(=O)N(C)c2cc(C\C(C)=C\C=C\[C@@H](OC)[C@@]3(O)C[C@H](OC(=O)N3)[C@@H](C)[C@@H]3O[C@@]13C)cc(OC)c2Cl,
BIX-01294 trihydrochloride,BIX 01294 Trihydrochloride; BIX 01294,1392399-03-9,Cl.COc1c(OC)cc2c(NC3CCN(Cc4ccccc4)CC3)nc(nc2c1)N1CCCN(C)CC1.Cl.Cl,
kb NB 142-70,,1233533-04-4,Oc1cc2c(sc3c2SCCNC3=O)cc1,
Temsirolimus,CCI-779; NSC 683864,162635-04-3,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OC(=O)C(C)(CO)CO,
6-Mercaptopurine hydrate,6-Mercaptopurine monohydrate; 6-Mercaptopurine hydrate; 6-Mercaptopurine (6-MP) Monohydrate,6112-76-1,c1nc2c([nH]1)c(=S)nc[nH]2.O,
Icotinib Hydrochloride,BPI-2009H,1204313-51-8,C#Cc1cc(ccc1)Nc1ncnc2cc3OCCOCCOCCOc3cc12.Cl,
INH1,IBT13131,313553-47-8,Cc1cc(C)c(c2csc(NC(=O)c3ccccc3)n2)cc1,
Crocin,Alpha-Crocin; Gardenia Yellow,42553-65-1,CC(\C=C\C=C(/C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)=C/C=C/C=C(C)/C=C/C=C(\C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O,
p-Coumaric acid,trans-4-Hydroxycinnamic acid; 4-Hydroxycinnamic acid; P-Hydroxycinnamic acid; 4-Coumaric acid; Trans-p-Coumaric acid; para-Coumaric Acid,501-98-4,c1cc(ccc1/C=C/C(=O)O)O,
Liensinine Perchlorate,,2385-63-9,OCl(=O)(=O)=O.COc1cc2CCN(C)[C@H](Cc3ccc(O)c(Oc4cc5[C@@H](Cc6ccc(O)cc6)N(C)CCc5cc4OC)c3)c2cc1OC,
Caudatin,,38395-02-7,CC(C)C(\C)=C\C(=O)O[C@@H]1C[C@@H]2[C@@]3(C)CC[C@H](O)CC3=CC[C@@]2(O)[C@@]2(O)CC[C@@](O)(C(C)=O)[C@@]12C,
NSC5844,RE-640,140926-75-6,c1cc2c(ccnc2cc1Cl)NCCNc1c2ccc(cc2ncc1)Cl,
Midostaurin,CGP 41251; PKC412; CGP41231; N-Benzoylstaurosporine,120685-11-2,CO[C@@H]1[C@@H](C[C@@H]2O[C@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1,
SZL P1-41,,222716-34-9,CCc1c(c(c2c(c1)c(=O)c(co2)c1nc2ccccc2s1)CN1CCCCC1)O,
trans-Chalcone,Chalcone; trans-Chalcone; Chalkone; Cinnamophenone,614-47-1,c1ccc(cc1)/C=C/C(=O)c1ccccc1,
Corosolic acid,Corsolic acid; Glucosol; Colosolic acid; Colosic acid; 2Î±-Hydroxyursolic acid,4547-24-4,C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]3[C@@]4(C[C@H]([C@@H](C3(C)C)O)O)C)C)[C@@H]2[C@H]1C)C)C(=O)O,
Hydroxytyrosol,"3,4-Dihydroxyphenylethanol; Hydroxytyrosol; 3-Hydroxytyrosol; 3,4-dihydroxyphenylethanol; Dihydroxyphenylethanol; 2-(3,4-Di-hydroxyphenyl)-ethanol",10597-60-1,c1cc(c(cc1CCO)O)O,
Lys05,Lys01 trihydrochloride,1391426-24-6,c12c(cc(cc1)Cl)nccc2NCCN(CCNc1ccnc2c1ccc(c2)Cl)C.Cl.Cl.Cl,
EED226,,2083627-02-3,c1(n2c(c(cn1)c1ccc(cc1)S(=O)(=O)C)nnc2)NCc1occc1,
CPI-455,CPI455; CPI 455; CPI-455; CPI-455 HCl,1628208-23-0,CC(C)c1c([nH]c2c(cnn2c1=O)C#N)c1ccccc1,
Atractyloside A,,126054-77-1,CC(C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@H]1CC[C@](O)(CO)[C@H]2CC(=O)[C@@](C)(O)[C@@H]2C1,
HMN-154,HMN154; HMN 154; HMN-154,173528-92-2,c1(c(cccc1)/C=C/c1ccncc1)NS(=O)(=O)c1ccc(cc1)OC,
Lapachol,Tecomin; CI75490; Bethabarra wood; Greenhartin,84-79-7,C\C(C)=C\CC1=C(O)C(=O)c2ccccc2C1=O,
R162,,64302-87-0,O=C(C1=C2C=CC=C1)C3=CC=C(CC=C)C(O)=C3C2=O,
OSS_128167,SIRT6-IN-1,887686-02-4,O=C(Nc1cc(ccc1)C(=O)Nc2cc(C(=O)O)c(O)cc2)c3ccco3,
Idarubicin hydrochloride,"Idarubicin HCl; 4-Demethoxydaunorubicin hydrochloride; Idarubicin hydrochloride; 4-demethoxydaunorubicin (NSC256439, 4-DMDR) HCl; Zavedos; Idamycin",57852-57-0,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]1C[C@@](Cc2c(c3c(c(c12)O)C(=O)c1ccccc1C3=O)O)(C(=O)C)O)N)O.Cl,
Gemcitabine hydrochloride,Gemcitabine HCl; Gemcitabine Hydrochloride; LY 188011 hydrochloride; LY188011; Gemzar,122111-03-9,Cl.Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,
Bleomycin Sulfate,NSC125066; Blenoxane,9041-93-4,OS([O-])(=O)=O.C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)[C@@H](NC(=O)c1nc(nc(N)c1C)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1cnc[nH]1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCC[S+](C)C,
Pralatrexate,Folotyn; 10-Propargyl-10-deazaaminopterin,146464-95-1,C#CCC(Cc1cnc2c(n1)c(nc(n2)N)N)c1ccc(cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O,
Pemetrexed disodium hemipenta hydrate,Pemetrexed Disodium Hydrate; Pemetrexed disodium hemipenta hydrate; Pemetrexed sodium hydrate; LY-231514 Disodium Hydrate,357166-30-4,OC(CC[C@@H](C(O)=O)NC(C(C=C1)=CC=C1CCC2=CNC(NC(N)=N3)=C2C3=O)=O)=O.OC(CC[C@@H](C(O)=O)NC(C(C=C4)=CC=C4CCC5=CNC(NC(N)=N6)=C5C6=O)=O)=O.[Na].O.[Na].O.[Na].O.[Na].O.O,
Lapatinib Ditosylate,GW-572016 ditosylate; Lapatinib (GW-572016) Ditosylate; Tykerb ditosylate,388082-77-7,Cc1ccc(cc1)S(O)(=O)=O.Cc1ccc(cc1)S(O)(=O)=O.CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,
Palbociclib Isethionate,PD 0332991 isethionate; Palbociclib (PD0332991) Isethionate,827022-33-3,OCCS(O)(=O)=O.CC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n(C2CCCC2)c1=O,
Tie2 kinase inhibitor 1,Tie2 kinase inhibitor,948557-43-5,COc1ccc2cc(ccc2c1)-c1[nH]c(nc1-c1ccncc1)-c1ccc(cc1)S(C)=O,
TAI-1,TAI1; TAI 1; TAI-1,1334921-03-7,COC1=CC=C(OC2=CC(C)=C(C3=CSC(NC(=O)C4=CC=NC=C4)=N3)C(C)=C2)C=C1,
Ulipristal,,159811-51-5,[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],
Dp44mT,,152095-12-0,CN(C)C(=S)NN=C(c1ccccn1)c1ncccc1,
Epoxomicin,"BU-4061T; BU-4061T,Aids010837",134381-21-8,CC[C@H](C)[C@H](NC(=O)[C@H]([C@@H](C)CC)N(C)C(C)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,
Fatostatin hydrobromide,Fatostatin; Fatostatin HBr; Fatostatin A; Fatostatin A HBr,298197-04-3,Cc1ccc(cc1)c1csc(c2cc(CCC)ncc2)n1.Br,
Flavopiridol,Alvocidib; HMR-1275; L868275; NSC 649890 HCl,146426-40-6,[H][C@@]1(CCN(C)C[C@H]1O)C1=C2OC(=CC(=O)C2=C(O)C=C1O)C1=C(Cl)C=CC=C1,
Marimastat,TA2516; BB2516; KB-R8898,154039-60-8,C(=O)([C@@H]([C@@H](C(=O)NO)O)CC(C)C)N[C@H](C(=O)NC)C(C)(C)C,
Pazopanib Hydrochloride,Pazopanib HCl; GW786034; Pazopanib Hydrochloride; GW786034 HCl; Votrient HCl; Armala,635702-64-6,Cl.CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=NC=C1,
Bellidifolin,Bellidifoline; Bellidifolium,2798-25-6,COC1=CC(=C2C(=C1)OC3=C(C=CC(=C3C2=O)O)O)O,
Punicalagin,,65995-63-3,OC1O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3-c3c(O)c(O)c4oc(=O)c5c(c(O)c(O)c6oc(=O)c3c4c56)-c3c(O)c(O)c(O)cc3C(=O)O[C@H]2[C@@H]2OC(=O)c3cc(O)c(O)c(O)c3-c3c(O)c(O)c(O)cc3C(=O)O[C@@H]12,
Bergaptol,4-Hydroxybergapten; 5-Hydroxypsoralen; 5-Hydroxyfuranocoumarin,486-60-2,Oc1c2ccoc2cc2oc(=O)ccc12,
Hydroxygenkwanin,7-O-Methylluteolin; Luteolin 7-methylether,20243-59-8,COc1cc(O)c2c(c1)oc(-c1ccc(O)cc1)c(O)c2=O,
gypenoside A,,157752-01-7,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C=O)[C@@H](CC[C@]5(C)[C@@H]4CC[C@@H]4[C@H](CC[C@@]54C)C4(O)CC(OC4O)\C=C(/C)C)C3(C)C)OC[C@H](O)[C@@H]2O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,
"N-Benzoyl-(2R,3S)-3-phenylisoserine","N-Benzoyl-(2R,3S)-3-phenylisoserine; taxol side chain",132201-33-3,O[C@H]([C@@H](NC(=O)c1ccccc1)c1ccccc1)C(O)=O,
Thonningianin A,,271579-11-4,O[C@H]1[C@H](Oc2cc(O)c(C(=O)CCc3ccccc3)c(O)c2)O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3-c3c(O)c(O)c(O)cc3C(=O)O[C@H]2[C@@H]1OC(=O)c1cc(O)c(O)c(O)c1,
Tubeimoside II,Tubeimoside-B,115810-12-3,C[C@@H]1O[C@H]2O[C@@H]3[C@H](O)[C@@H](O)CO[C@H]3OC(=O)[C@]34CCC(C)(C)C[C@H]3C3=CC[C@@H]5[C@@]6(C)C[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O[C@@H]7OC[C@H](OC(=O)C[C@](C)(O)CC(=O)O[C@@H]1[C@@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)[C@H]2O)[C@H](O)[C@H]7O)[C@@](C)(CO)[C@@H]6CC[C@@]5(C)[C@]3(C)C[C@H]4O,
AIM-100,AIM100; AIM 100; AIM-100,873305-35-2,C(Nc1ncnc2oc(c(-c3ccccc3)c12)-c1ccccc1)[C@@H]1CCCO1,
dBET6,,1950634-92-0,Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)NCCCCCCCCNC(=O)COc1cccc3C(=O)N(C4CCC(=O)NC4=O)C(=O)c13)c1nnc(C)n-21)c1ccc(Cl)cc1,
CA-5f,,1370032-19-1,COc1ccc(\C=C2/CN(C)C\C(=C/c3c[nH]c4ccccc34)C2=O)cc1OC,
DIM-C-pPhCO2Me,,151358-48-4,COC(=O)c1ccc(cc1)C(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,
S-Gboxin,,2101317-21-7,[I-].CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)Cn1c(-c2cccc(c2)C(F)(F)F)[n+](C)c2ccccc12,
BAY-8002,BAY8002; BAY 8002; BAY-8002,724440-27-1,OC(=O)c1ccccc1NC(=O)c1cc(ccc1Cl)S(=O)(=O)c1ccccc1,
ML216,CID-49852229,1430213-30-1,Fc1ccc(NC(=O)Nc2nnc(s2)-c2ccncc2)cc1C(F)(F)F,
DC661,,1872387-43-3,CN(CCCCCCNc1ccnc2cc(Cl)ccc12)CCCCCCNc1ccnc2cc(Cl)ccc12,
VK3-OCH3,"2-[(2-Methoxy)ethylthio]-3-methyl-1,4-na",255906-59-3,COCCSC1=C(C)C(=O)c2ccccc2C1=O,
Bropirimine,U-54461,56741-95-8,Nc1nc(-c2ccccc2)c(Br)c(=O)[nH]1,
Clanfenur,,51213-99-1,CN(C)c1cccc(F)c1C(=O)NC(=O)Nc1ccc(Cl)cc1,
Almonertinib,HS-10296; Almonertinib,1899921-05-1,COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1nccc(n1)-c1cn(C2CC2)c2ccccc12,
YF-2,YF 2,1311423-89-8,CCOc1cccc(OCCN(C)C)c1C(=O)Nc1ccc(Cl)c(c1)C(F)(F)F,
TRi-1,,246020-68-8,COc1ccc(c(n1)S(=O)(=O)c1ccc(Cl)cc1)[N+]([O-])=O,
(Â±)-Norcantharidin,Endothall Anhydride; Endothall anhydride,29745-04-8,[H][C@@]12[C@H]3CC[C@H](O3)[C@]1([H])C(=O)OC2=O,
BTR-1,5-Benzylidene-3-ethyl rhodanine,18331-34-5,CCN1C(=S)S\C(C1=O)=C/c1ccccc1,
Amsacrine hydrochloride,m-AMSA hydrochloride; acridinyl anisidide hydrochloride,54301-15-4,Cl.COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12,
3-Bromopyruvic acid,"Bromopyruvic acid; Hexokinase II Inhibitor II, 3-BP",1113-59-3,OC(=O)C(=O)CBr,
Trametinib (DMSO solvate),Trametinib DMSO solvate; GSK-1120212 (DMSO solvate); Trametinib dimethyl sulfoxide; JTP-74057 (DMSO solvate),1187431-43-1,CS(C)=O.CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O,
H3B-5942,,2052128-15-9,CC\C(=C(\c1ccc(OCCNC\C=C\C(=O)N(C)C)cc1)c1ccc2[nH]ncc2c1)c1ccccc1,
"2,2'-Anhydrouridine","2,2'-Cyclouridine; 2,2'-Anhydrouridine; O2,2'-Cyclouridine",3736-77-4,OC[C@H]1O[C@@H]2[C@@H](Oc3nc(=O)ccn23)[C@@H]1O,
Fadrozole,,102676-47-1,N#Cc1ccc(cc1)C1CCCc2cncn12,
JQEZ5,,1913252-04-6,CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(nc2n(ncc12)C(C)C)-c1ccc(nc1)N1CCN(C)CC1,
Methuosis inducer 1,,2240205-30-3,Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1Nc1cc(nc2[nH]ccc12)-c1cccnc1,
Tyr-Gly-Gly-Phe-Met-OH,Met-Enkephalin; Methionine enkephalin,58569-55-4,CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O,
KPT-6566,,881487-77-0,CC(C)(C)c1ccc(cc1)S(=O)(=O)\N=C1/C=C(SCC(O)=O)C(=O)c2ccccc12,
Theaflavin,,4670-05-7,O=c1c(O)cc([C@H]2Oc3cc(O)cc(O)c3C[C@H]2O)cc2c([C@H]3Oc4cc(O)cc(O)c4C[C@H]3O)cc(O)c(O)c12,
Fadrozole hydrochloride,CGS 16949A,102676-31-3,Cl.N#Cc1ccc(C2CCCc3cncn32)cc1,
Belotecan hydrochloride,CKD-602,213819-48-8,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNC(C)C.Cl,
Tetraethylammonium chloride,,56-34-8,CC[N+](CC)(CC)CC.[Cl-],
Fmoc-Ser(O-Î±-D-GalNAc(OAc)3)-OH,Fmoc-Ser-(GalNAc(Ac)3-alpha-D)-OH; Fmoc-Ser[GalNAc(Ac)3-Î±-D]-OH; Fmoc-Ser(Ac3AcNH-Î±-Gal)-OH,120173-57-1,CC(=O)N[C@H]1[C@@H](OC[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O,
IDO inhibitor 1,,1204669-37-3,NS(=O)(=O)NCCNc1nonc1/C(=N/O)Nc1ccc(F)c(Br)c1,
Larotrectinib,LOXO-101; ARRY-470,1223403-58-4,O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1,
Datelliptium chloride hydrochloride,,157000-76-5,CCN(CC)CC[n+]1ccc2c(C)c3[nH]c4ccc(O)cc4c3c(C)c2c1.Cl.[Cl-],
zanubrutinib,BGB-3111,1691249-45-2,C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,
BIX-01294,,935693-62-2,COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC,
Aminopterin,4-Aminofolic acid; APGA,54-62-6,Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1,
Hispidin,,555-55-5,O=c1cc(O)cc(/C=C/c2ccc(O)c(O)c2)o1,
CM10,CM 10,692269-09-3,C=CCc1cccc(CNc2nc3ccccc3n2CCC)c1O,
Flumatinib mesylate,HHGV678 mesylate,895519-91-2,CS(=O)(=O)O.Cc1ncc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1,
Salvigenin,,19103-54-9,COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1,
Milnacipran ((1S-cis) hydrochloride),Levomilnacipran Hydrochloride,175131-60-9,CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN.Cl,
CM-272,,1846570-31-7,COc1cc2c(NC3CCN(C)CC3)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,
USP25/28 inhibitor AZ1,AZ1,2165322-94-9,OCCNCc1cc(Br)ccc1OCc1ccc(F)c(C(F)(F)F)c1,
Dipyrithione,,3696-28-4,[O-][n+]1ccccc1SSc1cccc[n+]1[O-],
Methotrexate disodium,,7413-34-5,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1.[Na+].[Na+],
2-O-Î±-D-Glucopyranosyl-L-ascorbic Acid,ASCORBYL GLUCOSIDE; 2-O-Î±-D-Glucopyranosyl-L-ascorbic AcidÂ ,129499-78-1,O=C1O[C@H]([C@@H](O)CO)C(O)=C1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,
"(1E,6E)-Bis(demethoxy)curcumin",BDMC; Curcumin III; Didemethoxycurcumin,33171-05-0,Oc1ccc(/C=C/C(CC(/C=C/c(cc2)ccc2O)=O)=O)cc1,
"3,6-Dihydroxyflavone",,108238-41-1,Oc(cc1)cc(C2=O)c1OC(c1ccccc1)=C2O,
Î²-Ionone,Î²-lonone,14901-07-6,CC1(C)C(C=CC(C)=O)=C(C)CCC1,
(â)-Myrtenal,(1R)-(â)-Myrtenal,18486-69-6,CC1(C)[C@@H]2C[C@H]1C(C=O)=CC2,
Î±-Angelica lactone,Alpha-Angelica Lactone,591-12-8,CC1=CCC(=O)O1,
(Â±)-Catechin,(Â±)-Catechin hydrate,7295-85-4,O[C@@H](C1)[C@@H](c(cc2)cc(O)c2O)Oc2c1c(O)cc(O)c2,
10Z-Nonadecenoic acid,,73033-09-7,CCCCCCCC/C=C\CCCCCCCCC(O)=O,
Asiaticoside B,,125265-68-1,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OC(=O)[C@@]45CC[C@@]6(C(=CC[C@H]7[C@]6(C[C@H]([C@@H]8[C@@]7(C[C@H]([C@@H]([C@@]8(C)CO)O)O)C)O)C)[C@@H]4CC(CC5)(C)C)C)O)O)O)CO)O)O)O,
Prosapogenin A,Progenin III,19057-67-1,C[C@@H]([C@@H]([C@H](C1)O2)[C@@](C)(CC3)[C@@H]1[C@H]1[C@H]3[C@@](C)(CC[C@@H](C3)O[C@@H]([C@@H]([C@H]4O)O[C@@H]([C@@H]([C@@H]5O)O)O[C@@H](C)[C@@H]5O)O[C@H](CO)[C@H]4O)C3=CC1)[C@@]21OC[C@H](C)CC1,
Lentinan,,37339-90-5,C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)O)O)O)O)O)O,
Arenobufagin,,464-74-4,[H][C@]12CC[C@]3([H])[C@]([H])([C@H](O)C(=O)[C@]4(C)[C@H](CC[C@]34O)c3ccc(=O)oc3)[C@@]1(C)CC[C@H](O)C2,
Sophoraflavanone G,Kushenol F; Vexibinol,97938-30-2,CC(C)=CC[C@H](Cc(c(O[C@@H](CC1=O)c(ccc(O)c2)c2O)c1c(O)c1)c1O)C(C)=C,
Poricoic acid A,Poricoic acid A(F),137551-38-3,CC(C)C(CC[C@H]([C@@H]([C@@H](C1)O)[C@@](C)(CC=C2[C@@]3(C)CCC(O)=O)[C@]1(C)C2=CC[C@H]3C(C)=C)C(O)=O)=C,
Harringtonine,,26833-85-2,CC(C)(CC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O,
Podophyllotoxone,,477-49-6,COc1cc([C@@H]([C@H]([C@@H]2CO3)C3=O)c(cc3OCOc3c3)c3C2=O)cc(OC)c1OC,
Î³-Tocopherol,(+)-Î³-Tocopherol,54-28-4,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@](C)(CC1)Oc(c(C)c2C)c1cc2O,
Mogroside IV-E,mogroside Ive; Mogroside IV-EÂ ,88915-64-4,C[C@H](CC[C@H](C(C)(C)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)[C@H]3CC[C@@]4([C@@]3(C[C@H]([C@@]5([C@@H]4CC=C6[C@H]5CC[C@@H](C6(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)C)O)C)C,
Decursinol,,23458-02-8,CC1(C)Oc2cc(OC(C=C3)=O)c3cc2C[C@@H]1O,
1V209,TLR7 agonist T7,1062444-54-5,COCCOc1nc(N)c2[nH]c(=O)n(Cc3ccc(cc3)C(O)=O)c2n1,
Enzalutamide carboxylic acid,,1242137-15-0,CC1(C)N(C(=S)N(C1=O)c1ccc(C#N)c(c1)C(F)(F)F)c1ccc(C(O)=O)c(F)c1,
L-732138,,148451-96-1,CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCc1cc(cc(c1)C(F)(F)F)C(F)(F)F,
Mobocertinib,tak788,1847461-43-1,COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1ncc(C(=O)OC(C)C)c(n1)-c1cn(C)c2ccccc12,
Selpercatinib,LOXO-292,2152628-33-4,COc1ccc(CN2C3CC2CN(C3)c2ccc(cn2)-c2cc(OCC(C)(C)O)cn3ncc(C#N)c23)cn1,
Regorafenib Hydrochloride,BAY73-4506 hydrochloride,835621-07-3,Cl.CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,
Pamidronic acid,,40391-99-9,NCCC(O)(P(O)(O)=O)P(O)(O)=O,
Crizotinib hydrochloride,PF-02341066 hydrochloride,1415560-69-8,Cl.C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl,
Prednisone acetate,Prednisone 21-acetate,125-10-0,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
Alectinib hydrochloride,CH5424802 (Hydrochloride) ; RO5424802 (Hydrochloride) ; AF-802 (Hydrochloride),1256589-74-8,Cl.CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N1CCC(CC1)N1CCOCC1,
Bendamustine,SDX105,16506-27-7,Cn1c(CCCC(O)=O)nc2cc(ccc12)N(CCCl)CCCl,
Gambogenic acid,,173932-75-7,[H][C@@]12C[C@H]3C=C4C(=O)c5c(O)c(C\C=C(/C)CC\C=C(/C)C)c(O)c(C\C=C(/C)C)c5O[C@@]14[C@@](C\C=C(\C)C(O)=O)(OC2(C)C)C3=O,
FT113,,1630808-89-7,OC1(CC1)C(=O)N1CCN(CC1)C(=O)c1ccc(cc1)-c1nc2ccc(F)cc2o1,
Trifluoperazine,trifluoroperazine,117-89-5,CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1,
Adagrasib,MRTX849,2326521-71-3,CN1CCC[C@H]1COc1nc2CN(CCc2c(n1)N1CCN([C@@H](CC#N)C1)C(=O)C(F)=C)c1cccc2cccc(Cl)c12,
Phentolamine,,50-60-2,Cc1ccc(cc1)N(CC1=NCCN1)c1cccc(O)c1,
Valrubicin,AD-32,56124-62-0,CCCCC(OCC([C@]1(O)CC2=C(C(O)=C3C(C4=C(C(C3=C2O)=O)C=CC=C4OC)=O)[C@@H](O[C@]5C[C@](NC(C(F)(F)F)=O)[C@](O)[C@](C)O5)C1)=O)=O,
Ripretinib,DCC-2618,1442472-39-0,CCn1c2cc(NC)ncc2cc(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)c1=O,
CADD522,MFCD00167693,199735-88-1,OC(=O)C1C2CC(C=C2)C1C(=O)Nc1ccc(Cl)c(Cl)c1,
TED-347,,2378626-29-8,FC(F)(F)c1cccc(Nc2ccccc2C(=O)CCl)c1,
Gboxin,,2101315-36-8,[Cl-].CCc1n(CC(=O)O[C@@H]2C[C@H](C)CC[C@H]2C(C)C)c2ccccc2[n+]1C,
RA-9,,919091-63-7,[O-][N+](=O)c1ccc(\C=C2/CNC\C(=C/c3ccc(cc3)[N+]([O-])=O)C2=O)cc1,
Dabrafenib Mesylate,GSK2118436 Mesylate; GSK 2118436B,1195768-06-9,CS(O)(=O)=O.CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,
Savolitinib,Volitinib; HMPL-504; AZD-6094,1313725-88-0,C[C@H](N1N=NC2=NC=C(N=C12)C1=CN(C)N=C1)C1=CN2C=CN=C2C=C1,
Pralsetinib,Blu667,2097132-94-8,COC1(CCC(CC1)C1=NC(C)=CC(NC2=NNC(C)=C2)=N1)C(=O)N[C@@H](C)C1=CN=C(C=C1)N1C=C(F)C=N1,
MN58b,,203192-01-2,[Br-].[Br-].CN(C)C1=CC=[N+](CC2=CC=C(CCCCC3=CC=C(C[N+]4=CC=C(C=C4)N(C)C)C=C3)C=C2)C=C1,
ILK-IN-3,,6975-75-3,COC1=CC=C(C=C1)N=NC2=C(NN=C2N)N,
Nemorubicin,Methoxymorpholinyldoxorubicin ; PNU 152243 ; PNU-152243A,108852-90-0,CO[C@@H]1CN(CCO1)[C@H]1C[C@H](O[C@H]2C[C@@](O)(Cc3c(O)c4C(=O)c5cccc(OC)c5C(=O)c4c(O)c23)C(=O)CO)O[C@@H](C)[C@H]1O,
WYC-210,,2131803-93-3,CC1(C)CCS(=O)c2ccc(cc12)C#Cc1ncc(cn1)C(O)=O,
Bakuchiol,,10309-37-2,CC(=CCC[C@@](C)(C=C)/C=C/C1=CC=C(C=C1)O)C,
Ceritinib dihydrochloride,LDK378 dihydrochloride; Ceritinib dihydrochloride,1380575-43-8,Cl.Cl.CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,
Lenvatinib mesylate,E7080 (mesylate),857890-39-2,CS(O)(=O)=O.COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,
Masitinib mesylate,AB-1010 mesylate,1048007-93-7,CS(O)(=O)=O.CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,
TBOPP,,1996629-79-8,FC(F)(F)c1cccc(c1)-c1ccc(cc1)C(=O)Cn1cc(ccc1=O)S(=O)(=O)N1CCCC1,
Ribociclib succinate,LEE011 succinate,1374639-75-4,OC(=O)CCC(O)=O.CN(C)C(=O)c1cc2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n1C1CCCC1,
Pemigatinib,INCB054828,1513857-77-6,CCN(C(N(C(C(F)=C(OC)C=C1OC)=C1F)C2)=O)C(C2=CN3)=C4C3=NC(CN5CCOCC5)=C4,
Metoprine,,7761-45-7,Cc1nc(N)nc(N)c1-c1ccc(Cl)c(Cl)c1,
ETHYL 5-HYDROXY-2-METHYLINDOLE-3-CARBOXYLATE,,7598-91-6,CCOC(=O)c1c(C)nc2ccc(O)cc12,
TMIFRY8XAG,"4-oxo-1,4-dihydroquinoline-2-carboxylic acid",3312-04-7,C1=CC(=CC=C1C(CCCCl)C2=CC=C(C=C2)F)F,
SR-717,,2375421-09-1,[Li+].[O-]C(=O)c1cc(F)c(F)cc1NC(=O)c1ccc(nn1)-n1ccnc1,
XD14,,1370888-71-3,CCN(CC)S(=O)(=O)c1ccc(O)c(NC(=O)c2[nH]c(C)c(C(C)=O)c2CC)c1,
Naphthazarin,"DHNQ; 5,8-Dihydroxy-1,4-naphthoquinone",475-38-7,Oc1ccc(O)c2C(=O)C=CC(=O)c12,
Sotorasib,AMG-510; sotorasib,2296729-00-3,CC(C)c1nccc(C)c1-n1c2nc(c(F)cc2c(nc1=O)N1CCN(C[C@@H]1C)C(=O)C=C)-c1c(O)cccc1F,
Picrocrocin,,138-55-6,CC1=C(C=O)C(C)(C)C[C@@H](C1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,
Orelabrutinib,ICP-022,1655504-04-3,NC(=O)c1ccc(nc1-c1ccc(Oc2ccccc2)cc1)C1CCN(CC1)C(=O)C=C,
Toxoflavin,Xanthothricin; Toxoflavine; PKF-118-310,84-82-2,Cn1ncnc2c1nc(=O)n(C)c2=O,
Nilotinib monohydrochloride monohydrate,Nilotinib (monohydrochloride monohydrate); AMN107 (monohydrochloride monohydrate),923288-90-8,O.Cl.Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)cc(c1)C(F)(F)F,
Pentamidine,,100-33-4,NC(=N)c1ccc(OCCCCCOc2ccc(cc2)C(N)=N)cc1,
CAL-101,GS-1101,1146702-54-6,O=C1N(C2=CC=CC=C2)C([C@@H](NC3=C4N=CNC4=NC=N3)C)=NC5=C1C(F)=CC=C5,
Nandrolone phenylpropionate,Nandrolone phenpropionate,62-90-8,CC12CCC3C(C1CCC2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CCC35,
Isopsoralenoside,,905954-18-9,OC[C@H]1O[C@@H](Oc2c(\C=C/C(O)=O)ccc3occc23)[C@H](O)[C@@H](O)[C@@H]1O,
MYCi975,NUCC-0200975,2289691-01-4,Cn1nc(cc1-c1ccc(OCc2ccc(Cl)cc2)c(-c2ccc(Cl)c(c2)C(F)(F)F)c1O)C(F)(F)F,
Olutasidenib,FT-2102,1887014-12-1,C[C@H](Nc1ccc(C#N)n(C)c1=O)c1cc2cc(Cl)ccc2[nH]c1=O,
Telotristat ethyl,LX1606,1033805-22-9,CCOC(=O)[C@@H](N)Cc1ccc(cc1)-c1cc(O[C@H](c2ccc(Cl)cc2-n2ccc(C)n2)C(F)(F)F)nc(N)n1,
Temoporfin,m-THPC; KW2345,122341-38-2,Oc1cccc(c1)-c1c2CCc(n2)c(-c2cccc(O)c2)c2ccc([nH]2)c(-c2cccc(O)c2)c2ccc(n2)c(-c2cccc(O)c2)c2ccc1[nH]2,
Loxoribine,7-Allyl-8-oxoguanosine; RWJ 21757,121288-39-9,Nc1nc2n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c(=O)n(CC=C)c2c(=O)[nH]1,
4-Methoxycoumarine,,20280-81-3,COc1cc(=O)oc2ccccc12,
BI-3812,,2166387-64-8,CNC(=O)COc1cc2cc(Nc3nc(ncc3Cl)N3CCC(CC3)C(=O)N(C)C)cc(OC)c2n(C)c1=O,
Sonidegib diphosphate,Erismodegib diphosphate; Sonidegib diphosphate; LDE225 diphosphate; NVP-LDE 225 diphosphate,1218778-77-8,OP(O)(O)=O.OP(O)(O)=O.C[C@H]1CN(C[C@@H](C)O1)c1ccc(NC(=O)c2cccc(-c3ccc(OC(F)(F)F)cc3)c2C)cn1,
Rucaparib monocamsylate,Rucaparib Camsylate,1859053-21-6,CC1(C)[C@@H]2CC[C@@]1(CS(O)(=O)=O)C(=O)C2.CNCc1ccc(cc1)-c1[nH]c2cc(F)cc3C(=O)NCCc1c23,
12-O-Methylcarnosic acid,,62201-71-2,[H][C@@]12CCc3cc(C(C)C)c(OC)c(O)c3[C@]1(CCCC2(C)C)C(O)=O,
Temozolomide Acid,TMZA,113942-30-6,Cn1nnc2c(ncn2c1=O)C(O)=O,
Regorafenib monohydrate,,1019206-88-2,O.CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,
CTPI-2,,68003-38-3,OC(=O)c1ccccc1NS(=O)(=O)c1ccc(Cl)c(c1)[N+]([O-])=O,
CL2A-SN-38 DCA   1279680-68-0(free base),,T17731L,OC(=O)C(Cl)Cl.OC(=O)C(Cl)Cl.CCc1c2Cn3c(cc4c(COC(=O)[C@@]4(CC)OC(=O)OCc4ccc(NC(=O)[C@H](CCCCN)NC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCn5cc(CNC(=O)C6CCC(CN7C(=O)C=CC7=O)CC6)nn5)cc4)c3=O)-c2nc2ccc(O)cc12,
Fucoxanthin,all-trans-Fucoxanthin,3351-86-8,O=C(/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C([H])=[C@@]=C([C@@]1(O)C)C(C)(C[C@H](OC(C)=O)C1)C)C[C@]2(C3(C)C)[C@@](C)(C[C@@H](O)C3)O2,
Î²-Boswellic acid,Beta-boswellic acid,631-69-6,C[C@]12[C@@](CC=C3[C@]2(CC[C@]4(C)[C@@]3([H])[C@H]([C@H](C)CC4)C)C)([H])[C@@]5([C@@]([C@](C)([C@H](O)CC5)C(O)=O)([H])CC1)C,
Trilaciclib hydrochloride,G1T28 hydrochloride,1977495-97-8,O=C1C2=CC3=CN=C(NC4=CC=C(N5CCN(C)CC5)C=N4)N=C3N2C6(CCCCC6)CN1.[H]Cl.[H]Cl,
Methoxyamine HCl,TRC102; TRC 102; TRC-102; Methoxyamine,593-56-6,CON.Cl,
MSA-2,,129425-81-6,O=C(C1=CC(C(S1)=C2)=CC(OC)=C2OC)CCC(O)=O,
Fluzoparib,"SHR3162, HS10160",1358715-18-0,C1CN2C(=NC(=N2)C(F)(F)F)CN1C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,
Foslinanib Sodium,TRX818 Sodium,1256037-62-3,O=C1C=C(C2=CC=CC(F)=C2)NC3=C1C(OP([O-])([O-])=O)=C(OC)C=C3.[Na+].[Na+],
Capmatinib 2HCl.H2O,INC-280 hydrochloride; INCB28060 hydrochloride; NVP-INC280,1865733-40-9,O=C(NC)C1=CC=C(C2=NN3C(N=C2)=NC=C3CC4=CC=C5N=CC=CC5=C4)C=C1F.[H]Cl.[H]Cl.[H]O[H],
Arglabin,(+)-Arglabin,84692-91-1,C[C@]1(CC[C@](C2=C)([H])[C@@](OC2=O)([H])[C@@]3([H])C(C)=CC4)[C@]34O1,
Psoralenoside,,905954-17-8,O=C(O)/C=C\C1=C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O)C=C(OC=C3)C3=C1,
"3,â5,â6,â7,â8,â3',â4'-âHeptemthoxyflavone","3,3',4',5,6,7,8-heptamethoxyflavone",1178-24-1,O=C1C(OC)=C(C2=CC=C(OC)C(OC)=C2)OC3=C(OC)C(OC)=C(OC)C(OC)=C13,
13-Methylberberine chloride,13-Methylberberine,54260-72-9,CC1=C(C=CC(OC)=C2OC)C2=C[N+]3=C1C4=CC(OCO5)=C5C=C4CC3.[Cl-],
Methyl caffeate,Methyl caffeate acid,3843-74-1,O=C(OC)/C=C/C1=CC=C(O)C(O)=C1,
Piperlonguminine,,5950-12-9,O=C(NCC(C)C)/C=C/C=C/C1=CC=C(OCO2)C2=C1,
Copanlisib dihydrochloride,BAY 80-6946 dihydrochloride,1402152-13-9,O=C(C1=CN=C(N)N=C1)NC2=NC3=C(C=CC(OCCCN4CCOCC4)=C3OC)C5=NCCN25.[H]Cl.[H]Cl,
Isolongifolene,(-)-Isolongifolene,1135-66-6,CC1(C)[C@]23CC[C@](C3)([H])C(C)(C)C2=CCC1,
PF-06726304,,1616287-82-1,O=C1N(CC2=C(C)C=C(C)NC2=O)CCC3=C1C(Cl)=C(C4=C(C)ON=C4C)C=C3Cl,
Bavachalcone,,28448-85-3,O=C(C1=CC(C/C=C(C)\C)=C(O)C=C1O)/C=C/C2=CC=C(O)C=C2,
GYY4137,GYY 4137 morpholine salt,106740-09-4,SP(N1CCOCC1)(C2=CC=C(OC)C=C2)=S.N3CCOCC3,
AG-120 (racemic),,1448346-63-1,O=C1CC[C@@H](C(N(C(C(NC2CC(F)(F)C2)=O)C3=CC=CC=C3Cl)C4=CC(F)=CN=C4)=O)N1C5=NC=CC(C#N)=C5,
Sotorasib racemate,AMG-510 racemate,2252403-56-6,C[C@H]1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C,
W-7 hydrochloride,W-7 HCl; W-7 hydrochloride; W-7 hydrochloride; W-7 hydrochloride; W-7 HCl; W 7 HCl; W7 HCl,61714-27-0,C1=CC2=C(C=CC=C2Cl)C(=C1)S(=O)(=O)NCCCCCCN.Cl,
NITIDINE,,6872-57-7,C[N+]1=CC2=CC(=C(C=C2C3=C1C4=CC5=C(C=C4C=C3)OCO5)OC)OC,
Poricoic acid B,,137551-39-4,CC(=CCCC([C@H]1[C@@H](C[C@@]2([C@@]1(CC=C3C2=CC[C@H]([C@]3(C)CCC(=O)O)C(=C)C)C)C)O)C(=O)O)C,
Diphyllin,,22055-22-7,COC1=C(C=C2C(=C1)C(=C3C(=C2O)COC3=O)C4=CC5=C(C=C4)OCO5)OC,
Isoschaftoside,,52012-29-0,C1[C@@H]([C@@H]([C@H]([C@@H](O1)C2=C(C(=C3C(=C2O)C(=O)C=C(O3)C4=CC=C(C=C4)O)[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O)O,
Catharanthine Tartrate(2468-21-5(free base)),,T2782L,CCC1=C[C@H]2C[C@]3([C@@H]1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC.C(C(C(=O)O)O)(C(=O)O)O,
Peretinoin,NIK333,81485-25-8,CC(=CCC/C(=C/CC/C(=C/C=C/C(=C/C(=O)O)/C)/C)/C)C,
Hexaminolevulinate hydrochloride,Hexyl 5-aminolevulinate hydrochloride; P-1206; 5-Aminolevulinic acid hexyl ester hydrochloride,140898-91-5,CCCCCCOC(=O)CCC(=O)CN.Cl,
Treosulfan,NSC 39069; Treosulphan,299-75-2,CS(=O)(=O)OC[C@@H]([C@H](COS(=O)(=O)C)O)O,
KKI-5 acetate(97145-43-2 free base),,TP1792L,CC([C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H]1CCCN1C(C)=O)=O)CC2=CC=CC=C2)=O)CCC/N=C(N)\N)=O)CO)=O)C(N[C@H](C(N)=O)CCC(N)=O)=O)C.CC(O)=O,
IMT1B,"3-Piperidinecarboxylic acid, 1-[(2R)-2-[[4-(2-chloro-4-fluorophenyl)-2-oxo-2H-1-benzopyran-7-yl]oxy]-1-oxopropyl]-, (3S)-; LDC203974",2304621-06-3,C[C@H](C(=O)N1CCC[C@@H](C1)C(=O)O)OC2=CC3=C(C=C2)C(=CC(=O)O3)C4=C(C=C(C=C4)F)Cl,
PIN1 inhibitor API-1,,680622-70-2,C1=CC(=CC=C1CNC(=O)C(F)(F)F)COC2=NC(=NC3=C2NC=N3)N,
Metyrosine,Î±-Methyltyrosine,672-87-7,C[C@](C(O)=O)(N)CC1=CC=C(O)C=C1,
Vindesine sulfate,Desacetyl Vinblastine amide; Desacetylvinblastine amide; DAVA; DVA; VDS,59917-39-4,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O.OS(=O)(=O)O,
Pamiparib,BGB-290; Pamiparib,1446261-44-4,C[C@]12CCCN1CC3=NNC(=O)C4=C5C3=C2NC5=CC(=C4)F,
PAR-2-IN-1,IUN76750; PAR-2-IN-1,1690176-75-0,CC(C)(C)C1=CC(=NN2C1=NC(=C2)C(=O)OC)Cl,
AMD 3465 hexahydrobromide,GENZ-644494 (hexahydrobromide),185991-07-5,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CNCC3=CC=CC=N3.Br.Br.Br.Br.Br.Br,
Abarelix,R3827; PPI 149,183552-38-7,C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C,
JNJ-63576253 free base,JNJ-63576253; TRC253,2110426-27-0,C1CC2(C1)C(=O)N(C(=S)N2C3=CN=C(C=C3)OC4CCNCC4)C5=CC(=C(N=C5)C#N)C(F)(F)F,
HS-1793,,927885-00-5,C1=CC2=C(C=CC(=C2)O)C=C1C3=C(C=C(C=C3)O)O,
Germinone A,"3-Methyl-5-((3-nitro-[1,1'-biphenyl]-4-yl)oxy)furan-2(5H)-one",T9007,O=C1OC(OC2=CC=C(C3=CC=CC=C3)C=C2[N+]([O-])=O)C=C1C,
EN4,EN4 MYC inhibitor; EN4,1197824-15-9,CCOC1=CC=C(C=C1)OC2=CC=CC=C2NC(=O)C3=CC=C(C=C3)CNC(=O)C=C,
Hirsutine,,7729-23-9,O=C(OC)/C([C@H]([C@H](CN1CC2)CC)C[C@]1([H])C3=C2C(C=CC=C4)=C4N3)=C/OC,
Ginsenoside Ra3,,90985-77-6,CC12C3(C(C(O)CC1C4(C(C(C)(C(OC5C(C(C(O)C(CO)O5)O)OC6OC(C(O)C(O)C6O)CO)CC4)C)CC2)C)C(C(CC/C=C(C)/C)(C)OC7OC(C(O)C(O)C7O)COC8C(C(C(O)C(CO)O8)OC9C(C(C(O)CO9)O)O)O)CC3)C,
5-Geranoxy-7-methoxycoumarin,,7380-39-4,CC(=CCCC(=CCOC1=CC(=CC2=C1C=CC(=O)O2)OC)C)C,
TJ191,,1522415-97-9,CCCCCCCC1=CC(C(OC)=O)=C(N)S1,
WM-3835,,2229025-70-9,O=C(NNS(=O)(=O)C=1C=CC=C(O)C1)C2=CC(=CC(=C2F)C)C=3C=CC=CC3,
Juglanin,,5041-67-8,O=C1C(O[C@H]2[C@@H]([C@H]([C@H](CO)O2)O)O)=C(C3=CC=C(O)C=C3)OC4=CC(O)=CC(O)=C14,
Imperialine 3-Î²-D-glucoside,Sipeimine-3-beta-D-glucoside,67968-40-5,[H][C@]12C[C@H](CC[C@@]1([C@]3(C[C@]4([C@@]5(CN6C[C@H](CC[C@]6([C@@](O)([C@@]5(CC[C@]4([C@@]3(CC2=O)[H])[H])[H])C)[H])C)[H])[H])[H])C)O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](O7)CO,
CC-885,,1010100-07-8,Cc(ccc(NC(NCc(cc1)cc(CN2C(CCC(N3)=O)C3=O)c1C2=O)=O)c1)c1Cl,
Yadanziolide A,,95258-14-3,C[C@]([C@@H](C[C@H]1OC([C@@H]2O)=O)C(C)=CC3=O)([C@@H]([C@H]([C@@H]([C@@]4(CO)OC5)O)O)[C@]15[C@@]24O)[C@@H]3O,
"7,3',4'-Tri-O-methylluteolin","5-Hydroxy-3',4',7-trimethoxyflavone; 7,3',4'-Tri-O-methylluteolin",29080-58-8,COc(cc1O)cc(OC(c(cc2)cc(OC)c2OC)=C2)c1C2=O,
Alloimperatorin,Prangenidin,642-05-7,CC(C)=CCc(c1c2occ1)c(C=CC(O1)=O)c1c2O,
Bacopasaponin C,,178064-13-6,CC(C)([C@H](CC1)[C@](C)(CC2)[C@@H](CC3)[C@]1(C)[C@@](C1)(CO[C@]11OC[C@H]4C=C(C)C)[C@H]3[C@H]1[C@@]4(C)O)[C@H]2O[C@@H]([C@@H]([C@H]1O[C@@H]([C@@H]([C@H]2O)O)O[C@H](CO)[C@H]2O)O[C@@H]([C@@H]2O)O[C@@H](CO)[C@@H]2O)OC[C@@H]1O,
3'-âO-âAcetylhamaudol,,30358-88-4,O=C1C(C(O)=C(C[C@H](OC(C)=O)C(C)(C)O2)C2=C3)=C3OC(C)=C1,
Gadopentetic acid,Gd-DTPA; gadolinium complex,80529-93-7,O=C1[O-][Gd+3]23([O-]C4=O)([O-]C5=O)([O-]C6=O)([N](CC[N]3(C5)C6)(C1)CC[N]2(C7)C4)[O-]C7=O.[H+].[H+],
"1,4-Anthraquinone",,635-12-1,O=C(C=C1)c2cc3ccccc3cc2C1=O,
Acridone,Acridone,578-95-0,O=C1c(cccc2)c2Nc2c1cccc2,
SCR130,"1,7,9-Triazaspiro[4.5]dec-1-ene-6,10-dione, 2,4-bis(4-chlorophenyl)-8-thioxo-",2377858-38-1,O=C(NC(NC1=O)=S)C21C(C3=CC=C(Cl)C=C3)CC(C4=CC=C(Cl)C=C4)=N2,
Procyanidin A2,,41743-41-3,O[C@H](C1)[C@@H](c(cc2)cc(O)c2O)Oc2c1c(O)cc1c2[C@H]([C@H]2O)c(c(O)cc(O)c3)c3O[C@@]2(c(cc2)cc(O)c2O)O1,
Persicogenin,,28590-40-1,O=C1C[C@@H](C2=CC=C(OC)C(O)=C2)OC3=CC(OC)=CC(O)=C13,
Pinostrobin,,480-37-5,COc1cc(O[C@@H](CC2=O)c3ccccc3)c2c(O)c1,
Phenyl-Î²-D-glucopyranoside,,1464-44-4,O[C@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)[C@@H]1OC2=CC=CC=C2,
S55746,BLC201,1448584-12-0,Oc(cc1)ccc1N(C(c1c(CCCC2)n2c(-c(cc2OCOc2c2)c2C(N(C2)[C@H](CN3CCOCC3)Cc3c2cccc3)=O)c1)=O)c1ccccc1,
UNC3230,UNC 3230,1031602-63-7,NC(c1c(NC(C2CCCCC2)=O)sc(Nc2ccccc2)n1)=O,
IACS-13909,IACS 13909,2160546-07-4,NC1(C)CCN(C2=CN=C3C(NN=C3C4=CC=CC(Cl)=C4Cl)=N2)CC1,
RS-25344 hydrochloride,RS 25344 hydrochloride,152815-28-6,O=C1N(C2=CC=CC([N+]([O-])=O)=C2)C3=NC=CC=C3C(N1CC4=CC=NC=C4)=O.[H]Cl,
USP7-IN-8,"Benzamide, 4-[6-amino-4-ethyl-5-(4-hydroxyphenyl)-3-pyridinyl]-N-methyl-; GNE-6776",2009273-60-1,O=C(NC)C1=CC=C(C2=C(CC)C(C3=CC=C(O)C=C3)=C(N)N=C2)C=C1,
AST5902 mesylate(2412155-74-7 free base),,2412155-75-8,OS(=O)(C)=O.C=CC(NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OCC(F)(F)F)N=C1N(C)CCNC)=O,
WSB1 Degrader 1,,2306039-66-5,NC1=NC(C2=CC=C(OC)C(C)=C2)=C(C3=CC=C(OC)C(C)=C3)C=C1,
Loureirin C,,116384-24-8,COc1c(CCC(c(cc2)ccc2O)=O)ccc(O)c1,
Tirabrutinib hydrochloride,ONO-4059 (hydrochloride); GS-4059 (hydrochloride),1439901-97-9,O=C1N(C2=CC=C(OC3=CC=CC=C3)C=C2)C4=C(N)N=CN=C4N1[C@H]5CN(C(C#CC)=O)CC5.[H]Cl,
Fatostatin,Fatostatin A; 125B11,125256-00-0,CCCC1=NC=CC(C2=NC(C3=CC=C(C)C=C3)=CS2)=C1,
PFI-90,"2-Pyridinecarboxylic acid, 2-(2-pyridinyl)hydrazide",53995-62-3,O=C(C1=NC=CC=C1)NNC2=NC=CC=C2,
Rapanone,"2,5-Dihydroxy-3-tridecylcyclohexa-2,5-diene-1,4-dione; 2,5-Dihydroxy-3-tridecyl-[1,4]benzoquinone",573-40-0,CCCCCCCCCCCCCC(C(C(O)=CC1=O)=O)=C1O,
"4-Amino-6-(trifluoromethyl)benzene-1,3-disulfonamide","4-Amino-6-(trifluoromethyl)benzene-1,3-d; 2,4-Disulfamyl-5-trifluoromethylaniline; 2-amino-4-trifluoromethyl-1,5-benzendisulfonamide",654-62-6,Nc(cc(C(F)(F)F)c(S(N)(=O)=O)c1)c1S(N)(=O)=O,
Eribulin mesylate,B1939 mesylate; E7389 mesylate; ER-086526 mesylate,441045-17-6,[H][C@@]12O[C@]3(CCC4CC(C[C@H]5[C@@H](O[C@@H]([C@@H]5OC)C[C@@H](CN)O)C[C@H]6O[C@@H](CC[C@@H]7O[C@@H](CC[C@@]89C[C@H]([C@@H]2O9)O[C@H]1[C@H]([C@]3(O4)[H])O8)CC7=C)C[C@H](C6=C)C)=O)[H].CS(=O)(O)=O,
Beta-mangostin,Î²-Mangostin,20931-37-7,CC(C)=CCc(c(O)c(c(Oc(cc1O)c2c(CC=C(C)C)c1OC)c1)C2=O)c1OC,
H3B-120,,2194903-42-7,O=C(N1CCC(C(NC2=NC(C)=CS2)=O)CC1)N(C)CC3=CC=CC=C3,
Ensartinib hydrochloride,Ensartinib dihydrochloride; X-396 dihydrochloride,2137030-98-7,Cl.Cl.CC1CN(CC(C)N1)C(=O)C2=CC=C(NC(=O)C3=NN=C(N)C(=C3)OC(C)C4=C(Cl)C(=CC=C4Cl)F)C=C2,
Lobaplatin,D-19466,135558-11-1,CC1[O-][Pt+2]2([NH2]CC3C(CC3)C[NH2]2)[O-]C1=O,
Menin-MLL inhibitor 20,,2448173-47-3,CC(C)(C)OC(N[C@H]1CN(Cc2cc(C(Nc(cc3)ccc3-c([nH]3)cc4c3ncnc4N3CCOCC3)=O)ncc2)CCC1)=O,
Microhelenin C,,63569-07-3,C[C@@H]([C@H]([C@@H](C[C@@H](C)[C@@H]([C@@]12C)C=CC1=O)O1)[C@@H]2OC(/C(/C)=C/C)=O)C1=O,
Mogroside I E1,,88901-39-7,C[C@]12[C@](CC=C3[C@@]2([H])CC[C@H](O[C@]4([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)CO)C3(C)C)([H])[C@]5([C@@](C)([C@]([C@H](C)CC[C@@H](O)C(C)(O)C)([H])CC5)C[C@H]1O)C,
N-Methylbenzamide,,613-93-4,O=C(NC)C1=CC=CC=C1,
DCH36_06,"DCH36_06Â ; (5E)-1-(3-chloro-4-methylphenyl)-5-[(2E)-3-(furan-2-yl)prop-2-en-1-ylidene]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione",593273-05-3,Cc(ccc(N(C(C(C(N1)=O)=CC=Cc2ccco2)=O)C1=S)c1)c1Cl,
ZZW-115 hydrochloride,,10122-45-9,FC(F)(F)C1=CC=C(SC2=C3C=CC=C2)C(N3CCCN4CCN(CC4)CCN(C)C)=C1.[H]Cl.[H]Cl.[H]Cl,
"2,4,6-Trihydroxybenzaldehyde",,487-70-7,Oc1cc(O)c(C=O)c(O)c1,
NBDHEX,,787634-60-0,[O-][N+](c(c1nonc11)ccc1SCCCCCCO)=O,
NIC3,,494830-67-0,CC(C)(C)c(cc1)ccc1OCC(NCCNC(COc1ccc(C(C)(C)C)cc1)=O)=O,
Pyrotinib dimaleate,SHR-1258 dimaleate,1397922-61-0,O=C(NC1=C(OCC)C=C2N=CC(C#N)=C(NC3=CC=C(OCC4=NC=CC=C4)C(Cl)=C3)C2=C1)/C=C/[C@@H]5N(C)CCC5.O=C(O)/C=C\C(O)=O.O=C(O)/C=C\C(O)=O,
Entasobulin,,501921-61-5,O=C(C(Nc1cc2cccnc2cc1)=O)c1cn(Cc(cc2)ccc2Cl)c2c1cccc2,
Tazemetostat hydrobromide,EPZ-6438 hydrobromide; E-7438 hydrobromide,1467052-75-0,O=C(C1=CC(C2=CC=C(CN3CCOCC3)C=C2)=CC(N(CC)C4CCOCC4)=C1C)NCC5=C(C)C=C(C)NC5=O.[H]Br,
Aniline mustard,Lymphocin; Mesylerythrol; NSC-18429,553-27-5,ClCCN(CCCl)c1ccccc1,
TP-064,TP 064; TP064,2080306-20-1,CNCCN(CC1)CCC1c1nccc(CN(C)C(c2cc(Oc3ccccc3)ccc2)=O)c1,
Niraparib tosylate monohyrate,,1613220-15-7,CC1=CC=C(S(=O)(O)=O)C=C1.O=C(N)C(C2=N3)=CC=CC2=CN3C(C=C4)=CC=C4[C@@H]5CCCNC5.O,
3-Isomangostin,,19275-46-8,CC(C)(CC1)Oc(cc2Oc(cc3O)c4c(CC=C(C)C)c3OC)c1c(O)c2C4=O,
PHYTOSPHINGOSINE,,554-62-1,CCCCCCCCCCCCCC[C@H]([C@H]([C@H](CO)N)O)O,
Phellamurin,,52589-11-4,CC(C)=CCc(c(O[C@@H]([C@H](C1=O)O)c(cc2)ccc2O)c1c(O)c1)c1O[C@@H]([C@@H]([C@H]1O)O)O[C@H](CO)[C@H]1O,
GNE-781,,1936422-33-1,CNC(N(CC1)Cc2c1n(C1CCOCC1)nc2N(CCCc1c2)c1cc(C(F)F)c2-c1cn(C)nc1)=O,
Deoxylapachol,,3568-90-9,CC(C)=CCC(C(c1c2cccc1)=O)=CC2=O,
SM-276001,,473930-22-2,CCCCNc(nc1N)nc(N2Cc3cnc(C)cc3)c1NC2=O,
Apomine,APB-231-A-2; SK&F-99085; SR-45023A; SR-9223i; APB-231-A2,126411-13-0,OC1=C(C=C(C=C1C(C)(C)C)CC(P(OC(C)C)(OC(C)C)=O)P(OC(C)C)(OC(C)C)=O)C(C)(C)C,
Telomerase-IN-2,Telomerase inhibitor 2,1610878-54-0,COc(cc1OC)cc(OC(c(cc2OC)cc(OC)c2OC)=C2OCCCCN(CC3)CCN3C(c3ccncc3)=O)c1C2=O,
Dalpiciclib,SHR-6390,1637781-04-4,CC(C1=C(C)c2cnc(Nc3ncc(C4CCNCC4)cc3)nc2N(C2CCCC2)C1=O)=O,
Deoxylimonin,desoxylimonin; NSC 314317,989-23-1,O=C1C[C@]([C@@]23CO1)([H])OC(C)(C)[C@]2([H])CC([C@]4(C)[C@]3([H])CC[C@]([C@H](C5=COC=C5)O6)(C)C4=CC6=O)=O,
(Rac)-Idroxioleic acid,Minerval; 2-Hydroxyoleic acid; 2-OHOA; (Rac)-Idroxioleic acid,56472-29-8,CCCCCCCC/C=C\CCCCCCC(C(O)=O)O,
Pentamidine dihydrochloride,MP-601205 dihydrochloride,50357-45-4,NC(c(cc1)ccc1OCCCCCOc(cc1)ccc1C(N)=N)=N.Cl.Cl,
Coralyne chloride,,38989-38-7,CC1=C2C=C(OC)C(OC)=CC2=CC3=C4C=C(OC)C(OC)=CC4=CC=[N+]13.[Cl-],
M2N12,,2376577-06-7,Cc1ccc(Cn2nnc(CNC(C(c(nccc3)c3C3=O)=O)=C3Cl)c2)cc1,
10074-A4,,312631-87-1,OC(CN(C(CS1)=O)C1=O)Cn1c(ccc(Cl)c2)c2c2c1ccc(Cl)c2,
CB-6644,,2316817-88-4,CCOc(c(C(NCC(C)(C)CC(NC(C1=O)=C(COC)N(CCC2)N1c1c2cccc1)=O)=O)c1)cc(F)c1Cl,
CP-609754,OSI-754,1190094-64-4,Cn1c([C@@](c(cc2)ccc2Cl)(c(cc2)cc(C(c3cc(C#C)ccc3)=C3)c2N(C)C3=O)O)cnc1,
1A-116,,1430208-73-3,Cc1cc(NC(Nc2c(C(F)(F)F)cccc2)=N)cc(C)c1,
TMPyP4 tosylate,TMP 1363,36951-72-1,C[N+]1=CC=C(/C2=C3C=CC(/C(C4=CC=[N+](C)C=C4)=C5C=C/C(N/5)=C(C6=CC=[N+](C)C=C6)/C(C=C/7)=NC7=C(C8=CC=[N+](C)C=C8)/C9=CC=C2N9)=N\3)C=C1.O=S(C%10=CC=C(C)C=C%10)([O-])=O.O=S(C%11=CC=C(C)C=C%11)([O-])=O.O=S(C%12=CC=C(C)C=C%12)([O-])=O.O=S(C%13=CC=C(C)C=C%13)([O-])=O,
Belzutifan,MK-6482; PT2977,1672668-24-4,CS(c(cc1)c([C@@H]([C@@H]([C@@H]2F)F)O)c2c1Oc1cc(F)cc(C#N)c1)(=O)=O,
MP07-66,,1938056-90-6,CCCCCCOc1ccc(CNCC(OCC)OCC)cc1,
CK2 inhibitor 2,,2641079-92-5,O=C(NCCO)C=1C=CC2=C(N=C(NC=3C=CC=C(Cl)C3)C=4C=CN=CC24)C1,
WAY-309060,,309951-18-6,Cc1cc(NC(c(cc2)cc(OC)c2OC)=O)no1,
S-trityl-L-Cysteine,H-CYS(TRT)-OH,2799-07-7,N[C@@H](CSC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)C(O)=O,
2-Hydroxyanthraquinone,,605-32-3,Oc(cc1)cc(C(c2c3cccc2)=O)c1C3=O,
Mogroside IIe,,88901-38-6,CC1(C)[C@@H](O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O)CC[C@@]3([H])[C@]4(C)[C@H](O)C[C@]5(C)[C@@H]([C@H](C)CC[C@@H](O[C@H]6[C@@H]([C@H]([C@@H]([C@@H](CO)O6)O)O)O)C(C)(O)C)CC[C@](C)5[C@]4([H])CC=C13,
Carabrone,,1748-81-8,C[C@]1(C[C@H]([C@H](C2)C3=C)OC3=O)[C@@H]2[C@@H]1CCC(C)=O,
Platycodin D2,,66663-90-9,C[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3[C@H](O)[C@](CO)(O)CO3)[C@H](O)CO2)[C@@H](O)[C@@H](O)[C@H](O[C@@H]4[C@@H](O)[C@@H](O)CO[C@H]4OC([C@]56CCC(C)(C)C[C@H]5C7=CC[C@H]8[C@](CC[C@@H]9[C@]8(C)C[C@H](O)[C@H](O[C@H]%10[C@H](O)[C@@H](O[C@H]%11[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O%11)[C@H](O)[C@@H](CO)O%10)C9(CO)CO)(C)[C@]7(C)C[C@H]6O)=O)O1,
Calmidazolium chloride,R 24571,57265-65-3,ClC1=CC=C(COC(C2=CC=C(Cl)C=C2Cl)CN3C=[N+](C(C4=CC=C(Cl)C=C4)C5=CC=C(Cl)C=C5)C=C3)C(Cl)=C1.[Cl-],
ISA-2011B,,1395347-24-6,CN(CC(N([C@H]1C2)[C@H](c3c[nH]c(cc4)c3cc4Cl)c3c2cc2OCOc2c3)=O)C1=O,
Questiomycin A,3-aminophenoxazone,1916-59-2,NC1=CC2=Nc(cccc3)c3OC2=CC1=O,
Î±-Tocotrienol,D-ALPHA-TOCOTRIENOL,58864-81-6,C[C@@](CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C)(CC1)Oc(c(C)c2C)c1c(C)c2O,
RAGE antagonist peptide acetate,,TP1935L1,CC(O)=O.CSCC[C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CC(C)C)=O)CCC(O)=O)=O)CCCCN)=O)CCC(O)=O)=O)NC([C@@H](NC([C@H](C(C)C)NC([C@@H](NC([C@@H](NC([C@@H](NC(C)=O)CCC(O)=O)=O)CC(C)C)=O)CCCCN)=O)=O)CC(C)C)=O,
Proteasome inhibitor IX,PS-IX; AM114,856849-35-9,O=C(/C(CN(C)C/1)=C\C2=CC=C(B(O)O)C=C2)C1=C/C3=CC=C(B(O)O)C=C3,
Allyl Methyl Sulfide,,10152-76-8,CSCC=C,
Primin,,15121-94-5,CCCCCC(C(C(OC)=C1)=O)=CC1=O,
Nandrolone acetate,19-Nortestosterone 17Î²-acetate,1425-10-1,C[C@](CC1)([C@@H](CC2)[C@H](CC3)[C@H]1[C@@H](CC1)C3=CC1=O)[C@H]2OC(C)=O,
Methyl propyl disulfide,,2179-60-4,CCCSSC,
Î-Stat,NSC37044,3316-02-7,OC1=C2C(S(=O)(O)=O)=CC(S(=O)(O)=O)=CC2=CC(S(=O)(O)=O)=C1,
Sodium Camptothecin,,25387-67-1,O=C(O)[C@](O)(CC)C1=C(CO)C(N2CC3=CC4=CC=CC=C4N=C3C2=C1)=O.[Na+],
Tiazofurin,NSC 286193; Riboxamide,60084-10-8,NC(c1csc([C@@H]([C@@H]2O)O[C@H](CO)[C@H]2O)n1)=O,
BI-3802,,2166387-65-9,C[C@H](C[C@H](C)C1)CN1c(nc1)nc(Nc(cc2)cc(C=C3OCC(NC)=O)c2N(C)C3=O)c1Cl,
K145 hydrochloride,,1449240-68-9,O=C(N(CCN)C/1=O)SC1=C/CCC2=CC=C(OCCCC)C=C2.[H]Cl,
AAPK-25,,2247919-28-2,O=C(c1ccc(cc(cc2)NC(c(cc3)cc(Cl)c3Cl)=O)c2c1)Nc1nccs1,
GSK-3484862,,2170136-65-7,CCc(c(C#N)c(N(C)C)nc1S[C@@H](C(N)=O)c2ccccc2)c1C#N,
10-Methoxycamptothecin,,19685-10-0,CC[C@](C(C=C1N2Cc3cc4cc(OC)ccc4nc13)=C(CO1)C2=O)(C1=O)O,
iGOT1-01,,882256-55-5,O=C(N1CCN(C2=CC=CC3=C2C=CN3)CC1)NC4=CC=CC=C4,
Vidarabine phosphate,Ara-AMP,29984-33-6,Nc1c2ncn([C@@H]([C@H]3O)O[C@H](COP(O)(O)=O)[C@H]3O)c2ncn1,
Pirtobrutinib,LOXO-305,2101700-15-4,C[C@@H](C(F)(F)F)n(c(N)c1C(N)=O)nc1-c1ccc(CNC(c(cc(cc2)F)c2OC)=O)cc1,
"D-Saccharic acid 1,4-lactone hydrate",,61278-30-6,CC(C)(CCC1=Cc(cc2)ccc2Cl)C1(Cn1ncnc1)O,
CHM-1,NSC656158,154554-41-3,O=C1c(cc2OCOc2c2)c2NC(c(cccc2)c2F)=C1,
GO-203 acetate,GO-203 acetate (1222186-26-6 Free base),T35351L,NCCCC[C@@H](NC([C@H](NC([C@H](NC([C@H](NC([C@H](NC([C@H](NC([C@H](NC([C@H](NC([C@H](NC([C@H](NC([C@H](NC([C@H](NC([C@H](NC([C@H](NC([C@H](N)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CS)=O)CCC(N)=O)=O)CS)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)C(N[C@@H](C(O)=O)CC(N)=O)=O.O=C(O)C(F)(F)F.CC(O)=O,
RD162,,915087-27-3,CNC(c(ccc(N(C1(CCC1)C(N1c(cc2)cc(C(F)(F)F)c2C#N)=O)C1=S)c1)c1F)=O,
Quercetin pentaacetate,Pentaacetylquercetin,1064-06-8,CC(Oc(cc1OC(C)=O)cc(OC(c(cc2)cc(OC(C)=O)c2OC(C)=O)=C2OC(C)=O)c1C2=O)=O,
WAY-345989,,612829-80-8,NC(c1c(NC(C2CCC2)=O)sc2c1CCCC2)=O,
JAMM protein inhibitor 2Â ,"Acetamide, 2-(2-ethylphenoxy)-N-[2-methyl-4-(1-pyrrolidinyl)phenyl]-",848249-35-4,CCc(cccc1)c1OCC(Nc(cc1)c(C)cc1N1CCCC1)=O,
HIF1-IN-3Â ,"Benzenepropanamide, N-[(8-hydroxy-7-quinolinyl)(4-methoxyphenyl)methyl]-",333314-79-7,COc1ccc(C(c(ccc2cccnc22)c2O)NC(CCc2ccccc2)=O)cc1,
7-Troc-paclitaxel,7 Troc paclitaxel,114915-17-2,CC(C)([C@@](C1)([C@H]([C@H]([C@]2([C@@H](C[C@@H]3OC(OCC(Cl)(Cl)Cl)=O)OC2)OC(C)=O)[C@]3(C)C([C@@H]2OC(C)=O)=O)OC(c3ccccc3)=O)O)C2=C(C)[C@H]1OC([C@@H]([C@H](c1ccccc1)NC(c1ccccc1)=O)O)=O,
2-Fluoroadenine,NSC 27364;2- Fluoro-6-Aminopurine,700-49-2,Nc1c2nc[nH]c2nc(F)n1,
Borofalan(10B),L-4-Boronophenylalanine,80994-59-8,O=C(O)[C@@H](N)CC1=CC=C(B(O)O)C=C1,
Physcion 8-O-Î²-D-glucopyranoside,Physcion 8-O-beta-D-monoglucoside,23451-01-6,O=C(C1=C2C=C(OC)C=C1O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)C4=C(C2=O)C=C(C)C=C4O,
AMRI-59,AMRI 59; AMRI59,923515-92-8,O=C(N1CCC(CC2=CC=C(N3C=CC=C3)C=C2)CC1)NC4=CC=CC(C(C)=O)=C4,
AUNP-12 acetate,AUNP-12 acetate (1353563-85-5 Free base),TP1076L,O=C([C@@](C([H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H])([H])N([H])C([C@](C([H])([H])[H])([H])N([H])C([C@@](C([H])([H])C([H])([H])C(N([H])[H])=O)([H])N([H])C([C@@]([C@@](C([H])([H])[H])([H])C([H])([H])C([H])([H])[H])([H])N([H])C([C@@](C([H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H])([H])N([H])C([C@@](C([H])([H])C([H])([H])C(O[H])=O)([H])N([H])N([H])[H])=O)=O)=O)=O)=O)N1[C@@](C(N([H])[C@](C(C([C@@](C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H])([H])N([H])C([C@@](C([H])([H])C([H])([H])C(N([H])[H])=O)([H])N([H])C([C@@]([C@@](C([H])([H])[H])([H])O[H])([H])N([H])C([C@@](C(C([H])([H])[H])([H])C([H])([H])[H])([H])N([H])C([C@@](C([H])([H])C([H])([H])C([H])([H])N([H])/C(N([H])[H])=N/[H])([H])N([H])C([C@@](C([H])([H])C2=C([H])C([H])=C([H])C([H])=C2[H])([H])N([H])C(C(C([H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])N([H])[C@@](C(N([H])[C@](C([H])([H])O[H])([H])C(N([H])[C@@](C(N([H])[C@](C([H])([H])O[H])([H])C(N([H])[C@@](C(N([H])[C@@](C(N([H])[C@@](C([H])=O)([H])C([H])([H])O[H])=O)([H])C([H])([H])C(N([H])[H])=O)=O)([H])[C@@](C([H])([H])[H])([H])O[H])=O)=O)([H])C([H])([H])C([H])([H])C(O[H])=O)=O)=O)([H])C([H])([H])C3=C([H])C([H])=C([H])C([H])=C3[H])([H])N([H])C([C@@](C([H])([H])C4=C([H])C([H])=C([H])C([H])=C4[H])([H])N([H])C([C@@](C([H])([H])O[H])([H])N([H])C([C@@](C([H])([H])C([H])([H])C(O[H])=O)([H])N([H])C([C@@](C([H])([H])O[H])([H])N([H])C([C@@]([C@@](C([H])([H])[H])([H])O[H])([H])N([H])C([C@@](C([H])([H])C(N([H])[H])=O)([H])N([H])C([C@@](C([H])([H])O[H])([H])N([H])[H])=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)([H])C([H])([H])[H])=O)([H])C([H])([H])C([H])([H])C1([H])[H].CC(O)=O,
Tubulin inhibitor 24,,2415761-65-6,COC(C(OC)=C1)=C(OC)C=C1C2=CC=NC3=CC(C4=CC=C(C)C=C4)=NN32,
Caracemide,NSC-253272,81424-67-1,OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1Oc(cc1O)cc(OC(c2ccccc2)=C2)c1C2=O,
Vincristine,,57-22-7,CC[C@](C[C@@H](C1)C[C@]2(C(OC)=O)c(cc([C@](CC3)([C@H]4N3CC=C[C@@]4(CC)[C@H]([C@@]3(C(OC)=O)O)OC(C)=O)[C@H]3N3C=O)c3c3)c3OC)(CN1CCc1c2[nH]c2c1cccc2)O,
Lophine,"NSC 62790; NSC-62790; NSC62790; 2,4,5-Triphenylimidazole",484-47-9,c(cc1)ccc1-c1c(-c2ccccc2)nc(-c2ccccc2)[nH]1,
Tiomolibdate diammonium,Ammonium molybdenum sulfide; Ammonium tetrathiomolybdate; ATTM; Coprexa; NSC 286644,15060-55-6,S=[Mo]([S-])([S-])=S.[NH4+].[NH4+],
WAY-620645,,742116-45-6,CC1=C(NC(=O)CCC2=CNC3=CC=CC=C23)C(=O)N(C2=CC=CC=C2)N1C,
"Benzamide, N-(3-imidazo[2,1-b]thiazol-6-ylphenyl)-2-methoxy","N-(3-(imidazo[2,1-b]thiazol-6-yl)phenyl)-2-methoxybenzamide",667910-69-2,O=C(NC1=CC=CC(C2=CN3C(SC=C3)=N2)=C1)C4=CC=CC=C4OC,
WAY-272077,,1415662-57-5,COC1=C(OC)C=CC(/C=C/C(NC2=NC=CS2)=O)=C1,
"4H-1,2,4-Triazole, 3-(phenoxymethyl)-4-phenyl-5-[(phenylmethyl)thio]-",,129544-85-0,C(c(n1-c2ccccc2)nnc1SCc1ccccc1)Oc1ccccc1,
IPR-803,,892243-35-5,OC(c1cccc(Nc(cc(c2noc(-c3c4cccc3)c22)N3CCCCCC3)c2C4=O)c1)=O,
Ethyl 2-amino-4-methyl-5-[(3-nitrophenyl)carbamoyl]thiophene-3-carboxylate,DC-S239,303141-21-1,CCOC(c1c(N)sc(C(Nc2cc([N+]([O-])=O)ccc2)=O)c1C)=O,
ROC-325,,1859141-26-6,O=C1C=2C=CC=CC2SC=3C(=CC=C(NCCN(C)CCNC=4C=CN=C5C=C(Cl)C=CC54)C13)C,
WAY-324820-A,,7471-12-7,N=1C=CC=CC1C2=NC=3C=C(C=CC3N2)C,
WAY-604116,,121768-39-6,O=C(NCC=1C=CN=CC1)C23CC4CC(CC(C4)C2)C3,
Premarin,Estrone 3-sulfate; Estrone sulfate,481-97-0,C[C@@]12[C@]([C@]3([C@@](C=4C(CC3)=CC(OS(=O)(=O)O)=CC4)(CC1)[H])[H])(CCC2=O)[H],
Piperafizine A,,130603-59-7,C(=C/1\N(C)C(=O)\C(=C\C2=CC=CC=C2)\NC1=O)\C3=CC=CC=C3,
NSC2805,"2-(2,5-dihydroxy-4-methylphenyl)-5-methylbenzene-1,4-diol",4371-34-0,OC1=CC(=C(O)C=C1C=2C=C(O)C(=CC2O)C)C,
DRB18,,T22317,CC1=C(C=C(C=C1)CNC2=C(C=C(C=C2)Cl)NCC3=CC(=C(C=C3)C)O)O,
ErSO,,2407860-35-7,O=C1[C@@](C=2C(N1)=C(C(F)(F)F)C=CC2)(C3=CC=C(OC(F)(F)F)C=C3)C4=CC=C(O)C=C4,
YS-370,,2470908-79-1,BrC=1C=CC=CC1CN2C=3C=CC=CC3C(C=4N=CN=C5C=C(OC)C(OCCCN6CCOCC6)=CC54)=C2C=7C=CC=CC7,
AFMK,Acetyl-N-formyl-5-methoxykynurenamine; Formyl-N-acetyl-5-methoxykynurenamine,52450-38-1,O=CNC1=CC=C(OC)C=C1C(=O)CCNC(=O)C,
Ceranib-2,3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-4-phenyl-1H-quinolin-2-one,1402830-75-4,O=C(C=CC1=CC=C(OC)C=C1)C=2C(=O)NC=3C=CC=CC3C2C=4C=CC=CC4,
Adenosine Dialdehyde (ADOX),"Adenox; Adenosine, periodate oxidized; Periodate-oxidized adenosine; Adenosinedialdehyde",34240-05-6,O=C[C@@H](O[C@@H](N(C=N1)C2=C1C(N)=NC=N2)C=O)CO,
DB2313,Carboximidamide,2170606-74-1,CC(N=C(N)C1=CC2=C(N=C(C3=CC=C(OCC4=C(F)C(COC5=CC=C(C6=NC7=C(C=C(C(N)=NC(C)C)C=C7)N6)C=C5)=CC=C4)C=C3)N2)C=C1)C,
Enpp-1-IN-14,,2687222-59-7,COC1=CC2=NC=NC(N3CCN(S(N)(=O)=O)CCC3)=C2C=C1OC.Cl,
SHMT-IN-1,,1508286-18-7,N#CC1=C(OC=2NN=C(C2C1(C=3C=C(Cl)C=C(Cl)C3)C4CCC4)C)N,
PCC0208017,,2623158-64-3,FC(F)(F)C1=CN=C(N=C1NCC2=NNC=C2)NC3=CC=C4C(=C3)CCN(C)C4,
Alpha-Amyrone,Urs-12-en-3-one; Alfa-Amyrenone,638-96-0,C[C@]12[C@@]3(C)C([C@]4([C@@](C)(CC3)CC[C@@H](C)[C@@H]4C)[H])=CC[C@@]1([C@]5(C)[C@@](CC2)(C(C)(C)C(=O)CC5)[H])[H],
FT001,,1778655-51-8,C(=O)(N1C=2C(N(C(C)=O)[C@@H](C)C1)=CC=C(C2)C3=CC=C(C=C3)N4CCS(=O)(=O)CC4)C5CC5,
TD52 dihydrochloride,TD52 dihydrochloride(1798328-24-1 Free base); TD52 2HCl,T35528L,C#CC1=CC=CC(NC2=NC3=C(N=C2NC4=CC(C#C)=CC=C4)C=CC=C3)=C1.Cl.Cl,
EMT inhibitor-1,,1638526-21-2,ClC1=CC=C(C=C1Cl)C2=NSN=C2OCCCCO,
Eubulus-A80,,2703776-20-7,O=C(C#C)N(C=1C=CC=C(Cl)C1)C2(C(=O)NCC=3C=CC=CC3)CCOCC2,
CCT241161,,1163719-91-2,O=C1C=NC=2C(OC3=CC=C(NC(=O)NC4=CC(=NN4C=5C=CC=CC5)C(C)(C)C)C(SC)=C3)=CC=NC2N1,
Tilfrinib,,1600515-49-8,OC1=CC=CC(=C1)NC2=CC=NC=3NC=4C=CC=CC4C32,
PKUMDL-WQ-2101,,304481-72-9,O=C(NN=CC1=CC(=CC=C1O)N(=O)=O)C2=CC=C(O)C=C2O,
OXFBD04,,2231747-03-6,OC=1C=C(C=C(C1)C(O)C=2C=NC=CC2)C=3C(=NOC3C)C,
M7594_0037,M7594-0037;M7594 0037;M75940037,774551-07-4,O=C(N)COC1=C(Cl)C=C(C=C1OC)CNCCC2=CNC=3C=CC=CC32,
Phortress,,328087-38-3,CC1=C(NC([C@@H](N)CCCCN)=O)C=CC(C2=NC3=CC(F)=CC=C3S2)=C1.Cl.Cl,
NSC697923,2-[(4-methylphenyl)sulfonyl]-5-nitrofuran,343351-67-7,O=[N+](C1=CC=C(S(=O)(C2=CC=C(C)C=C2)=O)O1)[O-],
YAP/TAZ inhibitor-2Â ,,2762617-31-0,O=C(C(F)=C)N1CC(N2N=C(C=3C=CC(=CC3)C(F)(F)F)C=4C=CC=NC42)C1,
ROS kinases-IN-1,,370096-57-4,O=C1NN=C(C1=CC2=CN(N=C2C=3C=CC=CC3)C=4C=CC=CC4)C,
Thiodigalactoside,,51555-87-4,S([C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O,
Tirabrutinib,ONO-4059;GS-4059;Velexbru,1351636-18-4,NC1=C2C(N(C(=O)N2C3=CC=C(OC4=CC=CC=C4)C=C3)[C@H]5CN(C(C#CC)=O)CC5)=NC=N1,
Dasatinib hydrochloride,BMS-354825 HCl,854001-07-3,Cl.O=C(NC=1C(Cl)=CC=CC1C)C=2SC(=NC2)NC=3N=C(N=C(C3)N4CCN(CCO)CC4)C,
3-Methylcarbazole,NSC 10154,4630-20-0,C=1C=CC2=C(C1)NC=3C=CC(=CC32)C,
Cytarabine hydrochloride,Ara-C hydrochloride;Cytosine Arabinoside hydrochloride,69-74-9,O[C@@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(=O)N=C(N)C=C2.Cl,
EEDi-5285,EEDI5285;UM-EEDi-5285,2488952-40-3,O=S(=O)(C=1N=CN2C(=NC=C(C=3C=NC(=CC3)C4CC4)C12)NCC=5C(F)=CC=C6OCCC65)C,
RP-6685,,2832047-80-8,O=C(N(C1=CC=C(F)C=C1)CC#CC2=NN=C(N)C=C2)CC3=NC=C(C=C3C(F)(F)F)C(F)(F)F,
WAY-313137,Antiproliferative agent-16,15641-17-5,O=C(N/N=C/C1=CNC2=CC=CC=C12)CC3=CC=CC=C3,
Resistomycin,Heliomycin;Geliomycin,20004-62-0,O=C1C2=C(O)C=C(O)C=3C(=O)C(C=4C=C(O)C=5C(=C1C(O)=CC5C)C4C23)(C)C,
PBRM1-BD2-IN-3,,2819989-58-5,O=C1NC(NC=2C=CC=C(Cl)C12)C=3C=CC=CC3,
PBRM1-BD2-IN-5,,2819989-61-0,O=C1NC(NC=2C=CC=C(Cl)C12)C=3C=CC=C(C3)C,
PBRM1-BD2-IN-8,,2819989-75-6,O=C1NC(NC=2C=CC=C(Br)C12)C=3C=CC=C(C3)C,
Sunvozertinib,DZD9008; DZD 9008; DZD-9008,2370013-12-8,N(C(C=C)=O)C1=C(C=C(OC)C(NC=2N=C(NC3=C(C(C)(C)O)C=C(F)C(Cl)=C3)C=CN2)=C1)N4C[C@H](N(C)C)CC4,
Mopidamol,Rapenton; RA 233; RA-233; RA233; OLX 102,13665-88-8,OCCN(C1=NC=C2N=C(N=C(C2=N1)N3CCCCC3)N(CCO)CCO)CCO,
Ziprasidone hydrochloride,CP-88059 hydrochloride; Ziprasidone HCl; CP-88059,122883-93-6,Clc1c(cc2CC(=O)Nc2c1)CCN1CCN(c2nsc3ccccc23)CC1.Cl,
Ziprasidone,CP-88059; Geodon; Zeldox,146939-27-7,Clc1c(cc2CC(=O)Nc2c1)CCN1CCN(c2nsc3ccccc23)CC1,
Doxapram hydrochloride hydrate,Doxapram hydrochloride monohydrate; Doxapram hydrochloride hydrate; Doxapram HCl,7081-53-0,O.Cl.CCN1CC(CCN2CCOCC2)C(C1=O)(c1ccccc1)c1ccccc1,
MRT67307,MRT67307 HCl,1190378-57-4,O=C(NCCCNc1nc(Nc2cccc(CN3CCOCC3)c2)ncc1C1CC1)C1CCC1,
Efloxate,Angorlisin,119-41-5,CCOC(=O)COc1cc2c(cc1)c(=O)cc(o2)c1ccccc1,
Quetiapine,Quetiapin; ICI204636; Quetiapine,111974-69-7,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,
Tetrahydroxyquinone,"Tetroquinone; Tetrahydroxybenzoquinone; Tetrahydroxy-1,4-benzoquinone; Tetrahydroxyquinone; Tetrahydroxy-1; 4-benzoquinone",319-89-1,OC1=C(O)C(=O)C(O)=C(O)C1=O,
Amlodipine Besylate,Amlodipine benzenesulfonate,111470-99-6,OS(=O)(=O)c1ccccc1.CCOC(=O)C1=C(COCCN)NC(=C(C1c1ccccc1Cl)C(=O)OC)C,
Hydrocortisone Valerate,Westcort,57524-89-7,CCCCC(=O)O[C@@]1(CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C)C(=O)CO,
Q-VD-OPH,Quinoline-Val-Asp-Difluorophenoxymethylketone,1135695-98-5,C(=O)(C[C@@H](C(=O)COc1c(cccc1F)F)NC(=O)[C@H](C(C)C)NC(=O)c1nc2c(cc1)cccc2)O,
6Î±-Methylprednisolone 21-hemisuccinate sodium salt,Methylprodnisolone Sodium Succinate; 6-Methylprednisolone succinate sodium; Methylprednisolone sodium succinate; Asmacortone; Metypresol; Corticel,2375-03-3,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]2(C1=CC(=O)C=C2)C)O)C)(C(=O)COC(=O)CCC(=O)[O-])O.[Na+],
Estradiol benzoate,Benzhormovarine; Benzoestrofol; Benovocylin,50-50-0,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)c5ccccc5)ccc34)[C@@H]1CC[C@@H]2O,
Ropivacaine,LEA-103 HCl,84057-95-4,CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C,
Allylthiourea,N-Allylthiourea; Thiosinamine,109-57-9,NC(=S)NCC=C,
Deracoxib,SC 46; SC 59046; SC 046,169590-41-4,COc1c(F)cc(cc1)c1cc(nn1c1ccc(cc1)S(=O)(=O)N)C(F)F,
6-Methoxy-2-naphthoic acid,Naproxen impurity O; 6-Methoxy-2-naphthalenecarboxylic acid,2471-70-7,COC1=CC2=C(C=C1)C=C(C=C2)C(=O)O,
XCT790,,725247-18-7,COc1c(ccc(c1)/C=C(\C#N)/C(=O)Nc1nnc(s1)C(F)(F)F)OCc1c(cc(cc1)C(F)(F)F)C(F)(F)F,
Phthalic acid mono-2-ethylhexyl ester,Phthalic Acid Monooctyl Ester,4376-20-9,CCCCC(CC)COC(=O)c1ccccc1C(=O)O,
Benzyl butyl phthalate,"Butyl benzyl phthalate; BBP; 1,2-benzenedicarboxylic acid; butyl phenylmethyl ester",85-68-7,CCCCOC(=O)C1=CC=CC=C1C(=O)OCC1=CC=CC=C1,
Beta-Tetralone,2-Tetralone,530-93-8,O=C1CCc2ccccc2C1,
2-Bromo-6-methoxynaphthalene,,5111-65-9,COc1cc2c(cc1)cc(Br)cc2,
Ascorbyl palmitate,L-Ascorbyl 6-palmitate; 6-O-Palmitoyl-L-ascorbic acid; Ascorbyl palmitate; L-Ascorbic acid 6-hexadecanoate,137-66-6,CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O,
Butylhydroxyanisole,Butylated hydroxyanisole; BHA; E320; Butylhydroxyanisole,25013-16-5,COc1ccc(O)c(c1)C(C)(C)C.COc1ccc(O)cc1C(C)(C)C,
Propoxur,Baygon; Aprocarb; Propoxure,114-26-1,CNC(=O)Oc1ccccc1OC(C)C,
Retinyl palmitate,Vitamin A palmitate; Retinyl palmitate; Retinol palmitate; Retinyl (Vitamin A) Palmitate,79-81-2,C1(=C(CCCC1(C)C)C)/C=C/C(=C/C=C/C(=C/COC(=O)CCCCCCCCCCCCCCC)/C)/C,
Lidocaine Hydrochloride hydrate,,6108-05-0,c1(NC(=O)CN(CC)CC)c(cccc1C)C.Cl.O,
2-Benzothiazolamine,2-Aminobenzothiazole,136-95-8,Nc1nc2ccccc2s1,
5-Fluorouridine,,316-46-1,[C@H]1(n2c(=O)[nH]c(=O)c(c2)F)[C@@H]([C@@H]([C@H](O1)CO)O)O,
2-Amino-5-methyl-3-thiophenecarbonitrile,,138564-58-6,CC1=CC(C#N)=C(N)S1,
Fluorescein,Resorcinol phthalein; Solvent Yellow 94; Yellow fluorescein,2321-07-5,Oc1ccc2c(Oc3cc(O)ccc3C22OC(=O)c3ccccc23)c1,
3-Methylsalicylic acid,Hydroxytoluic acid; 3-Methylsalicylic acid; o-Cresotic acid,83-40-9,c1(c(c(ccc1)C)O)C(=O)O,
BH3I-1,BH3I1; BH3I 1; BH3I-1; BHI1,300817-68-9,CC(C)C(N1C(=S)SC(=Cc2ccc(Br)cc2)C1=O)C(O)=O,
Xylazine hydrochloride,BAY 1470 hydrochloride; Xylazine HCl,23076-35-9,Cl.Cc1cccc(C)c1NC1=NCCCS1,
Rosuvastatin calcium,ZD 4522 Calcium; Rosuvastatin hemicalcium; ZD4522,147098-20-2,[Ca++].CC(C)c1nc(nc(-c2ccc(F)cc2)c1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)N(C)S(C)(=O)=O.CC(C)c1nc(nc(-c2ccc(F)cc2)c1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)N(C)S(C)(=O)=O,
Mitiglinide calcium hydrate,Mitiglinide calcium dihydrate; S-21403 calcium hydrate; KAD-1229 calcium hydrate; Mitiglinide calcium hydrate,207844-01-7,[Ca+2].C(=O)([C@H](CC(=O)N1C[C@@H]2[C@H](C1)CCCC2)Cc1ccccc1)[O-].O.C(=O)([C@H](CC(=O)N1C[C@@H]2[C@H](C1)CCCC2)Cc1ccccc1)[O-].O,
Levamlodipine,(S)-Amlodipine; Levamlodipine; S-amlodipine,103129-82-4,C1(=C(NC(=C([C@H]1c1c(Cl)cccc1)C(=O)OCC)COCCN)C)C(=O)OC,
Naproxen sodium,RS-3650; Naprelan; Anaprox; Miranax,26159-34-2,c12c(cc(cc2)OC)ccc(c1)[C@@H](C(=O)[O-])C.[Na+],
Deoxythymidine triphosphate,,18423-43-3,[Na+].[Na+].[Na+].Cc1cn([C@H]2C[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)O2)c(=O)[nH]c1=O,
Actriol,Epiestriol,547-81-9,[C@@]12([C@@H](C[C@@H]([C@@H]1O)O)[C@@H]1CCc3cc(ccc3[C@H]1CC2)O)C,
Doxycycline,Vibramycin; Doxytetracycline; Doxiciclina; Doxycyclinum,564-25-0,[C@@H]12[C@](C(=C3[C@H]([C@@H]2O)[C@H](c2c(C3=O)c(ccc2)O)C)O)(C(=O)C(=C([C@H]1N(C)C)O)C(=O)N)O,
2-(1-Piperazinyl)pyrimidine,,20980-22-7,C1CN(CCN1)c1ncccn1,
5-Amino-3H-imidazole-4-Carboxamide,4-Amino-5-imidazolecarboxamide; AICA; 5-Amino-3H-imidazole-4-Carboxamide; 5-Aminoimidazole-4-carboxamide,360-97-4,NC(=O)c1[nH]cnc1N,
TAME hydrochloride,TOS-ARG-OME hydrochloride; TAME hydrochloride; Tos-Arg-OMe HCl,1784-03-8,Cl.COC(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)c1ccc(C)cc1,
WZ811,,55778-02-4,C(Nc1ccccn1)c1ccc(CNc2ccccn2)cc1,
Kartogenin,KGN,4727-31-5,C(=O)(c1c(cccc1)C(=O)Nc1ccc(cc1)c1ccccc1)O,
AL 082D06,AL082D06; D-06,256925-03-8,CN(C)c1ccc(cc1)C(c1ccc(cc1)N(C)C)c1c(Cl)ccc(c1)[N+](=O)[O-],
NS6180,,353262-04-1,FC(F)(F)c1cccc(CN2C(=O)CSc3ccccc23)c1,
D-64131,D64131,74588-78-6,COc1cc2c([nH]c(c2)C(=O)c2ccccc2)cc1,
ZM 306416,CB 676475,690206-97-4,COc1c(OC)cc2c(Nc3c(F)cc(Cl)cc3)ncnc2c1,
ML-323,ML323,1572414-83-5,CC(C)c1ccccc1-c1ncc(C)c(NCc2ccc(cc2)-n2ccnn2)n1,
RGFP966,RGFP 966,1357389-11-7,Nc1cc(F)ccc1NC(=O)\C=C\c1cnn(C\C=C\c2ccccc2)c1,
SB 525334,SB525334,356559-20-1,Cc1cccc(n1)-c1[nH]c(nc1-c1ccc2nccnc2c1)C(C)(C)C,
MDK83190,Apoptosis Activator 2; MDK83190,79183-19-0,Clc1c(Cl)cc(CN2C(=O)C(=O)c3ccccc23)cc1,
SAG,Smoothened Agonist; SAG; Smoothened Agonist (SAG) HCl,912545-86-9,CNC1CCC(CC1)N(Cc1cccc(c1)c1ccncc1)C(=O)c1c(Cl)c2ccccc2s1,
GW9508,GW 9508,885101-89-3,c1(ccc(cc1)NCc1cc(ccc1)Oc1ccccc1)CCC(=O)O,
GW788388,GW 788388,452342-67-5,O=C(NC1CCOCC1)c1ccc(cc1)-c1cc(ccn1)-c1cn[nH]c1-c1ccccn1,
SR9243,,1613028-81-1,Brc1cc(CCN(S(=O)(=O)c2c(cc(cc2C)C)C)Cc2ccc(cc2)c2cc(S(=O)(=O)C)ccc2)ccc1,
GNF-5,GNF5; GNF 5; GNF-5,778277-15-9,c1cc(cc(c1)C(=O)NCCO)c1cc(ncn1)Nc1ccc(cc1)OC(F)(F)F,
JW 55,JW55,664993-53-7,COc1ccc(cc1)C1(CCOCC1)CNC(=O)c1ccc(cc1)NC(=O)c1ccco1,
kb-NB77-78,,1350622-33-1,CC(C)(C)[Si](C)(C)Oc1cc2c(cc1)oc(=O)c1c2CCCN1,
AGI-6780,AGI6780; AGI 6780; AGI-6780,1432660-47-3,c1(cc(c(cc1)c1cscc1)NC(=O)Nc1cccc(c1)C(F)(F)F)S(=O)(=O)NC1CC1,
Purmorphamine,Shh Signaling Antagonist VI,483367-10-8,C1CCC(CC1)n1cnc2c(Nc3ccc(cc3)N3CCOCC3)nc(Oc3cccc4ccccc34)nc12,
WH-4-023,Dual LCK/SRC inhibitor; KIN001-112; KIN112,837422-57-8,COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2)c(OC)c1,
KX1-004,KX1004; KX1 004; KX1-004,518058-84-9,c1cc(cc(c1)O)CNC(=O)c1cc2c([nH]1)ccc(c2)F,
ICILIN,AG-3-5,36945-98-9,C1C=C(NC(=O)N1c1ccccc1O)c1cc(ccc1)[N+](=O)[O-],
GNF-2,GNF2; GNF 2; GNF-2,778270-11-4,c1cc(cc(c1)C(=O)N)c1cc(ncn1)Nc1ccc(cc1)OC(F)(F)F,
Tenovin-6,Tenovin 6,1011557-82-6,CC(C)(C)c1ccc(cc1)C(=O)NC(=S)Nc1ccc(cc1)NC(=O)CCCCN(C)C,
Nexturastat A,,1403783-31-2,CCCCN(Cc1ccc(cc1)C(=O)NO)C(=O)Nc1ccccc1,
CGK733,CGK 733,905973-89-9,[O-][N+](=O)c1cc(NC(=S)NC(NC(=O)C(c2ccccc2)c2ccccc2)C(Cl)(Cl)Cl)ccc1F,
IOX2,IOX 2; JICL38,931398-72-0,OC(=O)CNC(=O)c1c(O)c2ccccc2n(Cc2ccccc2)c1=O,
TGR5  Receptor Agonist,,1197300-24-5,CN(C(=O)c1c(C)onc1c1ccccc1Cl)c1ccc(Cl)cc1,
Reversine,,656820-32-5,C1CCC(CC1)Nc1nc(Nc2ccc(cc2)N2CCOCC2)nc2c1[nH]cn2,
CX-6258,CX6258; CX 6258; CX-6258,1202916-90-2,CN1CCCN(CC1)C(=O)c1cccc(c1)c1ccc(o1)/C=C/1\c2c(ccc(c2)Cl)NC1=O,
AZD2932,,883986-34-3,COc1c(OC)cc2c(Oc3ccc(CC(=O)Nc4cn(nc4)C(C)C)cc3)ncnc2c1,
Mps1-IN-2,,1228817-38-6,CCOc1c(Nc2ncc3N(C)C(=O)CCN(C4CCCC4)c3n2)ccc(c1)N1CCC(O)CC1,
Isoindigotin,,476-34-6,O=C1Nc2ccccc2/C/1=C/1\C(=O)Nc2ccccc12,
XMD17-109,XMD17109; XMD17 109; XMD17-109; ERK5-IN-1,1435488-37-1,CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C3CCCC3)c2n1)C(=O)N1CCC(CC1)N1CCN(C)CC1,
XMD8-92,,1234480-50-2,CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCC(O)CC1,
B-Raf IN 1,,950736-05-7,CN(C)Cc1ccc(cc1)c1c2nccc(n2nc1)c1cc(NC(=O)c2cc(ccc2)C(F)(F)F)ccc1,
Necrostatin-1,Necrostatin 1; Nec-1,4311-88-0,CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O,
ZM 336372,Zinc00581684,208260-29-1,CN(C)c1cccc(c1)C(=O)Nc1cc(NC(=O)c2ccc(O)cc2)c(C)cc1,
ZCL278,ZCL 278,587841-73-4,Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)COc3c(Cl)cc(Br)cc3)cc2)n1,
TMP269,,1314890-29-3,c1(nc(cs1)c1ccccc1)C1(CCOCC1)CNC(=O)c1cc(c2nc(C(F)(F)F)on2)ccc1,
CID-797718,CID 797718,370586-05-3,Oc1ccc2oc(=O)c3NCCCc3c2c1,
PR-619,"PR619; PR 619; PR-619; 2,6-Diamino-3,5-dithiocyanopyridine",2645-32-1,Nc1nc(N)c(SC#N)cc1SC#N,
Y-27632,Y27632,146986-50-7,c1cnccc1NC(=O)[C@@H]1CC[C@H](CC1)[C@H](N)C,
Tenovin-3,Tenovin3; Tenovin 3; Tenovin-3,1011301-27-1,CC(C)(C)c1ccc(cc1)C(=O)NC(=S)Nc1ccc(N)cc1,
PPQ-102,PPQ102; PPQ 102; PPQ-102; CFTR Inhibitor,931706-15-9,Cn1c2c3C(Nc4ccccc4n3c(c2c(=O)n(C)c1=O)c1ccccc1)c1ccc(C)o1,
Kobe0065,,436133-68-5,Cc1c(Cl)cc(NC(=S)NNc2c(cc(cc2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])cc1,
XAV-939,XAV939; XAV 939; XAV-939; NVP-XAV939,284028-89-3,FC(F)(F)c1ccc(cc1)-c1nc2CCSCc2c(=O)[nH]1,
Inauhzin,INZ,309271-94-1,CCC(Sc1nc2c(nn1)c1ccccc1[nH]2)C(=O)N1c2ccccc2Sc2ccccc12,
NSC 405020,,7497-07-6,CCCC(C)NC(=O)C1=CC(Cl)=C(Cl)C=C1,
Kobe2602,,454453-49-7,[O-][N+](=O)c1cc(cc(c1NNC(=S)Nc1ccc(F)cc1)[N+](=O)[O-])C(F)(F)F,
SKLB 610,,1125780-41-7,CNC(=O)c1nccc(Oc2ccc(NC(=O)c3cc(ccc3)C(F)(F)F)cc2)c1,
MDL-29951,MDL 29951,130798-51-5,OC(=O)CCc1c([nH]c2cc(Cl)cc(Cl)c12)C(=O)O,
RKI-1447,RKI1447; RKI 1447; RKI-1447,1342278-01-6,N(c1nc(cs1)c1ccncc1)C(=O)NCc1cccc(O)c1,
LDN-212854,LDN212854; BMP Inhibitor III,1432597-26-6,C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1cccc2ncccc12,
(E/Z)-TG003,TG003,300801-52-9,CCN1\C(Sc2ccc(OC)cc12)=C\C(C)=O,
BAY 11-7082,BAY 11-7821,19542-67-7,Cc1ccc(cc1)S(=O)(=O)\C=C\C#N,
MHY1485,,326914-06-1,[O-][N+](=O)c1ccc(Nc2nc(nc(n2)N2CCOCC2)N2CCOCC2)cc1,
L-701324,L701324; L 701324; L-701324,142326-59-8,Oc1c(c(=O)[nH]c2c1ccc(Cl)c2)c1cc(Oc2ccccc2)ccc1,
K02288,K 02288,1431985-92-0,COc1cc(cc(OC)c1OC)c1c(N)ncc(c1)c1cc(O)ccc1,
GSK 3 Inhibitor IX,6-BIO; BIO; MLS 2052; 6-Bromoindirubin-3'-oxime; GSK 3 Inhibitor IX; 6-bromoindirubin-3-oxime; GSK 3 IX,667463-62-9,O\N=C1c2ccccc2NC/1=C1\C(=O)Nc2cc(Br)ccc12,
Tenovin-1,Tenovin 1,380315-80-0,CC(=O)NC1=CC=C(NC(=S)NC(=O)C2=CC=C(C=C2)C(C)(C)C)C=C1,
LDN-57444,LDN57444; LDN 57444; LDN-57444,668467-91-2,CC(=O)O\N=C1/C(=O)N(Cc2cc(Cl)ccc2Cl)c2ccc(Cl)cc12,
JSH-23,JSH23; JSH 23; JSH-23,749886-87-1,Cc1ccc(NCCCc2ccccc2)c(N)c1,
NVP 231,,362003-83-6,O=C(Nc1nc2c(s1)cc(NC(=O)C13CC4CC(CC(C4)C1)C3)cc2)c1ccccc1,
Bay 11-7085,BAY 11-7083,196309-76-9,CC(C)(C)c1ccc(cc1)S(=O)(=O)\C=C\C#N,
FLT3-IN-2,,923562-23-6,FC(F)(F)c1ccc(CNc2ncc(Cc3c[nH]c4ncc(Cl)cc34)cc2)cc1,
DMOG,Dimethyloxallyl Glycine; Dimethyloxalylglycine; Dimethyloxaloylglycine,89464-63-1,COC(=O)CNC(=O)C(=O)OC,
BTB06584,,219793-45-0,[O-][N+](=O)c1c(OC(=O)c2ccc(Cl)cc2)cc(cc1)S(=O)(=O)c1ccccc1,
DMH-1,DMH1,1206711-16-1,CC(C)Oc1ccc(cc1)c1cn2ncc(c2nc1)c1ccnc2ccccc12,
ML347,LDN 193719,1062368-49-3,COc1ccc(cc1)c1cn2ncc(c2nc1)c1c2cccnc2ccc1,
LDN-214117,LDN214117; LDN 214117; LDN-214117,1627503-67-6,COc1cc(cc(OC)c1OC)-c1cc(cnc1C)-c1ccc(cc1)N1CCNCC1,
CZC24832,,1159824-67-5,CC(C)(C)NS(=O)(=O)c1cncc(c1)c1cn2nc(N)nc2c(F)c1,
L-779450,L779450; L 779450; L-779450,303727-31-3,Oc1c(Cl)ccc(c1)c1c([nH]c(n1)c1ccccc1)c1ccncc1,
SRPIN340,SRPK inhibitor,218156-96-8,FC(F)(F)c1cc(NC(=O)c2ccncc2)c(cc1)N1CCCCC1,
FR 180204,FR180204,865362-74-9,Nc1c2cc(nnc2n[nH]1)c1c2ccccn2nc1c1ccccc1,
AZ20,,1233339-22-4,C[C@@H]1COCCN1c1cc(nc(n1)-c1cccc2[nH]ccc12)C1(CC1)S(C)(=O)=O,
YL-109,YL109; YL 109; YL-109,36341-25-0,COc1cc(c2nc3ccccc3s2)ccc1O,
Bikinin,Abrasin,188011-69-0,OC(=O)CCC(=O)Nc1ncc(Br)cc1,
Tubastatin A,Tubastatin A BASE,1252003-15-8,CN1CCc2c(C1)c1ccccc1n2Cc1ccc(cc1)C(=O)NO,
AZD-3463,AZD3463; ALK/IGF1R inhibitor,1356962-20-3,COc1c(Nc2ncc(Cl)c(n2)c2c[nH]c3ccccc23)ccc(c1)N1CCC(N)CC1,
WAY-262611,WAY262611; WAY 262611; WAY-262611,1123231-07-1,NCC1CCN(CC1)c1nccc(n1)c1cc2ccccc2cc1,
Dorsomorphin,Compound C; BML-275,866405-64-3,C(CN1CCCCC1)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccncc1,
GW627368,GW 627368X; GW627368,439288-66-1,CCOc1c2CN(C(=O)c2c(OCC)c2ccccc12)c1ccc(CC(=O)NS(=O)(=O)c2ccccc2)cc1,
ZM323881 hydrochloride,ZM 323881 hydrochloride; ZM 323881 HCl,193000-39-4,Cl.Cc1cc(F)c(Nc2ncnc3c2ccc(OCc2ccccc2)c3)cc1O,
PF-4708671,PF4708671; PF 4708671; PF-4708671,1255517-76-0,CCc1cncnc1N1CCN(Cc2nc3c([nH]2)cc(cc3)C(F)(F)F)CC1,
ISX-9,Isx 9; Isoxazole 9; Isoxazole 9 (ISX-9),832115-62-5,O=C(NC1CC1)c1noc(c1)c1cccs1,
RQ-00203078,RQ00203078,1254205-52-1,OC(=O)c1ccc(cc1)S(=O)(=O)N(Cc1ccc(OC(F)(F)F)cc1)c1c(Cl)cc(cn1)C(F)(F)F,
SB-3CT,,292605-14-2,O=S(=O)(CC1CS1)c1ccc(Oc2ccccc2)cc1,
RKI1313,RKI 1313; RKI-1313,1342276-76-9,COc1cccc(CNC(=O)Nc2nc(cs2)c2ccncc2)c1,
Oclacitinib,PF-03394197,1208319-26-9,CNS(=O)(=O)C[C@@H]1CC[C@H](CC1)N(C)c1ncnc2c1cc[nH]2,
CCG-1423,CCG1423; CCG 1423; CCG-1423,285986-88-1,CC(ONC(=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C(=O)Nc1ccc(Cl)cc1,
U-104,U104; U 104; U-104; MST-104; NSC-213841,178606-66-1,NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(F)cc2)cc1,
OAC2,,6019-39-2,O=C(Nc1cc2c([nH]cc2)cc1)c1ccccc1,
MC1568,,852475-26-4,Cn1cc(\C=C\C(=O)c2cccc(F)c2)cc1\C=C\C(=O)NO,
ISRIB,,548470-11-7,Clc1ccc(OCC(NC2CCC(NC(COc3ccc(Cl)cc3)=O)CC2)=O)cc1,
NG 52,NG52; NG 52; NG-52; Compound 52,212779-48-1,CC(C)n1cnc2c1nc(NCCO)nc2Nc1cc(Cl)ccc1,
BML-277,BML277; BML 277; BML-277; Chk2 Inhibitor II; C 3742,516480-79-8,NC(=O)c1ccc2nc([nH]c2c1)-c1ccc(Oc2ccc(Cl)cc2)cc1,
AG1557,AG 1557; AG-1557,189290-58-2,COc1c(OC)cc2c(Nc3cc(I)ccc3)ncnc2c1,
WHI-P258,,21561-09-1,COc1c(OC)cc2c(Nc3ccccc3)ncnc2c1,
TH588,,1609960-31-7,Nc1nc(cc(NC2CC2)n1)c1c(Cl)c(Cl)ccc1,
OAC1,BAS 00287861,300586-90-7,O=C(Nc1ncc2[nH]ccc2c1)c1ccccc1,
LY-364947,LY364947; LY 364947; LY-364947; HTS466284,396129-53-6,[nH]1ncc(c1c1ccccn1)c1ccnc2ccccc12,
SKLB4771,FLT3-IN-1; FLT3-âIN-â1; SKLB4771,1370256-78-2,Cc1ccc(NC(=O)Nc2nnc(Sc3ncnc4c3ccc(OCCCN3CCOCC3)c4)s2)cc1,
KY02111,,1118807-13-8,COc1c(OC)cc(CCC(=O)Nc2nc3c(s2)cc(Cl)cc3)cc1,
WS3,,1421227-52-2,CN1CCN(Cc2c(cc(NC(=O)Nc3ccc(Oc4ncnc(NC(=O)C5CC5)c4)cc3)cc2)C(F)(F)F)CC1,
VEGFR-2-IN-5,"UNC0064-12; 2,4-Pyrimidinediamine with linker; 2, 4-Pyrimidinediamine with linker",1430089-64-7,NCCCNc1ccc(Nc2nccc(Nc3n[nH]c(c3)C3CC3)n2)cc1,
Purvalanol A,NG-60,212844-53-6,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(c2n1)C(C)C,
APY0201,,1232221-74-7,Cc1cccc(/C=N/Nc2nc3cc(nn3c(c2)N2CCOCC2)c2ccncc2)c1,
Semaxinib,SU5416,204005-46-9,Cc3cc(C)nc3C=C1c2ccccc2NC1=O,
Bioymifi,DR5 Activator,1420071-30-2,N=C1S/C(=C\c2ccc(o2)c2ccc3C(=O)NC(=O)c3c2)/C(=O)N1c1ccc(Br)cc1,
NS11394,NS 11394,951650-22-9,CC(C)(O)c1cc2c(cc1)n(cn2)c1cccc(c1)c1ccccc1C#N,
TH287,TH287 hydrochloride; TH287,1609960-30-6,CNc1nc(N)nc(c1)c1c(Cl)c(Cl)ccc1,
BET bromodomain inhibitor,,1505453-59-7,Cc1noc2[C@H](CC(N)=O)N=C(c3ccc(Cl)cc3)c3cc(ccc3-c12)-c1cnn(C)c1,
Raf inhibitor 1,B-Raf inhibitor 1,1093100-40-3,Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2nc[nH]c12,
Fimepinostat,PI3K/HDAC Inhibitor; CUDC 907; CUDC-907; Fimepinostat,1339928-25-4,c1nc(ncc1C(=O)NO)N(C)Cc1cc2c(s1)c(nc(n2)c1ccc(nc1)OC)N1CCOCC1,
LY2409881 trihydrochloride,LY2409881,946518-60-1,O=C(c1c2cc(c3nc(NCCCN4CCN(C)CC4)ncc3Cl)sc2ccc1)NC1CC1.Cl.Cl.Cl,
PI-3065,PI3065,955977-50-1,c1(c2c(nc(n1)c1c(ccc3c1cc[nH]3)F)cc(s2)CN1CCN(CC1)CC1CC1)N1CCOCC1,
ETP-46464,ETP46464,1345675-02-6,CC(C)(C#N)c1ccc(cc1)N1C(=O)OCc2cnc3ccc(cc3c12)-c1cnc2ccccc2c1,
PQ401,IGF-1R Inhibitor II,196868-63-0,c12c(cccc1)nc(cc2NC(=O)Nc1c(OC)ccc(c1)Cl)C,
PF 03716556,PF-3716556,928774-43-0,O1CC[C@@H](Nc2c3n(cc(c2)C(=O)N(CCO)C)cc(n3)C)c2c1cccc2C,
A 77-01,A77-01,607737-87-1,Cc1cccc(n1)-c1[nH]ncc1-c1ccnc2ccccc12,
WS6,,1421227-53-3,CN1CCN(Cc2ccc(NC(=O)Cc3ccc(Oc4cc(NC(=O)C5CC5)ncn4)cc3)cc2C(F)(F)F)CC1,
SC-514,SC514; SC 514; SC-514; GK 01140,354812-17-2,NC(=O)c1sc(cc1N)-c1ccsc1,
LY2109761,,700874-71-1,C(CN1CCOCC1)Oc1ccc2c(ccnc2c1)-c1c2CCCn2nc1-c1ccccn1,
PJ34 hydrochloride,PJ34 HCl,344458-15-7,Cl.CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,
1-NM-PP1,1 nM-PP1; PP1 Analog II,221244-14-0,Nc1ncnc2c1c(Cc1cccc3c1cccc3)nn2C(C)(C)C,
Thiazovivin,,1226056-71-8,O=C(NCc1ccccc1)c1csc(Nc2ccncn2)n1,
M344,Histone Deacetylase Inhibitor III; MS 344; M344,251456-60-7,CN(C)c1ccc(cc1)C(=O)NCCCCCCC(=O)NO,
Suramin Sodium Salt,BAY-205; NF-060; Suramin hexasodium salt,129-46-4,[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c1cccc(NC(=O)Nc2cccc(c2)C(=O)Nc2cc(ccc2C)C(=O)Nc2ccc(c3cc(cc(c23)S([O-])(=O)=O)S([O-])(=O)=O)S([O-])(=O)=O)c1)C(=O)Nc1ccc(c2cc(cc(c12)S([O-])(=O)=O)S([O-])(=O)=O)S([O-])(=O)=O,
TWS119,,601514-19-6,c1cc(cc(c1)N)c1cc2c([nH]1)ncnc2Oc1cccc(c1)O,
"2-(1,8-naphthyridin-2-yl)phenol",,65182-56-1,Oc1ccccc1c1ccc2cccnc2n1,
"2,3-Butanedione 2-Monoxime","2,3-Butanedione-2-monoxime; Diacetyl monoxime",57-71-6,CC(=O)/C(=N/O)/C,
Methiothepin mesylate,Ro 8-6837 mesylate; Metitepine mesylate,74611-28-2,CS(O)(=O)=O.CSc1ccc2Sc3ccccc3CC(N3CCN(C)CC3)c2c1,
Indazole,,271-44-3,c1n[nH]c2ccccc12,
2-Chloropyrazine,,14508-49-7,c1cnc(cn1)Cl,
Diaveridine,EGIS-5645; AI3-23935; CCRIS-3784,5355-16-8,COc1c(cc(cc1)Cc1cnc(nc1N)N)OC,
Bacitracin Zinc,Zinc bacitracin; Bacitracin Zinc; Bacitracin zinc salt,1405-89-6,CC(C)C[C@@H](C(=O)N[C@H](CCC(=O)[O-])C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(=O)N)NC(=O)[C@@H](CC(=O)[O-])NC(=O)[C@H](Cc2[nH]cnc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC1=O)NC(=O)C1CN=C(C(N)C(C)CC)S1.[Zn+2],
TCS JNK 5a,"SC202671; SC 202671; SC-202671; JNK Inhibitor IX; TCS JNK 5a; N-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thienyl-2-yl)-1-naphthalenecarboxamide",312917-14-9,C1CCc2c(C1)c(c(s2)NC(=O)c1cccc2ccccc12)C#N,
Wnt-C59,C59,1243243-89-1,Cc1cc(c2ccc(CC(=O)Nc3ccc(c4cnccc4)cc3)cc2)ccn1,
ESI-09,ESI09; ESI 09; ESI-09,263707-16-0,CC(C)(C)c1cc(no1)C(=O)C(\C#N)=N\Nc1cccc(Cl)c1,
LRRK2-IN-1,,1234480-84-2,COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)C(=O)N1CCC(CC1)N1CCN(C)CC1,
AS-605240,AS605240; AS 605240; AS-605240,648450-29-7,O=C1NC(=O)\C(S1)=C\c1ccc2nccnc2c1,
DY131,DY 131; DY-131; GSK 9089,95167-41-2,CCN(CC)c1ccc(cc1)\C=N\NC(=O)c1ccc(O)cc1,
UNC 669,UNC669,1314241-44-5,c1c(cncc1Br)C(=O)N1CCC(CC1)N1CCCC1,
TCS PIM-1 1,SC 204330,491871-58-0,c1(=O)c(c(cc([nH]1)c1cc(ccc1O)Br)c1ccccc1)C#N,
VER-50589,VER50589; VER 50589; VER-50589,747413-08-7,CCNC(=O)c1noc(c1-c1ccc(OC)cc1)-c1cc(Cl)c(O)cc1O,
GW9662,GW 9662; TIMTEC-BB SBB006523,22978-25-2,c1ccc(cc1)NC(=O)c1c(ccc(c1)[N+](=O)[O-])Cl,
IM-12,IM12; IM 12; IM-12,1129669-05-1,CN1C(=O)C(NCCc2ccc(F)cc2)=C(C1=O)c1c(C)[nH]c2ccccc12,
SantacruzaMate A,CAY-10683,1477949-42-0,CCOC(=O)NCCCC(=O)NCCc1ccccc1,
BQU57,,1637739-82-2,Cc1nn(c2c1C(C(=C(O2)N)C#N)c1ccc(cc1)C(F)(F)F)C,
SBE13 Hydrochloride,SBE 13 hydrochloride; SBE 13 HCl,1052532-15-6,Clc1ncc(COc2c(OC)cc(CNCCc3cc(OC)c(OC)cc3)cc2)cc1.Cl,
BPR1J-097,BPR1J097; BPR1J 097; BPR1J-097,1327167-19-0,CN1CCN(CC1)c1ccc(cc1)C(=O)Nc1n[nH]c(c1)c1cc(ccc1)NS(=O)(=O)c1ccccc1,
YK-4-279,,1037184-44-3,COC1=CC=C(C=C1)C(=O)CC1(O)C(=O)NC2=C(Cl)C=CC(Cl)=C12,
RI-1,RI1; RI 1; RI-1; RAD51 inhibitor 1,415713-60-9,ClC1=C(N2CCOCC2)C(=O)N(C1=O)c1ccc(Cl)c(Cl)c1,
RPI-1,RPI1; RPI 1; RPI-1,269730-03-2,COc1c(cc2c(c1)/C(=C/c1ccc(cc1)O)/C(=O)N2)OC,
PIK-75  hydrochloride,PIK-75; PIK-75 HCl,372196-77-5,Cc1ccc(cc1S(=O)(=O)N(C)/N=C/c1cnc2ccc(cn12)Br)[N+](=O)[O-].Cl,
BG45,,926259-99-6,N(C(=O)c1nccnc1)c1ccccc1N,
PIK-294,PIK294; PIK 294; PIK-294,900185-02-6,Cc1c2c(ccc1)nc(n(c2=O)c1ccccc1C)Cn1c2c(c(n1)c1cc(ccc1)O)c(ncn2)N,
ML204,,5465-86-1,c12c(cccc1)c(cc(n2)N1CCCCC1)C,
SB 202190,SB202190; FHPI,152121-30-7,Oc1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1,
HS-173,HS173; HS 173; HS-173,1276110-06-5,S(=O)(=O)(Nc1cc(cnc1)c1ccc2n(c1)c(cn2)C(=O)OCC)c1ccccc1,
Loxiglumide,CR-1505,107097-80-3,CCCCCN(CCCOC)C(=O)C(CCC(=O)O)NC(=O)c1cc(c(cc1)Cl)Cl,
AS601245,,345987-15-7,N#CC(c1nc2ccccc2s1)c1nc(NCCc2cccnc2)ncc1,
PTC-209,PTC209; PTC 209; PTC-209,315704-66-6,s1c(nc(c1)c1n2c(nccc2)nc1C)Nc1c(cc(cc1Br)OC)Br,
GSK2334470,,1227911-45-6,CNc1nc(cc(n1)-c1ccc2c(N)n[nH]c2c1)N1C[C@H](CC[C@H]1C)C(=O)NC1CCCCC1,
CFTR(inh)-172,CFTRinh172; CFTRinh 172; CFTRinh-172; CFTR Inhibitor-172; CFTR(inh)-172,307510-92-5,OC(=O)c1ccc(\C=C2\SC(=S)N(C2=O)c2cccc(c2)C(F)(F)F)cc1,
Ro-3306,Ro 3306,872573-93-8,O=C1N=C(NCc2cccs2)S\C1=C/c1ccc2ncccc2c1,
QNZ46,,1237744-13-6,COc1ccc2nc(\C=C\c3cccc(c3)[N+]([O-])=O)n(-c3ccc(cc3)C(O)=O)c(=O)c2c1,
SKF-86002,SKF86002; SKF 86002; SKF-86002,72873-74-6,Fc1ccc(cc1)c1c(n2CCSc2n1)c1ccncc1,
HTH-01-015,,1613724-42-7,CN1c2cc3ccccc3cc2C(=O)N(C)c2c(C)nc(Nc3cnn(c3)C3CCNCC3)nc12,
UNC1215,,1415800-43-9,O=C(N1CCC(CC1)N1CCCC1)c1ccc(C(=O)N2CCC(CC2)N2CCCC2)c(Nc2ccccc2)c1,
Vortioxetine hydrobromide,Vortioxetine HBr; Lu AA21004 hydrobromide; Vortioxetine hydrobromide; Vortioxetine (Lu AA21004) HBr,960203-27-4,c1c(c(cc(c1)C)C)Sc1ccccc1N1CCNCC1.Br,
FH535,,108409-83-2,Cc1c(ccc(c1)[N+](=O)[O-])NS(=O)(=O)c1c(ccc(c1)Cl)Cl,
Torkinib,PP 242,1092351-67-1,CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc12,
A66,,1166227-08-2,Cc1c(c2csc(C(C)(C)C)n2)sc(n1)NC(=O)N1CCC[C@H]1C(=O)N,
BMS-794833,BMS794833,1174046-72-0,c1cc(ccc1c1c[nH]cc(c1=O)C(=O)Nc1ccc(c(c1)F)Oc1ccnc(c1Cl)N)F,
SKLB1002,,1225451-84-2,COc1c(OC)cc2c(Sc3nnc(C)s3)ncnc2c1,
P 22077,P22077,1247819-59-5,CC(=O)c1cc(c(Sc2c(F)cc(F)cc2)s1)[N+](=O)[O-],
EHop-016,EHop016; EHop 016; EHop-016,1380432-32-5,CCn1c2ccccc2c2c1ccc(Nc1nc(NCCCN3CCOCC3)ncc1)c2,
TG6-10-1,,1415716-58-3,C(=O)(/C=C/c1cc(c(c(c1)OC)OC)OC)NCCn1c(cc2ccccc12)C(F)(F)F,
HPOB,,1429651-50-2,OCCN(C(=O)Cc1ccc(cc1)C(=O)NO)c1ccccc1,
ID-8,ID8; ID 8; ID-8,147591-46-6,COc1ccc(cc1)n1c(C)c(c2c1cc(O)cc2)[N+](=O)[O-],
PD 169316,,152121-53-4,[O-][N+](=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1,
NU 7026,NU7026; LY293646; DNA-PK Inhibitor II,154447-35-5,O=c1cc(oc2c1ccc1ccccc21)N1CCOCC1,
O4I2,,165682-93-9,CCOC(=O)c1csc(n1)Nc1ccc(cc1)Cl,
O4I1,,175135-47-4,COc1ccc(cc1)COc1ccc(cc1)CC#N,
IC261,SU-5607,186611-52-9,COc1cc(OC)c(\C=C2\C(=O)Nc3ccccc23)c(OC)c1,
KI8751,,228559-41-9,COc1cc2nccc(Oc3cc(F)c(NC(=O)Nc4c(F)cc(F)cc4)cc3)c2cc1OC,
D4476,D 4476; Casein Kinase I Inhibitor,301836-43-1,C1COc2c(O1)ccc(c2)c1c([nH]c(n1)c1ccc(cc1)C(=O)N)c1ccccn1,
SANT-1,SANT1; SANT 1; SANT-1,304909-07-7,Cc1nn(c(C)c1\C=N\N1CCN(Cc2ccccc2)CC1)-c1ccccc1,
GlyH-101,GlyH101; GlyH 101; GlyH-101,328541-79-3,c1ccc2cc(ccc2c1)NCC(=O)N/N=C/c1cc(c(c(c1O)Br)O)Br,
BAM7,,331244-89-4,CCOc1ccccc1N/N=C/1\C(=NN(C1=O)c1nc(cs1)c1ccccc1)C,
Dacinostat,LAQ824; NVP-LAQ824,404951-53-7,OCCN(CCc1c[nH]c2ccccc12)Cc1ccc(\C=C\C(=O)NO)cc1,
IRAK-1-4 Inhibitor I,IRAK-1/4 Inhibitor; IRAK-1-4 Inhibitor I; IRAK-1/4 Inhibitor I,509093-47-4,O1CCN(CCn2c3c(nc2NC(=O)c2cc([N+](=O)[O-])ccc2)cccc3)CC1,
CID755673,,521937-07-5,C1Cc2c(C(=O)NC1)oc1c2cc(cc1)O,
BRL 54443,BRL54443,57477-39-1,CN1CCC(CC1)c1c[nH]c2c1cc(cc2)O,
PIK-90,PIK90; PIK 90; PIK-90,677338-12-4,COc1ccc2C3=NCCN3C(NC(=O)c3cccnc3)=Nc2c1OC,
NSC319726,ZMC1,71555-25-4,C\C(c1ccccn1)=N/NC(=S)N1CCC1,
R406 free base,R406 (free base),841290-80-0,CC1(C(=O)Nc2c(O1)ccc(n2)Nc1nc(ncc1F)Nc1cc(c(c(c1)OC)OC)OC)C,
A-769662,A 769662,844499-71-4,c1ccc(c(c1)c1ccc(cc1)c1csc2c1c(c(c(=O)[nH]2)C#N)O)O,
MK-8745,MK8745,885325-71-3,C1CN(CCN1Cc1nc(ccc1)Nc1nccs1)C(=O)c1c(c(ccc1)Cl)F,
AZ-5104,AZ5104,1421373-98-9,CN(C)CCN(C)c1cc(c(cc1NC(=O)C=C)Nc1nccc(n1)c1c[nH]c2ccccc12)OC,
Adjudin,AF-2364,252025-52-8,Clc1c(Cn2nc(c3c2cccc3)C(=O)NN)ccc(Cl)c1,
1-Ethyl-2-benzimidazolinone,1-EBIO,10045-45-1,c1ccc2c(c1)[nH]c(=O)n2CC,
CHIR-98014,CHIR98014; CHIR 98014; CHIR-98014; CT98014,252935-94-7,c1cc(c(cc1Cl)Cl)c1nc(ncc1n1ccnc1)NCCNc1nc(c(cc1)[N+](=O)[O-])N,
CCT 137690,CCT137690,1095382-05-0,Cc1cc(no1)CN1CCN(CC1)c1c2c(ncc1Br)nc([nH]2)c1ccc(cc1)N1CCN(CC1)C,
PIK-93,PIK93; PIK 93; PIK-93,593960-11-3,CC(=O)Nc1nc(C)c(s1)c1cc(c(Cl)cc1)S(=O)(=O)NCCO,
PD98059,PD 98059,167869-21-8,COc1cccc(c1N)-c1cc(=O)c2ccccc2o1,
MK-0752,MK0752,471905-41-6,OC(=O)CC[C@H]1CC[C@@](CC1)(c1cc(F)ccc1F)S(=O)(=O)c1ccc(Cl)cc1,
SBC-115076,SBC115076; SBC 115076; SBC-115076,489415-96-5,Cc1cc(C(=O)C2=C(O)C(=O)N(C2c2ccncc2)CCCN2CCOCC2)ccc1OCc1ccccc1,
RI-2,RI2; RI 2; RI-2,1417162-36-7,COc1ccc(cc1)C1=C(N2CCOCC2)C(=O)N(C1=O)c1cc(Cl)c(Cl)cc1,
A-1210477,A1210477; A 1210477; A-1210477,1668553-26-1,CN(C)S(=O)(=O)N1CCN(CC1)c1ccc(OCc2c(c(C)nn2C)c2cccc3c2n(CCN2CCOCC2)c(C(=O)O)c3CCCOc2cccc3ccccc23)cc1,
GSK429286A,RHO-15,864082-47-3,CC1=C(C(CC(=O)N1)c1ccc(cc1)C(F)(F)F)C(=O)Nc1c(cc2c(c1)cn[nH]2)F,
KRCA-0008,KRCA0008; KRCA 0008; KRCA-0008,1472795-20-2,COc1c(Nc2ncc(Cl)c(Nc3c(OC)cc(cc3)N3CCN(CC3)C(=O)C)n2)ccc(c1)N1CCN(CC1)C(=O)C,
IWR-1,IWR-1-endo; endo-IWR 1; IWR-1,1127442-82-3,O=C(Nc1cccc2cccnc12)c1ccc(cc1)N1C(=O)[C@H]2[C@@H]3C[C@@H](C=C3)[C@H]2C1=O,
GSK2656157,,1337532-29-2,Cc1cccc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1,
IC-87114,IC87114; IC 87114; IC-87114,371242-69-2,Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc23)nc2cccc(C)c2c1=O,
GTS-21 dihydrochloride,GTS 21 dihydrochloride; DMBX-anabaseine; DMXB-A,156223-05-1,Cl.Cl.COc1ccc(\C=C2CCCN=C/2c2cccnc2)c(OC)c1,
PIK-75,PIK75,372196-67-3,CN(\N=C\c1cnc2ccc(Br)cn12)S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O,
JNK-IN-8,JNK Inhibitor XVI,1410880-22-6,Cc1c(ccc(c1)NC(=O)c1cc(ccc1)NC(=O)/C=C/CN(C)C)Nc1nccc(n1)c1cnccc1,
ML167,NCGC00188654; CID44968231,1285702-20-6,Cc1ccc(CNc2ncnc3c2cc(cc3)c2ccc(CO)o2)o1,
A 438079 hydrochloride,A-438079 hydrochloride; A 438079 (hydrochloride); A-438079 HCl,899431-18-6,c1cc(c(c(c1)Cl)Cl)c1nnnn1Cc1cnccc1.Cl,
GSK0660,,1014691-61-2,COc1c(ccc(c1)Nc1ccccc1)NS(=O)(=O)c1c(scc1)C(=O)OC,
BMS-265246,BMS265246; BMS 265246; BMS-265246,582315-72-8,CCCCOc1c2cn[nH]c2ncc1C(=O)c1c(F)cc(C)cc1F,
NVP-BVU972,,1185763-69-2,Cn1cc(cn1)c1nn2c(Cc3cc4c(cc3)nccc4)cnc2cc1,
LY310762,LY310762 HCl,192927-92-7,Cl.CC1(C)C(=O)N(CCN2CCC(CC2)C(=O)c2ccc(F)cc2)c2ccccc12,
AG1024,Tyrphostin AG 1024; Tyrphostin; AGS 200,65678-07-1,CC(C)(C)c1c(c(cc(c1)C=C(C#N)C#N)Br)O,
KN-62,KN62; KN 62; KN-62,127191-97-3,CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(CC1)c1ccccc1)S(=O)(=O)c1cccc2cnccc12,
TBB,"Casein Kinase II Inhibitor I; NSC 231634; 4,5,6,7-tetrabromobenzotriazole",17374-26-4,Brc1c(Br)c(Br)c(Br)c2n[nH]nc12,
IWP-2,IWP2; IWP 2; IWP-2,686770-61-6,CC1=CC2=C(C=C1)N=C(NC(=O)CSC1=NC3=C(SCC3)C(=O)N1C1=CC=CC=C1)S2,
MLN0905,PLK1 Inhibitor,1228960-69-7,CN(C)CCCc1cc(Nc2ncc3CC(=S)Nc4c(ccc(c4)C(F)(F)F)c3n2)c(C)nc1,
Mutant EGFR inhibitor,,1421373-62-7,COc1c(Nc2ncc(Cl)c(n2)c2c[nH]c3ccccc23)cc(NC(=O)C=C)c(c1)N(C)CCN(C)C,
Pifithrin-Î± hydrobromide,Pifithrin-Î±; PFTÎ± hydrobromide; Pifithrin hydrobromide; Pifithrin-Î± hydrobromide; Pifithrin-Î± (PFTÎ±) HBr; PFTÎ±,63208-82-2,Cc1ccc(cc1)C(=O)Cn1c2c(CCCC2)sc1=N.Br,
SL327,SL 327; SL-327,305350-87-2,NC(Sc1ccc(N)cc1)=C(C#N)c1ccccc1C(F)(F)F,
Chembridge-5861528,TCS 5861528; Chembridge-5861528,332117-28-9,CCC(C)c1ccc(NC(=O)Cn2cnc3n(C)c(=O)n(C)c(=O)c23)cc1,
Ginsenoside Rc,Panaxoside Rc,11021-14-0,C\C(C)=C/CC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2O[C@@H](CO)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C,
Digitonin,,11024-24-1,C[C@H]1[C@H]2[C@@H](O[C@]11CC[C@@H](C)CO1)[C@@H](O)[C@H]1[C@@H]3CC[C@H]4C[C@@H](O[C@@H]5O[C@H](CO)[C@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)C[C@]4(C)[C@H]3CC[C@]21C,
Glucosamine sulfate,D-Glucosaminesulfate; D-Glucosamine sulphate,29031-19-4,OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](N)C=O.O=S(=O)(O)O,
Tetrahydropalmatine,DL-Tetrahydropalmatine,2934-97-6,COc1cc2CCN3C(c2cc1OC)Cc1c(C3)c(OC)c(cc1)OC,
Lycopene,"Ï,Ï-Carotene",502-65-8,CC(=CCC/C(=C/C=C/C(=C/C=C/C(=C/C=C/C=C(/C=C/C=C(/C=C/C=C(/CCC=C(C)C)\C)\C)\C)/C)/C)/C)C,
Liquiritin,Liquiritoside; Liquiritigenin-4'-O-glucoside,551-15-5,C1[C@H](Oc2c(C1=O)ccc(c2)O)c1ccc(cc1)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,
Mogroside V,,88901-36-4,[C@@H]12[C@]([C@H]3C(=CC2)C([C@H](CC3)O[C@@H]2O[C@H](CO[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)CO)[C@H]([C@@H]([C@H]2O)O)O)(C)C)([C@@H](C[C@]2([C@]1(CC[C@@H]2[C@@H](CC[C@@H](O[C@H]1[C@H](O[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)[C@H]([C@@H]([C@H](O1)CO[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)O)O)C(C)(C)O)C)C)C)O)C,
Gypenoside XLIX,,94987-08-3,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C=O)[C@@H](CC[C@]5(C)[C@@H]4CC[C@@H]4[C@H](CC[C@@]54C)[C@@](O)(CC\C=C(/C)C)CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3(C)C)OC[C@H](O)[C@@H]2O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,
Phenibut,Aminophenylbutyric acid; Fenibut; Fenigam; Phenybut; PhGABA; Î²-Phenyl-Î³-aminobutyric acid,1078-21-3,Cl.NCC(CC(O)=O)c1ccccc1,
Trenbolone acetate,RU-1697; Trenbolone 17Î²-acetate,10161-34-9,O([C@@H]1[C@@]2([C@H]([C@H]3C(=C4C(=CC(=O)CC4)CC3)C=C2)CC1)C)C(=O)C,
ALK inhibitor 2,,761438-38-4,c1cc(c(cc1)Nc1c(cnc(n1)Nc1c(cc(cc1)N1CCN(CC1)C)OC)Cl)S(=O)(=O)NC,
NSC 42834,JAK2 Inhibitor V; Z3; NSC 42834; JAK2 Inhibitor V Z3,195371-52-9,O=C(C(CCc1ccccn1)(CCc1ccccn1)C)c1ccccc1,
10058-F4,c-Myc Inhibitor,403811-55-2,CCc1ccc(cc1)\C=C1\SC(=S)NC1=O,
TPCA-1,TPCA1; TPCA 1; TPCA-1; GW683965; IKK2 Inhibitor IV,507475-17-4,Fc1ccc(c2cc(C(=O)N)c(NC(=O)N)s2)cc1,
ML-7 hydrochloride,ML-7 HCl,110448-33-4,C1CNCCN(C1)S(=O)(=O)c1cccc2c1cccc2I.Cl,
(Z)-SMI-4a,SMI-4a; (Z)-SMI-4a; TCS PIM-1 4a,438190-29-5,c1cc(cc(c1)C(F)(F)F)/C=C\1/C(=O)NC(=O)S1,
WIKI4,,838818-26-1,COc1ccc(cc1)-n1c(SCCCN2C(=O)c3cccc4cccc(C2=O)c34)nnc1-c1ccncc1,
GANT 61,GANT61; NSC 136476,500579-04-4,C1(N(CCCN1Cc1c(N(C)C)cccc1)Cc1c(N(C)C)cccc1)c1ccncc1,
CHIR 98024,CT 98024,556813-39-9,c1cc(c(cc1Cl)Cl)c1nc(ncc1c1[nH]ccn1)NCCNc1nc(c(cc1)[N+](=O)[O-])N,
FLI-06,FLI06; FLI 06; FLI-06,313967-18-9,CC1=C(C(c2ccc(cc2)[N+](=O)[O-])C2=C(CC(C)(C)CC2=O)N1)C(=O)OC1CCCCC1,
GLPG0634 analog,GLPG0634 analogue; GLPG0634 analog,1206101-20-3,O=C(C1CC1)Nc1nn2c(c3ccc(OCc4ccc(C#N)nc4)cc3)cccc2n1,
SB 216763,SB216763,280744-09-4,N1C(=O)C(=C(C1=O)c1cn(c2c1cccc2)C)c1c(cc(cc1)Cl)Cl,
Pyridone 6,JAK Inhibitor; CMP 6; JAK Inhibitor I; Janus-Associated Kinase Inhibitor I,457081-03-7,CC(C)(C)c1nc2c([nH]1)c1ccc(F)cc1c1c2cc[nH]c1=O,
N-Ethylmaleimide,"NEM; Ethylmaleimide; 1-Ethyl-1H-pyrrole-2,5-dione",128-53-0,CCN1C(=O)C=CC1=O,
NQDI-1,NQDI1; NQDI 1; NQDI-1,175026-96-7,CCOC(=O)c1c2-c3ccccc3C(=O)c3cccc([nH]c1=O)c23,
L67,DNA Ligase Inhibitor,325970-71-6,Cc1c(Br)cc(NCC(=O)N\N=C\c2cc(ccc2O)[N+]([O-])=O)cc1Br,
PRT4165,PRT 4165; NSC600157,31083-55-3,c1ccc2c(c1)C(=O)C(=Cc1cnccc1)C2=O,
SC66,,871361-88-5,O=C1\C(CCC\C1=C/c1ccncc1)=C\c1ccncc1,
(Z)-Mirin,Mirin,1198097-97-0,NC1=NC(=O)\C(S1)=C\c1ccc(O)cc1,
KM11060,,774549-97-2,C1CN(CCN1c1c2ccc(cc2ncc1)Cl)S(=O)(=O)c1ccc(cc1)Cl,
Boldenone Undecylenate,Parenabol; Ba 29038; Boldenone Undecylenate; Vebonol,13103-34-9,C=CCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=CC(=O)C=C[C@]12C,
BML-284,Wnt agonist 1; BML-284,853220-52-7,COc1cccc(c1)-c1cc(NCc2ccc3OCOc3c2)nc(N)n1,
BMS-202,PD1-PDL1 inhibitor 2; BMS-202; PD-1/PD-L1 inhibitor 2,1675203-84-5,Cc1c(cccc1COc1nc(c(cc1)CNCCNC(=O)C)OC)c1ccccc1,
Pyrrolidinedithiocarbamate ammonium,1-Pyrrolidinedithiocarboxylic acid ammonium salt; APDC; PDTC; Ammonium pyrrolidinedithiocarbamate; Pyrrolidinedithiocarbamate,5108-96-3,[NH4+].[S-]C(=S)N1CCCC1,
Ciliobrevin A,HPI-4; Hedgehog Pathway Inhibitor 4,302803-72-1,Clc1ccc(C(=O)C(\C#N)=C2/NC(=O)c3ccccc3N2)c(Cl)c1,
PS 48,,1180676-32-7,OC(=O)\C=C(\CCc1ccc(Cl)cc1)c1ccccc1,
VX-11e,VTX-11e; Vertex-11e; TCS ERK 11e,896720-20-0,Cc1cnc(Nc2ccc(cc2Cl)F)nc1c1cc(C(=O)N[C@H](CO)c2cccc(c2)Cl)[nH]c1,
MN-64,MN64; MN 64; MN-64,92831-11-3,CC(C)c1ccc(cc1)c1cc(=O)c2ccccc2o1,
KC7F2,,927822-86-4,c1cc(c(cc1Cl)S(=O)(=O)NCCSSCCNS(=O)(=O)c1c(ccc(c1)Cl)Cl)Cl,
JNJ-42041935,HIF-PHD Inhibitor II; JNJ-42041935,1193383-09-3,c1c2c(cc(c1Cl)OC(F)(F)F)nc([nH]2)n1cc(cn1)C(=O)O,
WAY-181187,WAY181187; WAY 181187; WAY-181187; SAX-187,554403-49-5,c1ccc2c(c1)c(cn2S(=O)(=O)c1c(nc2n1ccs2)Cl)CCN,
Kevetrin hydrochloride,thioureido butyronitrile hydrochloride; 4-Isothioureidobutyronitrile hydrochloride; Thioureidobutyronitrile HCl,66592-89-0,C(CC#N)CSC(=N)N.Cl,
NS1643,,448895-37-2,c1c(ccc(c1NC(=O)Nc1c(O)ccc(c1)C(F)(F)F)O)C(F)(F)F,
Pimelic diphenylamide 106,Histone Deacetylase Inhibitor VII; TC-H 106; RGFA-8,937039-45-7,Cc1ccc(cc1)NC(=O)CCCCCC(=O)Nc1ccccc1N,
GNF-7,GNF7; GNF 7; GNF-7,839706-07-9,c1cc(cnc1C)Nc1nc2c(cn1)CN(C(=O)N2C)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F,
PTACH,NCH-51; Cpd 51,848354-66-5,CC(C)C(=O)SCCCCCCC(=O)Nc1nc(cs1)c1ccccc1,
DB07268,,929007-72-7,c1cccc(c1Nc1ccnc(n1)Nc1cccc(c1)O)C(=O)N,
WDR5-0103,WD-Repeat Protein 5-0103,890190-22-4,COC(=O)c1ccc(N2CCN(C)CC2)c(NC(=O)c2cccc(OC)c2)c1,
BML-210,BML210; BML 210; BML-210; CAY10433,537034-17-6,c1ccc(cc1)NC(=O)CCCCCCC(=O)Nc1ccccc1N,
UF010,,537672-41-6,CCCCNNC(=O)c1ccc(cc1)Br,
NKL 22,PAOA; NKL 22; Histone Deacetylase Inhibitor IV,537034-15-4,c1ccc(cc1)NC(=O)CCCCCC(=O)Nc1ccccc1N,
Oct3/4-inducer-1,2-(4-(4-methoxybenzyloxy)phenyl)acetonitrile,1016535-83-3,c1cc(ccc1CC#N)OCc1ccc(cc1)F,
NLRP3-IN-2,NLRP3 Inflammasome Inhibitor I; 5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide,16673-34-0,COc1c(cc(cc1)Cl)C(=O)NCCc1ccc(cc1)S(=O)(=O)N,
NVP-TNKS656,TNKS656,1419949-20-4,COc1ccc(cc1)C(=O)C1CCN(CC(=O)N(CC2CC2)Cc2nc(=O)c3COCCc3[nH]2)CC1,
Apoptozole,Apoptosis Activator VII,1054543-47-3,COC1=CC=C(C=C1)C2=C(N(C(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)CC4=CC=C(C=C4)C(=O)N)C5=CC=C(C=C5)OC,
Ciwujianoside B,Ciwujianoside-B; yemuoside YM; acanthopanax senticosides B,114902-16-8,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(=C)C[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O[C@@H]8OC[C@H](O)[C@H](O)[C@H]8O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,
AKT inhibitor VIII,AKTi-1/2,612847-09-3,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(cc2)-c2nc3cc4[nH]cnc4cc3nc2-c2ccccc2)CC1,
PIK-293,PIK293; PIK 293; PIK-293,900185-01-5,Cc1c2c(ccc1)nc(n(c2=O)c1ccccc1C)Cn1c2c(cn1)c(ncn2)N,
XL413,,1169558-38-6,Clc1ccc2oc3c(nc([nH]c3=O)[C@@H]3CCCN3)c2c1,
ITSA-1,ITSA1,200626-61-5,c1ccc2c(c1)nnn2C(=O)c1c(cc(cc1)Cl)Cl,
Wedelolactone,IKK Inhibitor II,524-12-9,COc1cc(c2c(c1)oc(=O)c1c2oc2cc(c(cc12)O)O)O,
Kuromanin chloride,Cyanidin 3-O-glucoside chloride; Chrysontemin; Chrysontemin chloride; Glucocyanidin chloride,7084-24-4,[Cl-].OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2ccc(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O,
Momordin Ic,Momordin 1c,96990-18-0,[C@@H]1([C@@H]([C@H]([C@@H]([C@@H](O1)O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@]1([C@@]3(CC[C@]4(CCC(C[C@H]4C3=CC[C@H]21)(C)C)C(=O)O)C)C)C)O)O[C@@H]1[C@H]([C@@H]([C@H](CO1)O)O)O)O)C(=O)O,
Pardoprunox hydrochloride,DU-126891 hydrochloride; SLV-308 hydrochloride,269718-83-4,O=c1oc2c(N3CCN(C)CC3)cccc2[nH]1.Cl.Cl,
Thiomyristoyl,,1429749-41-6,O=C(OCC1=CC=CC=C1)N[C@@H](CCCCNC(CCCCCCCCCCCCC)=S)C(NC2=CC=CC=C2)=O,
NVP-ACC789,ZK202650; ACC-789,300842-64-2,c1(nnc(c2ccccc12)Cc1ccncc1)Nc1cc(c(cc1)C)Br,
FIIN-3,FIIN3; FIIN 3; FIIN-3,1637735-84-2,C(=O)(C=C)Nc1ccc(cc1)CN(c1ncnc(c1)Nc1ccc(cc1)N1CCN(CC1)C)C(=O)Nc1c(c(cc(c1Cl)OC)OC)Cl,
PCI-27483,PCI27483; PCI 27483; PCI-27483,871266-63-6,NC(=N)c1ccc2nc([nH]c2c1)-c1cc(CC(=O)N[C@@H](CC(O)=O)C(O)=O)cc(c1O)-c1cc(ccc1O)S(N)(=O)=O,
Probimane,AT-2153; MM-159,108093-90-9,CC(CN1CC(=O)N(C(=O)C1)CN1CCOCC1)N1CC(=O)N(C(=O)C1)CN1CCOCC1,
HSP70-IN-1,,1268273-90-0,CN1CCN(CC1)c1ncc(Sc2cccc(NC(=O)CN)c2)c(OCc2ccccc2)n1,
PD-166866,PD166866; PD 166866; PD-166866,192705-79-6,COc1cc(OC)cc(c1)-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C,
LW6,LW8; HIF-1Î± inhibitor; CAY10585,934593-90-5,O=C(OC)C1=CC=C(O)C(NC(COC2=CC=C(C3(C4)CC5CC4CC(C5)C3)C=C2)=O)=C1,
Buprofezin,Applaud; Buprofezine; NNI 750,69327-76-0,CC(C)N1C(=O)N(CS\C1=N/C(C)(C)C)c1ccccc1,
CCG215022,,1813527-81-9,O=C(c1c(F)ccc(C2C(=C(C)NC(=O)N2)C(=O)Nc2ccc3[nH]ncc3c2)c1)NCc1ncccc1,
GSK180736A,GSK180736,817194-38-0,CC1=C(C(NC(=O)N1)c1ccc(cc1)F)C(=O)Nc1cc2c(cc1)[nH]nc2,
CZ415,,1429639-50-8,O=C(NCC)Nc1ccc(c2nc(N3[C@@H](C)COCC3)c3c(C(C)(C)S(=O)(=O)C3)n2)cc1,
RO8994,,1309684-94-3,O=C([C@@H]1N[C@@H](CC(C)(C)C)[C@]2([C@H]1c1cccc(Cl)c1F)C(=O)Nc1c2ccc(Cl)c1)Nc1ccc(C(=O)N)cc1OC,
GSK269962A,GSK 269962; GSK269962A HCl; GSK269962B,850664-21-0,CCn1c2cc(ncc2nc1c1nonc1N)Oc1cccc(c1)NC(=O)c1ccc(cc1)OCCN1CCOCC1,
Formosanin C,Polyphyllin B; Formosanin C,50773-42-7,[C@H]1([C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5O[C@@]6([C@H]([C@@H]5[C@]4(CC[C@@H]3[C@]2(CC1)C)C)C)CC[C@H](CO6)C)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O)O)CO,
Senicapoc,ICA-17043,289656-45-7,NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1,
Apilimod mesylate,STA 5326 mesylate,870087-36-8,Cc1cccc(c1)/C=N/Nc1nc(nc(c1)N1CCOCC1)OCCc1ccccn1.CS(=O)(=O)O.CS(=O)(=O)O,
GSK583,,1346547-00-9,O=S(=O)(c1ccc2nccc(Nc3n[nH]c4c3cc(F)cc4)c2c1)C(C)(C)C,
IMR-1A,,331862-41-0,COc1cc(\C=C2/SC(=S)NC2=O)ccc1OCC(O)=O,
STO-609,STO609; STO 609; STO-609,52029-86-4,c1ccc2c(c1)nc1n2c(=O)c2cccc3c(ccc1c23)C(=O)O,
Y16,,429653-73-6,Cc1cc(ccc1)COc1cccc(c1)C=C1C(=O)NN(C1=O)c1ccccc1,
RG14620,RG 14620; Tyrphostin RG14620,136831-49-7,Clc1cc(Cl)cc(\C=C(\C#N)c2cccnc2)c1,
ML364,,1991986-30-1,Cc1ccc(cc1)S(=O)(=O)Nc1cc(ccc1C(=O)Nc1nc(cs1)-c1ccccc1)C(F)(F)F,
NIH-12848,NIH12848; NIH 12848; NIH-12848,959551-10-1,FC(F)(F)c1ccccc1c1nc2ccccc2c(NCc2cccs2)n1,
EBE-A22,PD153035 Analog 63,229476-53-3,CN(c1cc(ccc1)Br)c1ncnc2cc(c(cc12)OC)OC,
Desmethylanethol trithione,ADT-OH,18274-81-2,Oc1ccc(cc1)-c1cc(=S)ss1,
SU5205,SU 5205,3476-86-6,Fc1ccc(\C=C2\C(=O)Nc3ccccc23)cc1,
SU5214,SU 5214,186611-04-1,COc1ccccc1\C=C1\C(=O)Nc2ccccc12,
NSC 15364,"1,3-Bis(4-aminophenyl)urea; NSC15364",4550-72-5,c1cc(ccc1N)NC(=O)Nc1ccc(cc1)N,
Sematilide hydrochloride,Sematilide HCl; CK-1752A; CK-1752,101526-62-9,CCN(CC)CCNC(=O)c1ccc(cc1)NS(=O)(=O)C.Cl,
KS176,,1253452-78-6,c1ccc(c(c1)C(=O)Nc1ccc(cc1)CCO)NC(=O)c1ccc(cc1)[N+](=O)[O-],
Compound 401,"2-morpholino-4H-pyrimido[2,1-a]isoquinolin-4-one",168425-64-7,C1COCCN1c1cc(=O)n2ccc3ccccc3c2n1,
NOD-IN-1,Compound 4,132819-92-2,O=C(c1n(S(=O)(=O)c2ccc(C)cc2)c2c(c1)cccc2)OCC,
JK184,,315703-52-7,CCOc1ccc(cc1)Nc1nc(cs1)c1c(nc2n1cccc2)C,
NSC23005 Sodium,,1796596-46-7,C1CCC(CC1)NS(=O)(=O)c1ccc(cc1)C(=O)[O-].[Na+],
NSC23005,,6314-70-1,C1CCC(CC1)NS(=O)(=O)c1ccc(cc1)C(=O)O,
Src Inhibitor 1,Src-l1; Src Kinase Inhibitor 1,179248-59-0,COc1c(cc2c(c1)c(ncn2)Nc1ccc(cc1)Oc1ccccc1)OC,
ML346,,100872-83-1,COc1ccc(cc1)\C=C\C=C1\C(=O)NC(=O)NC1=O,
IQ-1S free acid,IQ-1S; IQ-1; IQ-1S (free acid),23146-22-7,O/N=C/1\c2c(c3nc4ccccc4nc13)cccc2,
Madrasin,DDD00107587,374913-63-0,O=c1[nH]c(Nc2nc(C)c3ccc(OC)cc3n2)nc(C)c1C,
IQ 1,IQ1; IQ 1; IQ-1,331001-62-8,CC(=O)c1ccc(N\N=C(C(N)=O)/C2=NC(C)(C)Cc3ccccc23)cc1,
(E)-SIS3,SIS3; SIS3 HCl,521984-48-5,Cn1c(c(c2c1nccc2)/C=C/C(=O)N1CCc2cc(c(cc2C1)OC)OC)c1ccccc1.Cl,
A-804598,A804598; A 804598; A-804598,1125758-85-1,C[C@H](N\C(NC#N)=N/c1cccc2ncccc12)c1ccccc1,
NVP-BAW2881,BAW2881; NVP-BAW2881,861875-60-7,O=C(c1c2ccc(Oc3nc(N)ncc3)cc2ccc1)Nc1cccc(C(F)(F)F)c1,
U93631,,152273-12-6,CC1(c2c(ncn2c2ccccc2N1)C(=O)OC(C)(C)C)C,
Hypidone hydrochloride,YL0919,1339058-04-6,Cl.O=c1ccccn1CC1(O)CCN(Cc2ccccc2)CC1,
YM-58483,YM58483; YM 58483; YM-58483; BTP2,223499-30-7,Cc1nnsc1C(=O)Nc1ccc(cc1)-n1nc(cc1C(F)(F)F)C(F)(F)F,
KRIBB11,,342639-96-7,CNc1nc(c(cc1)[N+](=O)[O-])Nc1cc2c(cc1)[nH]nc2,
MX69,,1005264-47-0,Cc1cc(ccc1C)NS(=O)(=O)c1ccc2NC(C3CC=CC3c2c1)c1ccc(cc1)C(=O)O,
APY29,,1216665-49-4,C1CC1c1cc(n[nH]1)Nc1nc(ncc1)Nc1cc2c(cc1)nc[nH]2,
BMS-1,PD-1/PD-L1 inhibitor 1; BMS-1; PD1-PDL1 inhibitor 1,1675201-83-8,COc1cc(OCc2cccc(-c3ccccc3)c2C)cc(OC)c1CN1CCCC[C@H]1C(O)=O,
CP21R7,CP21,125314-13-8,C1(=O)C(=C(C(=O)N1)c1cc(ccc1)N)c1cn(c2c1cccc2)C,
10074-G5,,413611-93-5,c1ccc(cc1)c1ccccc1Nc1ccc(c2nonc12)[N+](=O)[O-],
GNE-477,GNE 477,1032754-81-6,Cc1c(sc2c1nc(nc2N1CCOCC1)c1cnc(nc1)N)CN1CCN(CC1)S(=O)(=O)C,
Bay 59-3074,,406205-74-1,O=S(=O)(CCCC(F)(F)F)Oc1cccc(Oc2cccc(C(F)(F)F)c2C#N)c1,
GNE-3511,GNE3511; GNE 3511; GNE-3511,1496581-76-0,N#CC=1C=CN=C(C1)NC=2N=C(C=C(C2)C3CCN(CC3)C4COC4)N5CCC(F)(F)C5,
BP-1-102,,1334493-07-0,O=C(O)C1=CC=C(C=C1O)N(C(=O)CN(C)S(=O)(=O)C=2C(F)=C(F)C(F)=C(F)C2F)CC3=CC=C(C=C3)C4CCCCC4,
XMD8-87,ACK1-B19,1234480-46-6,COc1cc(ccc1Nc1ncc2NC(=O)c3ccccc3N(C)c2n1)N1CCN(C)CC1,
XMD16-5,,1345098-78-3,CN1c2ccccc2C(=O)Nc2cnc(Nc3ccc(cc3)N3CCC(O)CC3)nc12,
RAF709,,1628838-42-5,O=C(NC1=CN=C(C(=C1)C=2C=NC(OC3CCOCC3)=C(C2)N4CCOCC4)C)C5=CC=CC(=C5)C(F)(F)F,
SUN11602,SUN 11602,704869-38-5,C(=O)(c1ccc(cc1)CN1CCC(CC1)N(C)C(=O)CNc1c(c(c(c(c1C)C)N)C)C)N,
Rolapitant,SCH619734,552292-08-7,C[C@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)OC[C@]1(CC[C@]2(CCC(=O)N2)CN1)c1ccccc1,
Avitinib maleate,,1557268-88-8,CN1CCN(CC1)c1c(cc(cc1)Nc1nc2c(cc[nH]2)c(n1)Oc1cccc(c1)NC(=O)C=C)F.C(=C\C(=O)O)\C(=O)O,
MK-1064,MK1064; MK 1064; MK-1064; Urokinase inhibitor 1,1207253-08-4,COc1c(nc(cc1)CNC(=O)c1c(ncc(c1)c1cc(cnc1)Cl)c1ccccn1)OC,
Rolapitant hydrochloride hydrat,Rolapitant HCl,858102-79-1,O.Cl.C[C@@H](OC[C@]1(CC[C@]2(CCC(=O)N2)CN1)c1ccccc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F,
K-Ras(G12C) Inhibitor 6,,2060530-16-5,Clc1ccc(OCC(=O)N2CCC(NC(=O)CCCS)CC2)c(Cl)c1,
Jujuboside A,,55466-04-1,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC[C@@H]4[C@@H]6[C@]7(C[C@@]54CO7)O[C@H](C[C@]6(C)O)\C=C(/C)C)C3(C)C)OC[C@H](O)[C@@H]2O[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,
20(R)-Ginsenoside Rh2,(R)Ginsenoside-Rh2; (20R)Ginsenoside Rh2; 20(R)-Ginsenoside Rh2,112246-15-8,C\C(C)=C/CC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C,
Polygalasaponin F,,882664-74-6,C1C(CC[C@@]2(CC[C@]3([C@@]4(CC[C@H]5[C@]([C@H]([C@H](C[C@@]5([C@H]4CC=C3[C@H]12)C)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)(C)CO)C)C)C(=O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O[C@H]1[C@@H]([C@H]([C@@H](CO1)O)O)O)O)O)(C)C,
20(R)-Ginsenoside Rg2,20R-Ginsenoside Rg2,80952-72-3,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@H]2C[C@]3(C)[C@H](C[C@@H](O)[C@@H]4[C@H](CC[C@@]34C)[C@](C)(O)CC\C=C(/C)C)[C@@]3(C)CC[C@H](O)C(C)(C)[C@H]23)[C@H](O)[C@H](O)[C@H]1O,
Dihydroresveratrol,"3,4',5-Trihydroxybibenzyl",58436-28-5,c1cc(ccc1CCc1cc(cc(c1)O)O)O,
Platycodin D,,58479-68-8,C1C(CC[C@@]2([C@@H](C[C@@]3([C@@]4(CC[C@H]5C([C@H]([C@H](C[C@@]5(C4CC=C3[C@H]12)C)O)O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)(CO)CO)C)C)O)C(=O)O[C@@H]1OC[C@@H]([C@@H]([C@H]1O[C@@H]1O[C@H]([C@@H]([C@H]([C@H]1O)O)O[C@@H]1OC[C@H]([C@@H]([C@H]1O)O[C@@H]1OC[C@@]([C@H]1O)(CO)O)O)C)O)O)(C)C,
Protopanaxatriol,20(R)-APPT; 20(R)-Protopanaxatriol; (20R)-Protopanaxatriol,1453-93-6,C\C(C)=C\CC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O)C[C@@]21C,
Ginsenoside Rb3,Gypenoside IV,68406-26-8,C\C(C)=C/CC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C,
Jatrorrhizine,neprotin; Yatrorizine,3621-38-3,c1[n+]2c(cc3ccc(c(c13)OC)OC)c1c(CC2)cc(c(c1)OC)O,
Methyl L-histidinate dihydrochloride,L-Histidine methyl ester dihydrochloride,7389-87-9,Cl.Cl.COC(=O)[C@@H](N)Cc1cnc[nH]1,
CID5721353,BCL6 inhibitor,301356-95-6,S=C1S/C(C(=O)N1C(CC(=O)O)C(=O)O)=C2/c3cc(Br)ccc3NC2=O,
NSC632839,F6; Ubiquitin Isopeptidase Inhibitor II,157654-67-6,Cl.Cc1ccc(cc1)\C=C1/CNC\C(C1=O)=C/c1ccc(C)cc1,
TPEN,TPEDA,16858-02-9,C(CN(Cc1ccccn1)Cc1ccccn1)N(Cc1ccccn1)Cc1ccccn1,
Salermide,,1105698-15-4,CC(C(=O)Nc1cccc(c1)\N=C\c1c(O)ccc2ccccc12)c1ccccc1,
Adelmidrol,,1675-66-7,C(CCCC(=O)NCCO)CCCC(=O)NCCO,
Sodium ionophore III,ETH2120; Sodium ionophore III,81686-22-8,O=C(N(C1CCCCC1)C1CCCCC1)COc1ccccc1OCC(=O)N(C1CCCCC1)C1CCCCC1,
Farampator,Org24448; CX-691,211735-76-1,O=C(N1CCCCC1)c1cc2nonc2cc1,
ICA-069673,ICA069673,582323-16-8,c1cc(c(cc1C(=O)Nc1cnc(nc1)Cl)F)F,
T56-LIMKi,T5601640,924473-59-6,Cc1noc(c1)C(=O)Nc1cccc(c1)C(=O)Nc1cccc(c1)C(F)(F)F,
TPI-1,TPI1; TPI 1; TPI-1,79756-69-7,c1cc(c(cc1Cl)C1=CC(=O)C=CC1=O)Cl,
CASIN,Pirl1-related Compound 2,425399-05-9,C1CC(c2c(C1)c1c([nH]2)ccc(c1)c1ccccc1)NCCO,
Cytosporone B,Dothiorelone G; Csn-B,321661-62-5,CCCCCCCC(=O)c1c(O)cc(O)cc1CC(=O)OCC,
Su1498,Tyrphostin SU 1498; AG 1498,168835-82-3,CC(C)c1cc(cc(C(C)C)c1O)\C=C(/C#N)C(=O)NCCCc1ccccc1,
TMP195,TMP 195; TFMO 2,1314891-22-9,CC(C)(CNC(=O)c1cccc(c1)c1noc(n1)C(F)(F)F)c1coc(n1)c1ccccc1,
GDC-0326,GDC0326; GDC 0326; GDC-0326,1282514-88-8,C(=O)([C@H](C)Oc1ccc2c3n(CCOc2c1)cc(n3)c1n(ncn1)C(C)C)N,
SMI-16a,PIM1/2 Kinase Inhibitor VI,587852-28-6,CCCOc1ccc(cc1)\C=C1/SC(=O)NC1=O,
FDI-6,FDI6; FDI 6; FDI-6,313380-27-7,C1=CSC(=C1)C2=NC3=C(C(=C2)C(F)(F)F)C(=C(S3)C(=O)NC4=CC=C(C=C4)F)N,
SGC2085 HCl,,1821908-49-9,C(=O)([C@H](C)N)NCc1cc(c(cc1)Oc1cc(cc(c1)C)C)C.Cl,
CP-724714,CP724714; CP 724714; CP-724714,383432-38-0,COCC(=O)NC\C=C\c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,
HG-14-10-04,,1356962-34-9,CN1CCN(C2CCN(c3ccc(Nc4ncc(Cl)c(c5c[nH]c6c5cccc6)n4)c(OC)c3)CC2)CC1,
Cambinol,SIRT1/2 Inhibitor IV; NSC 112546,14513-15-6,O=C1NC(=S)NC(C=2C=CC=CC2)=C1CC3=C(O)C=CC=4C=CC=CC43,
QS11,QS 11,944328-88-5,OC[C@H](Cc1ccccc1)Nc1c2c(n(Cc3ccc(c4ccccc4)cc3)cn2)nc(Oc2ccc3CCCc3c2)n1,
Norharmane,"2-Azacarbazole; Î²-Carboline; 2,9-Diazafluorene",244-63-3,c12ccccc1c1ccncc1[nH]2,
SU5408,VEGFR2 Kinase Inhibitor I; SU5408,15966-93-5,CCOC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccccc23)c1C,
ML329,,19992-50-8,c1(ccc(cc1)NC1=CC(=O)c2ccccc2C1=O)S(=O)(=O)N,
ML213,CID-3111211,489402-47-3,C12C(CC(CC1)C2)C(=O)Nc1c(cc(cc1C)C)C,
MSX-127,MSX127; MSX 127; MSX-127,6616-56-4,c1(c(cc(c(c1)O)CN1CCOCC1)O)CN1CCOCC1,
MSX-130,MSX130; MSX 130; MSX-130,4051-59-6,c1(ccc(cc1)c1nc(c([nH]1)c1ccccc1)c1ccccc1)c1[nH]c(c(n1)c1ccccc1)c1ccccc1,
R-IMPP,,2133832-83-2,COc1ccc(CCC(=O)N([C@@H]2CCCNC2)c2nccc3ccccc23)cc1,
CAY10602,,374922-43-7,Fc1ccc(cc1)n1c2nc3ccccc3nc2c(c1N)S(=O)(=O)c1ccccc1,
GSK-872,GSK872; GSK'872; GSK2399872A,1346546-69-7,CC(C)S(=O)(=O)c1ccc2c(c1)c(ccn2)Nc1cc2ncsc2cc1,
LY-294002 hydrochloride,SF 1101; NSC 697286,934389-88-5,C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC=C4.Cl,
MPTP hydrochloride,MPTP-hydrochloride,23007-85-4,Cl.CN1CCC(=CC1)c1ccccc1,
BAR501,BAR 501,1632118-69-4,CC[C@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]2CC[C@]3([C@H]([C@@H]2[C@H]1O)CC[C@@H]3[C@H](C)CCCO)C)C)O,
Paris saponin VII,Chonglou Saponin VII; Dioscinin; Polyphyllin-VII; Paris saponin-VII,68124-04-9,[C@@H]1([C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O[C@H]1[C@@H](O[C@H]([C@@H]([C@@H]1O)O)O[C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5O[C@@]6([C@H]([C@@]5([C@]4(CC[C@@H]3[C@]2(CC1)C)C)O)C)CC[C@H](CO6)C)CO)C,
FX1,,1426138-42-2,C1=CC2=C(C=C1Cl)/C(=C/3\C(=O)N(C(=S)S3)CCC(=O)O)/C(=O)N2,
AG126,AG 126; Tyrphostin AG126,118409-62-4,C1=CC(=C(C=C1C=C(C#N)C#N)O)[N+](=O)[O-],
ZINC00881524,ROCK inhibitor,557782-81-7,O=C(Nc1nc2c(CCc3c2cccc3)s1)Cc1ccc(OC)c(OC)c1,
SC-560,SC560; SC 560; SC-560,188817-13-2,COc1ccc(cc1)-n1nc(cc1-c1ccc(Cl)cc1)C(F)(F)F,
MK-8617,MK8617; MK 8617; MK-8617,1187990-87-9,COc1ccc(cc1)C(c1ccc(cc1)OC)NC(=O)c1cnc([nH]c1=O)c1nnccc1,
3-TYP,"3-(1H-1,2,3-triazol-4-yl) pyridine",120241-79-4,c1[nH]nnc1-c1cccnc1,
Zuclopenthixol,(Z)-Clopenthixol; Cisordinol; cis-Clopenthixol,53772-83-1,OCCN1CCN(CC\C=C2\c3ccccc3Sc3ccc(Cl)cc23)CC1,
HSF1A,,1196723-93-9,CCc1ccc(cc1)S(=O)(=O)Nc1cc(nn1-c1ccccc1)-c1cccs1,
CBL0137,CBLC137; Curaxin 137,1197996-80-7,CC(C)NCCn1c2c(cc(cc2)C(=O)C)c2c1ccc(c2)C(=O)C,
BPTU,BMS-646786,870544-59-5,CC(C)(C)C1=CC=CC=C1OC2=C(C=CC=N2)NC(=O)NC3=CC=C(C=C3)OC(F)(F)F,
CCT196969,,1163719-56-9,CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)cc2F)n(n1)-c1ccccc1,
IRAK4-IN-1,,1820787-94-7,N#Cc1cc2c(ncnc2N[C@@H]2CC[C@@H](N3CCOCC3)CC2)cc1,
CY-09,CY09; CY 09; CY-09,1073612-91-5,S=C3S\C(=C/c1ccc(cc1)C(=O)O)C(=O)N3Cc2cc(ccc2)C(F)(F)F,
Raf inhibitor 1 dihydrochloride,B-Raf inhibitor 1 dihydrochloride,1191385-19-9,Cc1c(c2c(cc1)c(ncc2)Nc1ccc(cc1)Cl)Nc1c(cccn1)c1c2c(ncn1)nc[nH]2.Cl.Cl,
PEAQX,NVP-AAM077,459836-30-7,O=c1c(=O)[nH]c2c(c(C(P(=O)(O)O)N[C@H](c3ccc(Br)cc3)C)ccc2)[nH]1,
Methoxy-PMS,1-Methoxy PMS; 1-Methoxyphenazine methosulfate; Methoxy-PMS,65162-13-2,COS([O-])(=O)=O.COc1cccc2[n+](C)c3ccccc3nc12,
rac-BHFF,"(R,S)-BHFF",123557-91-5,CC(C)(C)c1cc(c2c(c1)C(C(=O)O2)(C(F)(F)F)O)C(C)(C)C,
lavendustin C,HDBA; NSC 666251,125697-93-0,O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O,
SDZ285428,SDZ285-428,174262-13-6,O=C(c1ccc(c2ccc(Cl)cc2)cc1)NCC(n1ccnc1)c1ccccc1,
Ticlopidine,Ticlid; PCR 5332,55142-85-3,C1CN(Cc2c1scc2)Cc1ccccc1Cl,
Multi-kinase inhibitor 1,Multi-kinase inhibitor I,778274-97-8,O=C(NCCO)c1ccc(c2ncnc(Nc3ccc(OC(F)(F)F)cc3)c2)cc1,
Raf inhibitor 2,CID25014542; CID 25014542; CID-25014542,220904-99-4,Oc1c(Br)cc(cc1Br)\C=C1/C(=O)Nc2ccc(Cl)cc12,
Betahistine,Vasomotal; Serc base; PT 9 base,5638-76-6,CNCCc1ncccc1,
Desmethyl-VS-5584,,1246535-95-4,Nc1ncc(c2c3ncn(C(C)C)c3nc(N3CCOCC3)n2)cn1,
AG-494,AG 494; Tyrphostin AG-494; Tyrphostin B48,133550-35-3,Oc1ccc(cc1O)\C=C(/C#N)C(=O)Nc1ccccc1,
XMU-MP-1,,2061980-01-4,O=S(C1=CC=C(NC2=NC=C3C(N(C)C(C=CS4)=C4C(N3C)=O)=N2)C=C1)(N)=O,
NCT-503,NCT503; NCT 503; NCT-503,1916571-90-8,Cc1cc(nc(c1)NC(=S)N1CCN(CC1)Cc1ccc(cc1)C(F)(F)F)C,
TCS-PIM-1-4a,SMI-4a; TCS-PIM-1-4a,327033-36-3,FC(F)(F)c1cccc(C=C2SC(=O)NC2=O)c1,
STAT5-IN-1,STAT5 Inhibitor; STAT5-IN-1,285986-31-4,O=C(N\N=C\c1coc2ccccc2c1=O)c1cccnc1,
INF39,,866028-26-4,CCOC(=O)C(=C)Cc1ccccc1Cl,
Autophinib,,1644443-47-9,Cc1cc(n[nH]1)Nc1cc(nc(n1)Oc1ccc(cc1)[N+](=O)[O-])Cl,
BQR-695,BQR695; BQR 695; BQR-695; NVP-BQR695,1513879-21-4,CNC(=O)CNc1cnc2ccc(cc2n1)c1cc(c(cc1)OC)OC,
PF-06260933,PF6260933; PF 6260933; PF-6260933; PF-06260933,1811510-56-1,c1cc(ccc1c1c(ncc(c1)c1cnc(cc1)N)N)Cl,
ML335,,825658-06-8,CS(=O)(=O)Nc1ccc(cc1)C(=O)NCc1c(cc(cc1)Cl)Cl,
Nolatrexed,,147149-76-6,Cc1ccc2nc(N)[nH]c(=O)c2c1Sc1ccncc1,
HJC0152 hydrochloride,HJC0152,1420290-99-8,NCCOc1ccc(cc1C(=O)Nc1ccc(cc1Cl)[N+](=O)[O-])Cl.Cl,
IWP-4,IWP 4; Inhibitor of Wnt Production-4,686772-17-8,COc1ccccc1-n1c(SCC(=O)Nc2nc3ccc(C)cc3s2)nc2CCSc2c1=O,
GJ103 sodium salt,,1459687-96-7,[Na+].COc1cccc(c1)-n1c(SCC([O-])=O)nnc1-c1ccccn1,
ML327,,1883510-31-3,O=C(NCCCNC(=O)C1=CC=CNC1=O)c2cc(on2)c3ccccc3,
TM5441,,1190221-43-2,OC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)Nc1cccc(c1)-c1ccco1,
BPR1J-097 hydrochloride (1327167-19-0(free base)),,T4261,Cl.CN1CCN(CC1)c1ccc(cc1)C(=O)Nc1cc([nH]n1)-c1cccc(NS(=O)(=O)c2ccccc2)c1,
BAY 61-3606,Syk inhibitor IV,732983-37-8,COc1ccc(cc1OC)-c1cc2nccn2c(Nc2ncccc2C(N)=O)n1,
Takinib,EDHS-206,1111556-37-6,CCCN1C2=CC=CC=C2N=C1NC(=O)C3=CC=CC(=C3)C(=O)N,
LY334370,LY 334370,182563-08-2,O=C(NC1=CC2=C(NC=C2C3CCN(C)CC3)C=C1)C4=CC=C(F)C=C4,
Melitracen hydrochloride,Thymeol hydrochloride; Melixeran,10563-70-9,Cl.CN(C)CC\C=C1\c2ccccc2C(C)(C)c2ccccc12,
Hydroxyfasudil Hydrochloride,HA 1100 hydrochloride; Hydroxyfasudil (HA-1100) HCl,155558-32-0,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CNC3=O.Cl,
Endoxifen,(E/Z)-Endoxifen; Endoxifen; (E/Z)-N-desmethyl-4-hydroxy Tamoxifen,110025-28-0,CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1,
SRI-011381,SRI011381; SRI 011381; SRI-011381,1629138-41-5,O=C(NC1CCCCC1)N(CC1CCNCC1)Cc1ccccc1,
Succinobucol,Probucol monosuccinate; AGI-1067,216167-82-7,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc1cc(c(c(c1)C(C)(C)C)OC(=O)CCC(=O)O)C(C)(C)C,
hVEGF-IN-1,,1637443-98-1,CCN(CC)CCOc1ccc(cc1)Nc1nc(c2c(NC(=O)CCN3CCN(C)CC3)cccc2)nc2ccccc12,
(+)-Isocorydine hydrochloride,Isocorydine HCl,13552-72-2,Cl.COc1ccc2C[C@@H]3N(C)CCc4cc(OC)c(OC)c(c34)-c2c1O,
(R)-GNE-140,GNE-140,2003234-63-5,OC1=C(Sc2ccccc2Cl)C(=O)N[C@@](C1)(c1cccs1)c1ccc(cc1)N1CCOCC1,
AD80,,1384071-99-1,CC(C)N1C2=C(C(=N1)C3=CC=C(C=C3)NC(=O)NC4=C(C=CC(=C4)C(F)(F)F)F)C(=NC=N2)N,
iCRT3,,901751-47-1,O=C(NCCC1=CC=CC=C1)CSCC2=C(C)OC(C3=CC=C(CC)C=C3)=N2,
CCG-203971,CCG203971; CCG 203971; CCG-203971,1443437-74-8,O=C(C1CN(C(C2=CC=CC(C3=CC=CO3)=C2)=O)CCC1)NC4=CC=C(Cl)C=C4,
Prexasertib,LY2606368,1234015-52-1,COC1=C(C(=CC=C1)OCCCN)C2=CC(=NN2)NC3=NC=C(N=C3)C#N,
HAMNO,NSC111847,138736-73-9,Oc1ccccc1N\C=C1/C(=O)C=Cc2ccccc12,
ML365,,947914-18-3,COc1ccccc1C(=O)Nc1cccc(NC(=O)c2cccc(C)c2)c1,
AG 555,Tyrphostin AG 555; Tyrphostin B46,133550-34-2,c1ccc(cc1)CCCNC(=O)/C(=C/c1cc(c(cc1)O)O)/C#N,
CaCCinh-A01,,407587-33-1,CC(C)(C)C1CCC2=C(C1)SC(=C2C(=O)O)NC(=O)C3=CC=CO3,
GNE-617,GNE617; GNE 617; GNE-617,1362154-70-8,C1=CC(=CC=C1CNC(=O)C2=CN3C=CN=C3C=C2)S(=O)(=O)C4=CC(=CC(=C4)F)F,
PCI 29732,PCI29732; PCI 29732; PCI-29732,330786-25-9,C1CCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N,
USP7/USP47 inhibitor,USP7/47 inhibitor-1,1247825-37-1,CS(=O)(=O)C1=CC=C(C=C1)NC(=O)C2=CC(=C(S2)SC3=C(C=NC=C3Cl)Cl)C#N,
YU238259,,1943733-16-1,COc1ccc(cc1)S(=O)(=O)NCc2ccc(cc2)C(=O)NCCc3ccc(Cl)cn3,
ALW-II-41-27,Eph receptor tyrosine kinase inhibitor,1186206-79-0,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(c4)-c4cccs4)c3)cc2C(F)(F)F)CC1,
CeMMEC1,CeMMEC1 HCl,440662-09-9,O=C2c1ccccc1C(=CN2C)C(=O)Nc3ccc4OCCOc4c3,
DAMGO,DAGO; RX-783006; Dagol,78123-71-4,Oc2ccc(C[C@H](N)C(=O)N[C@H](C)C(=O)NCC(=O)N(C)[C@@H](Cc1ccccc1)C(=O)NCCO)cc2,
CGP52432,CGP 52432,139667-74-6,CCOC(OCC)P(=O)(CCCNCC1=CC(=C(C=C1)Cl)Cl)O,
Mycro 3,Mycro-3; Mycro 3,944547-46-0,CCOC(=O)c1c(n(nc1)c1ccccc1)NC(=O)c1nn2c(cc(nc2c1)c1ccco1)C(F)(F)Cl,
SCH-23390 hydrochloride,SCH 23390 hydrochloride; R-(+)-SCH23390 hydrochloride,125941-87-9,OC1=C(Cl)C=C2CCN(C)C[C@H](C3=CC=CC=C3)C2=C1.[H]Cl,
Resminostat hydrochloride,4SC-201 hydrochloride; RAS2410 hydrochloride,1187075-34-8,O=C(NO)/C=C/C1=CN(S(=O)(C2=CC=C(CN(C)C)C=C2)=O)C=C1.Cl,
PF-4840154,PF4840154; PF 4840154; PF-4840154,1332708-14-1,CC(C)CNc2nc(ncc2C(=O)NCc1ccccc1)N3CCN(CC3)CC4CCCOC4,
PHTPP,,805239-56-9,C1=CC=C(C=C1)C2=NN3C(=CC(=NC3=C2C4=CC=C(C=C4)O)C(F)(F)F)C(F)(F)F,
SR-4370,SR4370; SR 4370; SR-4370,1816294-67-3,Fc1c(cccc1F)c2ccc(cc2)C(=O)NNCCCC,
Syk Inhibitor II (hydrochloride),,227449-73-2,Cl.Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(c2)C(F)(F)F)n1,
LX2343,,333745-53-2,Clc1cc(c(OC)cc1)N(CC(=O)Nc2ccc3OCOc3c2)S(=O)(=O)c4ccccc4,
ML239,CID-49843203,1378872-36-6,Clc1cc(Cl)c(OCC(=O)N\N=C\c2ccc[nH]2)c(Cl)c1,
DIM-C-pPhOH,CDIM8,151358-47-3,Oc1ccc(cc1)C(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,
LM10,,1316695-35-8,Fc1ccc2c(\C=C\c3nnn[nH]3)c[nH]c2c1,
LDC-4297 HCl (1453834-21-3(free base)),,T4417,Cl.CC(C)c1cnn2c(NCc3ccccc3-n3cccn3)nc(OC3CCCNC3)nc12,
UNC2025 2HCl (1429881-91-3(free base)),,T4419,Cl.Cl.CCCCNc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(CN2CCN(C)CC2)cc1,
LY 303511 hydrochloride,LY303511 hydrochloride,2070014-90-1,Cl.O=C2C=C(Oc1c(cccc12)c3ccccc3)N4CCNCC4,
JK-P3,,942655-44-9,COc1c(cc(cc1)C(=O)Nc1n[nH]c(c1)c1ccccc1)OC,
CCT241736,,1402709-93-6,Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1,
Saclofen,,125464-42-8,NCC(CS(O)(=O)=O)c1ccc(Cl)cc1,
MK2-IN-1 hydrochloride,MK2 Inhibitor; MK 25,1314118-94-9,Cl.Clc1ccc(cc1)-c1ccc(o1)C(=O)N(Cc1ccccn1)c1ccc(cc1)N1CCNCC1,
Pyridostatin Trihydrochloride,RR-82 Trihydrochloride; Pyridostatin Trihydrochloride(free base 1085412-37-8 ),T4457,Cl.Cl.Cl.NCCOc1cc(nc(c1)C(=O)Nc1cc(OCCN)c2ccccc2n1)C(=O)Nc1cc(OCCN)c2ccccc2n1,
PK11000,,38275-34-2,O=S(C)(=O)c1nc(C(=O)O)c(Cl)cn1,
Pyridostatin TFA,,1472611-44-1,OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NCCOc1cc(nc(c1)C(=O)Nc1cc(OCCN)c2ccccc2n1)C(=O)Nc1cc(OCCN)c2ccccc2n1,
ST271,ST 271,106392-48-7,CC(C)c1cc(cc(c1O)C(C)C)/C=C(\C#N)/C(=O)N,
ML-18,ML 18,1422269-30-4,COc1ccc(cc1)C1(CCCCC1)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)Nc1ccc(cc1)[N+](=O)[O-],
AG 1406,,71308-34-4,CC(C)c1cc(cc(c1O)C(C)C)C=C(C#N)C#N,
Z-DEVD-FMK,Caspase-3 Inhibitor,210344-95-9,COC(=O)CC[C@H](NC(=O)[C@H](CC(=O)OC)NC(=O)OCc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)OC)C(=O)CF,
Birinapant,TL32711,1260251-31-7,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c([nH]c2cc(F)ccc12)-c1[nH]c2cc(F)ccc2c1C[C@@H]1C[C@H](O)CN1C(=O)[C@H](CC)NC(=O)[C@H](C)NC,
CNX-2006,CNX2006; CNX 2006; CNX-2006,1375465-09-0,COc1c(Nc2ncc(c(Nc3cccc(NC(=O)C=C)c3)n2)C(F)(F)F)ccc(NC2CN(CCF)C2)c1,
Linsitinib,OSI-906,867160-71-2,C[C@]1(C[C@@H](C1)c1nc(c2n1ccnc2N)c1cc2c(cc1)ccc(n2)c1ccccc1)O,
LY404039,pomaglumetad,635318-11-5,C1[C@]([C@@H]2[C@H]([C@@H]2S1(=O)=O)C(=O)O)(C(=O)O)N,
Zotarolimus,A 179578; ABT-578,221877-54-9,[H][C@@]12CCCCN1C(=O)C(=O)[C@]1(O)O[C@@H](CC[C@H]1C)C[C@H](OC)\C(C)=C\C=C\C=C\[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)\C(C)=C\[C@@H](C)C(=O)C[C@H](OC2=O)[C@H](C)C[C@@H]1CC[C@@H]([C@@H](C1)OC)N1C=NN=N1,
UMI-77,UMI77; UMI 77; UMI-77,518303-20-3,c1ccc2c(c1)c(cc(c2O)SCC(=O)O)NS(=O)(=O)c1ccc(cc1)Br,
E-64,E64; E 64; E-64; Proteinase inhibitor E 64,66701-25-5,CC(C)C[C@H](NC(=O)[C@@H]1O[C@H]1C(O)=O)C(=O)NCCCCNC(N)=N,
TAK-285,TAK285; TAK 285; TAK-285,871026-44-7,CC(C)(O)CC(=O)NCCN1C=CC2=C1C(NC1=CC=C(OC3=CC=CC(=C3)C(F)(F)F)C(Cl)=C1)=NC=N2,
Torin 1,,1222998-36-8,CCC(=O)N1CCN(CC1)c1c(cc(cc1)n1c(=O)ccc2cnc3ccc(cc3c12)c1cc2ccccc2nc1)C(F)(F)F,
TAK-700,(S/R)-Orteronel; Orteronel,426219-18-3,CNC(=O)C1=CC2=C(C=C1)C=C(C=C2)C3(CCN4C3=CN=C4)O,
GW 441756,,504433-23-2,Cn1cc(C=C2C(=O)Nc3cccnc23)c2ccccc12,
URMC-099,URMC099; URMC 099; URMC-099,1229582-33-5,CN1CCN(Cc2ccc(cc2)-c2cnc3[nH]cc(-c4ccc5[nH]ccc5c4)c3c2)CC1,
LMK-235,LMK235; LMK 235; LMK-235,1418033-25-6,Cc1cc(cc(c1)C(=O)NOCCCCCC(=O)NO)C,
LY-411575,LY411575,209984-57-6,C[C@H](NC(=O)[C@@H](O)c1cc(F)cc(F)c1)C(=O)N[C@H]1c2ccccc2-c2ccccc2N(C)C1=O,
Triciribine,NSC 154020; TCN; API-2; VD-0002; Tricyclic nucleoside,35943-35-2,Cn1c2ncnc3c2c(cn3[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)c(n1)N,
KPT276,KPT 276; KPT-276,1421919-75-6,C1C(CN1C(=O)/C=C\n1cnc(n1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)(F)F,
ZM-447439,ZM 447439,331771-20-1,COC1=C(OCCCN2CCOCC2)C=C2N=CN=C(NC3=CC=C(NC(=O)C4=CC=CC=C4)C=C3)C2=C1,
Milciclib,PHA-848125,802539-81-7,CNC(=O)C1=NN(C)C2=C1C(C)(C)CC1=CN=C(NC3=CC=C(C=C3)N3CCN(C)CC3)N=C21,
SSR128129E,SSR,848318-25-2,Cc1c(n2ccccc2c1OC)C(=O)c1cc(c(cc1)N)C(=O)[O-].[Na+],
Rabusertib,IC-83; LY2603618,911222-45-2,Cc1cc(c(cc1Br)NC(=O)Nc1ncc(nc1)C)OC[C@@H]1CNCCO1,
GNF-5837,GNF5837; GNF 5837; GNF-5837,1033769-28-6,Cc1c(cc(cc1)NC(=O)Nc1c(ccc(c1)C(F)(F)F)F)Nc1cc2c(cc1)/C(=C/c1ccc[nH]1)/C(=O)N2,
Torin 2,,1223001-51-1,c1cc(cc(c1)n1c(=O)ccc2cnc3ccc(cc3c12)c1cnc(cc1)N)C(F)(F)F,
IU1,,314245-33-5,Cc1cc(c(n1c1ccc(cc1)F)C)C(=O)CN1CCCC1,
Ki16425,Debio 0719,355025-24-0,Cc1noc(c1NC(=O)OC(C)c1ccccc1Cl)c1ccc(cc1)CSCCC(=O)O,
YM-201636,YM201636,371942-69-7,C1COCCN1c1nc(nc2c1oc1c2cccn1)c1cc(ccc1)NC(=O)c1cnc(cc1)N,
GSK-1070916,GSK1070916; GSK-1070916A,942918-07-2,CCN1C=C(C(=N1)C1=CC=C(NC(=O)N(C)C)C=C1)C1=C2C=C(NC2=NC=C1)C1=CC=CC(CN(C)C)=C1,
Skepinone-L,CBS3830,1221485-83-1,OC[C@@H](O)COc1ccc2CCc3cc(Nc4ccc(F)cc4F)ccc3C(=O)c2c1,
YO-01027,Dibenzazepine; DBZ; YO-01027; gamma-Secretase Inhibitor XX,209984-56-5,C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H]1c2ccccc2-c2ccccc2N(C)C1=O,
Canertinib,PD-183805; CI-1033,267243-28-7,C=CC(=O)Nc1c(cc2c(c1)c(ncn2)Nc1cc(c(cc1)F)Cl)OCCCN1CCOCC1,
TCS 359,FLT3 Inhibitor,301305-73-7,COc1ccc(cc1OC)C(=O)Nc1sc2CCCCc2c1C(N)=O,
Dorsomorphin dihydrochloride,Compound C dihydrochloride; BML-275 dihydrochloride; Dorsomorphin (Compound C) 2HCl; BML-275 2HCl; Compound C 2HCl,1219168-18-9,Cl.Cl.C(CN1CCCCC1)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccncc1,
CX-6258 hydrochloride,CX-6258 HCl; Pim-Kinase Inhibitor X,1353859-00-3,CN1CCCN(CC1)C(=O)c1cccc(c1)c1ccc(o1)/C=C/1\c2c(ccc(c2)Cl)NC1=O.Cl,
YH239-EE,,1364488-67-4,CCOC(=O)c1[nH]c2cc(Cl)ccc2c1C(N(Cc1ccc(Cl)cc1)C=O)C(=O)NC(C)(C)C,
TAK-715,TAK715; TAK 715; TAK-715,303162-79-0,CCc1nc(c(s1)c1cc(ncc1)NC(=O)c1ccccc1)c1cc(ccc1)C,
PD318088,,391210-00-7,c1cc(c(cc1I)F)Nc1c(c(c(cc1C(=O)NOCC(CO)O)Br)F)F,
Ruxolitinib (S enantiomer),S-Ruxolitinib; INCB18424; Ruxolitinib S enantiomer; INCB018424,941685-37-6,N#CC[C@@H](C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12,
LDN-193189 HCl,LDN193189 Hydrochloride,1062368-62-0,N1(c2ccc(c3cnc4n(c3)ncc4c3ccnc4c3cccc4)cc2)CCNCC1.Cl,
Tubastatin A Hydrochloride,Tubastatin A HCl; TSA HCl; Tubastatin A Hydrochloride,1310693-92-5,CN1CCc2c(C1)c1ccccc1n2Cc1ccc(cc1)C(=O)NO.Cl,
BS-181 hydrochloride,BS-181 HCl; BS-181 hydrochloride,1397219-81-6,Cl.CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12,
BI-D1870,,501437-28-1,CC(C)CCN1C(C)C(=O)N(C)c2cnc(Nc3cc(F)c(O)c(F)c3)nc12,
R406,R-406 besylate,841290-81-1,OS(=O)(=O)c1ccccc1.COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC,
IKK 16,IKK16; IKK 16; IKK-16; IKK Inhibitor VII,873225-46-8,O=C(N1CCC(CC1)N1CCCC1)c1ccc(Nc2nccc(n2)c2cc3ccccc3s2)cc1,
UPF 1069,,1048371-03-4,c1(=O)[nH]ccc2c(cccc12)OCC(=O)c1ccccc1,
ISRIB (trans-isomer),ISRIB trans-isomer; ISRIB; trans-isomer; trans-ISRIB,1597403-47-8,Clc1ccc(OCC(N[C@@H]2CC[C@@H](NC(COc3ccc(Cl)cc3)=O)CC2)=O)cc1,
Orantinib,TSU-68; SU6668; NSC 702827,252916-29-3,Cc1[nH]c(\C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,
TRAM-34,TRAM34; TRAM 34; TRAM-34; Triarylmethane-34,289905-88-0,n1(nccc1)C(c1ccccc1)(c1ccccc1)c1c(cccc1)Cl,
Desvenlafaxine succinate hydrate,O-Desmethylvenlafaxine succinate hydrate; Desvenlafaxine Succinate; WY 45233 Succinate,386750-22-7,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O.C(CC(=O)O)C(=O)O.O,
PP1,EI 275; AGL 1872,172889-26-8,Cc1ccc(cc1)c1nn(c2ncnc(N)c12)C(C)(C)C,
PJ34,,344458-19-1,CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,
QNZ,EVP4593; CAY10470,545380-34-5,c1ccc(cc1)Oc1ccc(cc1)CCNc1ncnc2c1cc(cc2)N,
PHA-767491,PHA767491; PHA 767491; PHA-767491; CAY10572,845714-00-3,C1CNC(=O)c2c1[nH]c(c2)c1ccncc1,
SC144,,895158-95-9,Fc1cc2c(cc1)n1cccc1c(NNC(=O)c1cnccn1)n2,
AS-252424,AS252424; AS 252424; AS-252424,900515-16-4,C1=CC(=C(C=C1F)O)C2=CC=C(O2)/C=C\3/C(=O)NC(=O)S3,
CW-069,CW069,1594094-64-0,O=C(O)c1cc(I)ccc1NC(=O)[C@@H](NCc1ccccc1)Cc1ccccc1,
Pifithrin-Î¼,2-Phenylethynesulfonamide; PFTÎ¼; NSC 303580,64984-31-2,c1ccc(cc1)C#CS(=O)(=O)N,
Adenine hydrochloride,Adenine HCl; 6-Aminopurine hydrochloride,2922-28-3,Cl.Nc1ncnc2[nH]cnc12,
WZ4002,,1213269-23-8,O=C(C=C)NC=1C=CC=C(OC2=NC(=NC=C2Cl)NC3=CC=C(C=C3OC)N4CCN(C)CC4)C1,
BAPTA-AM,BAPTA/AM,126150-97-8,CC(=O)OCOC(=O)CN(CC(=O)OCOC(=O)C)c1ccccc1OCCOc1ccccc1N(CC(=O)OCOC(=O)C)CC(=O)OCOC(=O)C,
H-89 dihydrochloride,H 89 2HCl; H-89 dihydrochloride; Protein kinase inhibitor H-89 dihydrochloride; 5-Isoquinolinesulfonamide,130964-39-5,Cl.Cl.Brc1ccc(\C=C\CNCCNS(=O)(=O)c2cccc3cnccc23)cc1,
Bromosporine,,1619994-69-2,CCOC(=O)Nc1cc(nn2c(C)nnc12)c1cc(NS(=O)(=O)C)c(C)cc1,
AZ191,,1594092-37-1,COc1cc(ccc1Nc1nccc(n1)-c1cn(C)c2cnccc12)N1CCN(C)CC1,
Zibotentan,ZD4054,186497-07-4,COC1=NC(C)=CN=C1NS(=O)(=O)C1=CC=CN=C1C1=CC=C(C=C1)C1=NN=CO1,
Bosentan (hydrate),Bosentan Hydrate; Ro 47-0203; Benzenesulfonamide; Actelion,157212-55-0,O.COC1=CC=CC=C1OC1=C(OCCO)N=C(N=C1NS(=O)(=O)C1=CC=C(C=C1)C(C)(C)C)C1=NC=CC=N1,
PP2,"AGL 1879; AG 1879,AGL 1879",172889-27-9,CC(C)(C)n1c2c(c(n1)c1ccc(cc1)Cl)c(ncn2)N,
Trichostatin A,TSA,58880-19-6,C[C@H](\C=C(C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C,
Tipifarnib,R115777; IND 58359; Zarnestra,192185-72-1,n1(c(=O)cc(c2cc(ccc12)[C@@](c1cncn1C)(c1ccc(cc1)Cl)N)c1cc(ccc1)Cl)C,
KU-57788,NU7441; KU-57788,503468-95-9,O=c1cc(oc2c(cccc12)-c1cccc2c3ccccc3sc12)N1CCOCC1,
TW-37,TW37; TW 37; TW-37,877877-35-5,CC(C)c1ccccc1Cc1c(c(c(c(c1)C(=O)Nc1ccc(cc1)S(=O)(=O)c1ccccc1C(C)(C)C)O)O)O,
WZ4003,,1214265-58-3,C(=O)(CC)Nc1cc(ccc1)Oc1nc(ncc1Cl)Nc1c(cc(cc1)N1CCN(CC1)C)OC,
NVP-BSK805 2HCl (1092499-93-8(free base)),NVP-BSK805 dihydrochloride ,T6294,Cl.Cl.Fc1cc(cc(F)c1CN1CCOCC1)-c1cccc2ncc(nc12)-c1cnn(c1)C1CCNCC1,
RAF265,CHIR-265,927880-90-8,CN1C(NC2=CC=C(C=C2)C(F)(F)F)=NC2=C1C=CC(OC1=CC=NC(=C1)C1=NC=C(N1)C(F)(F)F)=C2,
AT7867,,857531-00-1,ClC1=CC=C(C=C1)C1(CCNCC1)C1=CC=C(C=C1)C1=CNN=C1,
Stattic,STAT3 Inhibitor V,19983-44-9,[O-][N+](=O)c1ccc2C=CS(=O)(=O)c2c1,
AZ960,AZ 960,905586-69-8,Cc1cc(n[nH]1)Nc1c(cc(c(n1)N[C@@H](C)c1ccc(cc1)F)C#N)F,
R547,Ro 4584820,741713-40-6,COC1=CC=C(F)C(F)=C1C(=O)C1=C(N)N=C(NC2CCN(CC2)S(C)(=O)=O)N=C1,
MLN8054,,869363-13-3,C1c2cnc(nc2c2c(cc(cc2)Cl)C(=N1)c1c(cccc1F)F)Nc1ccc(cc1)C(=O)O,
AZ 628,,878739-06-1,CN1C=NC2=C(C=C(NC3=CC(NC(=O)C4=CC(=CC=C4)C(C)(C)C#N)=CC=C3C)C=C2)C1=O,
OSI-027,OSI027; OSI 027; OSI-027; ASP4786,936890-98-1,COC1=CC=CC2=C1NC(=C2)C1=C2N(N=CN=C2N)C(=N1)[C@H]1CC[C@@H](CC1)C(O)=O,
GDC-0879,GDC0879; GDC 0879; GDC-0879; AR-00341677,905281-76-7,C1C/C(=N\O)/c2c1cc(cc2)c1cn(nc1c1ccncc1)CCO,
BIX02188,,1094614-84-2,CN(C)Cc1cccc(N\C(c2ccccc2)=C2/C(=O)Nc3cc(ccc23)C(N)=O)c1,
Desmethyl Erlotinib,CP-473420; OSI-420; O-Desmethyl Erlotinib,183321-86-0,COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCO,
Pevonedistat,MLN4924,905579-51-3,NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)n1ccc2c(N[C@H]3CCc4ccccc34)ncnc12,
Amonafide,"AS1413; NSC308847,AS1413; Nafidimide; Quinamed",69408-81-7,CN(C)CCN1C(=O)C2=CC(N)=CC3=CC=CC(C1=O)=C23,
RepSox,SJN 2511; E-616452; ALK5 Inhibitor II,446859-33-2,Cc1cccc(n1)c1c(cn[nH]1)c1nc2c(cc1)nccc2,
PHA-680632,PHA680632; PHA 680632; PHA-680632,398493-79-3,CCC1=CC=CC(CC)=C1NC(=O)N1CC2=C(C1)C(NC(=O)C1=CC=C(C=C1)N1CCN(C)CC1)=NN2,
PF04929113,PF 04929113; PF-04929113; SNX-5422,908115-27-5,CC1(C)Cc2c(c(nn2-c2ccc(C(N)=O)c(N[C@H]3CC[C@@H](CC3)OC(=O)CN)c2)C(F)(F)F)C(=O)C1,
NSC 23766 trihydrochloride,NSC 23766; Rac1 Inhibitor,1177865-17-6,Cl.Cl.Cl.CCN(CC)CCCC(C)Nc1nc(C)cc(Nc2ccc3nc(C)cc(N)c3c2)n1,
NVP-BHG712,,940310-85-0,Cc1ccc(cc1Nc1nc(nc2n(C)ncc12)-c1cccnc1)C(=O)Nc1cccc(c1)C(F)(F)F,
1-Azakenpaullone,azakenpaullone,676596-65-9,BrC1=CC2=C(NC3=C2CC(=O)NC2=C3N=CC=C2)C=C1,
4Î¼8C,IRE1 Inhibitor III,14003-96-4,Cc1cc(=O)oc2c1ccc(c2C=O)O,
A-966492,A966492; A 966492; A-966492,934162-61-5,NC(=O)c1cccc2[nH]c(nc12)-c1ccc(cc1F)[C@@H]1CCCN1,
AGK2,,304896-28-4,c1cc2c(cccn2)c(c1)NC(=O)/C(=C/c1ccc(o1)c1c(ccc(c1)Cl)Cl)/C#N,
AMG-458,AMG458; AMG 458; AMG-458,913376-83-7,COC1=CC2=NC=CC(OC3=CN=C(NC(=O)C4=C(C)N(CC(C)(C)O)N(C4=O)C4=CC=CC=C4)C=C3)=C2C=C1,
ARQ 621,,1095253-39-6,NCCCN([C@H](CC#C)C1=NC2=C(C=CC(Cl)=C2)C(=O)N1NC1=CC=CC=C1)C(=O)C1=CC=CC(Cl)=C1F,
AS-604850,AS604850; AS 604850; AS-604850,648449-76-7,FC1(F)Oc2ccc(cc2O1)\C=C1/SC(=O)NC1=O,
AZD3514,,1240299-33-5,CC(=O)N1CCN(CCOC2=CC=C(C=C2)C2CCN(CC2)C2=NN3C(CC2)=NN=C3C(F)(F)F)CC1,
Betaxolol,SL 75212; Kerlone; Betoptic,63659-18-7,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O,
BML-190,BML190; BML 190; BML-190; IMMA; Indomethacin morpholinylamide,2854-32-2,Cc1c(c2c(n1C(=O)c1ccc(cc1)Cl)ccc(c2)OC)CC(=O)N1CCOCC1,
BMS-536924,BMS536924; BMS 536924; BMS-536924; CS-0117,468740-43-4,CC1=C2N=C(NC2=CC(=C1)N1CCOCC1)C1=C(NC[C@@H](O)C2=CC=CC(Cl)=C2)C=CNC1=O,
BRD73954,,1440209-96-0,c1ccc(cc1)CCNC(=O)c1cc(ccc1)C(=O)NO,
BRL-15572 dihydrochloride,BRL 15572 dihydrochloride; BRL 15573 dihydrochloride,193611-72-2,Cl.Cl.OC(CN1CCN(CC1)c1cccc(Cl)c1)C(c1ccccc1)c1ccccc1,
Buclizine dihydrochloride,Buclizine HCl; UCB-4445; Longifene; Buclina,129-74-8,CC(C)(C)c1ccc(cc1)CN1CCN(CC1)C(c1ccccc1)c1ccc(cc1)Cl.Cl.Cl,
CAY10505,,1218777-13-9,Fc1ccc(cc1)-c1ccc(\C=C2\SC(=O)NC2=O)o1,
CCT129202,,942947-93-5,CN(C)c1ccc(cc1)-c1nc2ncc(Cl)c(N3CCN(CC(=O)Nc4nccs4)CC3)c2[nH]1,
CGP 57380,MNK1 Inhibitor,522629-08-9,Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12,
Chloroprocaine hydrochloride,Chloroprocaine HCl,3858-89-7,Cl.CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1,
CORM-3,CORM3; CORM 3; CORM-3,475473-26-8,[C-]#[O+].[C-]#[O+].[C-]#[O+].NCC(=O)O[Ru]Cl,
CRT0044876,"NSC 69877,7-NO2-ICA; 7-Nitroindole-2-Carboxylic Acid; NSC 69877",6960-45-8,OC(=O)c1cc2cccc([N+]([O-])=O)c2[nH]1,
Deltarasin,,1440898-61-2,C(OC1=CC=C(C=C1)C1=NC2=C(C=CC=C2)N1CC1=CC=CC=C1)[C@H](C1CCNCC1)N1C2=CC=CC=C2N=C1C1=CC=CC=C1,
Detomidine hydrochloride,Detomidine HCl; Detomidine hydrochloride; Domosedan; MPV-253 AII,90038-01-0,Cl.CC1=C(C)C(CC2=CNC=N2)=CC=C1,
Dexamethasone Sodium Phosphate,Dalalone; Dexadreson; Dexagro,55203-24-2,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+],
Diclofenac Potassium,CGP-45840B; Cataflam; Voltfast,15307-81-0,[K+].[O-]C(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,
(Â±)-Carnitine chloride,DL-Carnitine HCl; (Â±)-Carnitine chloride; DL-Carnitine chloride; Monocamin; Bicarnesine,461-05-2,[Cl-].C[N+](C)(C)CC(O)CC(O)=O,
Dovitinib lactate hydrate,Dovitinib Lactate; Dovitinib (TKI258) Lactate; TKI258,915769-50-5,O.CC(O)C(O)=O.CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,
Droxinostat,NS 41080,99873-43-5,Cc1cc(Cl)ccc1OCCCC(=O)NO,
Epinastine hydrochloride,Epinastine HCl; WAL-801CL HCl; Alesion; Elestat,108929-04-0,Cl[H].NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21,
Fenoprofen Calcium,,34597-40-5,[Ca++].CC(C([O-])=O)C1=CC(OC2=CC=CC=C2)=CC=C1.CC(C([O-])=O)C1=CC(OC2=CC=CC=C2)=CC=C1,
Fluorometholone Acetate,NSC 47438; Eflone; Oxylone acetate; Flarex,3801-06-7,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)C[C@]([H])(O)[C@@]1(F)[C@@]2([H])C[C@]([H])(C)C2=CC(=O)C=C[C@]12C,
GDC-0349,GDC0349; GDC 0349; GDC-0349; RG-7603,1207360-89-1,CCNC(=O)NC1=CC=C(C=C1)C1=NC(N2CCOC[C@@H]2C)=C2CCN(CC2=N1)C1COC1,
Bisindolylmaleimide I,Go 6850; GF109203X,133052-90-1,CN(C)CCCn1cc(c2ccccc12)C1=C(C(=O)NC1=O)c1c[nH]c2ccccc12,
Glasdegib,PF-04449913,1095173-27-5,CN1CC[C@H](C[C@@H]1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,
GW 5074,GW5074; Raf1 Kinase Inhibitor I,220904-83-6,c1cc2c(cc1I)/C(=C/c1cc(c(c(c1)Br)O)Br)/C(=O)N2,
HC-030031,HC030031; HC 030031; HC-030031; TOSLAB 829227,349085-38-7,CC(C)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1,
Hesperadin,,422513-13-1,CCS(=O)(=O)Nc1cc2c(cc1)NC(=O)/C/2=C(/c1ccccc1)\Nc1ccc(cc1)CN1CCCCC1,
Histamine Phosphate,Histamine diphosphate; Histamine acid phosphate,51-74-1,OP(O)(O)=O.OP(O)(O)=O.NCCC1=CNC=N1,
HJC0350,,885434-70-8,Cc1cc(c(c(c1)C)S(=O)(=O)n1cc(cc1C)C)C,
HO-3867,HO3867; HO 3867; HO-3867,1172133-28-6,CC1(N(C(C(=C1)CN1C/C(=C\c2ccc(cc2)F)/C(=O)/C(=C/c2ccc(cc2)F)/C1)(C)C)O)C,
Ibuprofen Lysine,Neoprofen,57469-77-9,NCCCC[C@H](N)C(O)=O.CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,
K-Ras(G12C) inhibitor 12,,1469337-95-8,OC1=CC(Cl)=C(I)C=C1NCC(=O)N1CCN(CC1)C(=O)C=C,
K-Ras(G12C) inhibitor 9,,1469337-91-4,COC1=CC(Cl)=C(I)C=C1NCC(=O)N1CCC(CC1)NS(=O)(=O)C=C,
KU-0060648,KU0060648; KU 0060648; KU-0060648,881375-00-4,CCN1CCN(CC1)CC(=O)NC2=C3C4=CC=CC=C4SC3=C(C=C2)C5=CC=CC6=C5OC(=CC6=O)N7CCOCC7,
KW-2478,KW2478; KW 2478; KW-2478,819812-04-9,CCc1c(O)cc(O)c(C(=O)c2cc(OC)c(OCCN3CCOCC3)cc2)c1CC(=O)N(CCOC)CCOC,
LDC000067,LDC067,1073485-20-7,COc1ccccc1-c1cc(Nc2cccc(CS(N)(=O)=O)c2)ncn1,
Levobetaxolol hydrochloride,Levobetaxolol HCl; AL-1577A; (S)-Betaxolol hydrochloride; Levobetaxolol hydrochloride; Betaxon,116209-55-3,CC(C)NC[C@@H](COC1=CC=C(C=C1)CCOCC2CC2)O.Cl,
ME0328,,1445251-22-8,C[C@H](NC(=O)CCc1nc2ccccc2c(=O)[nH]1)c1ccccc1,
Medetomidine hydrochloride,Medetomidine HCl; Medetomidine hydrochloride; MPV785; Domitor,86347-15-1,Cl.CC(c1c[nH]cn1)c1cccc(C)c1C,
Mitiglinide Calcium,S21403; KAD-1229,145525-41-3,C1CC[C@H]2CN(C[C@H]2C1)C(=O)C[C@H](CC3=CC=CC=C3)C(=O)[O-].C1CC[C@H]2CN(C[C@H]2C1)C(=O)C[C@H](CC3=CC=CC=C3)C(=O)[O-].[Ca+2],
Nodinitib-1,ML130; CID-1088438; Nodinitib-1,799264-47-4,Cc1ccc(cc1)S(=O)(=O)n1c(N)nc2ccccc12,
ML133 hydrochloride,ML133 HCl,1222781-70-5,Cl.COC1=CC=C(CNCC2=CC=CC3=C2C=CC=C3)C=C1,
Moexipril hydrochloride,Moexipril HCl; Moexipril hydrochloride; RS-10085; CI-925; SPM 925,82586-52-5,Cl.CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O,
NMS-E973,,1253584-84-7,CN1CCC(CC1)NC(=O)c1cc(on1)-c1c(O)cc(O)cc1Oc1ccc(cc1)[N+]([O-])=O,
NSC-207895,NSC 207895; XI-006,58131-57-0,CN1CCN(CC1)C2=CC=C(C3=NO[N+](=C23)[O-])[N+](=O)[O-],
NU6027,,220036-08-8,NC1=NC(N)=C(N=O)C(OCC2CCCCC2)=N1,
Ondansetron,SN 307; GR 38032; GR 38032F; GR-C507/75,99614-02-5,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,
Optovin,,348575-88-2,Cc1cc(C=C2SC(=S)NC2=O)c(C)n1-c1cccnc1,
Orphenadrine Citrate,Banflex; Flexon; Flexoject,4682-36-4,OC(=O)CC(O)(CC(O)=O)C(O)=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C,
Desmethyl Erlotinib hydrochloride,OSI420; OSI 420; OSI-420; CP-473420; Desmethyl Erlotinib; DesMethyl Erlotinib (CP-473420) HCl,183320-51-6,Cl.COCCOC1=CC2=C(C=C1OCCO)C(NC1=CC=CC(=C1)C#C)=NC=N2,
PF-3758309,PF3758309; PF 3758309; PF-3758309; PF-03758309; PF-309,898044-15-0,CN(C)C[C@@H](NC(=O)N1Cc2c([nH]nc2Nc2nc(C)nc3c2scc3)C1(C)C)c1ccccc1,
Quinine hydrochloride dihydrate,Quinine HCl Dihydrate; Quinine hydrochloride dihydrate,6119-47-7,O.O.Cl.COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)c2c1,
RBC8,,361185-42-4,COc1ccc(c(c1)C1C(=C(N)Oc2c1c(c1ccc3ccccc3c1)[nH]n2)C#N)OC,
SB-269970 hydrochloride,SB269970 HCl; SB-269970 hydrochloride; SB-269970A,261901-57-9,Cl.CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1,
SB 415286,SB415286,264218-23-7,Oc1ccc(NC2=C(C(=O)NC2=O)c2ccccc2[N+]([O-])=O)cc1Cl,
Scopine,"6,7-Epoxytropine",498-45-3,CN1[C@H]2C[C@H](O)C[C@@H]1[C@H]1O[C@@H]21,
SF1670,PTPase CD45 Inhibitor; PTP CD45 Inhibitor,345630-40-2,CC(C)(C)C(=O)Nc1cc2c(cc1)c1ccccc1C(=O)C2=O,
SH-4-54,,1456632-40-8,CN(CC(=O)N(Cc1ccc(cc1)C1CCCCC1)c1ccc(cc1)C(O)=O)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F,
Sirtinol,,410536-97-9,CC(c1ccccc1)NC(=O)c1ccccc1/N=C/c1c(O)ccc2ccccc12,
Splitomicin,1-Naphthalenepropanoic Acid,5690-03-9,O=C1CCc2c3ccccc3ccc2O1,
Staurosporine,AM-2282; Antibiotic AM-2282; CGP 41251,62996-74-1,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13,
STF-083010,STF083010; STF 083010; STF-083010,307543-71-1,Oc1ccc2ccccc2c1\C=N\S(=O)(=O)c1cccs1,
T0070907,,313516-66-4,c1cc(c(cc1[N+](=O)[O-])C(=O)Nc1ccncc1)Cl,
TCID,UCH-L3 Inhibitor,30675-13-9,Clc1c2C(=O)CC(=O)c2c(Cl)c(Cl)c1Cl,
Terazosin hydrochloride dihydrate,Terazosin HCl Dihydrate; Dysalfa dihydrate; Flotrin dihydrate; Heitrin dihydrate,70024-40-7,O.O.Cl.COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1,
TG 100713,TG100713,925705-73-3,C1=CC(=CC(=C1)O)C2=CN=C3C(=N2)C(=NC(=N3)N)N,
TIC10 Isomer,ONC201 isomer; TIC10 Analogue,41276-02-2,CC1=C(CN2C3=NCCN3C(=O)C3=C2CCN(CC2=CC=CC=C2)C3)C=CC=C1,
Tyrphostin AG 879,AG 879,148741-30-4,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)\C=C(/C#N)C(N)=S,
VUF 10166,,155584-74-0,CN1CCN(CC1)C1=NC2=CC=CC=C2N=C1Cl,
WAY-600,WAY600; WAY 600; WAY-600,1062159-35-6,C(N1CCC(CC1)N1N=CC2=C1N=C(N=C2N1CCOCC1)C1=CC2=C(NC=C2)C=C1)C1=CC=CN=C1,
WYE-354,WYE354; WYE 354; WYE-354,1062169-56-5,COC(=O)Nc1ccc(cc1)c1nc2c(cnn2C2CCN(CC2)C(=O)OC)c(n1)N1CCOCC1,
WYE-687,WYE687; WYE 687; WYE-687,1062161-90-3,COC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCN(CC4)CC5=CN=CC=C5)C(=N2)N6CCOCC6,
WZ-3146,WZ3146,1214265-56-1,CN1CCN(CC1)c1ccc(Nc2ncc(Cl)c(Oc3cccc(NC(=O)C=C)c3)n2)cc1,
WZ8040,,1214265-57-2,CN1CCN(CC1)C1=CC=C(NC2=NC=C(Cl)C(SC3=CC(NC(=O)C=C)=CC=C3)=N2)C=C1,
5-Iodotubercidin,5-ITu; NSC 113939,24386-93-4,Nc1ncnc2n(cc(I)c12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,
6-Thio-2'-Deoxyguanosine,6-Thio-dG; Î²-TGdR; 6-Thio-2'-Deoxyguanosine,789-61-7,Nc1nc(=S)c2ncn([C@H]3C[C@H](O)[C@@H](CO)O3)c2[nH]1,
A-1155463,A1155463; A 1155463; A-1155463,1235034-55-5,CN(C)CC#Cc1cc(c(cc1)OCCCc1c(nc(s1)N1CCc2cccc(c2C1)C(=O)Nc1nc2ccccc2s1)C(=O)O)F,
A-1331852,A1331852; A 1331852; A-1331852,1430844-80-6,Cc1c(cnn1CC12CC3CC(C1)CC(C3)C2)c1c(nc(cc1)N1CCc2cccc(c2C1)C(=O)Nc1nc2ccccc2s1)C(=O)O,
S-Adenosyl-L-methionine disulfate tosylate,Ademetionine disulfate tosylate; S-Adenosyl-L-methionine disulfate tosylate,97540-22-2,OS(O)(=O)=O.OS(O)(=O)=O.CC1=CC=C(C=C1)S(O)(=O)=O.C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12,
AI-10-49,,1256094-72-0,FC(F)(F)OC1=CC=C2NC(=NC2=C1)C1=NC=C(OCCOCCOC2=CN=C(C=C2)C2=NC3=C(N2)C=CC(OC(F)(F)F)=C3)C=C1,
AMG 925,,1401033-86-0,C[C@H]1CC[C@@H](CC1)n1c2cnccc2c2cnc(Nc3ccc4CN(CCc4n3)C(=O)CO)nc12,
AMG319,,1608125-21-8,C[C@H](Nc1ncnc2nc[nH]c12)c1cc2ccc(F)cc2nc1-c1ccccn1,
AP-III-a4,ENOblock,1177827-73-4,C1CCC(CC1)CNc1nc(nc(n1)NCc1ccc(cc1)F)Nc1ccc(cc1)CC(=O)NCCOCCOCCN,
APS-2-79 hydrochloride,APS-2-79; APS-2-79 hydrochloride; APS-2-79 HCl,2002381-31-7,Cc1cc(Oc2ccccc2)ccc1Nc1c2cc(OC)c(OC)cc2ncn1.Cl,
Ossirene,AS101,106566-58-9,N.Cl[TeH]1(Cl)(Cl)OCCO1,
Atipamezole hydrochloride,MPV-1248 hydrochloride; Antisedan,104075-48-1,Cl.CCC1(Cc2ccccc2C1)c1cnc[nH]1,
Atipamezole,MPV 1248; Antisedan,104054-27-5,CCC1(CC2=C(C1)C=CC=C2)C1=CN=CN1,
TCS7010,Aurora A Inhibitor I,1158838-45-9,CCN1CCN(CC1)C(=O)CC1=CC=C(NC2=NC(NC3=CC=C(C=C3)C(=O)NC3=CC=CC=C3Cl)=C(F)C=N2)C=C1,
AZ6102,,1645286-75-4,C[C@H]1CN(C[C@@H](C)N1)c1cc(C)c(cn1)-c1ccc(cc1)-c1nc2n(C)ccc2c(=O)[nH]1,
AZD3264,,1609281-86-8,O=C(N)Nc1c(C(=O)N)cc(c2c(O[C@H]3CCNC3)cc(c3c(C)onc3C)cc2)s1,
BAY 61-3606 dihydrochloride,BAY-61-3606 dihydrochloride; BAY 61-3606,648903-57-5,COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC.Cl.Cl,
Bay K 8644,"SQ 28,873; (Â±)-BAY-K-8644",71145-03-4,COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)C(F)(F)F)[N+]([O-])=O,
Benzamide,Benzoylamide; Phenylcarboxyamide; Amid kyseliny benzoove,55-21-0,C1=CC=C(C=C1)C(=O)N,
BI-78D3,,883065-90-5,C1COc2c(O1)ccc(c2)n1c(=O)[nH]nc1Sc1ncc(s1)[N+](=O)[O-],
BIO-acetoxime,BIA; GSK-3 Inhibitor X,667463-85-6,CC(=O)O\N=C1/C(Nc2ccccc12)=C1/C(=O)Nc2cc(Br)ccc12,
BRD7552,,1137359-47-7,CCOC(=O)c1ccc(cc1)NC(=O)O[C@@H]1[C@H](O[C@@H]([C@@H]([C@H]1OC(=O)Nc1cc2c(cc1)OCO2)OC(=O)Nc1cc2c(cc1)OCO2)OC)CO,
CeMMEC13,,1790895-25-8,Cn1c2ccccc2c(cc1=O)C(=O)Nc1cc2c(cc1)OCCO2,
Cyclo(-RGDfK),Cyclo (-RGDfK),161552-03-0,NCCCC[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O,
DEL-22379,DEL22379; DEL 22379; DEL-22379,181223-80-3,COc1ccc2[nH]cc(C=C3C(=O)Nc4ccc(NC(=O)CCN5CCCCC5)cc34)c2c1,
D-Î±-Hydroxyglutaric acid disodium,Disodium (R)-2-Hydroxyglutarate; D-alpha-Hydroxyglutaric acid disodium salt,103404-90-6,[Na+].[Na+].O[C@H](CCC([O-])=O)C([O-])=O,
E3330,,136164-66-4,CCCCCCCCC/C(=C\C1=C(C(=O)C(=C(C1=O)OC)OC)C)/C(=O)O,
EAI045,,1942114-09-1,c1ccc2c(c1)CN(C2=O)C(C(=O)Nc1sccn1)c1cc(ccc1O)F,
EPI-001,EPI001; EPI 001; EPI-001,227947-06-0,CC(C)(C1=CC=C(OCC(O)CO)C=C1)C1=CC=C(OCC(O)CCl)C=C1,
FCCP,Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone; Trifluoromethoxy carbonylcyanide phenylhydrazone,370-86-5,FC(F)(F)Oc1ccc(N\N=C(\C#N)C#N)cc1,
Fenoldopam mesylate,SKF-82526 mesylate; Fenoldopam methanesulfonate; Corlopam mesylate; SKF 82526; mesylate,67227-57-0,CS(O)(=O)=O.OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12,
FIIN-2,FIIN2; FIIN 2; FIIN-2,1633044-56-0,CN1CCN(CC1)c1ccc(cc1)Nc1ncc2CN(C(=O)N(c2n1)Cc1ccc(cc1)NC(=O)C=C)c1cc(cc(c1)OC)OC,
FLLL32,,1226895-15-3,COc1ccc(cc1OC)\C=C\C(=O)C1(CCCCC1)C(=O)\C=C\c1ccc(OC)c(OC)c1,
G007-LK,,1380672-07-0,CS(=O)(=O)c1cnc(cc1)c1nnc(n1c1ccccc1Cl)/C=C/c1nnc(o1)c1ccc(cc1)C#N,
GNE-317,GNE317; GNE 317; GNE-317,1394076-92-6,COC1(COC1)c1c(C)c2c(s1)c(nc(n2)c1cnc(N)nc1)N1CCOCC1,
GSK1016790A,GSK101,942206-85-1,CC(C)C[C@H](NC(=O)c1cc2ccccc2s1)C(=O)N1CCN(CC1)C(=O)[C@H](CO)NS(=O)(=O)c1ccc(Cl)cc1Cl,
GSK481,GSK'481,1622849-58-4,CN1c2ccccc2OC[C@H](NC(=O)c2cc(Cc3ccccc3)on2)C1=O,
GSK621,,1346607-05-3,COC1=CC(=CC=C1)N1C(=O)NC2=C(N(C(Cl)=C2)C2=CC=C(C=C2)C2=C(O)C(OC)=CC=C2)C1=O,
HA15,,1609402-14-3,CC(=O)Nc1nc(c2cccc(NS(=O)(=O)c3c4cccc(N(C)C)c4ccc3)c2)cs1,
Halofuginone,RU-19110; Tempostatin; empostatin,55837-20-2,O[C@@H]1CCCN[C@H]1CC(=O)Cn1cnc2cc(Br)c(Cl)cc2c1=O,
Hydroxyprogesterone caproate,17Î±-Hydroxyprogesterone caproate; 17Î±-Hydroxyprogesterone hexanoate; Primolut Depot; Delalutin; Hormofort,630-56-8,[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
IMR-1,IMR1; IMR 1; IMR-1,310456-65-6,CCOC(=O)COc1ccc(C=C2SC(=S)NC2=O)cc1OC,
Quisinostat dihydrochloride,Quisinostat 2HCl; Quisinostat (JNJ-26481585) 2HCl; JNJ26854165(Quisinostat) 2HCl; JNJ-26481585 2HCl,875320-31-3,Cl.Cl.CN1C=C(CNCC2CCN(CC2)C2=NC=C(C=N2)C(=O)NO)C2=CC=CC=C12,
AUZ 454,K03861; AUZ 454,853299-07-7,CN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4ccnc(N)n4)cc3)cc2C(F)(F)F)CC1,
KYA1797K,,1956356-56-1,[K+].[O-]C(=O)CCN1C(=S)S\C(=C/c2ccc(o2)-c2ccc(cc2)[N+]([O-])=O)C1=O,
L-685458,"L-685,458; L-685,458",292632-98-5,CC(C)C[C@H](NC(=O)[C@@H](C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,
LJH685,,1627710-50-2,CN1CCN(CC1)c1ccc(cc1)c1ccncc1c1cc(F)c(O)c(F)c1,
LJI308,,1627709-94-7,Oc1c(F)cc(cc1F)-c1cnccc1-c1ccc(cc1)N1CCOCC1,
LLY-507,LLY507; LLY 507; LLY-507,1793053-37-8,Cc1cn(c2ccccc12)CCN1CCN(CC1)c1ccccc1c1cc(cc(c1)C#N)C(=O)NCCCN1CCCC1,
LTX-315,LTX315; LTX 315; LTX-315; K-K-W-W-K-K-W-Dip-K-NH2; Oncopore,1345407-05-7,NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,
MCB-613,MCB613; MCB 613; MCB-613,1162656-22-5,C1(C/C(=C\c2cnccc2)/C(=O)/C(=C/c2cnccc2)/C1)CC,
MCC950 sodium,CRID3 sodium salt; CP-456773 sodium; CP-456773; MCC950,256373-96-3,[Na+].CC(C)(O)c1coc(c1)S(=O)(=O)[N-]C(=O)Nc1c2CCCc2cc2CCCc12,
MI-136,MI136; MI 136; MI-136,1628316-74-4,N#Cc1cc2cc(CN3CCC(Nc4c5cc(CC(F)(F)F)sc5ncn4)CC3)ccc2[nH]1,
ML264,CID-51003603,1550008-55-3,O=C(NCC(=O)N(C1CCS(=O)(=O)CC1)C)/C=C/c1cccc(Cl)c1,
Tolimidone,MLR-1023; CP-26154; NSC 314335,41964-07-2,CC1=CC=CC(OC2=CNC(=O)N=C2)=C1,
Naloxone HCl Dihydrate,Naloxone hydrochloride dihydrate,51481-60-8,O.O.Cl.OC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5CC=C,
Necrosulfonamide,(E)-Necrosulfonamide,1360614-48-7,C(=O)(/C=C/c1ccc(s1)[N+](=O)[O-])Nc1ccc(cc1)S(=O)(=O)Nc1c(nccn1)OC,
NPS-1034,NPS1034; NPS 1034; NPS-1034,1221713-92-3,CN1N(C(=O)C(C(=O)NC2=CC=C(OC3=CC=NC4=C3C(=CN4)C3=CC=CC=C3)C(F)=C2)=C1C)C1=CC=C(F)C=C1,
NSC 228155,NSC228155,113104-25-9,[O-][N+](=O)c1ccc(Sc2cccc[n+]2[O-])c2nonc12,
NSC348884,,81624-55-7,Cc1cc2c(cc1)nc(CN(CCN(Cc1nc3c([nH]1)cc(C)cc3)Cc1nc3c([nH]1)cc(C)cc3)Cc1nc3c([nH]1)cc(C)cc3)[nH]2,
NSC59984,,803647-40-7,CN1CCN(CC1)C(=O)/C=C/c1ccc(o1)[N+](=O)[O-],
NU1025,NSC 696807,90417-38-2,Cc1nc2c(O)cccc2c(=O)[nH]1,
Oclacitinib maleate,PF-03394197 maleate; PF-03394197,1640292-55-2,OC(=O)\C=C/C(O)=O.CNS(=O)(=O)C[C@H]1CC[C@@H](CC1)N(C)C1=C2C=CNC2=NC=N1,
OICR-9429,OICR9429; OICR 9429; OICR-9429,1801787-56-3,CN1CCN(CC1)c1ccc(cc1NC(=O)c1c[nH]c(=O)cc1C(F)(F)F)-c1cccc(CN2CCOCC2)c1,
Omaveloxolone,RTA-408,1474034-05-3,CC(F)(F)C(=O)N[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2,
Riviciclib hydrochloride,P276-00,920113-03-7,Cl.CN1CC[C@H]([C@@H]1CO)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=C(Cl)C=CC=C1,
Pantoprazole,SKF96022; BY1023,102625-70-7,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,
Peficitinib,JNJ-54781532; ASP015K,944118-01-8,NC(=O)C1=C(N[C@H]2C3CC4CC2C[C@](O)(C4)C3)C2=C(NC=C2)N=C1,
Nirogacestat,PF03084014; PF 03084014; PF-03084014; Nirogacestat; PF-3084014,1290543-63-3,CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(cn1)C(C)(C)CNCC(C)(C)C,
PF-4989216,PF4989216; PF 4989216; PF-4989216,1276553-09-3,FC1=C(C=CC(=C1)C#N)C1=C(SC(N2CCOCC2)=C1C#N)C1=NC=NN1,
PFI-3,PFI3; PFI 3; PFI-3,1819363-80-8,C1[C@@H]2CN([C@H]1CN2c1ccccn1)/C=C/C(=O)c1ccccc1O,
Picolinamide,2-Pyridinecarboxamide; Picolinoylamide; 2-Carbamoylpyridine; 2-Picolinamide,1452-77-3,C1=CC=NC(=C1)C(=O)N,
Vps34-PIK-III,PIK-III; Vps34-PIK-III; VPS34-IN2,1383716-40-2,Nc1ncc(c(CC2CC2)n1)-c1ccnc(Nc2ccncc2)n1,
PLX7904,PB04,1393465-84-3,CCN(C)S(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CN=C(N=C2)C2CC2)=C1F,
Pramipexole dihydrochloride hydrate,Pramipexole 2HCl Monohydrate; Mirapex,191217-81-9,O.Cl.CCCN[C@H]1CCc2c(C1)sc(N)n2.Cl,
Prasugrel Hydrochloride,PCR 4099 (hydrochloride); Prasugrel HCl; LY 640315; LY 640315 Hydrochloride; Effient Hydrochloride,389574-19-0,Cl.CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=C(F)C=CC=C2)S1,
PRIMA-1,"PRIMA1; PRIMA 1; PRIMA-1; NSC-281668; 2,2-Bis(hydroxymethyl)-3-quinuclidinone",5608-24-2,C1CN2CCC1C(=O)C2(CO)CO,
Prucalopride Succinate,R-108512; Resolor Succinate,179474-85-2,OC(=O)CCC(O)=O.COCCCN1CCC(CC1)NC(=O)C1=C2OCCC2=C(N)C(Cl)=C1,
RHPS4,RHPS 4 methosulfate; NSC714187,390362-78-4,CC1=CC2=C3C(=C1)C4=C(C=CC(=C4)F)[N+](=C3C5=C(N2C)C=CC(=C5)F)C.COS(=O)(=O)[O-],
RK33,RK 33; RK-33,1070773-09-9,COc1ccc(Cn2cnc3c2ncnc2n(Cc4ccc(OC)cc4)c(=O)nc32)cc1,
Ro 5126766,RO5126766; CH5126766,946128-88-7,CNS(=O)(=O)NC1=NC=CC(CC2=C(C)C3=CC=C(OC4=NC=CC=N4)C=C3OC2=O)=C1F,
Saccharin 1-methylimidazole,Saccharin 1-methylimidazole (SMI); Saccharin 1-methylimidazole; SMI,482333-74-4,Cn1ccnc1.O=C1NS(=O)(=O)c2ccccc12,
SB-366791,SB366791,472981-92-3,COC1=CC=CC(=C1)NC(=O)/C=C/C2=CC=C(C=C2)Cl,
Scriptaid,GCK1026; Scriptide,287383-59-9,ONC(=O)CCCCCN1C(=O)c2cccc3cccc(C1=O)c23,
SGI-7079,SGI7079; SGI 7079; SGI-7079,1239875-86-5,CN1CCN(CC1)c1ccc(Nc2nc3c(c(C)c[nH]3)c(n2)c2cc(CC#N)ccc2)cc1F,
SirReal2,,709002-46-0,Cc1cc(C)nc(SCC(=O)Nc2ncc(Cc3cccc4ccccc34)s2)n1,
SKL2001,,909089-13-0,c1coc(c1)c1cc(no1)C(=O)NCCCn1ccnc1,
Nitroprusside disodium dihydrate,Sodium Nitroprusside Dihydrate; Sodium Nitroferricyanide(III) Dihydrate; Nitroprusside disodium dihydrate,13755-38-9,O.O.[Na+].[Na+].O=N[Fe--](C#N)(C#N)(C#N)(C#N)C#N,
Tauroursodeoxycholate sodium,Sodium Tauroursodeoxycholate (TUDC); Tauroursodeoxycholic acid sodium salt; Sodium tauroursodeoxycholate; Tauroursodeoxycholate Sodium; TUDC,35807-85-3,[Na+].C[C@H](CCC(=O)NCCS([O-])(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,
Ochromycinone,STA21; STA 21; STA-21; Ochromycinone,111540-00-2,CC1CC2=C(C(=O)C1)C3=C(C=C2)C(=O)C4=C(C3=O)C=CC=C4O,
SU6656,,330161-87-0,CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)c2c1,
UNC2025,UNC 2025; UNC-2025; mrx-6313,1429881-91-3,CCCCNc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(CN2CCN(C)CC2)cc1,
Vacquinol-1,Vacquinol 1,5428-80-8,C1CCNC(C1)C(c1cc(nc2ccccc12)c1ccc(cc1)Cl)O,
VER-155008,VER155008,1134156-31-2,Nc1ncnc2n([C@@H]3O[C@H](COCc4ccc(cc4)C#N)[C@@H](O)[C@H]3O)c(NCc3ccc(Cl)c(Cl)c3)nc12,
VO-Ohpic trihydrate,VO-Ohpic,476310-60-8,O=C1O[V+](=O)(Oc2c1nccc2)OC(=O)c1ncccc1O.O.O.O.O.[H-],
Vps34-IN-1,VPS34-IN1,1383716-33-3,CC(C)(O)CNc1ncc(c(CC2CC2)n1)-c1ccnc(Nc2ccnc(Cl)c2)n1,
VR23,,1624602-30-7,C1CN(CCN1c1c2ccc(cc2ncc1)Cl)S(=O)(=O)c1c(cc(cc1)[N+](=O)[O-])[N+](=O)[O-],
WNK463,,2012607-27-9,O=C(c1cncn1C1CCN(c2ncc(c3nnc(C(F)(F)F)o3)cc2)CC1)NC(C)(C)C,
WZB117,,1223397-11-2,Oc1cc(ccc1)C(=O)Oc1c(OC(=O)c2cc(O)ccc2)cccc1F,
Z-IETD-FMK,Z-IE(OMe)TD(OMe)-FMK; Caspase-8 Inhibitor,210344-98-2,CC[C@H](C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CCC(=O)OC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)OC)C(=O)CF,
RSL3,"1S,3R-RSL3; 1S,3R-RSL3; RSL3 1S",1219810-16-8,O=C(OC)[C@@H]1N(C(CCl)=O)[C@@H](C2=CC=C(C(OC)=O)C=C2)C3=C(C(C=CC=C4)=C4N3)C1,
CEP-33779,CEP33779; CEP 33779; CEP-33779,1257704-57-6,CS(=O)(=O)c1ccc(cc1)c2cccn3nc(nc23)Nc4cccc(c4)N5CCN(C)CC5,
(-)-Catechin gallate,(-)-Catechin 3-O-gallate; (-)-Catechin 3-gallate,130405-40-2,C1[C@H]([C@@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,
11-oxo-mogroside V,11-oxo Mogroside V,126105-11-1,C[C@H](CC[C@@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)(C)O)[C@H]1CC[C@@]2(C)[C@H]3CC=C4[C@@H](CC[C@H](O[C@@H]5O[C@H](CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O)[C@H]5O)C4(C)C)[C@]3(C)C(=O)C[C@]12C,
Tenuifoliside A,,139726-35-5,COc1cc(\C=C\C(=O)OC[C@H]2O[C@H](O[C@@]3(CO)O[C@@H](CO)[C@H](O)[C@H]3OC(=O)c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)cc(OC)c1OC,
Pulsatilla saponin D,Hederacolchiside A; SB365,68027-15-6,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO[C@H]2O[C@H]2CC[C@@]3(C)[C@@H](CC[C@]4(C)[C@@H]3CC=C3[C@@H]5CC(C)(C)CC[C@@]5(CC[C@@]43C)C(O)=O)[C@]2(C)CO)O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,
Neoliquiritin,,5088-75-5,C1[C@H](OC2=C(C1=O)C=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C4=CC=C(C=C4)O,
NVP-ADW742,ADW; GSK 552602A; ADW742,475488-23-4,C1CCN(C1)CC2CC(C2)N3C=C(C4=C3N=CN=C4N)C5=CC(=CC=C5)OCC6=CC=CC=C6,
RGFP966 (E-isomer),,1396841-57-8,Nc1cc(F)ccc1NC(=O)\C=C\c1cnn(C\C=C\c2ccccc2)c1,
Alvespimycin hydrochloride,BMS 826476; KOS-1022; 17-DMAG hydrochloride; Alvespimycin (17-DMAG) HCl; NSC 707545,467214-21-7,Cl.CO[C@H]1C[C@H](C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O,
Oligomycin A,MCH 32,579-13-5,CC[C@@H]1CC[C@@H]2O[C@]3(CC[C@H](C)[C@H](C[C@@H](C)O)O3)[C@@H](C)[C@H](OC(=O)\C=C\[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@](C)(O)[C@@H](O)[C@H](C)C\C=C\C=C\1)[C@@H]2C,
Lorcaserin HCl,APD-356,846589-98-8,Cl.C[C@H]1CNCCC2=C1C=C(Cl)C=C2,
MNS,5-(2-Nitrovinyl)benzodioxole; NSC 170724; 3ï¼4-Methylenedioxy-Î²-nitrostyrene; MDBN; Syk Inhibitor III,1485-00-3,C1OC2=C(O1)C=C(C=C2)/C=C/[N+](=O)[O-],
Ropivacaine hydrochloride monohydrate,Ropivacaine HCl monohydrate; Ropivacaine hydrochloride monohydrate; Ropivacaine HCl; LEA-103 HCl; LEA 103,132112-35-7,O.Cl.CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C,
Z-VAD-FMK,Z-VAD(OH)-FMK; Z-VAD; Caspase Inhibitor VI,161401-82-7,CC(C)[C@H](NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)CF,
Emodin-1-O-Î²-D-glucopyranoside,Emodin-1-O-glucoside,38840-23-2,Cc1cc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2C(=O)c3c(O)cc(O)cc3C(=O)c2c1,
Lycobetaine,Ungeremine,72510-04-4,Oc1cc2CC[n+]3cc4cc5OCOc5cc4c(c1)c23,
Dehydrocorydaline nitrate,,13005-09-9,[O-][N+]([O-])=O.COc1cc2CC[n+]3cc4c(OC)c(OC)ccc4c(C)c3-c2cc1OC,
N-trans-Feruloyltyramine,Feruloyltyramine; Moupinamide; N-trans-Feruloyltyramine; N-Feruloyltyramine,66648-43-9,COc1cc(\C=C\C(=O)NCCc2ccc(O)cc2)ccc1O,
Heteroclitin D,,140369-76-2,COC1=C(OC)C(=O)[C@@]23COc4c5OCOc5cc([C@H](OC(=O)C(\C)=C/C)[C@H](C)[C@H](C)CC2=C1)c34,
Poncirin,Isosakuranetin-7-neohesperidoside,14941-08-3,COc1ccc(cc1)[C@@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)cc2O1,
Coptisine sulfate,,1198398-71-8,OS([O-])(=O)=O.C1Oc2cc3CC[n+]4cc5c6OCOc6ccc5cc4-c3cc2O1,
Glaucocalyxin A,Leukamenin F; Wangzaozin B,79498-31-0,CC1(C)[C@H]2C[C@@H](O)[C@@]34[C@H](O)[C@@H](CC[C@H]3[C@]2(C)CCC1=O)C(=C)C4=O,
Bullatine A,,1354-84-3,CCN1C[C@]2(C)CCC[C@]34C1[C@H](C[C@H]23)C12CCC([C@H](O)C41)C(=C)[C@H]2O,
Agrimol B,,55576-66-4,CCCC(=O)c1c(O)c(Cc2c(O)c(Cc3c(O)c(C)c(OC)c(C(=O)CCC)c3O)c(O)c(C(=O)C(C)CC)c2O)c(O)c(C)c1OC,
Sanggenon C,Sanggenone C,80651-76-9,C\C(C)=C\CC12Oc3cc(O)c([C@H]4C=C(C)C[C@@H]([C@H]4C(=O)c4ccc(O)cc4O)c4ccc(O)cc4O)c(O)c3C(=O)C1(O)Oc1cc(O)ccc21,
Aconine,Jesaconine,509-20-6,CCN1C[C@@]2(COC)[C@H]3[C@@H](OC)[C@H]4C1[C@@]3([C@@H]1C[C@@]3(O)[C@H](O)[C@@H]1[C@]4(O)[C@@H](O)[C@@H]3OC)[C@H](C[C@H]2O)OC,
Coptisine,Coptisin,3486-66-6,C1Oc2cc3CC[n+]4cc5c6OCOc6ccc5cc4-c3cc2O1,
Ganoderic acid D,,108340-60-9,C[C@H](CC(=O)CC(C)C(O)=O)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O,
"(+)-(3R,8S)-Falcarindiol",Falcarindiol,225110-25-8,CCCCCCC\C=C/[C@H](O)C#CC#C[C@H](O)C=C,
Dehydrocorydaline,Dehydrocorydalin; 13-Methylpalmatine; Dehydrocorydaline,30045-16-0,COc1cc2CC[n+]3cc4c(OC)c(OC)ccc4c(C)c3-c2cc1OC,
Pectolinarigenin,Pectolinaringenin,520-12-7,COC1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)O)OC)O,
Hypericin,Hypericine; Cyclosan,548-04-9,CC1=CC(=C2C3=C1C4=C5C(=C(C=C4C)O)C(=O)C6=C(C=C(C7=C6C5=C3C8=C7C(=CC(=C8C2=O)O)O)O)O)O,
Praeruptorin C,,72463-77-5,C\C=C(\C)C(=O)O[C@@H]1[C@H](OC(=O)CC(C)C)c2c(OC1(C)C)ccc1ccc(=O)oc21,
Ginsenoside Rh4,,174721-08-5,C\C(C)=C/C\C=C(/C)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@H](C[C@@]21C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,
Ginsenoside Rk3,,364779-15-7,C\C(C)=C/CCC(=C)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@H](C[C@@]21C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,
Coumarin-3-carboxylic acid,3-Carboxycoumarin,531-81-7,C1=CC=C2C(=C1)C=C(C(=O)O2)C(=O)O,
Episyringaresinol 4'-O-Î²-D-glncopyranoside,(-)-Syringaresinol 4-O-Î²-D-glucopyranosi,137038-13-2,COc1cc(cc(OC)c1O)[C@@H]1OC[C@@H]2[C@H]1CO[C@H]2c1cc(OC)c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(OC)c1,
WAY 316606,,915759-45-4,FC(F)(F)c1ccc(cc1S(=O)(=O)NC1CCNCC1)S(=O)(=O)c1ccccc1,
CID 16020046,C390-0219,834903-43-4,Cc1ccc(cc1)-c1n[nH]c2C(=O)N(C(c12)c1cccc(O)c1)c1ccc(cc1)C(O)=O,
GSK-25,GSK25; GSK 25; GSK-25,874119-56-9,CC1=C(C(N=C(N1)c1ccnc(Cl)c1)c1ccc(Cl)cc1F)C(=O)Nc1cc2cn[nH]c2cc1F,
AKT-IN-1,AZD26; AZD 26; AZD-26; AKT-IN-1,1357158-81-6,NC(=O)c1cnc(-c2ccc(cc2)C2(N)CCC2)c(c1)-c1ccccc1,
PF-01247324,PF01247324; PF 01247324; PF-01247324,875051-72-2,CNC(=O)c1ccc(c(N)n1)-c1cc(Cl)cc(Cl)c1Cl,
LM22B-10,LM22B10; LM22B 10; LM22B-10,342777-54-2,OCCN(CCO)c1ccc(cc1)C(c1ccc(Cl)cc1)c1ccc(cc1)N(CCO)CCO,
L189,,64232-83-3,Nc1[nH]c(=S)[nH]c(=O)c1\N=C\c1ccccc1,
Licochalcone D,,144506-15-0,COc1c(O)c(O)ccc1\C=C\C(=O)c1ccc(O)c(C\C=C(\C)C)c1,
SBC-110736,SBC110736; SBC 110736; SBC-110736,1629166-02-4,CC(=O)Nc1ccc(cc1)C(=O)N1CCN(CC1c1ccccc1)c1ccc(C)cc1,
Piperoxan hydrochloride,Benodaine hydrochloride; dl-Piperoxan hydrochloride,135-87-5,Cl.C(C1COc2ccccc2O1)N1CCCCC1,
Tyrphostin AG 528,AG 528; Tyrphostin B66,133550-49-9,Oc1ccc(\C=C(/C#N)C(=O)N2CCc3ccccc23)cc1O,
anemarsaponin B,,139051-27-7,C[C@@H](CCC1=C(C)[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@H](CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O1)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,
Eupatorin,,855-96-9,COc1ccc(cc1O)-c1cc(=O)c2c(O)c(OC)c(OC)cc2o1,
Rosmanol,,80225-53-2,CC(C)c1cc2[C@H](O)[C@H]3OC(=O)[C@@]4(CCCC(C)(C)[C@H]34)c2c(O)c1O,
"1,5-Isoquinolinediol",,5154-02-9,Oc1cccc2c1cc[nH]c2=O,
Bz-RS-ISer(3-Ph)-Ome,"Methyl (2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoate",32981-85-4,COC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1,
CCCP,Carbonyl Cyanide m-Chlorophenylhydrazone; Carbonyl cyanide 3-chlorophenylhydrazone,555-60-2,Clc1cccc(NN=C(C#N)C#N)c1,
HDAC8-IN-1,,1417997-93-3,COc1cc(c(/C=C/C(=O)NO)cc1)c2ccc(cc2)c3ccccc3,
Diflubenzuron,Difubenzuron; Difluron; Dimilin; Larvakil,35367-38-5,Fc1cccc(F)c1C(=O)NC(=O)Nc1ccc(Cl)cc1,
BMS-3,BMS3; BMS 3; BMS-3,1338247-30-5,O=C(Nc1ncc(s1)c2cc(nn2c3c(Cl)cccc3Cl)C(F)F)C4CC4,
BMS-5,BMS5; BMS 5; BMS-5; LIMKi 3,1338247-35-0,O=C(Nc1ncc(s1)c2cc(nn2c3c(Cl)cccc3Cl)C(F)F)C(C)C,
HG-9-91-01,SIK inhibitor 1,1456858-58-4,CC1=C(C(=CC=C1)C)NC(=O)N(C2=C(C=C(C=C2)OC)OC)C3=NC=NC(=C3)NC4=CC=C(C=C4)N5CCN(CC5)C,
4-IBP,,155798-08-6,Ic1ccc(cc1)C(=O)NC3CCN(Cc2ccccc2)CC3,
TA-01,TA01; TA 01; TA-01,1784751-18-3,Fc1ccc(cc1)-c1nc([nH]c1-c1ccncc1)-c1c(F)cccc1F,
TA-02,TA02; TA 02; TA-02,1784751-19-4,Fc1ccc(cc1)-c1nc([nH]c1-c1ccncc1)-c1ccccc1F,
2-Aminoethyl diphenylborinate,2-APB; 2-Aminoethoxydiphenyl borate,524-95-8,NCCOB(c1ccccc1)c1ccccc1,
Nicainoprol,RU-42924,76252-06-7,CC(C)NCC(O)COc1cccc2CCCN(C(=O)c3cccnc3)c12,
BGG463,K 0859; BGG463,890129-26-7,CC(=O)Nc1cc(ncn1)Oc2ccc3c(c2)cccc3C(=O)Nc5ccc(CN4CCN(C)CC4)c(c5)C(F)(F)F,
UM-164,UM164; UM 164; UM-164; DAS-DFGO-II,903564-48-7,FC(F)(F)c1cccc(c1)C(=O)Nc5cc(NC(=O)c4cnc(Nc2nc(C)nc(c2)N3CCN(CCO)CC3)s4)c(C)cc5,
TFAP,N-(5-Aminopyridin-2-yl)-4-(trifluoromethyl)benzamide,1011244-68-0,O=C(Nc1ccc(N)cn1)c2ccc(cc2)C(F)(F)F,
MHP,Methyl caprooyl tyrosinate,1104874-94-3,Oc1ccc(C[C@H](NC(=O)CCCCC)C(=O)OC)cc1,
RAD51 Inhibitor B02,B02; RAD51 Inhibitor B02,1290541-46-6,O=C3c4ccccc4N=C(/C=C/c1cccnc1)N3Cc2ccccc2,
ML 297,ML297,1443246-62-5,Fc1ccc(cc1F)NC(=O)Nc3cc(C)nn3c2ccccc2,
GNE-6776,GEN6776; GNE-6776,2009273-71-4,O=C(NC)C1=CC=C(C2=C(CC)C(C3=CC=C(O)C=C3)=C(N)N=C2)C=N1,
R-7050,R7050; R 7050; R-7050; TNF-Î± Antagonist III,303997-35-5,FC(F)(F)c3nnc2c(nc1ccc(Cl)cc1n23)Sc4ccccc4,
SJ000291942,,425613-09-8,[O-][N+](=O)c1cc(ccc1F)NC(=O)COc2ccc(cc2)CC,
Fantofarone,SR 33557,114432-13-2,COc1ccc(cc1OC)CCN(C)CCCOc2ccc(cc2)S(=O)(=O)c3c4ccccn4cc3C(C)C,
ML241 hydrochloride,,2070015-13-1,Cl.c1ccc2OCCN(c2c1)c5nc3CCCCc3c(NCc4ccccc4)n5,
3'-Fluoro-3'-deoxythymidine,3'-Deoxy-3'-fluorothymidine,25526-93-6,CC1=CN(C(=O)NC1=O)[C@H]2C[C@H](F)[C@@H](CO)O2,
Bilobetin,,521-32-4,Oc1cc(O)cc2OC(=CC(=O)c12)c6cc(c5c(O)cc(O)c3c5OC(=CC3=O)c4ccc(O)cc4)c(OC)cc6,
HC-067047,HC067047; HC 067047; HC-067047,883031-03-6,FC(F)(F)c1cc(ccc1)NC(=O)c4cc(c2ccccc2)n(CCCN3CCOCC3)c4C,
iCRT 14,,677331-12-3,Cc1cc(\C=C2/SC(=O)N(C2=O)c2ccccc2)c(C)n1-c1cccnc1,
Pipequaline hydrochloride,PK-8165 hydrochloride,80221-58-5,Cl.C(Cc1cc(nc2ccccc12)-c1ccccc1)C1CCNCC1,
BMS202 hydrochloride (1675203-84-5(free base)),PD-1/PD-L1 inhibitor 2 hydrochloride,2089334-95-0,Cl.COc1nc(OCc2cccc(c2C)-c2ccccc2)ccc1CNCCNC(C)=O,
AG-1557 hydrochloride (189290-58-2(free base)),,T4694,Cl.COc1cc2ncnc(Nc3cccc(I)c3)c2cc1OC,
(-)-borneol,L-Borneol,464-45-9,C[C@]12CC[C@H](C1(C)C)C[C@H]2O,
JNJ0966,,315705-75-0,COc1ccccc1Nc1nc(cs1)-c1sc(NC(C)=O)nc1C,
TCS-OX2-29,,372523-75-6,COc1cc2CCN(Cc2cc1OC)C(=O)[C@@H](NCc1ccncc1)C(C)(C)C,
ML-098,ML098; ML 098; ML-098; CID-7345532,878978-76-8,Cc1ccc(C)c(OCCn2cc(C(O)=O)c3ccccc23)c1,
L-Kynurenine,(S)-Kynurenine,2922-83-0,N[C@@H](CC(=O)c1ccccc1N)C(O)=O,
Dimemorfan phosphate,"3,17-dimethylmorphinan",36304-84-4,OP(O)(O)=O.CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(C)cc31,
Afloqualone,HQ-495,56287-74-2,Cc1ccccc1-n1c(CF)nc2ccc(N)cc2c1=O,
SRT 1720,,925434-55-5,O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1,
FM-381,FM381,2226521-65-7,CN(C)C(=O)C(=C\c1ccc(o1)-c1nc2cnc3[nH]ccc3c2n1C1CCCCC1)\C#N,
IRAK inhibitor 6,,1042672-97-8,COc1cc(ccc1NC(=O)c1csc(n1)-c1cccnc1)N1CCOCC1,
Pim1/AKK1-IN-1,LKB1/AAK1 dual inhibitor; MDK-2275,1093222-27-5,O=C(Nc1c[nH]c2ncc(cc12)-c1ccc(cc1)C#N)c1cccnc1,
BTSA1,,314761-14-3,O=C1N(N=C(\C1=N/Nc1nccs1)c1ccccc1)c1nc(cs1)-c1ccccc1,
ML311,,315698-17-0,CCN1CCN(CC1)C(c1ccc(cc1)C(F)(F)F)c1ccc2cccnc2c1O,
1-(2-Pyridyl)piperazine,NSC13778,34803-66-2,C1CN(CCN1)c1ccccn1,
Iprodione,,36734-19-7,CC(C)NC(=O)N1CC(=O)N(C1=O)c1cc(Cl)cc(Cl)c1,
Pyridaben,,96489-71-3,CC(C)(C)c1ccc(CSc2cnn(c(=O)c2Cl)C(C)(C)C)cc1,
DJ-V-159,DJ-V159,2253744-53-3,FC(F)(F)c1cc(NC(=O)c2cccc(c2)C(=O)Nc2ccc(C#N)c(c2)C(F)(F)F)ccc1C#N,
SRI-011381 hydrochloride,,2070014-88-7,Cl.O=C(NC1CCCCC1)N(CC1CCNCC1)Cc1ccccc1,
SRT 1720 dihydrochloride[925434-55-5(free base)],,T5124,Cl.Cl.O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1,
WDR5-0103 hydrochloride[890190-22-4(free base)],WD-Repeat Protein 5-0103,T5140,Cl.COC(=O)c1ccc(N2CCN(C)CC2)c(NC(=O)c2cccc(OC)c2)c1,
Clonidine,Catapres; Kapvay; Nexiclon,4205-90-7,Clc1cccc(Cl)c1NC1=NCCN1,
TGN-020,TGN020,51987-99-6,O=C(Nc1nncs1)c1cccnc1,
Desmopressin acetate (16679-58-6 free base),DDAVP,62288-83-9,CC(O)=O.NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O,
Atosiban acetate,RW22164; RWJ22164; Atosiban acetate (90779-69-4 free base),914453-95-5,CC(O)=O.CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)cc1,
Treprostinil,LRX-15; Orenitram; Remodulin,81846-19-7,CCCCC[C@H](O)CC[C@H]1[C@H](O)C[C@@H]2Cc3c(C[C@H]12)cccc3OCC(O)=O,
(E)-AG 99,AG 99; (E)-Tyrphostin AG 99; (E)-Tyrphostin 46; Tyrphostin 46,122520-85-8,NC(=O)C(=C\c1ccc(O)c(O)c1)\C#N,
KHS101 hydrochloride,,1784282-12-7,Cl.CC(C)CNc1ccnc(NCc2csc(n2)-c2ccccc2)n1,
POL1-IN-1,Compound 3A,1822358-25-7,C[C@H]1CN(C[C@@H](C)N1)c1ccc2cc(C#N)c3nc4ccccc4n3c2n1,
Chalcone,benzylideneacetophenone; phenyl styryl ketone; benzalacetophenone; Î²-phenylacrylophenone; Cinnamophenone,94-41-7,O=C(\C=C\c1ccccc1)c1ccccc1,
MRT67307 HCl (1190378-57-4(free base)),,T5162,Cl.O=C(NCCCNc1nc(Nc2cccc(CN3CCOCC3)c2)ncc1C1CC1)C1CCC1,
AVN-492,AVN492,1220646-23-0,CNc1nn2c(C)c(N(C)C)c(C)nc2c1S(=O)(=O)c1ccccc1,
ERK5-IN-1,,1234479-76-5,COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCN(C)CC1,
AUT1,,1311136-84-1,CC[C@H]1NC(=O)N(C1=O)c1ccc(Oc2ccc(C)c(OC)c2)nc1,
SGC-GAK-1,,2226517-76-4,COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC,
EGFR-IN-12,EGFR Inhibitor,879127-07-8,FC(F)(F)c1cccc(Nc2cc(Nc3cccc(NC(=O)C4CC4)c3)ncn2)c1,
MK-3903,MK3903; MK 3903; MK-3903,1219737-12-8,Cc1ccc(Oc2nc3cc(c(Cl)cc3[nH]2)-c2ccc(cc2)-c2ccccc2)cc1C(O)=O,
SPHINX31,,1818389-84-2,FC(F)(F)c1ccc(N2CCN(Cc3ccccn3)CC2)c(NC(=O)c2ccc(o2)-c2ccncc2)c1,
Indirubin-3'-monoxime,Indirubin-3'-oxime,160807-49-8,O\N=C1c2ccccc2NC/1=C1\C(=O)Nc2ccccc12,
BIBF0775,,334951-90-5,CCN(C)C(=O)c1ccc2c(NC(=O)\C2=C(/Nc2ccc(CN3CCCCC3)cc2)c2ccccc2)c1,
666-15,CREB inhibitor; CREB inhibitor,1433286-70-4,Cl.NCCCOc1cc2ccccc2cc1C(=O)NCCOc1cc2ccccc2cc1C(=O)Nc1ccc(Cl)cc1O,
BI 01383298,,2227549-00-8,Fc1ccc(CNC(=O)C2CCN(CC2)S(=O)(=O)c2cc(Cl)cc(Cl)c2)cc1,
SKA-31,"SKA31; SKA 31; SKA-31; Naphtho[1,2-d]thiazol-2-ylamine",40172-65-4,Nc1nc2c(ccc3ccccc23)s1,
Zacopride hydrochloride,,101303-98-4,Cl.COc1cc(N)c(Cl)cc1C(=O)NC1CN2CCC1CC2,
JG-98,JG98; JG 98; JG-98,1456551-16-8,[Cl-].CCn1c(=O)\c(s\c1=C/c1scc[n+]1Cc1ccccc1)=C1/Sc2cc(Cl)ccc2N1C,
IACS-010759,IACS10759; IACS 10759; IACS-10759,1570496-34-2,Cc1nc(nn1Cc1cccc(c1)N1CCC(CC1)S(C)(=O)=O)-c1nc(no1)-c1ccc(OC(F)(F)F)cc1,
Y06036,,1832671-96-1,COc1ccc(Br)cc1S(=O)(=O)Nc1cc2c(C)noc2cc1OC,
Rimeporide hydrochloride,EMD-87580 hydrochloride,187870-95-7,Cl.Cc1cc(c(cc1C(=O)NC(N)=N)S(C)(=O)=O)S(C)(=O)=O,
INH14,,200134-22-1,CCc1ccc(NC(=O)Nc2ccccc2)cc1,
IWP-O1,,2074607-48-8,O=C(Cn1nnc(c1-c1ccccc1)-c1ccncc1)Nc1ccc(cn1)-c1ccccc1,
WYC-209,WYC209,2131803-90-0,CCOC(=O)c1cnc(nc1)C#Cc1ccc2c(c1)C(C)(C)CCS2=O,
BAI1,,335165-68-9,BrC1=CC=C2C(=C1)C=3C=C(Br)C=CC3N2CC(O)CN4CCNCC4,
BCI-121,BCI121; BCI 121; BCI-121,432529-82-3,NC(=O)C1CCN(CC(=O)Nc2ccc(Br)cc2)CC1,
mTOR inhibitor-1,,468747-17-3,C\C(=N/NC(=O)c1ccc(C)c(Br)c1)c1ccc(O)cc1O,
T-26c,,869296-13-9,COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(cc4)C(O)=O)c3c(=O)[nH]2)c1,
Fluralaner,AH252723; A1443,864731-61-3,Cc1cc(ccc1C(=O)NCC(=O)NCC(F)(F)F)C1=NOC(C1)(c1cc(Cl)cc(Cl)c1)C(F)(F)F,
LP-211,,1052147-86-0,O=C(CCCCCN1CCN(CC1)c1ccccc1-c1ccccc1)NCc1ccc(cc1)C#N,
Loreclezole,,117857-45-1,Cl\C(=C/n1cncn1)c1ccc(Cl)cc1Cl,
Longdaysin,,1353867-91-0,CC(C)n1cnc2c(NCc3cccc(c3)C(F)(F)F)ncnc12,
TBHQ,tert-Butylhydroquinone,1948-33-0,CC(C)(C)c1cc(O)ccc1O,
TH34,,2196203-96-8,Cc1ccc(cc1NCc1ccccc1)C(=O)NO,
Tempo,"2,2,6,6-Tetramethylpiperidinooxy; TEMPO",2564-83-2,CC1(C)CCCC(C)(C)N1[O],
(Rac)-Antineoplaston A10,,77658-84-5,O=C(Cc1ccccc1)NC1CCC(=O)NC1=O,
TP0463518,,1558021-37-6,OC(=O)CNC(=O)C1=C(O)CCN(Cc2ccc(Oc3ccc(Cl)cc3)nc2)C1=O,
PD158780,,171179-06-9,CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,
CK1-IN-1,PUN51207,1784751-20-7,Fc1ccc(cc1)-c1nc([nH]c1-c1ccncc1)-c1ccc2ccccc2c1F,
GeA-69,,2143475-98-1,CC(=O)Nc1ccccc1-c1cccc2c3ccccc3[nH]c12,
BI-1347,,2163056-91-3,CN(C)C(=O)Cn1cc(cn1)-c1ccc(cc1)-c1cncc2ccccc12,
AZD3229,,2248003-60-1,COCCOc1cc(F)c2c(Nc3ccc(NC(=O)Cn4cc(nn4)C(C)C)cc3)ncnc2c1,
BSJ-03-123,,2361493-16-3,CC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCN(CCOCCOCCOCCNC(=O)COc4cccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c45)CC3)cc2n(C2CCCC2)c1=O,
Glumetinib,SCC244,1642581-63-2,Cn1cc(cn1)-c1cnc2cnn(c2c1)S(=O)(=O)c1cnc2ccc(cn12)-c1cnn(C)c1,
BAY-293,,2244904-70-7,CNCc1ccccc1-c1csc(c1)[C@@H](C)Nc1nc(C)nc2cc(OC)c(OC)cc12,
N-acetylcysteine amide,,38520-57-9,CC(=O)N[C@@H](CS)C(N)=O,
BMS-687453,,1000998-59-3,COC(=O)N(CC(O)=O)Cc1cccc(OCc2nc(oc2C)-c2ccc(Cl)cc2)c1,
GSK-4716,,101574-65-6,CC(C)c1ccc(cc1)\C=N\NC(=O)c1ccc(O)cc1,
SCR-1481B1,c-Met inhibitor 2,1174161-86-4,NC(CO)(CO)CO.NC(CO)(CO)CO.Nc1nccc(Oc2ccc(NC(=O)c3cn(COP(O)(O)=O)cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl,
Decloxizine dihydrochloride,UCB 1402 dihydrochloride,13073-96-6,Cl.Cl.OCCOCCN1CCN(CC1)C(c1ccccc1)c1ccccc1,
JAK3-IN-6,,1443235-95-7,CCOC(=O)c1c[nH]c2ncnc(-c3cccc(NC(=O)C(C)=C)c3)c12,
Cetrorelix Acetate,Cetrorelix,145672-81-7,CC(O)=O.CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,
KDU691,,1513879-19-0,CNC(=O)c1ccc(cc1)-c1cnc2cnc(cn12)C(=O)N(C)c1ccc(Cl)cc1,
Hemin,Hemin chloride,16009-13-5,[Cl-].[Fe+3].Cc1c(CCC(O)=O)c2cc3[n-]c(cc4nc(cc5[n-]c(cc1n2)c(C=C)c5C)c(C=C)c4C)c(C)c3CCC(O)=O,
MW-150,MW01-18-150SRM,1628502-91-9,CN1CCN(CC1)c1cc(-c2ccncc2)c(nn1)-c1ccc2ccccc2c1,
IRAK4-IN-7,CA-4948,1801343-74-7,Nc1ccc(cn1)-c1cccc(n1)C(=O)Nc1cnc2nc(oc2c1)N1CCOCC1,
NMDAR antagonist 1,,2220162-06-9,Cc1ccc2N=C3CCC(N3Cc2c1)C(=O)NCCc1ccc(O)cc1,
AK-7,,420831-40-9,Brc1cccc(NC(=O)c2cccc(c2)S(=O)(=O)N2CCCCCC2)c1,
CXD101,CXD-101,934828-12-3,Cc1nn(C)cc1CN1CCC(CC1)c1ccc(cc1)C(=O)Nc1ccccc1N,
N-(p-amylcinnamoyl) Anthranilic Acid,ACA; N-(p-amylcinnamoyl) Anthranilic Acid,110683-10-8,CCCCCc1ccc(\C=C\C(=O)Nc2ccccc2C(O)=O)cc1,
WNK-IN-11,Allosteric WNK Kinase Inhibitor; WNK-IN-11,2123489-30-3,CNc1nc(cs1)-c1cc(C(=O)N2CCN(Cc3ccc(Cl)cc3)CC2)c(Cl)cn1,
SN 6,SN6,415697-08-4,CCOC(=O)C1CSC(Cc2ccc(OCc3ccc(cc3)[N+]([O-])=O)cc2)N1,
GNE-6640,GNE 6640; 4-[2-amino-4-ethyl-5-(1H-indazol-5-yl)pyridin-3-yl]phenol; GNE6640,2009273-67-8,CCc1c(cnc(N)c1-c1ccc(O)cc1)-c1ccc2[nH]ncc2c1,
Tyrosine kinase-IN-1,,705946-27-6,CCN1CCC(CC1)Nc1ccc2NC(=O)\C(=C(/c3ncc(C)[nH]3)c3cccc(F)c3)c2c1,
SAR125844,SAR125884,1116743-46-4,Fc1ccc(cc1)-c1ccc2nnc(Sc3ccc4nc(NC(=O)NCCN5CCOCC5)sc4c3)n2n1,
K-Ras-IN-1,,84783-01-7,Oc1ccccc1C(=S)N1CCCC1,
GUANABENZ,,5051-62-7,NC(=N)NN=Cc1c(Cl)cccc1Cl,
PQR620,,1927857-56-4,[H][C@]12CC[C@]([H])(COC1)N2c1nc(nc(n1)-c1cnc(N)cc1C(F)F)N1[C@@]2([H])CC[C@]1([H])COC2,
ASP5878,ASP-5878,1453208-66-6,COc1cc(OC)c(F)c(COc2cnc(Nc3cnn(CCO)c3)nc2)c1F,
ZD-4190,,413599-62-9,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1,
SRI 31215 TFA,SRI 31215,1832686-44-8,OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CC1CN(CC2CCN(Cc3ccccc3)CC2)C(=O)N(C1)c1cccc(c1)C(N)=N,
AMG 333,AMG-333,1416799-28-4,O=C(O)c1ccc(nc1)C(=O)N[C@H](c2ncccc2F)c3ccc(OC(F)(F)F)c(F)c3,
TG4-155,,1164462-05-8,COc1cc(\C=C\C(=O)NCCn2c(C)cc3ccccc23)cc(OC)c1OC,
DMX-5804,DMX-5084,2306178-56-1,COCCOc1ccc(cc1)-c1cn(-c2ccccc2)c2nc[nH]c(=O)c12,
CLP290,CLP-290,1181083-81-7,Fc1ccc(\C=C2/SC(=NC2=O)N2CCCCN2)c(OC(=O)N2CCCC2)c1,
Eganelisib,IPI-549,1693758-51-8,C[C@H](NC(=O)c1c(N)nn2cccnc12)c1cc2cccc(C#Cc3cnn(C)c3)c2c(=O)n1-c1ccccc1,
GSK963,GSK963 (Racemate),2049868-46-2,CC(C)(C)C(=O)N1N=CCC1c1ccccc1,
AM-92016 hydrochloride,,133229-11-5,Cl.CN(CCc1ccc(Cl)c(Cl)c1)CC(O)COc1ccc(NS(C)(=O)=O)cc1,
YKL-06-061,,2172617-15-9,COc1cc(ccc1Nc1ncc2CN(C(=O)N(C3CCC3)c2n1)c1c(C)cccc1C)N1CCN(C)CC1,
MC180295,(rel)-MC180295,2237942-08-2,Nc1nc(N[C@H]2CC3CCC2C3)sc1C(=O)c1ccccc1[N+]([O-])=O,
GSK8612,,2361659-62-1,Cc1nn(CC(F)(F)F)cc1Nc1ncc(Br)c(NCc2ccc(cc2)S(N)(=O)=O)n1,
DMNQ,,6956-96-3,COC1=C(OC)C(=O)c2ccccc2C1=O,
Fosphenytoin disodium,Fosphenytoin sodium; ACC-9653,92134-98-0,[Na+].[Na+].[O-]P([O-])(=O)OCN1C(=O)NC(C1=O)(c1ccccc1)c1ccccc1,
GSK2193874,,1336960-13-4,FC(F)(F)c1cccc(c1)-c1nc2cc(Br)ccc2c(C(=O)NC2(CC2)c2ccccc2)c1CN1CCC(CC1)N1CCCCC1,
Senexin A,,1366002-50-7,N#Cc1ccc2ncnc(NCCc3ccccc3)c2c1,
IDF-11774,,1429054-28-3,CN1CCN(CC1)C(=O)COc1ccc(cc1)C12CC3CC(CC(C3)C1)C2,
Belvarafenib,,1446113-23-0,Cc1ccc2c(Nc3cccc(Cl)c3F)nccc2c1NC(=O)c1csc2c(N)ncnc12,
Adavivint,Adavivint (SM04690),1467093-03-3,CC(C)CC(=O)Nc1cncc(c1)-c1ccc2[nH]nc(-c3nc4cncc(-c5cccc(F)c5)c4[nH]3)c2c1,
Darovasertib,LXS196,1874276-76-2,CC1(N)CCN(CC1)c1cccnc1NC(=O)c1nc(cnc1N)-c1ncccc1C(F)(F)F,
ZT-12-037-01,,2328073-61-4,COc1cc2nc(NC3CC3)nc(NC3CCN(CC3)C(C)C)c2cc1OC,
"Ethyl 3,4-dihydroxybenzoate",,3943-89-3,CCOC(=O)c1ccc(O)c(O)c1,
"2,4-Diaminophenoxyethanol HCl",,66422-95-5,Cl.Cl.Nc1ccc(OCCO)c(N)c1,
Bisphenol B,,77-40-7,CCC(C)(c1ccc(O)cc1)c1ccc(O)cc1,
Aurora kinase inhibitor-3,Aurora Kinase Inhibitor III,879127-16-9,FC(F)(F)c1cccc(Nc2ccnc(Nc3cccc(NC(=O)C4CC4)c3)n2)c1,
Suvecaltamide,MK-8998,953778-58-0,CC(C)c1ccc(CC(=O)N[C@H](C)c2ccc(OCC(F)(F)F)cn2)cc1,
SAR125884 hydrochlorid (1116743-46-4(free base)),,T5677,Cl.Fc1ccc(cc1)-c1ccc2nnc(Sc3ccc4nc(NC(=O)NCCN5CCOCC5)sc4c3)n2n1,
Tegatrabetan,BC2059,1227637-23-1,C[C@H]1C[C@@H](C)CN(C1)S(=O)(=O)c1ccc2\C(=N/O)c3ccc(cc3\C(=N/O)c2c1)S(=O)(=O)N1C[C@@H](C)C[C@@H](C)C1,
NG25,,1315355-93-1,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(Oc4ccnc5[nH]ccc45)c3)cc2C(F)(F)F)CC1,
SSE15206,,1370046-40-4,COc1cc(cc(OC)c1OC)C1CC(=NN1C(N)=S)c1ccccc1,
Iadademstat dihydrochloride,ORY-1001(trans),1431303-72-8,Cl.Cl.N[C@H]1CC[C@@H](CC1)N[C@@H]1C[C@H]1c1ccccc1,
CC-401 Hydrochloride,CC401 HCl,1438391-30-0,Cl.C(CN1CCCCC1)Oc1cccc(c1)-c1n[nH]c2ccc(cc12)-c1ncn[nH]1,
Rapastinel Trifluoroacetate,GLYX-13 Trifluoroacetate; Thr-Pro-Pro-Thr-NH2 Trifluoroacetate,1435786-04-1,OC(=O)C(F)(F)F.C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(N)=O,
SKLB-23bb,,1815580-06-3,COc1ccc(cc1OCCCC(=O)NO)N(C)c1nc(C)nc2ccccc12,
BMS-1166,BMS1166,1818314-88-3,Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3C[C@H](O)C[C@@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1,
ERK5-IN-2,,1888305-96-1,Fc1cccc(Br)c1C(=O)c1c[nH]c(c1)C(=O)Nc1cccnc1,
Selective PI3KÎ´ Inhibitor 1,,2088525-31-7,Cn1nc(nc1C1(CC1)c1ccccc1)-c1cnc(N)c(n1)-c1ccc(C(N)=O)c(F)c1,
TRPM8 antagonist 2,,259674-19-6,COC(=O)[C@H](Cc1c[nH]c2ccccc12)N(Cc1ccccc1)Cc1ccccc1,
7ACC1,7-(Diethylamino)coumarin-3-carboxylic acid; DEAC; Coumarin D 1421; D 1421,50995-74-9,CCN(CC)c1ccc2cc(C(O)=O)c(=O)oc2c1,
Stylopine hydrochloride,,96087-21-7,Cl.C1Oc2cc3CCN4Cc5c6OCOc6ccc5CC4c3cc2O1,
Tyrphostin AG30,Tyrphostin AG30(AG30),122520-79-0,OC(=O)C(=C\c1ccc(O)c(O)c1)\C#N,
VP3.15 dihydrobromide,,1281681-33-1,Br.Br.C(CN1CCOCC1)N=c1nc(-c2ccccc2)n(s1)-c1ccccc1,
Faltan,Folpet; Faltan,133-07-3,ClC(Cl)(Cl)SN1C(=O)c2ccccc2C1=O,
Omberacetam,Noopept; Omberacetam; GVS-111; SGS-111,157115-85-0,CCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)Cc1ccccc1,
GSK3326595,EPZ015938,1616392-22-3,CC(=O)N1CCC(CC1)Nc1cc(ncn1)C(=O)NC[C@H](O)CN1CCc2ccccc2C1,
ARN-3236,,1613710-01-2,COc1ccc(-c2c[nH]c3nccc(-c4ccsc4)c23)c(OC)c1,
Namodenoson,2-Cl-IB-MECA; CF-102; Namodenoson ,163042-96-4,CNC(=O)C1OC(C(O)C1O)n1cnc2c(NCc3cccc(I)c3)nc(Cl)nc12,
1-Aminobenzotriazole,ABT; 3-Aminobenzotriazole,1614-12-6,Nn1nnc2ccccc12,
Linperlisib,PI3KÎ´-IN-2,1702816-75-8,COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)O)cc(F)cc12)N1CCOCC1,
IITZ-01,,1807988-47-1,Fc1ccc(Nc2nc(Nc3ccc(cc3)-c3nc4ccccc4[nH]3)nc(n2)N2CCOCC2)cc1,
KB-R7943 mesylate,KB-R7943; KB-R7943 mesylate,182004-65-5,CS(O)(=O)=O.NC(=N)SCCc1ccc(OCc2ccc(cc2)[N+]([O-])=O)cc1,
4-Phenylbutyric acid,Benzenebutyric acid; 4-Phenylbutyric acid,1821-12-1,OC(=O)CCCc1ccccc1,
Calcium dobesilate,,20123-80-2,[Ca++].Oc1ccc(O)c(c1)S([O-])(=O)=O.Oc1ccc(O)c(c1)S([O-])(=O)=O,
HS-1371,HS1371,2158197-70-5,Cc1ccc(Oc2ccnc3cc(ccc23)-c2cnn(c2)C2CCNCC2)cc1,
Rafoxanide,,22662-39-1,Oc1c(I)cc(I)cc1C(=O)Nc1ccc(Oc2ccc(Cl)cc2)c(Cl)c1,
Nicotinamide riboside chloride,,23111-00-4,[Cl-].NC(=O)c1ccc[n+](c1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,
PROTAC ERRÎ± ligand 2,,2306388-57-6,COc1cc(\C=C(/C#N)C(O)=O)ccc1OCc1ccc(cc1C(F)(F)F)C(F)(F)F,
Aminooxyacetic acid hemihydrochloride,Carboxymethoxylamine Hemihydrochloride,2921-14-4,Cl.NOCC(O)=O.NOCC(O)=O,
Almitrine mesylate,Almitrine dimesylate; Almitrine mesylate; Almitrine bismesylate; Almitrine bismethanesulfonate,29608-49-9,CS(O)(=O)=O.CS(O)(=O)=O.Fc1ccc(cc1)C(N1CCN(CC1)c1nc(NCC=C)nc(NCC=C)n1)c1ccc(F)cc1,
TRPM8 antagonist WS-3,N-Ethyl-p-menthane-3-carboxamide; TRPM8 antagonist WS-3; Cyclohexanecarboxamide; N-Ethyl-2-isopropyl-5-methylcyclohexanecarboxamide,39711-79-0,CCNC(=O)C1CC(C)CCC1C(C)C,
Methyldopa hydrate,Alpha-Methyldopa Sesquihydrate; MK-351 hydrate; Methyldopa hydrate; Methyldopa Sesquihydrate; L-(-)-Î±-Methyldopa hydrate,41372-08-1,O.O.O.C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O.C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O,
idalopirdine,Lu AE58054,467459-31-0,FC(F)C(F)(F)COc1cccc(CNCCc2c[nH]c3cc(F)ccc23)c1,
Navarixin,SCH 527123; MK-7123,473727-83-2,CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1,
Dovitinib lactate,CHIR-258 lactate; TKI-258 lactate,692737-80-7,CC(O)C(O)=O.CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,
Hexaconazole,(-)-Hexaconazol,79983-71-4,CCCCC(O)(Cn1cncn1)c1ccc(Cl)cc1Cl,
BAPTA,,85233-19-8,OC(=O)CN(CC(O)=O)c1ccccc1OCCOc1ccccc1N(CC(O)=O)CC(O)=O,
AMG-47a,,882663-88-9,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1,
GSK369796 Dihydrochloride,N-tert-butylisoquine,1010411-21-8,Cl.Cl.CC(C)(C)NCc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1O,
Phenylbiguanide,N-Phenylbiguanide; PBG; 1-Phenylbiguanide,102-02-3,NC(=N)NC(=N)Nc1ccccc1,
Valbenazine,NBI-98854,1025504-45-3,[H][C@]12C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CCc1cc(OC)c(OC)cc21,
GNE-493,,1033735-94-2,CC(C)(O)c1cc2nc(nc(N3CCOCC3)c2s1)-c1cnc(N)nc1,
Bexagliflozin,EGT1442; Bexagliflozin; EGT0001442; THR-1442,1118567-05-7,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(OCCOC3CC3)cc2)c1,
E-4031,,113559-13-0,Cl.Cl.Cc1cccc(CCN2CCC(CC2)C(=O)c2ccc(NS(C)(=O)=O)cc2)n1,
TAK-960,,1137868-52-0,COc1cc(C(=O)NC2CCN(C)CC2)c(F)cc1Nc1ncc2N(C)C(=O)C(F)(F)CN(C3CCCC3)c2n1,
CAY10594,,1130067-34-3,O=C(NCCN1CCC2(CC1)N(CNC2=O)c1ccccc1)c1ccc2ccccc2c1,
PNU-74654,PNU 74654; PNU-74654,113906-27-7,Cc1ccc(\C=N\NC(=O)c2ccccc2Oc2ccccc2)o1,
NSC139021,ERGi-USU,1147-56-4,Oc1ccc2ccccc2c1N=Nc1nccs1,
Mirogabalin,DS5565,1138245-13-2,[H][C@@]12C[C@](CN)(CC(O)=O)[C@]1([H])C=C(CC)C2,
Urolithin A,,1143-70-0,Oc1ccc2c(c1)oc(=O)c1cc(O)ccc21,
Basmisanil,RG1662; RO5186582,1159600-41-5,Cc1onc(c1COc1ccc(cn1)C(=O)N1CCS(=O)(=O)CC1)-c1ccc(F)cc1,
FK 3311,FK-3311; COX-2 Inhibitor V,116686-15-8,CC(=O)c1ccc(NS(C)(=O)=O)c(Oc2ccc(F)cc2F)c1,
A-967079,A 967079; A-967079,1170613-55-4,CCC(=N/O)\C(C)=C\c1ccc(F)cc1,
GS-441524,GS 441524,1191237-69-0,Nc1ncnn2c(ccc12)[C@@]1(O[C@H](CO)[C@@H](O)[C@H]1O)C#N,
GDC-0575,ARRY-575; RG7741,1196541-47-5,N[C@@H]1CCCN(C1)c1c(Br)cnc2[nH]cc(NC(=O)C3CC3)c12,
CPI-444,V81444; ciforadenant,1202402-40-1,Cc1ccc(o1)-c1nc(N)nc2n(Cc3cccc(CO[C@H]4CCOC4)n3)nnc12,
TEPP-46,ML265; TEPP-46,1221186-53-3,Cn1c2cc(sc2c2cnn(Cc3cccc(N)c3)c(=O)c12)S(C)=O,
JMS-17-2,,1380392-05-1,Clc1ccc(cc1)C1CCN(CCCn2c3ccccc3n3cccc3c2=O)CC1,
Capsazepine,,138977-28-3,Oc1cc2CCCN(Cc2cc1O)C(=S)NCCc1ccc(Cl)cc1,
Metaflumizone,BAS-320I,139968-49-3,FC(F)(F)Oc1ccc(NC(=O)NN=C(Cc2ccc(cc2)C#N)c2cccc(c2)C(F)(F)F)cc1,
Piclidenoson,IB-MECA; CF-101,152918-18-8,CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCc3cccc(I)c3)ncnc12,
THZ2,CDK7-IN-1,1604810-84-5,CN(C)C\C=C\C(=O)Nc1cccc(c1)C(=O)Nc1cccc(Nc2ncc(Cl)c(n2)-c2c[nH]c3ccccc23)c1,
I-191,,1690172-25-8,CC(C)(C)c1cc(nn2cc(nc12)C(=O)N1CCNC(=O)C1(C)C)-c1ccc(F)cc1,
Î²-Estradiol 17-acetate,"beta-estradiol 17-acetate; 1,3,5(10)-Estratriene-3,17Î²-diol 17-acetate",1743-60-8,[H][C@@]12CC[C@H](OC(C)=O)[C@@]1(C)CC[C@]1([H])c3ccc(O)cc3CC[C@@]21[H],
TAS-103 dihydrochloride,TAS-103 (dihydrochloride); BMS-247615 dihydrochloride,174634-09-4,Cl.Cl.CN(C)CCNc1nc2cc(O)ccc2c2-c3ccccc3C(=O)c12,
BDP5290,,1817698-21-7,Clc1cn(nc1C(=O)Nc1cn[nH]c1-c1ccccn1)C1CCNCC1,
Ravuconazole,BMS-207147; ER-30346,182760-06-1,C[C@@H](c1nc(cs1)-c1ccc(cc1)C#N)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,
SB 242084,SB 242084 dihydrochloride hydrate; SB 242084,181632-25-7,Cc1cc2CCN(C(=O)Nc3ccc(Oc4cccnc4C)nc3)c2cc1Cl,
7-Methylguanosine,,20244-86-4,C[n+]1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2nc(N)[nH]c(=O)c12,
6H05 (TFA),6H05 TFA; 6H05 trifluoroacetate; 6H05 (TFA),2061344-88-3,OC(=O)C(F)(F)F.CN(C)CCSSCCNC(=O)C1CCN(CC1)C(=O)CSc1ccc(Cl)cc1,
Purvalanol B,NG 95,212844-54-7,CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(O)=O)c(Cl)c2)c2ncn(C(C)C)c2n1,
HSP27 inhibitor J2,J2,2133499-85-9,Cc1cc(=O)c2c(O)cc(OCC3CS3)cc2o1,
Grp94 Inhibitor-1,,2234897-35-7,CC(C)c1ccc(cc1)-c1ccc(N[C@H]2CC[C@H](O)CC2)c(c1)C(N)=O,
AZD-7648,,2230820-11-6,Cc1cc2ncnn2cc1Nc1ncc2n(C)c(=O)n(C3CCOCC3)c2n1,
DNQX,FG 9041,2379-57-9,[O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1[N+]([O-])=O,
SD 0006,SD-06,271576-80-8,OCC(=O)N1CCC(CC1)c1[nH]nc(c1-c1ccncn1)-c1ccc(Cl)cc1,
Oglufanide,H-Glu-Trp-OH; L-Glutamyl-L-tryptophan,38101-59-6,N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O,
BCTC,,393514-24-4,CC(C)(C)c1ccc(NC(=O)N2CCN(CC2)c2ncccc2Cl)cc1,
Y15,"1,2,4,5-Benzenetetramine tetrahydrochlor; FAK inhibitor Y15; FAK Inhibitor 14",4506-66-5,Cl.Cl.Cl.Cl.Nc1cc(N)c(N)cc1N,
Diphenyleneiodonium chloride,DPI,4673-26-1,[Cl-].[I+]1c2ccccc2-c2ccccc12,
Genz-644282,Genz644282,529488-28-6,CNCCn1c2c(cnc3cc4OCOc4cc23)c2cc(OC)c(OC)cc2c1=O,
AMG9810,,545395-94-6,CC(C)(C)c1ccc(cc1)\C=C\C(=O)Nc1ccc2OCCOc2c1,
F-15599,,635323-95-4,Cc1cnc(CNCC2(F)CCN(CC2)C(=O)c2ccc(F)c(Cl)c2)nc1,
Levalbuterol tartrate,Levosalbutamol tartrate,661464-94-4,O[C@H]([C@@H](O)C(O)=O)C(O)=O.CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1,
L-165041,,79558-09-1,CCCc1c(OCCCOc2ccc(OCC(O)=O)cc2)ccc(C(C)=O)c1O,
AnaMorelin hydrochloride,RC-1291 hydrochloride; ONO-7643 hydrochloride,861998-00-7,Cl.CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C1)C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(C)N,
Eupalinolide A,,877822-40-7,CC(OC/C1=C\C[C@@H](/C(C)=C/[C@H]2OC(C([C@@H]2[C@H](OC(/C(C)=C/CO)=O)C1)=C)=O)OC(C)=O)=O,
Pitolisant hydrochloride,Ciproxidine; BF 2649,903576-44-3,Cl.Clc1ccc(CCCOCCCN2CCCCC2)cc1,
CZC-8004,CZC-00008004,916603-07-1,NCc1ccc(Nc2ncc(F)c(Nc3ccccc3)n2)cc1,
AZD-6280,AZD6280,942436-93-3,CCCNC(=O)c1nnc2c(cccc2c1N)-c1cc(OC)ccc1OC,
CNQX,FG9065,115066-14-3,[O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1C#N,
Oxyphenisatin acetate,,115-33-3,CC(=O)Oc1ccc(cc1)C1(C(=O)Nc2ccccc12)c1ccc(OC(C)=O)cc1,
G15,,1161002-05-6,[H][C@]12CC=C[C@@]1([H])c1ccccc1N[C@H]2c1cc2OCOc2cc1Br,
WT-161,,1206731-57-8,ONC(=O)CCCCCCC(=O)N\N=C\c1ccc(cc1)N(c1ccccc1)c1ccccc1,
PF-04979064,,1220699-06-8,C[C@H](O)C(=O)N1CCC(CC1)n1c2c(cnc3ccc(nc23)-c2ccc(C)nc2)n(C)c1=O,
BCI-215,,1245792-67-9,Brc1ccc2C(=O)\C(C(NC3CCCCC3)c2c1)=C\c1ccccc1,
O-304,,1261289-04-6,Clc1ccc(Cn2sc(NC(=O)c3ccc(Cl)cc3)nc2=O)cc1,
Ralfinamide,FCE-26742A; Priralfinamide,133865-88-0,C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O,
Theliatinib,,1353644-70-8,[H][C@]12CCN(C)[C@@]1([H])CN(C2)C(=O)Nc1cc2c(Nc3cccc(c3)C#C)ncnc2cc1OC,
YK11,,1370003-76-1,[H][C@@]12CC[C@]3(OC(C)(OC)O\C3=C\C(=O)OC)[C@@]1(C)CC[C@]1([H])C3CCC(=O)C=C3CC[C@@]21[H],
Dihexa,PNB-0408; N-hexanoic-Try-Ile-(6)-amino hexanoic amide; Hexanoyl-Tyr-Ile-Ahx-NH2,1401708-83-5,CCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCCCCCC(N)=O,
BAY1125976,,1402608-02-9,NC(=O)c1ccc2nc(c(-c3ccccc3)n2n1)-c1ccc(cc1)C1(N)CCC1,
1-Ethynylnaphthalene,,15727-65-8,C#Cc1cccc2ccccc12,
7-Methoxyisoflavone,,1621-56-3,COc1ccc2c(c1)occ(-c1ccccc1)c2=O,
Vorasidenib,AG-881; PVM/MA,1644545-52-7,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(n1)-c1cccc(Cl)n1)C(F)(F)F,
ONC212,,1807861-48-8,FC(F)(F)c1ccc(CN2C3=NCCN3C3=C(CN(Cc4ccccc4)CC3)C2=O)cc1,
Talarozole,R115866,201410-53-9,CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1,
EC330,,2016795-77-8,[H][C@@]12CC[C@@](O)(C(F)(F)C#C)[C@@]1(C)C[C@H](c1ccc(cc1)C1CC1)C1=C3CCC(=O)C=C3CC[C@@]21[H],
3-Methylcytidine,,2140-64-9,Cn1c(=N)ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1=O,
GSK547,GSK'547,2226735-55-1,Fc1cc(F)cc(c1)[C@@H]1CC=NN1C(=O)C1CCN(CC1)c1cc(ncn1)C#N,
ICA-121431,"2,2-Diphenyl-N-[4-(thiazol-2-ylsulfamoyl",313254-51-2,O=C(Nc1ccc(cc1)S(=O)(=O)Nc1nccs1)C(c1ccccc1)c1ccccc1,
5'-N-Ethylcarboxamidoadenosine,NECA; 5'-N-Ethylcarboxamidoadenosine,35920-39-9,CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12,
NP118809,39-1B4,41332-24-5,O=C(CC(c1ccccc1)c1ccccc1)N1CCN(CC1)C(c1ccccc1)c1ccccc1,
Kinetin riboside,N6-Furfuryladenosine,4338-47-0,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCc3ccco3)ncnc12,
7-Hydroxy-4H-chromen-4-one,7-Hydroxy-4-chromone; 7-Hydroxychromone; 7-hydroxy-4-benzopyrone,59887-89-7,Oc1ccc2c(c1)occc2=O,
DHBP dibromide,"Diheptylviologen dibromide; 1,1'-DI-N-HEPTYL-4,4'-BIPYRIDINIUM DIBRO",6159-05-3,[Br-].[Br-].CCCCCCC[n+]1ccc(cc1)-c1cc[n+](CCCCCCC)cc1,
LF3,,664969-54-4,NS(=O)(=O)c1ccc(NC(=S)N2CCN(C\C=C\c3ccccc3)CC2)cc1,
WS-12,,68489-09-8,COc1ccc(NC(=O)[C@@H]2C[C@H](C)CC[C@H]2C(C)C)cc1,
Enclomiphene citrate,(E)-Clomiphene citrate; trans-Clomiphene citrate; Enclomifene citrate,7599-79-3,OC(=O)CC(O)(CC(O)=O)C(O)=O.CCN(CC)CCOc1ccc(cc1)C(\c1ccccc1)=C(\Cl)c1ccccc1,
360A,,794458-56-3,C[n+]1cc(NC(=O)c2cccc(n2)C(=O)Nc2c[n+](C)c3ccccc3c2)cc2ccccc12,
Furafylline,,80288-49-9,Cc1nc2n(Cc3ccco3)c(=O)n(C)c(=O)c2[nH]1,
Acumapimod,BCT-197,836683-15-9,Cc1ccc(cc1-n1ncc(C(=O)c2cccc(c2)C#N)c1N)C(=O)NC1CC1,
Nelotanserin,APD125,839713-36-9,COc1ccc(NC(=O)Nc2ccc(F)cc2F)cc1-c1c(Br)cnn1C,
CAY10471 Racemate,TM30089 Racemate,844639-57-2,CN(C1CCc2c(C1)c1ccccc1n2CC(O)=O)S(=O)(=O)c1ccc(F)cc1,
IC87201,,866927-10-8,Oc1c(Cl)cc(Cl)cc1CNc1ccc2nn[nH]c2c1,
Toceranib Phosphate,PHA 291639  phosphate ; SU11654 phosphate,874819-74-6,OP(O)(O)=O.Cc1[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NCCN1CCCC1,
RRX-001,,925206-65-1,[O-][N+](=O)C1(CN(C1)C(=O)CBr)[N+]([O-])=O,
SAR407899,,923359-38-0,O=c1[nH]ccc2cc(OC3CCNCC3)ccc12,
Lanifibranor,IVA337,927961-18-0,OC(=O)CCCc1cc2cc(Cl)ccc2n1S(=O)(=O)c1ccc2ncsc2c1,
1-Naphthyl PP1 hydrochloride,1-NA-PP 1 hydrochloride,956025-47-1,Cl.CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc12,
NDI-091143,,2375840-87-0,COC(=O)c1cc(Cl)c(O)c(S(=O)(=O)Nc2cc(-c3ccccc3)c(F)cc2F)c1,
Necrostatin 2 racemate,Necrostatin-2 racemate,852391-15-2,CN1C(=O)NC(Cc2c[nH]c3c(Cl)cccc23)C1=O,
ARS-853,,1629268-00-3,C=CC(=O)N1CC(N2CCN(C(=O)CNc3cc(C4(C)CC4)c(Cl)cc3O)CC2)C1,
AG-13958,AG-013958,319460-94-1,Cc1cc(C(=O)Nc2cc(Nc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2F)n(C)n1,
Selitrectinib,LOXO-195,2097002-61-2,C[C@@H]1CCc2ncc(F)cc2[C@H]2CCCN2c2ccn3ncc(c3n2)C(=O)N1,
Yoda 1,,448947-81-7,Clc1cccc(Cl)c1CSc1nnc(-c2cnccn2)s1,
Azimilide Dihydrochloride,NE-10064 Dihydrochloride,149888-94-8,CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1.Cl.Cl,
JNJ-17203212,,821768-06-3,O=C(Nc1ccc(C(F)(F)F)cn1)N1CCN(c2ncccc2C(F)(F)F)CC1,
BBT594,NVP-BBT594,882405-89-2,CC(=O)Nc1cc(Oc2ccc3c(c2)CCN3C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)ncn1,
SBI-115,,882366-16-7,CCS(=O)(=O)c1ncc(Cl)c(C(=O)Oc2cccc(C)c2)n1,
Diquafosol tetrasodium,INS365,211427-08-6,O=c1ccn(C2OC(COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OCC3OC(n4ccc(=O)[nH]c4=O)C(O)C3O)C(O)C2O)c(=O)[nH]1.[Na+].[Na+].[Na+].[Na+],
Didox,NSC-324360,69839-83-4,O=C(NO)c1ccc(O)c(O)c1,
1-BCP,Piperonylic acid piperidide,34023-62-6,O=C(c1ccc2c(c1)OCO2)N1CCCCC1,
ZD7288,ICI D7288,133059-99-1,CCN(c1ccccc1)c1cc(=NC)n(C)c(C)n1.Cl,
Ralfinamide mesylate,FCE-26742A (mesylate),202825-45-4,CC(NCc1ccc(OCc2ccccc2F)cc1)C(N)=O.CS(=O)(=O)O,
Tandospirone citrate,SM-3997 citrate,112457-95-1,O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C1C2C3CCC(C3)C2C(=O)N1CCCCN1CCN(c2ncccn2)CC1,
ARS-1620,,1698055-85-4,C=CC(=O)N1CCN(c2ncnc3c(F)c(-c4c(O)cccc4F)c(Cl)cc23)CC1,
CX546,,215923-54-9,O=C(c1ccc2c(c1)OCCO2)N1CCCCC1,
Avatrombopag,AKR-501;  E5501;  YM477,570406-98-3,O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1,
Afamelanotide Acetate,,1566590-77-9,CC(O)=O.CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,
Adefovir,,106941-25-7,Nc1ncnc2c1ncn2CCOCP(=O)(O)O,
A1874,,2064292-12-0,COc1cc(C(=O)NCCOCCOCCOCCNC(=O)CC2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)ccc1NC(=O)C1NC(CC(C)(C)C)C(C#N)(c2ccc(Cl)cc2F)C1c1cccc(Cl)c1F,
Deoxycytidine triphosphate trisodium salt,2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE TRISODI,109909-44-6,Nc1ccn(C2CC(O)C(COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O2)c(=O)n1.[Na+].[Na+].[Na+],
Azaphen,Azafen;  Pipofezin hydrochloride;  Pipofezine hydrochloride,24853-80-3,CN1CCN(c2cc3c(nn2)Oc2ccccc2N3C)CC1.Cl.Cl,
Clebopride malate,,57645-91-7,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1.O=C(O)CC(O)C(=O)O,
RN-1734,,946387-07-1,CC(C)NCCN(C(C)C)S(=O)(=O)c1ccc(Cl)cc1Cl,
Abametapir,HA-44;  BRN 0123183,1762-34-1,Cc1ccc(-c2ccc(C)cn2)nc1,
Rbin-1,Ribozinoindole-1,328023-11-6,C=C(C)CSc1nnc2c(n1)[nH]c1ccccc12,
"p,p'-DDE","4,4'-DDE; p,p'-DDE;  Dichlorodiphenyldichloroethylene;  p,p'-dichlorodiphenyldichloroethylene",72-55-9,ClC(Cl)=C(c1ccc(Cl)cc1)c1ccc(Cl)cc1,
6-O-Methyl Guanosine,,7803-88-5,COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,
Barnidipine,Mepirodipine;  YM-09730-5(Free base),104713-75-9,COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1,
Î±-Cyano-4-hydroxycinnamic acid,Î±-Cyano-4-hydroxycinnamic acid(Î±-CHCA),28166-41-8,N#C/C(=C\c1ccc(O)cc1)C(=O)O,
2-HBA,,131359-24-5,O=C(/C=C/c1ccccc1O)/C=C/c1ccccc1O,
Taurolidine,,19388-87-5,O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1,
RS-127445 hydrochloride,RS 127445; MT 500,199864-86-3,CC(C)c1cc(-c2ccc(F)c3ccccc23)nc(N)n1.Cl,
BMS-191011,BMS-A,202821-81-6,O=c1oc(-c2ccc(C(F)(F)F)cc2)nn1Cc1cc(Cl)ccc1O,
TH-257,TH 257,2244678-29-1,CCCCN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1,
CID-1067700,,314042-01-8,CC1(C)Cc2c(sc(NC(=S)NC(=O)c3ccccc3)c2C(=O)O)CO1,
6-Aminonicotinamide,,329-89-5,NC(=O)c1ccc(N)nc1,
NBI-98782,(+)-DTBZ;  (+)-Î±-Dihydrotetrabenazine;  (+)-Î±-DHTBZ,85081-18-1,COc1cc2c(cc1OC)C1CC(O)C(CC(C)C)CN1CC2,
AK-1,,330461-64-8,O=C(Nc1cccc([N+](=O)[O-])c1)c1cccc(S(=O)(=O)N2CCCCCC2)c1,
Levomefolate calcium,,151533-22-1,CN1c2c(nc(N)[nH]c2=O)NCC1CNc1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1.[Ca+2],
6-Bromo-2-hydroxy-3-methoxybenzaldehyde,NSC95682,20035-41-0,COc1ccc(Br)c(C=O)c1O,
O6-Benzylguanine,,19916-73-5,Nc1nc(OCc2ccccc2)c2nc[nH]c2n1,
3-Methoxybenzamide,3-MBA,5813-86-5,COc1cccc(C(N)=O)c1,
5-Bromoindole,,10075-50-0,Brc1ccc2[nH]ccc2c1,
RGX-202,3-Guanidinopropionic Acid; Î²-GPA,353-09-3,N=C(N)NCCC(=O)O,
o-Phenanthroline monohydrate,"1, 10-Phenanthroline monohydrate; Phenanthroline monohydrate",5144-89-8,O.c1cnc2c(c1)ccc1cccnc12,
4'-Methoxychalcone,,959-23-9,COc1ccc(C(=O)C=Cc2ccccc2)cc1,
"2,4-Diamino-6-hydroxypyrimidine",DAHP,56-06-4,Nc1cc(=O)[nH]c(N)n1,
"2,5-Di-tert-butylhydroquinone",BHQ,88-58-4,CC(C)(C)c1cc(O)c(C(C)(C)C)cc1O,
Eltoprazine hydrochloride,DU 28853 hydrochloride,98206-09-8,Cl.c1cc2c(c(N3CCNCC3)c1)OCCO2,
(-â)â-âÎ±-âTerpineol,Î±-Terpineol,10482-56-1,CC1=CC[C@@H](C(C)(C)O)CC1,
GW284543,UNC10225170,790186-68-4,COc1cc2nccc(Nc3cccc(Oc4ccccc4)c3)c2cc1OC,
5-Fluoro-2'-deoxycytidine,2'-DEOXY-5-FLUOROCYTIDINE; FdCyd,10356-76-0,Nc1nc(=O)n(C2CC(O)C(CO)O2)cc1F,
Gabazine,SR95531,104104-50-9,Br.COc1ccc(-c2ccc(=N)n(CCCC(=O)O)n2)cc1,
NPPB,,107254-86-4,O=C(O)c1cc([N+](=O)[O-])ccc1NCCCc1ccccc1,
BS194,,1092443-55-4,CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12,
Sodium 2-oxopropanoate,Sodium pyruvate,113-24-6,CC(=O)C(=O)[O-].[Na+],
Coluracetam,MKC-231,135463-81-9,Cc1oc2nc3c(c(NC(=O)CN4CCCC4=O)c2c1C)CCCC3,
DPN,Diarylpropionitrile,1428-67-7,N#CC(Cc1ccc(O)cc1)c1ccc(O)cc1,
ODM-203,,1430723-35-5,Cn1cc(-c2ccc3c(c2)ncn3-c2cc(NS(=O)(=O)C3CC3)cc(-c3ccc(F)cc3F)c2)cn1,
Bremelanotide Acetate,PT-141 Acetate,1607799-13-2,CC(=O)O.CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O,
SD-169,SD 169,1670-87-7,NC(=O)c1ccc2[nH]ccc2c1,
Mavacoxib,,170569-88-7,NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(F)cc2)cc1,
H3B-6527,,1702259-66-2,C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1,
GW 284543 hydrochloride,,179246-08-3,COc1cc2nccc(Nc3cccc(Oc4ccccc4)c3)c2cc1OC.Cl,
Alsterpaullone,,237430-03-4,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,
6-methoxy Naphthalene Acetic Acid,,23981-47-7,COc1ccc2cc(CC(=O)O)ccc2c1,
Calcium N5-methyltetrahydrofolate,NSC173328,26560-38-3,CN1c2c(nc(N)[nH]c2=O)NCC1CNc1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1.[Ca+2],
Tyrphostin A1,Tyrphostin 1; AG9,2826-26-8,COc1ccc(C=C(C#N)C#N)cc1,
Asymmetric dimethylarginine,,30315-93-6,CN(C)C(=N)NCCC[C@H](N)C(=O)O,
Sunifiram,DM-235,314728-85-3,CCC(=O)N1CCN(C(=O)c2ccccc2)CC1,
ICA 110381,,325457-99-6,O=C(Nc1ccc(Cl)nc1)c1ccc(Cl)cc1,
NSC 3852,,3565-26-2,O=Nc1ccc(O)c2ncccc12,
UBCS039,,358721-70-7,c1cncc(C2Nc3ccccc3-n3cccc32)c1,
Pyroxamide,,382180-17-8,O=C(CCCCCCC(=O)Nc1cccnc1)NO,
"2,4-DPD",,41438-38-4,CCOC(=O)c1ccnc(C(=O)OCC)c1,
R1487,,449811-92-1,Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21,
"DL-Buthionine-(S,R)-sulfoximine","D,L-Buthionine-(S,R)-sulfoximine; Butionine sulfoximine; NSC 381100",5072-26-4,CCCCS(=N)(=O)CCC(N)C(=O)O,
2-hydroxy Flutamide,,52806-53-8,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,
6-âThioinosine,6TI; 6-Mercaptopurine riboside,574-25-4,OC[C@H]1O[C@@H](n2cnc3c(S)ncnc32)[C@H](O)[C@@H]1O,
Eniluracil,5-Ethynyluracil; GW776C85,59989-18-3,C#Cc1c[nH]c(=O)[nH]c1=O,
Guvacine hydrochloride,,6027-91-4,Cl.O=C(O)C1=CCCNC1,
SJB2-043,,63388-44-3,O=C1c2ccccc2C(=O)c2oc(-c3ccccc3)nc21,
Rose Bengal sodium,Rose Bengal,632-69-9,O=C1OC2(c3cc(I)c([O-])c(I)c3Oc3c2cc(I)c([O-])c3I)c2c(Cl)c(Cl)c(Cl)c(Cl)c21.[Na+].[Na+],
Fialuridine,FIAU; DRG-0098,69123-98-4,O=c1[nH]c(=O)n(C2OC(CO)C(O)C2F)cc1I,
6-fluoro-DL-Tryptophan,,7730-20-3,N[C@@H](Cc1c[nH]c2cc(F)ccc12)C(=O)O,
Elagolix sodium,NBI-56418 sodium,832720-36-2,COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(CC(NCCCC(=O)[O-])c3ccccc3)c2=O)c1F.[Na+],
ATH686,ATH 686,853299-52-2,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4ccnc(N)n4)cc3)cc2C(F)(F)F)CC1,
PK11007,,874146-69-7,Cc1nnc(NC(=O)c2nc(S(=O)(=O)Cc3ccc(F)cc3)ncc2Cl)s1,
Pyributicarb,TSH-888,88678-67-5,COc1cccc(N(C)C(=S)Oc2cccc(C(C)(C)C)c2)n1,
JNJ 303,,878489-28-2,CC(C)(Oc1ccc(Cl)cc1)C(=O)NC1C2CC3CC1CC(NS(C)(=O)=O)(C3)C2,
CDN1163,,892711-75-0,Cc1ccc2cccc(NC(=O)c3ccc(OC(C)C)cc3)c2n1,
NSC 95397,,93718-83-3,O=C1C(SCCO)=C(SCCO)C(=O)c2ccccc21,
"LSKL, Inhibitor of Thrombospondin TSP-1",,T7676,CC(C)CC(N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(N)=O,
sodium lauroyl-Î±-hydroxyethyl sulfonate,,T7283,CCCCCCCCCCCC(=O)CC(O)S(=O)(=O)[O-].[Na+],
Cyclo(his-pro),,53109-32-3,O=C1NC(Cc2cnc[nH]2)C(=O)N2CCCC12,
LY-404187,LY404187,211311-95-4,CC(CNS(=O)(=O)C(C)C)c1ccc(-c2ccc(C#N)cc2)cc1,
DS-1001b,,1898207-64-1,CC(C)(C)N.Cc1cn(C(=O)c2c(-c3c(Cl)cc(Cl)cc3Cl)noc2C(C)(C)F)c2cccc(/C=C/C(=O)O)c12,
CCG-222740,,1922098-69-8,O=C(Nc1ccc(Cl)cc1)C1CN(C(=O)c2cccc(-c3ccco3)c2)CC(F)(F)C1,
A2793,,88349-90-0,CCOC(=O)COc1ccc(Cl)c2cccnc12,
A2764 dihydrochloride,,861038-72-4,CCN(CC)CCOc1ccc(Cl)c2cccnc12.Cl.Cl,
Reynoutrin,Quercetin-3-D-xyloside; Reinutrin,549-32-6,O=c1c(O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,
DRB,,53-85-0,OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O,
6-(4-Methoxyphenyl)-3-pyridazinamine,,4776-87-8,COc1ccc(-c2ccc(N)nn2)cc1,
RIPA-56,,1956370-21-0,CCC(C)(C)C(=O)N(O)Cc1ccccc1,
FGH10019,FGH-10019,1046045-61-7,CCCc1cc(-c2nc(-c3ccc(NS(C)(=O)=O)cc3)cs2)ccn1,
BMP signaling agonist sb4,SB 4,100874-08-6,Brc1ccc(CSc2nc3ccccc3o2)cc1,
M1001,,874590-32-6,O=S1(=O)N=C(Nc2ccccc2N2CCCC2)c2ccccc21,
GW791343 dihydrochloride,,1019779-04-4,Cc1ccc(CN2CCNCC2)cc1NC(=O)CNc1ccc(F)c(F)c1.Cl.Cl,
LY3177833,LY-3177833,1627696-51-8,CC1(c2ncncc2F)NC(=O)c2cc(-c3cn[nH]c3)ccc21,
TAS0728,,2088323-16-2,C=CC(=O)N1CCCC(n2nc(C(=O)Nc3ccc(CC(=O)N(C)C)c(C)c3C)c3c(N)ncnc32)C1,
Windorphen,,19881-70-0,COc1ccc(/C(Cl)=C(/C=O)c2ccc(OC)cc2)cc1,
Losartan Carboxaldehyde,,114798-36-6,CCCCc1nc(Cl)c(C=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,
Lasofoxifene Tartrate,CP-336156,190791-29-8,O=C(O)C(O)C(O)C(=O)O.Oc1ccc2c(c1)CCC(c1ccccc1)C2c1ccc(OCCN2CCCC2)cc1,
Norspermine,,4605-14-5,NCCCNCCCNCCCN,
Naphthol AS-E,nAS-E,92-78-4,O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2cc1O,
Cardiogenol C hydrochloride,Cardiogenol C;  Cardiogenol C HCl,1049741-55-0,COc1ccc(Nc2nccc(NCCO)n2)cc1.Cl,
Afuresertib hydrochloride,Afuresertib hydrochloride; Afuresertib hydrochloride; Afuresertib hydrochloride,1047645-82-8,Cl.Cn1ncc(Cl)c1-c1cc(C(=O)NC(CN)Cc2cccc(F)c2)sc1Cl,
Danofloxacin,Danofloxacin free base; Danofloxacine; Danofloxacin; Danofloxacino,112398-08-0,CN1CC2CC1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1,
BYK204165,RT-017290,1104546-89-5,Cn1cccc1C=C1C(=O)NC(=O)c2ccccc21,
IOX4,,1154097-71-8,CC(C)(C)OC(=O)c1ccc(-n2[nH]cc(-n3ccnn3)c2=O)nc1,
Bepotastine,Bepotastine free base; Bepotastine,125602-71-3,O=C(O)CCCN1CCC(OC(c2ccc(Cl)cc2)c2ccccn2)CC1,
TASP0415914,,1292300-75-4,CC(=O)Nc1nc(C)c(-c2nc(N3CCCC(O)C3)no2)s1,
C25-140,,1358099-18-9,Cc1nn(-c2ccc3nnc(C)n3n2)c(C)c1CCC(=O)N1CCC(Cc2ccccc2)CC1,
DG172 dihydrochloride,DG172 (dihydrochloride); DG-172 dihydrochloride,1361504-77-9,CN1CCN(c2ccc(/C=C(\C#N)c3ccccc3Br)cc2)CC1.Cl.Cl,
"VPS34 inhibitor 1 (Compound 19, PIK-III analogue)",PIK-III analogue,1383716-46-8,CC(C)(O)CNc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1,
Fingolimod,FTY-720A;  FTY-720,162359-55-9,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,
EB-3D,,1839150-63-8,CN(C)c1cc[n+](Cc2ccc(OCCOc3ccc(C[n+]4ccc(N(C)C)cc4)cc3)cc2)cc1.[Br-].[Br-],
VU0810464,,2126040-21-7,Cc1cc(NC(=O)Cc2ccc(F)c(Cl)c2)n(C2CCCCC2)n1,
Fluphenazine decanoate,,5002-47-1,CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,
Iberverin,,505-79-3,CSCCCN=C=S,
Oncrasin-1,Oncrasin 1,75629-57-1,O=Cc1cn(Cc2ccc(Cl)cc2)c2ccccc12,
CTP disodium dihydrate,,81012-87-5,Nc1ccn(C2OC(COP(=O)(O)OP(=O)([O-])OP(=O)([O-])O)C(O)C2O)c(=O)n1.O.O.[Na+].[Na+],
Blu-782,ALK2-IN-1Â ,2141955-96-4,CCOC1(c2ccc(-c3cc4c(N5CCN(C(=O)OC6CCOC6)CC5)ccnn4c3)nc2)CCN(C(C)C)CC1,
Bevantolol hydrochloride,NC-1400 hydrochloride,42864-78-8,COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC.Cl,
Calcium D-saccharate tetrahydrate,D-Saccharic acid calcium salt; D-Glucaric acid calcium salt,5793-89-5,O.O.O.O.O=C([O-])C(O)C(O)C(O)C(O)C(=O)[O-].[Ca+2],
Quinidine sulfate dihydrate,Quinidine sulfate; Quinidine sulfate dihydrate; Chinidin Sodium; Pitayine Sodium; Î²-quinine Sodium,6591-63-5,C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12.C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12.O.O.O=S(=O)(O)O,
Iron sucrose,Iron saccharate; Sucroferric oxyhydroxide,8047-67-4,O=C([O-])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)[O-].O=C([O-])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)[O-].O=C([O-])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)[O-].[Fe+3].[Fe+3],
Minoxidil sulfate,Minoxidil sulphate; U-58838,83701-22-8,N=c1cc(N2CCCCC2)nc(N)n1OS(=O)(=O)O,
AZD7325,AZD-7325,942437-37-8,CCCNC(=O)c1nnc2c(-c3c(F)cccc3OC)cccc2c1N,
Taurodeoxycholic acid sodium hydrate,,110026-03-4,C[C@@]12[C@]([C@]3([C@@]([C@]4(C)[C@](CC3)(C[C@H](O)CC4)[H])(C[C@@H]1O)[H])[H])(CC[C@@]2([C@@H](CCC(NCCS(=O)(=O)O)=O)C)[H])[H].[Na].O,
Diallyl Trisulfide,,2050-87-5,C=CCSSSCC=C,
Metenolone acetate,Methenolone acetate; Metenolone acetate,434-05-9,C[C@](CC1)([C@@H](CC2)[C@H](CC[C@H]3C4)[C@H]1[C@@]3(C)C(C)=CC4=O)[C@H]2OC(C)=O,
Î±-Thujone,Thujone; ALPHA-(-)-THUJONE,546-80-5,CC(C)[C@](C1)(C2)[C@H]1[C@@H](C)C2=O,
2-Hydroxychalcone,2-(2-Hydroxybenzal)Acetophenone,644-78-0,Oc1c(C=CC(c2ccccc2)=O)cccc1,
Galanthamine,Galantamine,357-70-0,CN(CC[C@]1([C@H](C2)O3)C=C[C@@H]2O)Cc(cc2)c1c3c2OC,
2-Undecanone,Methylnonylketone; 2-Undecanone,112-12-9,CCCCCCCCCC(C)=O,
Î±-âTerpinyl acetate,Terpinyl Acetate; Î±-âTerpinyl acetate,80-26-2,CC(C)(C1CC=C(C)CC1)OC(C)=O,
Citronellyl acetate,,150-84-5,CC(CCC=C(C)C)CCOC(C)=O,
Sodium Thiocyanate,,540-72-7,N#C[S-].[Na+],
N-Acetyl-L-arginine,Ac-Arg-OH,155-84-0,CC(N[C@@H](CCCNC(N)=N)C(O)=O)=O,
S-Methyl-L-cysteine,S-Methylcysteine,1187-84-4,CSC[C@@H](C(=O)O)N,
"6,2'-Dihydroxyflavone",,92439-20-8,Oc(cc1)cc2c1OC(c(cccc1)c1O)=CC2=O,
6-Methylflavone,,29976-75-8,CC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3,
Hederacolchiside A1,Raddeanoside R13,106577-39-3,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2O[C@H]3CC[C@]4([C@H](C3(C)C)CC[C@@]5([C@@H]4CC=C6[C@]5(CC[C@@]7([C@H]6CC(CC7)(C)C)C(=O)O)C)C)C)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)O,
Wilforine,,11088-09-8,C[C@@H](CCc(nccc1)c1C(OC[C@@](C)([C@@H]([C@H]1OC(C)=O)[C@H]([C@H]2OC(C)=O)OC(C)=O)O[C@@]1([C@](C)([C@H]([C@@H]1OC(c3ccccc3)=O)O3)O)[C@]2(COC(C)=O)[C@H]1OC(C)=O)=O)C3=O,
Isoliquiritin apioside,,120926-46-7,C1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC=C(C=C3)/C=C/C(=O)C4=C(C=C(C=C4)O)O)CO)O)O)O)(CO)O,
Myrislignan,,171485-39-5,C[C@@H]([C@@H](c(cc1)cc(OC)c1O)O)Oc(c(OC)cc(CC=C)c1)c1OC,
Alisol A,Alisol-A,19885-10-0,[H][C@@]12[C@@H](O)CC3=C(CC[C@]3(C)[C@@]1(C)CCC1C(C)(C)C(=O)CC[C@]21C)[C@H](C)C[C@H](O)[C@@H](O)C(C)(C)O,
Kaempferol-3-O-glucorhamnoside,Kaempferol 3-glucorhamnoside,40437-72-7,C[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H](O[C@H]2OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC=C(C=C5)O)CO)O)O)O)O)O,
3'-Hydroxypterostilbene,3'-HPT,475231-21-1,COc1cc(/C=C/c(cc2)cc(O)c2O)cc(OC)c1,
Glaucine,,475-81-0,CN(CC1)[C@@H](Cc(cc(c(OC)c2)OC)c2-c2c3OC)c2c1cc3OC,
Ginsenoside Rf,Ginsenoside-Rf; Panaxoside Rf,52286-58-5,[H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)CC1[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])[C@H](C[C@@]21C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@](C)(O)CC\C=C(\C)C,
Eudesmin,,526-06-7,COc(ccc([C@@H]1OC[C@H]2[C@H](c(cc3)cc(OC)c3OC)OC[C@@H]12)c1)c1OC,
(-)-Securinine,Securinine; (-)-Securinine,5610-40-2,O=C1O[C@](C2)([C@@H](CCCC3)N3[C@@H]2C=C2)C2=C1,
coniferyl ferulate,,63644-62-2,COc(cc(C=CCOC(C=Cc(cc1)cc(OC)c1O)=O)cc1)c1O,
9-amino-CPT,9-Aminocamptothecin; 9-amino-CPT; 9-amino-2(S)-camptothecin; Aminocamptothecin,91421-43-1,CC[C@](C(C=C(c1nc2ccc3)N4Cc1cc2c3N)=C(CO1)C4=O)(C1=O)O,
EGCG Octaacetate,,148707-39-5,CC(Oc1cc(O[C@@H]([C@@H](C2)OC(c(cc3OC(C)=O)cc(OC(C)=O)c3OC(C)=O)=O)c(cc3OC(C)=O)cc(OC(C)=O)c3OC(C)=O)c2c(OC(C)=O)c1)=O,
Ginkgolide K,,153355-70-5,CC1=C2[C@H]([C@@H]([C@@]34[C@@]25C(=O)O[C@@H]3C[C@H]([C@@]46[C@H](C(=O)O[C@H]6O5)O)C(C)(C)C)O)OC1=O,
Deslanoside,Deacetyllanatoside C; Desacetyllanatoside C,17598-65-1,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3C[C@H]([C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)O)C)O)O[C@H]7C[C@@H]([C@@H]([C@H](O7)C)O[C@H]8C[C@@H]([C@@H]([C@H](O8)C)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O)O,
Fucosterol,,17605-67-3,CC(C)/C(/CC[C@@H](C)[C@@H](CC1)[C@@](C)(CC2)[C@@H]1[C@H]1[C@H]2[C@@](C)(CC[C@@H](C2)O)C2=CC1)=C/C,
Cannabidivarin,,24274-48-4,CCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(C)=C)c(O)c1,
Erythrodiol,,545-48-2,[H][C@@]12CC(C)(C)CC[C@]1(CO)CC[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C,
Pennogenin 3-O-beta-chacotrioside,,55916-52-4,C[C@@H]1CC[C@@]2([C@H]([C@]3([C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)O)C)OC1,
"5,â7,â4'-âTrimethoxyflavone","4',5,7-Trimethoxyflavone",5631-70-9,COc(cc1)ccc1C(Oc1c2c(OC)cc(OC)c1)=CC2=O,
Isoflavone,,574-12-9,O=C1C(c2ccccc2)=COc2c1cccc2,
6-Demethoxytangeretin,,6601-66-7,COc(cc1)ccc1C(Oc1c2c(OC)cc(OC)c1OC)=CC2=O,
Gomisin N,,69176-52-9,COc1cc2C[C@@H](C)[C@@H](C)Cc3cc4OCOc4c(OC)c3-c2c(OC)c1OC,
Dimethyl lithospermate B,dmLSB,875313-64-7,COC([C@@H](Cc(cc1)cc(O)c1O)OC([C@H]1c2c(/C=C/C(O[C@H](Cc(cc3)cc(O)c3O)C(OC)=O)=O)ccc(O)c2O[C@@H]1c(cc1)cc(O)c1O)=O)=O,
Quercetagetin,6-Hydroxyquercetin,90-18-6,Oc(ccc(C(Oc(c(C1=O)c2O)cc(O)c2O)=C1O)c1)c1O,
Jatrorrhizine chloride,Neprotine chloride; Yatrorhizine chloride,6681-15-8,COc(ccc1cc(-c(cc2OC)c(CC3)cc2O)[n+]3cc11)c1OC.[Cl-],
Anisodamine Hydrobromide,6-Hydroxyhyoscyamine,55449-49-5,Br.[H][C@@]12C[C@H](O)[C@@]([H])(C[C@H](C1)OC(=O)[C@H](CO)C1=CC=CC=C1)N2C,
Hydroxy-Î±-sanshool,Hydroxy-âÎ±-âsanshool,83883-10-7,CC(C)(CNC(/C=C/CC/C=C\C=C\C=C\C)=O)O,
J14,J-14,1043854-13-2,OC(=O)c1ccc(CSc2nc(cc(n2)-c2ccccc2)N2CCN(CC2)c2ccccc2Cl)cc1,
BMS817378,,1174161-69-3,Nc1nccc(Oc2ccc(NC(=O)c3cn(COP(O)(O)=O)cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl,
Benzamidine hydrochloride,Benzamidine HCl,1670-14-0,Cl.NC(=N)c1ccccc1,
ADH-503,GB1275,2055362-74-6,C[N+](C)(C)CCO.[O-]C(=O)c1ccc(cc1)-c1ccc(\C=C2/SC(=S)N(Cc3ccccc3)C2=O)o1,
VBIT-12,,2089227-65-4,OC(=O)CNC(=O)C1(CCN(Cc2cccc3ccccc23)CC1)Nc1ccccc1,
PNU112455A hydrochloride,PNU 112455A,21886-12-4,Cl.Nc1cc(Nc2ccc(cc2)S(N)(=O)=O)ncn1,
SR-4835,,2387704-62-1,Cn1cc(cn1)-n1cnc2c(NCc3nc4cc(Cl)c(Cl)cc4[nH]3)nc(nc12)N1CCOCC1,
MMP-9-IN-1,,502887-71-0,CCCc1cc(=O)[nH]c(SCC(=O)Nc2ccc(OC(F)F)cc2)n1,
SU14813,,627908-92-3,Cc1[nH]c(C=C2C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,
Tetraethylammonium bromide,TEAB ; TEA bromide,71-91-0,[Br-].CC[N+](CC)(CC)CC,
RHC 80267,U-57908,83654-05-1,O=C(NCCCCCCNC(=O)O\N=C1/CCCCC1)O\N=C1\CCCCC1,
5'-Fluoroindirubinoxime,5'-FIO,861214-33-7,Oc1[nH]c2ccc(F)cc2c1-c1[nH]c2ccccc2c1N=O,
ASP7663,,1190217-35-6,CC(C)CN1C(=O)\C(=C\C(O)=O)c2cccc(F)c12,
Cinacalcet,AMG 073,226256-56-0,C[C@@H](NCCCc1cccc(c1)C(F)(F)F)c1cccc2ccccc12,
Efonidipine hydrochloride monoethanolate,NZ-105 hydrochloride monoethanolate,111011-76-8,Cl.CCO.CC1=C(C(c2cccc(c2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(Cc1ccccc1)c1ccccc1,
D-Serine,(R)-Serine,312-84-5,N[C@H](CO)C(O)=O,
Uridine triphosphate trisodium salt,"UTP, Trisodium Salt; Uridine triphosphate (trisodium salt) ;  Uridine 5'-triphosphate trisodium salt",19817-92-6,[Na+].[Na+].[Na+].O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)n1ccc(=O)[nH]c1=O,
Cesium chloride,CsCl,7647-17-8,[Cl-].[Cs+],
Cefazolin,,25953-19-9,[H][C@]12SCC(CSc3nnc(C)s3)=C(N1C(=O)[C@H]2NC(=O)Cn1cnnn1)C(O)=O,
Metoclopramide hydrochloride hydrate,Metoclopramide monohydrochloride monohydrate,54143-57-6,O.Cl.CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,
Cariprazine hydrochloride,Cariprazine HCl; RGH188 hydrochloride,1083076-69-0,Cl.CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2cccc(Cl)c2Cl)CC1,
SB-200646,,143797-63-1,Cn1ccc2cc(NC(=O)Nc3cccnc3)ccc12,
FPL 62064,,103141-09-9,COc1ccc(Nc2ccn(n2)-c2ccccc2)cc1,
Rifamycin S,,13553-79-2,CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2C(=O)C=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(=O)c2c(O)c3C,
Quinocetone,,81810-66-4,CC1=C(C(=O)\C=C\c2ccccc2)[N+](=O)c2ccccc2N1[O-],
BIO-013077-01,,746667-48-1,Cc1cccc(n1)-c1n[nH]cc1-c1ccc2nccnc2c1,
ONO-7475,,1646839-59-9,COc1cc2nccc(Oc3ccc(NC(=O)c4cc5C(=O)CCCc5n(-c5ccccc5)c4=O)nc3)c2cc1OC,
LJ570,,2252488-69-8,OC([C@@H](OC1=CC=C(C2=CC=CC=C2)C=C1)CC3=CC=C(C4=CC=CC=C4)C=C3)=O,
ML-210,CID 49766530,1360705-96-9,O=C(N1CCN(C(C2=CC=C(Cl)C=C2)C3=CC=C(Cl)C=C3)CC1)C4=NOC(C)=C4[N+]([O-])=O,
TBK1/IKKÎµ-IN-5,,1893397-65-3,N#Cc1cc(ccc1OC1CCOCC1)-c1ncnc(Nc2ccc(cc2)N2CCN(CC2)C2COC2)n1,
CPTH2,,357649-93-5,Clc1ccc(cc1)-c1csc(N\N=C2\CCCC2)n1,
TPCK,,402-71-1,Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc1ccccc1)C(=O)CCl,
GSK5182,,877387-37-6,CN(C)CCOc1ccc(cc1)C(\c1ccc(O)cc1)=C(\CCCO)c1ccccc1,
Triazavirin,,928659-17-0,O.O.[Na+].CSc1nc2[n-]nc([N+]([O-])=O)c(=O)n2n1,
SRT 1460,SRT1460,925432-73-1,COc1cc(cc(OC)c1OC)C(=O)Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1,
Mesotrione,,104206-82-8,CS(=O)(=O)c1ccc(C(=O)C2C(=O)CCCC2=O)c(c1)[N+]([O-])=O,
T-1101 tosylate,TAI-95 tosylate,2250404-95-4,Cc1ccc(cc1)S(O)(=O)=O.COCCOc1cnc(Sc2cc(C)c(-c3csc(NC(=O)c4ccncc4)n3)c(C)c2)cn1,
Procyanidin C1,,37064-30-5,[H][C@]1([C@@H](O)[C@H](Oc2cc(O)cc(O)c12)c1ccc(O)c(O)c1)c1c(O)cc(O)c2c1O[C@@H]([C@H](O)[C@@]2([H])c1c(O)cc(O)c2C[C@@H](O)[C@H](Oc12)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1,
VU0134992,VU 0134992,755002-90-5,CC(C)c1ccc(OCC(=O)NC2CC(C)(C)NC(C)(C)C2)c(Br)c1,
BMS-2,,888719-03-7,Fc1ccc(cc1)-n1cccc(C(=O)Nc2ccc(Oc3ccnc4[nH]ccc34)c(F)c2)c1=O,
E7046,,1369489-71-3,C[C@@H](c(cc1)ccc1C(O)=O)NC(c(c(C(F)F)nn1C)c1Oc1cccc(C(F)(F)F)c1)=O,
Transcrocetinate disodium,Disodium trans-crocetinate,591230-99-8,O=C([O-])/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C([O-])=O.[Na+].[Na+],
Nedisertib,M3814,1637542-33-6,COc1nnc([C@H](c(cc(c(F)c2)-c3ncnc4cc(N5CCOCC5)ccc34)c2Cl)O)cc1,
Seletalisib,UCB5857,1362850-20-1,FC(F)(F)[C@](NC1=C2C(C=CC=N2)=NC=N1)C3=CC4=CC=CC(Cl)=C4N=C3C5=CC=C[N+]([O-])=C5,
AM-0902,,1883711-97-4,Cn(cn1)c2c1N=CN(Cc1nc(CCc(cc3)ccc3Cl)no1)C2=O,
"14-Deoxy-11,12-didehydroandrographolide",14-dehydro Andrographolide; AP10,42895-58-9,O=C1OCC=C1/C=C/[C@@H]2C(CC[C@]3([H])[C@](C)(CO)[C@](O)CC[C@@]23C)=C,
Phorbol 12-myristate 13-acetate,PMA,16561-29-8,CCCCCCCCCCCCCC(O[C@H]([C@@H](C)[C@]([C@@H]1C=C(C)C2=O)([C@H]([C@@H]3C4(C)C)C=C(CO)C[C@]12O)O)[C@]34OC(C)=O)=O,
Hispidulin,,1447-88-7,COc(c(O)c(c(OC(c(cc1)ccc1O)=C1)c2)C1=O)c2O,
Brusatol,NSC 172924; (+)-Brusatol,14907-98-3,CC([C@](C[C@@](O1)2[H])3[H])=C(O)C(C[C@]3(C)[C@]4([H])[C@]2(CO[C@@]5([C@@H](O)[C@@H]4O)C(OC)=O)[C@@]5([H])[C@@H](OC(/C=C(C)/C)=O)C1=O)=O,
Tetrahydromagnolol,,20601-85-8,CCCc(cc1)cc(-c(cc(CCC)cc2)c2O)c1O,
Benzoyloxypaeoniflorin,Benzoyloxypeoniflorin,72896-40-3,Oc1ccc(cc1)C(=O)OC[C@@]46[C@H]7C[C@]4(O[C@@H]3O[C@H](COC(=O)c2ccccc2)[C@@H](O)[C@H](O)[C@H]3O)[C@]5(C)C[C@@]7(O)O[C@H]6O5,
Rosin,,85026-55-7,C1=CC=C(C=C1)/C=C/CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,
Vorolanib,CM082; X-82,1013920-15-4,CN(C)C(=O)N1CC[C@@H](C1)NC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C,
HDAC-IN-3,GSK3117391A,1018673-42-1,ONC(=O)CCc1ccc(CN[C@@H](C2CCCCC2)C(=O)OC2CCCC2)cn1,
TC-I2000,,1159996-20-9,Fc1ccc(NC(=O)N2CCc3ccccc3C2c2ccc(cc2)C(F)(F)F)cc1,
QO-40,,1259536-70-3,FC(F)(F)c1nn4C(=O)C=C(Nc4c1c3cccc2ccccc23)CCl,
DNQX disodium salt,DNQX Disodium,1312992-24-7,[Na+].[Na+].[O-]c1nc2cc(c(cc2nc1[O-])[N+]([O-])=O)[N+]([O-])=O,
Lerisetron,,143257-98-1,C(c1ccccc1)n1c(nc2ccccc12)N1CCNCC1,
BRD3308,,1550053-02-5,CC(=O)Nc1ccc(cc1)C(=O)Nc1ccc(F)cc1N,
YM90K,"YM90K hydrochloride; 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-",154164-30-4,Cl.[O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1-n1ccnc1,
SC-236,Sc 236,170569-86-5,NS(=O)(=O)c1ccc(cc1)-n1nc(cc1-c1ccc(Cl)cc1)C(F)(F)F,
Alobresib,Vorolanib; GS-5829,1637771-14-2,Cc1noc(C)c1-c1cc(c2nc([nH]c2c1)C1CC1)C(O)(c1ccccn1)c1ccccn1,
AS2863619,,2241300-51-4,Cl.Cl.Cc1nc2ccc(cc2[nH]1)-n1c(nc2cnccc12)-c1nonc1N,
CNQX disodium,,479347-85-8,[Na+].[Na+].[O-]c1nc2cc(C#N)c(cc2nc1[O-])[N+]([O-])=O,
LASSBio-1135,,852453-71-5,N(c1c(nc2ccccn12)-c1ccccn1)c1ccccc1,
M8-B Hydrochloride,,883976-12-3,Cl.COc1cc(CN(CCN)C(=O)c2cccs2)ccc1OCc1ccccc1,
ZSET1446,ZSET-1446; ST-101,887603-94-3,O=C1N=C2C=CC=CN2C11Cc2ccccc2C1,
BMVC-8C3O,,1301708-12-2,[I-].[I-].[I-].C[n+]1ccc(\C=C\c2ccc3n(CCOCCOCCOCC[N+]4(C)CCCCC4)c4ccc(\C=C\c5cc[n+](C)cc5)cc4c3c2)cc1,
N-Me-aminopyrimidinone9,,1356834-62-2,Cn1c(SCc2ccc(cc2)C(C)(C)C)nc(N)cc1=O,
Empesertib,BAY 1161909,1443763-60-7,COc1cc(ccc1Nc1nc2ccc(cn2n1)-c1ccc(NC(=O)[C@H](C)c2ccc(F)cc2)cc1)S(C)(=O)=O,
Senexin B,,1449228-40-3,CN1CCN(CC1)C(=O)c1ccc2cc(CCNc3ncnc4ccc(cc34)C#N)ccc2c1,
SX-682,,1648843-04-2,OB(O)c1ccc(OC(F)(F)F)cc1CSc1ncc(cn1)C(=O)Nc1ccc(F)cc1,
SR59230A,,174689-39-5,OC(=O)C(O)=O.CCc1ccccc1OC[C@@H](O)CN[C@H]1CCCc2ccccc12,
eCF506,,1914078-41-3,COc1cc(ccc1NC(=O)OC(C)(C)C)-c1nn(CCN2CCC(CC2)N(C)C)c2ncnc(N)c12,
STAT3-IN-1,,2059952-75-7,COc1cc(OC)cc(\C=C\c2ccc(NC(=O)\C=C\c3cc(OC)c(OC)c(OC)c3)cc2)c1,
MD-224,,2136247-12-4,Fc1c(Cl)cccc1[C@H]1[C@@H](NC2(CCCCC2)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)Nc1ccc(cc1)C(=O)NCCCC#Cc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O,
PF-06873600,,2185857-97-8,C[C@@]1(O)CCC[C@H]1n1c2nc(NC3CCN(CC3)S(C)(=O)=O)ncc2cc(C(F)F)c1=O,
DCLK1-IN-1,,2222635-15-4,COc1cc(ccc1Nc1ncc2N(CC(F)(F)F)C(=O)c3ccccc3N(C)c2n1)N1CCN(C)CC1,
JCN037,,2305154-31-6,Fc1c(Br)cccc1Nc1ncnc2cc3OCCOc3cc12,
SKI V,,24418-86-8,Oc1ccc(\C=C2\Oc3ccccc3C2=O)cc1O,
PU02,PU-02; 6-[(1-Naphthalenylmethyl)thio]-9H-purine,313984-77-9,C(Sc1ncnc2nc[nH]c12)c1cccc2ccccc12,
Taurohyodeoxycholic acid sodium salt,,38411-85-7,[Na+].[H][C@@]1(CC[C@@]2([H])[C@]3([H])C[C@H](O)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(=O)NCCS([O-])(=O)=O,
Tizanidine,,51322-75-9,Clc1ccc2nsnc2c1NC1=NCCN1,
Linoleoyl Ethanolamide,,68171-52-8,CCCCC\C=C/C\C=C/CCCCCCCC(=O)NCCO,
Encequidar,HM30181; HM30181A,849675-66-7,COc1cc2CCN(CCc3ccc(cc3)-n3nnc(n3)-c3cc(OC)c(OC)cc3NC(=O)c3cc(=O)c4ccccc4o3)Cc2cc1OC,
JNK Inhibitor VIII,TCS JNK 6o,894804-07-0,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,
4i,5-HT3 antagonist-4i; CHEMBL1269981,930478-88-9,Cc1c(Cl)cccc1NC(=O)c1cnc2ccccc2n1,
GFB-8438,,2304549-73-1,FC(F)(F)C1=CC=CC=C1CN1CCN(CC1=O)C1=C(Cl)C(=O)NN=C1,
BI-3406,,2230836-55-0,COC1=C(O[C@H]2CCOC2)C=C2C(N[C@H](C)C3=CC(=CC(N)=C3)C(F)(F)F)=NC(C)=NC2=C1,
CCT251545,,1661839-45-7,CN1C=C(C=N1)C1=CC=C(C=C1)C1=CN=CC(Cl)=C1N1CCC2(CCNC2=O)CC1,
Dapansutrile,,54863-37-5,CS(=O)(=O)CCC#N,
GSK3145095,,1622849-43-7,FC1=CC2=C(NC(=O)[C@H](CC2)NC(=O)C2=NNC(CC3=CC=CC=C3)=N2)C(F)=C1,
IK1 inhibitor PA-6,,500715-03-7,N=C(NC1=CC=C(OCCCCCOC2=CC=C(NC(=N)C3=CC=CC=C3)C=C2)C=C1)C1=CC=CC=C1,
TBK1/IKKÎµ-IN-2,,1292310-49-6,N#CC1=C(OC2CCOCC2)C=CC(=C1)C1=NC(NC2=CC=C(C=C2)N2CCOCC2)=NC=C1,
Mifobate,SR-202,76541-72-5,COP(=O)(OC)OC(C1=CC=C(Cl)C=C1)P(=O)(OC)OC,
MRX-2843,UNC2371,1429882-07-4,CN1CCN(CC2=CC=C(C=C2)C2=CN([C@H]3CC[C@H](O)CC3)C3=NC(NCCC4CC4)=NC=C23)CC1,
Firocoxib,ML 1785713,189954-96-9,CC1(C)OC(=O)C(OCC2CC2)=C1C1=CC=C(C=C1)S(C)(=O)=O,
BC-DXI-843,,2421117-98-6,COC1=CC=C(C=C1)C1=CSC(NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NS(=O)(=O)C2=CC=C(C)C=C2)=N1,
CIL62,,117593-36-9,CC1(C)CC(=O)C2=C(C1)OC1=C(C2C2=C(O)C=C(O)C=C2)C(=O)CC(C)(C)C1,
LQZ-7I,,195822-23-2,FC1=CC=C(NC2=NC3=CC=CC=C3N=C2NC2=CC=C(F)C=C2)C=C1,
BMS-1001,,2113650-03-4,CC1=CC(CN[C@H](CO)C(O)=O)=C(OCC2=CC(=CC=C2)C#N)C=C1OCC1=C(C)C(=CC=C1)C1=CC2=C(OCCO2)C=C1,
ERK1/2 inhibitor 2,ASTX029; ASTX-029,2095719-92-7,COC1=CC(F)=CC(=C1)[C@@H](CO)NC(=O)[C@@H](C)N1CC2=CC=C(C=C2C1=O)C1=NC(NC2CCOCC2)=NC=C1Cl,
MLS000532223,,16616-39-0,[O-][N+](=O)C1=CC=CC(=C1)C(=O)C#CC1=CC=CC=C1,
RSVA405,RSVA 405,140405-36-3,CCN(CC)C1=CC(O)=C(C=NNC(=O)C2=CC=NC=C2)C=C1,
IQ-3,IQ3,312538-03-7,O=C(ON=C1C2=CC=CC=C2C2=NC3=CC=CC=C3N=C12)C1=CC=CO1,
TNO155,,1801765-04-7,C[C@@H]1OCC2(CCN(CC2)C2=NC(N)=C(SC3=C(Cl)C(N)=NC=C3)N=C2)[C@@H]1N,
Gusacitinib,ASN-002,1425381-60-7,OC1CCN(CC1)C1=CC=C(NC2=NC(=NC3=C2C(=O)NN=C3)N2CCC(CC#N)CC2)C=C1,
Deucravacitinib,BMS-986165,1609392-27-9,[2H]C([2H])([2H])NC(=O)C1=NN=C(NC(=O)C2CC2)C=C1NC1=CC=CC(C2=NN(C)C=N2)=C1OC,
Amiselimod hydrochloride,MT-1303 hydrochloride,942398-84-7,Cl.CCCCCCCOC1=C(C=C(CCC(N)(CO)CO)C=C1)C(F)(F)F,
RAMB4,PTP1B-IN-9,145888-79-5,C1C(=CC2=CC(=C(C=C2)Cl)Cl)C(=O)C(=CC3=CC(=C(C=C3)Cl)Cl)CN1,
AB928,,2239273-34-6,CC1=C(C=CC=C1C1=CC(=NC(N)=N1)C1=CN(CC2=NC(=CC=C2)C(C)(C)O)N=N1)C#N,
8-âPrenylnaringenin,8-Prenylnaringenin,53846-50-7,CC(C)=CCC1=C2O[C@@H](CC(=O)C2=C(O)C=C1O)C1=CC=C(O)C=C1,
11-âKeto-âbeta-âboswellic acid,11-Keto-beta-boswellic acid,17019-92-0,[H][C@@]12[C@@H](C)[C@H](C)CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@@H](O)[C@](C)(C(O)=O)[C@]3([H])CC[C@@]12C,
Kadsurin,,51670-40-7,COC1=C(OC)C(OC)=C2C(C[C@@H](C)[C@@H](C)[C@@H](OC(C)=O)C3=CC4=C(OCO4)C(OC)=C23)=C1,
Okanin,,484-76-4,C1=CC(=C(C=C1C=CC(=O)C2=C(C(=C(C=C2)O)O)O)O)O,
Histone Acetyltransferase Inhibitor II,,932749-62-7,C1CC(=CC2=CC(=C(C=C2)O)Br)C(=O)C(=CC3=CC(=C(C=C3)O)Br)C1,
L-2-Hydroxyglutaric acid disodium,(S)-2-Hydroxyglutaric acid disodium,63512-50-5,[Na+].[Na+].O[C@@H](CCC([O-])=O)C([O-])=O,
VU0134992 hydrochloride,,1052515-91-9,Cl.CC(C)C1=CC=C(OCC(=O)NC2CC(C)(C)NC(C)(C)C2)C(Br)=C1,
p-MPPI hydrochloride,,220643-77-6,Cl.COC1=CC=CC=C1N1CCN(CCN(C(=O)C2=CC=C(I)C=C2)C2=CC=CC=N2)CC1,
SRT 2183,,1001908-89-9,O[C@@H]1CCN(CC2=CSC3=NC(=CN23)C2=CC=CC=C2NC(=O)C2=CC3=C(C=CC=C3)C=C2)C1,
ASP4132,,1640294-30-9,CC1=CC=C(C=C1)S(O)(=O)=O.CC1=CC=C(C=C1)S(O)(=O)=O.COC1=CC=C(CN2CCC(CC2)C2=CC=C3N=C(NC3=C2)C(=O)N2CCN(CC3=CC=C(C=C3)C(F)(F)F)CC2)C=N1,
3-AQC,,201216-42-4,C=CCN1CCN(CC1)C2=NC3=CC=CC=C3N=C2C#N.C(=CC(=O)O)C(=O)O,
Tenovin-6 Hydrochloride,,1011301-29-3,Cl.CN(C)CCCCC(=O)NC1=CC=C(NC(=S)NC(=O)C2=CC=C(C=C2)C(C)(C)C)C=C1,
JSH-150,,2247481-21-4,COCCN[C@H]1CC[C@@H](CC1)NC1=NC=C(Cl)C(=C1)C1=CSC(NCC2(CCOCC2)C#N)=N1,
GMB-475,,2490599-18-1,CC1=C(SC=N1)C1=CC=C(CNC(=O)C2CC(O)CN2C(=O)C(NC(=O)COCCOC2=CC=C(C=C2)C2=CC(NC3=CC=C(OC(F)(F)F)C=C3)=NC=N2)C(C)(C)C)C=C1,
Nepodin,,3785-24-8,CC(=O)C1=C(O)C2=C(C=CC=C2O)C=C1C,
KIRA6,,1589527-65-0,CC(C)(C)C1=NC(=C2N1C=CN=C2N)C1=CC=C(NC(=O)NC2=CC=CC(=C2)C(F)(F)F)C2=CC=CC=C12,
Lumateperone Tosylate,ITI-007,1187020-80-9,CC1=CC=C(C=C1)S(O)(=O)=O.[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=C3N2CCN(C)C3=CC=C1,
BAR502,,1612191-86-2,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)[C@H](CC)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCO,
PLX51107,,1627929-55-8,C[C@H](N1C=C(C2=C1C=C(C=N2)C1=C(C)ON=C1C)C1=CC=C(C=C1)C(O)=O)C1=CC=CC=N1,
PhiKan 083,,880813-36-5,CCN1C2=CC=CC=C2C2=C1C=CC(CNC)=C2,
Unesbulin,PTC596,1610964-64-1,CC1=NC2=C(C=C(F)C=C2)N1C1=NC(N)=C(F)C(NC2=CC=C(C=C2)C(F)(F)F)=N1,
H2DCFDA,"DCFH-DA; 2',7'-Dichlorodihydrofluorescein diacetate",4091-99-0,CC(=O)OC1=C(Cl)C=C2C(C3=CC(Cl)=C(OC(C)=O)C=C3OC2=C1)C1=C(C=CC=C1)C(O)=O,
1-Naphthohydroxamic acid,,6953-61-3,ONC(=O)C1=CC=CC2=CC=CC=C12,
R-268712,,879487-87-3,CC1=NC(=CC=C1)C1=NNC=C1C1=CC(C2=CN(CCO)N=C2)=C(F)C=C1,
AC1903,,831234-13-0,C(NC1=NC2=CC=CC=C2N1CC1=CC=CC=C1)C1=CC=CO1,
Gomisin J,,66280-25-9,COc1c(O)cc2C[C@H](C)[C@H](C)Cc3cc(O)c(OC)c(OC)c3-c2c1OC,
Tofogliflozin (hydrate),Tofogliflozin hydrate; CSG-452 hydrate,1201913-82-7,O.CCc1ccc(Cc2ccc3CO[C@]4(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c3c2)cc1,
PF-AKT400,AKT protein kinase inhibitor,1004990-28-6,CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12,
RO-3,RO3,1026582-88-6,COc1cc(Cc2cnc(N)nc2N)c(cc1OC)C(C)C,
Pachymic acid,3-O-Acetyltumulosic acid,29070-92-6,[H][C@]1([C@@H](CCC(=C)C(C)C)C(O)=O)[C@H](O)C[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](OC(C)=O)C(C)(C)[C@]1([H])CC3,
Metformin,"1,1-Dimethylbiguanide",657-24-9,CN(C)C(=N)NC(N)=N,
Tyrphostin AG 112,,144978-82-5,NC(=C(/C#N)C#N)\C(C#N)=C\c1ccc(O)cc1,
GAK inhibitor 49,,319492-82-5,COc1cc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC,
SP-141,SP 141,1253491-42-7,COc1ccc2[nH]c3c(nccc3c2c1)-c1cccc2ccccc12,
IM156,,1422365-93-2,FC(F)(F)OC1=CC=C(C=C1)NC(=N)NC(=N)N2CCCC2,
(R)â-âCR8,(R)-CR8; CR8 ; (R)-Isomer,294646-77-8,CC[C@H](CO)Nc1nc(NCc2ccc(cc2)-c2ccccn2)c2ncn(C(C)C)c2n1,
ZM39923 hydrochloride,ZM 39923 HCl; JAK3 Inhibitor IV,1021868-92-7,Cl.CC(C)N(CCC(=O)C1=CC=C2C=CC=CC2=C1)CC1=CC=CC=C1,
NSC-60339,,70-09-7,Clc1cc(ccc1C(=O)Nc1ccc(cc1)C1=NCCN1)C(=O)Nc1ccc(cc1)C1=NCCN1,
Lyn-IN-1,Bafetinib analog,887650-05-7,CN(C)[C@H]1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2ccc(C)c(Nc3ncc(cn3)-c3cncnc3)c2)C1,
RK-24466,KIN 001-51,213743-31-8,Nc1ncnc2n(cc(-c3ccc(Oc4ccccc4)cc3)c12)C1CCCC1,
WRG-28,,1913291-02-7,CCNS(=O)(=O)c1ccc(COc2ccc3nc4ccc(=O)cc4oc3c2)cc1,
"4-amino-1,8-Naphthalimide",,1742-95-6,Nc1ccc2C(=O)NC(=O)c3cccc1c23,
SC-43,,1400989-25-4,FC(F)(F)c1cc(NC(=O)Nc2cccc(Oc3ccc(cc3)C#N)c2)ccc1Cl,
BMS-345541 hydrochloride,,547757-23-3,Cl.Cc1cnc2c(NCCN)nc3ccc(C)cc3n12,
Ningetinib,CT-053; CT053PTSA,1394820-69-9,Cc1c(C(=O)Nc2ccc(Oc3ccnc4cc(OCC(C)(C)O)ccc34)c(F)c2)c(=O)n(-c2ccccc2)n1C,
Ilorasertib,ABT-348,1227939-82-3,Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,
Derazantinib,ARQ-087,1234356-69-4,COCCNCCc1cccc(Nc2ncc3C[C@@H](c4ccccc4F)c4ccccc4-c3n2)c1,
MSC2530818,,1883423-59-3,Cc1[nH]nc2ncc(cc12)C(=O)N1CCC[C@H]1c1ccc(Cl)cc1,
Ripasudil,Ripasudil hydrochloride dihydrate; K-115,887375-67-9,O.O.Cl.C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12,
Deoxypodophyllotoxin,,19186-35-7,[H][C@]12COC(=O)[C@]1([H])[C@H](c1cc(OC)c(OC)c(OC)c1)c1cc3OCOc3cc1C2,
MYCi361,NUCC-0196361,2289690-31-7,Cn1nc(cc1-c1ccc(OCc2ccc(Cl)cc2)c(-c2cc(cc(c2)C(F)(F)F)C(F)(F)F)c1O)C(F)(F)F,
AV-412,MP412,451493-31-5,Cc1ccc(cc1)S(O)(=O)=O.Cc1ccc(cc1)S(O)(=O)=O.CN1CCN(CC1)C(C)(C)C#Cc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=C,
BX430,,688309-70-8,CC(C)c1cc(Br)c(NC(=O)Nc2cccnc2)c(Br)c1,
Silmitasertib sodium salt,CX-4945 sodium salt,1309357-15-0,[Na+].[O-]C(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc21,
Toceranib,SU11654; PHA 291639E,356068-94-5,Cc1[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NCCN1CCCC1,
c-Met inhibitor 1,,1357072-61-7,Cn1cc(cn1)-c1ccc2nnc(Sc3ccc4nn(C)cc4c3)n2n1,
GSK-7975A,,1253186-56-9,Oc1ccc(Cn2ccc(NC(=O)c3c(F)cccc3F)n2)c(c1)C(F)(F)F,
LTURM34,,1879887-96-3,O=c1nc(oc2c(cccc12)-c1cccc2c3ccccc3sc12)N1CCOCC1,
ML418,,1928763-08-9,CC(C)OC(=O)NC1CCN(Cc2cc(Cl)c3cccnc3c2O)CC1,
BAY1082439,,1375469-38-7,COc1c(OC[C@H](O)CN2CCOCC2)ccc2C3=NCCN3C(NC(=O)c3cccnc3C)=Nc12,
Camalexin,,135531-86-1,C12=C(C=CC=C2)NC=C1C3=NC=CS3,
Tafluprost,AFP-168; MK2452,209860-87-7,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COc1ccccc1,
EIPA,L593754; MH 12-43,1154-25-2,CCN(C(C)C)c1nc(N)c(nc1Cl)C(=O)NC(N)=N,
Sakuranetin,,2957-21-3,COc1cc(O)c2C(=O)C[C@H](Oc2c1)c1ccc(O)cc1,
"7,4'-Dihydroxyflavone","4',7-Dihydroxyflavone; 7,4'-Dihydroxyflavone",2196-14-7,Oc1ccc(cc1)-c1cc(=O)c2ccc(O)cc2o1,
MAK683,,1951408-58-4,Cc1ncccc1-c1cnc(NCc2c3CCOc3ccc2F)n2cnnc12,
GRL0617,,1093070-16-6,C[C@@H](NC(=O)c1cc(N)ccc1C)c1cccc2ccccc12,
"2',5'-Dideoxyadenosine",,6698-26-6,C[C@H]1O[C@H](C[C@@H]1O)n1cnc2c(N)ncnc12,
LAU159,,2055050-87-6,COc1cccc(c1)-n1[nH]c2c(cnc3ccc(Cl)cc23)c1=O,
Edicotinib,JNJ-40346527; JNJ-527,1142363-52-7,CC1(C)CCC(=CC1)c1nc(ccc1NC(=O)c1ncc([nH]1)C#N)C1CC(C)(C)OC(C)(C)C1,
HJC0197,,1383539-73-8,Cc1ccc(C)c(CSc2nc(C3CCCC3)c(C#N)c(=O)[nH]2)c1,
Linopirdine,DuP 996,105431-72-9,O=C1N(c2ccccc2C1(Cc1ccncc1)Cc1ccncc1)c1ccccc1,
KO-947,,1695533-89-1,O=C1Nc2cc3[nH]nc(-c4ccncc4)c3cc2CN1Cc1ccccc1,
BD750,,892686-59-8,O=c1c2CCCCc2[nH]n1-c1nc2ccccc2s1,
NDMC101,,1308631-40-4,Oc1ccccc1C(=O)Nc1ccc(Cl)cc1F,
KCC-07,,315702-75-1,Oc1cccc(Nc2nc(cs2)-c2ccccn2)c1,
Apcin,,300815-04-7,Cc1ncc(n1CCOC(=O)NC(Nc1ncccn1)C(Cl)(Cl)Cl)[N+]([O-])=O,
CL 218872,,66548-69-4,Cc1nnc2ccc(nn12)-c1cccc(c1)C(F)(F)F,
A 425619,1-(4-(TRIFLUOROMETHYL)BENZYL)-3-(ISOQUINOLIN-5-YL)UREA,581809-67-8,FC(F)(F)c1ccc(CNC(=O)Nc2cccc3cnccc23)cc1,
DMNB,6-Nitroveratraldehyde; DMNB,20357-25-9,COc1cc(C=O)c(cc1OC)[N+](=O)[O-],
Phenibut (hydrochloride),3-Amino-4-phenylbutyric acid hydrochloride,3060-41-1,NC[C@@]([H])(CC(=O)O)c1ccccc1.[Cl],
"N4-benzyl-N2-methylquinazoline-2,4-diamine hydrochloride",,1135272-09-1,CNc3nc(NCc1ccccc1)c2ccccc2n3.[Cl],
Suritozole,MDL-26479,110623-33-1,S=C1N(C)N=C(C2=CC=CC(F)=C2)N1C,
DMH-25,,1685280-21-0,O=[N+](C(C(C1=CC=C(Br)C=C1)O2)=CC3=C2C(Br)=CC(Br)=C3)[O-],
P18IN011,P18IN011 - CAS 77408-67-4 - Calbiochem,77408-67-4,O=S(C1=CC=C(NC(C)=O)C=C1)(OC2=NOC3=CC=CC=C23)=O,
Nav1.8-IN-1,"5-(4-Chlorophenyl)-N-[[2-(2,2,2-trifluoroethoxy)pyridin-3-yl]methyl]pyridine-3-carboxamide; ",1026822-49-0,[F]C([F])([F])COc1ncccc1CNC(=O)c2cncc(c2)c3ccc([Cl])cc3,
Bupranolol,,14556-46-8,OC(COC1=C(Cl)C=CC(C)=C1)CNC(C)(C)C,
CTK8A3536,"(2-MORPHOLIN-4-YL-4-PHENYL-1,3-THIAZOL-5-YL)METHANOL",926228-58-2,OCc1[s]c(nc1c2ccccc2)N3CCOCC3,
RU 24969,"5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole",66611-26-5,COC1=CC=C2C(C(C3=CCNCC3)=CN2)=C1,
ML116,,744270-00-6,[H]C2(Cc1ccccc1)CCN(CC2)c3ncnc4[s]ccc34,
GS87,"4-[5-[[(3-Phenyl-1,2,4-oxadiazol-5-yl)methyl]thio]-1,3,4-oxadiazol-2-yl]pyridine",919936-70-2,C([S]c1nnc(o1)c2ccncc2)c3nc(no3)c4ccccc4,
NSC 139486,"1H-Benzimidazol-2-amine,N-butyl-(9CI); N-Butyl-1H-benzimidazol-2-amine",51314-51-3,CCCCNC1=NC2=CC=CC=C2N1.[H]Cl,
Baclofen hydrochloride,4-amino-3-(4-chlorophenyl)butanoic acid hydron chloride,28311-31-1,NC[C@]([H])(CC(=O)O)c1ccc([Cl])cc1.[Cl],
CI 75300,,94875-80-6,COc1c(O)ccc(C=CC(CC(C=Cc2cc(OC)c(O)cc2)=O)=O)c1,
OTSSP167 hydrochloride,,1431698-10-0,ClC1=CC(C2=CC=C(N=CC(C(C)=O)=C3N[C@H]4CC[C@H](CN(C)C)CC4)C3=N2)=CC(Cl)=C1O.[H]Cl,
1-Naphthyl PP1,1-NA-PP 1,221243-82-9,CC(N1N=C(C2=C3C=CC=CC3=CC=C2)C4=C(N)N=CN=C41)(C)C,
BO-264,,2408648-20-2,COC1=CC=C(C2=NOC(NC3=NC(N4CCOCC4)=NC=C3)=C2)C=C1,
GW6471,GW 6471,880635-03-0,CCC(NC[C@@H](N/C(C)=C\C(C1=CC=C(C(F)(F)F)C=C1)=O)CC2=CC=C(OCCC3=C(C)OC(C4=CC=CC=C4)=N3)C=C2)=O,
Substance P,Neurokinin P,33507-63-0,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,
Carcinoembryonic Antigen CEA,,168635-85-6,Oc1ccc(C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)cc1,
Neurotensin,,39379-15-2,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]5CCC(=O)N5)C(=O)N[C@@H](CC(C)C)C(O)=O ,
CMD178 TFA,,TP1433,Oc4ccc(C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)OCc3ccccc3)cc4.FC(F)(F)C(=O)O,
Colivelin,,867021-83-8,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@@H]3CCCN3C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)N,
Farudodstat,ASLAN003,1035688-66-4,O=C(C1=CC=CN=C1NC2=C(F)C=C(C3=CC=CC(OC)=C3)C=C2F)O,
CCT-251921,,1607837-31-9,Cn1ncc2cc(ccc12)-c1cnc(N)c(Cl)c1N1CCC2(CCNC2=O)CC1,
JH-RE-06,,1361227-90-8,O=C1C(C(CC(C)C)=O)=C(NC2=CC=C(Cl)C=C2Cl)NC3=C1C([N+]([O-])=O)=CC=C3Cl,
NVP-2,,1263373-43-8,ClC1=CN=C(N[C@H]2CC[C@H](N[C@H](C)COC)CC2)C=C1C3=CC=CC(NCC4(C#N)CCOCC4)=N3,
TMBIM6 antagonist-1,BIA,123134-61-2,Nc1ccccc1C(=O)\C=C\c1cccc(c1)[N+]([O-])=O,
BIX02189,BIX 02189,1265916-41-3,CN(C)Cc1cccc(N\C(c2ccccc2)=C2/C(=O)Nc3cc(ccc23)C(=O)N(C)C)c1,
CAY10404,3-(4-METHYLSULPHONYLPHENYL)-4-PHENYL-5-T,340267-36-9,CS(=O)(=O)c1ccc(cc1)-c1noc(c1-c1ccccc1)C(F)(F)F,
A-582941 dihydrochloride,A 582941,848591-90-2,[H][C@@]12CN(C)C[C@]1([H])CN(C2)c1ccc(nn1)-c1ccccc1,
CASP3 Activator 1541,,1100353-03-4,COc1cccc2cc(C(=O)Nc3cccc(c3)-c3cn4ccccc4n3)c(=O)oc12,
nifenalol.HCl,INPEA,5704-60-9,Cl.CC(C)NCC(O)c1ccc(cc1)[N+]([O-])=O,
SSD114 hydrochloride,,2319790-02-6,Cl.COc1cc(nc(NC2CCCCC2)n1)-c1ccc(cc1)C(F)(F)F,
NEO2734,EP31670,2081072-29-7,Cc1cc(cn(C)c1=O)-c1ccc2nc(C3CCOCC3)n(CCOC(F)(F)F)c2c1,
Epidermal Growth Factor,,62253-63-8,CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC4=CNC5=CC=CC=C54)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CC6=CC=C(C=C6)O)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC7=CC=C(C=C7)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC8=CC=C(C=C8)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC9=CN=CN9)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N,
FOY 251,,71079-09-9,CS(O)(=O)=O.NC(=N)Nc1ccc(cc1)C(=O)Oc1ccc(CC(O)=O)cc1,
HM03,,500565-15-1,COc1ccc2nc3cc(Cl)ccc3c(Nc3ccc(O)c(CN4CCN(C)CC4)c3)c2c1,
SR33805,,121345-64-0,COc1ccc(CCN(C)CCCOc2ccc(cc2)S(=O)(=O)c2c(C(C)C)n(C)c3ccccc23)cc1OC,
2-Aminopurine,,452-06-2,Nc1ncc2[nH]cnc2n1,
SP-146,,T8685,Cn1cc(cn1)c2ccc5c(c2)ncnc5Nc4cccc(NC(=O)Nc3cccc(F)c3)c4,
Zoliflodacin,ETX0914; AZD0914,1620458-09-4,[H][C@]12[C@H](C)O[C@H](C)CN1c1c(CC22C(=O)NC(=O)NC2=O)cc2c(noc2c1F)N1[C@@H](C)COC1=O,
ACY-775,,1375466-18-4,ONC(=O)c1cnc(NC2(CCCCC2)c2cccc(F)c2)nc1,
Exatecan Mesylate,DX8951f,169869-90-3,CS(O)(=O)=O.CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cc(F)c(C)c5CC[C@H](N)c(c3Cn1c2=O)c45,
Rilzabrutinib,PRN1008,1575596-29-0,CC(C)(\C=C(/C#N)C(=O)N1CCC[C@H](C1)n1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc12)N1CCN(CC1)C1COC1,
PSB-12062,N-(p-Methylphenylsulfonyl)phenoxazine,55476-47-6,Cc1ccc(cc1)S(=O)(=O)N1c2ccccc2Oc2ccccc12,
DHODH-IN-11,,1263303-95-2,O\N=C(/C#N)C(=O)Nc1ccc(cc1)-c1ccccc1,
AZD4320,,1357576-48-7,CN(CCO)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)[C@@H](O)c1ccccc1-c1ccc(Cl)cc1,
R-10015,,2097938-51-5,COC(=O)c1ccc2[nH]c(nc2c1)C1CCN(CC1)c1ncnc2[nH]cc(Cl)c12,
Asatone,,38451-63-7,[H][C@]12[C@H]3C(CC=C)=C[C@](OC)(C(=O)C3(OC)OC)[C@@]1(CC=C)C=C(OC)C(=O)C2(OC)OC,
CDK9-IN-2,,1263369-28-3,N[C@H]1CC[C@@H](CC1)Nc1cc(c(Cl)cn1)-c1cccc(NCc2cccc(F)c2)n1,
ETC-206,,1464151-33-4,O=C(N1CCOCC1)c1ccc(cc1)-c1ccc2ncc(-c3ccc(cc3)C#N)n2c1,
SEP-363856 hydrochloride,SEP-856 hydrochloride,1310422-41-3,Cl.CNC[C@@H]1OCCc2ccsc12,
Synta66,,835904-51-3,COc1ccc(OC)c(c1)-c1ccc(NC(=O)c2ccncc2F)cc1,
FG 7142,ZK 39106; LSU-65,78538-74-6,CNC(=O)c1cc2c(cn1)[nH]c1ccccc21,
BAY 2416964,,2242464-44-2,C[C@@H](CO)NC(=O)c1cc(nn(-c2cnn(C)c2)c1=O)-c1ccc(Cl)cc1,
BAY-985,,2409479-29-2,C[C@@H](N1CCN(CC1)C(=O)CC(F)(F)F)c1ccnc(Nc2nc3ccc(cc3[nH]2)-c2cc(ncn2)N(C)C)c1,
Mezigdomide,CC-92480,2259648-80-9,Fc1cc(ccc1N1CCN(Cc2ccc(COc3cccc4C(=O)N(Cc34)[C@H]3CCC(=O)NC3=O)cc2)CC1)C#N,
GSK-3Î² inhibitor 1,,187325-53-7,O=C1Nc2ccccc2\C1=C\c1ccccn1,
UT-34,,2168525-92-4,C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F,
Verubulin hydrochloride,MPC-6827 hydrochloride,917369-31-4,Cl.COc1ccc(cc1)N(C)c1nc(C)nc2ccccc12,
VU591 hydrochloride,,1315380-70-1,Cl.[O-][N+](=O)c1ccc2nc(COCc3nc4ccc(cc4[nH]3)[N+]([O-])=O)[nH]c2c1,
GW7647,,265129-71-3,CC(C)(Sc1ccc(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)cc1)C(O)=O,
Y-33075 dihydrochloride,,173897-44-4,Cl.Cl.C[C@@H](N)c1ccc(cc1)C(=O)Nc1ccnc2[nH]ccc12,
ML-9,,105637-50-1,Cl.Clc1cccc2c(cccc12)S(=O)(=O)N1CCCNCC1,
MT 63-78,,1179347-65-9,Oc1cccc(O)c1-c1ccc(cc1)-c1ccc2[nH]cc(C#N)c2c1,
Norverapamil hydrochloride,(Â±)-Norverapamil hydrochloride; D591 hydrochloride,67812-42-4,Cl.COc1ccc(CCNCCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC,
PTC-028,,1782970-28-8,Cc1nc2cc(F)c(F)cc2n1-c1cncc(Nc2ccc(cc2)C(F)(F)F)n1,
Pyr10,,1315323-00-2,Cc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)-n1nc(cc1C(F)(F)F)C(F)(F)F,
LCH-7749944,GNF-PF-2356,796888-12-5,COc1cccc(Nc2nc(NCC3CCCO3)c3ccccc3n2)c1,
SW-100,,2126744-35-0,ONC(=O)c1ccc(CN2CCCc3cc(Cl)ccc23)cc1,
BCH001,,384859-58-9,CCOC(=O)c1cnc2ccc(OC(F)(F)F)cc2c1Nc1ccccc1C(O)=O,
RBN012759,,2360851-29-0,O[C@H]1CC[C@@H](CC1)SCc1nc2cc(OCC3CC3)cc(F)c2c(=O)[nH]1,
USL311,,1373268-67-7,CC(C)N1CCC(CC1)N1CCCN(CC1)c1cccc(n1)C(=O)Nc1ccncc1,
VU591,,1222810-74-3,[O-][N+](=O)c1ccc2nc(COCc3nc4ccc(cc4[nH]3)[N+]([O-])=O)[nH]c2c1,
XE 991 dihydrochloride,,122955-13-9,Cl.Cl.O=C1c2ccccc2C(Cc2ccncc2)(Cc2ccncc2)c2ccccc12,
PRN1371,,1802929-43-6,CNc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(CCCN3CCN(CC3)C(=O)C=C)c2n1,
GW1929,,196808-24-9,CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(O)=O)cc1)c1ccccn1,
Miltirone,,27210-57-7,CC(C)C1=Cc2ccc3c(CCCC3(C)C)c2C(=O)C1=O,
N-Îµ-propargyloxycarbonyl-L-lysine hydrochloride,H-âL-âLys(Poc)â-âOH (hydrochloride); N6-((Prop-2-yn-1-yloxy)carbonyl)-L-lysine hydrochloride,1428330-91-9,Cl.N[C@@H](CCCCNC(=O)OCC#C)C(O)=O,
Nicotinamide riboside,,1341-23-7,NC(=O)c1ccc[n+](c1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,
Phentolamine Analogue 1,,47142-51-8,Cc1ccc(cc1)N(CC1=NCCN1)c1ccc(O)cc1,
(R)-Terazosin,,109351-34-0,COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)[C@H]1CCCO1,
BRD6989,,642008-81-9,CC1CCc2nc(N)c(C#N)c(-c3cccnc3)c2C1,
BT2,,34576-94-8,OC(=O)c1sc2cc(Cl)ccc2c1Cl,
Evocalcet,KHK7580,870964-67-3,C[C@@H](N[C@H]1CCN(C1)c1ccc(CC(O)=O)cc1)c1cccc2ccccc12,
BOC-D-FMK,,634911-80-1,COC(=O)CC(NC(=O)OC(C)(C)C)C(=O)CF,
Hydroxycitric acid tripotassium hydrate,Potassium citrate monohydrate,6100-05-6,O.[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,
LY 345899,,10538-99-5,Nc1nc(=O)c2N3C(CN(C3=O)c3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2[nH]1,
MK8722,,1394371-71-1,[H][C@]12OC[C@@H](Oc3nc4nc(c(Cl)cc4[nH]3)-c3ccc(cc3)-c3ccccc3)[C@@]1([H])OC[C@H]2O,
Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD,PF-05231023,1037589-69-7,O=C(CCN1C(=O)C=CC1=O)NCCOCCOCCC(=O)Nc1ccc(CCC(=O)N2CCC2=O)cc1,
Pimitespib,TAS-116,1260533-36-5,CCc1cc(ccc1-n1nc(C(C)C)c2c(ccnc12)-n1cnc(c1)-c1cnn(C)c1)C(N)=O,
Taletrectinib,DS-6051b; Taletrectinib; AB-106,1505515-69-4,OC(=O)CCCCC(O)=O.C[C@@H](N)COc1ccc(cc1)-c1cnc2ccc(N[C@H](C)c3cccc(F)c3)nn12,
Vancomycin,,1404-90-6,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@H](NC5=O)C(O)=O)c3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1)c(Cl)c2,
Paederosidic acid methyl ester,,122413-01-8,[H][C@]12[C@@H](O)C=C(COC(=O)SC)[C@@]1([H])[C@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)OC=C2C(=O)OC,
Norepinephrine bitartrate salt,,3414-63-9,C[C@H]([C@@H](O)C(O)=O)C(O)=O.NCC(O)c1ccc(O)c(O)c1,
LY255283,LY 255283,117690-79-6,CCc1cc(C(C)=O)c(O)cc1OCCCCCC(C)(C)c1nn[nH]n1,
cangrelor tetrasodium,,163706-36-3,[Na+].[Na+].[Na+].[Na+].CSCCNc1nc(SCCC(F)(F)F)nc2n(cnc12)[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)C(Cl)(Cl)P([O-])([O-])=O)[C@@H](O)[C@H]1O,
6-AZATHYMINE,,932-53-6,Cc1n[nH]c(=O)[nH]c1=O,
CHLOROQUINE,,54-05-7,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,
ZAP-180013,,873080-25-2,CCS(=O)(=O)c1ncc(Cl)c(n1)C(=O)N(Cc1ccco1)Cc1ccc(Cl)cc1,
TKIM,,326921-25-9,Clc1ccc(cc1)C(=O)NNC(=O)CSc1ccc2ccccc2n1,
Mibefradil dihydrochloride,Ro 40-5967 (dihydrochloride),116666-63-8,Cl.Cl.COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,
9-ING-41,,1034895-42-5,Cn1cc(C2=C(C(=O)NC2=O)c2coc3ccc(F)cc23)c2cc3OCOc3cc12,
RBN-2397,,2381037-82-5,FC(F)(F)c1cnc(nc1)N2CCN(CC2)C(=O)CCOC[C@H](C)NC=3C=NNC(=O)C=3C(F)(F)F,
ATN-161 trifluoroacetate salt,ATN-161 TFA salt,904763-27-5,OC(=O)C(F)(F)F.CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O,
EGFR-IN-7,TQB3804,2267329-76-8,COc1cc(N2CCC(CC2)N2CCN(C)CC2)c(C)cc1Nc1ncc(Br)c(Nc2ccc3nccnc3c2P(C)(C)=O)n1,
Dopexamine hydrochloride,FPL60278AR,86484-91-5,Cl.Cl.Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,
Tubulin inhibitor 6,iHAP1,105925-39-1,COc1ccc(cc1)C(=O)N1c2ccccc2Sc2ccc(Cl)cc12,
ICA-27243,,325457-89-4,Fc1ccc(cc1F)C(=O)Nc1ccc(Cl)nc1,
THAL-SNS-032,,2139287-33-3,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCN(CC(=O)NCCOCCOCCOCCNc4cccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c45)CC3)s2)o1,
Udenafil,DA8159,268203-93-6,CCCOc1ccc(cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1)S(=O)(=O)NCCC1CCCN1C,
JX06,,729-46-4,S=C(SSC(=S)N1CCOCC1)N1CCOCC1,
Escin IB,,26339-90-2,[H][C@@]12CC(C)(C)[C@@H](OC(=O)C(\C)=C/C)[C@H](OC(C)=O)[C@]1(CO)[C@H](O)C[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)CC[C@H](O[C@@H]4O[C@@H]([C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(O)=O)[C@](C)(CO)[C@]3([H])CC[C@@]12C,
Senkyunolide A,Senkyunolide,63038-10-8,O=C1O[C@@H](CCCC)C=2CCC=CC1=2,
Nigericin sodium salt,,28643-80-3,[Na+].[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]1(C)CC[C@@]([H])(O1)[C@]1(C)C[C@@H](C)[C@]2(O1)O[C@H](C[C@H]1CC[C@H](C)[C@@H](O1)[C@@H](C)C([O-])=O)C[C@@H](OC)[C@H]2C)[C@@]1([H])O[C@@](O)(CO)[C@H](C)C[C@@H]1C,
Theaflavin-3-gallate,THEAFLAVINE-3-GALLATE,30462-34-1,O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c2c1cc(cc(O)c2=O)[C@H]1Oc2cc(O)cc(O)c2C[C@H]1OC(=O)c1cc(O)c(O)c(O)c1,
Vacuolin-1,,351986-85-1,Ic1cccc(\C=N\Nc2nc(nc(n2)N2CCOCC2)N(c2ccccc2)c2ccccc2)c1,
Sodium Oxamate,"SO, oxamate sodium, Aminooxoacetic acid sodium salt, Oxamic acid sodium salt",565-73-1,[Na+].NC(=O)C([O-])=O,
Hydroxyzine,Hydroxyzine free base,68-88-2,OCCOCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1,
CRT0066101 dihydrochloride,,1883545-60-5,Cl.Cl.CC[C@@H](N)CNc1ccnc(n1)-c1cc(ccc1O)-c1cnn(C)c1,
ML-180,SR1848,863588-32-3,Clc1cccc(c1)N1CCN(CC1)c1cc(=O)n(C2CCCCC2)c(=O)[nH]1,
CB-103,,218457-67-1,CC(C)(C)c1ccc(Oc2ccc(N)cn2)cc1,
Brepocitinib P-Tosylate,PF-06700841 (P-Tosylate),2140301-96-6,Cc1ccc(cc1)S(O)(=O)=O.Cn1cc(Nc2nccc(n2)N2CC3CCC(C2)N3C(=O)[C@@H]2CC2(F)F)cn1,
Ceruletide,Caerulein; Cerulein; FI-6934,17650-98-5,C([C@@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC1=CC=CC=C1)C(N)=O)=O)CC(O)=O)=O)CCSC)=O)NC(CNC([C@@H](NC([C@H](CC2=CC=C(OS(=O)(=O)O)C=C2)NC([C@@H](NC([C@@H](NC(=O)[C@H]3NC(=O)CC3)CCC(N)=O)=O)CC(O)=O)=O)=O)[C@@H](C)O)=O)=O)C=4C=5C(NC4)=CC=CC5,
GABAA receptor agent 1,,1571-87-5,[O-][N+](=O)c1ccc2nc([nH]c2c1)-c1ccc(Cl)cc1,
Pamicogrel,KBT3022,101001-34-7,CCOC(=O)Cn1cccc1-c1nc(c(s1)-c1ccc(OC)cc1)-c1ccc(OC)cc1,
NS1652,,1566-81-0,OC(=O)c1ccccc1NC(=O)Nc1cccc(c1)C(F)(F)F,
PQR530,PQR-530,1927857-61-1,C[C@H]1COCCN1c1nc(nc(n1)-c1cnc(N)cc1C(F)F)N1CCOCC1,
"2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide",GDC046,1258292-64-6,Clc1cccc(Cl)c1C(=O)Nc1ccnc(NC(=O)C2CC2)c1,
S6K-18,,1265789-88-5,CC(C)(C)c1cc(C(O)=O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1,
Myristicin,Myristicine,607-91-0,COc1cc(CC=C)cc2OCOc12,
DMU2105,,1031063-36-1,O=C(\C=C\c1ccc2ccccc2c1)c1cccnc1,
DMU2139,,104890-70-2,COc1ccc2cc(ccc2c1)C(=O)\C=C\c1cccnc1,
SAR-020106,,1184843-57-9,C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N,
Niclosamide olamine,Niclosamide-olamine; Niclosamide Ethanolamine salt,1420-04-8,NCCO.Oc1ccc(Cl)cc1C(=O)Nc1ccc(cc1Cl)[N+]([O-])=O,
MSAB,,173436-66-3,COC(=O)c1cccc(NS(=O)(=O)c2ccc(C)cc2)c1,
BMS986260,,2001559-19-7,OCCn1cnc(c1-c1ccc2ncc(C#N)n2n1)-c1ccc(F)c(Cl)c1,
MDK-4025,,66774-02-5,OC(c1ccccc1)(c1ccccc1)c1ccccc1Cl,
SC99,,882290-02-0,Fc1ccc(N\N=C(/C#N)C(=O)c2ccc(Cl)cc2)cc1Cl,
CBR-5884,,681159-27-3,CCOC(=O)c1sc(NC(=O)c2ccco2)c(SC#N)c1C,
DGY-06-116,,T22306,CN1CCN(CC1)c1ccc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)c(Nc3ccccc3NC(=O)C=C)n2)cc1,
Oxindole,Indolin-2-one,59-48-3,O=C1Cc2ccccc2N1,
4-Hydroxycoumarin,,1076-38-6,Oc1cc(=O)oc2ccccc12,
Velsecorat,AZD7594; AZ13189620,1196509-60-0,C[C@H](NC(=O)C(C)(F)F)[C@H](Oc1ccc2n(ncc2c1)-c1cccc(c1)C(=O)N[C@@H]1CCOC1)c1ccc2OCCOc2c1,
Oleoylethanolamide,N-Oleoylethanolamide; Oleamide MEA; Oleic acid monoethanolamide,111-58-0,CCCCCCCC\C=C/CCCCCCCC(=O)NCCO,
4-Hydroxynonenal,4-HNE,75899-68-2,CCCCCC(O)\C=C\C=O,
Dabuzalgron,Ro 115-1240,219311-44-1,Cc1c(OCC2=NCCN2)ccc(Cl)c1NS(C)(=O)=O,
Dehydrocorydaline chloride,13-Methylpalmatine chloride,10605-03-5,[Cl-].COc1cc2CC[n+]3cc4c(OC)c(OC)ccc4c(C)c3-c2cc1OC,
DS16570511,,2446154-84-1,O=C(O)CCCN1C=C(C(=O)C=2C=CC=C(C2)NCC=3C(=NOC3C)C=4C(Cl)=CC=CC4Cl)C=5C=CC=CC51,
BAY-2402234,,2225819-06-5,CCn1c(CO)nn(-c2cc(O[C@@H](C)C(F)(F)F)c(cc2F)C(=O)Nc2c(F)cccc2Cl)c1=O,
APTO-253,LOR-253; LT-253,916151-99-0,Cc1[nH]c2ccc(F)cc2c1-c1nc2c([nH]1)c1cccnc1c1ncccc21,
Carboprost tromethamine,,58551-69-2,NC(CO)(CO)CO.CCCCC[C@](C)(O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O,
CDK2-IN-4,,2079895-42-2,NS(=O)(=O)c1ccc(Nc2nc(-c3cccc(c3)-c3ccccc3)c3nc[nH]c3n2)cc1,
T16Ainh-A01,,552309-42-9,CCc1c(C)nc(SCC(=O)Nc2nc(cs2)-c2ccc(OC)cc2)[nH]c1=O,
TK216,,1903783-48-1,OC1(CC(=O)c2ccc(cc2)C2CC2)C(=O)Nc2c1c(Cl)ccc2Cl,
Urolithin B,,1139-83-9,Oc1ccc2c(c1)oc(=O)c1ccccc21,
GSK2795039,,1415925-18-6,CC(C)n1cc(-c2ccc3CCN(C)c3c2)c2c(NS(=O)(=O)c3ccn(C)n3)ccnc12,
GW-870086,,827319-43-7,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3C(C)(C)C3(C)C)(C(=O)OCC#N)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,
Glucagon hydrochloride (16941-32-5 free base),Porcine glucagon hydrochloride,28270-04-4,Cl.CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O,
IRAK4-IN-4,,1850276-58-2,Cc1ccn2c(C(=O)C(=O)c3ccccc3)c(nc2c1)-c1ccccc1,
1588-A4,ARS-1620 Intermediate,1698027-20-1,CC(C)(C)OC(=O)N1CCN(CC1)c1ncnc2c(F)c(Br)c(Cl)cc12,
Bafilomycin A1,,88899-55-2,O[C@@]1(C[C@@H](O)[C@H](C)[C@H](O1)C(C)C)[C@@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)C(OC)=CC(C)=C[C@@H](C)[C@@H](O)[C@@H](C)CC(C)=CC=C[C@@H]2OC,
"4',6,7-Trimethoxyisoflavone",,798-61-8,COc1ccc(cc1)-c1coc2cc(OC)c(OC)cc2c1=O,
ASTX660,,1799328-86-1,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nc(CO)c(Cc4ccc(F)cc4)cc23)[C@@H](CN2CCOC[C@H]2C)CN1,
Glucoraphanin,,21414-41-5,CS(=O)CCCC\C(S[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)=N/OS(O)(=O)=O,
BAMB-4,ITPKA-IN-C14,891025-25-5,Cc1ccc(cc1)C(=O)Nc1noc2ccccc12,
Cabergoline,FCE-21336,81409-90-7,[H][C@@]12Cc3c[nH]c4cccc(c34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,
BMS-1001 hydrochloride,,2113650-04-5,Cl.Cc1cc(CN[C@H](CO)C(O)=O)c(OCc2cccc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1,
JR-AB2-011,,2411853-34-2,CC1CN=C(S1)N(C(=O)Nc1ccc(Cl)c(Cl)c1)c1ccc(F)cc1,
MRTX-1257,,2206736-04-9,CN1CCC[C@H]1COc1nc2CN(CCc2c(n1)N1CCN([C@@H](CC#N)C1)C(=O)C=C)c1cccc2cccc(C)c12,
O-Desmethyl gefitinib,,847949-49-9,Oc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,
LG-100064,,153559-46-7,Cc1cc2c(cc1C(=O)c1ccc(cc1)C(O)=O)C(C)(C)CCC2(C)C,
Nicardipine,Nicardipine; Cardene; Antagonil; Dagan; Flusemide,55985-32-5,COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN(C)Cc1ccccc1,
L-Albizziin,Albizziin; L-Albizziin; L-beta-Ureidoalanine; L-Albizziine; Albizzine; NSC 132089; NSC-132089,1483-07-4,N[C@@H](CNC(N)=O)C(O)=O,
Fz7-21,(Ac)-LPSDDLEFWCHVMY-NH2,2247635-23-8,CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(C)=O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,
BAY-474,,1033767-86-0,Cc1n[nH]c2ccc(cc12)C1C(C#N)=C(C)NC(C)=C1C#N,
2-Methoxyidazoxan monohydrochloride,RX 821002 hydrochloride,109544-45-8,Cl.COC1(COc2ccccc2O1)C1=NCCN1,
BOT-64,,113760-29-5,CC1(C)Cc2oc(=Nc3ccccc3)sc2C(=O)C1,
AZD8931 diFuMaric acid,,1196531-39-1,OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O.CNC(=O)CN1CCC(CC1)Oc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC,
PF-05186462,PF-05150122,1235406-03-7,Fc1cc(Oc2ccc(cc2-c2ccnnc2)C(F)(F)F)c(Cl)cc1S(=O)(=O)Nc1nncs1,
Poziotinib hydrochloride,NOV120101 hydrochloride; HM 781-36B hydrochloride,1429757-68-5,Cl.COc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3F)c2cc1OC1CCN(CC1)C(=O)C=C,
GR 125743,,148547-33-5,COc1ccc(NC(=O)c2ccc(c(C)c2)-c2ccncc2)cc1N1CCN(C)CC1,
BAR 501 impurity,,1632118-70-7,[H][C@@]12CC[C@H]([C@H](C)CCCO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H](O)[C@@H](CC)[C@]2([H])C[C@H](O)CC[C@]12C,
Elimusertib,BAY-1895344; Elimusertib,1876467-74-1,C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccn[nH]3)c2n1,
Loxapine,,1977-10-2,CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12,
KRAS inhibitor-9,DUN09716,300809-71-6,Nc1ccc(Sc2nc3ccccc3s2)c(Cl)c1,
MID-1,,312608-54-1,CCOc1ccc(cc1)C(=O)Nc1ncc(s1)[N+]([O-])=O,
Beclometasone,BecloMethasone; Beclometasone,4419-39-0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
SW106065,SW-106065,62289-81-0,O=C(Nc1cccnc1)c1cccs1,
COH-SR4,COH-SR4 (Mitochondria uncoupler SR4),73439-19-7,Clc1cc(Cl)cc(NC(=O)Nc2cc(Cl)cc(Cl)c2)c1,
PRX-07034 hydrochloride,PRX-07034,903580-39-2,Cl.COc1cc(Cl)cc(C(C)Nc2cc(ccc2S(C)(=O)=O)N2CCNCC2)c1OC,
G5-7,JAK2 inhibitor G5-7,939681-36-4,Fc3ccccc3/C=C2\CN(C\C(=C/c1ccccc1F)C2=O)C(=O)OCC,
I-49 free base,"Pyrido[4,3-d]pyrimidin-7(6H)-one, 2-methyl-4-[[(1R)-1-[2-methyl-3-(trifluoromethyl)phenyl]ethyl]amino]-6-(tetrahydro-2H-pyran-4-yl)-",T8746L,Cl.C[C@@H](Nc1nc(C)nc2cc(=O)n(cc12)C1CCOCC1)c1cccc(c1C)C(F)(F)F,
A-674563 2HCl(552325-73-2(fb-2hcl)),,T6139L,Cl.Cl.Cc1n[nH]c2ccc(cc12)-c1cncc(OC[C@@H](N)Cc2ccccc2)c1,
LUN42518 HCl  47142-51-8(free base),,T8738,Cl.Cc1ccc(cc1)N(CC1=NCCN1)c1ccc(O)cc1,
N-Nornuciferine hydrochloride(4846-19-9 free base),,TQ0296L,Cl.[H][C@]12Cc3ccccc3-c3c(OC)c(OC)cc(CCN1)c23,
UNC0064-12 hydrochloride (1430089-64-7(free base)),,T2056L,Cl.NCCCNc1ccc(Nc2nccc(Nc3cc([nH]n3)C3CC3)n2)cc1,
I-37 free base( 2359690-13-2(free base)),,T8721L,Cl.C[C@@H](Nc1nc(C)nc2cc(=O)n(cc12)C1(C)CC1)c1cccc(c1C)C(F)(F)F,
EX229,C99; Compound 991,1219739-36-2,O=C(O)C1=CC(OC2=NC3=CC(Cl)=C(C4=CC5=C(N(C)C=C5)C=C4)C=C3N2)=CC=C1C,
Chebulagic acid,,23094-71-5,OC(CC(C(O[C@H]([C@@H](COC(C1=CC(O)=C2O)=O)O[C@@H]3OC(C4=CC(O)=C(O)C(O)=C4)=O)[C@H](OC(C5=CC(O)=C(O)C(O)=C5C1=C2O)=O)[C@H]3OC6=O)=O)C(C7O)C(C6=CC(O)=C8O)=C8OC7=O)=O,
Chebulinic acid,,18942-26-2,OC(C[C@H](C(O[C@@]([C@H](O[C@H]1OC(C2=CC(O)=C(O)C(O)=C2)=O)COC(C3=CC(O)=C(O)C(O)=C3)=O)([H])[C@@](OC(C4=CC(O)=C(O)C(O)=C4)=O)([H])[C@@]1([H])OC5=O)=O)[C@@]([C@H]6O)([H])C(C5=CC(O)=C7O)=C7OC6=O)=O,
Ailanthone,Î13-Dehydrochaparrinone,981-15-7,C[C@@]1([C@@H]2O)[C@]([C@@]3([C@@H]4O)O)([H])[C@@]([C@](C5)([H])C4=C)(CO3)[C@@](OC5=O)([H])C[C@@]1([H])C(C)=CC2=O,
Dimethylcurcumin,ASC-J9; GO-Y025,52328-98-0,O=C(/C=C(O)/C=C/C1=CC=C(OC)C(OC)=C1)/C=C/C2=CC=C(OC)C(OC)=C2,
MLN120B,,783348-36-7,O=C(C1=CC=CN=C1C)NC2=C(OC)C(Cl)=CC3=C2NC4=C3C=CN=C4,
Skullcapflavone II,,55084-08-7,COC1=C2C(C(C=C(C3=C(C=CC=C3O)OC)O2)=O)=C(O)C(OC)=C1OC,
Osthenol,,484-14-0,O=C1C=CC2=CC=C(O)C(C/C=C(C)\C)=C2O1,
Desmethylglycitein,"6,7,4'-Trihydroxyisoflavone",17817-31-1,O=C1C(C2=CC=C(O)C=C2)=COC3=CC(O)=C(O)C=C13,
Ethoxysanguinarine,6-Ethoxydihydrosanguinarine,28342-31-6,CN1C2=C3C(C=C4OCOC4=C3)=CC=C2C5=C(C6=C(OCO6)C=C5)C1OCC,
Dihydrokaempferol,Aromadendrin,480-20-6,O=C1C2=C(O)C=C(O)C=C2O[C@H](C3=CC=C(O)C=C3)[C@H]1O,
Bisabolangelone,,30557-81-4,O=C1C=C(C)C[C@@]2([H])[C@]1([H])[C@@](C)(O)/C(O2)=C/C=C(C)\C,
Effusol,,73166-28-6,OC(C(C)=C1CC2)=CC=C1C3=C2C=C(O)C=C3C=C,
Eurycomalactone,,23062-24-0,C[C@]12[C@@]([C@H]([C@@](O3)([H])[C@@](C)([H])[C@]2([H])C3=O)O)([H])[C@]([C@@](C(C)=CC4=O)([H])CC1=O)([C@@H]4O)C,
Hamaudol,,735-46-6,OC1=C2C(OC(C)(C)[C@@H](O)C2)=CC3=C1C(C=C(C)O3)=O,
Methyl rosmarinate,,99353-00-1,OC1=C(O)C=CC(/C=C/C(O[C@@H](C(OC)=O)CC2=CC(O)=C(O)C=C2)=O)=C1,
Regaloside B,,114420-67-6,O[C@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)[C@@H]1O[C@H](COC(/C=C/C2=CC=C(O)C=C2)=O)COC(C)=O,
DCPIB,,82749-70-0,O=C(O)CCCOC1=CC2=C(C(C(C3CCCC3)(CCCC)C2)=O)C(Cl)=C1Cl,
ALLO-2,,1357350-60-7,FC(F)(OC1=CC=C(C=C1)C2=NC(NC3=CC4=C(C=C3)NN=C4)=NC=C2)F,
AMG 487,,473719-41-4,O=C(N([C@@H](C1=NC2=NC=CC=C2C(N1C3=CC=C(OCC)C=C3)=O)C)CC4=CC=CN=C4)CC5=CC=C(OC(F)(F)F)C=C5,
Denifanstat,FASN-IN-2; TVB-2640,1399177-37-7,N#CC1=CC=C(C2CCN(C(C3=CC(C4=NC(C)=NN4)=C(C5CCC5)C=C3C)=O)CC2)C=C1,
SYP-5,,1384268-04-5,O=C(C1=C(O)C(C=CC(C)(C)O2)=C2C=C1)/C=C/C3=CC=CS3,
Inobrodib,CBP-IN-1,2222941-37-7,O=C1N(C2=CC=C(F)C(F)=C2)[C@H](C3=NC4=CC(C5=C(C)ON=C5C)=CC=C4N3[C@H]6CC[C@H](OC)CC6)CCC1,
Î²-Elemene,(-)-Î²-Elemene; Levo-Î²-elemene,515-13-9,CC([C@H]1[C@@](C)(CC[C@@H](C(C)=C)C1)C=C)=C,
Pyr6,"N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-3-fluoro-4-pyridinecarboxamide",245747-08-4,O=C(C1=C(F)C=NC=C1)NC2=CC=C(N3N=C(C(F)(F)F)C=C3C(F)(F)F)C=C2,
TAK-243,MLN7243,1450833-55-2,O=S(OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](NC2=CC=NC3=CC(C4=CC=CC(SC(F)(F)F)=C4)=NN23)C1)(N)=O,
Ilexgenin A,,108524-94-3,CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C(=O)O)O)C)C)C2C1(C)O)C)C(=O)O,
Brevilin A,,16503-32-5,C/C=C(C)\C(O[C@H]1[C@@]([C@@H]2C)([H])[C@@](OC2=O)([H])C[C@@H](C)[C@@]3([H])[C@]1(C(C=C3)=O)C)=O,
Demethylwedelolactone,,6468-55-9,O=C1C2=C(OC3=CC(O)=C(O)C=C32)C4=C(O)C=C(O)C=C4O1,
Kurarinone,,34981-26-5,O=C1C[C@@H](C2=CC=C(O)C=C2O)OC3=C(C[C@H](C(C)=C)C/C=C(C)\C)C(O)=CC(OC)=C13,
Phenylethyl isothiocyanate,JC-5411; JC5411; JC 5411,2257-09-2,C1=CC=C(C=C1)CCN=C=S,
CP-380736,CP 380736; CP380736; PF-00520893; PF 00520893; PF00520893,179688-29-0,COCCOC1=C(C=C2C(=C1)C(=O)NC=N2)OCCOC,
5-Fluoroorotic acid,,703-95-7,O=C(C(NC1=O)=C(F)C(N1)=O)O,
HODHBt,,28230-32-2,C1=CC=C2C(=C1)C(=O)N(N=N2)O,
NSAH,NSAHÂ ; 2-hydroxy-N'-[(E)-(2-hydroxynaphthalen-1-yl)methylidene]benzohydrazide,1099592-35-4,O=C(C1=CC=CC=C1O)N/N=C/C2=C3C=CC=CC3=CC=C2O,
CAN508,,140651-18-9,OC1=CC=C(/N=N/C2=C(N)NN=C2N)C=C1,
BMS-P5 free base,,1550371-22-6,O=C(N1[C@@H](C)CC[C@@H](N)C1)C2=CC(OC)=C3C(N=C(C4=CC5=CC=CN=C5N4CC6CC6)N3C)=C2,
TH287 hydrochloride,,1638211-05-8,NC1=NC(C2=CC=CC(Cl)=C2Cl)=CC(NC)=N1.[H]Cl,
Cyclo(-RGDfK) TFA,,500577-51-5,C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCCCN)CC2=CC=CC=C2)CC(=O)O.C(=O)(C(F)(F)F)O,
HALOFUGINONE LACTATE,,82186-71-8,CC(O)C(O)=O.O=C1N(CC(C[C@@H]2NCCC[C@H]2O)=O)C=NC3=C1C=C(Cl)C(Br)=C3,
NLX-204 hydrochlorideï¼2170405-10-2 free baseï¼,,T22379L,[H]Cl.O=C(C1=CC=C(F)C(Cl)=C1)N2CCC(CNCCOC3=NC=CC=C3)(F)CC2,
WHI-P97 HCl 211555-05-4(free base),,T4657L,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C(=C3)Br)O)Br)OC.Cl,
LYN-1604 dihydrochloride,LYN-1604 2HClï¼2216753-86-3 free basel); ,2310109-38-5,[H]Cl.[H]Cl.ClC1=CC=C(C(OCC2=CC=C3C=CC=CC3=C2)CN4CCN(C(CN(CC(C)C)CC(C)C)=O)CC4)C(Cl)=C1,
Locostatin,,133812-16-5,CC=CC(=O)N1C(COC1=O)CC2=CC=CC=C2,
MK-6892,,917910-45-3,O=C(C1=C(NC(C(C)(C)CC2=NC(C3=NC=C(O)C=C3)=NO2)=O)CCCC1)O,
Helichrysetin,,62014-87-3,O=C(C1=C(OC)C=C(O)C=C1O)/C=C/C2=CC=C(O)C=C2,
N-(p-Coumaroyl) serotonin,,68573-24-0,O=C(NCCC1=CNC2=C1C=C(O)C=C2)/C=C/C3=CC=C(O)C=C3,
Syrosingopine,,84-36-6,[H][C@@]12C(NC3=C4C=CC(OC)=C3)=C4CCN1C[C@]5(C[C@@H](OC(C6=CC(OC)=C(OC(OCC)=O)C(OC)=C6)=O)[C@H](OC)[C@@H](C(OC)=O)[C@]5(C2)[H])[H],
DCZ0415,,2242470-43-3,O=C1N(C2=CC=C(CC3=CC=NC=C3)C=C2)C(C4C5C(C6)C6C(C=C5)C14)=O,
ARQ 531,,2095393-15-8,O=C(C1=CC=C(OC2=CC=CC=C2)C=C1Cl)C3=CNC4=NC=NC(N[C@H]5CO[C@H](CO)CC5)=C43,
Tanzisertib,CC-930,899805-25-5,O[C@H]1CC[C@@H](CC1)NC2=NC=C3N=C(N(C3=N2)[C@@H]4COCC4)NC5=C(C=C(C=C5F)F)F,
CDKI-73,,1421693-22-2,CNC1=NC(C)=C(C2=C(F)C=NC(NC3=CC(S(=O)(N)=O)=CC=C3)=N2)S1,
Ciliobrevin D,,1370554-01-0,O=C(C1=C(C=C(Cl)C=C1)Cl)/C(C#N)=C(N2)/NC3=CC(Cl)=CC=C3C2=O,
Glycerol phenylbutyrate,HPN-100,611168-24-2,O=C(CCCC1=CC=CC=C1)OC(COC(CCCC2=CC=CC=C2)=O)COC(CCCC3=CC=CC=C3)=O,
Etifoxine hydrochloride,HOE 36-801 hydrochloride,56776-32-0,ClC1=CC=C2C(C(C3=CC=CC=C3)(C)OC(NCC)=N2)=C1.Cl,
Hck-IN-1,,1473404-51-1,S=C(N1N=C(C2=CC=C([N+]([O-])=O)C=C2)C(/N=N/C3=CC=CC(Cl)=C3)=C1O)N,
Indibulin,ZIO 301; D 24851,204205-90-3,O=C(NC1=CC=NC=C1)C(C2=CN(CC3=CC=C(Cl)C=C3)C4=C2C=CC=C4)=O,
JTE-013,,383150-41-2,CC(C1=C2C(N(C)N=C2C)=NC(NNC(NC3=CC(Cl)=NC(Cl)=C3)=O)=C1)C,
Col003,,328565-16-8,O=CC1=CC(CC2=CC=CC=C2)=CC([N+]([O-])=O)=C1O,
ZLDI-8,,667880-38-8,O=C(/C(C(N1)=O)=C/C2=C(C)N(CCOC3=CC=C(C)C=C3C)C4=C2C=CC=C4)NC1=S,
NIK SMI1,,1660114-31-7,O=C(N)C1=NC(C2=CC=CC(C#C[C@@]3(O)C(N(C)CC3)=O)=C2)=CC(OC)=C1,
ONC206,,1638178-87-6,FC1=CC(F)=CC=C1CN2C(C(C3)=C(N4CCN=C42)CCN3CC5=CC=CC=C5)=O,
PT2399,,1672662-14-4,N#CC1=CC(F)=CC(OC2=CC=C(S(=O)(C(F)F)=O)C3=C2CC(F)(F)[C@H]3O)=C1,
Toyocamycin,Vengicide,606-58-6,O[C@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C3=C(C(N)=NC=N3)C(C#N)=C2,
AZ9482,,1825345-33-2,O=C1NN=C(CC2=CC=CC(C(N3CCN(C4=NC=CC=C4C#N)CC3)=O)=C2)C5=CC=CC=C51,
BRITE-338733,BRITE338733,503105-88-2,OC1=CC=C(C)C=C1C2=NC(NC3CC(C)(C)NC(C)(C)C3)=CC(C4=CC=C(CC)O4)=C2,
MDL 100009,,175673-57-1,O[C@@H](C1=CC=CC(OC)=C1OC)C2CCN(CCC3=CC=C(F)C=C3)CC2,
RO495,CS-2667,1258296-60-4,O=C(NC1=CC(NC2=NC(N)=NC(C)=C2)=NC=C1)C3=C(Cl)C=CC=C3Cl,
SU5204,3-[(2-Ethoxyphenyl)methylidene]-1H-indol-2-one,186611-11-0,O=C1NC2=C(C=CC=C2)/C1=C/C3=CC=CC=C3OCC,
SU5208,3-[(Thien-2-yl)methylene]-2-indolinone,62540-08-3,O=C1NC2=C(C=CC=C2)/C1=C/C3=CC=CS3,
Finerenone,BAY94-8862; BAY 94-8862; BAY-94-8862; BAY948862; BAY 948862; BAY-948862,1050477-31-0,O=C(C1=C(C)NC2=C(C(OCC)=NC=C2C)[C@@H]1C3=CC=C(C#N)C=C3OC)N,
Methylnaltrexone bromide,MOA-728; MOA 728; MOA728; Methylnaltrexone; Relistor,73232-52-7,O=C1[C@@](OC2=C(O)C=CC3=C24)([H])[C@@]54CC[N+](C)(CC6CC6)[C@@](C3)([H])[C@]5(O)CC1.[Br-],
SC-58125,SC 58125,162054-19-5,FC(C1=NN(C2=CC=C(S(=O)(C)=O)C=C2)C(C3=CC=C(F)C=C3)=C1)(F)F,
"3-AMINO-1,2,4-TRIAZINE",,1120-99-6,NC1=NC=CN=N1,
TC-G 1005,,1415407-60-1,O=C(N1CCN(C2CC2)C3=C1C=CC=C3)C4=C(OC5=CC(C)=CC=C5C)C=CN=C4,
"2',4'-DIHYDROXYCHALCONE","2',4'-DHC",1776-30-3,O=C(C1=CC=C(O)C=C1O)C=CC2=CC=CC=C2,
S63845,,1799633-27-4,O=C(O)[C@@H](CC1=C(OCC2=CC=NN2CC(F)(F)F)C=CC=C1)OC3=C4C(SC(C5=CC=C(F)O5)=[C@@]4[C@@]6=C(C)C(Cl)=C(OCCN7CCN(C)CC7)C=C6)=NC=N3,
SRI-29329,,2086809-58-5,CC(N1C=NC2=C(NC3=CC=CC(Cl)=C3)N=C(N[C@@H]4[C@@H](N)CCCC4)N=C12)C,
BML-284 hydrochloride,BML-284 HCL; Wnt agonist 1 HCL,2095432-75-8,NC1=NC(C2=CC=CC(OC)=C2)=CC(NCC3=CC=C(OCO4)C4=C3)=N1.[H]Cl,
MS7972,,352553-42-5,O=C1C(N(C(C)=O)C2=C3C=CC=C2)=C3CCC1,
Azumolene,EU4093 free base,64748-79-4,O=C1NC(CN1/N=C/C2=NC=C(C3=CC=C(Br)C=C3)O2)=O,
NAE-IN-M22,NEDD8 inhibitor M22,864420-54-2,ClC1=CC=C(CCNC2CCN(CC3=CC=CC=C3)CC2)C(Cl)=C1,
Abrocitinib,PF-04965842,1622902-68-4,CCCS(=O)(N[C@H]1C[C@@H](N(C)C2=C3C(NC=C3)=NC=N2)C1)=O,
Navoximod,GDC-0919; NLG-â919,1402837-78-8,O[C@@H]([C@H]1CC[C@H](O)CC1)C[C@@H](C2=C3C=CC=C2F)N4C3=CN=C4,
LDN-192960,,184582-62-5,NCCCSC1=C(C=C(OC)C=C2)C2=NC3=CC=C(OC)C=C31,
GI254023X,GI 254023X,260264-93-5,O=C(N[C@H](C(NC)=O)C(C)(C)C)[C@@H]([C@@H](N(C=O)O)C)CCCC1=CC=CC=C1,
Geissoschizine methyl ether,,60314-89-8,COC(/C([C@H]1C[C@@]2([H])C3=C(CCN2C/C1=C/C)C4=CC=CC=C4N3)=C\OC)=O,
Irisolidone,,2345-17-7,O=C1C(C2=CC=C(OC)C=C2)=COC3=CC(O)=C(OC)C(O)=C13,
1-Caffeoylquinic acid,,1241-87-8,O[C@@H]1[C@H](O)C[C@@](OC(/C=C/C2=CC(O)=C(O)C=C2)=O)(C(O)=O)C[C@H]1O,
Î±-Spinasterol,alpha-Spinasterol,481-18-5,CC[C@@H](C(C)C)/C=C/[C@@H](C)[C@H]1CC[C@@]2([H])C3=CC[C@@]4([H])C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C,
Gossypin,,652-78-8,O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC3=C(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)C(O)=CC(O)=C13,
Mogrol,,88930-15-8,CC1(C)[C@@H](O)CC[C@@]2([H])[C@]3(C)[C@H](O)C[C@]4(C)[C@@H]([C@H](C)CC[C@@H](O)C(C)(O)C)CC[C@](C)4[C@]3([H])CC=C12,
N-desmethyl Enzalutamide,N-desmethyl MDV 3100,1242137-16-1,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)N)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,
PI4KIIIbeta-IN-10,,1881233-39-1,COC1=CC=C(C2=C(C)N=C(NC(C(C)(C)C)=O)S2)C=C1S(NC3=CC=C(O)C=C3)(=O)=O,
PI4KIIIbeta-IN-9,,1429624-84-9,CC(N=C1NC(C2CCCC2)=O)=C(S1)C3=CC=C(C(S(=O)(NC4=CC=C(O)C=C4)=O)=C3)OC,
Desmethyl Celecoxib,,170569-87-6,FC(F)(C1=NN(C(C2=CC=CC=C2)=C1)C3=CC=C(C=C3)S(=O)(N)=O)F,
DUPA(OtBu)-OH,,1026987-94-9,CC(C)(C)OC(=O)CC[C@@H](C(=O)OC(C)(C)C)NC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C,
Anamorelin,RC-1291; ONO-7643,249921-19-5,[H][C@](CC1=CNC2=CC=CC=C21)(NC(C(C)(C)N)=O)C(N3CCC[C@@](C(N(C)N(C)C)=O)(CC4=CC=CC=C4)C3)=O,
Fluxametamide,,928783-29-3,CC1=C(C=CC(=C1)C2=NOC(C2)(C3=CC(=CC(=C3)Cl)Cl)C(F)(F)F)C(=O)N/C=N/OC,
GW806742X,,579515-63-2,O=S(C1=CC=CC(NC2=NC=CC(N(C)C3=CC=C(NC(NC4=CC=C(OC(F)(F)F)C=C4)=O)C=C3)=N2)=C1)(N)=O,
VBIT-4,,2086257-77-2,OCC(N1CCN(C2=CC=C(OC(F)(F)F)C=C2)CC1)CC(NC3=CC=C(Cl)C=C3)=O,
(Â±)-Enitociclib,(Â±)-BAY-1251152,1610358-53-6,N=S(CC1=CC(NC2=NC=C(F)C(C3=CC=C(F)C=C3OC)=C2)=NC=C1)(C)=O,
SAR405,,1523406-39-4,O=C1C=C(N2[C@H](C)COCC2)N=C3N(CC4=CC(Cl)=CN=C4)[C@H](C(F)(F)F)CCN31,
LXH254,,1800398-38-2,O=C(C1=CC(C(F)(F)F)=NC=C1)NC2=CC=C(C)C(C3=CC(OCCO)=NC(N4CCOCC4)=C3)=C2,
VER-246608,,1684386-71-7,O=C(C1=CC=C(O)C=C1O)N(CC2=CC=C(CNC(C(F)F)=O)C=C2)C(C=C3)=CC=C3C4=NC(Cl)=NC=C4C,
Icatibant Acetate,,138614-30-9,CC(=O)O.N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC(=O)N[C@@H](Cc3cccs3)C(=O)N[C@@H](CO)C(=O)N4Cc5ccccc5C[C@@H]4C(=O)N6[C@H]7CCCC[C@H]7C[C@H]6C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,
Karanjin,,521-88-0,O=C1C(OC)=C(C2=CC=CC=C2)OC3=C1C=CC4=C3C=CO4,
Cinobufotalin,,1108-68-5,C[C@]([C@@H](C(C=C1)=COC1=O)[C@H]2OC(C)=O)(CC[C@@]3([H])[C@@]4([H])CC[C@@]5(O)[C@@]3(CC[C@H](O)C5)C)[C@@]64[C@@H]2O6,
Hinokiflavone,,19202-36-9,O=C1C=C(C2=CC=C(O)C=C2)OC3=CC(O)=C(OC4=CC=C(C5=CC(C6=C(O)C=C(O)C=C6O5)=O)C=C4)C(O)=C13,
Cucurbitacin E,,18444-66-1,O[C@H](C1)[C@@]([C@@](C)(O)C(/C=C/C(OC(C)=O)(C)C)=O)([H])[C@](C2)(C)[C@]1(C)[C@]3([H])CC=C4C(C)(C)C(C(O)=C[C@@]4([H])[C@]3(C)C2=O)=O,
"2,3-Dihydroxy-4-methoxyacetophenone","2',3'-Dihydroxy-4'-methoxyacetophenone",708-53-2,CC(C1=CC=C(OC)C(O)=C1O)=O,
Clomipramine,Clomipramine; Anafranil (free base); Anafranil; Chlorimipramine; Clomicalm; Clomipramina,303-49-1,N1(CCCN(C)C)c2c(CCc3ccccc13)ccc(c2)Cl,
Almotriptan,Almotriptan; LAS 31416,154323-57-6,c1c(cc2c(c[nH]c2c1)CCN(C)C)CS(N1CCCC1)(=O)=O,
Levoglucosenone,,37112-31-5,O=C1C=C[C@@]2([H])CO[C@]1([H])O2,
tubuloside B,,112516-04-8,CC(O[C@@H]([C@@H](O1)OCCC(C=C2)=CC(O)=C2O)[C@H]([C@@H]([C@H]1COC(/C=C/C(C=C3)=CC(O)=C3O)=O)O)O[C@H](O[C@H]4C)[C@@H]([C@@H]([C@H]4O)O)O)=O,
E7449,UNII-9X5A2QIA7C,1140964-99-3,O=C1NN=C(N2)C3=C(C=CC=C31)N=C2CN(C4)CC5=C4C=CC=C5,
ML277,CID-53347902,1401242-74-7,O=C([C@@H]1N(S(=O)(C2=CC=C(C)C=C2)=O)CCCC1)NC3=NC(C4=CC=C(OC)C=C4)=CS3,
PF-543 hydrochloride,PF-543,1706522-79-3,OC[C@@H]1N(CC2=CC=C(COC3=CC(CS(=O)(C4=CC=CC=C4)=O)=CC(C)=C3)C=C2)CCC1.[H]Cl,
sbp-7455,,1884222-74-5,COC1=C(OC)C=CC(NC2=NC(NC3CC3)=C(C(F)(F)F)C=N2)=C1,
Terlipressin Acetate,Terlipressin diacetate anhydrous; Terlipressin acetate anhydrous,1884420-36-3,O=C([C@H](CSSC[C@@H](C(N[C@H](C1=O)CC2=CC=C(O)C=C2)=O)NC(CNC(CNC(CN)=O)=O)=O)NC([C@@H](NC([C@@H](NC([C@](N1)([H])CC3=CC=CC=C3)=O)CCC(N)=O)=O)CC(N)=O)=O)N(CCC4)[C@@H]4C(N[C@@H](CCCCN)C(NCC(N)=O)=O)=O.CC(O)=O.CC(O)=O,
APS6-45,,2188236-41-9,O=C(NC)C1=NC=CC(OC2=CC=C(NC(NC3=CC(C(C(F)(F)F)(F)C(F)(F)F)=CC=C3F)=O)C=C2)=C1,
I3MT-3,HMPSNE,459420-09-8,O=C1NC(SCC(C2=C3C=CC=CC3=CC=C2)=O)=NC(C)=C1,
4-MMPB,15-Lipoxygenase Inhibitor 1; 4-MMPB ,928853-86-5,CC1=C2C(=NC(=N1)N3CCN(CC3)C)SC4=CC=CC=C4N2,
TT-232 TFAï¼147159-51-1 free baseï¼,,2703745-48-4,C[C@H]([C@@H](C(N)=O)NC([C@@H]1CSSC[C@@H](C(N[C@H](C(N[C@@H](C(N[C@H](C(N1)=O)CCCCN)=O)Cc(c[nH]2)c3c2cccc3)=O)Cc4ccc(O)cc4)=O)NC([C@@H](Cc5ccccc5)N)=O)=O)O.C(=O)(C(F)(F)F)O,
MOTS-c(Human) Acetateï¼1627580-64-6 freeï¼,,TP2312,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)N.CC(O)=O,
Arimoclomol maleate,BRX-220,289893-26-1,Cl/C(C1=C[N+]([O-])=CC=C1)=N\OC[C@H](O)CN2CCCCC2.OC(/C=C\C(O)=O)=O,
Elexacaftor,VX-445,2216712-66-0,C[C@H]1CC(N(C1)C2=C(C=CC(=N2)N3C=CC(=N3)OCC(C)(C)C(F)(F)F)C(=O)NS(=O)(=O)C4=CN(N=C4C)C)(C)C,
RS102895 hydrochloride,,1173022-16-6,[H]Cl.O=C1NC2=CC=CC=C2C3(CCN(CCC4=CC=C(C(F)(F)F)C=C4)CC3)O1,
Amcenestrant,SAR439859,2114339-57-8,C1CC2=C(C=CC(=C2)C(=O)O)C(=C(C1)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)O[C@H]5CCN(C5)CCCF,
BI-749327,,2361241-23-6,NC1=NN=C(C2CCN(C(C3=CC=C(OC4=CC=C(C(F)(F)F)C=C4)C=C3)=O)CC2)C=C1,
BPK-29 hydrochloride,,2444815-73-8,C1CC(CCN(C1)C(=O)C2=CC=C(C=C2)N3CCOCC3)N(CC4=CC=CC=C4)C(=O)CCl.Cl,
Arhalofenate,MBX 102; JNJ 39659100,24136-23-0,CC(=O)NCCOC(=O)[C@@H](C1=CC=C(C=C1)Cl)OC2=CC=CC(=C2)C(F)(F)F,
"2,4-D","2,4-Dichlorophenoxyacetic acid; 2,4-D acid; Chloroxone; Chloroxone; Macondray; Hedonal",94-75-7,C1=CC(=C(C=C1Cl)Cl)OCC(=O)O,
Decloxizine,,3733-63-9,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=CC=C3,
PF-5274857,PF-5274857 freebase; PF-5274857; PF 5274857; PF5274857,1373615-35-0,CC1=CC(=C(N=C1)C2=CC(=NC=C2Cl)N3CCN(CC3)C(=O)CCS(=O)(=O)C)C,
LY-2584702 free base,,1082949-67-4,CN1C=C(N=C1C2CCN(CC2)C3=NC=NC4=C3C=NN4)C5=CC(=C(C=C5)F)C(F)(F)F,
RO2959 Hydrochloride,RO2959 HCl,1219927-22-6,CC1=C(CN(CC1)C2=NC=C(S2)C)C3=CN=C(C=N3)NC(=O)C4=C(C=CC=C4F)F.Cl,
Bractoppin,,2290527-07-8,O=C(N1CCN(CC2=CC=CC=C2F)CC1)C3=CC=C4NC(C5=CC=CC=C5)=NC4=C3,
IMT1,"LDC195943(IMT1); Propanamide, N,N-dimethyl-2-[[4-(2-methylphenyl)-2-oxo-2H-1-benzopyran-7-yl]oxy]-",2304621-31-4,CC1=CC=CC=C1C2=CC(=O)OC3=C2C=CC(=C3)OC(C)C(=O)N(C)C,
PROTAC BRAF-V600E degrader-1,,2417296-84-3,CCCS(=O)(NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C4=NC(N(C5CCN(C(CCOCCOCCOCCNC6=CC=CC(C(N7C(CC8)C(NC8=O)=O)=O)=C6C7=O)=O)CC5)C)=CC=C42)=C1F)=O,
(E/Z)-IT-603,IT603,292168-90-2,BrC1=CC(/C=C2NC(NC/2=O)=S)=C(O)C(OC)=C1,
AMG131,INT-131; AMG-131; CHS 131,315224-26-1,C1=CC=C2C(=C1)C=C(C=N2)OC3=C(C=C(C=C3Cl)NS(=O)(=O)C4=C(C=C(C=C4)Cl)Cl)Cl,
1-(4-methansulfinylphenyl)ethanone,,32361-73-2,CC(=O)C1=CC=C(C=C1)S(=O)C,
GW779439X,,551919-98-3,CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC=CC(=N3)C4=C5C=CC=NN5N=C4)C(F)(F)F,
AER-271,,634913-39-6,C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)OP(=O)(O)O,
Phthalazinone pyrazole,,880487-62-7,CC1=CC(NC(C2=C3C=CC=C2)=NN(C4=CC=CC=C4)C3=O)=NN1,
DTHIB,,897326-30-6,O=C(NC1=CC=C(F)C=C1)NC2=CC=C(Cl)C([N+]([O-])=O)=C2,
Isolinderalactone,,957-66-4,CC1=COC2=C1[C@H]3[C@H](C(=C)C(=O)O3)[C@@](C2)(C)C=C,
NEUROTENSIN TFA (39379-15-2 free base),Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OH TFAï¼55508-42-4 free base),TP2309,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]5CCC(=O)N5.C(=O)(C(F)(F)F)O,
(Rac)-JBJ-04-125-02,,2140807-05-0,C1CN(CCN1)C2=CC=C(C=C2)C3=CC4=C(CN(C4=O)C(C5=C(C=CC(=C5)F)O)C(=O)NC6=NC=CS6)C=C3,
CD73-IN-3,LY-3475070; EX-A4254,2375815-63-5,CC1=NN=C(C=C1[C@H]2C[C@@H]2C(C)C)C3=CNC(=O)NC3=O,
Graveoline,"2-(Benzo[d][1,3]dioxol-5-yl)-1-methylquinolin-4(1H)-one; Foliosine",485-61-0,CN1C2=CC=CC=C2C(=O)C=C1C3=CC4=C(C=C3)OCO4,
BI-882370,,1392429-79-6,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)N2C=C(C3=C2C=CC(=N3)N(C)C4CCN(CC4)CC)C5=CN=CN=C5)F,
Deoxyelephantopin,,29307-03-7,O=C(O[C@H]([C@]([H])([C@]([H])(OC1=O)C=C(C)C2)C1=C)CC3=C[C@@]2(OC3=O)[H])C(C)=C,
Pseudolaric acid A-O-Î²-D-glucopyranoside,Pseudolaric acid A-O-beta-D-glucopyranoside,98891-44-2,CC1=CC[C@]23CC[C@]([C@]2(CC1)CC(=O)C)([C@@](OC3=O)(C)/C=C/C=C(\C)/C(=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C,
8-Oxocoptisine,8-Oxycoptisine,19716-61-1,C1CN2C(=CC3=C(C2=O)C4=C(C=C3)OCO4)C5=CC6=C(C=C51)OCO6,
Tetramethylcurcumin,,52328-97-9,CC(C(=O)/C=C/C1=CC(=C(C=C1)OC)OC)(C(=O)/C=C/C2=CC(=C(C=C2)OC)OC)C,
Epertinib hydrochloride,S-22611 hydrochloride,2071195-74-7,CC#C/C(=N\OC[C@H]1COCCN1)/C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl.Cl,
Lerociclib dihydrochloride,G1T38 dihydrochloride,2097938-59-3,CC(C)N1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C=C5C(=O)NCC6(N5C4=N3)CCCCC6.Cl.Cl,
GNF4877,,2041073-22-5,CC(C)OC1=CC(=C(C=C1)F)C2=CN=C(C(=N2)C(=O)NC3=C(C=CN=C3)N4CCC[C@H](C4)C(=O)O)N,
DIDS sodium salt,MDL101114ZA,67483-13-0,C1=CC(=C(C=C1N=C=S)S(=O)(=O)[O-])/C=C/C2=C(C=C(C=C2)N=C=S)S(=O)(=O)[O-].[Na+].[Na+],
RegorafÃ©nib N-oxyde (M2),,835621-11-9,CNC(=O)C1=[N+](C=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F)[O-],
Quinoclamine,,2797-51-5,C1=CC=C2C(=C1)C(=O)C(=C(C2=O)Cl)N,
LAT1-IN-1,BCH,20448-79-7,C1CC2CC1CC2(C(=O)O)N,
Relacorilant,CORT 125134,1496510-51-0,CN1C=C(C=N1)S(=O)(=O)N2CCC3=CC4=C(C[C@@]3(C2)C(=O)C5=NC=CC(=C5)C(F)(F)F)C=NN4C6=CC=C(C=C6)F,
Tegoprazan,,942195-55-3,CC1=NC2=C(N1)C=C(C=C2O[C@H]3CCOC4=C3C(=CC(=C4)F)F)C(=O)N(C)C,
Vicenin 2,Vicenin -2,23666-13-9,C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C(=C3O2)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O,
Atraric acid,,4707-47-5,CC1=CC(=C(C(=C1C(=O)OC)O)C)O,
Terrestrosin D,,179464-23-4,C[C@@]12[C@]3([H])[C@](O[C@]4(CC[C@@H](C)CO4)[C@H]3C)([H])C[C@@]1([H])[C@@]5([H])[C@]([C@@]6([C@@](C[C@@H](O[C@]7([H])O[C@@H]([C@H](O[C@@]8([H])[C@@H]([C@H]([C@H](O)[C@@H](CO)O8)O[C@@]9([H])[C@@H]([C@H]([C@H](O)CO9)O)O)O[C@]%10([H])O[C@@H]([C@H](O)[C@H](O)[C@H]%10O)CO)[C@H](O)[C@H]7O)CO)CC6)([H])CC5)C)([H])CC2=O,
UCB9608,,1616413-96-7,C[C@H]1CN(CCN1C2=NC(=NC3=C2C=NN3C)N)C(=O)NC4=C(C=C(C=C4)OC)C,
Meranzin,,23971-42-8,COC1=CC=C(C=C2)C(OC2=O)=C1C[C@H](O3)C3(C)C,
Murrayone,,19668-69-0,O=C1C=CC2=CC=C(OC)C(CC(C(C)=C)=O)=C2O1,
Seneciphylline,,480-81-9,O=C(O[C@]1([H])CCN2[C@]1([H])C(COC([C@](C)(O)C(C/3)=C)=O)=CC2)C3=C/C,
Rubrofusarin gentiobioside,Rubrofusarin-6-O-beta-D-gentiobioside,24577-90-0,OC1=C2C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)CO[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)CO)=CC(OC)=CC2=CC5=C1C(C=C(C)O5)=O,
E-7386,,1799824-08-0,CCN1CCN(CC1)C2CN(C2)C3=CC=CC(=N3)CN4C[C@H]5N([C@H](C4=O)CC6=C(C=C(C=C6)O)F)C(=O)CN(N5C(=O)NCC7=CC=CC=C7)CC=C,
BAY-1797,,2055602-83-8,C1=CC=C(C=C1)CC(=O)NC2=CC(=C(C=C2)OC3=CC(=CC=C3)Cl)S(=O)(=O)N,
JNJ-10198409,JNJ-â10198409,627518-40-5,COC1=C(C=C2C(=C1)CC3=C2NN=C3NC4=CC(=CC=C4)F)OC,
TCPOBOP,,76150-91-9,ClC1=CN=C(OC2=CC=C(OC3=NC=C(Cl)C=C3Cl)C=C2)C(Cl)=C1,
Vericiguat,BAY1021189,1350653-20-1,COC(=O)NC1=C(N=C(N=C1N)C2=NN(C3=C2C=C(C=N3)F)CC4=CC=CC=C4F)N,
exo-IWR-1,,1127442-87-8,C1[C@@H]2C=C[C@H]1[C@H]3[C@@H]2C(=O)N(C3=O)C4=CC=C(C=C4)C(=O)NC5=CC=CC6=C5N=CC=C6,
Gemcitabine elaidate hydrochloride,CP-4126 hydrochloride; CO-101 hydrochloride; Gemcitabine 5'-elaidate hydrochloride; Gemcitabine elaidate hydrochloride(210829-30-4(free base)),2918768-08-6,O[C@@H](C(F)(F)[C@H](N1C(N=C(C=C1)N)=O)O2)[C@H]2COC(CCCCCCC/C=C/CCCCCCCC)=O.Cl,
"Î³-1-MSH, amide acetate (72629-65-3 free base)",,TP1002L,O=C(N[C@@H](CC(O)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(N)=O)CC1=CC=CC=C1)=O)=O)[C@@H](NC([C@H](CCCNC(N)=N)NC([C@@H](NC([C@@H](NC(CNC([C@H](CCSC)NC([C@H](C(C)C)NC([C@@H](N)CC2=CC=C(O)C=C2)=O)=O)=O)=O)CC3=CNC=N3)=O)CC4=CC=CC=C4)=O)=O)CC5=CNC6=C5C=CC=C6.CC(O)=O,
NITD-2,,1197896-79-9,O=C(O)C1=CC=CC=C1NS(=O)(C2=CC=CC(C3=CN(CC4=CC=CC=C4)N=C3)=C2)=O,
WEE1-IN-3,JUN76288; WEE1-IN-3,2272976-28-8,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC5=C(C=C4)C6(CC6)CN(C5)C)O,
TRPV4 agonist-1 free base,OUN67600,2314467-59-7,CN1CCN(CC1)C2=NC3=C(C=CC=C3F)C(=O)N2C4=CC=C(C=C4)OC5=CC=C(C=C5)F,
YUM70,,423145-35-1,O=C(CCC)NC(C1=CC=C2C(OCO2)=C1)C(C=C(Cl)C3=C4N=CC=C3)=C4O,
DC_AC50,,497061-48-0,NC1=C(SC2=C1C=C3CCCC3=N2)C(NC4=C(Br)C=C(C=C4F)F)=O,
4-Chloro-2'-bromoacetophenone,,536-38-9,C1=CC(=CC=C1C(=O)CBr)Cl,
3-demethylcolchicine,,7336-33-6,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)O,
2'MeO6MF,,89112-85-6,O=C1C=C(C2=CC=CC=C2OC)OC3=CC=C(C)C=C13,
6-Benzoylheteratisine,"Heteratisan-14-one, 6-(benzoyloxy)-20-ethyl-8-hydroxy-1-methoxy-4-meth",99759-48-5,CCN1C[C@@]2(CC[C@@H]([C@@]34[C@@H]2[C@@H]([C@@H]([C@H]31)[C@@]5(CC[C@H]6C[C@@H]4[C@@H]5C(=O)O6)O)OC(=O)C7=CC=CC=C7)OC)C,
PF-06869206,,2227425-05-8,CC1=C(C2=C(N1)C(=C(C(=N2)C(F)(F)F)C#N)N3CCO[C@@H](C3)CO)Cl,
Coumestrol,,479-13-0,C1=CC2=C(C=C1O)OC3=C2C(=O)OC4=C3C=CC(=C4)O,
Thapsigargin,,67526-95-8,CCCCCCCC(=O)O[C@H]1[C@H]2C(=C([C@@H]1OC(=O)/C(=C\C)/C)C)[C@H]3[C@]([C@H](C[C@]2(C)OC(=O)C)OC(=O)CCC)([C@](C(=O)O3)(C)O)O,
Quercimeritrin,Quercetin-7-O-beta-D-glucopyranoside,491-50-9,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O)O,
Cnidicin,,14348-21-1,CC(=CCOC1=C2C=COC2=C(C3=C1C=CC(=O)O3)OCC=C(C)C)C,
Marein,,535-96-6,C1=CC(=C(C=C1/C=C/C(=O)C2=C(C(=C(C=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O)O,
Norathyriol,,3542-72-1,C1=C(C=C2C(=C1O)C(=O)C3=CC(=C(C=C3O2)O)O)O,
Phenethyl ferulate,Caffeic Acid 3-Methyl Phenethyl Ester; Phenethyl ferulate,71835-85-3,O=C(OCCC1=CC=CC=C1)C=CC2=CC(OC)=C(O)C=C2,
Navitoclax-piperazine,ABT-263-piperazine,2143096-93-7,CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)N[C@H](CCN5CCNCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C,
"Pifithrin-Î±, p-Nitro, Cyclic",PFN-Î±,60477-38-5,C1CCC2=C(C1)N3C=C(N=C3S2)C4=CC=C(C=C4)[N+](=O)[O-],
AX-15836,,2035509-96-5,CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCN(CC3)C)NC4=NC=C5C(=N4)N(C6=CC=CC=C6C(=O)N5C)S(=O)(=O)C,
AZ1495,IRAK4-IN-28,2196204-23-4,C1CC(CCC1NC2=NC=NC3=C2C(=CN3)C4CCOCC4)N5CCOCC5,
AES-135,,2361659-61-0,CC(C)(C)C1=CC=C(C=C1)CN(C2=CC=C(C=C2)C(=O)NO)C(=O)CN(CC3=C(C(=C(C(=C3F)F)F)F)F)S(=O)(=O)C4=CC=C(C=C4)F,
CMPD101,,865608-11-3,CN1C(=NN=C1C2=CC=NC=C2)CNC3=CC=CC(=C3)C(=O)NCC4=CC=CC=C4C(F)(F)F,
G-1,,881639-98-1,CC(=O)C1=CC2=C(C=C1)NC(C3C2C=CC3)C4=CC5=C(C=C4Br)OCO5,
Solabegron,GW 427353,252920-94-8,C1=CC(=CC(=C1)C(=O)O)C2=CC(=CC=C2)NCCNC[C@@H](C3=CC(=CC=C3)Cl)O,
Sodium stibogluconate,Stibogluconate trisodium nonahydrate,16037-91-5,O=[Sb](O[C@]1([H])[C@H](O)CO)(O[C@@H](C(O)=O)[C@H]1O)O[Sb](O[C@]2([H])[C@H](O)CO)(O[C@@H](C(O)=O)[C@H]2O)=O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+],
Tenalisib,RP6530,1639417-53-0,CC[C@@H](C1=C(C(=O)C2=CC=CC=C2O1)C3=CC(=CC=C3)F)NC4=NC=NC5=C4NC=N5,
HPPH,Photochlor,149402-51-7,OC(CC[C@@H]([C@@H]1C)/C2=C(C3)/C4=C(C(C)=C(/C=C5C(CC)=C(C)C(/C=C6N/C(C(C)=C\6C(C)OCCCCCC)=C\C1=N2)=N/5)N4)C3=O)=O,
IMB-XH1,Mcl1-IN-2,292057-76-2,C1=CC=NC(=C1)NC(C2=C(C3=C(C=CC=N3)C=C2)O)C4=CC=CS4,
Remetinostat,SHP-141,946150-57-8,COC(=O)C1=CC=C(C=C1)OC(=O)CCCCCCC(=O)NO,
Maritoclax,Marinopyrrole A,1227962-62-0,C1=CC=C(C(=C1)C(=O)C2=CC(=C(N2C3=C(NC(=C3Cl)Cl)C(=O)C4=CC=CC=C4O)Cl)Cl)O,
Metarrestin,ML246,1443414-10-5,C1CC(CCC1N2C=NC3=C(C2=N)C(=C(N3CC4=CC=CC=C4)C5=CC=CC=C5)C6=CC=CC=C6)O,
SJ-172550,,431979-47-4,CCOC1=C(C(=CC(=C1)/C=C/2\C(=NN(C2=O)C3=CC=CC=C3)C)Cl)OCC(=O)OC,
TAS6417,,1661854-97-2,CC1=C[C@@H](CN2C1=C(C3=C(N=CN=C32)N)C4=CC5=CC=CC=C5N=C4)NC(=O)C=C,
(Z)-Guggulsterone,,39025-23-5,C/C=C/1\C(=O)C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,
ZL006,,1181226-02-7,C1=CC(=C(C=C1NCC2=C(C(=CC(=C2)Cl)Cl)O)O)C(=O)O,
Dendrophenol,SLIGRL-NH2 acetate,108853-14-1,COC1=CC(=CC(=C1O)OC)CCC2=CC(=C(C=C2)O)OC,
PP 3,,5334-30-5,C1=CC=C(C=C1)N2C3=NC=NC(=C3C=N2)N,
Cetraxate hydrochloride,Cetraxate HCl; DV 1006; DV-1006; DV1006; Cetraxate hydrochloride,27724-96-5,C1CC(CCC1CN)C(=O)OC2=CC=C(C=C2)CCC(=O)O.Cl,
"CTTHWGFTLC, CYCLIC acetate(244082-19-7  free base)",,TP1501L,C[C@@H](O)[C@H]1C(N[C@@H]([C@H](O)C)C(N[C@@H](CC2=CN=CN2)C(N[C@@H](CC3=CNC4=CC=CC=C43)C(NCC(N[C@@H](CC5=CC=CC=C5)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC(C)C)C(N[C@H](C(O)=O)CSSC[C@H](N)C(N1)=O)=O)=O)=O)=O)=O)=O)=O)=O.CC(O)=O,
NLS PKKKRKV acetate(95088-49-6  free base),,TP1606L,CC([C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H]1CCCN1)=O)CCCCN)=O)CCCCN)=O)CCCCN)=O)CCC/N=C(N)\N)=O)CCCCN)=O)C(O)=O)C.CC(O)=O,
MLS-573151,,10179-57-4,C1C(N(N=C1C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N)C4=CC=CC=C4,
Sepimostat,,103926-64-3,C1CN=C(N1)NC2=CC=C(C=C2)C(=O)OC3=CC4=C(C=C3)C=C(C=C4)C(=N)N,
Lipoic acid,"(R)-(+)-Î±-Lipoic acid; (R)-(+)-1,2-Dithiolane-3-pentanoic acid; R-(+)-Thioctic acid",1200-22-2,C1CSS[C@@H]1CCCCC(=O)O,
CID44216842,KUC103479N-02,1222513-26-9,O=S(C1=CC=C(N2N=C(C3=CC=CC(OC)=C3)CC2C4=CC=C(Br)C=C4)C=C1)(N)=O,
N-Desethylsunitinib hydrochloride,,1261432-05-6,O=C1C(C2=CC(F)=CC=C2N1)=CC(NC(C)=C3C(NCCNCC)=O)=C3C.Cl,
Vodobatinib,K-0706,1388803-90-4,CC1=C(C(=CC=C1)Cl)C(=O)NNC(=O)C2=CC(=C(C=C2)C)C#CC3=CC4=CC=CC=C4N=C3,
5-Ph-IAA,,168649-23-8,C1=CC=C(C=C1)C2=CC3=C(C=C2)NC=C3CC(=O)O,
BC1618,"2-Propanol, 1-[bis(phenylmethyl)amino]-3-[4-(trifluoromethyl)phenoxy]-",2222094-18-8,OC(COC1=CC=C(C(F)(F)F)C=C1)CN(CC2=CC=CC=C2)CC3=CC=CC=C3,
Pemafibrate,(R)-K-13675,848259-27-8,CC[C@H](C(=O)O)OC1=CC=CC(=C1)CN(CCCOC2=CC=C(C=C2)OC)C3=NC4=CC=CC=C4O3,
Cucurbitacin I,Elatericin B; JSI-124; NSC-521777,2222-07-3,CC(C)(C1=CC[C@@]2([H])[C@@]3(C[C@@H](O)[C@@H]([C@]3(C4)C)[C@@](C)(O)C(/C=C/C(C)(O)C)=O)C)C(C(O)=C[C@@]1([H])[C@]2(C)C4=O)=O,
Hexahydrocurcumin,,36062-05-2,O=C(CC(O)CCC1=CC=C(O)C(OC)=C1)CCC2=CC=C(O)C(OC)=C2,
Atranorin,,479-20-9,O=C(OC1=CC(C)=C(C(OC)=O)C(O)=C1C)C2=C(C)C=C(O)C(C=O)=C2O,
Glycycoumarin,,94805-82-0,O=C1C(C2=CC=C(O)C=C2O)=CC3=C(OC)C(C/C=C(C)\C)=C(O)C=C3O1,
Protohypericin,,548-03-8,O=C(C1=C(O)C=C(C)C=C1C2=C34)C3=C(O)C=C(O)C4=C5C(O)=CC(O)=C6C(C7=C(O)C=C(C)C=C7C2=C65)=O,
PTUPB,,1287761-01-6,C1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)CCCNC(=O)NC4=CC=C(C=C4)C(F)(F)F,
Tizaterkib,AZD-0364,2097416-76-5,CC1=CN=C(N=C1C2=CN3C[C@@H](N(C(=O)C3=N2)CC4=CC(=C(C=C4)F)F)COC)NC5=CC=NN5C,
Carboxyamidotriazole Orotate,L-651582 Orotate; CAI Orotate,187739-60-2,O=C(C(NC1=O)=CC(N1)=O)O.O=C(C2=C(N)N(CC3=CC(Cl)=C(C(C4=CC=C(Cl)C=C4)=O)C(Cl)=C3)N=N2)N,
DNA2 inhibitor C5,,35973-25-2,O=C(C1=C(O)C2=CC=CC([N+]([O-])=O)=C2N=C1)O,
GANT 58,NSC 75503,64048-12-0,C1(C2=C(C(C3=CC=NC=C3)=C(S2)C4=CC=NC=C4)C5=CC=NC=C5)=CC=NC=C1,
(R)-Elagolix,NBI-56418,834153-87-6,CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F,
BAY885,,2307249-33-6,CN1CCN(CC1)C2=CC3=C(C(=NC=N3)C4CCN(CC4)C(=O)C5=C(C=C(C=C5)OC(F)(F)F)N)N=C2,
IU1-47,,670270-31-2,CC1=CC(=C(N1C2=CC=C(C=C2)Cl)C)C(=O)CN3CCCCC3,
JPH203 dihydrochloride,KYT-0353 dihydrochloride,1597402-27-1,C1=CC=C(C=C1)C2=NC3=CC(=CC(=C3O2)COC4=C(C=C(C=C4Cl)C[C@@H](C(=O)O)N)Cl)N.Cl.Cl,
PRX-08066,,866206-54-4,C1CN(CCC1NC2=C3C=C(SC3=NC=N2)Cl)CC4=CC(=C(C=C4)F)C#N,
MARK4 inhibitor 1,,2271081-58-2,O=C(C1=CN(CC2=CC=C(OC)C=C2)N=N1)N\N=C3C4=CC=CC(C)=C4NC\3=O,
680C91,,163239-22-3,C1=CC(=CN=C1)/C=C/C2=CNC3=C2C=CC(=C3)F,
Rotigotine Hydrochloride,N-0923 Hydrochloride; N-0923; N-0924; Rotigotine Hydrochloride; Rotigotine HCl; Rotigotine (Hydrochloride),125572-93-2,OC1=C2CC[C@H](N(CCC)CCC3=CC=CS3)CC2=CC=C1.Cl,
MK 212 hydrochloride,,61655-58-1,C1CN(CCN1)C2=CN=CC(=N2)Cl.Cl,
SB-203186 hydrochloride,SB 203186 hydrochloride,207572-69-8,O=C(C1=CNC2=C1C=CC=C2)OCCN3CCCCC3.Cl,
GSK872 HClï¼1346546-69-7 free baseï¼,GSK2399872A,2703752-81-0,CC(C)S(=O)(=O)C1=CC2=C(C=CN=C2C=C1)NC3=CC4=C(C=C3)SC=N4.Cl,
Seralutinib,GB002,1619931-27-9,CC1=CC(=CN=C1)C(=O)NC2=CC=CC(=C2)[C@H](C)NC3=NC(=CN=C3)C4=CC(=C(C=C4)OC)OC,
TTA-A2,,953778-63-7,C[C@H](C1=NC=C(C=C1)OCC(F)(F)F)NC(=O)CC2=CC=C(C=C2)C3CC3,
MKC3946,,1093119-54-0,CN1CCN(CC1)C(=O)C2=CC=C(S2)C3=CC4=C(C=C3)C(=C(C=C4)O)C=O,
CDDO-Im,RTA-403; TP-235; CDDO-Imidazolide,443104-02-7,C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)C(=O)N6C=CN=C6,
Mitoquinone mesylate,MitoQ mesylate; MitoQ10 mesylate,845959-50-4,[O-]S(=O)(C)=O.O=C(C(CCCCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)=C4C)C(OC)=C(OC)C4=O,
Ilginatinib hydrochloride,NS-018 hydrochloride,1239358-85-0,C[C@@H](C1=CC=C(C=C1)F)NC2=CC(=CC(=N2)NC3=NC=CN=C3)C4=CN(N=C4)C.Cl,
Ilginatinib maleate,NS-018 maleate,1354799-87-3,C[C@@H](C1=CC=C(C=C1)F)NC2=CC(=CC(=N2)NC3=NC=CN=C3)C4=CN(N=C4)C.C(=C\C(=O)O)\C(=O)O,
Ilginatinib,NS-018,1239358-86-1,C[C@@H](C1=CC=C(C=C1)F)NC2=CC(=CC(=N2)NC3=NC=CN=C3)C4=CN(N=C4)C,
D-AP5,D-APV; D-2-Amino-5-phosphonovaleric acid,79055-68-8,C(C[C@H](C(=O)O)N)CP(=O)(O)O,
Dafadine-A,,1065506-69-5,CC1=C(C(=CC=C1)C)OCC2=CC(=NO2)C(=O)N3CCC(CC3)C4=CC=NC=C4,
Recilisib,Ex-RAD; ON 01210,334969-03-8,C1=CC(=CC=C1CS(=O)(=O)/C=C/C2=CC=C(C=C2)C(=O)O)Cl,
ROCK inhibitor-2,,1127308-52-4,O=C(N[C@@H](C1=CC=CC(OC)=C1)C)C2=CC=C(C3=CC=NC=C3)C=C2,
Golidocitinib,AZD4205,2091134-68-6,C[C@H](C(=O)NC1=CC=CC2=C1NC=C2C3=NC(=NC=C3)NC4=CN(N=C4OC)C)N5CCN(CC5)C,
CGS 15943,,104615-18-1,C1=COC(=C1)C2=NN3C(=N2)C4=C(C=CC(=C4)Cl)N=C3N,
FGFR1/DDR2 inhibitor 1,,2308497-58-5,CC1=C(C=C(C=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)C3=CC4=C(C=C3)C(=NN4)C5=CN(N=C5)C6CC6,
VTP50469,,2169916-18-9,CC(C)N(C(C)C)C(=O)C1=C(C=CC(=C1)F)OC2=CN=CN=C2N3CC4(C3)CCN(CC4)CC5CCC(CC5)NS(=O)(=O)C,
PF-04995274,,1331782-27-4,C1COC[C@@H]1OC2=CC=CC3=C2C(=NO3)OCC4CCN(CC4)CC5(CCOCC5)O,
PS210,,1221962-86-2,C1=CC=C(C=C1)C(CC(=O)C2=CC=C(C=C2)C(F)(F)F)C(C(=O)O)C(=O)O,
TX1-85-1,,1603845-32-4,CC(N1CCN(C2CCC(N3N=C(C4=CC(NC(C=C)=O)=C(OC5=CC=CC=C5)C=C4)C6=C3N=CN=C6N)CC2)CC1)=O,
UNC2541,,1612782-86-1,C1CCCNC2=NC=C(C(=N2)NCCCC[C@@H](C(=O)NCC1)N)C(=O)NCC3=CC=C(C=C3)F,
Polmacoxib,CG100649; CG-100649; CG 100649; polmacoxib,301692-76-2,CC1(C(=O)C(=C(O1)C2=CC=C(C=C2)S(=O)(=O)N)C3=CC(=CC=C3)F)C,
ML-191,,931695-79-3,CC1=CC=C(C=C1)C2(CC2)C(=O)N3CCC(CC3)N4C(=O)OC(=N4)C5=CC=CC=C5,
GSK3i XIII,GSK3i-XIII; GSK3iXIII; GSK3 inhibitor XIII,404828-08-6,CC1=CC(=NN1)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4,
"Phe-Met-Arg-Phe, amide acetate(64190-70-1 freebase)",,TP1858L,O=C(C)O.CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)N,
CVT-11127,,1018674-83-3,CC(=O)NCCN1C2=C(C=CC(=N2)NCC3=CC(=C(C=C3)Cl)Cl)N=C(C1=O)C4=CC=C(C=C4)OC,
AEM1,,1030123-90-0,C1OC2=C(O1)C=C(C=C2)CNC3=C4C(=CSC4=NC=N3)C5=CC=C(C=C5)F,
(6R)-FR054,FR054; (6R)-FR054,10378-06-0,CC1=N[C@@]([C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H](COC(C)=O)O2)([H])[C@@]2([H])O1,
FIT-039,,1113044-49-7,C1CCN(CC1)C2=C(C=C(C=C2)F)NC(=S)C3=CC=NC=C3,
Indophagolin,,1207660-00-1,O=S(C1=CC2=C(C=C1Br)CCN2C(C3CC3)=O)(NC4=CC=C(Cl)C(C(F)(F)F)=C4)=O,
4'-bromo-Resveratrol,,1224713-90-9,C1=CC(=CC=C1/C=C/C2=CC(=CC(=C2)O)O)Br,
SKI-178,,1259484-97-3,O=C(C1=CC(C2=CC=C(OC)C=C2)=NN1)N/N=C(C3=CC=C(OC)C(OC)=C3)\C,
ON1231320,GBO-006,1312471-39-8,CN1C2=NC(=NC=C2C=C(C1=O)S(=O)(=O)C3=C(C=C(C=C3)F)F)NC4=CC5=C(C=C4)NC=C5,
BRD6688,,1404562-17-9,C1CCN(C1)C(=O)NC2=C(C=CC(=C2)C3=CC=NC=C3)N,
JNJ-47965567,JNJ-479655,1428327-31-4,O=C(C1=CC=CN=C1SC2=CC=CC=C2)NCC3(N4CCN(C5=CC=CC=C5)CC4)CCOCC3,
Soticlestat,OV935; TAK-935,1429505-03-2,C1CN(CCC1(CC2=CC=CC=C2)O)C(=O)C3=C(N=CC=C3)C4=CC=NC=C4,
FLTX1,,1481401-71-1,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C3=CC=C(C4=NON=C34)[N+](=O)[O-])C5=CC=CC=C5,
BC-â1258,BC-1258,1507370-40-2,C1=CC(=CC=C1CNCCNCC2=CC=C(C=C2)C3=NC=CS3)C4=NC=CS4,
Imidazenil,,151271-08-8,C1C2=C(N=CN2C3=C(C=C(C=C3)F)C(=N1)C4=CC=CC=C4Br)C(=O)N,
MONNA,,1572936-83-4,COC1=CC(=CC2=CC=CC=C21)NC3=C(C=C(C=C3)[N+](=O)[O-])C(=O)O,
"5-ETHYL-4,5,6,7-TETRAHYDRO-THIAZOLO[5,4-C]PYRIDIN-2-YLAMINE",,17899-49-9,CCN1CCC2=C(C1)SC(=N2)N,
PD-089828,PD 089828; PD-089828; PD089828,179343-17-0,CC(C)(C)NC(=O)NC1=C(C=C2C=NC(=NC2=N1)N)C3=C(C=CC=C3Cl)Cl,
CA-4948,Emavusertib; CA-4948,1801344-14-8,CC1=NC=CC(=C1)C2=NC(=CO2)C(=O)NC3=CC4=C(N=C3N5CC[C@H](C5)O)N=C(O4)N6CCOCC6,
ICCB-19 hydrochloride,ICCB-19 HClï¼750621-52-4 free baseï¼; ,1803605-68-6,C1CCCC(CC1)NC(=O)CSC2=NCCN2.Cl,
AZD9977,AZD 9977,1850385-64-6,CNC(=O)C[C@H]1COC2=C(N1C(=O)C3=CC4=C(C=C3)OCC(=O)N4)C=CC(=C2)F,
SU4984,,186610-89-9,C1CN(CCN1C=O)C2=CC=C(C=C2)C=C3C4=CC=CC=C4NC3=O,
DD1,"3,3'-Diamino-4'-methoxyflavone; HUN85111",187585-11-1,COC1=C(C=C(C=C1)C2=C(C(=O)C3=CC=CC=C3O2)N)N,
HPK1-IN-2,"Thieno[2,3-b]pyridin-6(7H)-one, 4-amino-5-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-HPK1-IN-2",2056122-11-1,O=C1C(C2=NC3=CC=C(N4CCN(C)CC4)C=C3N2)=C(N)C(C=CS5)=C5N1,
LY900009,,209984-68-9,C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2C3=CC=CC=C3N(C1=O)C)NC(=O)[C@H](C(C)C)O,
KY19382,"2H-Indol-2-one, 5,6-dichloro-3-[1,3-dihydro-3-(methoxyimino)-2H-indol-2-ylidene]-1,3-dihydro-Ky19382; A3051",2226664-93-1,CO/N=C\1/C2=CC=CC=C2N=C1C3=C(NC4=CC(=C(C=C43)Cl)Cl)O,
ICA-105574,ICA; 3-nitro-N-[4-phenoxyphenyl]-benzamide,316146-57-3,C1=CC=C(C=C1)OC2=CC=C(C=C2)NC(=O)C3=CC(=CC=C3)[N+](=O)[O-],
AS1269574,AS 1269574; AS1269574,330981-72-1,CC1=CC(=NC(=N1)C2=CC=C(C=C2)Br)NCCO,
NCGC00262650,,344359-25-7,COC1=CC=C(C=C1)C2=CN(C3=NC=NC(=C23)N)C4CCCC4,
API-1,NSC177223,36707-00-3,C1=C(C(=O)C2=C(N=CN=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)C(=O)N,
SW155246,,420092-79-1,C1=CC=C2C(=C1)C(=CC=C2O)NS(=O)(=O)C3=CC(=C(C=C3)Cl)[N+](=O)[O-],
PCNA-I1,,444930-42-1,CC1=C(SC=C1)C(=O)N/N=C/C2=C(C3=CC=CC=C3C=C2)O,
2-AMINO-5-PHENYL-THIOPHENE-3-CARBOXYLIC,,4815-35-4,C1=CC=C(C=C1)C2=CC(=C(S2)N)C(=O)N,
"methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate",,517870-17-6,COC1=C(C=C(C=C1)C2=CC(=NO2)C(=O)OC)OC,
Testosterone undecanoate,,5949-44-0,CCCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,
OUL35,NSC39047,6336-34-1,C1=CC(=CC=C1C(=O)N)OC2=CC=C(C=C2)C(=O)N,
Kv2-IN-A1,RY785,689297-68-5,CC(CC(=O)NC1=CC2=C(C=C1)N=C(N2)C3=CSC=N3)C4=CC(=CC=C4)Cl,
NPD8733,,696655-62-6,CC(=O)NC1=C(OC2=CC=CC=C21)C(=O)C3=CC=C(C=C3)OC,
CFI-400945,,1338806-73-7,C[C@@H]1CN(C[C@@H](O1)C)CC2=CC=C(C=C2)/C=C/C3=NNC4=C3C=CC(=C4)[C@@H]5C[C@]56C7=C(C=CC(=C7)OC)NC6=O,
Zimlovisertib,PF06650833; PF-06650833,1817626-54-2,CC[C@H]1[C@H](NC(=O)[C@H]1F)COC2=NC=CC3=CC(=C(C=C32)OC)C(=O)N,
Angeloylgomisin H,,66056-22-2,COc1cc2C[C@H](C)[C@@](C)(O)Cc3cc(OC)c(OC)c(OC)c3-c2c(OC(=O)C(\C)=C/C)c1OC,
Maohuoside A,,128988-55-6,O=C1C(O)=C(C2=CC=C(OC)C=C2)OC3=C(CCC(C)(O)C)C(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)=CC(O)=C13,
Platycodin D3,,67884-03-1,OC(C(C(OC1C(C(C(O)CO1)OC2C(C(CO)(O)CO2)O)O)C(C)O3)O)C3OC(C(C(O)CO4)O)C4OC(C56C(CC(C)(C)CC6)C7=CCC(C8(C(C(CO)(C(OC9OC(C(O)C(O)C9O)COC%10OC(C(O)C(O)C%10O)CO)C(O)C8)CO)CC%11)C)C%11(C)C7(C)CC5O)=O,
Pratensein,,2284-31-3,COC1=C(C=C(C=C1)C2=COC3=CC(=CC(=C3C2=O)O)O)O,
MIM1,Inhibitor of Mcl-1,509102-00-5,OC1=C(O)C(/C=N/N2/C(SC=C2C)=N/C3CCCCC3)=CC=C1O,
Samuraciclib hydrochloride,CT7001 hydrochloride; ICEC0942 hydrochloride,1805789-54-1,CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NC[C@H]4CCNC[C@@H]4O.Cl,
Dehydroaripiprazole,OPC-14857; DM-14857,129722-25-4,O=C1NC2=C(C=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=C2)C=C1,
Borussertib,,1800070-77-2,C=CC(=O)NC1=CC2=C(C=C1)NC(=O)N2C3CCN(CC3)CC4=CC=C(C=C4)C5=C(C=C6C(=N5)C=CNC6=O)C7=CC=CC=C7,
Pyropheophorbide-a,Ppa,24533-72-0,CC1=C2C(N/C1=C\3)=C(CC2=O)C([C@H]4CCC(O)=O)=N/C([C@H]4C)=C\C5=C(C)C(C=C)=C(N5)/C=C6C(C)=C(CC)C3=N/6,
Eact,,461000-66-8,COCCN(C1=NC(=CS1)C2=CC=CC=C2)C(=O)C3=CC(=C(C(=C3)OC)OC)OC,
Eleclazine hydrochloride,GS 6615 hydrochloride,1448754-43-5,C1COC2=C(C=C(C=C2)C3=CC=C(C=C3)OC(F)(F)F)C(=O)N1CC4=NC=CC=N4.Cl,
Upamostat,WX-671,590368-25-5,CCOC(=O)N1CCN(CC1)C(=O)[C@H](CC2=CC(=CC=C2)/C(=N/O)/N)NS(=O)(=O)C3=C(C=C(C=C3C(C)C)C(C)C)C(C)C,
CDDO-dhTFEA,RTA dh404,1191265-33-4,C[C@@]12CC[C@@H]3[C@@]([C@H]1CC(=O)[C@H]4[C@]2(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)NCC(F)(F)F)C)(C=C(C(=O)C3(C)C)C#N)C,
HBX 19818,,1426944-49-1,CN(CCCNC(=O)C1=CC2=C(C=C1)N=C3CCCCC3=C2Cl)CC4=CC=CC=C4,
IPI-3063,,1425043-73-7,C[C@@H](C1=CC2=C(C(=CC=C2)C3=CN(C(=O)C=C3)C)C(=O)N1C(C)C)NC4=NC=NC(=C4C#N)N,
NU6140,,444723-13-1,CCN(CC)C(C(C=C1)=CC=C1NC2=NC(OCC3CCCCC3)=C4C(N=CN4)=N2)=O,
Ritanserin,R 55667,87051-43-2,CC1=C(C(N(C=CS2)C2=N1)=O)CCN(CC/3)CCC3=C(C4=CC=C(F)C=C4)\C5=CC=C(F)C=C5,
TAO Kinase inhibitor 1,,850467-66-2,O=C(CNC(C1=CC=C(C2=CC=CC=C2)C=C1)=O)NC(CCC3)C4=C3C=CC=C4,
YKL-05-099,,1936529-65-5,CC1=C(C(=CC=C1)Cl)N2CC3=CN=C(N=C3N(C2=O)C4=NC=C(C=C4)OC)NC5=C(C=C(C=C5)C6CCN(CC6)C)OC,
Phenylephrine,(R)-(-)-Phenylephrine; L-Phenylephrine,59-42-7,O[C@H](C1=CC(O)=CC=C1)CNC,
Gaultherin,,490-67-5,COC(C1=C(C=CC=C1)O[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO[C@H]3[C@@H]([C@H]([C@@H](CO3)O)O)O)=O,
Ardisiacrispin A,Deglucocyclamin; LTS-4; Saxifragifolin B,23643-61-0,[H][C@@]1(O[C@@H]2[C@H]([C@@H]([C@H](O[C@]2(O[C@H]3CO[C@@](O[C@@H]4C(C)([C@@]([H])([C@@]5(CC4)C)CC[C@@]6(C)[C@@](C)([C@@]7(CC[C@@]65[H])OC8)C[C@H]([C@]98[C@]7(C[C@@](C=O)(CC9)C)[H])O)C)([C@@H]([C@@H]3O)O[C@@]%10([H])[C@@H]([C@H]([C@@H]([C@H](O%10)CO)O)O)O)[H])[H])CO)O)O)OC[C@H]([C@@H]([C@H]1O)O)O,
Segetalin B,,164991-89-3,C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC2=CNC3=CC=CC=C32)C)C(C)C,
Strophanthidin,Strophanthidine,66-28-4,C[C@]12CC[C@H]3[C@H]([C@]1(CC[C@@H]2C4=CC(=O)OC4)O)CC[C@]5([C@@]3(CC[C@@H](C5)O)C=O)O,
ODQ,,41443-28-1,O=C1ON=C2N1C3=C(C=CC=C3)N=C2,
Dacomitinib hydrate,PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804,1042385-75-0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4.O,
CRT0066101 dihydrochloride(956121-30-5 free base),,2308510-39-4,OC(C=CC(Cl)=C1)=C1C2=NC(C=CC=C3)=C3C(NC[C@H](N)CC)=N2.Cl.Cl,
LY3143921 hydrate,,1627696-53-0,C[C@]1(C2=C(C=C(C=C2)C3=CNN=C3)C(=O)N1)C4=NC=NC=C4F.O,
EGFR/ErbB-2/ErbB-4 inhibitor-2,EGFR/ErbB2 Inhibitor,179248-61-4,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)OCC4=CC=CC=C4)OC,
squarunkinA,,2101958-02-3,CCOC(=O)N1CCC(CC1)NC2=C(C(=O)C2=O)NCCN3CCN(CC3)C4=CC=CC(=C4)C(F)(F)F,
XL092,JUN04542; CL-092,2367004-54-2,CNC(=O)C1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,
BTYNB,MDK6620; BTYNB IMP1 Inhibitor; BTYNB,304456-62-0,C1=CC=C(C(=C1)C(=O)N)N=CC2=CC=C(S2)Br,
MK2-IN-3,MK2 Inhibitor III,724711-21-1,C1CNC(=O)C2=C1NC(=C2)C3=CC(=NC=C3)C4=CC5=CC=CC=C5N=C4,
PRL-3 Inhibitor I,BR-1; PRL-3 Inhibitor,893449-38-2,C1=CC=C(C(=C1)COC2=C(C=C(C=C2)Br)/C=C/3\C(=O)NC(=S)S3)Br,
Cintirorgon,LYC-55716,2055536-64-4,CC(C)(C[C@H]1CN(C2=C(O1)C=CC(=C2)C3=CC(=CC(=C3)F)OC(F)F)S(=O)(=O)C4=CC=CC(=C4)C(F)(F)F)C(=O)O,
Dihydromethysticin,(+)-Dihydromethysticin,19902-91-1,O=C1C=C(OC)C[C@H](CCC2=CC=C(OCO3)C3=C2)O1,
Tricin,,520-32-1,O=C1C=C(C2=CC(OC)=C(O)C(OC)=C2)OC3=CC(O)=CC(O)=C13,
Tormentic acid,,13850-16-3,OC([C@]12[C@]([C@](O)([C@H](C)CC2)C)([H])C3=CC[C@@]([C@@]4([C@@](C(C)([C@@H](O)[C@H](O)C4)C)([H])CC5)C)([H])[C@]5(C)[C@]3(C)CC1)=O,
Asperulosidic acid,ASPA,25368-11-0,OC[C@H]([C@@H](O)[C@H](O)[C@H]1O)O[C@@]1([H])O[C@H]2[C@@]3([H])[C@@]([C@@H](O)C=C3COC(C)=O)([H])C(C(O)=O)=CO2,
Cimiracemoside C,Cimicifugoside M,256925-92-5,C[C@]12[C@@]3([H])[C@@]4(CC[C@@]1([C@]5([H])C(O[C@H](C(C)(O)C)[C@@]6([H])C[C@H]5C)(O6)[C@@H]2O)C)[C@@]7([C@@](C(C)([C@@H](O[C@@]8([H])[C@@H]([C@H]([C@@H](O)CO8)O)O)CC7)C)([H])CC3)C4,
Karacoline,,39089-30-0,O[C@@H]1C23C4C([C@]5(O)[C@]6([H])[C@@]3([H])C[C@@]([C@@H](OC)C5)([H])[C@@H]6O)C[C@]2([H])[C@@](CN4CC)(C)CC1,
Soyasapogenol B,,595-15-3,C[C@]12[C@]3(C([C@@]4([H])[C@](C)([C@@H](CC(C)(C)C4)O)CC3)=CC[C@]1([H])[C@@]5([C@@]([C@](C)([C@@H](O)CC5)CO)([H])CC2)C)C,
"5Î±-Pregnane-3Î²,6Î±-diol-20-one",,21853-11-2,C[C@@]12[C@]3([H])[C@](C[C@H](O)[C@@]1([H])C[C@@H](O)CC2)([H])[C@@]4([H])[C@@](C)([C@@H](C(C)=O)CC4)CC3,
QX-314 chloride,,5369-03-9,O=C(NC1=C(C)C=CC=C1C)C[N+](CC)(CC)CC.[Cl-],
Succinyl phosphonate trisodium salt,,864167-45-3,O=C(O[Na])CCC(P(O[Na])(O[Na])=O)=O,
Pictilisib dimethanesulfonate,GDC-0941 dimethanesulfonate; GDC-0941 2 MeSO3H salt,957054-33-0,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6.CS(=O)(=O)O.CS(=O)(=O)O,
NSC781406,,1676893-24-5,FC1=CC(F)=CC=C1S(=O)(NC2=CC(C3=CC=C(N=CC=C4C#CCN5CCN(S(C)(=O)=O)CC5)C4=C3)=CN=C2OC)=O,
Netarsudil hydrochloride,AR-13324 Dihydrochloride,1253952-02-1,CC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)[C@@H](CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C.Cl.Cl,
PF-3644022,,1276121-88-0,O=C1C2=C(NC[C@@H](C)N1)C3=C(C=CC4=NC(C5=CN=C(C)C=C5)=CC=C34)S2,
Rhosin hydrochloride,,1281870-42-5,O=C(N/N=C/C1=CC=C2N=CC=NC2=C1)[C@H](N)CC3=CNC4=C3C=CC=C4.Cl,
Mito-TEMPO,,1334850-99-5,[O]N1C(C)(C)CC(NC(C[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)=O)CC1(C)C.[Cl-],
Valemetostat,DS-3201,1809336-39-7,CC1=CC(=C(C(=O)N1)CNC(=O)C2=CC(=C3C(=C2C)O[C@@](O3)(C)C4CCC(CC4)N(C)C)Cl)C,
(1E)-CFI-400437 dihydrochloride,CFI-400437 dihydrochloride,1247000-76-5,CN1CCN(CC1)C2=NC=C(C=C2)/C=C/C3=C4C=CC(=CC5=C(NC6=C5C=C(C=C6)OC)O)C=C4N=N3.Cl.Cl,
JNJ-38158471,CS-2660; JNJ-38158471,951151-97-6,CCNC(=O)NC1=C(C=C(C=C1)OC2=NC=NC(=C2/C=N/OC)N)Cl,
Voacamine,Voacanginine,3371-85-5,O=C(C1(C(C(C2)CC)N3CC2C1)C4=C(CC3)C(C=C(OC)C([C@H](CC(/C(CN5C)=C/C)C(C(OC)=O)[C@H]5C6)C7=C6C(C=CC=C8)=C8N7)=C9)=C9N4)OC,
Rubiadin-1-methyl ether,Rubiadin 1-methyl ether; Rubiadin-1-methyl ether,7460-43-7,O=C1C2=C(C=CC=C2)C(C3=CC(O)=C(C)C(OC)=C13)=O,
Vasicinone,,486-64-6,C1CN2C(=NC3=CC=CC=C3C2=O)[C@H]1O,
Sulforaphene,,592-95-0,O=S(/C=C/CCN=C=S)C,
Tomatidine,,77-59-8,[H][C@]1(O[C@]2(NC[C@@H](C)CC2)[C@H]3C)C[C@@]4([H])[C@]5([H])CC[C@@]6([H])C[C@@H](O)CC[C@]6(C)[C@@]5([H])CC[C@]4(C)[C@]13[H],
Hydroxyfasudil,HA-1100; Hydroxy-Fasudil,105628-72-6,O=C1NC=CC2=C1C=CC=C2S(=O)(N3CCNCCC3)=O,
Î³-Tocotrienol,gamma-Tocotrienol; Plastochromanol; D-gamma-Tocotrienol; gamma-Tocotrienol; gamma Tocotrienol; gammaTocotrienol,14101-61-2,OC1=C(C)C(C)=C2C(CC[C@](CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/C)(C)O2)=C1,
Cetrorelix diacetate,NS-75A diacetate; SB-075 diacetate; Cetrorelix diacetate,130143-01-0,C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C.CC(=O)O.CC(=O)O,
Nemifitide acetate(173240-15-8 free base),INN 00835 acetate,TP1127L1,O=C(N[C@H](C(NCC(N[C@H](C(N)=O)CC1=CNC2=CC=CC=C21)=O)=O)CCC/N=C(N)\N)[C@H]3N(C([C@@H](N)CC4=CC=C(F)C=C4)=O)C[C@H](O)C3.CC(O)=O,
LY3405105,"1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester",2326428-25-3,O=C(N1CCC(NC2=CC(C)=NC3=C(C(C)C)C=NN23)CC1)OC4CN(C(/C=C/CN(C)C)=O)CC4,
Tuxobertinib,BDTX-189,2414572-47-5,C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)OCCN5CCOCC5,
Aurora kinase inhibitor-2,Aurora Kinase Inhibitor II; IUN-70219,331770-21-9,O=C(NC1=CC=C(NC2=C3C=C(OC)C(OC)=CC3=NC=N2)C=C1)C4=CC=CC=C4,
AS-041164,,6318-41-8,O=C(N1)/C(SC1=O)=C/C2=CC=C3C(OCO3)=C2,
ASP2905,ASP-2905,792184-90-8,FC1=CC=C(NC2=NC(NC3=CC=CC=C3)=NC(NCC4=NC=CC=N4)=N2)C=C1,
"1,4-Cineole",Isocineole,470-67-7,CC(C12CCC(O2)(C)CC1)C,
A-317491,ABT 202,475205-49-3,O=C(C1=CC(C(N(CC2=CC=CC(OC3=CC=CC=C3)=C2)[C@H]4CCCC5=C4C=CC=C5)=O)=C(C(O)=O)C=C1C(O)=O)O,
SH5-07,,1456632-41-9,O=C(NO)C1=CC=C(N(CC2=CC=C(C3CCCCC3)C=C2)C(CN(C)S(=O)(C4=C(F)C(F)=C(F)C(F)=C4F)=O)=O)C=C1,
Uzansertib phosphate,INCB053914 phosphate,2088852-47-3,O=C(C1=NC(C2=C(F)C=CC=C2F)=C(F)C=C1)NC3=CN=C4C(CC[C@H]4O)=C3N5C[C@@H](N)[C@H](O)[C@@H](C)C5.O=P(O)(O)O,
DT2216,,2365172-42-3,CC1(C)CCC(C2=CC=C(Cl)C=C2)=C(C1)CN3CCN(C4=CC=C(C(NS(=O)(C5=CC(S(C(F)(F)F)(=O)=O)=C(N[C@@H](CSC6=CC=CC=C6)CCN7CCN(C(CCCCCC(N[C@@H](C(C)(C)C)C(N8[C@@H](C[C@@H](O)C8)C(N[C@H](C9=CC=C(C%10=C(N=CS%10)C)C=C9)C)=O)=O)=O)=O)CC7)C=C5)=O)=O)C=C4)CC3,
Lucitanib,E-3810,1058137-23-7,O=C(NC)C1=C2C=CC(OC3=CC=NC4=CC(OCC5(N)CC5)=C(OC)C=C34)=CC2=CC=C1,
Estrogen receptor modulator 1,,63676-22-2,OC1=CC=C(C=C(C2=CC=C(O)C=C2)S3)C3=C1,
Indotecan,LMP-400; NSC-724998,915303-09-2,O=C1N(CCCN2CCOCC2)C3=C(C(C4=C3C=C(OCO5)C5=C4)=O)C6=C1C=C(OC)C(OC)=C6,
Testosterone acetate,NSC 523836; NSC-523836; NSC523836,1045-69-8,C[C@@]12CCC[C@@]1([H])[C@]3([H])CCC4=CC(C(OC(C)=O)C[C@]4(C)[C@@]3([H])CC2)=O,
Tenapanor,AZD-1722; AZD 1722; AZD1722; RDX 5791; RDX-5791; RDX5791,1234423-95-0,O=S(C1=CC=CC([C@@H]2CN(C)CC3=C2C=C(Cl)C=C3Cl)=C1)(NCCOCCOCCNC(NCCCCNC(NCCOCCOCCNS(=O)(C4=CC=CC([C@@H]5CN(C)CC6=C5C=C(Cl)C=C6Cl)=C4)=O)=O)=O)=O,
Tocainide,,41708-72-9,CC(N)C(NC1=C(C)C=CC=C1C)=O,
Liarozole,R75251 dihydrochloride,115575-11-6,ClC1=CC(C(C2=CC=C3NC=NC3=C2)N4C=CN=C4)=CC=C1,
TC11,"1H-Isoindole-1,3(2H)-dione, 5-amino-2-[2,6-bis(1-methylethyl)phenyl]-TC11; CLT-003",100823-03-8,CC(C)C1=C(C(=CC=C1)C(C)C)N2C(=O)C3=C(C2=O)C=C(C=C3)N,
Ganirelix Acetate,,123246-29-7,CCN/C(NCC)=N/CCCC[C@@H](NC([C@@H](NC([C@@H](NC([C@H](NC([C@H](NC([C@H](NC(C)=O)CC1=CC2=CC=CC=C2C=C1)=O)CC3=CC=C(Cl)C=C3)=O)CC4=CN=CC=C4)=O)CO)=O)CC5=CC=C(O)C=C5)=O)C(N[C@H](C(N[C@H](C(N6CCC[C@H]6C(N[C@@H](C(N)=O)C)=O)=O)CCCC/N=C(NCC)/NCC)=O)CC(C)C)=O.CC(O)=O,
NMS-P118,,1262417-51-5,O=C(C1=CC(F)=CC(CN2C3CCN(C4CCC(F)(F)CC4)CC3)=C1C2=O)N,
L-765314,,189349-50-6,O=C(N1[C@H](C(NC(C)(C)C)=O)CN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)OCC4=CC=CC=C4,
Deoxythymidine-5'-triphosphate trisodium,thymidine 5'-(trisodium hydrogen triphosphate); Deoxythymidine-5'-triphosphate (dTTP) trisodium salt; dTTP trisodium salt,27821-54-1,O=C1N(C=C(C(N1)=O)C)[C@]2([H])O[C@@H]([C@H](C2)O)COP(OP(OP(O)(O[Na])=O)(O[Na])=O)(O[Na])=O,
BVDV-IN-1,,345651-04-9,OCCN1CCN(C2=C3C=CC=CC3=NC(C4=CC=CC=C4)=N2)CC1,
norbergenin,,79595-97-4,O=C1C2=CC(O)=C(O)C(O)=C2[C@@]3([H])[C@]([C@@H](O)[C@H](O)[C@@H](CO)O3)([H])O1,
NY2267,"Acetic acid, 2-[[6-[2-(cyclohexylamino)-1-[[(4-methoxyphenyl)methyl](2-pyridinylcarbonyl)amino]-2-oxoethyl]-2-naphthalenyl]oxy]-, 1,1-dimethylethyl ester",886053-73-2,O=C(OC(C)(C)C)COC1=CC=C2C=C(C(N(CC3=CC=C(OC)C=C3)C(C4=NC=CC=C4)=O)C(NC5CCCCC5)=O)C=CC2=C1,
AS1810722,,909561-15-5,O=C(N)CN1CCN(C2=CC=C(NC3=NC=C4C(N(CC5=CC(F)=CC(F)=C5)C=C4)=N3)C=C2)CC1,
SR-3677,,1072959-67-1,CN(C)CCOC1=C(NC(C2OC(C=CC=C3)=C3OC2)=O)C=CC(C4=CNN=C4)=C1,
ETP-46321,,1252594-99-2,NC1=NC=C(C2=CN3C(C(N4CCOCC4)=N2)=NC(CN5CCN(S(=O)(C)=O)CC5)=C3)C=N1,
Traxoprodil,CP101606,134234-12-1,OC1(C2=CC=CC=C2)CCN([C@@H](C)[C@@H](O)C3=CC=C(O)C=C3)CC1,
Onjisaponin B,,35906-36-6,OC[C@](C1=CC[C@]2([H])[C@]3(C[C@H](O)[C@@H]4O[C@]([C@@H]([C@@H](O)[C@@H]5O)O)([H])O[C@@H]5CO)C)(CC[C@]6(C(O[C@H](O[C@H](C)[C@H](OC(/C=C/C7=CC=C(OC)C=C7)=O)[C@@H]8O[C@@](O[C@@H](C)[C@H](O)[C@H]9O)([H])[C@@H]9O)[C@@H]8O[C@@](O[C@@H](C)[C@H](O[C@@](OC[C@@H](O[C@]([C@@H]([C@@H](O)[C@H]%10O)O)([H])O[C@@H]%10CO)[C@@H]%11O)([H])[C@@H]%11O)[C@H]%12O)([H])[C@@H]%12O)=O)[C@@]1([H])CC(C)(C)CC6)[C@@]2(CC[C@@]3([H])[C@]4(C)C(O)=O)C,
(-)-Butin,,492-14-8,O=C1C[C@@H](C2=CC=C(O)C(O)=C2)OC3=CC(O)=CC=C13,
Decursinol angelate,,130848-06-5,C/C=C(C)\C(O[C@H]1CC(C=C(C=CC(O2)=O)C2=C3)=C3OC1(C)C)=O,
BOS-172722,,1578245-44-9,CC1=CC2=CN=C(NC3=CC=C(C4=NN=CN4C)C=C3OCC)N=C2C(NCC(C)(C)C)=N1,
SNDX-5613,,2169919-21-3,O=C(C1=CC(F)=CC=C1OC2=CN=CN=C2N3CC4(C3)CCN(CC4)C[C@H]5CC[C@@H](CC5)NS(=O)(CC)=O)N(C(C)C)CC,
CEP-28122 mesylate salt (1022958-60-6 free base),,T10759,COC1=C(C=CC2=C1CC[C@H](CC2)N3CCOCC3)NC4=NC=C(C(N[C@@H]5[C@@H]6C[C@H]([C@@H]5C(N)=O)C=C6)=N4)Cl.CS(=O)(O)=O,
IMD-0560,,439144-66-8,O=C(NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F)C2=CC(Br)=CC=C2O,
MKC8866,,1338934-59-0,O=CC1=C(O)C(OC)=CC2=C1OC(C(CC(N3CCOCC3)=O)=C2C)=O,
KJ Pyr 9,,581073-80-5,O=C(N)C1=CC=C(C2=CC(C3=CC=CO3)=NC(C4=CC=C([N+]([O-])=O)C=C4)=C2)C=C1,
Maytansinol,Ansamitocin P-0,57103-68-1,C[C@]1([C@H](CC(N(C(C=C2C=C3OC)=C3Cl)C)=O)O)[C@H]([C@@H]([C@](OC4=O)([H])C[C@]([C@](/C=C/C=C(C)/C2)([H])OC)(N4)O)C)O1,
RX-3117,TV-1360; fluorocyclopentenylcytosine,865838-26-2,OCCC#CC1=NC(C2=CC=C(F)C=C2)=C(C3=CC=NC=C3)N1CCCC4=CC=CC=C4,
Bavdegalutamide,ARV-110,2222112-77-6,ClC1=CC(O[C@H]2CC[C@@H](CC2)NC(C3=CC=C(N=N3)N4CCC(CC4)CN5CCN(CC5)C6=CC(C(N7C8CCC(NC8=O)=O)=O)=C(C=C6F)C7=O)=O)=CC=C1C#N,
Etalocib,LY293111; VML295,161172-51-6,O=C(O)C1=CC=CC=C1OC2=CC=CC(OCCCOC3=C(CC)C=C(C4=CC=C(F)C=C4)C(O)=C3)=C2CCC,
DR2313,DR 2313,284028-90-6,O=C(N=C(C)N1)C2=C1CCSC2,
Levolansoprazole,(S)-Lansoprazole; (-)-Lansoprazole,138530-95-7,Cc1c(C[S@@](c([nH]2)nc3c2cccc3)=O)nccc1OCC(F)(F)F,
VU0071063,VU-0071063; VU 0071063,333415-38-6,O=C(N1C)N(C)C2=C(N(CC3=CC=C(C(C)(C)C)C=C3)C=N2)C1=O,
Topovale,Topoval; ARC 111; ARC111; ARC-111,500214-53-9,COC1=C(OC)C=C(C(N(CCN(C)C)C2=C3C=NC4=C2C=C(OCO5)C5=C4)=O)C3=C1,
NF-ÎºB-IN-1,"1,6-Heptadiene-3,5-dione, 1,7-bis(3,4-dimethoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methylene]-, (1E,6E)-",1227098-15-8,O=C(/C=C/C(C=C1)=CC(OC)=C1OC)/C(C(/C=C/C(C=C2)=CC(OC)=C2OC)=O)=C/C(C=C3)=CC(OC)=C3O,
ZYN57939,MTR-106,1639357-93-9,O=C1C(C(NCC2=NC=C(N=C2)C)=O)=C(SC3=CC=CC=C34)N4C5=NC(C6C[C@@](CN(C)C7)([H])[C@@]7([H])C6)=CC=C15,
FTO-IN-1,UUN44923; FTO-IN-1,2243944-92-3,O=C(NO)C1=CC=CC=C1NC2=C(Cl)C=C(C3=C(C)NN=C3C)C=C2Cl,
AES-350,,847249-57-4,CC(C)(C)C1=CC=C(C(NC2=CC=C(C(NO)=O)C=C2)=O)C=C1,
SAR131675,SAR 131675Â ,1433953-83-3,O=C1C(C(NC)=O)=C(N)N(CC)C2=NC(C#C[C@@](COC)(C)O)=CC=C21,
GNE-131,,1629063-81-5,O=S(C1CC1)(NC2=NN=C3C=C(OCC45CC6CC(C5)CC(C6)C4)C(C7CC7)=CN32)=O,
Levcromakalim,(-)-Cromakalim; BRL 38227,94535-50-9,CC(O1)(C)[C@@H](O)[C@H](N2CCCC2=O)C3=C1C=CC(C#N)=C3,
Inulicin,1-O-Acetylbritannilactone,33627-41-7,O[C@H]1[C@@](C2=C)([H])[C@@](OC2=O)([H])CC(C)=C1[C@@H](C)CCCOC(C)=O,
NVP-CGM097,CGM097,1313363-54-0,O=C1N(C2=CC=C(N(C)C[C@H]3CC[C@H](N4CC(N(C)CC4)=O)CC3)C=C2)[C@@H](C5=CC=C(Cl)C=C5)C6=C(C=C(OC)C(OC(C)C)=C6)C1,
Chrysoeriol,,491-71-4,O=C1C=C(C2=CC=C(O)C(OC)=C2)OC3=CC(O)=CC(O)=C13,
Phyllanthin,,10351-88-9,COC[C@@H](CC1=CC=C(OC)C(OC)=C1)[C@@H](COC)CC2=CC=C(OC)C(OC)=C2,
DL-Norepinephrine hydrochloride,DL-lysine; Lys,55-27-6,OC1=CC=C(C(O)CN)C=C1O.[H]Cl,
BMS-986158,,1800340-40-2,OC(C)(C)C1=CC=C2C(N([C@H](C3=CC=CC=C3)C4CCOCC4)C5=C2N=CC(C6=C(C)N=NN6C)=C5)=C1,
Centrinone,LCR-263,1798871-30-3,CC1=CC(NC2=NC(SC3=CC=C(S(=O)(CC4=CC=CC([N+]([O-])=O)=C4F)=O)C=C3F)=NC(N5CCOCC5)=C2OC)=NN1,
Cl-amidine hydrochloride,,1373232-26-8,O=C(N[C@H](C(N)=O)CCCNC(CCl)=N)C1=CC=CC=C1.[H]Cl,
FLT3-IN-3,,2229050-90-0,N[C@H](CC1)CC[C@@H]1NC2=NC3=C(N=CN3C4CCCC4)C(NC5=CC=C(CN6CCOCC6)C=C5)=N2,
Batabulin,T138067,195533-53-0,O=S(C1=C(F)C(F)=C(F)C(F)=C1F)(NC2=CC=C(OC)C(F)=C2)=O,
BRD0705,,2056261-41-5,O=C1CC(C)(C)CC2=C1[C@@](CC)(C3=CC=CC=C3)C4=CNNC4=N2,
Zinc Protoporphyrin,Zn(II)-protoporphyrin IX; ZnPP; Zinc Protoporphyrin-9,15442-64-5,OC(CCC1=C(C=C2[N]3=C4C(C)=C2CCC(O)=O)[N-]([Zn+2]35[N]6=C7C=C(C(C=C)=C8C)[N-]5C8=C4)C(C=C6C(C=C)=C7C)=C1C)=O,
MBQ-167,,2097938-73-1,CCN1C2=C(C3=C1C=CC=C3)C=C(N4N=NC=C4C5=CC=CC=C5)C=C2,
Nimbolide,,25990-37-8,C[C@]12[C@@]3([H])[C@](OC([C@@]3(C=CC2=O)C)=O)([H])[C@]4([H])[C@]([C@@H]1CC(OC)=O)(C5=C(C)[C@@](C6=COC=C6)([H])C[C@@]5([H])O4)C,
Ogerin,,1309198-71-7,OCC1=C(C2=NC(N)=NC(NCC3=CC=CC=C3)=N2)C=CC=C1,
Org-26576,,1026791-61-6,O=C1N2[C@](CCC2)([H])COC3=NC=CC=C13,
OTX008,Calixarene 0118; PTX008,286936-40-1,O=C(NCCN(C)C)COC1=C(C2)C=CC=C1CC3=C(OCC(NCCN(C)C)=O)C(CC4=CC=CC(CC5=CC=CC2=C5OCC(NCCN(C)C)=O)=C4OCC(NCCN(C)C)=O)=CC=C3,
Voreloxin hydrochloride,Vosaroxin; SNS-595 hydrochloride,175519-16-1,[H]Cl.O=C(C1=CN(C2=NC=CS2)C3=C(C=CC(N4C[C@H](OC)[C@@H](NC)C4)=N3)C1=O)O,
DPO-1,,43077-30-1,O=P(C1=CC=CC=C1)(C2=CC=CC=C2)[C@@H]3[C@H](C(C)C)CC[C@@H](C)C3,
Teriflunomide impurity 3,4-Amino-N-(4-trifluoromethylphenyl)benzamide,1011244-72-6,O=C(NC1=CC=C(C(F)(F)F)C=C1)C2=CC=C(N)C=C2,
CCG-100602,,1207113-88-9,ClC1=CC=C(NC(C2CN(C(C3=CC(C(F)(F)F)=CC(C(F)(F)F)=C3)=O)CCC2)=O)C=C1,
CP-31398 dihydrochloride,CP 31398 dihydrochloride,1217195-61-3,CN(C)CCCNC1=C2C=CC=CC2=NC(/C=C/C3=CC=C(OC)C=C3)=N1.[H]Cl.[H]Cl,
AG-636,,1623416-31-8,O=C(C1=C(N(C)N=N2)C2=CC(C3=CC=C(C4=CC=CC=C4C)C=C3)=C1)O,
Epoxyazadiradione,,18385-59-6,C[C@@]1([C@]2([C@@]3([H])O2)[C@]4(C)[C@H](OC(C)=O)C[C@@]5([H])C(C)(C)C(C=C[C@]5(C)[C@@]4([H])CC1)=O)[C@H](C6=COC=C6)C3=O,
XL177A,,2417089-74-6,O=C(NC1=CC(N=CN2CC3(O)CCN(C([C@H](CC4=CC=CC=C4)CCCNC(C5=CC(N=C(CCCC6)C6=C7Cl)=C7C=C5)=O)=O)CC3)=C(C=C1)C2=O)CCN8CCN(C)CC8,
Gedunin,,2753-30-2,O=C1O[C@H](C2=COC=C2)[C@@]3(C)[C@]4([C@]5(C)[C@@H](CC3)[C@@](C)(C=C6)[C@@H](C(C)(C)C6=O)C[C@@H]5OC(C)=O)O[C@@H]41,
Caroverine hydrochloride,Caroverine HCL,55750-05-5,O=C1N(CCN(CC)CC)C2=C(C=CC=C2)N=C1CC3=CC=C(OC)C=C3.[H]Cl,
"Benzonitrile, 3,3'-[(2-oxo-1,3-cyclohexanediylidene)dimethylidyne]bis- (9CI)",,63476-70-0,O=C(/C(CCC/1)=C/C2=CC(C#N)=CC=C2)C1=C\C3=CC=CC(C#N)=C3,
JAK/HDAC-IN-1,,2284621-75-4,ONC(CCCCCn1ncc(Nc(nc2)nc(Nc(cc3)ccc3Cl)c2Cl)c1)=O,
Lifirafenib,Beigene-283; BGB-283,1446090-79-4,O=C1Nc2nccc(Oc(cc3)cc(C45)c3OC4C5c3nc(ccc(C(F)(F)F)c4)c4[nH]3)c2CC1,
Tesevatinib,XL-647; EXEL-7647;  KD-019,781613-23-8,CN1C[C@H](CC(COc(cc(c2c3)ncnc2Nc(c(F)c2Cl)ccc2Cl)c3OC)C2)[C@H]2C1,
(Â±)-Cannabichromene,Cannabichromene; Cannabichrome,20675-51-8,CCCCCc1cc(OC(C)(CCC=C(C)C)C=C2)c2c(O)c1,
Serotonin,5-hydroxytryptamine,50-67-9,NCCc1c[nH]c(cc2)c1cc2O,
3-Acetyl-beta-boswellic acid,3-O-Acetyl-beta-boswellic acid; 3-Acetyl-beta-boswellic acid,5968-70-7,C[C@H]1[C@H](C)[C@H]2C3=CC[C@H]([C@@](C)(CC[C@H]4OC(C)=O)[C@@H](CC5)[C@@]4(C)C(O)=O)[C@]5(C)[C@]3(C)CC[C@@]2(C)CC1,
Continentalic acid,,19889-23-7,C[C@](CCC1)([C@@H](CC2)[C@@]1(C)C(O)=O)[C@@H](CC1)C2=C[C@]1(C)C=C,
Kudinoside D,,173792-61-5,C[C@@H]([C@@H]([C@H]([C@H]1O)O)O)O[C@H]1O[C@H]([C@H]1O[C@@H]([C@@H]([C@H]2O)O)O[C@H](CO)[C@H]2O)[C@H](O[C@@H](CC2)C(C)(C)[C@H](CC[C@@]3(C)[C@]4(C)CC5)[C@@]2(C)[C@H]3C=CC4=C([C@@](C)(C(C)(CC2)O3)O)[C@@]25C3=O)OC[C@H]1O,
Pseudobufarenogin,Ï-Bufarenogin,17008-69-4,C[C@]([C@H](CC1)C(C=C2)=COC2=O)([C@H](C([C@@H]([C@H]2CC3)[C@@](C)(CC4)[C@H]3C[C@H]4O)=O)O)[C@@]12O,
Evocarpine,,15266-38-3,CCCCC=CCCCCCCCC(N(C)c1c2cccc1)=CC2=O,
Ergolide,,54999-07-4,C[C@H](C[C@@H]([C@H]([C@@H]1OC(C)=O)C2=C)OC2=O)[C@H](CC2)[C@@]1(C)C2=O,
Mitraphylline,,509-80-8,C[C@@H]([C@@H]1[C@@H]2C[C@@H]([C@@](CC3)(c(cccc4)c4N4)C4=O)N3C1)OC=C2C(OC)=O,
Gypsogenin,639-14-5,639-14-5,CC(C)(CC1)C[C@H]2C3=CC[C@H]([C@@](C)(CC[C@@H]4O)[C@@H](CC5)[C@]4(C)C=O)[C@]5(C)[C@]3(C)CC[C@]12C(O)=O,
XL228,,898280-07-4,CC(C)c1noc(CNc2nc(N3CCN(C)CC3)cc(Nc3n[nH]c(C4CC4)c3)n2)c1,
NS3623,,343630-41-1,O=C(Nc1cc(C(F)(F)F)ccc1)Nc(ccc(Br)c1)c1-c1n[nH]nn1,
Vamorolone,VBP15,13209-41-1,C[C@H](C[C@@H]([C@@H]1CC2)[C@]3(C)CC=C1[C@@](C)(C=C1)C2=CC1=O)[C@@]3(C(CO)=O)O,
4F 4PP oxalate,,144734-36-1,OC(C(O)=O)=O.FC1=CC=C(C(C2CCN(CC2)CCCCC3=CC=CC=C3)=O)C=C1,
Aurintricarboxylic acid,ATA; NSC-4056; NSC 4056; NSC4056,4431-00-9,OC(c(cc(cc1)C(c(cc2)cc(C(O)=O)c2O)=C(C=C2)C=C(C(O)=O)C2=O)c1O)=O,
FPL64176,FPL 64176,120934-96-5,Cc1c(C(c2c(Cc3ccccc3)cccc2)=O)c(C(OC)=O)c(C)[nH]1,
VER-49009,CCT 129397,558640-51-0,CCNC(c([nH]nc1-c(c(O)c2)cc(Cl)c2O)c1-c(cc1)ccc1OC)=O,
ERK-IN-3,ASN007 free base,2055597-12-9,O=C(C1=CN(C2=NC(NC3CCOCC3)=NC=C2C)C=N1)N[C@@H](C4=CC(F)=CC(Cl)=C4)CN,
Bigelovin,,3668-14-2,C[C@H](C[C@@H]([C@H]([C@@H]([C@]12C)OC(C)=O)C3=C)OC3=O)[C@@H]2C=CC1=O,
LB-100,,1026680-07-8,CN1CCN(C(C(C2CCC3O2)C3C(O)=O)=O)CC1,
Licofelone,ML-3000,156897-06-2,CC(C)(C1)Cn(c(CC(O)=O)c2-c(cc3)ccc3Cl)c1c2-c1ccccc1,
Indirubin-3â²-oxime,Indirubin-3-monoxime,667463-82-3,Oc([nH]c1c2cccc1)c2-c([nH]c1c2cccc1)c2N=O,
8-Azaadenosine,,10299-44-2,Nc1c2nnn([C@@H]([C@@H]3O)O[C@H](CO)[C@H]3O)c2ncn1,
BSJ-4-116,,2519823-34-6,O=C(NCCCCCCCN1C[C@H](NC2=NC=C(Cl)C(NC3=CC=CC=C3S(=O)(C(C)C)=O)=N2)CCC1)COC4=CC=CC(C(N5C(CC6)C(NC6=O)=O)=O)=C4C5=O,
NS 11021,NS11021; NS 11021,956014-19-0,FC(c1cc(NC(Nc(ccc(Br)c2)c2-c2n[nH]nn2)=S)cc(C(F)(F)F)c1)(F)F,
MYLS22,,306959-01-3,Cc(c1c2sc(C(NC(C3=O)=C(C)N(C)N3c3ccccc3)=O)c1)nn2-c1ccccc1,
TRC051384,,1333327-56-2,O=C(NC1=CC=C(C(/C=C/C2=NC(N3CCOCC3)=CC=C2)=O)C=C1)NCCN4CCOCC4,
NP-G2-044,,1807454-59-6,Cc(occ1)c1C(Nc1nn(Cc2ccc(C(F)(F)F)cc2)c2c1cccc2)=O,
Î±-Lipoic Acid,Lipoic acid,62-46-4,O=C(O)CCCCC1SSCC1,
Lorediplon,,917393-39-6,CC(N(C)c(cc(cc1)-c(n2nc3)ccnc2c3C(c2cccs2)=O)c1F)=O,
Ningetinib Tosylate,,1394820-77-9,O=C(C1=C(C)N(C)N(C2=CC=CC=C2)C1=O)NC3=CC=C(OC4=CC=NC5=CC(OCC(C)(O)C)=CC=C45)C(F)=C3.CC6=CC=C(S(=O)(O)=O)C=C6,
BAY-1436032,,1803274-65-8,C[C@@H](C1)CC(C)(C)C[C@@H]1n1c(Nc(cc2)ccc2OC(F)(F)F)nc2c1ccc(CCC(O)=O)c2,
JPH203,KYT-0353,1037592-40-7,N[C@@H](Cc(cc1Cl)cc(Cl)c1OCc1c2oc(-c3ccccc3)nc2cc(N)c1)C(O)=O,
ROCK-IN-2,Azaindole 1; TC-S 7001; ROCK-IN-2,867017-68-3,Cc1c[nH]c2nccc(Oc(c(F)cc(Nc3cc(Cl)nc(N)n3)c3)c3F)c12,
Grapiprant,CJ-023423; RQ-00000007; AAT-007,415903-37-6,CCc1nc(c(C)nc(C)c2)c2n1-c1ccc(CCNC(NS(c2ccc(C)cc2)(=O)=O)=O)cc1,
GSK163090,,844903-58-8,Cc1ccc(c(N2CCN(CCc3cccc(N(CCN4)C4=O)c3)CC2)ccc2)c2n1,
"3,29-O-Dibenzoyloxykarounidiol",,389122-01-4,CC1(C)[C@H](OC(C2=CC=CC=C2)=O)CC[C@]3(C)C4=CC[C@@]5(C)[C@]6([H])C[C@](C)(COC(C7=CC=CC=C7)=O)CC[C@@](C)6CC[C@@](C)5C4=CC[C@@]13[H],
Keracyanin chloride,Cyanidin-3-O-rutinoside chloride; Cyanidin 3-rutinoside chloride; Cyanidin 3-O-rutinoside chloride,18719-76-1,OC1=C2C([O+]=C(C3=CC(O)=C(O)C=C3)C(O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)CO[C@H]5[C@@H]([C@@H]([C@@H](O)[C@H](C)O5)O)O)=C2)=CC(O)=C1.[Cl-],
Morellic acid,,5304-71-2,CC(C)(C(CC1C=C23)C33Oc(c(CC=C(C)C)c4OC(C)(C)C=Cc4c4O)c4C2=O)OC3(CC=C(C)C(O)=O)C1=O,
8-Deoxygartanin,,33390-41-9,CC(C)=CCc(c(O)c(CC=C(C)C)c(Oc1c2cccc1O)c1C2=O)c1O,
8-Geranyloxypsoralen,,7437-55-0,CC(C)=CCCC(C)=CCOc(c(occ1)c1cc1C=C2)c1OC2=O,
Cannabigerol,,25654-31-3,CCCCCc1cc(O)c(C/C=C(\C)/CCC=C(C)C)c(O)c1,
Diallyl disulfide,,2179-57-9,C=CCSSCC=C,
Gardenin B,,2798-20-1,O=C1C=C(OC2=C(OC)C(OC)=C(OC)C(O)=C12)C=3C=CC(OC)=CC3,
Hypophyllanthin,,33676-00-5,COC[C@H](Cc1c2)[C@H](COC)[C@@H](c(cc3)cc(OC)c3OC)c1c1OCOc1c2OC,
Isomerazin,Isomeranzin; Isomerazin,1088-17-1,CC(C)C(Cc(c(O1)c(cc2)C=CC1=O)c2OC)=O,
Kaempferol 3-neohesperidoside,Kaempferol 3-O-neohesperidoside,32602-81-6,C[C@@H]([C@@H]([C@H]([C@H]1O)O)O)O[C@H]1O[C@H]([C@H]1O)[C@H](OC2=C(c(cc3)ccc3O)Oc(cc(cc3O)O)c3C2=O)O[C@H](CO)[C@H]1O,
Kahweol,,6894-43-5,C[C@]1([C@@H]2CC[C@](C3)(C4)[C@H]1CC[C@H]3[C@]4(CO)O)C=Cc1c2cco1,
Meranzin hydrate,,5875-49-0,CC(C)([C@@H](Cc(c(O1)c(cc2)C=CC1=O)c2OC)O)O,
Pinoresinol,(+)-Pinoresinol,487-36-5,COc(cc([C@H]1OC[C@@H]2[C@@H](c(cc3)cc(OC)c3O)OC[C@H]12)cc1)c1O,
Sarracenin,,59653-37-1,CC(C1C2C3)OC3OC1OC=C2C(OC)=O,
Xanthyletin,,553-19-5,CC1(C)Oc2cc(OC(C=C3)=O)c3cc2C=C1,
ORM-15341,,1297537-33-7,C[C@@H](Cn(cc1)nc1-c(cc1)cc(Cl)c1C#N)NC(c1cc(C(C)=O)n[nH]1)=O,
"2,2,5,7,8-Pentamethyl-6-Chromanol",PMC,950-99-2,CC(C)(CC1)Oc(c(C)c2C)c1c(C)c2O,
C527,,192718-06-2,O=C(c1c2oc(-c(cc3)ccc3F)n1)c(cccc1)c1C2=O,
CC-90003,,1621999-82-3,Cc(cc1)cc(NC(C=C)=O)c1Nc1c(C(F)(F)F)cnc(Nc2c(C)cnc(OC)c2)n1,
SU3327,,40045-50-9,Nc1nnc(Sc2ncc([N+]([O-])=O)s2)s1,
Tipepidine hydrochloride,,1449686-84-3,CN1C/C(CCC1)=C(C2=CC=CS2)\C3=CC=CS3.[H]Cl,
CSF1R-IN-2,,2271119-26-5,N#CC1=C2CN(CC)C(C=C3)=NC(N3N=C4N)=C4C(NC[C@H](C)OC2=CC=C1F)=O,
UT-155,,2031161-35-8,C[C@](Cn(cc1)c(cc2)c1cc2F)(C(Nc(cc1)cc(C(F)(F)F)c1C#N)=O)O,
Vabicaserin hydrochloride,SCA 136,887258-94-8,C(C[C@H]1C2)C[C@@H]1c1c3N2CCNCc3ccc1.Cl,
Centanafadine hydrochloride,EB-1020 hydrochloride,923981-14-0,[H][C@@]12CNC[C@]1(C3=CC=C4C=CC=CC4=C3)C2.[H]Cl,
ITI-214,ITI214,1642303-38-5,O=C(C1=C(NC2=CC=CC=C2)N(CC3=CC=C(C4=NC(F)=CC=C4)C=C3)N=C1N56)N(C)C5=N[C@@]7([H])[C@]6([H])CCC7.O=P(O)(O)O,
LUT014,,2274819-46-2,Cc1ccc2c(Nc3cccc(OC(F)(F)F)c3)nccc2c1Nc1ncccc1-c1ncnc2c1[nH]cn2,
Oteseconazole,VT-1161,1340593-59-0,O[C@](Cn1nnnc1)(C(c(cc1)ncc1-c(cc1)ccc1OCC(F)(F)F)(F)F)c(ccc(F)c1)c1F,
Quarfloxin,CX-3543,865311-47-3,CN1C(CCN=C(C(C(c2cc(F)c3N(CC4)CC4c4nccnc4)=O)=CN4c2c3Oc2cc3ccccc3cc24)O)CCC1,
S 3304,,203640-27-1,Cc(cc1)ccc1C#Cc(s1)ccc1S(N[C@H](Cc1c[nH]c2c1cccc2)C(O)=O)(=O)=O,
Temanogrel,APD791,887936-68-7,Cn1nccc1-c(cc(cc1)NC(c2cc(OC)ccc2)=O)c1OCCN1CCOCC1,
PF-6274484,PF 6274484,1035638-91-5,COc(cc(c1c2)ncnc1Nc(cc1)cc(Cl)c1F)c2NC(C=C)=O,
Octahydrocurcumin,,36062-07-4,COc(cc(CCC(CC(CCc(cc1)cc(OC)c1O)O)O)cc1)c1O,
Actein,,18642-44-9,C[C@]12[C@]3([C@]4([C@]5(C4)[C@@](CC3)(C(C)(C)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)CO6)CC5)[H])C[C@@H](OC(C)=O)[C@]1(C)[C@@]7([C@](C2)(O[C@@]8(C[C@H]7C)[C@]9([C@](C)(O9)[C@@H](O)O8)[H])[H])[H])[H],
SR 57227A,SR 57227 hydrochloride,77145-61-0,ClC1=NC(N2CCC(N)CC2)=CC=C1.[H]Cl,
Ethionine,L-Ethionine; ETH; NSC 82393; NSC-82393; NSC82393,13073-35-3,CCSCC[C@@H](C(O)=O)N,
E1231,,1031195-19-3,CC(N(CC1)CCN1C(c1cc(-c2ccc(C)o2)nc2ccccc12)=O)=O,
Teplinovivint,,1428064-91-8,O=C(C1=NNC2=C1C=C(C3=CC(CN4CCCCC4)=CN=C3)C=C2)NC5=CC=C(OC)N=C5,
Angoline,6-Methoxyldihydrochelerythrine,21080-31-9,CN(C1OC)c2c(cc3OCOc3c3)c3ccc2-c(cc2)c1c(OC)c2OC,
Î²-Damascone,Damascone,23726-91-2,CC1(C)C(C(/C=C/C)=O)=C(C)CCC1,
STM2457,,2499663-01-1,O=C(C(N=C1N2C=CC=C1)=CC2=O)NCC3=CN4C=C(CNCC5CCCCC5)C=CC4=N3,
Telekin,,6752-90-5,C[C@@](CCCC1=C)(C[C@H]([C@H](C2)C3=C)OC3=O)[C@@]12O,
FGFR4-IN-1,,1708971-72-5,COCCNc1cc(NC(N2c3nc(C=O)c(CN(CCOC4)C4=O)cc3CCC2)=O)ncc1C#N,
Procyanidin A1,Proanthocyanidin A1,103883-03-0,O[C@@H](C1)[C@@H](c(cc2)cc(O)c2O)Oc2c1c(O)cc1c2[C@H]([C@@H]2O)c(c(O)cc(O)c3)c3O[C@@]2(c(cc2)cc(O)c2O)O1,
D-Menthol,(+)-MENTHOL; Menthol,15356-60-2,CC(C)[C@@H](CC[C@H](C)C1)[C@H]1O,
"N6,N6-Dimethyladenosine",,2620-62-4,CN(C)c1c2ncn([C@@H]([C@@H]3O)O[C@H](CO)[C@H]3O)c2ncn1,
MP7,PDK1 inhibitor,1001409-50-2,O=C(C1=CC=CN(Cc(cc2)cc(F)c2F)C1=O)N[C@@H](COc(cc1)cc(N2)c1NC2=O)c1ccccc1,
2OH-BNPP1,,833481-73-5,CC(C)(C)n1nc(Cc(cccc2)c2O)c2c(N)ncnc12,
AZD5423,,1034148-04-3,O=C(N[C@@H](C)[C@H](OC1=CC2=C(N(C3=CC=C(F)C=C3)N=C2)C=C1)C4=CC=CC(OC)=C4)C(F)(F)F,
BNC105,,945771-74-4,Cc1c(C(c(cc2OC)cc(OC)c2OC)=O)c(ccc(OC)c2O)c2o1,
Afoxolaner,,1093861-60-9,O=C(CNC(c1ccc(C(C2)=NOC2(C(F)(F)F)c2cc(C(F)(F)F)cc(Cl)c2)c2ccccc12)=O)NCC(F)(F)F,
DPA-714,,958233-07-3,CCN(CC)C(Cc1c2nc(C)cc(C)n2nc1-c(cc1)ccc1OCCF)=O,
Evenamide,NW-3509,1092977-61-1,CCCCOc1cccc(CCNCC(N(C)C)=O)c1,
Dilmapimod,SB-681323; GW 681323,444606-18-2,Cc(cc(cc1)F)c1-c1c(C=CC(N2c(c(F)ccc3)c3F)=O)c2nc(NC(CO)CO)n1,
Subasumstat,TAK-981; Subasumstat,1858276-04-6,Cc1c([C@@H]2NCCc(cc3)c2cc3Cl)cc(C(c2c(N[C@H](C[C@@H]3COS(N)(=O)=O)C[C@@H]3O)ncnc2)=O)s1,
Tebuconazole,,107534-96-3,CC(C)(C)C(CCc(cc1)ccc1Cl)(Cn1ncnc1)O,
Isoguanine,,3373-53-3,O=C1NC2=C(NC=N2)C(N)=N1,
Lotilaner,,1369852-71-0,Cc1c(C(NCC(NCC(F)(F)F)=O)=O)sc(C(C2)=NO[C@]2(C(F)(F)F)c(cc2Cl)cc(Cl)c2Cl)c1,
RWJ-67657,JNJ 3026582,215303-72-3,OCCC#Cc1nc(-c(cc2)ccc2F)c(-c2ccncc2)n1CCCc1ccccc1,
Mutated EGFR-IN-1,Osimertinib analog,1421372-66-8,NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C,
GSK2643943A,,2449301-27-1,FC1=CC=CC(/C=C/C2=CC(NC(N)=C3C#N)=C3C=C2)=C1,
LY518674,LY-674,425671-29-0,CC(C)(C(O)=O)Oc1ccc(CCCC(N2)=NN(Cc3ccc(C)cc3)C2=O)cc1,
RG7800,RO6885247,1449598-06-4,CCc(c1c2)nc(C)cn1nc2C(N=C1N2C=C(C3CCN(C)CC3)C=C1C)=CC2=O,
Zamicastat,BIA 5-1058,1080028-80-3,Fc(cc1F)cc(C2)c1OC[C@@H]2N(C(CCNCc1ccccc1)=CN1)C1=S,
Giredestrant,GDC-9545,1953133-47-5,C[C@H](Cc1c2[nH]c3c1cccc3)N(CC(CO)(F)F)[C@@H]2c(c(F)cc(NC1CN(CCCF)C1)c1)c1F,
Maytansine,NSC153858; NSC 153858; NSC-153858; maytansine; Maitansine; Maitansina,35846-53-8,CC(C(OC(CC(N(C)c1cc(CC(C)=CC=CC(C(C2)(N3)O)OC)cc(OC)c1Cl)=O)C1(C)OC1C(C)C2OC3=O)=O)N(C)C(C)=O,
SB 204741,,152239-46-8,Cc1nsc(NC(Nc(cc2)cc3c2n(C)cc3)=O)c1,
Aurothiomalate sodium,Sodium aurothiomalate; gold sodium thiomalate; Aurothiomalate sodium; Miochrysin; Myochrysine; Myocrisin; Myocrisine,12244-57-4,OC(CC(S)C(O)=O)=O.[x].[Na].[Au],
NGB 2904,NGB2904 HCl; NGB2904; NGB 2904; NGB-2904,189060-98-8,O=C(c(cc1)cc(C2)c1-c1c2cccc1)NCCCCN(CC1)CCN1c1cccc(Cl)c1Cl.Cl,
PHPS1,PHPS 1; PHPS-1,314291-83-3,[O-][N+](Cc(cc1)ccc1C(NN(C1=O)c2ccccc2)=C1N=Nc1ccc(CS(O)(=O)=O)cc1)=O,
TrxR1-IN-B19,TrxR1 IN B19; TrxR1INB19; Go-Y015; Go Y015,170950-29-5,COc1cccc(C=CC(C=Cc(cccc2OC)c2OC)=O)c1OC,
Telotristat,,1033805-28-5,Cc(cc1)nn1-c1c([C@H](C(F)(F)F)Oc2nc(N)nc(-c3ccc(C[C@@H](C(O)=O)N)cc3)c2)ccc(Cl)c1,
Siremadlin,NVP-HDM 201,1448867-41-1,CC(C)n1c(-c(cnc(OC)n2)c2OC)nc(C2=O)c1[C@H](c(cc1)ccc1Cl)N2C1=CC(Cl)=CN(C)C1=O,
BMS-986242,BMS986242; BMS 986242,1923844-48-7,O=C(N[C@@H]([C@H]1CC[C@@H](C2=CC=NC3=CC=C(F)C=C23)CC1)C)C4=CC=C(Cl)C=C4,
NSC 617145,NSC617145; NSC-617145; NSC 617145,203115-63-3,CC(C)(CN(C(C(Cl)=C1Cl)=O)C1=O)CN(C(C(Cl)=C1Cl)=O)C1=O,
HM-30181 mesylate monohydrate,,2097125-58-9,O.COc1cc2CCN(CCc3ccc(cc3)n4nnc(n4)c5cc(OC)c(OC)cc5NC(=O)C6=CC(=O)c7ccccc7O6)Cc2cc1OC.CS(=O)(=O)O,
PF-9363,CTX-3648,2569009-58-9,O=S(C1=C(OC)C=CC=C1OC)(NC2=NOC3=C2C(OC)=CC(CN4N=CC=C4)=C3)=O,
AZD5305,,2589531-76-8,O=C(C1=NC=C(N2CCN(CC3=CC(N4)=C(N=C3)C=C(CC)C4=O)CC2)C=C1)NC,
Necrostatin-34,"2-{[3-cyano-4-(4-methylphenyl)-6-oxo-1,4",375835-43-1,O=C(NC1=NC=CS1)CSC2=C(C#N)C(C3=CC=C(C)C=C3)CC(N2)=O,
1-HEXACOSANOL,,506-52-5,CCCCCCCCCCCCCCCCCCCCCCCCCCO,
Bax inhibitor peptide V5 acetate(579492-81-2 free base),,T10463L,O=C(N[C@H](C(N[C@H](C(N[C@@H](CCCCN)C(O)=O)=O)CC(C)C)=O)CCSC)[C@@H]1CCCN1C([C@H](C(C)C)N)=O.CC(O)=O,
SIBA,5'-Isobutylthioadenosine; 5'-Deoxy-5'-isobutylthioadenosine,35899-54-8,CC(C)CSC[C@H]([C@H]([C@H]1O)O)O[C@H]1n1c2ncnc(N)c2nc1,
FIDAS-3,,1266684-01-8,CN(C)C1=CC=C(/C=C/C2=C(F)C=CC=C2F)C=C1,
ONO-8590580,CS-2894,1802661-73-9,Cc1c2ncn(CC3CC3)c2cc(Nc(cc2)ncc2-c2cn(C)cn2)c1F,
Olafertinib,EGFR-IN-3; RX-518; CK-101,1660963-42-7,C=CC(Nc1cccc(-c2c3nc(Nc(c(F)c4F)ccc4N4CCN(CCO)CC4)ncc3ccc2)c1)=O,
3-Epiursolic acid,,989-30-0,C[C@H](CC1)[C@H](C)[C@H]2C3=CC[C@H]([C@@](C)(CC4)[C@@H](CC5)C(C)(C)[C@@H]4O)[C@]5(C)[C@]3(C)CC[C@]12C(O)=O,
MS1943,,2225938-17-8,CC(C)n(c1cc(-c(cc2)cnc2N2CCN(CCNC(CC3(CC(C4)C5)CC5CC4C3)=O)CC2)c2)ncc1c2C(NCC1=C(C)C=C(C)NC1=O)=O,
NTP42,,2055599-51-2,CC(C)(C)NC(NS(c(cc(cc1)C#N)c1Oc1cc(-c(cc2)ccc2OC(F)F)ccc1)(=O)=O)=O,
PKR-IN-2,,1628428-01-2,CC(C)CC(CC1)(CCN1C(c(cc1)ccc1NS(c1cccc2nccnc12)(=O)=O)=O)O,
AB-680,,2105904-82-1,C[C@@H](c(cccc1)c1F)Nc1cc(Cl)nc2c1cnn2[C@@H]([C@@H]1O)O[C@H](COP(CP(O)(O)=O)(O)=O)[C@H]1O,
ACHP Hydrochloride,IKK-2 Inhibitor VIII,406209-26-5,N#CC1=C(C=C(N=C1N)C2=C(C=CC=C2OCC3CC3)O)C4CCNCC4.[H]Cl,
CITCO,,338404-52-7,Clc(cc1)ccc1-c1c(/C=N/OCc(cc2)cc(Cl)c2Cl)n(ccs2)c2n1,
DSP-2230,,1233231-30-5,C[C@H](C(N)=O)NCc(n1C2CCC2)nc(cc2)c1nc2Oc(cc1F)cc(F)c1F,
Cav 2.2 blocker 1,,1567335-29-8,CC1(C)CC(C2=NN(C3=CC=CC=C3OC)C(C4=CC=C(Cl)C=C4)=C2)CC(C)(C)O1,
GV-58,,1402821-41-3,CCCn1c(nc(N[C@H](CC)CO)nc2NCc3ccc(C)s3)c2nc1,
MA-0204,,2095128-17-7,C[C@H](CCCOc1c(Cn2c(-c(cc3)ccc3OC(F)(F)F)ncc2C)cccc1)CC(O)=O,
KPLH1130,,906669-07-6,O=C1NN=C(C2=CC=C(O)C=C2O)N1C3=CC=C(C)C=C3,
RK-287107,,2171386-10-8,OCCN(C1)c2cc(F)cc(F)c2C1(CC1)CCN1C(N1)=NC(CCCC2)=C2C1=O,
YKL-5-124,,1957203-01-8,CC(C)(c1c(C2)c(NC(c(cc3)ccc3NC(C=C)=O)=O)n[nH]1)N2C(N[C@H](CN(C)C)c1ccccc1)=O,
AT-130,AT 130; AT130,211364-06-6,COc(cccc1)c1C(Br)=C(C(N1CCCCC1)=O)NC(c(cc1)ccc1[N+]([O-])=O)=O,
PIK-108,PIK 108; PIK108,901398-68-3,O=C1C=C(N2CCOCC2)OC3=C(C(NC4=CC=CC=C4)C)C=C(C)C=C13,
BPAM344,,1204572-55-3,FC1=CC=C(C2=C1)N(C3CC3)CNS2(=O)=O,
SHR0302,ARQ252,1445987-21-2,CN(C(C1)C[C@@H](C2)[C@H]1CN2C(Nc1nc(OC)ns1)=O)c1ncnc2c1cc[nH]2,
SCH54292,,188480-51-5,OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1N(CCOc1cc2ccccc2cc1)S(c(cc1)ccc1NO)(=O)=O,
KEA1-97,,2138882-71-8,Fc(cc1)ccc1-c(cc1)ccc1Nc1nc(Cl)nc(Cl)n1,
JH-X-119-01,,2227368-54-7,O=C(C1=NC(C2=NNC=C2)=CC=C1)NC3=CC=C(NC(C4=CC=CC(NC(C=C)=O)=C4)=O)C=C3,
NRX-252262,,2438637-61-5,O=C1C(C(N2CC3=C(C=C(OC)C(OC)=C3)C2)=O)=C(SC4=C(Cl)C=CC=C4Cl)C=C(C(F)(F)F)N1,
Exo-1,Methyl 3-(4-fluorobenzoyl)-6-methyl-2-pyridinecarboxylate,461681-88-9,O=C(C1=NC(C)=CC=C1C(C2=CC=C(F)C=C2)=O)OC,
5-Hydroxymethyldeoxyuridine,,5116-24-5,OC[C@H]([C@H](C1)O)O[C@H]1N(C=C(CO)C(N1)=O)C1=O,
SYN1143,AMG-1; RON-IN-1; SYN1143,913376-84-8,CC(C)(CN(C(C)=C(C(Nc(cc1)cc(F)c1Oc1ccnc2cc(OC)ccc12)=O)C1=O)N1c1ccccc1)O,
XMD-17-51 Trifluoroacetate,XMD-17-51 Trifluoroacetate (1628614-50-5 free base),2436579-93-8,O=C1N(C)C2=CN=C(NC3=CN(C4CCNCC4)N=C3)N=C2N(C)C5=CC=CC=C15.FC(C(O)=O)(F)F,
NCGC00378430,,920650-00-6,O=C(NC1=CC=C(OC)C(S(=O)(N2CCOCC2)=O)=C1)C3=CC=CC(N4C=CC=C4)=C3,
PAP-1,5-(4-Phenoxybutoxy)psoralen,870653-45-5,O=C(C=C1)Oc2c1c(OCCCCOc1ccccc1)c(cco1)c1c2,
AC710,,1351522-04-7,CCN(C(C)(C)C1)C(C)(C)CC1Oc(cc1)cnc1C(Nc(cc1)ccc1NC(Nc1noc(C(C)(C)C)c1)=O)=O,
Quinizarin,"1,4-Dihydroxyanthraquinone",81-64-1,Oc(c(C(c1c2cccc1)=O)c1C2=O)ccc1O,
Nampt-IN-5,,2380013-17-0,O=C(N1CC(C2=CC=CN=C2)C1)NC3=CC=C(CN4C5=CC=CC=C5N=C4OCC)C=C3,
NV-5138,,2095886-80-7,O=C(O)[C@@H](N)CC(C)(C)C(F)F,
Barasertib,AZD1152; Barasertib,722543-31-9,CCN(CCCOc1cc2ncnc(Nc3n[nH]c(CC(Nc4cc(F)ccc4)=O)c3)c2cc1)CCOP(O)(O)=O,
Endovion,NS3728,265646-85-3,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc(cc(cc1)Br)c1-c1n[nH]nn1,
BMS-191095,,166095-21-2,CC(C)([C@@H]([C@H]1N(Cc2ncc[nH]2)c(cc2)ccc2Cl)O)Oc(cc2)c1cc2C#N,
BRAF inhibitor,,918505-61-0,CC(S(=O)(NC1=CC=C(F)C(C(C2=CNC3=NC=C(C4=CC=CN=C4)C=C32)=O)=C1F)=O)C,
CDK4/6-IN-2,,1800506-48-2,CC(N1C2=CC(C3=CC(NC4=NC=C(CN5CCN(CC)CC5)C=N4)=NC=C3F)=CC(F)=C2N=C1C)C,
IA-Alkyne,Iodoacetamide-alkyne; N-Hex-5-ynyl-2-iodo-acetamide,930800-38-7,C#CCCCCNC(CI)=O,
JNJ-38877618,OMO-1,943540-74-7,FC(c1nnc(cc2)n1nc2-c1ccncc1)(c1cc2cccnc2cc1)F,
Leptomycin B,CI 940; LMB,87081-35-4,CC/C(/C=C/[C@@H]([C@@H](C)C=C1)OC1=O)=C/[C@H](C)C/C=C/C(/C)=C/[C@@H](C)C([C@@H](C)[C@@H]([C@@H](C)C/C(/C)=C/C(O)=O)O)=O,
Pericyazine,Propericiazine; RP 8909,2622-26-6,N#Cc(cc1)cc2c1Sc(cccc1)c1N2CCCN(CC1)CCC1O,
Pulrodemstat benzenesulfonate,LSD1-IN-7 benzenesulfonate; CC-90011 benzenesulfonate,2097523-60-7,N#CC1=CC=C(C(N=C(N2CCC(N)CC2)N3C)=C(C4=CC=C(OC)C(F)=C4)C3=O)C=C1F.O=S(C5=CC=CC=C5)(O)=O,
Gypenoside XLVI,,94705-70-1,CC(CCC=C(C)C)(C(CC1)C(C(C2)O)C1(C)C(C)(CC1)C2C(C)(CC2O)C1C(C)(C)C2OC(C(C1O)OC(C(C2O)O)OC(CO)C2O)OC(CO)C1O)OC(C(C1O)O)OC(CO)C1O,
Carminic acid,,1260-17-9,Cc1c(C(O)=O)c(O)cc(C(c(c2c(c([C@H]([C@@H]([C@H]3O)O)O[C@H](CO)[C@H]3O)c3O)O)c3O)=O)c1C2=O,
Taxol C,,153415-45-3,CCCCCC(N[C@H]([C@H](C(O[C@@H](C1)C(C)=C([C@H](C([C@](C)([C@H](C[C@H]2OC3)O)[C@H]([C@@H]4OC(c5ccccc5)=O)[C@@]23OC(C)=O)=O)OC(C)=O)C(C)(C)[C@]14O)=O)O)c1ccccc1)=O,
PNU 22394 hydrochloride,,15923-42-9,CN1C(CCNCC2)=C2C3=C1C=CC=C3.[H]Cl,
PS47,PS-47; PS 47; PS47,1180676-33-8,OC(/C=C(\CCc(cc1)ccc1Cl)/c1ccccc1)=O,
Naftopidil hydrochloride,KT-611 hydrochloride; BM-15275 hydrochloride; 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-,1164469-60-6,OC(COC1=C2C=CC=CC2=CC=C1)CN3CCN(C4=CC=CC=C4OC)CC3.[H]Cl,
CH5424802 analog,,1256577-71-5,CC(C)(c1c2c(ccc(C#N)c3)c3[nH]1)c(cc(cc1)N(CC3)CCC3N3CCOCC3)c1C2=O,
LY2880070,,1375637-35-6,Cc(cc1)nc(OC)c1-c1cc(Nc2cncc(O[C@H]3CNCCC3)n2)n[nH]1,
HC067047 Hydrochloride(883031-03-6 free base),,1481646-76-7,O=C(C1=C(C)N(CCCN2CCOCC2)C(C3=CC=CC=C3)=C1)NC4=CC=CC(C(F)(F)F)=C4.[H]Cl,
Mito-LND,Mito-Loidamine,2361564-49-8,O=C(NCCCCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)C4=NN(CC5=CC=C(Cl)C=C5Cl)C6=C4C=CC=C6.[Br-],
KM 91104,,304481-60-5,Oc1c(C=NNC(c(cc2)cc(O)c2O)=O)cccc1,
TRPM4-IN-1,CBA; 4-chloro-2-(2-(2-chlorophenoxy)acetamido)benzoic acid,351424-20-9,OC(c(ccc(Cl)c1)c1NC(COc(cccc1)c1Cl)=O)=O,
Malabaricone B,,63335-24-0,Oc1ccc(CCCCCCCCC(c(c(O)ccc2)c2O)=O)cc1,
Acetoxyvalerensre,acetylvalerenolic acid,81397-67-3,O=C(O)C(C)=CC1C2=C(C)CC(OC(C)=O)C2C(C)CC1,
Andrograpanin,"19-HYDROXY-8(17),13-LABDADIEN-16,15-OLIDE",82209-74-3,C[C@@](CO)(CCC1)[C@@H](CC2)[C@]1(C)[C@H](CCC1=CCOC1=O)C2=C,
Vanilloid receptor antagonist 1,4-(7-Hydroxy-2-isopropyl-4-oxoquinazolin-3(4H)-yl)benzonitrile,871814-52-7,CC(C)C(N1c(cc2)ccc2C#N)=Nc(cc(cc2)O)c2C1=O,
LY2510924 acetate(1088715-84-7 free base),,T15805L,O=C(C(NC(C(NC(C(CCCCNC(C)C)N1)=O)CCCNC(N)=O)=O)CC2=CC=C3C=CC=CC3=C2)NCC(N[C@H](CCC(N[C@H](C(N[C@H](C1=O)CC4=CC=C(C=C4)O)=O)CC5=CC=CC=C5)=O)C(N[C@H](C(N)=O)CCCCNC(C)C)=O)=O.CC(O)=O,
JTP 0819958 - HOIPIN-1,,T8951,O=C(O[Na])C1=CC=CC=C1/C=C/C(C2=C(OC)C=CC=C2)=O,
Compound 3344 hydrochloride,"4-(2,3-dihydro-1,4-benzodioxin-5-yl)-~{N}-[3-[(dimethylamino)methyl]phenyl]-2-methoxy-aniline hydrochloride(2368246-78-8 free base); Compound 3344 hydrochloride (2368246-78-8 free base)",T9184L,COC1=CC(C2=C3OCCOC3=CC=C2)=CC=C1NC4=CC=CC(CN(C)C)=C4.[H]Cl,
GNE-495,,1449277-10-4,Nc(ncc(C(NC(C1)CN1C(C1CC1)=O)=O)c1cc2)c1nc2-c1cccc(F)c1,
MYCMI-6,NSC354961,681282-09-7,CCOc(ccc1nc2cc(N=Nc(cc3)c(N)nc3N)ccc22)cc1c2N,
NS8593 hydrochloride,NS8593 HCl,875755-24-1,[H]Cl.C1(N[C@@H]2CCCC3=C2C=CC=C3)=NC4=CC=CC=C4N1,
Parsaclisib,INCB050465,1426698-88-5,CCOc(c([C@H](C)n1nc(C)c2c(N)ncnc12)c1)c([C@@H](C2)CNC2=O)c(F)c1Cl,
Pimethixene,Pimetixene; Calmixen,314-03-4,CN(CC1)CCC1=C1c(cccc2)c2Sc2c1cccc2,
3CAI,,28755-03-5,O=C(CCl)c1c[nH]c2c1cccc2,
AZD9056 hydrochloride,,345303-91-5,O=C(NCC12CC3CC(C2)CC(C3)C1)C4=CC(CCCNCCCO)=CC=C4Cl.[H]Cl,
SIRT-IN-2,,1431411-66-3,CS(NCCC(CC1)CCN1c1ncnc2c1sc(C(N)=O)c2)(=O)=O,
Elimusertib hydrochloride(1876467-74-1 free base),BAY-1895344 hydrochloride,T10468,CN1N=CC=C1C2=CC(N3[C@@H](COCC3)C)=NC4=C(N=CC=C24)C5=CC=NN5.[H]Cl,
BD-AcAc 2,Ketone Ester,1208313-97-6,C[C@H](CCOC(C[C@@H](C)O)=O)O,
Bozitinib,PLB-1001; CBT-101,1440964-89-5,Cn1nc(cc(c(C(c2nnc(cc3)n2nc3-c2cn(C3CC3)nc2)(F)F)c2)F)c2c1,
VUF11207 fumarate,,1785665-61-3,C/C(CN(CCC1N(C)CCC1)C(C2=CC(OC)=C(OC)C(OC)=C2)=O)=C\C3=C(F)C=CC=C3.OC(/C=C/C(O)=O)=O,
CG347B,,1598426-03-9,CCOC(c1cnc(NC2(CC2)c2ccccc2)nc1)=O,
Incyclinide,CMT-3; COL-3,15866-90-7,NC(C(C(C[C@H](C[C@H](Cc1cccc(O)c11)C(C2=O)=C1O)[C@]21O)=O)=C1O)=O,
Tirbanibulin Mesylate,KX2-391 Mesylate; KX01 Mesylate,1080645-95-9,O=C(NCC1=CC=CC=C1)CC2=NC=C(C3=CC=C(OCCN4CCOCC4)C=C3)C=C2.OS(=O)(C)=O,
CNDAC hydrochloride,,134665-72-8,Cl.NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2C#N,
Poloxin,,321688-88-4,CC(C)C(C(C=C1C)=O)=C/C1=N/OC(c1c(C)cccc1)=O,
Taminadenant,,1337962-47-6,Nc1nc(-n2nccc2)nc(-n2nccc2)c1Br,
Galloflavin,,568-80-9,OC(C=C1OC(C2=CC3=O)=O)=C(O)OC1=C2C(O)=C3O,
Proflavine,"3,6-Diaminoacridine",92-62-6,Nc1cc2nc3cc(N)ccc3cc2cc1,
"Tyrphostin B44, (+) enantiomer",,133550-37-5,C[C@@H](c1ccccc1)NC(/C(/C#N)=C/c(cc1)cc(O)c1O)=O,
NNK,Nicotine-derived nitrosamine ketone,64091-91-4,CN(CCCC(c1cnccc1)=O)N=O,
Tesmilifene fumarate,DPPE fumarate,1185241-83-1,CCN(CC)CCOC1=CC=C(C=C1)CC2=CC=CC=C2.OC(/C=C/C(O)=O)=O,
ML-SA1,ML SA1; Mucolipin synthetic agonist 1,332382-54-4,CC(CC1(C)C)c(cccc2)c2N1C(CN(C(c1c2cccc1)=O)C2=O)=O,
Buformin hydrochloride,NSC 528218; NSC-528218; NSC528218,1190-53-0,CCCCN=C(N)N=C(N)N.Cl,
Hepln-13,Hepln 13; Hepln13,64369-13-7,Brc1ccc(C(N2)Nc3cccc4cccc2c34)cc1,
GS143,GS-143; GS 143; GS143,916232-21-8,OC(c(cc1)ccc1N(C1=O)N=C(Cc2ccccc2)C1=Cc1ccc(-c(cccc2)c2F)o1)=O,
Fedratinib hydrochloride hydrate,TG-101348 hydrochloride hydrate; SAR 302503 hydrochloride hydrate,1374744-69-0,O=S(C1=CC=CC(NC2=NC(NC3=CC=C(OCCN4CCCC4)C=C3)=NC=C2C)=C1)(NC(C)(C)C)=O.[H]Cl.[H]Cl.[H]O[H],
WH-4-025,,1876463-35-2,O=C(OC1=CC(C(NC2=CC=CC(C(F)(F)F)=C2)=O)=CC=C1C)N(C3=CC=C(OC)C=C3OC)C4=NC(NC5=CC=C(N6CCN(C)CC6)C=C5)=NC=C4,
CD73-IN-4,,2216764-29-1,O[C@H]1[C@H](N2N=CC3=C(NC4CCCC4)N=C(Cl)N=C32)O[C@H](COCP(O)(O)=O)[C@H]1O,
(E/Z)-GSK-3Î² inhibitor 1,GSK-3Î² inhibitor 1,3367-88-2,O=C1Nc(cccc2)c2C1=Cc1ncccc1,
CDK-IN-2,CDK inhibitor II,1269815-17-9,COc(ccc(F)c1)c1-c(cc(NC([C@H]1CNCCC1)=O)nc1)c1Cl,
Atrasentan,ABT-627; (+)-A 127722; A-147627,173937-91-2,CCCCN(CCCC)C(CN(C[C@@H]([C@H]1C(O)=O)c(cc2)cc3c2OCO3)[C@H]1c(cc1)ccc1OC)=O,
ONO-AE3-208,AE 3-208,402473-54-5,CC(C(Nc1c(CCCC(O)=O)ccc(C#N)c1)=O)c(c1ccccc11)ccc1F,
Euscaphic acid,,53155-25-2,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CCC4[C@@]5(C)C[C@@H](O)[C@@H](O)C(C)(C)C5CC[C@@]34C)C2[C@]1(C)O)C(O)=O,
mTOR inhibitor-3,,1207358-59-5,O=C(NC1=CC=C(C2=NC(N3[C@@H](C)COCC3)=C4C(CN(C5=NC=CC=N5)CC4)=N2)C=C1)NCC,
Clobetasone butyrate,,25122-57-0,C[C@@]1(C2)[C@](C(CCl)=O)(OC(CCC)=O)[C@@H](C)C[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(F)C2=O)=O,
PROTAC ERRÎ± ligand 1,,1264754-13-3,N#CC1=CC=C(OC2=CC=C(/C=C(SC(N3)=O)/C3=O)C=C2OC)C(C(F)(F)F)=C1,
Etripamil,MSP-2017; (-)-MSP-2017,1593673-23-4,O=C(OC)C1=CC=CC(CCN(CCC[C@](C2=CC=C(OC)C(OC)=C2)(C#N)C(C)C)C)=C1,
FF-10101,,1472797-69-5,O=C(N([C@@H](C)C(NCCCC#CC1=CN=C(NC2=CC=C(C#N)C=C2)N=C1NCCC)=O)C)/C=C/CN(C)C,
FN-1501,,1429515-59-2,O=C(C1=NNC=C1NC2=NC=NC3=C2C=CN3)NC4=CC=C(CN5CCN(C)CC5)C=C4,
Inavolisib,GDC-0077; RG6114,2060571-02-8,C[C@@H](C(N)=O)NC1=CC=C(C2=NC(N3[C@H](C(F)F)COC3=O)=CN2CCO4)C4=C1,
Talmapimod,SCIO-469,309913-83-5,O=C(N(C)C)C(C1=CN(C)C2=C1C=C(C(N3[C@H](C)CN(CC4=CC=C(F)C=C4)[C@@H](C)C3)=O)C(Cl)=C2)=O,
"ICI 118,551 hydrochloride",ICI 118551 hydrochloride,72795-01-8,CC1=C(CCC2)C2=C(OC[C@H](O)[C@@H](C)NC(C)C)C=C1.[H]Cl,
JNJ-18038683,,851376-05-1,ClC1=CC=C(C2=NN(CC3=CC=CC=C3)C4=C2CCNCC4)C=C1.O=C(CC(C(O)=O)(O)CC(O)=O)O,
MMV390048,,1314883-11-8,NC1=NC=C(C2=CC=C(S(=O)(C)=O)C=C2)C=C1C3=CC=C(C(F)(F)F)N=C3,
Pimonidazole,,70132-50-2,OC(CN1C=CN=C1[N+]([O-])=O)CN2CCCCC2,
RIPGBM,,355406-76-7,CC(N(C(C1=O)=C(NCC2=CC=CC=C2)C(C3=C1C=CC=C3)=O)CC4=CC=C(F)C=C4)=O,
TAK-593,,1005780-62-0,O=C(C1=CC(C)=NN1C)NC2=CC(OC3=NN4C(C=C3)=NC(NC(C5CC5)=O)=C4)=CC=C2C,
PF 05089771,PF-05089771; PF 05089771; PF05089771; PF-05089771; PF05089771; PF 05089771,1235403-62-9,O=S(C1=CC(Cl)=C(OC2=CC=C(Cl)C=C2C3=C(N)NN=C3)C=C1F)(NC4=CSC=N4)=O,
KA2507,,1636894-46-6,O=C(NO)C1=CC=C(CN(C2=NC=CN=C2)C3=NC=CN=C3)C=C1,
RAD51-IN-1,RAD5-IN-1,2101739-18-6,O=C1N(CC2=CC=C(Cl)C=C2)C(/C=C/C3=CC=CN=C3)=NC4=C1C=CC=C4,
DDO-5936,,2355377-13-6,O=C(O)CN(C1=CC=C(NC2=NC(N3CCCC3)=NC=C2)C=C1)S(=O)(C4=C(C)C=C(C)C=C4C)=O,
Sulfopin,PIN1-3,2451481-08-4,O=C(N(CC(C)(C)C)C(CC1)CS1(=O)=O)CCl,
DUB-IN-2,,924296-19-5,N#CC1=C(C#N)N=C2C(/C(C3=C2C=CC=C3)=N/OCC)=N1,
Imrecoxib,BAP-909,395683-14-4,O=C1N(CCC)CC(C2=CC=C(S(=O)(C)=O)C=C2)=C1C3=CC=C(C)C=C3,
Mefentrifluconazole,,1417782-03-6,OC(C)(C1=CC=C(OC2=CC=C(Cl)C=C2)C=C1C(F)(F)F)CN3N=CN=C3,
TP-353,EOS-61973,1253799-29-9,O=C(OC1=CC=CC=C1)C2=C(C)C(F)=CC(N(CC3=CC=CC=C3)CC4=CC=CC=C4)=C2OCC5=CC=CC=C5,
Ketorolac,Â RS37619; Toradol; Acular; Sprix; Macril; Acuvail,74103-06-3,O=C(C1C2=CC=C(C(C3=CC=CC=C3)=O)N2CC1)O,
Colcemid,Demecolcine; Colcemid; C-12669; C 12669; C12669; Kolchicin; NSC-3096,477-30-5,O=C1C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=CC=C1OC,
CIM0216,"N-(5-methyl-1,2-oxazol-3-yl)-2-phenyl-2-(1,2,3,4-tetrahydroquinolin-1-yl)acetamide",1031496-06-6,O=C(NC1=NOC(C)=C1)C(C2=CC=CC=C2)N3CCCC4=C3C=CC=C4,
Ï1 Receptor antagonist-1,"Ï1 Receptor antagonist-1Â ; 4H-1-Benzothiopyran-4-one, 2,3-dihydro-2-[1-(phenylMethyl)-4-piperidinyl]-",1204401-49-9,O=C1CC(C2CCN(CC3=CC=CC=C3)CC2)SC4=CC=CC=C14,
CDC25B-IN-2,BIA,134271-74-2,O=C(C1=CC=CC=C1N)/C=C/C2=CC=CC([N+]([O-])=O)=C2,
Dexketoprofen trometamol,,156604-79-4,O=C(C1=CC=CC([C@H](C)C(O)=O)=C1)C2=CC=CC=C2.OCC(CO)(CO)N,
JNJ-63576253,JNJ63576253; TRC-253,2110428-64-1,N#CC1=NC=C(N(C2=O)C(N(C3=CC=C(OC4CCNCC4)N=C3)C52CCC5)=S)C=C1C(F)(F)F.[H]Cl,
SBC-115337,,423148-46-3,O=C(C1=CC2=CC=CC=C2O1)NC3=CC=C(C(NC4=CC=C(C5=NC6=CC=CC=C6O5)C=C4)=O)C=C3,
Xaliproden hydrochloride,SR57746A; SR57746 hydrochloride; xaliprodene; Xaprila,90494-79-4,FC(C1=CC(C2=CCN(CCC3=CC=C4C=CC=CC4=C3)CC2)=CC=C1)(F)F.[H]Cl,
Clomethiazole,Chlormethiazole; 5-(2-CHLOROETHYL)-4-METHYLTHIAZOLE; Distraneurin,533-45-9,Cc1c(CCCl)scn1,
Dotinurad,"(3,5-dichloro-4-hydroxyphenyl)(1,1-dioxidobenzo[d]thiazol-3(2H)-yl)methanone",1285572-51-1,Oc(c(Cl)cc(C(N(C1)c(cccc2)c2S1(=O)=O)=O)c1)c1Cl,
Pamufetinib,TAS-115; H2OL3Q4XRD; 4-(2-Fluoro-4-(3-(2-phenylacetyl)thioureido)phenoxy)-7-methoxy-N-methylquinoline-6-carboxamide; pamufetinib,1190836-34-0,CNC(c(cc1c(Oc(ccc(NC(NC(Cc2ccccc2)=O)=S)c2)c2F)ccnc1c1)c1OC)=O,
NS13001,"N-(4-chlorophenyl)-2-(3,5-dimethylpyrazol-1-yl)-9-methylpurin-6-amine; N-(4-Chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-9-methyl-9H-purin-6-amine",1063331-94-1,Cc1cc(C)nn1-c(nc1Nc(cc2)ccc2Cl)nc2c1ncn2C,
Prazosin,Furazosin; Prazosine; Prazocin,19216-56-9,COc(cc1c(N)nc(N(CC2)CCN2C(c2ccco2)=O)nc1c1)c1OC,
Caspase-3 Inhibitor I,Ac-DEVD-CHO acetate (169332-60-9 free base); N-acetyl-asp-glu-val-asp-al,TQ0146L,CC(O)=O.CC(C)[C@@H](C(NC([C@H](CCC(O)=O)NC([C@H](CC(O)=O)N)=O)=O)=O)N(C(C)=O)[C@H](C=O)CC(O)=O,
Zegocractin,"CM4620; N-(5-(6-Chloro-2,2-difluorobenzo[d][1,3]dioxol-5-yl)pyrazin-2-yl)-2-fluoro-6-methylbenzamide",1713240-67-5,Cc1cccc(F)c1C(Nc(nc1)cnc1-c(cc(c(O1)c2)OC1(F)F)c2Cl)=O,
Chrysotoxine,"4-[2-(3,4-Dimethoxyphenyl)ethyl]-2,6-dimethoxyphenol; Phenol, 4-[2-(3,4-dimethoxyphenyl)ethyl]-2,6-dimethoxy-",156951-82-5,COc(ccc(CCc(cc1OC)cc(OC)c1O)c1)c1OC,
Diethylmaleate,"DIETHYL MALEATE; Maleic acid, diethyl ester; Diethylmaleate",141-05-9,O=C(OCC)/C=C\C(OCC)=O,
(S)-Sunvozertinib,DZD9008; N-[5-[[4-[5-Chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide,2370013-49-1,CC(C)(c(c(Nc1nc(Nc(cc(c(N(CC2)C[C@H]2N(C)C)c2)NC(C=C)=O)c2OC)ncc1)c1)cc(F)c1Cl)O,
AZD-5597,(S)-(4-((5-Fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrimidin-2-yl)amino)phenyl)(3-(methylamino)pyrrolidin-1-yl)methanone,924641-59-8,CC(C)n1c(-c(nc(Nc(cc2)ccc2C(N(CC2)C[C@H]2NC)=O)nc2)c2F)cnc1C,
Gartanin,,33390-42-0,CC(C)=CCc(c(O)c(CC=C(C)C)c(Oc1c2c(O)ccc1O)c1C2=O)c1O,
Reparixin L-lysine salt,Repertaxin L-lysine salt,266359-93-7,N[C@@H](CCCCN)C(O)=O.O=C(NS(=O)(C)=O)[C@@H](C)C1=CC=C(CC(C)C)C=C1,
DM4,Ravtansine,796073-69-3,CO[C@@H]1/C=C/C=C(Cc2cc(N(C(C[C@@H]([C@@]3(O[C@H]3[C@@H]([C@@H]4C[C@]1(NC(O4)=O)O)C)C)OC([C@@H](N(C(CCC(C)(S)C)=O)C)C)=O)=O)C)c(Cl)c(OC)c2)\C,
EN6,,1808714-73-9,C=CC(Nc(cc(cc1)NC(c2cn(-c(cccc3)c3F)nc2)=O)c1F)=O,
JNJ-64619178,,2086772-26-9,Nc1c(ccn2[C@H](C[C@H](CCc3ccc(cc(c(N)n4)Br)c4c3)[C@H]3O)[C@@H]3O)c2ncn1,
Pico145,HC-608,1628287-16-0,CN(c1c(C(N2CCCO)=O)n(Cc(cc3)ccc3Cl)c(Oc3cc(OC(F)(F)F)ccc3)n1)C2=O,
Midodrine,(Â±)-Midodrin,42794-76-3,COc(cc1)cc(C(CNC(CN)=O)O)c1OC,
Trazodone,Desyrel,19794-93-5,O=C1N(C=CC=C2)C2=NN1CCCN(CC1)CCN1c1cccc(Cl)c1,
N-trans-Sinapoyltyramine,,200125-11-7,COc1cc(/C=C/C(NCCc(cc2)ccc2O)=O)cc(OC)c1O,
Tetramethylkaempferol,,16692-52-7,COc(cc1)ccc1C(Oc(cc(cc1OC)OC)c1C1=O)=C1OC,
CyPPA,,73029-73-9,Cc1cc(C)nn1-c1nc(NC2CCCCC2)cc(C)n1,
Chlorothymol,4-Chloro-2-isopropyl-5-methylphenol,89-68-9,CC(C)c1cc(Cl)c(C)cc1O,
WAY-169916,,669764-18-5,C=CCn(c1c(C(F)(F)F)cccc11)nc1-c(ccc(O)c1)c1O,
SYR127063,BDBM92454,871026-18-5,OCCOCCn(cc1)c2c1ncnc2Nc(cc1)cc(Cl)c1Oc1cc(C(F)(F)F)ccc1,
Hydroxychloroquine,,118-42-3,CCN(CCCC(C)Nc1c(ccc(Cl)c2)c2ncc1)CCO,
YK-3-237,,1215281-19-8,COc1c(B(O)O)cc(/C=C/C(c(cc2OC)cc(OC)c2OC)=O)cc1,
Necroptosis-IN-1,,1391980-92-9,O=C(C(Cc(c1ccc2)c[nH]c1c2Cl)N1)NC1=O,
Guanabenz hydrochloride,NE56490,23113-43-1,ClC1=C(C=NNC(N)=N)C(Cl)=CC=C1.[H]Cl,
Suberoyl bis-hydroxamic acid,SBHA; Suberohydroxamic acid; Suberoyl bis-hydroxamic acid,38937-66-5,ONC(CCCCCCC(NO)=O)=O,
Amitriptyline,,50-48-6,CN(C)CCC=C(c1c(CC2)cccc1)c1c2cccc1,
Ambazone,Ambazon; Primal,539-21-9,NC(NN=C(C=C1)C=CC1=NNC=NN)=S,
Palvanil,Hexadecanamide,69693-13-6,CCCCCCCCCCCCCCCC(NCc(cc1)cc(OC)c1O)=O,
Arnicolide D,,34532-68-8,C[C@@H]([C@H]([C@@H](C[C@@H](C)[C@@H]([C@@]12C)C=CC1=O)O1)[C@@H]2OC(C(C)=C)=O)C1=O,
(-)-Bornyl acetate,L-(-)-Bornyl acetate,5655-61-8,CC(C)([C@@H](CC1)C2)[C@@]1(C)[C@@H]2OC(C)=O,
Niraparib (R-enantiomer),Niraparib R-enantiomer; MK 4827 (R-enantiomer),1038915-58-0,O=C(C1=CC=CC2=CN(C3=CC=C([C@@H]4CNCCC4)C=C3)N=C12)N,
MKC9989,,1338934-20-5,O=CC1=C(O2)C(C(C)=C(CCOCCOC)C2=O)=CC(OC)=C1O,
NS19504,,327062-46-4,NC1=NC=C(S1)CC2=CC=C(Br)C=C2,
Pivagabine,CXB-722,69542-93-4,O=C(O)CCCNC(C(C)(C)C)=O,
1-Methylxanthine,,6136-37-4,O=C(N1C)NC2=C(N=CN2)C1=O,
4-Methylamino antipyrine,,519-98-2,O=C1N(C2=CC=CC=C2)N(C)C(C)=C1NC,
DFP00173,,672286-03-2,O=C(NC1=CSC([N+]([O-])=O)=C1)NC2=C(Cl)C=CC=C2Cl,
DUB-IN-1,,924296-18-4,N#CC1=C(C#N)N=C2C(/C(C3=C2C=CC=C3)=N/OCC4=CC=CC=C4)=N1,
DUB-IN-3,,924296-17-3,C=CCO/N=C1C2=C(N=C(C#N)C(C#N)=N2)C3=CC=CC=C/13,
AG 1295,,71897-07-9,CC1=C(C)C=C2N=CC(C3=CC=CC=C3)=NC2=C1,
AR antagonist 1,,1818885-54-9,N#CC1=CC=C(O[C@H]2C(C)(C)[C@H](N)C2(C)C)C=C1Cl,
AZ7550,,1421373-99-0,C=CC(NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(C)CCNC)=O,
CMP8,,851107-28-3,O=C1CCC2(CC3=CC=C(Cl)C=C3)CC4=C(C=CC(O)=C4)C2=C1C5=CC=C(OCCN6CCCCC6)C=C5,
DREADD agonist 21,,56296-18-5,C12=CC=CC=C1NC3=CC=CC=C3C(N4CCNCC4)=N2,
Azosemide,,27589-33-9,ClC1=CC(NCC2=CC=CS2)=C(C3=NN=NN3)C=C1S(N)(=O)=O,
BRD-6929,,849234-64-6,O=C(NC1=CC(C2=CC=CS2)=CC=C1N)C3=CC=C(NC(C)=O)C=C3,
N-Desmethyl imatinib,Norimatinib; Imatinib metabolite N-Desmethyl imatinib,404844-02-6,O=C(NC1=CC=C(C)C(NC2=NC(C3=CC=CN=C3)=CC=N2)=C1)C4=CC=C(CN5CCNCC5)C=C4,
EHP-101,VCE-004.8,1818428-24-8,O=C1C(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(C(NCC3=CC=CC=C3)=C1CCCCC)=O,
Vimseltinib,DCC-3014,1628606-05-2,O=C1N(C)C(NC(C)C)=NC=C1C2=NC(C)=C(OC3=CC(C4=CN(C)N=C4)=NC=C3)C=C2,
GSK-626616,,1025821-33-3,O=C1N=C(NC2=C(Cl)C=CC=C2Cl)S/C1=C\C3=CC=C4N=CC=NC4=C3,
7-Ethoxyresorufin,Resorufin ethyl ether,5725-91-7,CCOc(cc1)cc(O2)c1N=C(C=C1)C2=CC1=O,
Talinolol,(Â±)-Talinolol,57460-41-0,CC(C)(C)NCC(COc(cc1)ccc1NC(NC1CCCCC1)=O)O,
(E/Z)-GO289,,694522-87-7,COc(c(O)c1)cc(C=Nn2c(SC)nnc2-c2ccccc2)c1Br,
NSC 66811,,6964-62-1,Cc1ccc(ccc(C(c2ccccc2)Nc2ccccc2)c2O)c2n1,
Cefpodoxime (free acid),,80210-62-4,COCC(CS[C@@H]1[C@@H]2NC(/C(/c3csc(N)n3)=N\OC)=O)=C(C(O)=O)N1C2=O,
Thalidomide 4-fluoride,E3 ligase Ligand 4,835616-60-9,O=C(c1cccc(F)c11)N(C(CCC(N2)=O)C2=O)C1=O,
Uniconazole,,83657-22-1,CC(C)(C)C(/C(/n1ncnc1)=C\c(cc1)ccc1Cl)O,
2-hexyl-4-Pentynoic Acid,,96017-59-3,CCCCCCC(CC#C)C(O)=O,
Glabrone,,60008-02-8,CC(C)(C=C1)Oc(cc2)c1c(O)c2C1=COc(cc(cc2)O)c2C1=O,
JW74,,863405-60-1,CC1=CC=C(C2=NOC(CSC3=NN=C(C4=CC=NC=C4)N3C5=CC=C(OC)C=C5)=N2)C=C1,
YQ128,,2454246-18-3,O=S(C1=CC=C(CCN(CC2=C(C=CC(Cl)=C2)OCCC)C(CC3=CSC=C3)=O)C=C1)(NCC#C)=O,
P110Î´-IN-1,ME-401; P110Î´-IN-1; PWT-143,1595129-71-7,O=S(C1=NC2=CC=CC=C2N1C3=NC(N4CCOCC4)=NC(NC(C)(C)CC5=CC=CC=C5C6CCN(C)CC6)=N3)(C)=O,
L002,,321695-57-2,O=C1C(C)=C/C(C=C1C)=N\OS(=O)(C2=CC=C(OC)C=C2)=O,
(RS)-(Tetrazol-5-yl)glycine,"D,L-(tetrazol-5-yl)glycine; LY 285265",138199-51-6,O=C(O)C(N)C1=NNN=N1,
MAP4K4-IN-3,Compound 17,1811510-58-3,NC1=NC=C(C2=CC(C3=CC=C(Cl)C=C3)=C(N)N=C2)C=N1,
TVB-3166,,1533438-83-3,CC1=CC(C)=C(C(=O)N2CC(C3=CC=C(C#N)C=C3)C2)C=C1C1=NNC(C)=C1C,
SR18662,,T22429,ClC1=C(Cl)C=C(/C=C/C(NCC(N2CCN(S(=O)(C)=O)CC2)=O)=O)C=C1,
(E)-Ferulic acid methyl ester,Methyl (E)-ferulate; Methyl (E)-ferulate,22329-76-6,COC(/C=C/c(cc1)cc(OC)c1O)=O,
Cichoriin,,531-58-8,OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1Oc1cc(OC(C=C2)=O)c2cc1O,
Memantine,,19982-08-2,C1[C@@]2(CC3(CC(C2)C[C@@]1(C3)C)N)C,
SHP099,SHP099 free base; SHP099; SHP-099; SHP 099,1801747-42-1,NC1=NC(N2CCC(C)(N)CC2)=CN=C1C3=CC=CC(Cl)=C3Cl,
SR 16832,SR-16832; SR16832,2088135-12-8,O=C(NC1=CC=NC2=CC=C(OC)C=C12)C3=CC([N+]([O-])=O)=CC=C3Cl,
Ellagic Acid Dihydrate,,133039-73-3,O=C1C2=CC(O)=C(O)C(O3)=C2C4=C(C3=O)C=C(O)C(O)=C4O1.[H]O[H].[H]O[H],
Misonidazole,,13551-87-6,COCC(Cn1c([N+]([O-])=O)ncc1)O,
Harman hydrochloride,Harmane hydrochloride(486-84-0 Free base),21655-84-5,Cc1nccc2c1[nH]c1c2cccc1.Cl,
AG-270,,2201056-66-6,COc(cc1)ccc1C(C(n1nc2-c3ccccc3)=O)=C(Nc3ncccc3)Nc1c2C1=CCCCC1,
Lansoprazole sodium,Lansoprazole (sodium); Â AG-1749 sodium,226904-00-3,O=S(C1=NC2=CC=CC=C2[N-]1)CC3=NC=CC(OCC(F)(F)F)=C3C.[Na+],
AZ 11645373,"3-[1-[[(3'-NITRO[1,1'-BIPHENYL]-4-YL)OXY]METHYL]-3-(4-PYRIDINYL)PROPYL]-2,4-THIAZOLIDINEDIONE",227088-94-0,[O-][N+](c1cccc(-c(cc2)ccc2OCC(CCc2ccncc2)N(C(CS2)=O)C2=O)c1)=O,
zapnometinib,"2-(2-chloro-4-iodoanilino)-3,4-difluorobenzoic acid; PD0184264; ATR-002",303175-44-2,OC(c(c(Nc(ccc(I)c1)c1Cl)c1F)ccc1F)=O,
Dimebolin,Latrepirdine; Dimebon; Dimebone,3613-73-8,Cc(cc1)cc2c1n(CCc1cnc(C)cc1)c1c2CN(C)CC1,
(S)-Flurbiprofen,Esflurbiprofen; esflurbiprofen; (S)-Flurbiprofen,51543-39-6,C[C@H](C(O)=O)c(cc1)cc(F)c1-c1ccccc1,
Guanidinoethyl sulfonate,Taurocyamine,543-18-0,NN=CNCCS(O)(=O)=O,
CRAC intermediate 2,,123066-64-8,NC1=CC=C(N2N=C(C(F)(F)F)C=C2C(F)(F)F)C=C1,
JP1302 dihydrochloride,,1259314-65-2,CN1CCN(C2=CC=C(NC3=C(C=CC=C4)C4=NC5=CC=CC=C53)C=C2)CC1.[H]Cl.[H]Cl,
MS4078,,2229036-62-6,CC(C)S(C1=C(NC2=NC(NC3=C(OC(C)C)C=C(C4CCN(CC(NCCNC5=C(C(N(C6C(NC(CC6)=O)=O)C7=O)=O)C7=CC=C5)=O)CC4)C(C)=C3)=NC=C2Cl)C=CC=C1)(=O)=O,
Nitroaspirin,NCX 4016,175033-36-0,O=C(OC1=CC=CC(CO[N+]([O-])=O)=C1)C2=CC=CC=C2OC(C)=O,
Propyl pyrazole triol,PPT,263717-53-9,CCCC1=C(C2=CC=C(O)C=C2)N(C3=CC=C(O)C=C3)N=C1C4=CC=C(O)C=C4,
Risdiplam,RG7916; RO7034067,1825352-65-5,O=C(C=C(C(C=C1C)=NN2C1=NC(C)=C2)N=C3C=C4)N3C=C4N(CCN5)CC65CC6,
Telratolimod,MEDI9197; 3M-052,1359993-59-1,NC1=NC2=CC=CC=C2C3=C1N=C(CCCC)N3OCCCCNC(CCCCCCCCCCCCCCCCC)=O,
L-838417 D9,CTP354; C-21191,1213669-91-0,CN1N=CN=C1COC2=NN3C(C=C2C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=NN=C3C4=CC(F)=CC=C4F,
Diclofenac Epolamine,DHEP; DIEP; diclofenac hydroxyethylpyrrolidine,119623-66-4,OCCN1CCCC1.OC(=O)CC2=C(NC3=C(Cl)C=CC=C3Cl)C=CC=C2,
Fenamic acid,N-Phenylanthranilic acid; 2-(Phenylamino)benzoic acid; 2-Anilinobenzoic acid; Diphenylamine-2-carboxylic acid,91-40-7,OC(=O)C1=C(NC2=CC=CC=C2)C=CC=C1,
Isonipecotic acid,4-Piperidinecarboxylic acid; 4-Carboxypiperidine; Hexahydroisonicotinic acid,498-94-2,OC(=O)C1CCNCC1,
Lanthanum(III) chloride heptahydrate,,10025-84-0,O.O.O.O.O.O.O.Cl[La](Cl)Cl,
MDR-652,,1933528-96-1,CC(C)(C)c1nc(-c2cccc(Cl)c2)c(CNC(Nc2cc(F)c(CO)cc2)=O)s1,
Phenidone,1-phenyl-3-pyrazolidinone,92-43-3,O=C1CCN(N1)C2=CC=CC=C2,
1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-(4-cyanophenoxy)phenyl)urea,SC-1,1313019-65-6,N#Cc(cc1)ccc1Oc(cc1)ccc1NC(Nc(cc1)cc(C(F)(F)F)c1Cl)=O,
Sevoflurane,Fluoromethyl,28523-86-6,FCOC(C(F)(F)F)C(F)(F)F,
Triglycidyl isocyanurate,"Tris(2,3-epoxypropyl) Isocyanurate; TGI; TGIC; Teroxirone",2451-62-9,O=C(N(CC1OC1)C(N1CC2OC2)=O)N(CC2OC2)C1=O,
Alisol F 24-acetate,,443683-76-9,[H][C@@]12[C@@H](O)CC3=C4C(C[C@]3(C)[C@@]1(C)CCC1C(C)(C)C(=O)CC[C@]21C)O[C@@H](C[C@H]4C)[C@@H](OC(C)=O)C(C)(C)O,
5-BDBD,,768404-03-1,BrC1=CC(C2=NCC(NC3=C2OC4=CC=CC=C34)=O)=CC=C1,
1-Aminocyclobutanecarboxylic acid,ACBC,22264-50-2,OC(C1(CCC1)N)=O,
SR1664,SR 1664,1338259-05-4,CC(C1=C2C=CC(/C(O)=N/[C@@](C3=CC=C(N(=O)=O)C=C3)([H])C)=C1)=C(N2CC4=CC=C(C5=CC=CC=C5C(O)=O)C=C4)C,
IMM-01,,218795-74-5,S=C(N/N=C/C1=CC=C(O)C=C1O)NC(C)(C)C,
GDC0575 monohydrochloride,,1196504-54-7,O=C(C1CC1)NC2=CNC3=NC=C(Br)C(N4C[C@H](N)CCC4)=C32.[H]Cl,
MOMIPP,,1363421-46-8,O=C(C1=CC=NC=C1)/C=C/C2=C(C)NC3=C2C=C(OC)C=C3,
"N-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine",,1071135-06-2,C(CC1)CCC1Nc1nccc(-c2cc3cnccc3c(N3CCNCC3)n2)c1,
AG957,Tyrphostin AG957Â ; AG957,140674-76-6,COC(c(cc1)ccc1NCc(cc(cc1)O)c1O)=O,
AKI603,,1432515-73-5,Cc1cc(Nc2nc(Nc(cc3)ccc3[N+]([O-])=O)nc(N3CCN(C)CC3)c2)n[nH]1,
Apcin A HCL,,1683535-53-6,O=C(OCCCN)NC(NC1=NC=CC=N1)C(Cl)(Cl)Cl.[H]Cl,
PF-04745637,,1917294-46-2,OC(CC1)(CCN1C(Cc1ccccc1)CNC(C1(CCCC1)c(cc1)ccc1Cl)=O)C(F)(F)F,
Arformoterol Tartrate,"(R,R)-Formoterol tartrate",200815-49-2,O=CNC1=CC([C@@H](O)CN[C@H](C)CC2=CC=C(OC)C=C2)=CC=C1O.O=C(O)[C@H](O)[C@@H](O)C(O)=O,
PD184161,PD 184161,212631-67-9,O=C(c(c(Nc(ccc(I)c1)c1Cl)c1F)cc(Br)c1F)NOCC1CC1,
Nitroarginine,N'-Nitro-L-arginine,2149-70-4,N[C@@H](CCCNC(N[N+]([O-])=O)=N)C(O)=O,
IU1-248,,2307472-03-1,Cc1cc(C(CN(CC2)CCC2O)=O)c(C)n1-c(cc1)ccc1C#N,
Terameprocol,EM-1421; tetramethyl Nordihydroguaiaretic Acid,24150-24-1,C[C@H](Cc(cc1)cc(OC)c1OC)[C@@H](C)Cc(cc1)cc(OC)c1OC,
ASK1-IN-2,,2541792-70-3,CC(C)n1c(-c2cccc(NC(c3cc(ccc(F)c4)c4[nH]3)=O)n2)nnc1,
Tiprenolol,,26481-51-6,CC(C)NCC(COc(cccc1)c1SC)O,
methyl chlorogenate,,29708-87-0,COC([C@](C[C@H]([C@H]1O)O)(C[C@H]1OC(C=Cc(cc1)cc(O)c1O)=O)O)=O,
Org 25543,,363628-88-0,CN(C)C1(CNC(c(cc2OC)cc(OC)c2OCc2ccccc2)=O)CCCC1,
TIQ-A,,420849-22-5,O=C1Nc(scc2)c2-c2c1cccc2,
Lonazolac,,53808-88-1,OC(Cc1cn(-c2ccccc2)nc1-c(cc1)ccc1Cl)=O,
Lofemizole,,65571-68-8,Cc1c(-c(cc2)ccc2Cl)[nH]cn1,
MC2184,,74901-20-5,O=C(C1=Cc(cccc2)c2OC1=N1)NC1=O,
"5-amino-1,2-dihydroisoquinolin-1-one",,93117-08-9,Nc1cccc2c1C=CNC2=O,
Ko 143,,461054-93-3,O=C(OC(C)(C)C)CC[C@@H]1NC([C@]2([H])CC3=C([C@H](CC(C)C)N2C1=O)NC4=C3C=CC(OC)=C4)=O,
Î±-Lapachone,alpha-Lapachone,4707-33-9,CC(C)(CC1)OC(C(c2c3cccc2)=O)=C1C3=O,
Yangambin,,13060-14-5,COc1cc([C@H]2OC[C@@H]3[C@@H](c(cc4OC)cc(OC)c4OC)OC[C@H]23)cc(OC)c1OC,
Monomethyl fumarate,,2756-87-8,O=C(OC)/C=C/C(O)=O,
MSC2360844,,1305267-37-1,O=C(C1=NN(C2=CC=C(CN3CCOCC3)C=C2)C(C4=CC=CC(F)=C45)=C1CS5(=O)=O)N6CCOCC6,
Nandrolone propionate,,7207-92-3,C[C@@]12[C@](CC[C@@H]2OC(CC)=O)([H])[C@@]3([H])[C@]([C@]4([H])C(CC3)=CC(CC4)=O)([H])CC1,
NaV1.7 inhibitor-1,,1494585-79-3,FC1=CC(OCC2(C)CCC3(CC3)CC2)=C(C4CC4)C=C1C(NS(C5CC5)(=O)=O)=O,
PF-04885614,,1480833-70-2,NC(C)(C)C1=NC=C(C2=CC=C(OC(F)(F)F)C=C2)N1,
Xanthopterin (hydrate),Xanthopterin Hydrate,5979-01-1,O.NC1=NC(=C2N=C(O)C=NC2=N1)O,
AR-C155858,,496791-37-8,O=C(C1=C2SC(CC3=C(NN=C3C)C)=C1C(N4C[C@@H](CO4)O)=O)N(C(N2CC(C)C)=O)C,
RIPK1-IN-7,,2300982-44-7,NC1=C2C(N(CC)C=C2C3=CC(CCN4C(CC5=CC=CC(OC(F)(F)F)=C5)=O)=C4C=C3)=NC=N1,
ALK inhibitor 1,,761436-81-1,O=S(C1=C(NC2=C(Br)C=NC(NC3=C(OC)C=C(N4CCN(C)CC4)C=C3)=N2)C=CC=C1)(NC)=O,
BRD 4354,,315698-07-8,OC1=C2N=CC=CC2=C(Cl)C=C1C(N3CCN(CC)CC3)C4=CC=CN=C4,
EF-5,EF5; 2-Nitroimidazole,152721-37-4,O=C(NCC(F)(F)C(F)(F)F)CN1C=CN=C1[N+]([O-])=O,
TAS4464 hydrochloride,,1848959-11-4,NC1=NC=NC2=C1C(C#CC3=C(F)C=CC=C3OCC)=CN2[C@@H]4O[C@H](CNS(=O)(N)=O)[C@@H](O)[C@H]4O.Cl,
Elacestrant,RAD1901,722533-56-4,OC1=CC=C2C[C@H](C3=CC=C(OC)C=C3N(CC)CC4=CC=C(CCNCC)C=C4)CCC2=C1,
BI-4020,,2664214-60-0,O=C(C1=CC(C)=NC(C2=C(OCCC[C@@H](C)C3)N(C)N=C2)=C1)/N=C(N4)/N3C5=C4C=CC(CN6CCN(C)CC6)=C5,
Ca2+ channel agonist 1,,1402821-24-2,CC[C@@H](NC1=NC(NCC2=CC=CC=C2)=C3C(N(CCC)C=N3)=N1)CO,
Carebastine,,90729-42-3,O=C(CCCN1CCC(OC(C2=CC=CC=C2)C3=CC=CC=C3)CC1)C4=CC=C(C=C4)C(C)(C(O)=O)C,
GNE-1858,,2680616-96-8,FC1(CCN(C2=NC(C3CCNC3)=CC(NC4=CC5=C(C=N4)C=NN5C(C)C)=N2)C1)F,
"4-(2-fluorophenyl)-2,3-dihydro-1,3-thiazol-2-one",,1095051-79-8,O=C1SC=C(c(cccc2)c2F)N1,
2-(4-methoxyphenyl)-2-oxoethyl 2-hydroxy-5-methylbenzoate,,1197834-98-2,Cc(cc1)cc(C(OCC(c(cc2)ccc2OC)=O)=O)c1O,
"5-phenylthieno[2,3-d]pyrimidin-4-amine",,195193-10-3,Nc1c(c(-c2ccccc2)cs2)c2ncn1,
Tinoridine,"ethyl 2-amino-6-benzyl-4H,5H,6H,7H-thieno[2,3-c]pyridine-3-carboxylate",24237-54-5,CCOC(c1c(N)sc2c1CCN(Cc1ccccc1)C2)=O,
M50054,Apoptosis Inhibitor,54135-60-3,O=C(CCC1)C(CC(C(CCC2)=O)C2=O)C1=O,
NSC 73150,NSC 97967,66680-03-3,OC1=CC=CC=C1C=NNC2=NC(C)=CC(N2)=O,
Rasarfin,,674359-73-0,CC(C)C(N(CC1)CCN1c(ccc(NC(c1cc(cccc2)c2o1)=O)c1)c1Cl)=O,
RO8191,CDM-3008; RO4948191,691868-88-9,FC(c1cc(C(F)(F)F)nc2c1ccc1nc(-c3nnco3)cn12)(F)F,
HNHA,,926908-04-5,ONC(CCCCCCSc1cc2ccccc2cc1)=O,
(E)-Akt inhibitor-IV,(E)-Akt inhibitor-IVÂ ; CS-1992; (E)-AKTIV,959841-49-7,CCN(C1/C=C/N(C)c2ccccc2)c(cc(cc2)-c3nc(cccc4)c4s3)c2N1c1ccccc1.I,
Epidermal Growth Factor Receptor Peptide Acetate,Epidermal Growth Factor Receptor Peptide  Acetate(96249-43-3 Free base)  ,T21723L,O=C(N)CC[C@@H](C(O)=O)NC([C@H]1N(C([C@H]([C@@H](C)CC)NC([C@H](CC(C)C)NC([C@H](CC2=CC=C(O)C=C2)NC([C@H](CCC(O)=O)NC([C@H](CC(O)=O)NC([C@H](C)NC([C@H](CC(O)=O)NC([C@H](C(C)C)NC([C@H](C(C)C)NC([C@H](CC(O)=O)N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CCC1)=O.CC(O)=O,
Temgicoluril,mebikar; Tetramethylglycoluril,10095-06-4,CN(C(C(N1C)N2C)N(C)C2=O)C1=O,
BMS-777607,,1196681-44-3,O=C(C1=C(OCC)C=CN(C2=CC=C(F)C=C2)C1=O)NC3=CC=C(OC4=C(Cl)C(N)=NC=C4)C(F)=C3,
Icenticaftor,QBW251,1334546-77-8,C[C@](CNC(c1nc(OC)c(C(F)(F)F)cc1N)=O)(C(F)(F)F)O,
Fosciclopirox,CPX-POM,1380539-06-9,CC(C=C(C1CCCCC1)N1OCOP(O)(O)=O)=CC1=O,
"2,3-dihydrothieno-Thiadiazole Carboxylate",,152467-47-5,COC(c1csc2c1nns2)=O,
AZ194,CRMP2-Ubc9-NaV1.7 inhibitor 194,2241651-99-8,COc(cc(cc1)C(N(CC2)CCC2c2nc(cccc3)c3n2Cc2cc(F)ccc2)=O)c1OCc1cccc(F)c1,
HPK1-IN-7,,2320462-65-3,CC(C)(c1c2ccc(Nc(nc3)nc(N[C@H](CO)c4ccccc4)c3-c3nnco3)c1)OC2=O,
KB-0742 dihydrochloride,KB-0742 dihydrochloride,2416874-75-2,CCC(C1=NC2=CC=NN2C(N[C@@H]3C[C@H](CC3)N)=C1)CC.Cl.Cl,
HM43239,,2294874-49-8,ClC=1C(C=2C=3C(NC2)=CC(C)=CC3)=NC(NC4=CC(=CC(CN5C[C@@H](C)N[C@@H](C)C5)=C4)C6CC6)=NC1,
Stafia-1,,2582757-90-0,COC1=CC(C2=CC(OP(O)(O)=O)=CC(C3=CC(OC)=C(OC)C(OC)=C3)=C2)=CC(OC)=C1OC,
MRTX1133,,2621928-55-8,C#Cc1c2c(-c(ncc(c3n4)c(N5CC(CC6)NC6C5)nc4OC[C@](CCC4)(C5)N4C[C@@H]5F)c3F)cc(O)cc2ccc1F,
Canolol,"Phenol, 4-ethenyl-2,6-dimethoxy-",28343-22-8,COc1cc(C=C)cc(OC)c1O,
FR054,,35954-65-5,CC(OC[C@H]([C@H]1OC(C)=O)O[C@@H]2OC(C)=N[C@@H]2[C@H]1OC(C)=O)=O,
SM-7368,NF-ÎºB Activation Inhibitor III; SM 7368,380623-76-7,[O-][N+](c1cnc(NC(c(cc2)cc(Cl)c2[N+]([O-])=O)=O)s1)=O,
MS37452,,423748-02-1,Cc1cccc(OCC(N(CC2)CCN2C(c(cccc2OC)c2OC)=O)=O)c1,
CBFÎ² Inhibitor,5-Ethyl-4-(4-methoxy-phenyl)-thiazol-2-ylamine,493028-20-9,CCc1c(-c(cc2)ccc2OC)nc(N)s1,
HPI 1,,599150-20-6,CC(NC(CC(C1)c(cccc2)c2OC)=C(C2c3cc(O)ccc3)C1=O)=C2C(OCCOC)=O,
ML-031,,852230-33-2,Cc1cc(C(CN(C(CC2)=O)C2=O)=O)c(C)n1Cc1ccccc1,
Astragenol,,86541-79-9,CC1(C)[C@@H](O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@](C)(O5)CC[C@H]5C(C)(O)C)[C@@H](O)C[C@](C)4[C@]3([H])C[C@H](O)[C@@]12[H],
GW 610,,872726-44-8,COc(ccc(-c1nc(cc(cc2)F)c2s1)c1)c1OC,
4SC-203,,895533-09-2,Cc(cc1)cc(NC(Nc2nc(ccc(Nc(c3c4)ncnc3cc(OCCCN3CCN(C)CC3)c4OC)c3)c3s2)=O)c1OC,
7BIO,,916440-85-2,ON=C(c(cccc1)c1N1)C1=C(c1cccc(Br)c1N1)C1=O,
HBX 41108,HBX-41108,924296-39-9,N#Cc1nc(-c(ccc(Cl)c2)c2C2=O)c2nc1C#N,
BI-6015,BI 6015; BI6015,93987-29-2,Cc1nc(cccc2)c2n1S(c1c(C)ccc([N+]([O-])=O)c1)(=O)=O,
BAY-8400,,T9498,FC(F)C1=CN=CC(C2=CC=C(N=CC3=NN=C(C4=CCCOCC4)N35)C5=C2)=C1,
Fadraciclib,CYC065,1070790-89-4,CC[C@@H]([C@@H](C)O)Nc1nc(NCc2c(C)cc(C)nc2)c2ncn(C(C)C)c2n1,
LY2857785,,1619903-54-6,CC(C)c1c(cc(cc2)-c3ccnc(N[C@H](CC4)CC[C@@H]4NC4CCOCC4)n3)c2nn1C,
MK-8033,,1001917-37-8,Cn1ncc(-c2cc(C(c(cc(CS(NCc3ncccc3)(=O)=O)cc3)c3C=C3)=O)c3nc2)c1,
Polyporenic acid C,,465-18-9,CC1(C)C(CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@H](C(O)=O)CCC(C(C)C)=C)[C@H](O)C[C@](C)4C3=CC[C@@]12[H])=O,
Eriocalyxin B,,84745-95-9,C=C([C@H](CC1)C2)C([C@]2([C@@]1([C@]34CO5)[H])[C@]5(O)[C@@H](O)[C@]4([H])C(C)(C)C=CC3=O)=O,
Iriflophenone,,52591-10-3,Oc(cc1)ccc1C(c(c(O)cc(O)c1)c1O)=O,
Lasiodin,Lasiokaurin,28957-08-6,C=C([C@H](CC1)[C@H]2O)C([C@@]32[C@]4(O)[C@@H](O)[C@]5([H])C(C)(C)CC[C@H](OC(C)=O)[C@@]5(CO4)[C@@]31[H])=O,
MK2-IN-3 hydrate,MK-2 Inhibitor III,1186648-22-5,O=C1C2=C(NC(C3=CC(C4=CC5=CC=CC=C5N=C4)=NC=C3)=C2)CCN1.[H]O[H],
N-Desmethyl-Apalutamide,N-Desmethyl Apalutamide,1332391-11-3,NC(c(ccc(N(C1(CCC1)C(N1c(cc2C(F)(F)F)cnc2C#N)=O)C1=S)c1)c1F)=O,
N-Desmethyltamoxifen hydrochloride,,15917-65-4,CC/C(C1=CC=CC=C1)=C(C2=CC=C(OCCNC)C=C2)\C3=CC=CC=C3.[H]Cl,
NAN-190 hydrobromide,,115338-32-4,O=C1N(CCCCN2CCN(C3=CC=CC=C3OC)CC2)C(C4=C1C=CC=C4)=O.[H]Br,
p38-Î± MAPK-IN-1,,443913-15-3,CC(C)(C)c(cc1NC(Nc(cc2)ccc2OCCN2CCOCC2)=O)nn1-c1ccc(C)cc1,
CUDA,,479413-68-8,OC(CCCCCCCCCCCNC(NC1CCCCC1)=O)=O,
CWP232228,,1144044-02-9,O=C(N([C@](CN1CC2=CC=CC3=CN(C)N=C23)([H])N4[C@@H](CC5=CC=C(OP(O)(O)=O)C=C5)C1=O)N(CC=C)CC4=O)NCC6=CC=CC=C6,
DRI-C21045,,2101765-81-3,O=C(OC)C1=CC=C(C(NC2=CC=C(C3=CC=C(C(NC4=C5C(S(=O)(O)=O)=CC=CC5=CC=C4)=O)C=C3)C=C2)=O)C=C1,
A-443654,,552325-16-3,Cc1n[nH]c(cc2)c1cc2-c1cc(OC[C@H](Cc2c[nH]c3c2cccc3)N)cnc1,
Adarotene,ST1926,496868-77-0,OC(/C=C/c(cc1)ccc1-c(cc1)cc(C2(CC(C3)C4)CC4CC3C2)c1O)=O,
ARS-1630,,1698055-86-5,C=CC(N1CCN(C2=C3C=C(Cl)[C@]([C@]4=C(O)C=CC=C4F)=C(F)C3=NC=N2)CC1)=O,
Flindokalner,BMS-204352,187523-35-9,COc(cc1)c([C@@](c(ccc(C(F)(F)F)c2)c2N2)(C2=O)F)cc1Cl,
SGN-2FF,,2089647-47-0,OC1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1F,
Endoxifen (E-isomer),E-Endoxifen; Endoxifen E-isomer,114828-90-9,CC/C(/c1ccccc1)=C(/c(cc1)ccc1O)\c(cc1)ccc1OCCNC,
Gut restricted-7,GR-7,2553218-46-3,O=S(O)(O[C@@H]1CC[C@@]2([C@]3(CC[C@@]4([C@H](CC[C@]4([C@@]3(CC[C@@]2(C1)[H])[H])[H])[C@@H](C)CCC(CF)=O)C)[H])C)=O.[Na],
Encequidar mesylate,HM30181 mesylate; HM30181A mesylate,849675-87-2,O=C(C1=CC(C2=CC=CC=C2O1)=O)NC3=CC(OC)=C(OC)C=C3C4=NN(C5=CC=C(CCN6CC7=C(C=C(OC)C(OC)=C7)CC6)C=C5)N=N4.CS(=O)(O)=O,
UC-514321,,299420-83-0,CC(C)(C)c1cc(C(c(cc2OCOc2c2)c2O)N2CCOCC2)cc(C(C)(C)C)c1O,
HI-TOPK-032,,487020-03-1,N#Cc1c(cc(cc2)NC(c3cccs3)=O)n2c2nc3ccccc3nc12,
Indobufen,Ibustrin,63610-08-2,CCC(C(O)=O)c(cc1)ccc1N(Cc1c2cccc1)C2=O,
Kira8,AMG-18,1630086-20-2,Cc1ccc2c(NS(c(cccc3)c3Cl)(=O)=O)cccc2c1Oc1ncccc1-c1nc(N[C@@H]2CNCCC2)ncc1,
CP-809101 hydrochloride,,1215721-40-6,[H]Cl.ClC1=CC(COC2=NC(N3CCNCC3)=CN=C2)=CC=C1,
NS5806,NS-5806,426834-69-7,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc(c(-c1n[nH]nn1)cc(Br)c1)c1Br,
BEBT-908,PI3KÎ± inhibitor 1; MDK9521,1235449-52-1,CNc(cc1)ncc1-c1nc(N2CCOCC2)c2sc(CN(C)c(nc3)ncc3C(NO)=O)cc2n1,
Riboflavin Tetrabutyrate,,752-56-7,CC1=CC2=C(C=C1C)N=C(C(N2C[C@@H](OC(CCC)=O)[C@@H](OC(CCC)=O)[C@@H](OC(CCC)=O)COC(CCC)=O)=N3)C(NC3=O)=O,
Supinoxin,RX-5902,888478-45-3,COc1cc(N(CC2)CCN2C(Nc(nc(cc(cc2)F)c2n2)c2OC)=O)cc(OC)c1,
Talampanel,GYKI-53773; LY-300164,161832-65-1,C[C@H](C1)N(C(C)=O)N=C(c(cc2)ccc2N)c2c1cc1OCOc1c2,
BMS-P5,,1549811-36-0,O=C(C1=CC(OC)=C2C(N=C(N2C)C3=CC4=CC=CN=C4N3CC5CC5)=C1)N6[C@H](CC[C@H](C6)N)C.Cl,
Methylprednisolone succinate,Methylprednisolone hydrogen succinate; Methylprednisolone hemisuccinate ,2921-57-5,C[C@@H](C[C@@H]([C@H](CC1)[C@](C)(C[C@@H]2O)[C@]1(C(COC(CCC(O)=O)=O)=O)O)[C@H]2[C@@]1(C)C=C2)C1=CC2=O,
NIBR-17,,944396-88-7,COc(cc1)ncc1Nc1cc(-c2cnc(N)nc2)nc(N2CCOCC2)n1,
S-99,,1124381-69-6,CC(C)Nc1cc(C(F)(F)F)cc2nc(NC(c3cnccc3)=O)nn12,
Takeda-6d,,1125632-93-0,N#CC1(CC1)c1cccc(C(Nc(cc(cc2)Oc(cc3)nc4c3nc(NC(C3CC3)=O)s4)c2F)=O)c1Cl,
Ponicidin,Rubescensine B,52617-37-5,C=C1C([C@@]23[C@](O)(O4)[C@@H](O)[C@]5([H])C(C)(C)CC[C@H](O)[C@@]5([C@@]4([H])O[C@@]3([H])[C@H]1CC6)[C@@]26[H])=O,
Brilliant blue G-250,"Brilliant Blue G; BBG; Acid blue 90, Coomassie Brilliant Blue G",6104-58-1,O=S(C1=CC=CC(CN(CC)C2=CC=C(/C(C3=CC=C(NC4=CC=C(OCC)C=C4)C=C3)=C5C(C)=C/C(C=C/5)=[N+](CC)\CC6=CC=CC(S(=O)([O-])=O)=C6)C(C)=C2)=C1)([O-])=O.[Na+],
8-Hydroxy-DPAT hydrobromide,8-OH-DPAT hydrobromide,76135-31-4,CCCN(CCC)C(CCc1ccc2)Cc1c2O.Br,
PD-161570,PD 161570; PD-161570,192705-80-9,CCN(CC)CCCCNc1ncc(cc(-c(c(Cl)ccc2)c2Cl)c(NC(NC(C)(C)C)=O)n2)c2n1,
SAR407899 hydrochloride,,923262-96-8,O=C(NC=C1)C(C1=C2)=CC=C2OC3CCNCC3.Cl,
8-Chloroadenosine,8 Chloroadenosine; 8Chloroadenosine; NSC-354258; NSC 354258; NSC354258; 8-Cl-Ado,34408-14-5,Nc1ncnc(n2[C@@H]([C@@H]3O)O[C@H](CO)[C@H]3O)c1nc2Cl,
SB399885 HCl,SB399885 Hydrochloride,402713-80-8,COc(ccc(S(Nc1cc(Cl)cc(Cl)c1OC)(=O)=O)c1)c1N1CCNCC1,
AMTB hydrochloride,AMTB HCl,926023-82-7,O=C(N(CCCN)CC1=CC=CS1)C2=CC=CC=C2OCC3=CC=CC(C)=C3.[H]Cl,
Simazine,Aquazine; Herbex; Tafazine; Radocon,122-34-9,CCNc1nc(Cl)nc(NCC)n1,
CKI-7,CKI-7 2HCl; CKI-7 dihydrochloride; CKI 7 dihydrochloride; CKI7 dihydrochloride; CKI-7 2HCl; CKI 7 2HCl; CKI7 2HCl,1177141-67-1,O=S(C1=CC=C(Cl)C2=C1C=NC=C2)(NCCN)=O.[H]Cl.[H]Cl,
Mefloquine,Lariam; Ro 215998; Ro-215998; Ro215998; WR 142490,53230-10-7,O[C@H]([C@@H]1NCCCC1)C2=CC(C(F)(F)F)=NC3=C(C(F)(F)F)C=CC=C23,
ETP-45658,ETP 45658; ETP45658,1198357-79-7,Cn1ncc2c1nc(-c1cc(O)ccc1)nc2N1CCOCC1,
Ifenprodil,RC 61-91; RC-61-91; RC61-91; RC 6191; RC61-91,23210-56-2,CC(C(c(cc1)ccc1O)O)N1CCC(Cc2ccccc2)CC1,
(S)-Amisulpride,Esamisulpride; SEP-4199,71675-92-8,CCN1[C@H](CNC(c(c(OC)c2)cc(S(CC)(=O)=O)c2N)=O)CCC1,
DCLX069,DCLX-069; DCLX 069,792946-69-1,CCOC(c(cc1)cc(N)c1N1CCN(Cc2ccccc2)CC1)=O,
Iptakalim Hydrochloride,,642407-63-4,CC(C)C(C)(C)NC(C)C.[H]Cl,
MTOB,4-methylthio 2-oxobutyric acid; KMBA; MTOB salt; Î±-keto-Î³-Methylthiobutyric acid,51828-97-8,O=C([O-])C(CCSC)=O.[Na+],
Fosifloxuridine nafalbenamide,NUC-3373; NUC 3373; NUC3373; Fosifloxuridine nafalbenamide,1332837-31-6,O(P(OC[C@H]1O[C@H](C[C@@H]1O)N2C(=O)NC(=O)C(F)=C2)(N[C@H](C(OCC3=CC=CC=C3)=O)C)=O)C=4C5=C(C=CC4)C=CC=C5,
Amifostine thiol dihydrochloride,WR-1065 dihydrochloride; Amifostine thiol dihydrochloride,14653-77-1,SCCNCCCN.Cl.Cl,
PEPA,,141286-78-4,NC(COc(c(F)cc(SCCNS(c1ccccc1)(=O)=O)c1)c1F)=O,
PI-273,,925069-34-7,CCc1c(C)sc(NC(NC(c(cc2)ccc2Cl)=O)=S)c1C(N)=O,
1-Octanol,Octanol,111-87-5,CCCCCCCCO,
Dofequidar fumarate,MS-209,153653-30-6,OC(COC1=CC=CC2=C1C=CC=N2)CN3CCN(C(C(C4=CC=CC=C4)C5=CC=CC=C5)=O)CC3.O=C(O)/C=C/C(O)=O,
AZ7550 hydrochloride,AZ7550 hydrochloride (1421373-99-0 free base),2309762-40-9,C=CC(NC1=CC(NC2=NC=CC(C3=CN(C4=C3C=CC=C4)C)=N2)=C(C=C1N(CCNC)C)OC)=O.[H]Cl,
BVT948,,39674-97-0,CC(C)(C(C(c(cccc1)c1C1=O)=N2)=C1O)C2=O,
CMPD1,,41179-33-3,Oc(cc1)ccc1NC(CCCc(cc1)ccc1-c(cccc1)c1F)=O,
Simurosertib,TAK-931,1330782-76-7,Cc1n[nH]cc1-c1cc(N=C([C@H]2N(CC3)CCC3C2)NC2=O)c2s1,
Aminopurvalanol A,,220792-57-4,CC(C)[C@H](CO)Nc(nc1Nc2cc(N)cc(Cl)c2)nc2c1ncn2C(C)C,
Amsilarotene,TAC101; TAC-101; TAC 101,125973-56-0,C[Si](C)(C)c1cc(C(Nc(cc2)ccc2C(O)=O)=O)cc([Si](C)(C)C)c1,
9-Phenanthrol,,484-17-3,Oc1cc2ccccc2c2ccccc12,
BADGE,,1675-54-3,CC(C)(c(cc1)ccc1OCC1OC1)c(cc1)ccc1OCC1OC1,
6-Hydroxy-DOPA,6-Hydroxy-DL-DOPA; 6-Hydroxy-DOPA,21373-30-8,N[C@@H](Cc(cc(c(O)c1)O)c1O)C(O)=O,
Î»-Cyhalothrin,Icon; Karate; lambda-Cyhalothrin,91465-08-6,CC(C)([C@@H]1/C=C(/C(F)(F)F)\Cl)[C@H]1C(O[C@H](c1cc(Oc2ccccc2)ccc1)C#N)=O,
Dexamethasone Phosphate disodium,EGP-437; EGP 437; EGP437. Dex-Phos,2392-39-4,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(COP([O-])([O-])=O)=O)O)C)O)F)C)=O.[Na+].[Na+],
Nafoxidine,,1845-11-0,COc(cc1)cc(CC2)c1C(c(cc1)ccc1OCCN1CCCC1)=C2c1ccccc1,
Eliapixant,BAY 1817080,1948229-21-7,C[C@H](c1cnc(C(F)(F)F)nc1)NC(c1cc(-c2ncc(C)s2)cc(O[C@H]2COCC2)c1)=O,
Rimtuzalcap,CAD-1883,2167246-24-2,Cc(cc1)nn1-c1nc(N2CCOCC2)cc(NC(CC2)CCC2(F)F)n1,
NMS-P715,,1202055-32-0,CCc1cccc(CC)c1NC(c1nn(C)c-2c1CCc1c2nc(Nc(ccc(C(NC2CCN(C)CC2)=O)c2)c2OC(F)(F)F)nc1)=O,
Pipamperone,Floropipamide; McN-JR 3345; R 3345,1893-33-0,NC(C1(CCN(CCCC(c(cc2)ccc2F)=O)CC1)N1CCCCC1)=O,
A 438079,,899507-36-9,Clc(cccc1-c2nnnn2Cc2cnccc2)c1Cl,
DCEBIO,,60563-36-2,CCN(c(c(N1)c2)cc(Cl)c2Cl)C1=O,
Allitinib,AST-1306; ALS 1306,897383-62-9,C=CC(Nc(cc12)ccc2ncnc1Nc(cc1)cc(Cl)c1OCc1cc(F)ccc1)=O,
Cinanserin hydrochloride,SQ 10643,54-84-2,CN(C)CCCSc(cccc1)c1NC(C=Cc1ccccc1)=O.Cl,
Heme Oxygenase-1-IN-1,HO-1-IN-1; Heme Oxygenase-1-IN-1,1093058-52-6,Brc1ccc(CCCCn2cncc2)cc1,
KY1220,,292168-79-7,[O-][N+](c(cc1)ccc1-n1c(C=C(C(N2)=O)NC2=S)ccc1)=O,
YS-49,,132836-42-1,OC1=CC2=C(C=C1O)C(NCC2)CC3=C4C=CC=CC4=CC=C3.[H]Br,
Pranidipine,OPC-13340,99522-79-9,CC(NC(C)=C(C1c2cccc([N+]([O-])=O)c2)C(OC/C=C/c2ccccc2)=O)=C1C(OC)=O,
Wnt pathway activator 1,,1360540-81-3,O=C(CCC(c(cc1)cc2c1OCCO2)=O)c1ccccc1,
MRT-10,MRT 10,330829-30-6,COc1cc(C(NC(Nc2cc(NC(c3ccccc3)=O)ccc2)=S)=O)cc(OC)c1OC,
Benzolamide,CL 11366; CL-11366; CL11366; W 1803; W-1803,3368-13-6,NS(c1nnc(NS(c2ccccc2)(=O)=O)s1)(=O)=O,
Linzagolix,,935283-04-8,COc(c(COc(c(OC)c1)cc(N(C(c2c(C(O)=O)scc2N2)=O)C2=O)c1F)c1F)ccc1F,
LOXO-195,BAY 2731954; (6RS)-LOXO-195,1350884-56-8,O=C1C2=C(N3N=C2)N=C(C=C3)N4[C@@](CCC4)([H])C5=CC(F)=CN=C5CCC(C)N1,
Compound 1T-0219 (SC),,383147-92-0,COc(cc1)ccc1C(ON=C(CCCC1)C1c(ccc([N+]([O-])=O)c1)c1[N+]([O-])=O)=O,
iMDK,,881970-80-5,O=C1Oc(cccc2)c2C=C1c1cn(cc(Cc(cc2)ccc2F)s2)c2n1,
(E/Z)-Zotiraciclib,(E/Z)-SB1317; (E/Z)-TG02,937270-47-8,CN(CC=CCCOc1cc(-c2nc(N3)ncc2)ccc1)Cc1cccc3c1,
TGFÎ²RI-IN-3,,2763602-67-9,O=S(C1=CC=C(C2=CC(N=CC=C3NC4=CC(C5=CC=CC(C)=C5)=NC=C4)=C3C=C2)C=C1)(C)=O,
NEO 376,SPI-376,496921-73-4,O=C(CCC1)c2c1n(CCN(CC1)CCN1c1cccc(Cl)c1)cc2,
Aripiprazole Lauroxil,,1259305-29-7,CCCCCCCCCCCC(OCN(C(CC1)=O)c2c1ccc(OCCCCN(CC1)CCN1c1cccc(Cl)c1Cl)c2)=O,
AZ-Dyrk1B-33,"3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine",1679330-37-0,Cc1nccc(-c2cn(Cc3ccccc3)c3c2ccnc3)n1,
CGP37157,"7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepine-2(3H)-one",75450-34-9,O=C(CSC1c(cccc2)c2Cl)Nc(cc2)c1cc2Cl,
Alflutinib,AST2818; ASK120067,1869057-83-9,CN(C)CCN(C)c(nc(c(Nc1nc(-c2cn(C)c3c2cccc3)ccn1)c1)OCC(F)(F)F)c1NC(C=C)=O,
Protosappanin A,PTA,102036-28-2,Oc(cc1)cc(OCC(C2)=O)c1-c(cc1O)c2cc1O,
S-23,S 23; S23; (S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide,1010396-29-8,C[C@](COc(cc1)cc(F)c1Cl)(C(Nc(cc1)cc(C(F)(F)F)c1C#N)=O)O,
Diphenhydramine,Syntedril; PM255; PM-255; Diphenhydramine; Dabylen; Debendrin,58-73-1,CN(C)CCOC(c1ccccc1)c1ccccc1,
Tolazoline,Vasimid; Benzalolin; Divascol; Pridazole; Priscol; Priscoline,59-98-3,C(C1=NCCN1)c1ccccc1,
DBT,"NSC-701994; NSC 701994; NSC701994; 4,7-Bis(thiophen-2-yl)benzo[c][1,2,5]thiadiazole",165190-76-1,c1csc(-c2ccc(-c3cccs3)c3nsnc23)c1,
Hematin,Ferrihemate; Ferriheme; Ferriheme hydroxide; Ferrihemic acid,15489-90-4,CC1=C(N23)/C=C4C(C)=C(C(/C=C(C(C)=C(/C5=C/C(C(C)=C/6CCC(O)=O)=NC6=C/C3=C1CCC(O)=O)C=C)\N5[Fe]2O)=N/4)C=C,
"N-(3-(5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide",,918504-27-5,CCCS(Nc(c(F)c1C(c(c2c3)c[nH]c2ncc3Br)=O)ccc1F)(=O)=O,
DHQ,"2,3-dihydroxy-quinoxalin",15804-19-0,O=C1Nc(cccc2)c2NC1=O,
Sepin-1,"Sepin 1; Sepin1; 2H-Benzimidazole, 2,2-dimethyl-5-nitro-, 1,3-dioxide",163126-81-6,CC1(C)[N+]([O-])=C(C=C(C=C2)[N+]([O-])=O)C2=[N+]1[O-],
Cerlapirdine,"SAM531; SAM-531; SAM 531; PF-05212365; P -05212365; WAY-262,531",925448-93-7,CN(C)CCCOc(cc1)cc2c1[nH]nc2S(c1cccc2ccccc12)(=O)=O,
BC-LI-0186,"4-(2,3-dimethyl-5-oxo-4-propan-2-ylpyrazol-1-yl)-N-(2-phenoxyethyl)benzenesulfonamide",695207-56-8,CC(C)C(C1=O)=C(C)N(C)N1c(cc1)ccc1S(NCCOc1ccccc1)(=O)=O,
BAZ1A-IN-1,,941521-45-5,[O-][N+](c1cccc(NC(Nc2nc(-c3ccccc3)cs2)=O)c1)=O,
NVP-LCQ195,LCQ-195; AT9311,902156-99-4,CS(N(CC1)CCC1NC(c1n[nH]cc1NC(c(c(Cl)ccc1)c1Cl)=O)=O)(=O)=O,
Naquotinib,ASP8273,1448232-80-1,CCc(nc(C(N)=O)c(Nc(cc1)ccc1N(CC1)CCC1N1CCN(C)CC1)n1)c1O[C@H](CC1)CN1C(C=C)=O,
"Kaempferol 3,7,4'-trimethyl ether","Kaempferol 3,7,4'-trimethylether",15486-34-7,COc(cc1)ccc1C(Oc(cc(cc1O)OC)c1C1=O)=C1OC,
N-âFeruloyloctopamine,N-Feruloyloctopamine,66648-44-0,COc(cc(/C=C/C(NCC(c(cc1)ccc1O)O)=O)cc1)c1O,
Crolibulin,EPC2407,1000852-17-4,COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC,
RMC-4550,,2172651-73-7,C[C@@H]1OCC(CC2)(CCN2c(nc2C)c(CO)nc2-c2cccc(Cl)c2Cl)[C@@H]1N,
MELK-IN-1,MELK inhibitor 17; Nintedanib Impurity L,2095596-44-2,CN(C(CN1CCN(C)CC1)=O)c(cc1)ccc1N/C(/c1ccccc1)=C(/c(cc(cc1)C(OC)=O)c1N1)\C1=O,
Tulrampator,CX-1632; S-47445,1038984-31-4,O=C1N(CCc2cccc(F)c2)N=Nc(cc23)c1cc3OCN(C1CC1)C2=O,
MK6-83,MK6 83; MK683,1062271-24-2,Cc(s1)ccc1S(Nc(cccc1)c1N1CCCCC1)(=O)=O,
BI-69A11,BI 69A11; BI69A11; (E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one,1233322-09-2,O=C(/C=C/c1nc(cccc2)c2[nH]1)C1=C(c2ccccc2)c(cc(cc2)Cl)c2NC1=O,
Venadaparib,IDX-1197; NOV140101,1681017-83-3,O=C(c(cc(CC(c1c2cccc1)=NNC2=O)cc1)c1F)N1CC(CNC2CC2)C1,
PTC299,"Emvododstat; (4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate",1256565-36-2,COc1ccc([C@@H](c2c(CC3)c(cc(cc4)Cl)c4[nH]2)N3C(Oc(cc2)ccc2Cl)=O)cc1,
AZD7624,AZD-7624,1095004-78-6,Cc(c(N(C=CN=C1NC2(CC2)c(cccc2)c2OCCNC)C1=O)cc(C(NC1CC1)=O)c1)c1F,
STL127705,"Compound L; 7-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]-3-(3-fluorophenyl)pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione",1326852-06-5,COc(ccc(CCNc(nc1)nc(NC(N2c3cccc(F)c3)=O)c1C2=O)c1)c1OC,
Broflanilide,,1207727-04-5,O=C(c1ccccc1)CN(C)c2c(F)c(C(Nc3c(Br)cc(C(C(F)(F)F)(F)C(F)(F)F)cc3C(F)(F)F)=O)ccc2,
IBR2,Isoquinoline,313526-24-8,O=S(Cc1ccccc1)(N(C1c2c[nH]c3c2cccc3)C=Cc2c1cccc2)=O,
Adaphostin,"NSC 680410; 1-Adamantyl 4-((2,5-Dihydroxybenzyl)Amino)Benzoate",241127-58-2,Oc(cc1)cc(CNc(cc2)ccc2C(OC2(CC(C3)C4)CC4CC3C2)=O)c1O,
TASIN-1,"1-[(4-methoxyphenyl)sulfonyl]-4'-methyl-4,1'-bipiperidine",792927-06-1,CC(CC1)CCN1C(CC1)CCN1S(c(cc1)ccc1OC)(=O)=O,
QX-222 chloride,QX 222; Lidocaine N-Methyl Hydrochloride,5369-00-6,Cc1cccc(C)c1NC(C[N+](C)(C)C)=O.[Cl-],
Brimonidine,AGN 190342; AGN-190342; AGN190342; Bromoxidine,59803-98-4,Brc(c1nccnc1cc1)c1NC1=NCCN1,
Regaloside H,,126239-77-8,OC[C@H](CO[C@@H]([C@@H]([C@H]1O)O)O[C@H](CO)[C@H]1O)OC(/C=C/c(cc1)ccc1O)=O,
CLP-3094,2-([2-(4-CHLOROPHENOXY)ETHYL]THIO)-1H-BE,312749-73-8,Clc(cc1)ccc1OCCSc1nc(cccc2)c2[nH]1,
(-)-Epipodophyllotoxin,(-)-Epipodophyllotoxin,4375-07-9,O=C(OC1)[C@@]2([H])[C@@]1([H])[C@H](O)C(C=C(OCO3)C3=C4)=C4[C@H]2C5=CC(OC)=C(OC)C(OC)=C5,
Gomisin G,,62956-48-3,O[C@@]([C@H]1OC(C2=CC=CC=C2)=O)(C)[C@@H](C)CC3=CC(OC)=C(OC)C(OC)=C3C4=C1C=C5OCOC5=C4OC,
Ganoderic acid B,,81907-61-1,CC1(C)[C@@H](O)CC[C@]2(C)C3=C([C@@]4(C(C[C@@H]([C@]4(CC3=O)C)[C@H](C)CC(C[C@@H](C)C(O)=O)=O)=O)C)[C@@H](O)C[C@@]12[H],
Pradefovir mesylate,Remofovir mesylate; Hepavir B; Pradefovir mesilate,625095-61-6,CS(O)(=O)=O.Nc1c2ncn(CCOC[P@@](OCC3)(O[C@@H]3c3cccc(Cl)c3)=O)c2ncn1,
Puerarin-4'-O-Î²-D-glucopyranoside,Puerarin4'-O-glucoside,117047-08-2,OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1c(c(OC=C1c(cc2)ccc2O[C@@H]([C@@H]([C@H]2O)O)O[C@H](CO)[C@H]2O)c(cc2)C1=O)c2O,
DMAPT,Dimethylamino Parthenolide,870677-05-7,O=C1[C@H](CN(C)C)[C@@](CC/C(C)=C/CC[C@]2(C)[C@]3([H])O2)([H])[C@]3([H])O1,
F-1,,2244775-31-1,CN(CC1)CCN1c(cc1)nc(OC)c1Nc(nc1)nc(Nc(cccc2)c2NS(C)(=O)=O)c1Cl,
HLY78,"4-Ethyl-5-methyl-5,6-dihydro-[1,3]dioxolo[4,5-j]phenanthridine",854847-61-3,CCc1cccc(-c2c3)c1N(C)Cc2cc1c3OCO1,
IDH-305,,1628805-46-8,C[C@@H]([C@@H](COC1=O)N1c1ccnc(N[C@@H](C)c(nc2)cc(C)c2-c2cc(C(F)(F)F)ncc2)n1)F,
NCT-502,"N-(4,6-dimethylpyridin-2-yl)-4-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carbothioamide",1542213-00-2,Cc1cc(NC(N(CC2)CCN2c2ncc(C(F)(F)F)cc2)=S)nc(C)c1,
Cinitapride,Cidine; Blaston; Cinmove; Cintapro; Paxapride; cinitapride tartrate,66564-14-5,CCOc(c(C(NC1CCN(CC2CC=CCC2)CC1)=O)c1)cc(N)c1[N+]([O-])=O,
Fexofenadine,Carboxyterfenadine; Allegra; MDL 16.455; Telfast; Carboxyterfenadine,83799-24-0,CC(C)(C(O)=O)c1ccc(C(CCCN(CC2)CCC2C(c2ccccc2)(c2ccccc2)O)O)cc1,
Diphenylcyclopropenone,Diphencyprone; DPCP; Diphenylcyclopropenone,886-38-4,O=C1C(c2ccccc2)=C1c1ccccc1,
L-745870 trihydrochloride,,866021-03-6,ClC1=CC=C(C=C1)N2CCN(CC2)CC3=CNC4=C3C=CC=N4.Cl.Cl.Cl,
Sitagliptin phosphate,Januvia; MK-0431 phosphate,654671-78-0,N[C@@H](CC(N1Cc2nnc(C(F)(F)F)n2CC1)=O)Cc(c(F)c1)cc(F)c1F.OP(O)(O)=O,
Indican,NSC-87517; NSC 87517; NSC87517; Indoxyl-Î²-D-glucoside; 3-Indoxyl-beta-D-glucopyranoside,487-60-5,OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1Oc1c[nH]c2c1cccc2,
TASIN-1 Hydrochloride,TASIN 1 Hydrochloride; TASIN1 Hydrochloride; TASIN-1 HCl; TASIN 1 HCl; TASIN1 HCl,1678515-13-3,CC1CCN(CC1)C2CCN(CC2)S(=O)(C3=CC=C(C=C3)OC)=O.[H]Cl,
EF24,"EF-24; 3,5-Bis[(2-fluorophenyl)Methylene]-4-piperidinone",342808-40-6,O=C1C(=CC=2C=CC=CC2F)CNCC1=CC=3C=CC=CC3F,
N-Caffeoyltryptophan,trans-Caffeoyl-L-tryptophan,109163-69-1,OC([C@H](Cc1c[nH]c2c1cccc2)NC(/C=C/c(cc1)cc(O)c1O)=O)=O,
Crocin III,Crocin-3; Crocetin-mono-(Î²-D-gentiobiosyl)-ester,55750-85-1,O[C@H]1[C@H](OC(/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C(O)=O)=O)O[C@H](CO[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O)[C@@H](O)[C@@H]1O,
R1530,R 1530; R-1530,882531-87-5,CC1=C2N=C(c(cccc3)c3Cl)c(cc(c(OC)c3)F)c3N=C2NN1,
Vipivotide tetraxetan,PSMA-617,1702967-37-0,OC(CC[C@@H](C(O)=O)NC(N[C@@H](CCCCNC([C@H](Cc1cc2ccccc2cc1)NC([C@H]1CC[C@H](CNC(CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)=O)CC1)=O)=O)C(O)=O)=O)=O,
ACP-105,,899821-23-9,N#CC1=CC=C(N2[C@@H]3C[C@@](C)(O)C[C@H]2CC3)C(C)=C1Cl,
Talipexole dihydrochloride,B-HT 920 dihydrochloride; Domnin,36085-73-1,C=CCN(CC1)CCc2c1nc(N)s2.Cl.Cl,
Bragsin2,6-methoxy-5-nitro-2-(trifluoromethyl)chromen-4-one; Bragsin 2,342795-08-8,COc(ccc(OC(C(F)(F)F)=C1)c2C1=O)c2[N+]([O-])=O,
Isoguvacine hydrochloride,"1,2,3,6-tetrahydro-4-pyridinecarboxylic acid hydrochloride",68547-97-7,C1CNCC=C1C(=O)O.Cl,
K-Ras G12C-IN-4,,2376328-55-9,Cc1c2n(CC(NC(C3)CN3C(C=C)=O)=O)c(C3CC3)c(C(N(CC3)Cc4c3c(OC)ccc4)=O)c2cc(Cl)c1,
Tropisetron,ICS 205-930; Tropisetronum; Tropisteron,89565-68-4,CN1[C@@H]2CC[C@H]1C[C@@H](OC(C3=CNC4=CC=CC=C43)=O)C2,
FR 122047 hydrochloride,"1-[(4,5-Bis(4-methoxyphenyl-2-thiazoyl)carbonyl]-4-methylpiperazine, Hydrochloride; 4,5-Bis(4-methoxyphenyl-2-[(1-methylpiperazin-4-yl)carbonyl]thiazole, Hydrochloride",130717-51-0,CN1CCN(CC1)C(=O)C2=NC(=C(S2)C3=CC=C(C=C3)OC)C4=CC=C(C=C4)OC.Cl,
ICI 89406,1-[2-[[3-(2-cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylurea,53671-71-9,N#Cc(cccc1)c1OCC(CNCCNC(Nc1ccccc1)=O)O,
Idalopirdine Hydrochloride,Lu AE58054 Hydrochloride; Idalopirdine hydrochloride; Idalopirdine HCl,467458-02-2,C1=CC(=CC(=C1)OCC(C(F)F)(F)F)CNCCC2=CNC3=C2C=CC(=C3)F.Cl,
MIRA-1,"NSC 19630; 1-[(1-Oxopropoxy)methyl]-1H-pyrrole-2,5-dione; (2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl propionate; WRN Helicase Inhibitor; p53 Activator VIII",72835-26-8,CCC(OCN(C(C=C1)=O)C1=O)=O,
MK-4827 Racemate,Niraparib Racemate; 2-(4-piperidin-3-ylphenyl)indazole-7-carboxamide,1038915-75-1,NC(c1cccc2cn(-c3ccc(C4CNCCC4)cc3)nc12)=O,
N-tert-butyl-Î±-Phenylnitrone,(Z)-N-benzylidene-2-Methylpropan-2-aMine oxide,3376-24-7,CC(C)(C)[N+]([O-])=Cc1ccccc1,
SR 11302,,160162-42-5,CC1(C)C(/C=C/C(/c2ccc(C)cc2)=C/C=C/C(/C)=C/C(O)=O)=C(C)CCC1,
8-Hydroxy-2'-deoxyguanosine,8-Oxo-dG; 8-Hydroxydeoxyguanosine; 8-Oxo-2'-deoxyguanosine; 2'-Deoxy-8-oxoguanosine; 8 OHdG; 8-Hydroxy-2-Deoxyguanosine,88847-89-6,NC(NC1=O)=NC(N2[C@@H](C3)O[C@H](CO)[C@H]3O)=C1NC2=O,
SKLB-163,SKLB 163; SKLB163,1255099-06-9,O=C(CSc1nc(ccc(NC(CCl)=O)c2)c2s1)NCc1ccccc1,
BMS-8,BMS8; BMS 8; BMS-8,1675201-90-7,Cc1c(COc(ccc(CN(CCCC2)C2C(O)=O)c2)c2Br)cccc1-c1ccccc1,
Suprafenacine,"N'-[(E)-(4-methylphenyl)methylidene]-4,5,6,7-tetrahydro-1H-indazole-3-carbohydrazide",1477482-50-0,Cc1ccc(/C=N/NC(c2n[nH]c3c2CCCC3)=O)cc1,
VPC-13163,"VPC 13163; VPC13163; NSC 52361; NSC52361; NSC52361; 2,3-dihydro-2,3'-Bi-1H-indole",6637-10-1,C1(C2=CNC3=C2C=CC=C3)NC4=C(C=CC=C4)C1,
IXA4,,1185329-96-7,Cc(cc1)ccc1OCCN(C)C(Cn1ncc(NC(CCOc2ccccc2)=O)c1)=O,
AMP-945,,1393653-34-3,CN(CC1)CCC1c(cc1)cc(OC)c1Nc1nc(CCc2c(CC(N)=O)cccc2)c(C(F)(F)F)cn1,
Methyl oleanonate,3-Oxoolean-12-en-28-oic acid methyl ester; Methyl oleanonate,1721-58-0,CC1(C)C(CC[C@]2(C)[C@@]3([H])CC=C4[C@]5([H])CC(C)(C)CC[C@@](C(OC)=O)5CC[C@](C)4[C@@](C)3CC[C@@]12[H])=O,
1-phenoxazin-10-ylethanone,10-acetylphenoxazine; N-Acetylphenoxazine; HJ-PI01,6192-43-4,CC(N1c(cccc2)c2Oc2c1cccc2)=O,
Nastorazepide,Z-360,209219-38-5,CC(C)(C)C(CN(c(cccc1)c1N(C[C@H]1NC(Nc2cc(C(O)=O)ccc2)=O)C2CCCCC2)C1=O)=O,
DL-Tryptophan,Tryptophan; DL-Tryptophan; (Â±)-Tryptophan,54-12-6,N[C@@H](Cc1c[nH]c2c1cccc2)C(O)=O,
Delgocitinib,JTE-052; Corectimï¼Delgocitinibï¼,1263774-59-9,C[C@@H](C1)[C@](CC2)(CN2c2ncnc3c2cc[nH]3)N1C(CC#N)=O,
Esaxerenone,CS-3150; XL-550,1632006-28-0,O=C(NC1=CC=C(C=C1)S(=O)(C)=O)C2=CN(C(C3=CC=CC=C3C(F)(F)F)=C2C)CCO,
SK33,,1928724-23-5,CC(COc1cc(C(F)(F)F)cc(C(F)(F)F)c1)(C(Nc(cc1)cc(C(F)(F)F)c1C#N)=O)O,
JNJ-61432059,,2035814-50-5,OC(CC1)CCN1c(n1nc2-c(cc3)ccc3F)nccc1c2-c(cc1)cc(C2)c1NC2=O,
ZX-29,,2254805-62-2,CN(CC1)CCN1c(cc1)cc(OC)c1Nc(nc1)nc(Nc(cccc2)c2NS(C)(=O)=O)c1Cl,
Isoasatone A,,67451-73-4,O=C1C(OC)(C2C(C(/C=C/C)=CC3(C2(C=C1OC)CC=C)OC)C(OC)(C3=O)OC)OC,
m-Chlorophenylbiguanide hydrochloride,1-(3-Chlorophenyl)biguanidehydrochloride,2113-05-5,NC(NC(Nc1cccc(Cl)c1)=N)=N.Cl,
"Methyl 2,5-dihydroxycinnamate",,63177-57-1,COC(C=Cc(cc(cc1)O)c1O)=O,
Ononetin,"2',4'-Dihydroxy-2-(4-methoxyphenyl)acetophenone",487-49-0,COc1ccc(CC(c(ccc(O)c2)c2O)=O)cc1,
LIMK-IN-22j,LIMK IN 22j; LIMKIN22j; LIMK inhibitor 22j; LIMK inhibitor-22j,1116571-01-7,C[C@@H](CN(CC1)c2ncnc3c2c(C)c[nH]3)N1C(NC#N)=Nc1cccc(Br)c1,
CAY10526,CAY-10526; CAY 10526; BTH,938069-71-7,OC(C(c1cc(cccc2)c2s1)=C1Br)OC1=O,
AC-90179 HCl,AC-90179; AC 90179; AC90179; AC-90179 HCl; AC-90179 hydrochloride,359878-19-6,O=C(CC1=CC=C(C=C1)OC)N(C2CCN(CC2)C)CC3=CC=C(C=C3)C.[H]Cl,
VPC-13566,VPC13566; VPC 13566,218464-59-6,Cc1cccc2c1[nH]cc2-c1nc2ccccc2cc1,
CLEFMA,,1246964-32-8,OC(/C=C\C(N(C/C(/C1=O)=C\c(cccc2)c2Cl)C/C1=C\c(cccc1)c1Cl)=O)=O,
NT157,,1384426-12-3,Oc1cc(CNC(/C=C/c(cc2O)cc(Br)c2O)=S)cc(O)c1O,
ARRY 520 hydrochloride,,1385020-40-5,O=C(N1[C@@](C2=CC=CC=C2)(CCCN)SC(C3=CC(F)=CC=C3F)=N1)N(OC)C.[H]Cl,
CCTA-1523,,1616271-41-0,COc(ccc(-c1cccc(NC(C(Cl)Cl)=O)c1)c1)c1OC,
CCT128930 hydrochloride,CCT128930 hydrochloride(885499-61-6 Free base),2453324-32-6,NC1(CC2=CC=C(Cl)C=C2)CCN(C3=C4C(NC=C4)=NC=N3)CC1.[H]Cl,
MRTX9768,MRTX-9768; MRTX9768,2629314-68-5,FC1=C(C2=C(C3=CC=C(C(NN=C4CN)=O)C4=C3)C=NN2C)C(C#N)=C(C=CC=C5)C5=C1,
trifarotene,CD5789,895542-09-3,CC(C)(C)c(cc(cc1)-c(cc(cc2)-c(cc3)ccc3C(O)=O)c2OCCO)c1N1CCCC1,
(-)-Î±-Pinene,(1S)-(-)-Alpha-Pinene,7785-26-4,CC1(C)[C@@H]2C(C)=CC[C@H]1C2,
3-O-Methylgallic acid,"3,4-Dihydroxy-5-methoxybenzoic acid; 3,4-Dihydroxy-5-methoxybenzoic acid",3934-84-7,COc(cc(cc1O)C(O)=O)c1O,
Myristyl nicotinate,Tetradecyl nicotinate,273203-62-6,CCCCCCCCCCCCCCOC(c1cnccc1)=O,
2-(Methylamino)-1H-purin-6(7H)-one,N2-methylguanine,10030-78-1,CNC(NC1=O)=Nc2c1nc[nH]2,
N-Oleoyl glycine,,2601-90-3,CCCCCCCC/C=C\CCCCCCCC(NCC(O)=O)=O,
DMTr-LNA-5MeU-3-CED-phosphoramidite,,206055-75-6,CC(C)N(C(C)C)P(OCCC#N)O[C@@H]([C@H]1OC2)[C@@]2(COC(c2ccccc2)(c(cc2)ccc2OC)c(cc2)ccc2OC)O[C@H]1N(C=C(C)C(N1)=O)C1=O,
Elacestrant dihydrochloride,RAD1901 dihydrochloride; Elacestrant dihydrochloride,1349723-93-8,OC1=CC=C2C[C@@H](CCC2=C1)C3=CC=C(C=C3N(CC4=CC=C(C=C4)CCNCC)CC)OC.[H]Cl.[H]Cl,
EOAI3402143,,1699750-95-2,CCCC(c(cc1)ccc1OCCN1CCOCC1)NC(/C(/C#N)=C/c(nc(cc1)Cl)c1Cl)=O,
CDD3505,4-nitro-1-trityl-1H-imidazole,173865-33-3,[O-][N+](c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1)=O,
CDD3506,1-TRITYL-1H-IMIDAZOL-4-AMINE,197913-15-8,Nc1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1,
LP-935509,,1454555-29-3,CC(C)OC(N(CC1)CCN1c(ccn1nc2)nc1c2-c(cccn1)c1OC)=O,
Phenoxodiol,Idronoxil; Dehydroequol; Haginin E,81267-65-4,Oc(cc1)ccc1C1=Cc(ccc(O)c2)c2OC1,
Nesolicaftor,PTI-428; Nesolicaftor,1953130-87-4,C[C@H](c1nnc([C@H](C2)C[C@@H]2NC(c2cc(-c3ccccc3)no2)=O)o1)O,
RN-1747,,1024448-59-6,[O-][N+](c(cc(cc1)Cl)c1S(N1CCN(Cc2ccccc2)CC1)(=O)=O)=O,
Voruciclib,,1000023-04-0,CN(CC1)[C@@H](CO)[C@@H]1c(c(OC(c(ccc(C(F)(F)F)c1)c1Cl)=C1)c(c(O)c2)C1=O)c2O,
Doxazosin,UK 33274,74191-85-8,COc(cc1c(N)nc(N(CC2)CCN2C(C2Oc(cccc3)c3OC2)=O)nc1c1)c1OC,
SB 452533,,459429-39-1,CCN(CCNC(Nc(cccc1)c1Br)=O)c1cc(C)ccc1,
AVN-101,AVN 101; AVN101,1061354-48-0,CC1=CC2=C(N(CCC3=CC=CC=C3)C4=C2CN(C)CC4)C=C1.[H]Cl,
CRT0273750,CRT 0273750; CRT-0273750,1979939-16-6,C[C@@H](c(cc1)ccc1Cl)NC(CCc(n1Cc(cc2)ccc2OC(F)(F)F)nc2c1nccc2)=O,
Piperonylic acid,"2H-1,3-benzodioxole-5-carboxylic acid",94-53-1,OC(c(cc1)cc2c1OCO2)=O,
Senaparib,IMP4297,1401682-78-7,O=C(c(cc(CN(c1cccc(F)c1C(N1)=O)C1=O)cc1)c1F)N(CC1)CCN1c1ncccn1,
LP-261,,915412-67-8,COc1nccc(C(c2cc(NS(C)(=O)=O)cc(-c3c(cc[nH]4)c4ccc3)c2)=O)c1,
Gentisin,,437-50-3,COc(cc1O)cc(Oc(cc2)c3cc2O)c1C3=O,
AZD7507,,1041852-85-0,Cc(cc1)cc(F)c1Nc(c1c2)c(C(N)=O)nnc1cc(OC)c2N1CCN(CCO)CC1,
(S)-(-)-5-Fluorowillardiine,(5S)-Fluorowillardiine; (S)-5-Fluorowillardiine,140187-23-1,N[C@@H](CN(C=C(C(N1)=O)F)C1=O)C(O)=O,
Ganciclovir sodium,RS-21592 sodium; Cytovene IV sodium; BW 759 sodium; 2'-Nor-2'-deoxyguanosine sodium,107910-75-8,NC(NC1=C2N=CN1COC(CO)CO)=NC2=O.[Na],
Esomeprazole,,119141-88-7,Cc1cnc(C[S@@](c2nc(ccc(OC)c3)c3[nH]2)=O)c(C)c1OC,
Ocinaplon,DOV 273547,96604-21-6,O=C(c1c2nccc(-c3ccncc3)n2nc1)c1ncccc1,
Rebamipide mofetil,,1527495-76-6,O=C(C(CC(c(cccc1)c1N1)=CC1=O)NC(c(cc1)ccc1Cl)=O)OCCN1CCOCC1,
1-Methylguanosine,N1-Methylguanosine,2140-65-0,CN(C1=O)C(N)=Nc2c1ncn2[C@@H]([C@@H]1O)O[C@H](CO)[C@H]1O,
1-Methylinosine,"N1-Methylinosine;Inosine, 1-methyl",2140-73-0,CN(C=Nc1c2ncn1[C@@H]([C@@H]1O)O[C@H](CO)[C@H]1O)C2=O,
Apararenone,MT-3995,945966-46-1,CC(C)(C1=O)Oc(cc(cc2)NS(C)(=O)=O)c2N1c(cc1)ccc1F,
Ivachtin,Caspase-3 Inhibitor VII,745046-84-8,CC(OCCN(C(c1c(C)nc(ccc(S(N2CCOCC2)(=O)=O)c2)c2c11)=O)C1=O)=O,
Carboprost,15(S)-15-Methyl Prostaglandin F2Î±;15-Methyl-PGF2Î±,35700-23-3,CCCCC[C@@](C)(/C=C/[C@H]([C@@H](C/C=C\CCCC(O)=O)[C@H](C1)O)[C@@H]1O)O,
Lenaldekar,LDK,418800-15-4,C1(C=NNC2=C3N=CC=CC3=CC=C2)=CNC4=C1C=CC=C4,
Methotrexate metabolite,DAMPA,19741-14-1,CN(Cc1nc2c(N)nc(N)nc2nc1)c(cc1)ccc1C(O)=O,
5-Benzyloxygramine,,1453-97-0,CN(C)Cc1c[nH]c(cc2)c1cc2OCc1ccccc1,
"Benzo[b]thiophene-2-sulfonamide, N-[3-(aminomethyl)phenyl]-5-chloro-3-methyl-",,2428737-43-1,Cc(c(cc(cc1)Cl)c1s1)c1S(Nc1cc(CN)ccc1)(=O)=O,
Arjunolic acid,,465-00-9,C[C@@]1(CO)[C@@H](O)[C@H](O)C[C@]2(C)[C@@]3([H])CC=C4[C@]5([H])CC(C)(C)CC[C@@](C(O)=O)5CC[C@](C)4[C@@](C)3CC[C@@]12[H],
Atuveciclib Racemate,BAY-1143572 Racemate; BAY-1143572,1414943-88-6,COc(cc(cc1)F)c1-c1ncnc(Nc2cccc(CS(C)(=N)=O)c2)n1,
3BDO,,890405-51-3,O=C(O1)C(CC2=CC=CC=C2)CC1COC3=CC=CC=C3[N+]([O-])=O,
Selisistat R-enantiomer,EX-527 (R-enantiomer),848193-69-1,NC([C@H](CCC1)c2c1c(cc(cc1)Cl)c1[nH]2)=O,
NRC-2694,,936446-61-6,COc1cc2ncnc(Nc3cc(C#C)ccc3)c2cc1OCCCN1CCOCC1,
Piperazine citrate,,144-29-6,OC(CC(O)=O)(CC(O)=O)C(O)=O.OC(CC(O)=O)(CC(O)=O)C(O)=O.C1NCCNC1.C1NCCNC1.C1NCCNC1,
Sulcotrione,,99105-77-8,CS(c(cc1)cc(Cl)c1C(C(C(CCC1)=O)C1=O)=O)(=O)=O,
Tepoxalin,ORF-20485; ORF20485; ORF 20485; RWJ-20485; RWJ 20485; RWJ20485,103475-41-8,CN(C(CCc(cc1-c(cc2)ccc2Cl)nn1-c(cc1)ccc1OC)=O)O,
Se-Methylselenocysteine,MSeC; Se-MSC; SeMCys; Se MSC; SeMSC,26046-90-2,C[Se]C[C@@H](C(O)=O)N,
BUR1,BUR-1; BUR 1; BMP upregulator 1; BMP upregulator-1,23000-46-6,C(CC1)CCN1c1ncnc2c1cnn2-c1ccccc1,
BRD32048,BRD-32048; BRD 32048,433694-46-3,COc(cc1)ccc1Nc1nc(N)nc(CN2CCCCC2)n1,
AC-262536,AC 262536; AC262536,870888-46-3,N#CC1=C2C=CC=CC2=C(C=C1)N3[C@H]4C[C@@H](C[C@@H]3CC4)O,
Z944,Z-944; Z 944; Z944,1199236-64-0,CC(C)(C)NC(CN1CCC(CNC(c2cc(Cl)cc(F)c2)=O)CC1)=O,
Selisistat S-enantiomer,EX-527 (S-enantiomer); EX-527 S-enantiomer,848193-68-0,NC([C@@H](CCC1)c2c1c(cc(cc1)Cl)c1[nH]2)=O,
Paltusotine,,2172870-89-0,NC(CC1)CCN1c(c1cc(-c(cccc2C#N)c2O)ccc1nc1)c1-c1cc(F)cc(F)c1,
"3-(7,7-dimethyl-5-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-2-yl)-1H-indole-7-carbonitrile",,2759137-87-4,CC1(C)NC(C2=C1N=C(C3=CNC4=C3C=CC=C4C#N)C=C2)=O,
MHY-1685,"5-(4-hydroxyphenyl)methylenehexahydropyrimidine-2,4,6-trione",27406-31-1,Oc1ccc(C=C(C(NC(N2)=O)=O)C2=O)cc1,
beta-Estradiol 17-hemisuccinate,,7698-93-3,C[C@@]12[C@@H](OC(CCC(O)=O)=O)CC[C@@]1([H])[C@]3([H])CCC4=C(C=CC(O)=C4)[C@@]3([H])CC2,
dGTP,2'-deoxyguanosine 5'-(tetrahydrogen triphosphate),2564-35-4,O[C@@H](C[C@H](N1C=NC2=C1N=C(N)NC2=O)O3)[C@H]3COP(O)(OP(OP(O)(O)=O)(O)=O)=O,
CTCE 9908 acetate,CTCE 9908 acetate(1030384-98-5 Free base),TP2051L,CC(O)=O.O=C(N)[C@H](CCCCNC([C@H](CCCNC(N)=N)NC([C@H](CC1=CC=C(O)C=C1)NC([C@H](CO)NC([C@H](CC(C)C)NC([C@H](CO)NC([C@H](C(C)C)NC(CNC([C@H](CCCCN)N)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CC2=CC=C(O)C=C2)NC([C@H](CO)NC([C@H](CC(C)C)NC([C@H](CO)NC([C@H](C(C)C)NC(CNC([C@H](CCCCN)N)=O)=O)=O)=O)=O)=O)=O)=O,
Fosifidancitinib,,1237168-58-9,Cc1cc(Nc2ncc(C)c(Nc(cc3)cc(N4COP(O)(O)=O)c3OC4=O)n2)cc(OC)c1F,
Fanotaprim,,2120282-75-7,COc(nc1)ncc1-c1cc(N(CC2)CCN2c2c(N)nc(N)nc2)ccc1,
VY-3-135,,1824637-41-3,CCn1c(cc(cc2)C(NC[C@@H](C)O)=O)c2nc1C(c1ccccc1)(c1ccccc1)O,
CDK4/6-IN-6,,2380321-51-5,CC(C)n1c2cc(-c(nc(N[C@H](CCOC3)[C@@H]3O)nc3)c3Cl)cc(F)c2nc1C(C)(C)O,
2'-Fluoro-2'-Deoxyadenosine,,64183-27-3,Nc1c2ncn([C@@H]([C@@H]3F)O[C@H](CO)[C@H]3O)c2ncn1,
DS-7423,,1222104-37-1,C[C@H](CN(CC1)c2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)nc3n2CC(F)(F)F)N1C(C)=O,
2â-OMe-Guanosine,,2140-71-8,CO[C@H]1[C@H](n2c(N=C(N)NC3=O)c3nc2)O[C@H](CO)[C@H]1O,
2'-Deoxy-2'-fluorocytidine,,10212-20-1,NC(C=CN1[C@@H]([C@@H]2F)O[C@H](CO)[C@H]2O)=NC1=O,
2â²-Deoxy-2â²-fluoroguanosine,,78842-13-4,NC(NC1=O)=Nc2c1ncn2[C@@H]([C@@H]1F)O[C@H](CO)[C@H]1O,
2â²-O-Methylcytidine,,2140-72-9,CO[C@H]1[C@H](N(C=CC(N)=N2)C2=O)O[C@H](CO)[C@H]1O,
1-Ethynylpyrene,,34993-56-1,C#Cc1ccc(ccc2ccc3)c4c2c3ccc14,
Soyasaponin Ab,,118194-13-1,CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](CO[C@H]([C@@H]2O)O[C@@H]3[C@@H](C(C[C@@H]4[C@]3(CC[C@@]5(C4=CC[C@H]6[C@]5(CC[C@@H]7[C@@]6(CC[C@@H]([C@]7(C)CO)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)C(=O)O)O)O)O[C@H]9[C@@H]([C@H]([C@H]([C@H](O9)CO)O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)C)C)C)C)(C)C)O)O)OC(=O)C)OC(=O)C)OC(=O)C,
A 1070722,,1384424-80-9,COc1ccc(c(NC(Nc2cccc(C(F)(F)F)n2)=O)ccn2)c2c1,
Autogramin-1,,2375541-73-2,CCCN(C(c(ccc(C(Nc1nc(CCN(C2)C(OC(C)(C)C)=O)c2s1)=O)c1)c1N1)=O)C1=O,
RY785,,1393748-80-5,CC(Cc1cc(OC)ccc1)C(Nc(cc1)cc2c1nc(-c1cscn1)[nH]2)=O,
SKF89976A hydrochloride,"d,l-SKF89976A hydrochloride",85375-15-1,O=C(C1CN(CC/C=C(C2=CC=CC=C2)/C3=CC=CC=C3)CCC1)O.[H]Cl,
SN 2,CS-1190,823218-99-1,Cc1cc(C)c(C2=NOC3C2C2CC3CC2)c(C)c1,
USP7-IN-1,,1381291-36-6,OC(CN(C=Nc1c2ccc(Cl)c1)C2=O)(CC1)CCN1C(CCc1ccccc1)=O,
KBU2046,,1143863-69-7,O=C1c(cccc2)c2OCC1c(cc1)ccc1F,
ON-013100,,865783-95-5,COc1cc(OC)c(/C=C/S(Cc(cc2)cc(O)c2OC)(=O)=O)c(OC)c1,
KY-05009,,1228280-29-2,Cc(cc1)ccc1C(Nc1c(C(N)=O)nc(Nc2ccccc2)s1)=O,
Prochloraz,Prelude; Prochloraz; Sporgon,67747-09-5,CCCN(CCOc(c(Cl)cc(Cl)c1)c1Cl)C(n1cncc1)=O,
Bretazenil,Ro 16-6028,84379-13-5,CC(C)(C)OC(c(nc1)c([C@H]2N3CCC2)n1-c1cccc(Br)c1C3=O)=O,
JW 67,JW67,442644-28-2,O=C(C1(OC2)OCC22COC(c(cccc3)c3N3)(C3=O)OC2)Nc2c1cccc2,
Pentabromophenol,NSC 5717; NSC-5717; NSC5717,608-71-9,Oc(c(Br)c(c(Br)c1Br)Br)c1Br,
Amperozide,FG 5606; Amperozida; Amperozidum,75558-90-6,CCNC(N1CCN(CCCC(c(cc2)ccc2F)c(cc2)ccc2F)CC1)=O,
cjoc42,cjoc-42; cjoc 42,2171519-89-2,O=C(OC)C1=CC=C(N2N=NC(CCCOS(=O)(C3=CC=C(C)C=C3)=O)=C2)C=C1,
CC-90001,,1403859-14-2,C[C@H](CC[C@H](C1)Nc(nc(NC(C)(C)C)nc2)c2C(N)=O)[C@@H]1O,
DS-1971a,,1450595-86-4,Cn1nccc1[C@@H](CCCC1)[C@H]1Oc(cc(c(S(Nc1ncncc1)(=O)=O)c1)F)c1Cl,
TL-895,,1415823-49-2,C=CC(N(CC1)CCC1(CNc1ncnc(N)c1-c(cc1)ccc1Oc1ccccc1)F)=O,
WAY-303290,,323176-64-3,O=C(c(sc1c2cccc1)c2Cl)NCc1cnccc1,
SIRT7 inhibitor 97491,,1807758-81-1,Nc1cccc(Nc2ncc(-c(cc3)ccc3Cl)o2)c1,
3-Deazauridine,,23205-42-7,OC[C@H]([C@H]([C@H]1O)O)O[C@H]1N(C=CC(O)=C1)C1=O,
N-Acetyl-D-cysteine,(S)-2-Acetamido-3-mercaptopropanoic acid,26117-28-2,CC(N[C@H](CS)C(O)=O)=O,
DSRM-3716,5-Iodoisoquinoline,58142-99-7,Ic1cccc2cnccc12,
Niaprazine,Nopron; 1709 CERM,27367-90-4,CC(CCN(CC1)CCN1c(cc1)ccc1F)NC(c1cnccc1)=O,
Ara-G,9-(BETA-D-ARABINOFURANOSYL)GUANINE,38819-10-2,NC(NC1=O)=Nc2c1ncn2[C@@H]([C@H]1O)O[C@H](CO)[C@H]1O,
Chlorcyclizine,1-((4-chlorophenyl)(phenyl)Methyl)-4-Methylpiperazine,82-93-9,CN(CC1)CCN1C(c1ccccc1)c(cc1)ccc1Cl,
COR659,Methyl 2-(4-chlorobenzamido)-4-ethyl-5-methylthiophene-3-carboxylate,544450-68-2,CCc1c(C)sc(NC(c(cc2)ccc2Cl)=O)c1C(OC)=O,
NSC622608,,2593254-90-9,CN(C)C(SS1)=NC1=NCC2=CC=CO2.[H]Br,
VX-150,,1793080-72-4,Cc(cc(cc1)F)c1Oc(cc(C(F)(F)F)cc1)c1C(NC(C=CN1COP(O)(O)=O)=CC1=O)=O,
TBAP-001,,1777832-90-2,CC(C)(C)c(cc1NC(Nc(ccc(Oc(ccnc2N3)c2N=CC3=O)c2)c2F)=O)nn1-c1cc(F)ccc1,
LOX-IN-3 dihydrochloride,,2409964-23-2,NC/C=C(F)/CS(=O)(C1=C2N=CC=CC2=CC=C1)=O.[H]Cl.[H]Cl,
"2,5-dimethyl Celecoxib",Celecoxib-13; Celecoxib Impurity 42; Celecoxib Impurity K,457639-26-8,Cc1cc(-c2cc(C(F)(F)F)nn2-c(cc2)ccc2S(N)(=O)=O)c(C)cc1,
TH5427,,2253744-56-6,CN(c1c(C(N2C)=O)n(Cc3nnc(-c(cc4)cc(Cl)c4Cl)o3)c(N3CCNCC3)n1)C2=O,
Urolithin C,,165393-06-6,Oc(cc1)cc(O2)c1-c(cc(c(O)c1)O)c1C2=O,
ML339,,2579689-83-9,O=C(NC1=CC=CC=C1Cl)CN2[C@H]3C[C@@H](NC(C4=CC(OC)=C(OC)C(OC)=C4)=O)C[C@@H]2CCC3,
Elevenostat,JB3-22,1454902-97-6,COc(cccc1)c1NC(NCc(cc1)ccc1C(NO)=O)=O,
IRAK-4 protein kinase inhibitor 2,,301675-24-1,[O-][N+](c1cc(C(Nc2nc(cccc3)c3[nH]2)=O)ccc1)=O,
TNIK-IN-2,,2754265-76-2,COc1cccc(NC(c(ccc(-c2cnc3[nH]ccc3c2)c2)c2OC)=O)c1,
ML115,,912798-42-6,COc(c(NC(c1noc(C2CC2)c1)=O)c1)cc(Cl)c1OC,
NAV-2729,,419547-11-8,[O-][N+](c(cc1)ccc1C(Nc(n1nc2Cc3ccccc3)c2-c(cc2)ccc2Cl)=CC1=O)=O,
Cyfluthrin,,68359-37-5,CC(C)(C1C=C(Cl)Cl)C1C(OC(c(cc1)cc(Oc2ccccc2)c1F)C#N)=O,
Feretoside,,27530-67-2,COC(C([C@H]([C@H]1C(CO)=C2)[C@@H]2O)=CO[C@H]1O[C@@H]([C@@H]([C@H]1O)O)O[C@H](CO)[C@H]1O)=O,
Î±-Humulene,Humulene; Î±-Caryophyllene,6753-98-6,CC1(C)/C=C/C/C(/C)=C/CC/C(/C)=C/C1,
Beta-Tocopherol,,148-03-8,CC1=C2C(CC[C@](C)(O2)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C(O)=C1)C,
Chrysosplenol D,,14965-20-9,COc(cc(c(C1=O)c2O)OC(c(cc3)cc(O)c3O)=C1OC)c2OC,
Isookanin,,1036-49-3,Oc(ccc([C@H](C1)Oc(c(O)c(cc2)O)c2C1=O)c1)c1O,
Kuwanon H,,76472-87-2,CC(C)=CCc(c(O)c(cc1)C([C@@H]([C@@H](CC(C)=C2)c(ccc(O)c3)c3O)[C@H]2c(c(OC(c(ccc(O)c2)c2O)=C2CC=C(C)C)c(c(O)c3)C2=O)c3O)=O)c1O,
Naspm trihydrochloride,1-Naphthylacetyl spermine trihydrochloride,1049731-36-3,[H]Cl.[H]Cl.[H]Cl.NCCCNCCCCNCCCNC(CC1=C2C=CC=CC2=CC=C1)=O,
OMDM-5,,616884-66-3,CCCCCCCC/C=C\CCCCCCCC(NNCC1=CC=C(O)C(OC)=C1)=O,
Palmitelaidic Acid,9-trans-Hexadecenoic acid; trans-Palmitoleic acid,10030-73-6,CCCCCC/C=C/CCCCCCCC(O)=O,
PDK4-IN-1 hydrochloride,,2310262-11-2,O=C1C2=C(C=CC=C2)C(C3=CC=CC(C4=CN(C5CCNCC5)N=C4)=C13)=O.[H]Cl,
2-Methyl-5-HT,2-Methyl-5-hydroxytryptamine,78263-90-8,Cc1c(CCN)c(cc(cc2)O)c2[nH]1,
CCG-63802,,620112-78-9,Cc1cccc(OC(N=C2N3C=CC=C2C)=C(C=C(c2nc(cccc4)c4s2)C#N)C3=O)c1,
CCG-63808,,620113-73-7,CC(C1=NC(Oc(cc2)ccc2F)=C2C=C(c3nc(cccc4)c4s3)C#N)=CC=CN1C2=O,
Chroman 1,,1273579-40-0,CN(C)CCOc(cc(cc1)-c2c[nH]nc2)c1NC([C@@H](C1)COc(cc2)c1cc2OC)=O,
Darodipine,PY 108-068; PY-108068,72803-02-2,CCOC(C(C1c2cccc3nonc23)=C(C)NC(C)=C1C(OCC)=O)=O,
Dexamethasone palmitate,DXP,14899-36-6,CCCCCCCCCCCCCCCC(OCC([C@@]([C@H](C)C1)([C@@](C)(C[C@@H]2O)[C@@H]1[C@H](CCC([C@]1(C)C=C3)=CC3=O)[C@@]12F)O)=O)=O,
Glibornuride,,26944-48-9,CC(C)([C@H](CC1)[C@@H]2NC(NS(c3ccc(C)cc3)(=O)=O)=O)[C@]1(C)[C@H]2O,
SB 258719,,195199-95-2,C[C@H](CCN1CCC(C)CC1)N(C)S(c1cc(C)ccc1)(=O)=O,
Sigma-1 receptor antagonist 3,,1639220-17-9,Cc1nc(-c(cc2)ccc2F)nc(OCCCN2CCCCC2)c1Cl,
TC ASK 10,,1005775-56-3,O=C(NC1=CN2C=C(N3C=CN=C3)C=CC2=N1)C4=CC=C(C(C)(C)C)C=C4.[H]Cl.[H]Cl,
Gestonorone Capronate,,1253-28-7,CC([C@@]1(OC(CCCCC)=O)CC[C@@]2([H])[C@]3([H])CCC4=CC(CC[C@]4([H])[C@@]3([H])CC[C@]12C)=O)=O,
Tyrphostin AG1433,SU1433; AG1433,168835-90-3,Cc(cc1nc2)c(C)cc1nc2-c(cc1)cc(O)c1O,
ICA,N-[4-(2-Pyridinyl)-2-thiazolyl]-2-pyridinamine,3374-88-7,c1c(-c2ncccc2)nc(Nc2ncccc2)s1,
Linaprazan,AZD0865,248919-64-4,Cc1c(C)nc(c(NCc2c(C)cccc2C)c2)n1cc2C(NCCO)=O,
ZLN024,,723249-01-2,Cc(cc1)cc(Br)c1OCCSc1ncccn1,
P-1075,,60559-98-0,CCC(C)(C)NC(NC#N)=Nc1cnccc1,
Pivanex,AN-9; Pivalyloxymethyl butyrate,122110-53-6,CCCC(OCOC(C(C)(C)C)=O)=O,
Î´-Tocotrienol,,25612-59-3,C[C@@](CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C)(CC1)Oc(c(C)c2)c1cc2O,
Hydrangenol,,480-47-7,Oc1ccc(C(Cc2cccc(O)c22)OC2=O)cc1,
Kansuinine A,,57701-86-7,C[C@@H](C[C@@]([C@H]1[C@H](C([C@@H]([C@H]([C@H](C2(C)C)OC(C)=O)OC(c3ccccc3)=O)OC(C)=O)=C)OC(C)=O)([C@]([C@@H]3C)(O)O[C@H]2C3=O)OC(C)=O)[C@@H]1OC(C)=O,
cis-PDA,"2,5-Dibromopiperidine",46026-75-9,OC([C@@H]1[C@H](C(O)=O)NCCC1)=O,
RU 59063,,155180-53-3,CC(C)(C(N1c(cc2)cc(C(F)(F)F)c2C#N)=O)N(CCCCO)C1=S,
BAY32-5915,8-Hydroxyquinoline-2-carboxylic acid,1571-30-8,OC(c(ccc1ccc2)nc1c2O)=O,
Darglitazone,CP-86325,141200-24-0,Cc1c(CCC(c2ccc(CC(C(N3)=O)SC3=O)cc2)=O)nc(-c2ccccc2)o1,
ML-099,CID-888706,496775-95-2,OC(c1cccnc1SCCc1ccccc1)=O,
SCS,Salicylidene salicylhydrazide,3232-36-8,Oc1c(C=NNC(c(cccc2)c2O)=O)cccc1,
Gepirone,,83928-76-1,CC(C)(CC(N1CCCCN(CC2)CCN2c2ncccn2)=O)CC1=O,
DNDS,DNS,3709-43-1,O=S(C1=CC([N+]([O-])=O)=CC=C1C=CC2=CC=C([N+]([O-])=O)C=C2S(=O)([O-])=O)([O-])=O.[Na+].[Na+],
RBC10,,362503-73-9,CCCCC(N(C1c(cccc2)c2Cl)c(cccc2)c2NC(CCC2)=C1C2=O)=O,
TP0427736,,864374-00-5,Cc1csc(-c2c(-c(cc3)cc4c3ncs4)nc[nH]2)n1,
Allethrin,,584-79-2,CC(C)(C1C=C(C)C)C1C(OC(C1)C(C)=C(CC=C)C1=O)=O,
Geranylgeraniol,Tetraprenol; FT0626663; CJ24095,24034-73-9,CC(C)=CCC/C(/C)=C/CC/C(/C)=C/CC/C(/C)=C/CO,
DPI 201-106,SDZ 201106,97730-95-5,N#Cc([nH]c1ccc2)cc1c2OCC(CN(CC1)CCN1C(c1ccccc1)c1ccccc1)O,
Facinicline hydrochloride,RG3487 hydrochloride,677305-02-1,O=C(C1=NNC2=C1C=CC=C2)N[C@@H]3CN4CCC3CC4.[H]Cl,
Hentriacontane,hentriacontane,630-04-6,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC,
Tienilic Acid,Ticrynafen; ANP 3624,40180-04-9,OC(COc1ccc(C(c2cccs2)=O)c(Cl)c1Cl)=O,
ARN-21934,,2230854-93-8,CN(C)c(cc1)ccc1Nc1c(CC(CC2)N)c2nc(-c2ccncc2)n1,
1-Hydroxyanthraquinone,,129-43-1,Oc(cccc1C(c2c3cccc2)=O)c1C3=O,
cis-4-Hydroxy-L-proline,,618-27-9,O[C@@H](C1)CN[C@@H]1C(O)=O,
"2,2,2-Trichloroethanol",,115-20-8,OCC(Cl)(Cl)Cl,
Triclabendazole sulfoxide,TCBZ-SO,100648-13-3,CS(c([nH]c1c2)nc1cc(Oc1cccc(Cl)c1Cl)c2Cl)=O,
PMEDAP,,113852-41-8,Nc1c2ncn(CCOCP(O)(O)=O)c2nc(N)n1,
DMT-2â²Fluoro-dU Phosphoramidite,2'-F-dU Phosphoramidite,146954-75-8,O=C(NC(C=C1)=O)N1[C@H](O2)[C@H](F)[C@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@H]2COC(C3=CC=C(OC)C=C3)(C4=CC=C(OC)C=C4)C5=CC=CC=C5,
TPX-0046,,2359650-19-2,O=C1NC[C@@H](C)OC2=NC=C(F)C=C2CN3C4=NC5=C1C=NN5C=C4O[C@@]6([H])[C@]3([H])CCC6,
TRPM4 inhibitor 8,,1353979-43-7,CCN(CCN)Cc1cccc(Br)c1,
Homocarnosine acetate,Homocarnosine acetate(3650-73-5 free base),T32098L,NCCCC(N[C@@H](Cc1c[nH]cn1)C(O)=O)=O,
Eclitasertib,DNL-758; SAR-443122,2125450-76-0,CN(c1ncccc1OC[C@@H]1NC(c2nc(Cc3ccccc3)n[nH]2)=O)C1=O,
MRT-14,,1263131-83-4,COc1cc(C(NC=NNc2cccc(NC(c3ccccc3)=O)c2)=O)cc(OC)c1OC,
AAL-993,,269390-77-4,O=C(c(cccc1)c1NCc1ccncc1)Nc1cccc(C(F)(F)F)c1,
JI130,,2234271-86-2,COc1cccc2c1[nH]cc2/C=C/C(NCCc(cccc1)c1OCC=C)=O,
SR-318,,2413286-32-3,Nc(n(-c1ccccc1)nc1)c1C(NCc(cc1)ccc1C(NCCCC1CCCCC1)=O)=O,
LY450108,,376594-67-1,CC(C)S(NC[C@H](C)c(cc1)ccc1NC(c1cc(F)cc(F)c1)=O)(=O)=O,
Ethyl cinnamate,,103-36-6,CCOC(C=Cc1ccccc1)=O,
Rineterkib,LTT-462; ERK-IN-1,1715025-32-3,CNC[C@H](c1cc(Br)cc(F)c1)NC(c(ccc(-c1nc([C@@H](CC[C@@H]2O)C[C@@H]2F)cnc1N)c1)c1F)=O,
GSK840,GSK'840,2361146-30-5,CC(C)(C)OC(Cc(cc1)ccc1-n1c(ccc(C(NC)=O)c2)c2nc1)=O,
Valecobulin hydrochloride,CKD-516 hydrochloride,1240321-53-2,CC(C)[C@H](N)C(NC1=NC(C2=CC=C(C(C3=CC(OC)=C(OC)C(OC)=C3)=O)C(N4N=CN=C4)=C2)=CS1)=O.[H]Cl,
BF738735,,1436383-95-7,Cc1c(-c(cc2)cc(F)c2O)n(ccnc2NCc3cccc(S(C)(=O)=O)c3)c2n1,
Sorivudine,BV-araU,77181-69-2,OC[C@H]([C@H]([C@@H]1O)O)O[C@H]1N(C=C(/C=C/Br)C(N1)=O)C1=O,
T-00127_HEV1,,900874-91-1,Cc1nn2c(NCCN3CCOCC3)cc(C)nc2c1-c(cc1)cc(OC)c1OC,
"3â²,4â²,7-TrihydroxyflavoneÂ ",,2150-11-0,Oc(cc1)cc(OC(c(cc2)cc(O)c2O)=C2)c1C2=O,
Sulindac sulfone,,59864-04-9,CC1=C(CC(O)=O)c(cc(cc2)F)c2C1=Cc(cc1)ccc1S(C)(=O)=O,
Amtolmetin guacil,,87344-06-7,Cc(cc1)ccc1C(c1ccc(CC(NCC(Oc(cccc2)c2OC)=O)=O)n1C)=O,
8-Azahypoxanthine,NSC 22709; NSC-22709; NSC22709,2683-90-1,O=C1NC=Nc2c1nn[nH]2,
Mesendogen,,864716-85-8,CC(C)c(cc1)ccc1C(NC(Nc(cc(C(F)(F)F)cc1)c1Cl)=S)=O,
Cimicoxib,UR-8880; UR8880; UR8880; Cimicoxib,265114-23-6,COc(ccc(-c(n(cn1)-c(cc2)ccc2S(N)(=O)=O)c1Cl)c1)c1F,
Etidocaine Hydrochloride,Duranest; W-19053; W 19053; W19053,36637-19-1,CCCN(CC)C(CC)C(Nc1c(C)cccc1C)=O.Cl,
DMU-212,,134029-62-2,COc1ccc(/C=C/c(cc2OC)cc(OC)c2OC)cc1,
L-Allylglycine,(S)-(-)-2-Amino-4-pentenoic acid,16338-48-0,C=CC[C@@H](C(O)=O)N,
5-HT1A modulator 2 hydrochloride,,3880-76-0,COc1c(CC(CC2)N)c2ccc1.Cl,
Dibenamine hydrochloride,N-â(2-âChloroethyl)âdibenzylamine hydrochloride,55-43-6,ClCCN(Cc1ccccc1)Cc1ccccc1.Cl,
GSK717,,1595278-21-9,O=C(CNCCc1nc(cccc2)c2n1CC(Nc1cc(CCC2)c2cc1)=O)c1ccccc1,
Millepachine,,1393922-01-4,CC(C)(C=Cc1c(cc2)OC)Oc1c2C(/C=C/c(cc1)ccc1OC)=O,
Bocidelpar,,2095128-20-2,C[C@H](CCCOc1c(Cn2c(-c3ccc(C(F)(F)F)cc3)ncc2C)cccc1)CC(O)=O,
GSK3685032,GSK-3685032,2170137-61-6,CCc(c(C#N)c(N(CC1)CCC1N)nc1SC(C(N)=O)c2ccccc2)c1C#N,
Î²-catenin-IN-2,,1458664-10-2,CN(C)c(cc1)ccc1-c1nc(ccc(F)c2)c2[nH]1,
GDC-0214,IJAK-381,1831144-46-7,CN(CCC#N)C(CC1)CCN1C(Cn(cc1NC(c2c3ncccn3nc2)=O)nc1-c(cc(cc1)Cl)c1OC(F)F)=O,
Tetradecylthioacetic acid,,2921-20-2,CCCCCCCCCCCCCCSCC(O)=O,
(E)-AG 556,(E)-Tyrphostin AG 556,133550-41-1,N#C/C(/C(NCCCCc1ccccc1)=O)=C\c(cc1)cc(O)c1O,
CID-2858522,,758679-97-9,CC(C)(C)c1cc(C(Cn2c(NCCCO)nc3c2cc(C)c(C)c3)=O)cc(C(C)(C)C)c1O,
MK-8353,SCH900353,1184173-73-6,CC(C)Oc(cc1)ncc1-c1n[nH]c(cc2)c1cc2NC([C@]1(CN(CC(N(CC2)CC=C2c(cc2)ccc2-c2nn(C)cn2)=O)CC1)SC)=O,
Benzyl-Î±-GalNAc,,3554-93-6,CC(N[C@H]([C@H]1O)[C@@H](OCc2ccccc2)O[C@H](CO)[C@@H]1O)=O,
AMG2850,,1470018-52-0,C[C@@H](C(F)(F)F)NC(N1[C@H](c2ccc(C(F)(F)F)cc2)c2ncccc2CC1)=O,
Calicheamicin,Calicheamicin Î³1,108212-75-5,CCN[C@@H](CO[C@H](C1)O[C@H]([C@H]2O)[C@H](O[C@H](C(/C3=C\CSSSC)=C(C(C4)=O)NC(OC)=O)C#C/C=C\C#C[C@@]34O)O[C@H](C)[C@H]2NO[C@@H](C[C@@H]2O)O[C@H](C)[C@H]2SC(c(c(OC)c2OC)c(C)c(I)c2O[C@@H]([C@@H]([C@@H]2OC)O)O[C@@H](C)[C@@H]2O)=O)[C@H]1OC,
Ipatasertib dihydrochloride,GDC-0068 dihydrochloride; RG-7440 dihydrochloride,1396257-94-5,C[C@@H]1C[C@@H](O)C2=NC=NC(N3CCN(C([C@H](CNC(C)C)C4=CC=C(Cl)C=C4)=O)CC3)=C21.[H]Cl.[H]Cl,
SB-616234-A,,908601-49-0,O=C(N1CCC2=C1C=C(N3C[C@@H](C)N[C@@H](C)C3)C(OC)=C2)C4=CC=C(C5=CC=C(C6=NOC(C)=N6)C=C5C)C=C4.[H]Cl,
SIRT-IN-1,,1431411-60-7,CC(C)(C)C(NCCC(CC1)CCN1c1c2sc(C(N)=O)cc2ncn1)=O,
GSK2850163,,2121989-91-9,Cc1ccc(CNC(N2C[C@]3(CN(Cc(cc4)cc(Cl)c4Cl)CC3)CCC2)=O)cc1,
HKI-357,,848133-17-5,CCOc(cc(c1c2)ncc(C#N)c1Nc(cc1)cc(Cl)c1OCc1cc(F)ccc1)c2NC(/C=C/CN(C)C)=O,
Ubiquitination-IN-1,,1819330-15-8,O=S(c1cc(C(F)(F)F)ccc1)(Nc1ccc(-c2cnccc2)c2cccnc12)=O,
Zandelisib,ME-401; PWT-143,1401436-95-0,CC(C)(Cc1c(C2CCN(C)CC2)cccc1)Nc1nc(-n2c(cccc3)c3nc2C(F)F)nc(N2CCOCC2)n1,
MPI_5a,,1259296-46-2,Cn1c(C(N(CC2)Cc(cc3)c2cc3C(NO)=O)=O)ccc1,
Pan-RAS-IN-1,,1835283-94-7,NC1(CCNCC1)C(NCCCn1c(ccc(CN2CCN(Cc(c(Cl)ccc3)c3Cl)CC2)c2)c2c(-c(cc2)ccc2OC(F)(F)F)c1)=O,
Pumaprazole,BY-841,158364-59-1,Cc1c(C)nc2n1cccc2NCc(c(C)ccc1)c1NC(OC)=O,
LMP744 hydrochloride,MJ-III65 hydrochloride; NSC706744 hydrochloride,308246-57-3,O=C1N(CCCNCCO)C2=C(C(C3=C2C=C(OCO4)C4=C3)=O)C5=C1C=C(OC)C(OC)=C5.[H]Cl,
Sinapyl alcohol,,537-33-7,COc1cc(C=CCO)cc(OC)c1O,
XRP44X,XRP-44X; XRP 44X; XRP-44-X; XRP 44 X,729605-21-4,Cc(cc1C(N(CC2)CCN2c2cccc(Cl)c2)=O)nn1-c1ccccc1,
GSA-10,,300833-95-8,CCCCCCN(c(cccc1)c1C(O)=C1C(Nc(cc2)ccc2C(OCCC)=O)=O)C1=O,
CK7,[4-(2-Amino-4-methyl-thiazol-5-YL)-pyrimidin-2-YL]-(3-nitro-phenyl)-amine,507487-89-0,Cc1c(-c2nc(Nc3cc([N+]([O-])=O)ccc3)ncc2)sc(N)n1,
PEN (human) aceate,PEN (human) aceate (597578-70-6 Free base),TP1949L,CC(O)=O.CC(C)[C@@H](C(O)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](C)NC(CNC([C@H](CC(C)C)NC([C@H](C(C)C)NC(CNC([C@H](CCC(O)=O)NC([C@H]1N(C([C@H]2N(C([C@H](CC(C)C)NC([C@H](CCC(O)=O)NC([C@H](CO)NC(CNC([C@H](C(C)C)NC([C@H](CC(O)=O)NC([C@H](CC3=CNC=N3)NC([C@H](CC(O)=O)NC([C@H](C)NC([C@H](C)N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CCC2)=O)CCC1)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O,
PD-1/PD-L1-IN-10,,2487550-41-2,C[C@H]([C@@H](C(O)=O)NCc(c(OCc1cc(C#N)ccc1)c1)cc([N+]([O-])=O)c1OCc1c(C)c(-c2ccccc2)ccc1)O,
difelikefalin acetate,difelikefalin acetate(1024828-77-0 Free base),TP2485,CC(O)=O.O=C(C1(N)CCN(C([C@@H](CCCCN)NC([C@@H](CC(C)C)NC([C@@H](CC2=CC=CC=C2)NC([C@@H](CC3=CC=CC=C3)N)=O)=O)=O)=O)CC1)O,
PF-04802367,PF-367,1962178-27-3,COc(ccc(-c1c(C(NCCCn2ncnc2)=O)nco1)c1)c1Cl,
IRE1Î± kinase-IN-1,,2328097-41-0,CN1CCC(CNc2cc(Cl)nn3c2ncc3-c(cc2nc(Nc3ccccc3)[nH]c2c2)c2F)CC1,
MF-766,,1050656-06-8,OC(c1ccc(C2(CC2)NC(c2c3n(Cc4ccc(C(F)(F)F)cc4)ccc3ccc2)=O)cc1)=O,
Opiranserin hydrochloride,Opiranserin hydrochloride(1441000-45-8 Free base),1440796-75-7,O=C(NCC1(N(C)C)CCOCC1)C2=CC(OC)=C(OCCCC)C(OC)=C2.[H]Cl,
Benoxaprofen,LRCL 3794,51234-28-7,CC(C(O)=O)c(cc1)cc2c1oc(-c(cc1)ccc1Cl)n2,
Eslicarbazepine,BIA 2-194,104746-04-5,NC(N(c1c(C[C@@H]2O)cccc1)c1c2cccc1)=O,
NO-711ME,NO 711ME; NO711ME; NO711 Methyl ester; N-O711 Methyl ester; N O711 Methyl ester,127586-66-7,COC(C1=CCCN(CCON=C(c2ccccc2)c2ccccc2)C1)=O,
"Akt-I-1,2","Akt I 1,2; AktI1,2",473382-50-2,NC(C)(C)C1=CC=C(C2=NC3=CC=CC=C3N=C2C4=CC=CC=C4)C=C1.[H]Cl,
VPC-14228,VPC 14228; VPC14228,19983-28-9,C(COCC1)N1c1nc(-c2ccccc2)cs1,
L-822179,"L 822179; L822179; L-822,179; L 822,179; L822,179",215874-86-5,Cc1cc(-c2nnc(c3c4cccc3)n2nc4OCc2cn(C)nn2)no1,
NLRP3-IN-9,NLRP3 IN 9; NLRP3IN9; INF-4E; INF 4E; INF4E,88039-46-7,CCOC(C(C(c(cccc1)c1Cl)O)=C)=O,
PZ-II-029,PZII-029; PZ II-029; PZ-II029; PZII029; PZ II029,164025-44-9,COc(cc1)ccc1N1N=C2c(ccc(OC)c3)c3NC=C2C1=O,
Pinacidil,P-1134; P 1134; P1134; S-1230; S 1230,60560-33-0,CC(C(C)(C)C)N=C(Nc1ccncc1)NC#N,
Ataquimast,,182316-31-0,O=C1N(CC)C2=C(C=CC=C2)N=C1NC.[H]Cl,
ARRY-382,ARRY382,1313407-95-2,Cc1cccc(Cn(c2ccc3)nc(C4CC4)c2c3NC(c2cnc3n2ccc(OCCN2CCN(C)CC2)c3)=O)n1,
MTI-31,LXI-15029,1567915-38-1,C[C@@H](COCC1)N1c1nc(N2C3COCC2CC3)c(ccc(-c2cccc(C(NC)=O)c2)n2)c2n1,
JAK2-IN-7,,2593402-36-7,C(/C=C/CN(C)C)(=O)N1CC=2C(=CC(NC=3N=C(C(C)=CN3)C4=CN(C(C)C)N=C4)=CC2)CC1,
JNJ-67856633,,2230273-76-2,O=C(c1c(C(F)(F)F)n(-c2c(C=CNC3=O)c3ccc2)nc1)Nc1cc(C(F)(F)F)ncc1,
RA375,,T36902,O=C(CCl)N[C@H](C(N1C/C(C(/C(C1)=C/C2=CC=C([N+]([O-])=O)C=C2)=O)=C\C3=CC=C([N+]([O-])=O)C=C3)=O)CC4=CC=CC=C4,
Terevalefim,ANG-3777,1070881-42-3,C(c1n[nH]cc1)=C/c1cccs1,
AKR1C3-IN-4,,1284180-11-5,OC(c1cccc(Nc2ccc(C(F)(F)F)cc2)c1)=O,
ARD-2128,,2222111-87-5,CC(C)([C@H](C1(C)C)NC(c(cc2)ccc2N2CCN(CC(CC3)CCN3c(cc3)cc(C(N4C(CCC(N5)=O)C5=O)=O)c3C4=O)CC2)=O)[C@H]1Oc(cc1)cc(Cl)c1C#N,
Desmorpholinyl Navitoclax-NH-Me,Desmorpholinyl ABT-263-NH-Me,2365172-82-1,CC(C)(CC1)CC(CN(CC2)CCN2c(cc2)ccc2C(NS(c(cc2)cc(S(C(F)(F)F)(=O)=O)c2N[C@H](CCNC)CSc2ccccc2)(=O)=O)=O)=C1c(cc1)ccc1Cl,
NF-ÎºÎ activator 2,,2375281-44-8,OC(c1cccc(-c2cnc(Nc(cccc3)c3F)o2)c1)=O,
Sovilnesib,AMG 650,2410796-79-9,Cc1cc(NC(c(ccc(NS(CCO)(=O)=O)c2)c2N2CCC3(CC3)CC2)=O)nc(N(CC2)CCC2(F)F)n1,
Evifacotrep,,2413739-88-3,O=C1NN=CC(N2Cc3ncnc(Oc(cc4)c(C(F)(F)F)cc4F)c3CC2)=C1Cl,
Sivopixant,S-600918,2414285-40-6,C[C@@H](CN(C(N/C(/N1Cc(cc2)ccc2Cl)=N\c(cc2)ccc2Oc2ncccc2)=O)C1=O)C(O)=O,
Acifluorfen,,50594-66-6,[O-][N+](c(ccc(Oc(ccc(C(F)(F)F)c1)c1Cl)c1)c1C(O)=O)=O,
PARP1-IN-5 dihydrochlorideÂ ,,2823308-89-8,O=C1C=C(C2=CC=C(O)C=C2)OC3=C(CN4CCN(CC5=CC=CS5)CC4)C(O)=CC(O)=C31.Cl[H].Cl[H],
Atpenin A5,,119509-24-9,C[C@@H](C[C@H](C)C(C(C(NC(OC)=C1OC)=O)=C1O)=O)[C@H](CCl)Cl,
BDA-366,,1909226-00-1,O=C1C2=C(C(C3=C(C=CC(NC[C@@H](CN(CC)CC)O)=C13)NC[C@@H]4OC4)=O)C=CC=C2,
"N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-bromoaniline",,1352608-94-6,Cc1cccc(-c2c(-c3cn4ncnc4cc3)nc(CNc(cccc3)c3Br)[nH]2)n1,
"Fmoc-1,6-diaminohexane hydrochloride","Fmoc-1,6-diaminohexane hydrochloride (166410-37-3 Free base)",T13695L,[H]Cl.O=C(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)NCCCCCCN,
Brepocitinib,PF-06700841,1883299-62-4,Cn1ncc(Nc2nccc(N(CC3CC4)CC4N3C([C@H](C3)C3(F)F)=O)n2)c1,
Atrasentan hydrochloride,ABT-627 hydrochloride; (+)-A 127722 hydrochloride; A-147627 hydrochloride,195733-43-8,O=C([C@H]1[C@H](C2=CC=C(OC)C=C2)N(CC(N(CCCC)CCCC)=O)C[C@@H]1C3=CC=C(OCO4)C4=C3)O.[H]Cl,
Ayanin,,572-32-7,COc(cc1O)cc(OC(c(cc2)cc(O)c2OC)=C2OC)c1C2=O,
Tigloylgomisin H,,66069-55-4,COc1cc2C[C@H](C)[C@@](C)(O)Cc3cc(OC)c(OC)c(OC)c3-c2c(OC(=O)C(\C)=C\C)c1OC,
ARS-1323,,1698024-73-5,C=CC(N(CC1)CCN1c1c(cc(c(-c(c(O)ccc2)c2F)c2F)Cl)c2ncn1)=O,
CGP60474,,164658-13-3,OCCCNc1nccc(-c2ccnc(Nc3cccc(Cl)c3)n2)c1,
FGTI-2734,,1247018-19-4,Cn1c(CN(CCN(CC2CCCCC2)S(c2ncccc2)(=O)=O)c(ccc(C#N)c2)c2F)cnc1,
Furegrelate sodium,U-63557A,85666-17-7,C1=CC(=CN=C1)CC2=CC3=C(C=C2)OC(=C3)C(=O)[O-].[Na+],
BPO-27 racemate,,1314873-02-3,CN(c(c(C(N1C)=O)c2-c3ccccc3)c3n2-c(cc(cc2)C(O)=O)c2OC3c(o2)ccc2Br)C1=O,
K-756,,130017-40-2,COc(cc1c(N2CCC(CN(Cc(cccc3)c3N3)C3=O)CC2)ncnc1c1)c1OC,
MCHR1 antagonist 2,,863115-70-2,O=C(C(Oc(cc1)c2cc1F)=CC2=O)NC1CCN(Cc(cc2)cc3c2OCO3)CC1,
Omeprazole Sodium,H 16868 sodium,95510-70-6,Cc1cnc(CS(c2nc(ccc(OC)c3)c3[nH]2)=O)c(C)c1OC.[Na],
Atherosperminine,Atherospermine,5531-98-6,CN(C)CCc(c1ccc(cccc2)c2c11)cc(OC)c1OC,
Nylestriol,Lilly 49825; LY 49825; LY-49825; LY49825; Nilestriolum,39791-20-3,C#C[C@@]1(O)[C@H](O)C[C@@]2([H])[C@]3([H])CCC4=C(C=CC(OC5CCCC5)=C4)[C@@]3([H])CC[C@]12C,
UC2288,,1394011-91-6,O=C(N[C@H]1CC[C@H](OC2=NC=C(C(F)(F)F)C=C2)CC1)NC3=CC=C(Cl)C(C(F)(F)F)=C3,
Almonertinib mesylate,HS-10296 mesylate,2134096-06-1,C=CC(NC1=CC(NC2=NC=CC(C3=CN(C4CC4)C5=C3C=CC=C5)=N2)=C(OC)C=C1N(CCN(C)C)C)=O.CS(=O)(O)=O,
FUREGRELATE,5-(pyridin-3-ylmethyl)-1-benzofuran-2-carboxylic acid,85666-24-6,OC(=O)c1cc2cc(Cc3cccnc3)ccc2o1,
AS-2444697,,1287665-60-4,O=C(C1=COC(C2=CC(C)=NC=C2)=N1)NC3=CN(C4CCOCC4)N=C3C(N)=O.[H]Cl,
Lumateperone,ITI-007; ITI-722,313368-91-1,CN(CC1)c2cccc3c2N1[C@@H]1[C@H]3CN(CCCC(c(cc2)ccc2F)=O)CC1,
N-Nitrosodiethylamine,,55-18-5,CCN(CC)N=O,
Thailanstatin A,,1426953-21-0,C[C@@H](/C=C\C(N[C@H]1[C@@H](C)O[C@@H](C/C=C(\C)/C=C/[C@H]([C@H]2O)O[C@H](CC(O)=O)C[C@]22OC2)[C@@H](C)C1)=O)OC(C)=O,
Boc-Asp(OMe)-fluoromethyl ketone,Boc-Asp(OMe)-FMK,187389-53-3,CC(C)(C)OC(N[C@@H](CC(OC)=O)C(CF)=O)=O,
ARV-471,,2229711-68-4,Oc1cc(CC[C@@H]([C@@H]2c(cc3)ccc3N3CCC(CN(CC4)CCN4c(cc4)cc(CN5[C@@H](CCC(N6)=O)C6=O)c4C5=O)CC3)c3ccccc3)c2cc1,
L-Phenylalanine-15N,(S)-2-Amino-3-phenylpropionic acid-15N,29700-34-3,[15NH2][C@@H](CC1=CC=CC=C1)C(O)=O,
GSK778 hydrochloride,GSK778 hydrochloride (2451862-42-1 Free base),2863657-79-6,C[C@@H](N1C(COC)=NC2=C1C3=CC(OC[C@@H]4CNCC4)=C(C5=C(C)ON=C5C)C=C3N=C2)C6=CC=CC=C6.[H]Cl,
Indomethacin heptyl ester,,282728-47-6,O=C(OCCCCCCC)CC1=C(C)N(C(C2=CC=C(Cl)C=C2)=O)C3=C1C=C(OC)C=C3,
Ophiopogonin D',,65604-80-0,C[C@@H]1CC[C@]2(OC1)[C@@H](C)[C@H]3[C@H](C[C@@H]4[C@]3(C)CC[C@H]5[C@H]4CC=C6[C@]5(C)CC[C@H](O[C@H]7[C@H](O[C@H]8[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O8)[C@@H](O[C@H]9[C@H](O)[C@@H](O)[C@H](O)CO9)[C@H](O)[C@@H](CO)O7)C6)O2,
Mogroside IIA1,Mogroside II-A1,88901-44-4,C[C@H]([C@@H]1CC[C@@]2(C)[C@@]1(C)C[C@@H](O)[C@]3(C)C2CC=C4[C@H]3CC[C@H](O)C4(C)C)CC[C@H](O[C@@H]5[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO[C@@H]6[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O6)O5)C(C)(O)C,
Podocarpic acid,,5947-49-9,C[C@](CCC1)([C@H](CC2)[C@@]1(C)c1c2ccc(O)c1)C(O)=O,
AZ10606120 dihydrochloride,,607378-18-7,O=C(NC1=CC=CC2=C1C=CC(NCCNCCO)=N2)CC(C3)(C4)CC5CC4CC3C5.Cl.Cl,
Bifenazate,,149877-41-8,CC(C)OC(NNc(cc(cc1)-c2ccccc2)c1OC)=O,
inS3-54A18,,328998-53-4,Oc(cc1)ccc1N(C(c1ccccc1)=CC1=Cc(cc2)ccc2Cl)C1=O,
5J-4,5J 4; 5J4,827001-82-1,Oc1ccc2c(NC(NC(c3ccco3)=O)=S)cccc2c1,
INI-43,INI 43; INI43; INI-43,881046-01-1,CN(C)CCCn1c2nc3ccccc3nc2c(-c2nc(cccc3)c3[nH]2)c1N,
MK-2295,MK2295; MK 2295,878811-00-8,C[C@H](CCC1)N1c1nc(N(CC2)[C@H](C)CN2c(c(C)c2)ncc2C(O)=O)cc(-c(cc2)ccc2F)n1,
XY028-140,,2229974-83-6,CC(C1=C(C)c2cnc(Nc(cc3)ncc3N(CC3)CCN3C(CNc(cccc3C(N4C(CCC(N5)=O)C5=O)=O)c3C4=O)=O)nc2N(C2CCCC2)C1=O)=O,
"2,6-Dimethylquinoline",,877-43-0,Cc1ccc2nc(C)ccc2c1,
NGD-8243,N-[4-(trifluoromethyl)phenyl]-7-[3-(trifluoromethyl)pyridin-2-yl]quinazolin-4-amine; NGD8243; NGD 8243,573678-04-3,FC(c(cc1)ccc1Nc1c(ccc(-c2c(C(F)(F)F)cccn2)c2)c2ncn1)(F)F,
Inotilone,,906366-79-8,CC(O/C1=C\c(cc2)cc(O)c2O)=CC1=O,
Osteogenic Growth Peptide (10-14) acetate,Osteogenic Growth Peptide (10-14) acetate(105250-85-9 Free base),T37603L,O=C(NCC(NCC(O)=O)=O)[C@@H](NC(CNC([C@@H](N)CC1=CC=C(O)C=C1)=O)=O)CC2=CC=CC=C2.CC(O)=O,
Caloxin 2A1 acetate,Caloxin 2A1 acetate (350670-85-8 Free base),T40437L,CC([C@H](N)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N1CCC[C@H]1C(N[C@H](C(N[C@H](C(N2CCC[C@H]2C(N[C@H](C(N[C@H](C(NCC(NCC(NCC(N)=O)=O)=O)=O)CO)=O)CO)=O)=O)CC3=CC=CC=C3)=O)CO)=O)=O)CC4=CNC5=CC=CC=C54)=O)CC(N)=O)=O)CO)=O)CC(N)=O)=O)CO)=O)C.CC(O)=O,
SP-96,,2682114-54-9,Cn1ncc(-c2ccc3c(Nc4cccc(NC(Nc5cccc(F)c5)=O)c4)ncnc3c2)c1,
(S)-(-)-Bay-K-8644,(S)-(-)-Bay K 8644,98625-26-4,CC(NC(C)=C([C@H]1c2c(C(F)(F)F)cccc2)[N+]([O-])=O)=C1C(OC)=O,
Afzelin,Kaempferol-3-O-rhamnoside,482-39-3,C[C@@H]([C@@H]([C@H]([C@H]1O)O)O)O[C@H]1OC1=C(c(cc2)ccc2O)Oc(cc(cc2O)O)c2C1=O,
Brilaroxazine,RP5063,1239729-06-6,O=C1Nc(cc(cc2)OCCCCN(CC3)CCN3c3cccc(Cl)c3Cl)c2OC1,
JT010,,917562-33-5,COCCCN(C(CCl)=O)c1nc(-c(cc2)ccc2OC)cs1,
Y06137,,2226534-49-0,C[C@@H](COCC1)N1c(cc1)cc2c1nc(-c(cc1)cc3c1onc3C)n2CC1CCCCC1,
N-alpha-Tosyl-L-lysine chloromethyl ketone hydrochloride,N-alpha-Tosyl-L-lysine_chloromethyl_ketone_hydrochloride;N-alpha-Tosyl-L-lysine chloromethyl ketone hydrochloride,4272-74-6,O=S(C1=CC=C(C)C=C1)(N[C@H](C(CCl)=O)CCCCN)=O.[H]Cl,
PF-05105679,,1398583-31-7,C[C@H](c(cc1)ccc1F)N(Cc1cc(C(O)=O)ccc1)C(c1cc2ccccc2nc1)=O,
SMIP004,,143360-00-3,CCCCc(cc1)cc(C)c1NC(C)=O,
p-Tolylmaleimide,p Tolylmaleimide;pTolylmaleimide;p-Tolylmaleimide,1631-28-3,Cc(cc1)ccc1N(C(C=C1)=O)C1=O,
Naphazoline,Naphazoline;Naphcon-a;AK-Con;All Clear;Clear Eyes,835-31-4,C(C1=NCCN1)c1cccc2ccccc12,
Co 102862,V 102862,181144-66-1,NC(NN=Cc(cc1)ccc1Oc(cc1)ccc1F)=O,
Roslin 2 bromide,Benzylhexamethylenetetramine bromide,29574-21-8,N12C[N+]3(CN(CN(C2)C3)C1)CC4=CC=CC=C4.[Br-],
Inz-1,Inz1;Inz 1,897776-15-7,COC(Cn(c1c2cccc1)nc2-c1ccccc1)=O,
Merodantoin,,143413-73-4,CCCCN(C(C(N1CCCC)=O)=O)C1=S,
Chiauranib,CS2164,1256349-48-0,COc1ccc2c(Oc3ccc4c(C(Nc(cccc5)c5N)=O)cccc4c3)ccnc2c1,
TRPM8 antagonist 3,,2102179-29-1,Oc1c(C(N2OCCC2)=O)sc(-c(cccc2)c2O)n1,
SN32976,,1246202-11-8,CN(C)CCS(N(CC1)CCN1c1nc(N2CCOCC2)nc(-n2c(cccc3OC)c3nc2C(F)F)n1)(=O)=O,
MBP MAPK Substrate acetate,MBP MAPK Substrate acetate(138028-00-9 free base),T38796L,N=C(N)NCCC[C@H](C(O)=O)NC([C@H](CCCNC(N)=N)NC(CNC(CNC([C@H]1N(C([C@]([C@@H](O)C)([H])NC([C@H](CCCNC(N)=N)NC([C@H]2N(C([C@H](C)N)=O)CCC2)=O)=O)=O)CCC1)=O)=O)=O)=O.CC(O)=O,
LyP-1 acetate,LyP-1 acetate (454487-07-1 Free base),T40555L,O=C(N[C@@](C(N[C@@](C(NCC(N[C@@H]1C(O)=O)=O)=O)([H])CCCNC(N)=N)=O)([H])[C@H](O)C)[C@](NC([C@@H](NC([C@@H](NC(CNC([C@H](CSSC1)N)=O)=O)CC(N)=O)=O)CCCCN)=O)([H])CCCNC(N)=N.CC(O)=O,
RUVBL1/2 ATPase-IN-1,,423128-55-6,Cc1ccc(Cc2c(C)n3ncc(C(N(CC4)CCN4c4cccc(C(F)(F)F)c4)=O)c3nc2C)cc1,
CC618,,1680204-90-3,Cc1c(C(NCCS(c2ncc(C(F)(F)F)cc2)(=O)=O)=O)sc(-c2ccc(C(F)(F)F)cc2)n1,
PARP1-IN-8Â ,N-(3-chlorophenyl)-3-(1-oxo-4-phenylphthalazin-2(1H)-yl)propanamide,836640-15-4,O=C(CCN1N=C(c2ccccc2)c(cccc2)c2C1=O)Nc1cccc(Cl)c1,
T3Inh-1,,50440-30-7,[O-][N+](c(ccc1ncc2)cc1c2Nc(cc1)ccc1C(Nc(cc1)ccc1Nc1ccncc1)=O)=O,
ZX-J-19J,"N-(2,3-Diphenyl-6-quinoxalinyl)octanamide",1352576-02-3,CCCCCCCC(Nc1cc2nc(-c3ccccc3)c(-c3ccccc3)nc2cc1)=O,
CGP 35348,,123690-79-9,CCOC(OCC)P(CCCN)(O)=O,
PK68,,2173556-69-7,CC(Nc1nc(ccc(-c2cnc(C)c(NC(OC3CCCCC3)=O)c2)c2)c2s1)=O,
ROCK2-IN-2,,1995065-79-6,c1coc(-c2cccc(-c3nnc(Nc(cc4)cc5c4[nH]nc5)s3)c2)n1,
Trovafloxacin mesylate,,147059-75-4,O=C1C(C=C2F)=C(N=C2N3C[C@@]4([H])[C@H](N)[C@@]4([H])C3)N(C=C1C(O)=O)C5=CC=C(F)C=C5F.CS(O)(=O)=O,
PF 04531083,,1079400-07-9,Cn1nccc1C(Nc(cc1)nc(N)c1-c(cc(cc1)OC)c1Cl)=O,
VU0463271,N-Cyclopropyl-N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide,1391737-01-1,Cc1csc(N(C2CC2)C(CSc(cc2)nnc2-c2ccccc2)=O)n1,
Jolkinolide B,,37905-08-1,CC1(C)[C@@]([C@@]2(C)CCC1)([H])CC[C@@](C2[C@@H](O3)[C@]43O5)(O6)[C@H]6C4=C(C)C5=O,
NSC756093,NSC-756093;NSC 756093,1629908-92-4,COc1cc(N(CCO)C(CO2)=C(C3c4ccccc4)C2=O)c3cc1,
ICL-CCIC-0019,ICL CCIC 0019;ICLCCIC0019,936498-64-5,CN(C1=CC=[N+](CCCCCCCCCCCC[N+]2=CC=C(N(C)C)C=C2)C=C1)C.[Br-].[Br-],
STAT3-IN-B9,STAT3 IN B9;STAT3INB9;B9,825611-06-1,Oc(cc1)ccc1NS(c(cc1)cc(C(c2c3cccc2)=O)c1C3=O)(=O)=O,
AKB-6899,AKB 6899;AKB6899,1007377-55-0,OC(CNC(c(c(O)c1)ncc1-c1cccc(F)c1)=O)=O,
DMT-dG(ib) Phosphoramidite,,93183-15-4,COC1=CC=C(C=C1)C(C2=CC=CC=C2)(OC[C@H]3[C@H](OP(OCCC#N)N(C(C)C)C(C)C)C[C@@H](N(C=N4)C(N=C5NC(C(C)C)=O)=C4C(N5)=O)O3)C6=CC=C(OC)C=C6,
DMT-dU-CE Phosphoramidite,,109389-30-2,O(CCC#N)P(O[C@H]1C[C@@H](O[C@@H]1COC(C1C=CC=CC=1)(C1C=CC(=CC=1)OC)C1C=CC(=CC=1)OC)N1C=CC(NC1=O)=O)N(C(C)C)C(C)C,
pCPA methyl ester hydrochloride,4-Chloro-DL-phenylalanine methyl ester hydrochloride,14173-40-1,COC([C@H](Cc(cc1)ccc1Cl)N)=O.Cl,
ZLN 024 hydrochloride,,1883548-91-1,BrC1=C(C=CC(C)=C1)OCCSC2=NC=CC=N2.Cl,
GW590735,,343321-96-0,Cc1nc(sc1C(=O)NCc1ccc(OC(C)(C)C(O)=O)cc1)-c1ccc(cc1)C(F)(F)F,
Sangivamycin,NSC 65346;BA-90912,18417-89-5,NC(c1cn([C@@H]([C@@H]2O)O[C@H](CO)[C@H]2O)c2ncnc(N)c12)=O,
Lu AF27139,,2097117-06-9,O=C(c1c(C(F)(F)F)nc(-c2ncccn2)s1)NC[C@H](c(cc1)ccc1Cl)N1CCOCC1,
MPT0B390,,1817802-18-8,COc(cc1)ccc1S(N1c2ncc(/C=C/C(NO)=O)cc2CC1)(=O)=O,
Sivifene,,2675-35-6,OC1=CC=C(/C(C2=CC=C(O)C=C2)=N\NC3=CC=C([N+]([O-])=O)C=C3[N+]([O-])=O)C=C1,
MeBIO,,667463-95-8,CN(c(cc(cc1)Br)c1/C1=C2/Nc(cccc3)c3/C2=N\O)C1=O,
Src Inhibitor 3,,2380027-49-4,CC(C)(CC(N(CC1)CCC1n1nc(C(Nc(cc2)cc(Cl)c2NC(c2c(ccc(OC)c3)n3nc2)=O)=O)c2c1ccc(F)c2)=O)C#N,
EGFR-IN-8,,2407957-87-1,O=C(C1CC1)Nc(cc1)c(C(F)(F)F)cc1NC(Nc1cccc(-c2nc(-c(ccc(NC(c3cnccc3)=O)c3)c3Cl)no2)c1)=O,
Boldenone Cypionate,,106505-90-2,C[C@](CC1)([C@@H](CC2)[C@H](CC3)[C@H]1[C@@](C)(C=C1)C3=CC1=O)[C@H]2OC(CCC1CCCC1)=O,
TL02-59,,1315330-17-6,CCN1CCN(Cc(cc2)c(C(F)(F)F)cc2NC(c2cc(Oc(c3c4)ncnc3cc(OC)c4OC)c(C)cc2)=O)CC1,
JAK-IN-5,,2096999-92-5,OC1=CC(CC)=C(C2=CC3=C(C=C2)C(C(N4)=NC5=C4CN(C6CCN(C)CC6)CC5)=NN3)C=C1F,
RS 17053 hydrochloride,RS-17053,169505-93-5,ClC1=CC2=C(C=C1)NC=C2CC(C)(C)NCCOC3=C(C=CC=C3)OCC4CC4.Cl,
TPA 023,,252977-51-8,FC1=CC=CC=C1C2=NN=C3C=C(C(C)(C)C)C(OCC4=NC=NN4CC)=NN32,
GNE-490,,1033739-92-2,CC(C)(c1cc2nc(-c3c(C)nc(N)nc3)nc(N3CCOCC3)c2s1)O,
Buspirone,Buspirone free base; Ansial,36505-84-7,O=C(N(CCCCN1CCN(C2=NC=CC=N2)CC1)C(C3)=O)CC43CCCC4,
AKT-I-1,AKT I 1; AKTI1,473382-39-7,CC(C)(CNc1nn2c(-c3ccccc3)nnc2cc1C1CCC1)CN(C)C,
Ursodeoxycholic acid sodium,Ursodeoxycholate sodium; UDCA sodium; UDCA Na; Sodium Ursodeoxycholate; Ursodeoxycholic Acid (sodium salt),2898-95-5,C[C@@]12[C@]([C@@H](C)CCC(O)=O)([H])CC[C@@]1([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC2.[Na+],
"2-Aminooctadecane-1,3,4-Triol","2-aminooctadecane-1,3,4-triol; Phytosphingosine",13552-11-9,CCCCCCCCCCCCCCC(C(C(CO)N)O)O,
Iprindole,,5560-72-5,CN(C)CCCn1c(cccc2)c2c2c1CCCCCC2,
3-Phenylpropyl isothiocyanate,,2627-27-2,S=C=NCCCc1ccccc1,
EZM0414,,2411748-50-8,FC1=C(C=C(C(N[C@H]2C[C@@H](N3CCN(C(C)=O)CC3)CCC2)=O)N4)C4=C(C)C=C1,
JMJD6 inhibitor WL12,"2H-1-Benzopyran-2-one, 3-(3H-imidazo[4,5-c]pyridin-2-yl)-6-methyl-; ZINC6733033",899548-78-8,Cc(cc1)cc(C=C2c3nc(ccnc4)c4[nH]3)c1OC2=O,
WAY-647802,,852225-20-8,CC(N1CCN(C2=CC=C([N+]([O-])=O)N=C2)CC1)=O,
ElteN378,,1421366-99-5,O=C([C@@H]1N(C(C(C2=CC=CC=C2)=O)=O)CCCC1)NCCCC3=CC=CC=C3,
Fosgonimeton acetate,Fosgonimeton acetate (2093305-05-4 Free base),T39507L,O=C(N[C@@H]([C@@H](C)CC)C(NCCCCCC(N)=O)=O)[C@@H](NC(CCCCC)=O)CC1=CC=C(OP(O)(O)=O)C=C1.CC(O)=O,
Cenupatide acetate,Cenupatide acetate(1006388-38-0 Free base),TP2338L,C[C@@](NC([C@H](CCCNC(N)=N)NC(C(C)(C)NC([C@@H](NC(C)=O)CCCNC(N)=N)=O)=O)=O)(C(N)=O)CC1=CC=CC=C1.CC(O)=O,
EX-A5758,,308277-46-5,CC(C)[C@@H](C(OC)=O)NC(CC(OC)=O)=O,
NSC 370284,,116409-29-1,OC1=C(C(N2CCCC2)C3=CC(OC)=C(OC)C(OC)=C3)C=C(OCO4)C4=C1,
WAY-302159,,62802-77-1,[O-][N+](C1=CC(C(NC2=CC=CC3=CC=CN=C23)=O)=CC=C1)=O,
MKC-1,,125313-92-0,Cn1c(cccc2)c2c(C(C(N2)=O)=C(c3cn(C)c4c3ccc([N+]([O-])=O)c4)C2=O)c1,
NSC 146109 hydrochloride,,59474-01-0,N=C(N)SCC1=C(C=CC=C2)C2=C(C)C3=CC=CC=C13.Cl,
P-gp inhibitor 1,,2050747-49-2,COC1=CC2=C(C=C1OC)CCN(CCC3=CC=C(NC4=C5C=CC=CC5=NC(C6=CC=NC=C6)=N4)C=C3)C2,
CE-224535,PF-04905428,724424-43-5,CC(N(C(NC)=O)OC(NC)=O)=O,
Gallopamil,Methoxyverapamil,16662-47-8,CC(C)(CCc(c1c(cc2O)Oc3cc(C)c(CC=C(C)C)c(O)c3C1=O)c2O)O,
GSK2983559 free acid,,1579965-12-0,O=S(C1=CC2=C(NC3=CC=C(SC=N4)C4=C3)N=CN=C2C=C1OCCOP(O)(O)=O)(C(C)(C)C)=O,
Abemaciclib metabolite M20,CDK4/6-IN-4; LSN3106726,2138499-06-4,OCC1=NC2=C(F)C=C(C3=NC(NC4=NC=C(CN5CCN(CC)CC5)C=C4)=NC=C3F)C=C2N1C(C)C,
Verapamil,NSC 135784; CP-16533-1; (Â±)-Verapamil,52-53-9,CC(C)C(C#N)(C1=CC(OC)=C(OC)C=C1)CCCN(C)CCC2=CC(OC)=C(OC)C=C2,
Alpidem,Ananxyl,82626-01-5,CC[C@H](C)[C@@H]([C@@H](CC(N(CCC1)[C@@H]1[C@@H]([C@@H](C)C(N[C@@H](Cc1ccccc1)C(O)=O)=O)OC)=O)OC)N(C)C([C@H](C(C)C)NC([C@H](C(C)C)N(C)C)=O)=O,
HA-1004,,91742-10-8,N=C(N)NCCNS(=O)(=O)C1=CC=CC2=C1C=CN=C2,
A2A receptor antagonist 1,CPI-444 analog,443103-97-7,NC1=NC(C2=CC=CO2)=C3C(N(CC4=CC=CC=C4F)N=C3)=N1,
MPP hydrochloride,MPP hydrochloride (289726-02-9 Free base),T21897L,OC1=CC=C(C2=NN(C3=CC=C(O)C=C3)C(C4=CC=C(OCCN5CCCCC5)C=C4)=C2C)C=C1.Cl,
Bucindolol Formate,Bucindolol Formate (71119-11-4 Free base),T10631L,N#CC1=CC=CC=C1OCC(O)CNC(C)(C)CC2=CNC3=C2C=CC=C3.[H]C(O)=O,
GSK-1520489A,,1042433-41-9,CC(C)(C)S(c1cc2c(Nc(cc3)cc4c3scn4)ncnc2cc1OCCOP(O)(O)=O)(=O)=O,
AP 18,,55224-94-7,CC(C(C)=CC1=CC=C(Cl)C=C1)=NO,
(E/Z)-ZINC09659342,,591726-26-0,O=C(C1=CC=C(C=C1)N2N=C(C(C2=O)=CC3=CC=C(O3)C4=CC=CC(C(F)(F)F)=C4)C)O,
WAY-328173,,912790-59-1,O=C(C1=NOC(C2=CC=C(Cl)C=C2)=C1)NCCCN3C=CN=C3,
WAY-352753,,478482-74-5,ClC1=CC=CC=C1CSC2=NN=C(C3=CC=NC=C3)O2,
MNK8Â ,"3-methyl-6-(naphthalen-1-yl)pyrimidine-2,4(1H,3H)-dione",2055078-49-2,CN(C(C=C(c1cccc2ccccc12)N1)=O)C1=O,
"3,4-Dihydroxybenzylamine hydrobromide",NSC 263475 hydrobromide,16290-26-9,NCc(cc1)cc(O)c1O.Br,
Fananserin,RP 62203,127625-29-0,O=S(c1ccc2)(N(CCCN(CC3)CCN3c(cc3)ccc3F)c3c1c2ccc3)=O,
Halopemide,,59831-65-1,O=C(c(cc1)ccc1F)NCCN(CC1)CCC1N(c(ccc(Cl)c1)c1N1)C1=O,
DM1-SMe,,138148-68-2,C/C(CC1=CC(N2C)=C(Cl)C(OC)=C1)=C\C=C\[C@](OC)([H])[C@@](NC(O3)=O)(O)C[C@@]3([H])[C@H]([C@H](O4)[C@]4(C)[C@](CC2=O)(OC([C@@H](N(C(CCSSC)=O)C)C)=O)[H])C,
CP94253 hydrochloride,CP 94253 hydrochloride,845861-39-4,CCCOc(cc1)nc2c1[nH]cc2C1=CCNCC1.Cl,
Givinostat hydrochloride,Givinostat HCl; ITF2357; ITF-2357; ITF 2357; ITF2357 HCl; ITF2357 hydrochloride,199657-29-9,CCN(CC)Cc1ccc(cc(COC(Nc(cc2)ccc2C(NO)=O)=O)cc2)c2c1.Cl,
Jineol,"NSC 694081; NSC694081; NSC-694081; 3,8-Quinolinediol",178762-28-2,Oc1cnc2c(O)cccc2c1,
N6-Methyladenine,6-(Methylamino)Purine,443-72-1,CNc1ncnc2c1[nH]cn2,
Ac-rC Phosphoramidite,,121058-88-6,CC(C)N(C(C)C)P(OCCC#N)OC(C(COC(c1ccccc1)(c(cc1)ccc1OC)c(cc1)ccc1OC)OC1N(C=CC(NC(C)=O)=N2)C2=O)C1O[Si](C)(C)C(C)(C)C,
"3,5-Di-tert-butylphenol",,1138-52-9,CC(C)(C)c1cc(O)cc(C(C)(C)C)c1,
Mapenterol hydrochloride,,54238-51-6,CCC(C)(C)NCC(c(cc1C(F)(F)F)cc(Cl)c1N)O.Cl,
MCC-555,Netoglitazone; Isaglitazone,161600-01-7,O=C(C(Cc(ccc1c2)cc1ccc2OCc(cccc1)c1F)S1)NC1=O,
"Benzamide, 3-methoxy-N-(3-thiazolo[5,4-b]pyridin-2-ylphenyl)","3-methoxy-N-(3-(thiazolo[5,4-b]pyridin-2-yl)phenyl)benzamide",863589-52-0,O=C(NC1=CC=CC(C2=NC3=CC=CN=C3S2)=C1)C4=CC=CC(OC)=C4,
Uvaol,,545-46-0,C[C@@H]1[C@@H](C)[C@@H]2C3=CC[C@@H]([C@](C)(CC4)[C@H](CC5)C(C)(C)[C@@H]4O)[C@@]5(C)[C@@]3(C)CC[C@]2(CO)CC1,
Gallopamil hydrochloride,Methoxyverapamil hydrochloride,16662-46-7,CC(C)C(CCCN(C)CCc(cc1)cc(OC)c1OC)(c(cc1OC)cc(OC)c1OC)C#N.Cl,
Tarloxotinib bromide,TH-4000,1636180-98-7,Cn(cn1)c(C[N+](C)(C)C/C=C/C(Nc(cc23)ncc3ncnc2Nc(cc2)cc(Br)c2Cl)=O)c1[N+]([O-])=O.[Br-],
GCN2-IN-1,A-92,1448693-69-3,C(COCC1)C1n1ncc(Nc(nc2)nc3c2nnn3-c2cc([nH]nc3)c3cc2)c1,
BioE-1115,,1268863-35-9,CC(C)N(C)c1nc2cc(C(O)=O)ccc2nc1-c(cc1)ccc1F,
GW843682X,GW843682,660868-91-7,COc(c(OC)c1)cc2c1ncn2-c1cc(OCc2c(C(F)(F)F)cccc2)c(C(N)=O)s1,
Nitroflurbiprofen,HCT 1206; NO-flurbiprofen; Nitroxybutyl flurbiprofen,158836-71-6,CC(C(OCCCCO[N+]([O-])=O)=O)c(cc1)cc(F)c1-c1ccccc1,
LEQ506,NVP-LEQ506,1204975-42-7,CC(CN(CC1)c2nnc(Cc3ccccc3)c(C)c2C)N1c1cnc(C(C)(C)O)cn1,
MELK-8a hydrochloride,,2096992-20-8,CN(CC1)CCN1c(cc1)ccc1-n1ncc(-c(ccnc2)c2OCC2CCNCC2)c1.Cl,
Rec 15/2615 dihydrochloride,,173059-17-1,CC(C)c1cccc(OC)c1OCC(N(CC1)CCN1c(nc(c1c2)N)nc1cc(OC)c2OC)=O.Cl.Cl,
Triparanol,NSC 65345; NSC-65345; NSC65345,78-41-1,CCN(CC)CCOc1ccc(C(Cc(cc2)ccc2Cl)(c2ccc(C)cc2)O)cc1,
AVE-0118,AVE 0118; AVE0118,498577-53-0,COc1ccc(CC(NCc(cccc2)c2-c(cccc2)c2C(NCCc2cnccc2)=O)=O)cc1,
PNU-96391,OSU-6162; PNU96391; OSU6162; PNU 96391; OSU 6162,146798-66-5,CCCN(CCC1)C[C@@H]1c1cccc(S(C)(=O)=O)c1,
ABT 102,ABT-102; ABT102; CHEMBL398338,808756-71-0,CC(C1=CC=C2C(CC[C@H]2NC(NC3=C4C=NNC4=CC=C3)=O)=C1)(C)C,
BAY-6035,,2247890-13-5,C[C@@H](C1)N(C(N2CC(C3)C3C2)=O)c(ccc(C(NCCC2CC2)=O)c2)c2NC1=O,
CL097,,1026249-18-2,CCOCc1nc(c2ccccc2nc2N)c2[nH]1,
Ro60-0175,,169675-08-5,C[C@@H](Cn(ccc1c2)c1cc(Cl)c2F)N.OC(/C=C/C(O)=O)=O,
Befotertinib,D-0316,1835667-63-4,C=CC(=O)NC1=CC(NC2=NC=CC(C3=CN(CC(F)(F)F)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(C)CCN(C)C,
ML-60218,,577784-91-9,Cc1c(-c2nn(C)c(NS(c(cccc3)c3Cl)(=O)=O)c2)sc(cc2)c1cc2Cl,
CFT7455,,2504235-67-8,O=C1C2=C3C(C(CC4=CC=C(CN5CCOCC5)C=C4)=CC=C3N1[C@@H](CCC6=O)C(N6)=O)=CC=C2,
PRLX-93936 HCL,PRLX-93936 hcl(903499-49-0 Free base),1094210-96-4,O=C1N(C2=CC=CC=C2OCC)C(CN3CCNCC3)=NC4=C1C=CC=C4.Cl,
MM41,,1429028-96-5,O=C(N(CCCN1CCOCC1)C(C2=C3C4=C(C(N5CCCN6CCOCC6)=O)C=C2NCCCN7CCN(C)CC7)=O)C3=CC(NCCCN8CCN(C)CC8)=C4C5=O,
Povorcitinib phosphate,,1637677-33-8,O=P(O)(O)O.N#CCC1(N2C=C(C(C(C)=NN3)=C3C)C=N2)CN(C(C=C(F)C(C(N[C@@H](C)C(F)(F)F)=O)=C4)=C4F)C1,
SOS1-IN-11,,2654741-64-5,C[C@@H](NC1=NN=C(C)C2=CN=C(N3CCOCC3)C=C21)C4=CC=CC(C(F)(F)F)=C4C,
Eciruciclib,,1868086-40-1,CC(C1=C2C=C(C3=NC(NC4=NC=C(CN5CCN(CC)CC5)C=C4)=NC=C3F)C=CC2=NN1C)C,
L82-G17,,92285-87-5,OC1=CC(C=NNC(C=NN2)=C(Cl)C2=O)=CC=C1,
(+)-OSU 6162,"Piperidine, 3-[3-(methylsulfonyl)phenyl]-1-propyl-, (3R)-",160777-43-5,S(C)(=O)(=O)C=1C=C(C=CC1)[C@@H]2CN(CCC)CCC2,
GQ-16,,870554-67-9,Cc1ccc(CN(C(/C(/S2)=C/c(cc(cc3)Br)c3OC)=O)C2=O)cc1,
BRD7389,,376382-11-5,O=C1NC2=CC=CC=3C(=O)C=4C=CC=CC4C(=C1NCCC=5C=CC=CC5)C23,
ESI-08,,301177-43-5,N#CC=1C(=O)N=C(SCC2=CC(=CC=C2C)C)NC1C3CCCCC3,
MBM-55,,2083622-09-5,O=C(N)C=1C=CC(=CC1OCC=2C=CC=C(F)C2)C3=CN=C4C=C(C=CN43)C=5C=NN(C5)CCN(C)C,
Flurochloridone,EPA Pesticide Chemical Code 128401; R 40244; R-40244; R40244,61213-25-0,O=C1N(C2=CC=CC(=C2)C(F)(F)F)CC(CCl)C1Cl,
Bucillamine,DE-019; DE 019; DE019; SA96; Thiobutarit; Tiobutarit; ,65002-17-7,O=C(O)C(NC(=O)C(S)(C)C)CS,
Fluticasone furoate,Fluticasone furoate; Avamys; Veramyst; Allermist,397864-44-7,O=C1C=CC2(C(=C1)C(F)CC3C4CC(C)C(OC(=O)C=5OC=CC5)(C(=O)SCF)C4(C)CC(O)C32F)C,
Exisulind,Sulindac sulfone; CP248,59973-80-7,O=C(O)CC=1C=2C=C(F)C=CC2C(=CC3=CC=C(C=C3)S(=O)(=O)C)C1C,
TC-AQP1-1,,37710-81-9,O=C(O)C=CC1=CC=CC(C=CC(=O)O)=C1,
BAY 2666605,,2275774-60-0,O=C1OC(C(=NN1)C=2C=CC(C=3C=CC(F)=CC3)=C(C2)C(F)(F)F)C,
HS-243,,848249-10-5,O=C(NC1=NC=2C=CC=CC2N1CCC)C3=CC=CC(=C3)N(=O)=O,
HS220,,1570374-32-1,O=C(O)C1=CC=CC(=C1)C(=O)NC2=NC=3C=CC=CC3N2CCC,
SR15006,,2505001-54-5,O=C(C=CC=1C=CC=C(Cl)C1)NCC(=O)N2CCN(CC2)S(=O)(=O)C,
UNC 569 hydrochloride,UNC 569 hydrochloride (1350547-65-7 Free base),T21302L,CCCCNC1=NC=C(C2=N1)C(C3=CC=C(F)C=C3)=NN2C[C@@H]4CC[C@@H](N)CC4.Cl,
VPC-70063,"Thiourea, N-[3,5-bis(trifluoromethyl)phenyl]-N'-(phenylmethyl)-",13571-44-3,FC(F)(F)C1=CC(=CC(=C1)C(F)(F)F)NC(=S)NCC=2C=CC=CC2,
Oleoyl Serotonin,,1002100-44-8,O=C(NCCC1=CNC=2C=CC(O)=CC21)CCCCCCCC=CCCCCCCCC,
N6-(2-Phenylethyl)adenosine,N6-Phenethyladenosine; N6-Phenylethyladenosine,20125-39-7,N(CCC1=CC=CC=C1)C2=C3C(N(C=N3)[C@@]4(O[C@H](CO)[C@@H](O)[C@H]4O)[H])=NC=N2,
PF-06821497,,1844849-10-0,ClC1=C2C(=C(Cl)C=C1[C@H](OC)C3COC3)CCN(CC4=C(OC)C=C(C)NC4=O)C2=O,
Pz-1,,1800505-64-9,O=C(NC1=NOC(=C1)C(C)(C)C)CC2=CC=C(C=C2)N3C=NC=4C=C(C=CC43)C=5C=NN(C5)C,
AL 8697,,1057394-06-5,O=C(NC1CC1)C=2C=C(F)C(=C(C2)C=3C(F)=CN4C(=NN=C4C(C)(C)C)C3F)C,
Eplivanserin,SR-46349,130579-75-8,C(/C=C/C1=CC=C(O)C=C1)(=N\OCCN(C)C)\C2=C(F)C=CC=C2,
Inolitazone,Efatutazone; CS-7017; RS5444,223132-37-4,O=C1SC(C(=O)N1)CC2=CC=C(OCC3=NC=4C=CC(OC=5C=C(C(N)=C(C5)C)C)=CC4N3C)C=C2,
Mavatrep,JNJ-39439335,956274-94-5,C(=C/C1=CC=C(C(F)(F)F)C=C1)\C=2NC=3C(N2)=CC=C(C3)C4=C(C(C)(C)O)C=CC=C4,
CID 5951923,,749872-43-3,O=C(OCC(=O)N(C)C1CCS(=O)(=O)C1)C=CC2=CC=CC(=C2)N(=O)=O,
Dehydroabiethylamine,Leelamine; Leelamine free base; NSC-2955; NSC 2955; NSC2955,1446-61-3,C[C@@]12C=3C(CC[C@]1([C@@](CN)(C)CCC2)[H])=CC(C(C)C)=CC3,
Aureusidin,Auresudidin; Auresidin,38216-54-5,O=C\1C=2C(O/C1=C\C3=CC(O)=C(O)C=C3)=CC(O)=CC2O,
KG5,,877874-85-6,FC(F)(F)C=1C=CC=C(C1)NC2=NN=C(N2)C=3C=CC(OC4=NC(=NC(N)=C4)SC)=CC3,
(R)-Lisofylline,,100324-81-0,O=C1C2=C(N(C)C(=O)N1CCCC[C@@H](C)O)N=CN2C,
Pregnenolone Carbonitrile,5-Pregnen-3Î²-ol-20-one-16Î±-carbonitrile; Pregnenolone 16Î±-carbonitrileÂ ,1434-54-4,C[C@@]12[C@]([C@]3([C@](CC1)([C@]4(C)C(=CC3)C[C@@H](O)CC4)[H])[H])(C[C@@H](C#N)[C@@H]2C(C)=O)[H],
ZN-c3,,2376146-48-2,C(C=C)N1N(C=2C(C1=O)=CN=C(NC3=CC=C(C=C3)N4CCN(C)CC4)N2)C=5N=C6C(=CC5)CC[C@@]6(CC)O,
SIRT1-IN-1,,352554-02-0,O=C(N)C1C=2NC=3C=CC(=CC3C2CCC1)C,
MST-312,Telomerase Inhibitor IX,368449-04-1,O=C(NC1=CC=CC(=C1)NC(=O)C=2C=CC=C(O)C2O)C=3C=CC=C(O)C3O,
BIMU 8,,134296-40-5,C(N[C@H]1C[C@@H]2N(C)[C@H](C1)CC2)(=O)N3C=4C(N(C(C)C)C3=O)=CC=CC4.Cl,
PD 198306,,212631-61-3,O=C(NOCC1CC1)C2=CC(F)=C(F)C(F)=C2NC3=CC=C(I)C=C3C,
NNC 55-0396,NNC 55-0396 dihydrochloride,357400-13-6,Cl.Cl.CC(C)[C@H]1c2ccc(F)cc2CC[C@@]1(CCN(C)CCCc1nc2ccccc2[nH]1)OC(=O)C1CC1,
PI3K/mTOR Inhibitor-2,,1848242-58-9,O=C1C(Cl)=CN=C2C=CC(=CN12)C=3C=NC(OC)=C(C3)NS(=O)(=O)C4=CC=C(F)C=C4F,
5-HT4 antagonist 1,,261766-73-8,O=C(NCC1CCN(CCCS(=O)(=O)N2CCN(C)CC2)CC1)C=3C=CC=C4OCCOC43,
A-385358,,406228-55-5,N(=O)(=O)C1=C(N[C@@H](CSC2=CC=CC=C2)CCN(C)C)C=CC(S(NC(=O)C3=CC=C(C=C3)N4CCC(C)(C)CC4)(=O)=O)=C1,
CLK-IN-T3,,2109805-56-1,O=C(NC=1N=C2C=CC(=CN2C1)C=3C=CN=CC3)C4=CC=C(C=C4)C(C(=O)N5CCN(C)CC5)(C)C,
Sirtuin modulator 1,SRT3025 Hydrochloride,2070015-26-6,Cl.O=C(NC=1C=CC=CC1C2=NC3=CC(=CN=C3S2)CN4CCCC4)C=5N=C(SC5CCCOC)C=6C=CC=CC6,
CJ 033466,,519148-48-2,O=C(NCC1CCN(CC1)CC(C)C)C2=CC(Cl)=C(N)N3C=C(N=C23)C,
MCP110,MCP-110; MCP 110,521310-51-0,O=C(N(CC1=CC=C(OCC=2C=CC=CC2)C(OC)=C1)CCC3=NC=CC=C3)CCCCC=4C=CC=CC4,
Pyrazoloacridine,"PD 115934; PD-115934; PD 115,934; NSC 366140; NSC-366140",99009-20-8,O=N(=O)C1=CC=C2C=3C(=NN2CCCN(C)C)C=4C=C(OC)C=CC4NC13,
Vedaprofen,Quadrisol; CERM 10202; PM 150,71109-09-6,O=C(O)C(C=1C=CC(=C2C=CC=CC21)C3CCCCC3)C,
dUTP trisodium,2'-Deoxyuridine-5'-triphosphate trisodium salt; Deoxyuridine triphosphate,102814-08-4,[Na+].[Na+].[Na+].O[C@H]1C[C@@H](O[C@@H]1COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)n1ccc(=O)[nH]c1=O,
GNF2133,,2561414-56-8,O=C(NC1=NC=CC(=C1)C2=CN(C=3C=NC=CC23)C4CCOCC4)N5CCN(CC)CC5,
PACMA 31,,1401089-31-3,O=C(C#C)N(C1=CC=C(OC)C=C1OC)C(C(=O)NCC(=O)OCC)C=2SC=CC2,
Olomoucine,,101622-51-9,OCCNC=1N=C(NCC=2C=CC=CC2)C=3N=CN(C3N1)C,
WAY-270360,"N-[4-(1H-benzimidazol-2-yl)phenyl]-2,4-dimethoxybenzamide",476633-98-4,O=C(NC=1C=CC(=CC1)C2=NC=3C=CC=CC3N2)C4=CC=C(OC)C=C4OC,
Specific PXR antagonist 70,,931314-31-7,O=S(=O)(C=1N=NN(C2=CC(OC)=CC=C2OC)C1C)C3=CC=C(C=C3)C(C)(C)C,
AZD-9574,,2756333-39-6,O=C(NC)C1=NC(F)=C(C=C1)N2CCN(CC=3C=CC=4N=C(C(=O)NC4C3F)C)CC2,
3MB-PP1,,956025-83-5,N=1C=NC2=C(C1N)C(=NN2C(C)(C)C)CC=3C=CC=C(C3)C,
CCT 031374 hydrobromide,,1219184-91-4,Br.O=C(C=1C=CC(=CC1)C=2C=CC=CC2)CN3C=4C=CC=CC4N5C3=NCC5,
Ninerafaxstat trihydrochloride,Ninerafaxstat trihydrochloride(2254741-41-6 Free base),2311824-72-1,Cl.Cl.Cl.COc1ccc(CN2CCN(CCOC(=O)c3cccnc3)CC2)c(OC)c1OC,
Hamaline,"9-(4-chlorobenzyl)-6-methoxy-1-methyl-4,9-dihydro-3H-pyrido[3,4-b]indole",2411677-02-4,ClC1=CC=C(C=C1)CN2C=3C=CC(OC)=CC3C4=C2C(=NCC4)C,
DK419,,2102672-22-8,O=C(NC1=CC=C(C=C1)C(F)(F)F)C2=CC(Cl)=CC=3N=C(NC32)C(F)(F)F,
CL 316243,,138908-40-4,C[C@@H](NC[C@H](O)C1=CC(Cl)=CC=C1)CC2=CC3=C(OC(C([O-])=O)(C([O-])=O)O3)C=C2.[Na+].[Na+],
Pimonidazole hydrochloride,,70132-51-3,OC(CN1CCCCC1)CN2C=CN=C2[N+]([O-])=O.Cl,
SERCA2a activator 1,,2139330-34-8,O=C(NS(=O)(=O)C=1C=CC=2C=CC=CC2C1)C3=CC=NC(=C3)C=4C=C(C(=O)N(C4)CCCC)CC=5C=CC=CC5,
INCB054329,"INCB-054329,INCB-54329",1628607-64-6,O=C1N2C3=C(C(=CC=C3N1)C=4C(C)=NOC4C)OC[C@@]2(C5=CC=CC=N5)[H],
beta-Amyrone,Î²-Amyron,638-97-1,C[C@]12[C@@]3(C)C([C@]4([C@@](C)(CC3)CCC(C)(C)C4)[H])=CC[C@@]1([C@]5(C)[C@@](CC2)(C(C)(C)C(=O)CC5)[H])[H],
Maclurin,Morintannic acid; NSC 83240; Fustic extract,519-34-6,O=C(C1=CC=C(O)C(O)=C1)C=2C(O)=CC(O)=CC2O,
K201,K 201; K-201; JTV 519; JTV-519,1038410-88-6,Cl.O=C(N1CC2=CC(OC)=CC=C2SCC1)CCN3CCC(CC=4C=CC=CC4)CC3,
CT-1,CT1; CT 1,1983924-33-9,C(=C\1/C(=O)\C(=C\C2=C(F)C=CC=C2)\CN(CC3=CN(CC4=CC=C(F)C=C4)N=N3)C1)\C5=C(F)C=CC=C5,
BML-259,CAY10554,267654-00-2,O=C(NC1=NC=C(S1)C(C)C)CC=2C=CC=CC2,
LP-922056,,1365060-22-5,O=C(O)CSC1=NC=NC2=C1SC(Cl)=C2C3CC3,
Oritinib,SH-1028,2035089-28-0,O=C(C=C)NC1=CC(NC=2N=CC=C(N2)C=3C=4C=CC=CC4N5C3CCCC5)=C(OC)C=C1N(C)CCN(C)C,
NPX800,CCT361814,1693734-80-3,O=C(NC1=CC=C(F)C(=C1)NC(=O)C=2C=CC=3N=C(C=CC3C2)CN4CCN(CC)CC4)C5=CC=C6OCCOC6=C5,
RU-TRAAK-2,,1210538-56-9,O=C(NCC#CC=1C=CC=CC1)N(C)CC2=NC=3C=CC=CC3S2,
IC 86621,,404009-40-1,O=C(C1=CC=C(C=C1O)N2CCOCC2)C,
TNIK-IN-5,,2754265-66-0,O=C1OC=2C=C(C=CC2N1CC=3C=CC=C(OC)C3)C4=CN=C5NC=CC5=C4,
Veraguensin,,19950-55-1,C[C@@H]1[C@@H](O[C@@H]([C@H]1C)C2=CC(OC)=C(OC)C=C2)C3=CC(OC)=C(OC)C=C3,
Bemesetron,"MDL 72222; 3-TROPANYL-3,5-DICHLOROBENZOATE; TROPANYL 3,5-DICHLOROBENZOATE",40796-97-2,O(C(=O)C1=CC(Cl)=CC(Cl)=C1)[C@H]2C[C@@H]3N(C)[C@H](C2)CC3,
RU-302,"[2-[(3,5-dimethyl-1,2-oxazol-4-yl)methylsulfanyl]phenyl]-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methanone",1182129-77-6,O=C(C=1C=CC=CC1SCC=2C(=NOC2C)C)N3CCN(C4=CC=CC(=C4)C(F)(F)F)CC3,
SPOP-IN-6b,"2-Imino-10-methyl-N-(3-morpholinopropyl)-5-oxo-1-phenethyl-1,5-dihydro-2H-dipyrido[1,2-a:2',3'-d]pyrimidine-3-carboxamide",2136270-20-5,O=C(NCCCN1CCOCC1)C2=CC=3C(=O)N4C=CC=C(C4=NC3N(C2=N)CCC=5C=CC=CC5)C,
Sudoxicam,"4-Hydroxy-2-methyl-N-2-thiazolyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide",34042-85-8,O=C(NC1=NC=CS1)C2=C(O)C=3C=CC=CC3S(=O)(=O)N2C,
GR 46611,,185259-85-2,C(CN(C)C)C=1C=2C(NC1)=CC=C(C=CC(NCC3=CC=C(OC)C=C3)=O)C2,
MM 77 dihydrochloride,,159187-70-9,O=C(CC1)N(CCCCN2CCN(C3=CC=CC=C3OC)CC2)C1=O.[H]Cl.[H]Cl,
YH-306,YH306,1373764-75-0,O=C(N1CC=2NC=3C=CC=CC3C2CC1)CC4=CC=C(O)C=C4,
ZINC69391,"ZINC-69391; N'-(4,6-dimethylpyrimidin-2-yl)-N-[2-(trifluoromethyl)phenyl]guanidine",303094-67-9,FC(F)(F)C=1C=CC=CC1NC(=N)NC=2N=C(C=C(N2)C)C,
Ani9,Ani 9,356102-14-2,O=C(NN=CC=1C=CC=CC1OC)COC2=CC=C(Cl)C=C2C,
PD 174265,PD174265; PD-174265; N-{4-[(3-Bromophenyl)amino]quinazolin-6-Yl}propanamide,216163-53-0,O=C(NC=1C=CC2=NC=NC(NC=3C=CC=C(Br)C3)=C2C1)CC,
TRPC6-PAM-C20,"3-(6,7-Dimethoxy-3,3-dimethyl-3,4-dihydro-isoquinolin-1-yl)-chromen-2-one",667427-75-0,O=C1OC=2C=CC=CC2C=C1C3=NC(C)(C)CC=4C=C(OC)C(OC)=CC34,
BMS986299,Unii-VS58MO4P47,2242952-69-6,O=C(N(CC1=NC=2C(=NC=3C=C(C=CC3C2N1)C4=NNC=C4)N)CC)C,
GNE-9815,"3-(2-cyanopropan-2-yl)-N-[2-fluoro-4-methyl-5-(7-methyl-8-oxo-7,8-dihydropyrido[2,3-d]pyridazin-3-yl)phenyl]benzamide",2729996-45-4,N#CC(C=1C=CC=C(C1)C(=O)NC=2C=C(C3=CN=C4C(C=NN(C4=O)C)=C3)C(=CC2F)C)(C)C,
Chromeceptin,2-amino-7-(dimethylamino)-4-[3-(trifluoromethyl)phenyl]-4H-chromene-3-carbonitrile,331859-86-0,N#CC1=C(OC2=CC(=CC=C2C1C3=CC=CC(=C3)C(F)(F)F)N(C)C)N,
Apelin-12 acetate,Apelin-12 acetate (229961-08-4 Free base),T39823L,CC(O)=O.O=C([C@H]1N(CCC1)C([C@@H](N)CCCNC(N)=N)=O)N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@H](C(N[C@H](C(NCC(N2[C@H](C(N[C@H](C(N3CCC[C@H]3C(N[C@H](C(O)=O)CC4=CC=CC=C4)=O)=O)CCSC)=O)CCC2)=O)=O)CCCCN)=O)CC5=CN=CN5)=O)=O)=O)CCCNC(N)=N,
SU 4981,3-(4-Morpholinobenzylidene)indolin-2-one,186610-88-8,O=C1NC=2C=CC=CC2C1=CC3=CC=C(C=C3)N4CCOCC4,
AMI-193,Spiramide; Espiramida,510-74-7,O=C1NCN(C=2C=CC=CC2)C13CCN(CCCOC4=CC=C(F)C=C4)CC3,
VU 0240551,N-(4-Methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide; VU0240551-2-D4,893990-34-6,O=C(NC1=NC(=CS1)C)CSC=2N=NC(=CC2)C3=CC=CC=C3,
Retusin,"5-Hydroxy-3,7,3',4'-tetramethoxyflavone; Quercetin-3,7,3',4'-tetramethyl ether",1245-15-4,O=C1C(OC)=C(OC=2C=C(OC)C=C(O)C12)C=3C=CC(OC)=C(OC)C3,
AOH1160,N-(2-Oxo-2-(2-phenoxyphenylamino)ethyl)-1-naphthamide,2089314-57-6,O=C(NCC(=O)NC=1C=CC=CC1OC=2C=CC=CC2)C3=CC=CC=4C=CC=CC43,
FR183998 free base,,239440-20-1,O=C(NC(=N)N)C=1C=C(C=C(C1)C=2C=C(Cl)SC2Cl)C(=O)NCCN(C)C,
INDY,"-(3-ethyl-5-hydroxy-1,3-benzothiazol-2-ylidene)propan-2-one",1169755-45-6,C(C)N\1C=2C(S/C1=C\C(C)=O)=CC=C(O)C2,
Tildacerfont,,1014983-00-6,ClC=1N=C(SC1C2=C3N=C(C=C(N3N=C2C)C(CC)CC)C)N4CCOCC4,
AZD-5672,AZD 5672; AZD5672; UNII-61XQN688TW,780750-65-4,[C@@H](CCN1CCC(N(C(CC2=CC=C(S(C)(=O)=O)C=C2)=O)CC)CC1)(C3=CC=C(S(C)(=O)=O)C=C3)C4=CC(F)=CC(F)=C4,
Et-29,NRD167,2166487-23-4,C([C@H](NC([C@@H](NC(OCC1=CC=CC=C1)=O)CCCCNC(NCCC(OCC)=O)=S)=O)C(NC(C)C)=O)C=2C=3C(NC2)=CC=CC3,
T2AA,"4-[4-[(2S)-2-amino-3-hydroxypropyl]-2,6-diiodophenoxy]phenol; ZINC95605533",1380782-27-3,O(C1=C(I)C=C(C[C@@H](CO)N)C=C1I)C2=CC=C(O)C=C2,
3-Phenyltoxoflavin,ZINC267655; Phenyltoxoflavin,32502-63-9,O=C1N=C2C(=NC(=NN2C)C3=CC=CC=C3)C(=O)N1C,
Zoniporide hydrochloride,CP-597396 hydrochloride,241800-97-5,Cl.O=C(NC(=N)N)C=1C=NN(C2=CC=CC3=NC=CC=C32)C1C4CC4,
AZ12672857,,945396-55-4,N1=CC=2C(=CC=CC2N(C3=NC(=NC=C3)NC=4C=C(C=C(C4)N5CCOCC5)N6CCOCC6)C)N1,
JGB1741,ILS-JGB-1741,1256375-38-8,C(NCC1=CC=CC=C1)(=O)C=2C3=C(SC2/N=C/C=4C5=C(C=CC4O)C=CC=C5)CCCC3,
EPZ031686,EPZ-031686,1808011-22-4,ClC1=CC(NC(C2)=O)=C2C=C1C(N[C@@H]3C[C@H](CC4)N(S(CC5CCN(CCCC(F)(F)F)CC5)(=O)=O)[C@H]4C3)=O,
Bufarenogin,"3beta,12beta,14-Trihydroxy-11-oxo-5beta-bufa-20,22-dienolide",17008-65-0,C[C@@]12[C@@](O)([C@]3([C@](C(=O)[C@H]1O)([C@]4(C)[C@](CC3)(C[C@@H](O)CC4)[H])[H])[H])CC[C@@]2(C=5C=CC(=O)OC5)[H],
NHE3-IN-1,,632355-68-1,ClC=1SC=C(C1NC2=NC=3C=CC=CC3N2)C,
ON 146040,ZINC211117138,1404231-34-0,O=C1NC2=CN=C(N=C2SC1=CC3=CC=C(C=C3)N(=O)=O)NC4=CC=C(C=C4)N5CCN(C)CC5,
1-Methylcytosine,4-amino-1-methylpyrimidin-2(1H)-one; 1-methylcytosin; N-Methylcytosine,1122-47-0,O=C1N=C(N)C=CN1C,
5-HT1A modulator 1,5-HT1Amodulator1,142477-34-7,O=C1SC2=CC(=CC=C2N1C)CCN3CCN(C=4C=CC=CC4OC)CC3,
D-Kynurenine,(R)-2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid; ZINC901103,13441-51-5,C(C[C@H](C(O)=O)N)(=O)C1=C(N)C=CC=C1,
GSK-3Î² inhibitor 2,"5-Thiazolecarboxamide,2-[2-[(cyclopropylcarbonyl)amino]-4-pyridinyl]-4-methoxy-; GSK 3Î² inhibitor 2",1702428-31-6,O=C(N)C=1SC(=NC1OC)C=2C=CN=C(C2)NC(=O)C3CC3,
ML402,ZINC3671497; N-[2-(4-chloro-2-methylphenoxy)ethyl]thiophene-2-carboxamide,298684-44-3,O=C(NCCOC1=CC=C(Cl)C=C1C)C=2SC=CC2,
Olvanil,N-Vanillyloleamide; N-Vannilyloleoylamide,58493-49-5,C(NC(CCCCCCC/C=C\CCCCCCCC)=O)C1=CC(OC)=C(O)C=C1,
S 14506 hydrochloride,,286369-38-8,Cl.O=C(NCCN1CCN(C2=CC=CC3=CC=C(OC)C=C32)CC1)C4=CC=C(F)C=C4,
ABC99,ABC-99; ABC 99,2331255-53-7,O=C(ON1C(=O)N2CCN(CC3=CC=C(Cl)C=C3)CC2C1=O)N4C=5C=CC=CC5OCC4,
RK-9123016,RK 9123016; RK9123016,955900-27-3,O=N(=O)C=1C=NN(C1)CC2=CC(C=NNC(=S)NCC=C)=CC=C2OC,
LCB 03-0110 dihydrochloride,,1962928-28-4,Cl.Cl.Oc1cccc(Nc2ccnc3cc(sc23)-c2cccc(CN3CCOCC3)c2)c1,
GSK251,,2125968-05-8,O=S(=O)(NC=1C=CN=C(C1)C=2C=CC(=CC2F)CN3CCN(CC3)C(C)C)C4=CC(=CN=C4OC)N5CCOCC5,
NCT-58,NCT58,2411429-33-7,O=C(NC1=CC=C(OCCC2NCCCC2)C(OC)=C1)C3=CC=C4OC(C=CC4=C3OC)(C)C,
d-Epigalbacin,(-)-Zuonin A,84709-25-1,C[C@@H]1[C@](O[C@@]([C@@H]1C)(C=2C=C3C(=CC2)OCO3)[H])(C=4C=C5C(=CC4)OCO5)[H],
RBN013209,,2597933-17-8,C(N[C@@H]1CC[C@@H](OCCOC)CC1)(=O)C2=C3C(=NC(=N2)N4C=CN=C4)C=CN3,
NVP-DKY709,,2291360-73-9,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC(=C3)C4CCN(CC4)CC5=CC=CC=C5,
Potassium Channel Activator 1,ZINC34634569,908608-06-0,O=C(OCC=1C=CC=CC1)NC=2C(=NC(=CC2C)N3CCOCC3)C,
CCG 203769,"Thiadiazolidinone (TDZD) deriv. 6; RGS4 inhibitor 11b; 4-butyl-2-ethyl-1,2,4-thiadiazolidine-3,5-dione",410074-60-1,O=C1SN(C(=O)N1CCCC)CC,
Pipendoxifene hydrochloride,,245124-69-0,Cl.OC=1C=CC(=CC1)C2=C(C3=CC(O)=CC=C3N2CC4=CC=C(OCCN5CCCCC5)C=C4)C,
(+)-KCC2 blocker 1,,1228439-71-1,C(C1(C(OCC2=CC=CC=C2)=O)N(C(C)=O)CCC1)C3=CC=C(S(C)(=O)=O)C=C3,
5-Aminouridine,4-Chloro-2-isopropyl-5-methylphenol(chlorothymol),2149-76-0,O[C@H]1[C@@](O[C@H](CO)[C@H]1O)(N2C(=O)NC(=O)C(N)=C2)[H],
Indeglitazar,PPM 204,835619-41-5,O=C(O)CCC1=CN(C=2C=CC(OC)=CC21)S(=O)(=O)C3=CC=C(OC)C=C3,
Pyr3,,1160514-60-2,O=C(OCC)C=1C=NN(C2=CC=C(C=C2)NC(=O)C(Cl)=C(Cl)Cl)C1C(F)(F)F,
Sorafenib-d3,Sorafenib (D3); Bay 43-9006 (D3),1130115-44-4,O(C=1C=C(C(NC([2H])([2H])[2H])=O)N=CC1)C2=CC=C(NC(NC3=CC(C(F)(F)F)=C(Cl)C=C3)=O)C=C2,
WAY-204688,SIM-688; SIM688,796854-35-8,[C@H]([C@](C(=O)N1CCC(CC1)C2=CC(C(F)(F)F)=CC=C2)(C#N)C)(C=3C4=C(C=CC3)C=CC=C4)C5=C(OC)C=CC=C5,
WJ460,,1415251-36-3,O=C(NCCCCC=1C=CC=CC1)C2=CC=CC(=C2)C3SCC(=O)N3C=4C=CC=CC4OC,
5-Hydroxy-2'-deoxyuridine,5-OHdU,5168-36-5,O=C1N([C@@]2(O[C@H](CO)[C@@H](O)C2)[H])C=C(O)C(=O)N1,
PF-249,PF 249; PF249; PF-06685249; PF06685249; PF 06685249,1467059-70-6,O=C(O)C1=CNC=2C=C(Cl)C(=CC21)C=3C=CC(=NC3OC)N(C)C,
K00135,"K-00135; K 00135; IMIDAZOPYRIDAZIN 1; Imidazol[1,2-b]pyridazine 1",869650-21-5,O=C(C1=CC=CC(=C1)C2=CN=C3C=CC(=NN32)NCC4CC4)C,
CGP77675,"CGP-77675; CGP 77675; 1-(4-(4-amino-5-(3-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)phenethyl)piperidin-4-ol; ZINC1488120",234772-64-6,OC1CCN(CCC2=CC=C(C=C2)N3C=C(C=4C=CC=C(OC)C4)C=5C(=NC=NC53)N)CC1,
THZ1 2HCl,THZ1 Dihydrochloride,2095433-94-4,O=C(NC1=CC=C(C(NC2=CC(NC3=NC(C4=CNC5=C4C=CC=C5)=C(Cl)C=N3)=CC=C2)=O)C=C1)C=CCN(C)C.Cl.Cl,
Bcl-xL antagonist 2,,1235032-75-3,O=C(O)C=1N=C(SC1)N2CC=3C(=CC=CC3CC2)C(=O)NC4=NC=5C=CC=CC5S4,
CDK12-IN-2,CDK12 inhibitor 2,2244987-03-7,N(C(NCC1=CC=CC=C1)=O)(C2=CC=C(C=C2)C3=CN(C)C(=O)C=C3)[C@H]4CC[C@H](NC5=CC=C(C#N)C=N5)CC4,
Donitriptan hydrochloride,Donitriptan monohydrochloride; Donitriptan HCl,170911-68-9,Cl.N#CC1=CC=C(C=C1)N2CCN(C(=O)COC=3C=CC=4NC=C(C4C3)CCN)CC2,
hSMG-1 inhibitor 11j,,1402452-15-6,O=C(NC1=CC=C(C=C1)C2=NC=CC(=C2)C3=NC(=NC=C3)NC4=CC=C(Cl)C(=C4)S(=O)(=O)N(CC)CC)NC,
ART558,,2603528-97-6,C(N(C)C1=CC(C)=CC=C1)(=O)[C@H]2N(CC[C@H]2O)C3=C(C#N)C(C(F)(F)F)=CC(C)=N3,
(E/Z)-Sivopixant,(E/Z)-S-600918,1640808-39-4,C(N1C(NC2=CC=C(OC3=CC=CC=N3)C=C2)=NC(=O)N(C[C@@H](C(O)=O)C)C1=O)C4=CC=C(Cl)C=C4,
PF07104091,PF-07104091,2460249-19-6,N(C(=O)C1=CC(COC)=NN1C)C2=CC(=NN2)[C@@H]3C[C@H](OC(NC(C)C)=O)CC3,
LSZ-102,LSZ102,2135600-76-7,O(C1=C(SC=2C1=CC=C(O)C2)C3=C(C(C)(F)F)C=C(F)C=C3)C4=CC=C(/C=C/C(O)=O)C=C4,
Filanesib,ARRY 520; ARRY-520,885060-09-3,C(CCN)[C@@]1(N(C(N(OC)C)=O)N=C(S1)C2=C(F)C=CC(F)=C2)C3=CC=CC=C3,
Cedazuridine,"(4R)-2'-Deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridine",1141397-80-9,FC1(F)[C@@H](O[C@H](CO)[C@H]1O)N2C(=O)N[C@H](O)CC2,
HC-070,HC 070,1628291-95-1,O=C1C2=C(N=C(OC=3C=CC=C(Cl)C3)N2CC4=CC=C(Cl)C=C4)N(C(=O)N1CCCO)C,
SMANT hydrochloride,"N-(4-bromophenyl)-3-(3,5-dimethylpiperidin-1-yl)propanamide hydrochloride; N-(4-Bromophenyl)-3,5-dimethyl-1-piperidinepropanamide hydrochloride; N-(4-bromophenyl)-3-(3,5-dimethylpiperidin-1-yl)propanamide;hydrochloride; SMANT HCl",1177600-74-6,Cl.O=C(NC1=CC=C(Br)C=C1)CCN2CC(C)CC(C)C2,
Mibampator,LY451395,375345-95-2,[C@@H](CNS(C(C)C)(=O)=O)(C)C1=CC=C(C=C1)C2=CC=C(CCNS(C)(=O)=O)C=C2,
Ch55,"CH 55; Ch-55; 3,5-Di-tert-butylchalcone",110368-33-7,C(/C=C/C1=CC=C(C(O)=O)C=C1)(=O)C2=CC(C(C)(C)C)=CC(C(C)(C)C)=C2,
RS 100329,RS-100329,1215654-26-4,Cl.O=C1NC=C(C(=O)N1CCCN2CCN(C=3C=CC=CC3OCC(F)(F)F)CC2)C,
TRAM 39,"2-(2-chlorophenyl)-2,2-diphenylacetonitrile; 2-Chloro-alpha,alpha-diphenylbenzeneacetonitrile; TRAM-39; ZINC27105797",197525-99-8,N#CC(C=1C=CC=CC1)(C=2C=CC=CC2)C=3C=CC=CC3Cl,
UCT943,,1450666-80-4,O=C(C=1C=CC(=CC1)C2=NC(=C(N=C2)N)C3=CC=C(C=C3)C(F)(F)F)N4CCNCC4,
5-HT7 agonist 1,4-[4-(2-chlorobenzyl)piperazino]-1H-indole; 4-[4-[(2-chlorophenyl)methyl]-1-piperazinyl]-1H-indole; 4-[4-[(2-chlorophenyl)methyl]piperazin-1-yl]-1H-indole,334974-31-1,ClC=1C=CC=CC1CN2CCN(C=3C=CC=C4NC=CC43)CC2,
Dehydronitrosonisoldipine,,87375-91-5,O=NC=1C=CC=CC1C=2C(C(=O)OC)=C(N=C(C2C(=O)OCC(C)C)C)C,
ACSS2-IN-2,MTB-9655,2332820-04-7,O=C(OC)C1=CC=CC(=C1)N2N=C(C)C(C(=O)NC3=CC=CC(=C3)C(F)(F)C)C2=O,
Ajmalicine,Raubasine; Delta-Yohimbine; Ajmalicin; Lamuran,483-04-5,C(OC)(=O)C=1[C@]2(C[C@]3(C4=C(C=5C(N4)=CC=CC5)CCN3C[C@@]2([C@H](C)OC1)[H])[H])[H],
Azepexole hydrochloride,"4H-Oxazolo[4,5-d]azepin-2-amine, 6-ethyl-5,6,7,8-tetrahydro-, hydrochloride (1:1)",147663-20-5,Cl.N1=C(OC2=C1CCN(CC)CC2)N,
EAD1 HCl,EAD1 HCL(1644388-26-0 Free base),T35329L,ClC1=CC=C(CN2N=NC(CNCCN(CCNC3=C4C=CC(Cl)=CC4=NC=C3)C)=C2)C=C1.Cl,
BMS-919373,BMS 919373; BMS919373,1272353-82-8,O=S(=O)(N)C=1C=NC=C(C1)C2=NC3=CC=CC(C=4C=CC=CC4)=C3C(=N2)NCC5=NC=CC=C5,
SU16f,SU 16F; 3-substituted indolin-2-one 16f; SU-16F,251356-45-3,O=C(O)CCC1=C(NC(C=C2C(=O)NC=3C=C(C=CC32)C=4C=CC=CC4)=C1C)C,
SCD1 inhibitor-3,SCD1 inhibitor 17a; SCD1-IN-3,1282606-48-7,O=C(NCC=1C=NC=CC1)C2=NNC(=C2)N3C=NN(C3=O)CC4=CC=C(F)C=C4,
Elacytarabine,CP 4055; 5'-O-(Elaidoyl) 1-beta-D-arabinofuranosylcytosine; 5'-Oleoyl cytarabine; 5'-Oleoyl cytosine arabinoside,188181-42-2,O[C@@H]1[C@@H](O[C@H](COC(CCCCCCC/C=C/CCCCCCCC)=O)[C@H]1O)N2C(=O)N=C(N)C=C2,
RS 67333 hydrochloride,RS 67333 HCl; RS 67333 (hydrochloride),168986-60-5,Cl.O=C(C=1C=C(Cl)C(N)=CC1OC)CCC2CCN(CCCC)CC2,
PD0176078,PD176078,248922-46-5,C(CCCNC([C@H](CC(C)C)NC)=O)(C1=CC=C(F)C=C1)C2=CC=C(F)C=C2,
BLU-945,BLU945; BLU 945,2660250-10-0,C(C)(C)C=1C2=C(C(=CC1)N3[C@H](C)[C@@H](CS(C)(=O)=O)C3)C=NC(NC4=NC(=NC=C4)N5C[C@H](F)[C@H](OC)CC5)=C2,
Aldometanib,,2904601-67-6,CC1=[N+](C=CN1CCCCCCCCCCCCCCCC)CC2=C(Cl)C=CC=C2Cl.[I-],
Chimmitecan,(S)-9-Allyl-10-hydroxycamptothecin,185425-25-6,C(C)[C@]1(O)C2=C(C(=O)N3C(=C2)C=4C(C3)=CC=5C(N4)=CC=C(O)C5CC=C)COC1=O,
SEL120-34A,,1609522-33-9,BrC1=C(Br)C2=C3C(N=C(N3CCC2)N4CCNCC4)=C1C,
TC-S 7005,,1082739-92-1,N([C@@H](C)C1=CC=CC=C1)C=2C=C3C(=NOC3=CN2)C=4C=C5C(=CC4)OCO5,
CAY10462,CTK8E8405,502656-68-0,CN(C)CCCCCCOC(C=C1)=CC=C1N2C=CN=C2.Cl.Cl,
Bucolome,Paramidin; Paramidine; Bucolomum; 5-Butyl-1-cyclohexylbarbituric acid; Bucolom,841-73-6,O=C1NC(=O)C(C(=O)N1C2CCCCC2)CCCC,
CDC801,CDC-801,192819-27-5,O=C(N)CC(C1=CC=C(OC)C(OC2CCCC2)=C1)N3C(=O)C=4C=CC=CC4C3=O,
(Rac)-Acolbifene,EM-343; (Rac)-EM-652,151533-34-5,OC=1C=CC(=CC1)C2=C(C3=CC=C(O)C=C3OC2C4=CC=C(OCCN5CCCCC5)C=C4)C,
HS271,,2410393-15-4,O=C(NC1=CC2=CN(N=C2C=C1C(O)(C)C)CCN(C)C)C=3N=C(C=CC3)C(F)(F)F,
Cyt-PTPÎµ Inhibitor-1,Cyt-PTP|A Inhibitor-1,428478-94-8,O=C(NC1=NN=C(S1)COC2=CC=C(C=C2C)C)NC3=CC=C(C=C3)C,
CHMFL-KIT-033,,2351801-41-5,C(=C/C1=CC=CC=N1)\C=2C=3C(=CC(NC(CC(NC4=CC(F)=CC=C4)=O)=O)=CC3)NN2,
PF-06952229,PF06952229,1801333-55-0,O=C(NC(CO)CO)C=1C=NC=CC1NC2=CC(=NC=C2C(C)C)C=3C=C(Cl)C=CC3F,
CYP11B2-IN-1,,1356479-78-1,FC1=CC=C2N=C(C=3C=NC=C(C3)C(O)(C)C)N(C2=C1)C4CC4,
CHMFL-EGFR-202,,2089381-40-6,NC1=C2C(=NN(C2=NC=N1)[C@H]3CN(C(C=C)=O)CCC3)C4=CC(Cl)=C(OCC5=CC=CC=N5)C=C4,
p38Î± inhibitor 1,P38alpha inhibitor 1; ARRY-797; P38a inhibitor 1,1034189-82-6,O=C(NCCN(C)C)C1=CC2=C(C=NN2CC(C)C)C=C1OC3=CC=C(F)C=C3F,
cis-Urocanic acid,(Z)-Urocanic acid; cis-UCA; (E)-Urocanic acid; (Z)-Imidazole-4-acrylic acid; (Z)-3-(1H-Imidazol-5-yl)acrylic acid,7699-35-6,C(=C\C(O)=O)\C1=CN=CN1,
D-3263 hydrochloride,D3263 HCl salt; EC D-3263 HCl,1008763-54-9,C(=O)(N1C=2C(N(CCN)C1=O)=CC(OC)=CC2)[C@H]3[C@H](C(C)C)CC[C@@H](C)C3.Cl,
CK2/ERK8-IN-1,TMCB,1085822-09-8,O=C(O)CN1C=2C(Br)=C(Br)C(Br)=C(Br)C2N=C1N(C)C,
Ceranib1,,328076-61-5,O=C(C=CC1=CC=C(OC)C=C1)C=2C(=O)NC=3C=CC(=CC3C2C=4C=CC=CC4)C,
Diethylnorspermine HCl,Diethylnorspermine tetrahydrochloride,156886-85-0,Cl.Cl.Cl.Cl.CCNCCCNCCCNCCCNCC,
HDAC-IN-40,,2463198-51-6,O=C(NOCCCCCC(=O)NO)C=1C=C(OC)C=C(OC)C1,
"N-[(1S)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]-N'-1H-indazol-4-ylurea",,808756-70-9,N(C(NC1=C2C(NN=C2)=CC=C1)=O)[C@@H]3C=4C(=CC(C(C)(C)C)=CC4)CC3,
PD-1/PD-L1-IN-9,,2628506-54-5,OCCNCC=1C=CC(=NC1OC)C=2C=CC=C(C=3C=CC=CC3)C2C,
GX 201,GX-201,1788071-27-1,O=C(NS(=O)(=O)C)C=1C=C(C(OCC2CCN(CC3=CC(=CC=C3Cl)C(F)(F)F)CC2)=CC1F)C4CC4,
VU0359595,ML-270; VU0359595-1,1246303-14-9,O=C1N(C=2C(N1)=CC(Br)=CC2)C3CCN(C[C@@H](NC(=O)[C@H]4[C@@H](C4)C5=CC=CC=C5)C)CC3,
LY 344864 racemate,,186543-64-6,O=C(NC=1C=CC=2NC3=C(C2C1)CC(N(C)C)CC3)C4=CC=C(F)C=C4,
Salinomycin,Procoxacin,53003-10-4,CC[C@H](C1OC([C@@H](C)CC1)[C@@H](C)[C@H](O)[C@H](C)C([C@H](CC)C2O[C@@]3([C@H](C)C[C@@H]2C)C=C[C@@H](O)[C@@]4(O[C@@](C5O[C@@H](C)[C@@](O)(CC)CC5)(C)CC4)O3)=O)C(O)=O,
MBM-55S,,2083624-07-9,O=C(CCC(O)=O)O.O=C(C1=C(OCC2=CC(F)=CC=C2)C=C(C3=CN=C4C=C(C5=CN(CCN(C)C)N=C5)C=CN43)C=C1)N.O=C(CCC(O)=O)O,
AICAR monophosphate,Aica ribonucleotide; AICA riboside; Acadesine 5'-monophosphate; Z-nucleotide,3031-94-5,NC=1N(C=NC1C(N)=O)[C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O,
Rezatomidine,AGN-203818; AGN203818; AGN 203818,847829-38-3,[C@H](C)(C1=C(C)C(C)=CC=C1)C2=CNC(=S)N2,
PP58,,212391-58-7,O=C1C(=CC=2C=NC(=NC2N1C)NC3=CC=C(OCCN)C=C3)C4=C(Cl)C=CC=C4Cl,
RS 42358-197,RS42358-197; RS-42358-197; RS 25259-007,135729-55-4,O=C1C2=C3C(=CN1[C@H]4C5CCN(C4)CC5)CCCC3=CC=C2.Cl,
Antitumor agent-19,,2379727-90-7,O=C(NC1=CC=C(Cl)C(=C1)C(F)(F)F)NC2CC=3C4=C(C=CC=C4C=5C=NN(C5)C)NC3CC2,
CDDO-2P-Im,CDDO-2-P-Im,1883650-96-1,C(=O)([C@]12[C@]([C@@]3([C@@](C)(CC1)[C@@]4(C)C(=CC3=O)[C@]5(C)[C@@](CC4)(C(C)(C)C(=O)C(C#N)=C5)[H])[H])(CC(C)(C)CC2)[H])N6C=C(N=C6)C7=CC=CC=N7,
STAT5-IN-2,,2111834-61-6,N1=CC=CC(=C1)C2=CC=C3C(=C2)C(C)(C)CCN3CCOC=4C=CC=5NC=CC5C4,
Cyclo-Val-Pro-diketopiperazine,Cyclo(prolylvalyl),5654-87-5,O=C1NC(C(=O)N2CCCC12)C(C)C,
inS3-54-A26,,328998-77-2,O=C1C(=CC2=CC=C(Cl)C=C2)C=C(C=3C=CC=CC3)N1C4=CC=C(C=C4)NC(=O)C,
D-I03,DI03,688342-78-1,S=C(NC=1C=CC=2N=C(C=C(C2C1)C)N3CCN(CC)CC3)NCCN(CC)CC,
CHMFL-ABL-039,,2304344-56-5,O=C(NC1=CC=C(C=C1)CC(=O)NC2=CN=C(C=C2)NC(=O)C3CC3)C4=CC=C(C(=C4)C(F)(F)F)CN5CCN(C)CC5,
Clocapramine dihydrochloride hydrate,,60789-62-0,O=C(C1(CCN(CC1)CCCN2C3=C(CCC4=CC=C(C=C42)Cl)C=CC=C3)N5CCCCC5)N.Cl.O.Cl,
CHK1-IN-3,,2097252-39-4,N(C)C=1C(=CN=C(NC=2C=C(O[C@@H]3CCCNC3)C(C#N)=NC2)N1)C4=CN(C)N=C4,
Paroxetine hydrochloride hemihydrate,Paxil; Seroxat,110429-35-1,FC(C=C1)=CC=C1[C@H](CCNC2)[C@@H]2COC3=CC=C(OCO4)C4=C3.FC(C=C5)=CC=C5[C@H](CCNC6)[C@@H]6COC7=CC=C(OCO8)C8=C7.Cl.O.Cl,
CM-675,,1872466-47-1,O=C1N=C(NC=2C(=NN(C12)C)CCC)C=3C=C(C=CC3OCC)CC4=CC=C(C=C4)C(=O)NC=5C=CC=CC5N,
SCP1-IN-1,,2764615-55-4,O=C(NCCOCCNS(=O)(=O)C1=CC=C(OC(F)(F)F)C=C1)C2=CC=3C=CC=CC3S2(=O)=O,
CDK9 inhibitor HH1,,204188-41-0,O=C(C=1C=CC=CC1)C=2SC(=NC2N)NC(C)C,
Pyoluteorin,,25683-07-2,O=C(C1=CC(Cl)=C(Cl)N1)C=2C(O)=CC=CC2O,
Filibuvir,PF-00868554,877130-28-4,C(CC=1C=C(CC)N=C(CC)C1)[C@@]2(CC(O)=C(CC3=NN4C(=N3)N=C(C)C=C4C)C(=O)O2)C5CCCC5,
hSMG-1 inhibitor 11e,,1402452-10-1,O=C(NC1=CC=C(C=C1)C2=NC=CC(=C2)C3=NC(=NC=C3)NC4=CC=C(C(=C4)S(=O)(=O)N(C)C)C)NC,
Rupestonic acid,,115473-63-7,O=C(C([C@H]1CC2=C(C(C[C@]2([C@H](CC1)C)[H])=O)C)=C)O,
SCH529074,SCH 529074,922150-11-6,ClC1=CC=C(C=C1)C(C2=CC=C(Cl)C=C2)N3CCN(CC4=NC=5C=CC=CC5C(=N4)NCCCN(C)C)CC3,
AZ13705339,AZ-13705339; AZ 13705339,2016806-57-6,N#CC=1C=CC=CC1CN(C2=NC(=NC=C2F)NC3=CC=C(C(=C3)S(=O)(=O)CC)N4CCN(C)CC4)C5=CC(=CC=C5C)CO,
Muscimol HBr,Muscimol Hydrobromide; Agarin hydrobromide; Agarin HBr,18174-72-6,Br.O=C1C=C(ON1)CN,
Antihistamine-1,,1186430-60-3,FC1=CC=C(C=C1)CN2C(=NC=3C=CC=CC32)N4CCC(N5N=CC(=C5)C)CC4,
MRT 67307 dihydrochloride,,1781882-89-0,O=C(C1CCC1)NCCCNC2=NC(NC3=CC=CC(CN4CCOCC4)=C3)=NC=C2C5CC5.Cl.Cl,
Anxiolytic/nonsedative agent-1,TCS 1205,355022-97-8,C(C(N[C@H](C)C1=CC=CC=C1)=O)(=O)C=2C=3C(NC2)=CC=C(N(=O)=O)C3,
Upidosin,Rec 15-2739; SB 216469; SB-216469; Recordati 15/2739,152735-23-4,O=C(NCCCN1CCN(C=2C=CC=CC2OC)CC1)C3=CC=CC=4C(=O)C(=C(OC34)C=5C=CC=CC5)C,
Muraglitazar,Pargluva; BMS-298585,331741-94-7,O=C(O)CN(C(=O)OC1=CC=C(OC)C=C1)CC2=CC=C(OCCC=3N=C(OC3C)C=4C=CC=CC4)C=C2,
Org-12962,,132834-56-1,FC(F)(F)C=1C=CC(=NC1Cl)N2CCNCC2,
SB 699551 dihydrochloride,,864741-95-7,O=C(CCC1CCCC1)N(CCN(C)C)CC2=CC=C(C3=CC=C(CNCCC4=CC=CC=C4)C=C3)C=C2.Cl.Cl,
COX-2-IN-1,,787623-48-7,O=S(=O)(N)C1=CC=C(C=C1)N2N=C(CC2C3=CNC=4C(Cl)=CC=CC34)C(F)(F)F,
RWJ 63556,RWJ-63556,190967-35-2,O=S(=O)(NC=1SC(OC2=CC=C(F)C=C2)=CC1)C,
5-HT3 antagonist 3,,120635-47-4,O=C1C=2C=3C=CC=C4C3N(C2CCC1CN5C=CN=C5C)CCC4,
CDK9-IN-10,,3542-63-0,O=C1C=C(OC2=C(O)C(OCC=3C=CC=CC3)=CC(O)=C12)C=4C=CC=CC4,
Acrizanib,LHA510,1229453-99-9,O=C(NC1=NN(C(=C1)C(F)(F)F)C)N2C=CC=3C=C(OC4=NC=NC(=C4)CNC)C=CC32,
MS-PPOH,,206052-02-0,O=C(NS(=O)(=O)C)CCCCCC=1C=CC=CC1OCC#C,
Lisaftoclax,Bcl-2/Bcl-xl inhibitor 1; APG-2575,2180923-05-9,C(C1=C(CC2(CC1)CCC2)C3=CC=C(Cl)C=C3)N4CCN(CC4)C5=CC(OC=6C=C7C(=NC6)NC=C7)=C(C(NS(=O)(=O)C8=CC(N(=O)=O)=C(NC[C@H]9COCCO9)C=C8)=O)C=C5,
Sabizabulin,VERU-111; ABI-231,1332881-26-1,O=C(C1=CC(OC)=C(OC)C(OC)=C1)C2=CN=C(N2)C3=CNC=4C=CC=CC43,
Garsorasib,,2559761-14-5,O=C1N(C=2C(=NC=NC2C3CC3)C4CC4)C=5C(C(=N1)N6[C@@H](C)CN(C(C=C)=O)[C@H](C)C6)=CC(F)=C(N5)C7=C(F)C=CC=C7N,
LY392098,AMPA receptor modulator-3 ; LY 392098; LY-392098,211311-39-6,O=S(=O)(NCC(C=1C=CC(=CC1)C=2C=CC=CC2F)C)C(C)C,
TC-N 1752,,1211866-85-1,O=C(NC=1C=CC=C(NC2=NC=NC(=N2)N3CCC(OCC4=CC=C(OC(F)(F)F)C=C4)CC3)C1C)C,
Saroglitazar,Lipaglyn,495399-09-2,C(COC1=CC=C(C[C@H](OCC)C(O)=O)C=C1)N2C(=CC=C2C)C3=CC=C(SC)C=C3,
BIP-135,,941575-71-9,O=C1NC(=O)C(C2=CN(C=3C=CC(Br)=CC23)C)=C1C4=COC=5C=CC=CC54,
Progabide,SL 76002; Halogabide; Gabren; Gabrene,62666-20-0,O=C(N)CCCN=C(C1=CC=C(Cl)C=C1)C2=CC(F)=CC=C2O,
EMDT oxalate,,263744-72-5,O(C=1C=CC=2NC(=C(C2C1)CCN(C)C)CC)C,
UC-112,,383392-66-3,OC1=C2N=CC=CC2=C(C=C1CN3CCCC3)COCC=4C=CC=CC4,
(E)-GABAB receptor antagonist 1,,1611483-29-4,C(=C/C(C(O)=O)=O)\C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1,
"Eg5 Inhibitor V, trans-24",,869304-55-2,O=C1N2[C@@H](C3=C(C[C@]2(C(=O)N1CC4=CC=CC=C4)[H])C=5C(N3)=CC=CC5)C6=CC(O)=CC=C6,
RS-1,,312756-74-4,O=C(NC1=CC=C(Br)C=C1)C2=CC=C(Br)C(=C2)S(=O)(=O)NCC=3C=CC=CC3,
GP-82996,Cdk4/6 Inhibitor IV,359886-84-3,C(N1C=2C(=CC(NC=3N=C(N[C@@H]4CC[C@@H](O)CC4)C=C(NCC)N3)=CC2)C=C1)C5=CC=CC=C5,
Vialinin A,Terrestrin A,858134-23-3,O=C(OC1=C(OC(=O)CC=2C=CC=CC2)C(=C(O)C(O)=C1C=3C=CC(O)=CC3)C4=CC=C(O)C=C4)CC=5C=CC=CC5,
CSRM617 hydrochloride,CSRM617 hydrochloride(787504-88-5 Free base),1353749-74-2,Cl.O=C(NN=CC1=CC=C(O)C(O)=C1O)C(N)CO,
ACY-1083,,1708113-43-2,O=C(NO)C1=CN=C(N=C1)NC2(C=3C=CC=CC3)CCC(F)(F)CC2,
Zandatrigine,XEN901; NBI-921352,2154406-04-7,N(C)(C1=C(C)C=C(S(NC2=CSC=N2)(=O)=O)C(F)=C1)[C@@H]3CN(CC4=CC=CC=C4)CC3,
Alrizomadlin,APG-115; AA-115,1818393-16-6,O=C1[C@@]2([C@]3(N(CC)[C@@H](C(NC45CCC(C(O)=O)(CC4)CC5)=O)[C@@H]2C6=C(F)C(Cl)=CC=C6)CCCCC3)C=7C(N1)=CC(Cl)=CC7,
Amosulalol,,85320-68-9,O=S(=O)(N)C1=CC(=CC=C1C)C(O)CNCCOC=2C=CC=CC2OC,
IT1t dihydrochloride,,1092776-63-0,CC(C)(CN12)N=C1SC=C2CSC(NC3CCCCC3)=NC4CCCCC4.Cl.Cl,
DSR-6434,,1059070-10-8,O=C1NC=2C(=NC(=NC2N1CC3=CN=C(OCCN(C)C)C=C3)NCCCC)N,
(Rac)-AMG8379,(Rac)-AMG8380,1641574-26-6,O=C1C=CC=2C=C(C=CC2N1C3=CC(F)=C(C=C3OC)C=4C=C(F)C=C(Cl)C4)S(=O)(=O)NC5=NOC=C5,
K777,APC-3316,233277-99-1,[C@H](CC1=CC=CC=C1)(C(N[C@@H](CCC2=CC=CC=C2)C=CS(=O)(=O)C3=CC=CC=C3)=O)NC(=O)N4CCN(C)CC4,
Rho-Kinase-IN-1,,1035094-83-7,N1=CC=2C=C(C=CC2N1)NC3CN(CC4=CC=C(SC)C=C4)CCC3,
Sirt2-IN-1,,1862238-00-3,O=C(NC1=NC=C(S1)CC=2C=CC=C(OCC=3N=NN(C3)CC=4C=CC=CC4)C2)CSC=5N=C(C=C(N5)C)C,
CGP52411,DAPH,145915-58-8,O=C1NC(=O)C2=CC(NC=3C=CC=CC3)=C(C=C12)NC=4C=CC=CC4,
Epitinib succinate,,2252334-12-4,O=C(O)CCC(=O)O.O=C(NC1=CC=2C(=NC=NC2NC=3C=CC=C(C#C)C3)C=C1OC)N4CCN(CC)CC4,
JAK-IN-11,R-348,916742-11-5,O=C(NS(=O)(=O)C1=CC(=CC=C1C)NC2=NC=C(F)C(=N2)NC3=CC=C(OCC#C)C=C3)CC,
6RK73,,1895050-66-4,N(C(=O)[C@@H]1CN(C#N)CC1)C=2SC(=CN2)N3CCOCC3,
CHMFL-ABL-121,,2270879-07-5,C(=C/C1=CC=CC=N1)\C=2C=3C(=CC(SCCC(NC4=CC(C(F)(F)F)=C(CN5CCN(C)CC5)C=C4)=O)=CC3)NN2,
EB-47,,366454-36-6,O[C@H]1[C@H](N2C=3C(N=C2)=C(N)N=CN3)O[C@H](C(=O)N4CCN(CC(NC5=C6C(C(=O)NC6)=CC=C5)=O)CC4)[C@H]1O,
YM 511,,148869-05-0,N#CC1=CC=C(C=C1)N(N2C=NN=C2)CC3=CC=C(Br)C=C3,
IHMT-PI3KÎ´-372 S-isomer,,2429889-61-0,[C@@H](CC)(N1C=2C(C(=N1)C3=CC(F)=C(OC)C=C3)=C(N)N=CN2)C=4N(C(=O)C=5C(N4)=CC=CC5F)C6CC6,
FGFR2-IN-3,,2549174-42-5,O=C(NC1=CC=C(C=C1)C2=C(C=3C=CC(OC4=NC=CC(=N4)C)=C(F)C3)C5=C(N=CN=C5N2C)N)C(=C)C,
VB124,,2230186-18-0,O=C(O)C(OCC1=NN(C=2C=CC=CC2Cl)C(=C1)C=3C=CC=C(OC4CC4)C3)(C)C,
AZ5576,,2751721-40-9,O(C)C1=C(C=2C=C(NC(=O)[C@@H]3C[C@H](NC(C)=O)CCC3)N=CC2)C=CC(F)=C1,
PF-4981517,CYP3cide,1390637-82-7,CN1C=2C(C(=N1)C3=C(N(C)N=C3)C4=CC=C(C)C=C4)=C(N=CN2)N5C[C@H](CC5)N6CCCCC6,
OMDM-6,,616884-67-4,C(NNC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)C1=CC(OC)=C(O)C=C1,
IHMT-PI3KÎ´-372,,2429889-62-1,[C@H](CC)(N1C=2C(C(=N1)C3=CC(F)=C(OC)C=C3)=C(N)N=CN2)C=4N(C(=O)C=5C(N4)=CC=CC5F)C6CC6,
JNJ-55308942,,2166558-11-6,C[C@H]1CC=2N(N=NC2CN1C(=O)C=3C(F)=C(C(F)(F)F)N=CC3)C=4N=CC(F)=CN4,
M-110,,1395048-49-3,O=C(NN=C(C1=CC=C(Cl)C=C1O)CC)C=2C=CN=C(C2)NCCCN3CCOCC3,
JAK-IN-10,,916741-98-5,O=S(=O)(N)C1=CC(=CC=C1C)NC2=NC=C(F)C(=N2)NC3=CC=C(OCC#C)C=C3,
GA-017,,2351906-74-4,O=C(NN=C(C1=CC=C(O)C(=C1O)C)CC)NCC=2C=CC=C(O)C2,
Varlitinib,ASLAN001;ARRY-334543,845272-21-1,N(C=1C2=C(C=CC(NC3=N[C@H](C)CO3)=C2)N=CN1)C4=CC(Cl)=C(OCC5=NC=CS5)C=C4,
IndiMitecan,LMP776,915360-05-3,O=C1C=2C=C3OCOC3=CC2C4=C1C5=CC(OC)=C(OC)C=C5C(=O)N4CCCN6C=NC=C6,
JND3229,,2260886-64-2,O=C1N(C=2C(CN1C3=C(Cl)C=CC=C3)=CN=C(NC4=CC(C)=C(C=C4)N5CCN(C)CC5)N2)[C@H]6CC[C@H](NC(CC)=O)CC6,
Ropsacitinib,PF-06826647;Tyk2-IN-8,2127109-84-4,C(C#N)[C@@]1(C[C@H](C#N)C1)N2C=C(C=N2)C=3C=4N(C=C(N3)C=5C=NN(C)C5)N=CC4,
Vernakalant Hydrochloride,RSD1235 hydrochloride,748810-28-8,O(CCC1=CC(OC)=C(OC)C=C1)[C@H]2[C@@H](CCCC2)N3CC[C@@H](O)C3.Cl,
Oxyfedrine L-form HCl,Oxyfedrine L-form hydrochloride;Ildamen;D563;D 563;D-563;Modacor;,16777-42-7,C(CCN[C@H]([C@H](O)C1=CC=CC=C1)C)(=O)C2=CC(OC)=CC=C2.Cl,
AS-0141,Cdc7-IN-6;PNT-141;SRA-141,1402057-88-8,O=C(OCC)C=1C(=O)C(OC1NN2CCN(CC2)CC(F)(F)F)=CC3=CNC=4N=CC=CC43,
DPH,,484049-04-9,O=C1NC(=O)C(N1)C2=CN(N=C2C=3C=CC(F)=CC3)C=4C=CC=CC4,
Cdc7-IN-7,,1402059-17-9,O=C(OCC1CC1)C=2C(=O)C(OC2NN3CCOCC3)=CC4=CNC=5N=CC=CC54,
PHY34,,2130033-55-3,O=C1C2=C(C=3C(C(O[C@H]4[C@H](O)[C@@]5([C@]([C@@H](CO)O4)(OC(C)(C)O5)[H])[H])=C2CO1)=CC(OC)=C(OC)C3)C=6C=C7C(=CC6)OCO7,
CHMFL-PI3KD-317,,2244992-76-3,CC1=C(C=2C=C(NS(=O)(=O)C3=CC(C)=CC=C3)C(Cl)=NC2)SC(NC([C@H](C(C)C)N)=O)=N1,
DMH4,,515880-75-8,N1=CC(=CN2N=CC(C=3C=CC=CC3)=C12)C=4C=CC(OCCN5CCOCC5)=CC4,
CFM-2,,178616-26-7,O=C1NN=C(C=2C=CC(N)=CC2)C=3C=C(OC)C(OC)=CC3C1,
BSH-IN-1,,2553217-91-5,C[C@@]12[C@]([C@]3([C@@]([C@]4(C)[C@](C[C@H]3O)(C[C@H](O)CC4)[H])(CC1)[H])[H])(CC[C@@]2([C@@H](CCC(CF)=O)C)[H])[H],
SI-2 hydrochloride,EPH 116 hydrochloride,1992052-49-9,Cl.N=1C=CC=CC1C(=NNC2=NC=3C=CC=CC3N2C)C,
Gallium maltolate,,108560-70-9,CC1=C(O[Ga](OC(C(C=CO2)=O)=C2C)OC(C(C=CO3)=O)=C3C)C(C=CO1)=O,
TAS1553,,2166023-31-8,[C@@H]([C@H](C)C1=C(C)C(C)=CC=C1F)(NS(=O)(=O)C2=C(C(N)=O)C=C(Cl)C=C2)C3=NNC(=O)O3,
Tabernanthalog,TBG,2483829-58-7,O(C=1C=CC2=C(C1)NC3=C2CCN(C)CC3)C,
"N,N-Didesethyl Sunitinib Hydrochloride",,873077-70-4,NCCNC(C1=C(C)NC(/C=C(C2=C(N3)C=CC(F)=C2)\C3=O)=C1C)=O.Cl,
MMRi62,"7-[(2,3-dichlorophenyl)-(pyridin-2-ylamino)methyl]quinolin-8-ol",352693-80-2,ClC1=CC=CC(=C1Cl)C(NC2=NC=CC=C2)C=3C=CC4=CC=CN=C4C3O,
Pim-1/2 kinase inhibitor 1,,6320-51-0,O=C1SC(=CC2=CC=C(OC)C=C2)C(=O)N1,
Gimatecan,LBQ707;STI481,292618-32-7,C(=N/OC(C)(C)C)\C1=C2C(C=3N(C2)C(=O)C4=C(C3)[C@](CC)(O)C(=O)OC4)=NC=5C1=CC=CC5,
Cevipabulin,TTI-237,849550-05-6,N([C@H](C(F)(F)F)C)C1=C(C(Cl)=NC=2N1N=CN2)C3=C(F)C=C(OCCCNC)C=C3F,
CF53,,1808160-52-2,N=1OC(=C(C1C)C2=CC=3NC=4N=C(N=C(NC5=CC(=NN5C)C6CC6)C4C3C=C2OC)C)C,
5-HT2 antagonist 1,,191592-09-3,O=C1C=2C=CN(C2C(O)CCN1CCCN3CCN(C4=CC=C(F)C=C4)CC3)C,
(Rac)-WAY-161503,,75704-24-4,O=C1NC2=CC(Cl)=C(Cl)C=C2N3CCNCC13,
Ecastolol,,77695-52-4,O=C(NC=1C=CC(OCC(O)CNCCC2=CC=C(OC)C(OC)=C2)=C(C1)C=3ON=CC3)CCC,
DBPR112,,1226549-49-0,N([C@H](CO)C1=CC=CC=C1)C2=C3C(=C(OC3=NC=N2)C4=CC=CC=C4)C5=CC(NC(/C=C/CN(C)C)=O)=CC=C5,
EGFR-IN-9,,1226549-39-8,N([C@H](CO)C1=CC=CC=C1)C2=C3C(=C(OC3=NC=N2)C4=CC=CC=C4)C5=CC(NC(C=C)=O)=CC=C5,
Ponatinib Hydrochloride,AP24534 Hydrochloride;AP-24534 Hydrochloride,1114544-31-8,Cl.O=C(NC1=CC=C(C(=C1)C(F)(F)F)CN2CCN(C)CC2)C3=CC=C(C(C#CC4=CN=C5C=CC=NN45)=C3)C,
YLF-466D,C24,1273323-67-3,C(=C/1\C=2C(N(CC3=CC(C(O)=O)=CC=C3)C1=O)=CC=CC2)(\C4=CC=C(Cl)C=C4)/C5=CC=CC=C5,
Uridine triacetate,RG 2133 triacetate;RG2133 triacetate;Tri-O-acetyluridine;PN-401,4105-38-8,O(C(C)=O)[C@H]1[C@@H](O[C@H](COC(C)=O)[C@H]1OC(C)=O)N2C(=O)NC(=O)C=C2,
Gimatecan HCl,ST1481 HCL;Gimatecan HCl(292618-32-7 Free base),T21319L,CC(C)(C)O/N=C/C1=C2C(C(N3C2)=CC([C@](O)(C(OC4)=O)CC)=C4C3=O)=NC5=CC=CC=C51.Cl,
Questiomycin A derivatives 1,,T60172,O=C1C(NC(C)=O)=CC2=NC3=C(C=CC=C3)OC2=C1,
AP-1/NF-ÎºB activation inhibitor 1,,188936-12-1,O=C(OCC)C1=CN=C(N=C1NN2C(=O)C=C(C2=O)C)C(F)(F)F,
TAK-653,,1358751-06-0,O=S1(=O)N=C2C(=NC(=CN2CC1)C)C3=CC=C(OC4CCCCC4)C=C3,
SB-747651A Dihydrochloride,,1781882-72-1,NC1=NON=C1C2=NC3=CN=CC(CNC4CCNCC4)=C3N2CC.Cl.Cl,
FMK,,821794-92-7,O=C(C1=C(C=2C=CC(=CC2)C)C=3C(=NC=NC3N1CCCO)N)CF,
Gilmelisib,,1845777-61-8,O=C1C(OCCN(C)C)=CN=C2C=CC(=CN12)C=3C=NC(OC)=C(C3)NS(=O)(=O)C4=CC=C(F)C=C4Cl,
R(+)-IAA-94,R(+)-Methylindazone,54197-31-8,O=C1C2=C(Cl)C(Cl)=C(OCC(O)=O)C=C2C[C@@]1(C3CCCC3)C,
ZLD1039,ZLD-1039;ZLD 1039,1826865-46-6,O=C(NCC=1C(=O)NC(=C2C1CCCC2)C)C=3C=C(C=C(C3C)N(CC)C4CCOCC4)C=5C=NC(=CC5)N6CCN(C)CC6,
Furosemide sodium,Lasix;Frusemide Sodium,41733-55-5,O=C([O-])C1=CC(S(=O)(N)=O)=C(Cl)C=C1NCC2=CC=CO2.[Na+],
Falnidamol,BIBX 1382,196612-93-8,FC1=CC=C(C=C1Cl)NC2=NC=NC3=CN=C(N=C32)NC4CCN(C)CC4,
MRS1220,MRS 1220,183721-15-5,O=C(NC1=NC=2C=CC(Cl)=CC2C3=NC(=NN13)C=4OC=CC4)CC=5C=CC=CC5,
CM-579,,1846570-40-8,N1=C(C=C(NCC2CCN(C)CC2)C3=CC(OC)=C(OCCCN4CCCC4)C=C13)C=5OC(=CC5)C,
COX-2-IN-2,,134729-13-8,N#CC1=NN(C2=CC=C(F)C=C2)C(=C1)C=3C=CC(=CC3)S(=O)(=O)C,
ACY-957,HDAC Inhibitor C001,1609389-52-7,O=C(NC=1C=C(C=CC1N)C=2SC=CC2)C=3C=CC=4N=C(C=CC4C3)N5CCNCC5,
RTC-5,TRC-382,1423077-49-9,O=S(=O)(NCCCN1C=2C=CC=CC2CCC3=CC=C(Cl)C=C31)C4=CC=C(OC(F)(F)F)C=C4,
2-Iodomelatonin,,93515-00-5,O=C(NCCC1=C(I)NC=2C=CC(OC)=CC21)C,
SNX0723,SNX 0723;SNX- 0723,1073969-18-2,CC=1C2=C(N(C1)C3=CC(N[C@H]4CCOC4)=C(C(N)=O)C(F)=C3)CC(C)(C)CC2=O,
(R)-(-)-Ibuprofen,(R)-Ibuprofen;levibuprofen,51146-57-7,[C@@H](C(O)=O)(C)C1=CC=C(CC(C)C)C=C1,
Sodium oleate,cis-9-Octadecenoic acid sodium salt;Oleic acid sodium salt,143-19-1,CCCCCCCC/C=C\CCCCCCCC([O-])=O.[Na+],
Debio-0123,WEE1-IN-5,2243882-74-6,O=C1C2=CN=C(N=C2N(C)CN1C=3C(Cl)=CC=CC3Cl)NC4=CC=C(C(=C4)C)C5CCN(C)CC5,
CT52923,,205256-55-9,S=C(NCC1=CC=C2OCOC2=C1)N3CCN(C=4N=CN=C5C=C(OC)C(OC)=CC54)CC3,
CB-5339,,1863952-15-1,O=C(N)C1=CC=CC2=C1C=C(N2C3=NC(NCC=4C=CC=CC4)=C5C(=NCCC5)N3)C,
Canagliflozin hemihydrate,JNJ 28431754;JNJ-28431754;JNJ28431754;TA 7284;TA-7284;TA7284;,928672-86-0,O[C@H]1[C@H](C2=CC(CC3=CC=C(C4=CC=C(C=C4)F)S3)=C(C=C2)C)O[C@@H]([C@H]([C@@H]1O)O)CO.O[C@H]5[C@H](C6=CC(CC7=CC=C(C8=CC=C(C=C8)F)S7)=C(C=C6)C)O[C@@H]([C@H]([C@@H]5O)O)CO.O,
NLG802,,2071683-99-1,C([C@@H](NC([C@H](CC(C)C)N)=O)C(OCC)=O)C=1C=2C(N(C)C1)=CC=CC2.Cl,
SB-224289 hydrochloride,SB-224289A,180084-26-8,Cl.O=C(C=1C=CC(=CC1)C=2C=CC(=CC2C)C3=NOC(=N3)C)N4C5=CC6=C(OCC67CCN(C)CC7)C=C5CC4,
Cilobradine hydrochloride,DK-AH 269,186097-54-1,O(C)C=1C=C2C(=CC1OC)CCN(C[C@@H]3CN(CCC4=CC(OC)=C(OC)C=C4)CCC3)C(=O)C2.Cl,
NCGC00029283,,714240-31-0,O=C1NC=2C=CC(OC)=CC2C=C1C3=NOC(=N3)C=4C=CC(F)=CC4,
5-Hydroxydecanoate sodium,Sodium 5-hydroxydecanoate,624-00-0,CCCCCC(CCCC(=O)[O-])O.[Na+],
MT-4,,2327925-35-7,O=C(NC1=CC=C(C=C1)NC=2N=C(C=C(N2)C)N(C)C)CC=3C=CC=CC3,
Apyramide,,68483-33-0,O=C(OC1=CC=C(C=C1)NC(=O)C)CC=2C=3C=C(OC)C=CC3N(C(=O)C4=CC=C(Cl)C=C4)C2C,
SB-216,,2756818-39-8,O=C1NC2=CC(OC)=CC=C2N(C3=NC(=NC4=C3CCC4)C)C1,
Procainamide,Novocainamide;Biocoryl,51-06-9,O=C(NCCN(CC)CC)C1=CC=C(N)C=C1,
KU-60019,,925701-46-8,O=C1C=C(C2=C3C(CC=4C(S3)=CC=C(NC(CN5C[C@@H](C)O[C@@H](C)C5)=O)C4)=CC=C2)OC(=C1)N6CCOCC6,
NPS ALX Compound 4a hydrochloride(1:1),,T12262L1,O=S(C1=CC=CC2=C1C=CC=C2)(N3C=CC4=C3C=C(N5CCN6CCCC6C5)C=C4)=O.Cl,
ALDH1A3-IN-3,,18962-05-5,O=CC1=CC=C(OC(C)C)C=C1,
Midaglizole hydrochloride,(Â±)-DG5128  hydrochloride;DG5128  hydrochloride,79689-25-1,C1(C(CC2=NCCN2)C3=CC=CC=C3)=NC=CC=C1.Cl.Cl,
Vecabrutinib,SNS-062,1510829-06-7,C(N)(=O)[C@@H]1[C@H](CN(CC1)C=2C(F)=C(N)N=CN2)N3C(=O)[C@H](NC4=CC(C(F)(F)F)=CC(Cl)=C4)CCC3,
LLY-283,,2040291-27-6,O[C@H]1[C@H](N2C=3C(C=C2)=C(N)N=CN3)O[C@]([C@H](O)C4=CC=CC=C4)([C@H]1O)[H],
SP-100030,SP 100030;SP100030,154563-54-9,O=C(NC=1C=C(C=C(C1)C(F)(F)F)C(F)(F)F)C2=CN=C(Cl)N=C2C(F)(F)F,
CRT0066854 hydrochloride,,2250019-91-9,N[C@@H](CC1=CC=CC=C1)CNC2=C3C4=C(CCCC4)SC3=NC(C5=CC=NC=C5)=N2.Cl.Cl,
CDK9-IN-7,,2369981-71-3,O=C(NC1=CC=C(C=C1)NC=2N=CC=3C=C(C(=O)N(C)C)N(C3N2)C4CCCC4)CCCCCCCN=C=S,
Enbezotinib,,2359649-81-1,FC=1C=C2CN3C=4C(=CN5C(N4)=C(C=N5)C(=O)NC[C@H](C)OC2=NC1)O[C@@]6([C@]3(CCC6)[H])[H],
SHMT-IN-2,,2102681-49-0,N#CC1=C(OC2=NNC(=C2C1(C=3C=C(C=C(C3)C(F)(F)F)N4CCCC4)C(C)C)C)N,
MSC-4106,,2738542-58-8,O=C(O)C=1C=CC2=C(C1)C3=CN(N=C3N2C4=CC=C(C=C4)C(F)(F)F)C,
AD57,,1093380-42-7,O=C(NC=1C=CC(=CC1)C2=NN(C=3N=CN=C(N)C23)C(C)C)NC4=CC=CC(=C4)C(F)(F)F,
AGI-43192,,2377491-54-6,O=C1C(C=2C=CC(Cl)=CC2)=C3N=C(N=CC3=CN1C=4C=CC5=NN(C=C5C4)C)NCC(F)(F)F,
PBRM1-BD2-IN-7,,2819989-68-7,O=C1NC(NC=2C=CC=C(Cl)C12)C=3C(=CC=CC3C)C,
STX-0119,,851095-32-4,O=C(NC1=NN=C(O1)C=2OC=CC2)C3=CC(=NC=4C=CC=CC43)C=5C=CC=CC5,
TNIK-IN-3,,2754265-25-1,O=C1C=2C=CC(=CC2OCCN1CC3=CC=C(F)C=C3)C4=CN=C5NC=CC5=C4,
PBRM1-BD2-IN-2,,2819989-57-4,O=C1NC(NC=2C=CC=C(Cl)C12)C=3C(F)=CC=CC3Cl,
4-Aminobenzamidine dihydrochloride,p-Aminobenzamidine dihydrochloride,2498-50-2,N=C(N)C1=CC=C(N)C=C1.Cl.Cl,
INCB086550,PD-1/PD-L1-IN-8,2230911-59-6,C(#N)C1=C2C(N=C(O2)C3=C(C)C(=CC=C3)C4=C(C)C(NC=5C6=C(C=C(CN7CC[C@@H](O)C7)C=N6)C=CN5)=CC=C4)=CC(CN8C[C@H](C(O)=O)CC8)=C1,
PI3KÎ±/mTOR-IN-1,,1013098-90-2,O=C1C(=CC2=C(N=C(N=C2C)N)N1C3CCCC3)C=4C=NNC4,
QN523Â ,,878581-60-3,O=C(NC1=CC=CC2=CC=CN=C21)C3=NC=CN=C3,
CDK1-IN-2,cdk1 inhibitor 2,220749-41-7,O=C1NC=2C=CC=CC2C1=CC3=C(Cl)NC=4C=CC=CC43,
PI3KÎ´-IN-1,,1911564-39-0,N#CC=1C=CC(=CC1N2C(=O)C(N(C(=O)C)CC2)(C)C)C3=CC(=C4C(=NC=NN34)N)C(F)(F)F,
Droloxifene,3-Hydroxytamoxifen,82413-20-5,C(=C(/CC)\C1=CC=CC=C1)(\C2=CC=C(OCCN(C)C)C=C2)/C3=CC(O)=CC=C3,
Mepacrine,Erion; Haffkinine,83-89-6,ClC=1C=CC=2C(=NC=3C=CC(OC)=CC3C2NC(C)CCCN(CC)CC)C1,
BLU2864,,2810747-89-6,N(C(=O)C=1C=CC(=NC1)C2=C3C(NC=C3C)=NC=C2)[C@@H]4C=5C(=CC(C(F)F)=CC5F)C[C@@H]4O,
E7016,GPI 21016,902128-92-1,O=C1NN=C2C=3C=C(C=CC3OC4=CC=CC1=C42)CN5CCC(O)CC5,
NR2F6 modulator-1,,904449-84-9,O=C1OC=2C=CC(=CC2C=C1S(=O)(=O)C=3C=CC=CC3)C(=O)NCC=4C=CC=CC4,
CHIR-99021 HCl,CT99021 HCl; Laduviglusib HCl,1797989-42-4,Cl.N#CC1=CN=C(C=C1)NCCNC=2N=CC(C3=NC=C(N3)C)=C(N2)C=4C=CC(Cl)=CC4Cl,
BRD 9757,N-Hydroxy-1-cyclopentene-1-carboxamide,1423058-85-8,O=C(NO)C1=CCCC1,
(Z)-FeCP-oxindole,,1137967-28-2,C(\[C-]12[Fe+2]3456789([CH]1=[CH]3[CH]4=[CH]52)[CH-]%10[CH]6=[CH]7[CH]8=[CH]9%10)=C\%11/C=%12C(NC%11=O)=CC=CC%12,
SRX3207,,2254693-15-5,O=C1C=C(OC2=C1SC=C2C=3C=CC(=CC3)NC4=NC=CC(=N4)N5N=C(C(=C5)CN6CCC6)C)N7CCOCC7,
Trotabresib,CC-90010,1706738-98-8,O=C1C=2C=CC=CC2C(=CN1C)C=3C=C(C=CC3OCC4CC4)S(=O)(=O)C,
ST 91,,4749-61-5,Cl.N1=C(NC=2C(=CC=CC2CC)CC)NCC1,
RIP2 Kinase Inhibitor 3,,1398053-50-3,O=S(=O)(C1=CC=2C(=NC=CC2NC3=NNC(=C3C)C)C=C1OC)C(C)(C)C,
K-8012,,1346513-17-4,C(=C/1\C=2C(C(CCC=3NN=NN3)=C1C)=CC(F)=CC2)\C4=CC=C(C(C)C)C=C4,
Asperphenamate,,63631-36-7,[C@@H](CC1=CC=CC=C1)(NC(=O)C2=CC=CC=C2)C(OC[C@H](CC3=CC=CC=C3)NC(=O)C4=CC=CC=C4)=O,
Apraclonidine hydrochloride,Apraclonidine HCl;ALO 2145;P-aminoclonidine,73218-79-8,Cl.ClC=1C=C(N)C=C(Cl)C1NC2=NCCN2,
Penehyclidine hydrochloride,Penequinine hydrochloride,151937-76-7,Cl.OC(C=1C=CC=CC1)(COC2CN3CCC2CC3)C4CCCC4,
C6 Ceramide,N-hexanoylsphingosine;N-(hexanoyl)sphing-4-enine,124753-97-5,[C@@H](NC(CCCCC)=O)([C@@H](/C=C/CCCCCCCCCCCCC)O)CO,
CHPG hydrochloride,CHPG hydrochloride(170846-74-9 Free base),T10809L,O=C(C(C1=CC(O)=CC=C1Cl)N)O.Cl,
CHPG sodium salt,,1303993-73-8,C1=CC(=C(C=C1O)C(C(=O)[O-])N)Cl.[Na+],
CID-663143,,578723-96-3,N=1N=C(C=2C=CC=CC2OC)N3N=C(C=4C=CC(OCC)=CC4)CSC13,
PAT-1251,,2007885-39-2,O(C=1N=C(C(F)(F)F)C=C(CN)C1)C2=CC(C(=O)N3C[C@@H](F)[C@H](O)C3)=CC=C2,
LY3295668,AK-01,1919888-06-4,C([C@]1(C(O)=O)C[C@@H](C)N(CC2=C(F)C(Cl)=CC=C2)CC1)C=3N=C(NC4=NNC(C)=C4)C=CC3F,
Cyclo(L-Phe-L-Pro),,3705-26-8,O=C1N2[C@](C(=O)N[C@H]1CC3=CC=CC=C3)(CCC2)[H],
Corin,,1808113-09-8,N[C@H]1[C@@H](C1)C2=CC=C(NC(CCCC3=CC=C(C(NC4=C(N)C=CC=C4)=O)C=C3)=O)C=C2,
Hematein,Hydroxybrasilein,475-25-2,O=C1C=C2C(C=C1O)=C3C=4C=CC(O)=C(O)C4OCC3(O)C2,
ANI-7,,931417-26-4,C(=C\C1=CC=CN1)(\C#N)/C2=CC(Cl)=C(Cl)C=C2,
Eravacycline HCl,Eravacycline HCL(1207283-85-9 Free bse);TP-434 HCl,T11227L1,O[C@]12[C@](C[C@@]3([H])C(C(C4=C(O)C(NC(CN5CCCC5)=O)=CC(F)=C4C3)=O)=C2O)([H])[C@@H](C(O)=C(C1=O)C(N)=O)N(C)C.Cl,
Hispolon,,173933-40-9,C(=C/C(=C/C(C)=O)/O)\C1=CC(O)=C(O)C=C1,
Camizestrant TFA,Camizestrant TFA(2222844-89-3 Free base);AZD-9833 TFA,T11237L,FC(F)(F)CN1[C@H](C2=CC=C(C=N2)NC3CN(C3)CCCF)C4=C(C[C@H]1C)C5=C(NN=C5)C=C4.O=C(O)C(F)(F)F,
SKLB 1028,Ruserontinib,1350544-93-2,N=1C=CC=C(C1)NC2=NC=3C=NC(=NC3N2C(C)C)NC4=CC=C(C=C4)N5CCN(C)CC5,
Cdc7-IN-5,,1402057-86-6,O=C(OCC)C=1C(=O)C(OC1N2CC3=CC(OC)=CC=C3CC2)=CC4=CNC=5N=CC=CC45,
SMN-C3,MV8T2MCK57,1449597-34-5,O=C1C=C(N=C2C(=CC(=CN12)C3CCN(CC)CC3)C)C4=NN5C=C(N=C(C5=C4)C)C,
B-Raf IN 2,,2649372-20-1,C(#N)C1=C(OC=2C=C3C(=CC2)N=CN(C)C3=O)C(F)=CC=C1NS(=O)(=O)N4C[C@H](F)CC4,
Carboxypeptidase G2 (CPG2) Inhibitor,CPG2 Inhibitor;Carboxypeptidase G2 Inhibitor,192203-60-4,S(C(N[C@@H](CCC(O)=O)C(O)=O)=O)C1=CC=C(OC)C=C1,
SI-2,EPH116,223788-33-8,N=1C=CC=CC1C(=NNC2=NC=3C=CC=CC3N2C)C,
RIPK1-IN-4,,1481641-08-0,O=C(NC1=NOC(=C1)C(C)(C)C)NC2=CC=C(C=C2)C3=CC=CC=4C(=NC=CC43)N,
Cloperastine fendizoate,Hustazol,85187-37-7,O=C(O)C=1C=CC=CC1C(=O)C=2C=CC(O)=C(C2)C=3C=CC=CC3.ClC1=CC=C(C=C1)C(OCCN2CCCCC2)C=3C=CC=CC3,
SRI 37892,,1030769-75-5,O=C(NC1=NC(=CS1)C=2C=CC=3NC(=O)CCC3C2)C4=CC=C(C=C4)N5C=NC=6C=CC=CC65,
FIIN-4,,2093088-81-2,O=C(C=C)NC1=CC=CC(=C1)CN2C(=O)N(C=3C=C(OC)C=C(OC)C3)CC4=CN=C(N=C42)NC5=CC=C(C=C5)N6CCN(C)CC6,
M2698,MSC2363318A,1379545-95-5,N([C@H](CN1CCC1)C2=CC(C(F)(F)F)=C(Cl)C=C2)C=3C4=C(C(C(N)=O)=CC=C4)N=CN3,
AZD 3147,,1101810-02-9,S(=O)(=O)(C1(CC1)C=2C=C(N=C(N2)C3=CC=C(NC(NCCO)=S)C=C3)N4[C@@H](C)COCC4)C5CC5,
(E)-FeCP-oxindole,,884338-18-5,C(\[C-]12[Fe+2]3456789([CH]1=[CH]3[CH]4=[CH]52)[CH-]%10[CH]6=[CH]7[CH]8=[CH]9%10)=C/%11\C=%12C(NC%11=O)=CC=CC%12,
BMY-14802 hydrochloride,BMY-14802-1;BMS 181100 hydrochloride,105565-55-7,Cl.FC1=CN=C(N=C1)N2CCN(CC2)CCCC(O)C3=CC=C(F)C=C3,
TRAF-STOP inhibitor 6877002,CD40-TRAF6 inhibitor,433249-94-6,O=C(C=CNC1=CC(=CC=C1C)C)C=2C=CC=CC2,
CB2R/FAAHÂ modulator-2,,2876918-68-0,O=C(NC12CC3CC(CC(C3)C1)C2)C=4C=CC=CC4OCC5CCCCC5,
EMI1,,35773-42-3,O=C1OC2=CC(=CC=C2C=C1C3=NC=4C=CC=CC4O3)N(CC)CC,
CB2R/FAAH modulator-3,,2876918-67-9,O=C(NC12CC3CC(CC(C3)C1)C2)C=4C=CC=CC4OCCCCC,
IMS2186,,1031206-36-6,O=C\1C=2C(OC/C1=C\C3=CC(O)=C(OC)C=C3)=CC=C(C)C2,
WAY-606956,,748145-19-9,O=C1C2=C(NC=3NN=C(C3C2C=4C=NC=CC4)C)CC(C)(C)C1,
Aldoxorubicin hydrochloride,Aldoxorubicin hydrochloride (1361644-26-9 Free baseï¼,1361563-03-2,OC=1C2=C([C@@H](O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C[C@@](\C(=N\NC(CCCCCN4C(=O)C=CC4=O)=O)\CO)(O)C2)C(O)=C5C1C(=O)C=6C(C5=O)=C(OC)C=CC6.Cl,
CRA-026440 hydrochloride,CRA-026440 hydrochlorideï¼847460-34-8 Free baseï¼,847459-98-7,Cl.O=C(NO)C1=CC=C(C#CCNC(=O)C2=CC=3C=C(OCCN(C)C)C=CC3N2)C=C1,
CHK1-IN-4 hydrochloride,CHK1-IN-4 hydrochlorideï¼2120398-41-4 Free baseï¼,T10792L,N#CC1=NC=C(NC2=NNC(C3=C(OCCCN)C=C(Br)C=C3OC)=C2)N=C1.Cl,
6-Aminochrysene,6-Chrysenamine,2642-98-0,NC1=CC=2C=3C=CC=CC3C=CC2C=4C=CC=CC14,
(S)-PF-06873600,,2185859-59-8,O=C1N(C=2C(C=C1C(F)F)=CN=C(NC3CCN(S(C)(=O)=O)CC3)N2)[C@@H]4[C@@](C)(O)CCC4,
T025,,2407433-00-3,N=1C=CC=NC1CNC=2N=C(N=C3NC=C(C=4C=CC=5N=CC=CC5C4)C32)NC,
UCM05,G28UCM,1094451-90-7,O=C(OC=1C=C(OC(=O)C2=CC(O)=C(O)C(O)=C2)C=3C=CC=CC3C1)C4=CC(O)=C(O)C(O)=C4,
Duvelisib (R enantiomer) hydrochloride,Duvelisib (R enantiomer) hydrochloride(1261590-48-0 Free base);IPI-145 R enantiomer HCl;INK1197 R enantiomer HCl,T11129L,C[C@H](C(N1C2=CC=CC=C2)=CC3=CC=CC(Cl)=C3C1=O)NC4=C5C(N=CN5)=NC=N4.Cl,
CUDC-427,GDC-0917,1446182-94-0,N(C(=O)[C@H]1N(C([C@@H](NC([C@@H](NC)C)=O)[C@H]2CCCCC2)=O)CCC1)C3=C(N=C(S3)C4=NC=CO4)C5=CC=CC=C5,
TAK-441,,1186231-83-3,O=C(NC1CCN(C(=O)CO)CC1)C2=C(OCC(F)(F)F)C=3C(=O)N(C(=CC3N2C)CC)CC(=O)C=4C=CC=CC4,
BMS-605541,,639858-32-5,O=C(NC1CC1)C2=CC(NCC=3SC(=NC3)NC4=NC=CC=C4)=C(F)C=C2F,
DuP-697,,88149-94-4,O=S(=O)(C1=CC=C(C=C1)C=2C=C(Br)SC2C=3C=CC(F)=CC3)C,
P53R3,,922150-12-7,C(N1CCN(CC=2N=C(N[C@H](C(OC)=O)C(C)C)C3=C(N2)C=CC=C3)CC1)(C4=CC=C(Cl)C=C4)C5=CC=C(Cl)C=C5,
Lurtotecan,OSI-21GI14721,149882-10-0,C(C)[C@]1(O)C2=C(C(=O)N3C(=C2)C=4C(C3)=C(CN5CCN(C)CC5)C=6C(N4)=CC7=C(C6)OCCO7)COC1=O,
Compound TPX-0046,,2411115-73-4,C[C@H]1CNC(=O)C2=C3N=C4C(=CN3N=C2)O[C@H]5CCC[C@H]5N4CC6=C(O1)N=CC(=C6)F,
PRI-724,C-82 prodrug;ICG-001 analog;Foscenvivint,1422253-38-0,C([C@@H]1N2[C@@](N(C(NCC3=CC=CC=C3)=O)N(C)CC2=O)([C@H](C)N(CC=4C5=C(C=CC4)C=CC=N5)C1=O)[H])C6=CC=C(OP(=O)(O)O)C=C6,
Enpp/Carbonic anhydrase-IN-1,,2883495-35-8,O=C(NC1=CC=C(OS(=O)(=O)C=2C=CC=CC2)C=C1)C34CC5CC(CC(C5)C3)C4,
AS 1892802,,928320-12-1,N(C(N[C@H](CO)C1=CC=CC=C1)=O)C2=CC=C(C=C2)C=3C=CN=CC3,
NLRP3-IN-10,ZVN2639,2641826-39-1,C(=C/C(=O)C1=CC=C(F)C=C1)\C2=C(OC)C=C(Br)C(OC)=C2,
FiVe1,,932359-76-7,ClC1=CC=CC(=C1)N2CCN(C3=CN=NC4=C(Cl)C=CC=C43)CC2,
MKI-1,MASTL Kinase Inhibitor-,1190277-80-5,O=C(NC1=NC=2C=CC=CC2N1)C3=CC=CC(=C3)N4C=CC=C4,
ABC1183,,1042735-18-1,N#CC1=CC=C(C=C1)C(=O)C=2SC(=NC2N)NC3=CC=C(C=C3)C,
PI-828,LY 294002,942289-87-4,O=C1C=C(OC=2C1=CC=CC2C3=CC=C(N)C=C3)N4CCOCC4,
VU0155069,CAY10593,1130067-06-9,O=C1N(C=2C(N1)=CC(Cl)=CC2)C3CCN(C[C@@H](NC(=O)C4=CC5=C(C=C4)C=CC=C5)C)CC3,
Tamsulosin,LY253351 free base;(R)-(-)-YM12617 free base,106133-20-4,S(N)(=O)(=O)C1=C(OC)C=CC(C[C@H](NCCOC2=C(OCC)C=CC=C2)C)=C1,
BRD0209,,1597439-87-6,C[C@@]1(C2=C(NN=C2NC3=C1C(=O)CC(C)(C)C3)C4CC4)C5=CC=CC=C5,
EGFR-IN-1 hydrochloride,,2227455-78-7,Cl.O=C(C=C)NC1=CC=CC(=C1)N2C(=O)C=C(C=3C=NC(=NC32)NC4=CC=C(OCCN(C)C)C=C4OC)C,
Zabedosertib,BAY 1834845,1931994-81-8,O=C(NC1=CC2=CN(N=C2C=C1C(O)(C)C)CCS(=O)(=O)C)C=3N=C(C=CC3)C(F)(F)F,
G36,,1392487-51-2,BrC1=C([C@H]2[C@@]3([C@](C=4C(N2)=CC=C(C(C)C)C4)(C=CC3)[H])[H])C=C5C(=C1)OCO5,
"1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-cyclopropylurea",,1144075-40-0,O=C(NC1=CC=C(C=C1)C2=NC=3C=CSC3C(=N2)N4CC5OC(C4)CC5)NC6CC6,
GSK-F1,PI4KA inhibitor-F,1384097-27-1,O=C1C=2C=C(C=CC2N=C(N)N1C=3C=CC=CC3C(F)(F)F)C=4C=NC(OC)=C(C4)S(=O)(=O)NC5=CC=C(F)C=C5F,
"1-(2-fluoroethyl)-3-{4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)thieno[3,2-d]pyrimidin-2-yl]phenyl}urea",,1144075-36-4,O=C(NC1=CC=C(C=C1)C2=NC=3C=CSC3C(=N2)N4CC5OC(C4)CC5)NCCF,
SU056,,2376580-08-2,O=C1OCC2=C1C(C=3C=CC=C(F)C3)C4=CC=5OCOC5C=C4N2CCO,
"Urea, N-[4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)thieno[3,2-d]pyrimidin-2-yl]phenyl]-N'-3-pyridinyl-",,1144075-44-4,O=C(NC=1C=NC=CC1)NC2=CC=C(C=C2)C3=NC=4C=CSC4C(=N3)N5CC6OC(C5)CC6,
"1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-phenylurea",,1144075-42-2,O=C(NC=1C=CC=CC1)NC2=CC=C(C=C2)C3=NC=4C=CSC4C(=N3)N5CC6OC(C5)CC6,
MPT0B014,,1215208-59-5,O=C(C=1C=CC2=NC=CC=C2C1)C3=CC(OC)=C(OC)C(OC)=C3,
ROCK-IN-5,,692870-25-0,O=C(NC1=NC(=CS1)C=2C=CN=CC2)CC=3C(F)=CC=CC3Cl,
Laduviglusib trihydrochloride,CHIR 99021 trihydrochloride;CT99021 trihydrochloride,1782235-14-6,N#CC1=CN=C(NCCNC2=NC(C3=C(Cl)C=C(Cl)C=C3)=C(C4=NC=C(C)N4)C=N2)C=C1.Cl.Cl.Cl,
JC124,,1638611-48-9,O=C(NCCC1=CC=C(C=C1)S(=O)(=O)NC)C2=CC(Cl)=CC=C2OC,
EGFR-IN-11,,2463200-44-2,N(C=1N(C=2C(N1)=CN=C(NC3=CC=C(C=C3)N4CCN(C)CC4)N2)[C@H]5CN(S(=O)(=O)C6CC6)CC5)C7=CC=CC=C7,
OPC-28326,,167626-17-7,O=C(C=1C=C(C(NC(=O)CC)=C(C1)C)C)N2CCC(N(C)CCC=3C=CC=CC3)CC2,
H-1152 dihydrochloride,,871543-07-6,O=S(C1=CC=CC2=C1C(C)=CN=C2)(N3[C@H](CNCCC3)C)=O.Cl.Cl,
NecroX-5,,1383718-29-3,CS(=O)(=O)O.CS(=O)(=O)O.C1COCCC1CNC2=CC(=CC3=C2NC(=C3)C4=CC=CC=C4)CN5CCS(=O)(=O)CC5,
ERG240,EGR240,1415683-79-2,CC(C(C)CCC([O-])=O)=O.[Na+],
DX3-213B,,2749555-66-4,S(=O)(=O)(N1C[C@H](C(=O)N2CCC(F)(F)CC2)CCC1)C3=CC=C(S(C(C)C)(=O)=O)C=C3,
RP-6306,(S)-RP-6306,2719793-90-3,O=C(N)C=1C=2C=C(C(=NC2N(C1N)C=3C(=CC=C(O)C3C)C)C)C,
Auristatin23,,2375388-36-4,[C@H]([C@H](C(N[C@@H](CC1=CC=CC=C1)C(O)=O)=O)C)(OC)[C@]2(N(C(C[C@H]([C@@H](N(C([C@@H](NC([C@@H](N(CCCCN(C(OC(C)(C)C)=O)C)C)[C@@H](C)C)=O)C(C)C)=O)C)[C@H](CC)C)OC)=O)CCC2)[H],
CHD1Li 6.11,,2716890-91-2,O=C(NC1=CC=C(C=C1)NC2=NC(=NC(=C2)C)N3CCCC3)CC=4SC=C(Br)C4,
ARUK2001607,,T67845,CC1=CC2=C(N=CN=C2S1)NC3=CC=C(C=C3)S(=O)(=O)C,
WAY-333184,"1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)-",863004-48-2,O=C1N(C=2C=CC=CC2SC(C)C1)CC=3C=CC=CC3,
AKR1C3-IN-9,,T67846,CC1=C(C(=NO1)C)COC2=CC=CC=C2C(=O)NC3=CC=CC=C3OC,
GSK3Î² inhibitor II,,478482-75-6,IC1=CC=CC(=C1)CSC2=NN=C(O2)C=3C=CN=CC3,
(R)-Simurosertib,(R)-TAK-93,1330782-69-8,O=C1N=C([C@@H]2N3CCC(C2)CC3)NC4=C1SC(=C4)C=5C(C)=NNC5,
AKT-IN-6,INCB-047775,1430056-54-4,O=C1C=2C(=CC(=CC2)C3=C(C#N)C=NN3C)CN1[C@@H](CC4=CC(F)=CC=C4)CN,
MIK665,S-64315,1799631-75-6,O=C(O)C(OC=1N=CN=C2SC(C3=CC=C(F)C=C3)=C(C=4C=CC(OCCN5CCN(C)CC5)=C(Cl)C4C)C12)CC=6C=CC=CC6OCC7=NC(=NC=C7)C=8C=CC=CC8OC,
AZ044,,1800017-49-5,N(C[C@@H]1CC[C@@H](C(O)=O)CC1)C=2SC=3C(N2)=CC=C(C3)C4=CC(=O)N(CC5CC5)C=C4,
WAY-601035,,304645-61-2,O=C1N=C(SC1=CC=2C=CC3=NC=CC=C3C2)N,
Antiproliferative agent-15,,19819-18-2,O=C1N=C(NC=2SC3=C(C12)CCCC3)C=4C=CC=CC4,
"N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-5-ethyl-6-[ethyl(tetrahydropyran-4-yl)amino]-2-(1-piperidylmethyl)benzofuran-4-carboxamide",,2098545-98-1,O=C1NC(=CC(=C1CNC(=O)C2=C3C=C(OC3=CC(=C2CC)N(CC)C4CCOCC4)CN5CCCCC5)C)C,
BRD4 Inhibitor-20,,2490311-14-1,O=C1NC2=CC=C(C=C2C1=C(C)C)NS(=O)(=O)C=3C=CC=CC3OC,
MCT1-IN-3,,2878360-80-4,N#CC(=CC1=CN(C=2C=CC=CC12)CC(=O)NC3=CC=C(OC)C=C3)C(=O)OC,
Geranylgeranyl pyrophosphate tetrabutylammonium(1ï¼2),Geranylgeranyl pyrophosphate tetrabutylammoniumï¼1ï¼2ï¼(6699-20-3 Free base),T40781L1,CCCC[N+](CCCC)(CCCC)CCCC.[O-]P(O)(OP([O-])(OC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)\C)=O)=O.CCCC[N+](CCCC)(CCCC)CCCC,
Cort108297,,1018679-79-2,C(OCC)[C@@]12C(=CC3=C(C1)C=NN3C4=CC=C(F)C=C4)CCN(S(=O)(=O)C5=CC=C(C(F)(F)F)C=C5)C2,
Umbralisib R-enantiomer,TGR-1202 R-enantiomer; RP5264 R-enantiomer,1532533-69-9,NC1=C2C(=NN([C@H](C)C3=C(C(=O)C=4C(O3)=CC=C(F)C4)C5=CC(F)=CC=C5)C2=NC=N1)C6=CC(F)=C(OC(C)C)C=C6,
VX-984,M9831,1476074-39-1,[C@H](CNC=1C=C(N=CN1)C=2C(=NC(C)=NC2[2H])[2H])(C)C=3C4=C(C(C(NC)=O)=CC=N4)C=CC3,
NF-ÎºÎ activator 1,,2387524-59-4,O=C(O)C1=CC=CC(=C1)C=2N=C(SC2)NC=3C=CC=CC3F,
AZA197,,1249398-09-1,N=1C(=NC(=CC1NCCC2=CNC=3C=CC=CC32)C)NC(C)CCCN(CC)CC,
Talibegron hydrochloride,ZD2079 hydrochloride,178600-17-4,C(C(O)=O)C1=CC=C(OCCNC[C@H](O)C2=CC=CC=C2)C=C1.Cl,
N-Acetyl-L-cysteine ethyl ester,N-Acetylcysteine ethyl ester; NACET,59587-09-6,[C@H](C(OCC)=O)(NC(C)=O)CS,
Fasnall HCl,Fasnall HClï¼929978-58-5 Free baseï¼,T27307L,CC1=C(C)SC2=NC=NC(NC3CN(CC3)CC4=CC=CC=C4)=C21.Cl,
BMS-599626 Hydrochloride,AC480 Hydrochloride,873837-23-1,N(C=1C=2N(C=C(NC(OC[C@@H]3COCCN3)=O)C2C)N=CN1)C=4C=C5C(=CC4)N(CC6=CC(F)=CC=C6)N=C5.Cl,
Go6976,GÃ¶ 6976,136194-77-9,N#CCCN1C=2C=CC=CC2C=3C1=C4C(C5=CC=CC=C5N4C)=C6C(=O)NCC63,
VT104,,2417718-25-1,C(N[C@@H](C)C1=CC=CC=N1)(=O)C2=CC3=C(C(=CC=C3)C4=CC=C(C(F)(F)F)C=C4)C=C2,
WAY-323966,,451515-89-2,N#CC1=NC2=C(N=C1C#N)N(C(N)=C2C3=NC=4C=CC=CC4N3)CCCN(CC)CC,
Acalabrutinib enantiomer,R-Acalabrutinib,1952316-43-6,C(C#CC)(=O)N1[C@@H](C=2N3C(=C(N2)C4=CC=C(C(NC5=CC=CC=N5)=O)C=C4)C(N)=NC=C3)CCC1,
Adenosine 5'-monophosphate disodium salt,5â-AMP-NA2; Adenosine Phosphate Disodium,4578-31-8,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])[O-])O)O)N.[Na+].[Na+],
HDAC8-IN-20a,,1884231-52-0,O=C(NO)C1=CC=C(OC)C(OCC=2C=CC=CC2)=C1,
CDK4/6/1 Inhibitor,,2099128-41-1,FC=1C=NC(=NC1C=2C=C(F)C=3N=C(C)C4(C3C2)CCCC4)NC5=NC=C(C=C5)C6CCN(C)CC6,
PhIP,,105650-23-5,N1=CC(=CC2=C1N=C(N)N2C)C=3C=CC=CC3,
9-hydroxy Stearic Acid,,3384-24-5,O=C(O)CCCCCCCC(O)CCCCCCCCC,
Y134,,849662-80-2,O=C(C1=CC=C(C=C1)N2CCN(CC2)C(C)C)C3=C(SC4=CC(O)=CC=C43)C=5C=CC(O)=CC5,
UPGL00004,,1890169-95-5,O=C(NC1=NN=C(S1)NC2CCN(C3=NN=C(S3)NC(=O)CC=4C=CC=CC4)CC2)CC=5C=CC=CC5,
CID-5056270,,681173-76-2,O=C(NC1=NC(=CS1)C=2C=CN=CC2)C3OC=4C=CC=CC4OC3,
Galocitabine,,124012-42-6,O[C@H]1[C@@H](O[C@H](C)[C@H]1O)N2C(=O)N=C(NC(=O)C3=CC(OC)=C(OC)C(OC)=C3)C(F)=C2,
"D-Fructose-1,6-bisphosphate sodium salt hydrate",,81028-91-3,C([C@H]([C@H]([C@@H](C(=O)COP(=O)(O)[O-])O)O)O)OP(=O)([O-])[O-].O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+],
USP15-IN-1,,2260826-16-0,O=C(NCCO)C=1C=CC=2NC3=C(C2C1)CCN(C(=O)CC=4C=CC=CC4)C3,
Unecritinib,,1418026-92-2,O([C@H](C)C1=C(Cl)C(F)=CC=C1Cl)C2=CC(=CN=C2NC(C)=O)C3=CN(N=C3)C4CCNCC4,
Divarasib,,2417987-45-0,C[C@H]1CN(C(C=C)=O)CCN1C2=NC(OC[C@@H]3CCCN3C)=NC4=C(F)C(C5=C(C(F)(F)F)C(C)=CC(N)=N5)=C(Cl)C=C42,
"6,7-Dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Perchlorate",,1334529-08-6,O=Cl(=O)(=O)[O-].N1=C2N(C=[N+]1C=3C(=CC(=CC3C)C)C)CCC2,
Holomycin,,488-04-0,O=C1NC2=CSSC2=C1NC(=O)C,
DHODH-IN-23,,1346705-53-0,O=C(O)C=1C=CC=CC1C(=O)NC2=C(F)C=C(C=C2Cl)C3=CC=CC(OCCCC)=C3,
Necrostatin-5,,337349-54-9,N#CCSC1=NC=2SC3=C(C2C(=O)N1C4=CC=C(OC)C=C4)CCCC3,
Lepidiline A,,596093-98-0,[Cl-].C=1C=CC(=CC1)CN2C=[N+](C(=C2C)C)CC=3C=CC=CC3,
IRAK4-IN-20,,1931994-80-7,O=C(NC1=CC2=CN(N=C2C=C1C(O)(C)C)CCC(O)(C)C)C=3N=C(C=CC3)C(F)(F)F,
ITX3,,347323-96-0,O=C1C(SC2=NC=3C=CC=CC3N21)=CC=4C=C(N(C=5C=CC=CC5)C4C)C,
Hydrocortisone aceponate,,74050-20-7,C(COC(C)=O)(=O)[C@]1(OC(CC)=O)[C@]2(C)[C@@](CC1)([C@]3([C@]([C@@H](O)C2)([C@]4(C)C(CC3)=CC(=O)CC4)[H])[H])[H],
Giredestrant tartrate,,2407529-33-1,[C@@H]([C@H](C(O)=O)O)(C(O)=O)O.C(C(CO)(F)F)N1[C@@H](C2=C(C=3C(N2)=CC=CC3)C[C@H]1C)C4=C(F)C=C(NC5CN(CCCF)C5)C=C4F,
LTÎ²R-IN-1,,2189366-77-4,O=C1C=2C(CN1[C@@H](C(NC=3NC=4C(N3)=CC=CC4)=O)C)=CC=CC2,
Piflufolastat,,1423758-00-2,C(NCCCC[C@H](NC(N[C@@H](CCC(O)=O)C(O)=O)=O)C(O)=O)(=O)C=1C=CC(F)=NC1,
BCL6-IN-3,,2253878-44-1,C(CC(C)(C)O)N1C=2C(N(C)C1=O)=CC=C(NC3=NC(=NC=C3Cl)N4C[C@H](C)C(F)(F)[C@H](C)C4)C2,
Wnt/Î²-catenin agonist 2,,943820-93-7,O=C(NCCN1N=CC=C1)C2=NOC(=C2)C=3OC=CC3,
Cancer-Targeting Compound 1,,1007581-62-5,N#CC=1C=CC(=CC1)C=2N=C(SC2)N3C(=O)OCC3(C)C,
Netivudine,,84558-93-0,O=C1N(C=C(C#CC)C(=O)N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O,
TG-89,TG 89,936091-56-4,O=S(=O)(NC(C)(C)C)C=1C=CC=C(C1)NC2=NC(=NC=C2C)NC3=CC=CC(=C3)CN4CCOCC4,
BAY-069,,2639638-66-5,O=C1C=C(NC(=O)N1C2=CC(OC=3C=CC=CC3C)=C(Cl)C=4C=CC=CC42)C(F)(F)F,
USP8-IN-2,,2477651-11-7,FC(F)(F)C1=NC(=CC=C1)N2CCC(NC(=S)NC3=CC(Cl)=CC=C3OC)CC2,
HIF-2Î± agonist 2,,2750141-15-0,O=S1(=O)N=C(NC=2C=C(Br)C=C(Br)C2)C=3C=CC=CC31,
USP8-IN-3,,2477651-10-6,O=[N+]([O-])C1=CC=C(NC(NC2CCN(CC2)C3=CC=CC(C(F)(F)F)=N3)=S)C=C1,
2-(Cyclopropylethynyl)benzoic acid,,1313028-09-9,O=C(O)C=1C=CC=CC1C#CC2CC2,
Thymohydroquinone,Thymoquinol,2217-60-9,CC(C)c1cc(O)c(C)cc1O,
NSC 694623,,907957-34-0,CCCCc1ccc(cc1)-n1sc2ncccc2c1=O,
DIF-3,,113411-17-9,CCCCCC(=O)c1c(O)cc(OC)c(Cl)c1O,
JAK2-IN-6,,353512-04-6,Nc1nc(Nc2ccccc2)sc1C(=O)c1ccc(Cl)s1,
SC57666,,158959-32-1,O=S(=O)(C1=CC=C(C=C1)C2=C(C=3C=CC(F)=CC3)CCC2)C,
AY 77,Unk-Cha-Chg-NH2,1835734-92-3,C1CCC(CC1)C[C@@H](C(=O)N[C@@H](C2CCCCC2)C(=O)N)NC(=O)C3=CC=NO3,
Cot inhibitor-1,,915365-57-0,Fc1ccc(Nc2c(cnc3c(Cl)cc(NCc4cn(CCN5CCCCCC5)nn4)cc23)C#N)cc1Cl,
LY 456236 hydrochloride,MPMQ hydrochloride,338736-46-2,Cl.COc1ccc(Nc2ncnc3ccc(OC)cc23)cc1,
CPI-0610 carboxylic acid,,1380089-81-5,ClC1=CC=C(C2=N[C@@H](CC(O)=O)C(ON=C3C)=C3C4=C2C=CC=C4)C=C1,
Loxoprofen sodium,CS-600,80382-23-6,CC(C1=CC=C(C=C1)CC2CCCC2=O)C(=O)[O-].[Na+],
KDM5-C49 HCl,KDM5-C49  HCl(1596348-16-1  Free  base);KDOAM-20 hydrochloride,T27723L,OC(C1=CC(CNCC(N(CC)CCN(C)C)=O)=NC=C1)=O.Cl,
WAY-647636,,556055-08-4,O=C(CSc1nnc(-c2ccncc2)n1-c1ccccc1)c1ccc2OCCOc2c1,
Cdc7-IN-7c,Cdc7 inhibitor-7c,1330781-04-8,O=C1N=C(NC=2C=C(SC12)C3=CNN=C3C)CN4CCCC4,
JAK3i,JAK-3i,1918238-72-8,O=C(OCC)C1=CNC2=NC=NC(C=3C=C(C=CC3F)NC(=O)C=C)=C21,
AZA1,Rac1/Cdc42-IN-1,1071098-42-4,N=1C=CC(=NC1NC=2C=CC=3NC(=CC3C2)C)NC=4C=CC=5NC(=CC5C4)C,
PKI-166,,187724-61-4,N([C@H](C)C1=CC=CC=C1)C2=C3C(NC(=C3)C4=CC=C(O)C=C4)=NC=N2,
LM-1685,LM 1685,416901-58-1,O=C(OC)C1=CC=2C=C(C=CC2N1CC3=CC=C(Cl)C=C3)S(=O)(=O)C,
WAY-639446,,724746-07-0,O=C1N=C(NC=2SC(=C(C=3C=CC=CC3)C12)C)C=4N=CC=CC4,
JB062,,2417988-00-0,O=C1OC=2C=CC=CC2C(O)=C1C(=NCC3=CC=C(OC)C=C3)C,
S19-1035,,T67950,CC1=C(C(=NO1)C)COC2=CC=CC=C2C(=O)NC3=CC=CC=C3Cl,
JB061,,T67951,OC(C1=CC=CC=C1O2)=C(/C(C)=N/CC3=CC=CC(OC)=C3)C2=O,
WAY-620473,,743451-55-0,O=C1N=C(NC=2C=CC=CC12)CCC(=O)N3CCC(C(=O)N)CC3,
Tenifatecan,SN2310,850728-18-6,C(C)C1=C2C(C=3N(C2)C(=O)C4=C(C3)[C@](CC)(O)C(=O)OC4)=NC=5C1=CC(OC(CCC(OC=6C(C)=C7C(=C(C)C6C)O[C@@](CCC[C@@H](CCC[C@@H](CCCC(C)C)C)C)(C)CC7)=O)=O)=CC5,
KT-362 fumarate,KT-362,105394-80-7,C(=C/C(O)=O)\C(O)=O.C(CCNCCC1=CC(OC)=C(OC)C=C1)(=O)N2C=3C(=CC=CC3)SCCC2,
MnTBAP chloride,Mn(III)TBAP,55266-18-7,[H+].O=C([O-])C=1C=CC(=CC1)C2=C3C=CC=4C(C=5C=CC(=CC5)C(=O)[O-])=C6C=CC7=C(C8=CC=C(C=C8)C(=O)[O-])C=9C=CC%10=C(C%11=CC=C(C=C%11)C(=O)[O-])C%12=CC=C2[N-]%12[Mn+3]([Cl-])([N]34)([N]%109)[N-]67,
Telomerase-IN-1,,666859-49-0,O=C(C1=CC=C(F)C=C1)C2CCN(CC2)CC(OC)C3=CC=C(C=C3)N(=O)=O,
"3',â4',â5',â5,â7-âPentamethoxyflavone","5,7,3',4',5'-Pentamethoxyflavone",53350-26-8,O=C1C=C(OC2=CC(OC)=CC(OC)=C12)C=3C=C(OC)C(OC)=C(OC)C3,
Neldazosin,,109713-79-3,O=C(N1CCN(C=2N=C(N)C=3C=C(OC)C(OC)=CC3N2)CC1)CC(O)C,
Ropidoxuridine,IPdR,93265-81-7,O=C1N([C@@H]2O[C@H](CO)[C@@H](O)C2)C=C(I)C=N1,
MMP-2/MMP-9 Inhibitor I,,193807-58-8,S(N[C@H](CC1=CC=CC=C1)C(O)=O)(=O)(=O)C2=CC=C(C=C2)C3=CC=CC=C3,
BPHA,MMP-2/MMP-9 Inhibitor II,193807-60-2,S(N[C@H](CC1=CC=CC=C1)C(NO)=O)(=O)(=O)C2=CC=C(C=C2)C3=CC=CC=C3,
Deriglidole,SL 86-0715,122830-14-2,C(CC)C1(N2C=3C(C1)=CC=CC3CC2)C=4NCCN4,
Xinidamine,BRN 0891979,50264-78-3,O=C(O)C1=NN(C=2C=CC=CC12)CC3=CC=C(C=C3C)C,
Silperisone HCl,RGH-5002;SILA-336,140944-30-5,Cl.FC1=CC=C(C=C1)C[Si](C)(C)CN2CCCCC2,
GS-9191,GS 9191,859209-84-0,C(COCP(N[C@@H](CC1=CC=CC=C1)C(OCC(C)C)=O)(N[C@@H](CC2=CC=CC=C2)C(OCC(C)C)=O)=O)N3C=4C(=C(NC5CC5)N=C(N)N4)N=C3,
RV01,,1016897-10-1,C(=C/C1=CC(O)=CC(O)=C1)\C=2C3=C(N=CC2)C=CC=C3,
PCSK9-IN-10,,368434-98-4,O=C1C2=C(N=C(NCCOC)N2CC=3C=CC=C(OC)C3)N(C(=O)N1C)C,
ZIM,,301298-87-3,O=C1C(=C(N(N1C=2C=CC=CC2)C)C)N3C(=O)C4C5C=CC(C5)C4C3=O,
p53-MDM2-IN-1,,381717-91-5,O=C(C=1C=CC=CC1)C2=C(O)C(=O)N(CCCN3C=NC=C3)C2C4=CC=C(Cl)C=C4,
6-Methyl-3-pyridinecarboxaldehyde,6-Methoxynicotinaldehyde,65873-72-5,O=CC1=CN=C(OC)C=C1,
A-935142,,1031335-85-9,C(F)(F)(F)C1=CC(=NN1)C2=CC=C(C=C2)[C@H]3CC[C@H](CC(O)=O)CC3,
Î²-NF-JQ1,,2380000-55-3,CC=1C2=C(N3C([C@H](CC(NCCOCCOCCOCC4=CC=C(C=C4)C=5OC=6C(C(=O)C5)=C7C(=CC6)C=CC=C7)=O)N=C2C8=CC=C(Cl)C=C8)=NN=C3C)SC1C,
Dactolisib Tosylate,BEZ235 Tosylate;NVP-BEZ 235 Tosylate,1028385-32-1,N#CC(C1=CC=C(C=C1)N2C(=O)N(C=3C=NC4=CC=C(C=C4C32)C=5C=NC6=CC=CC=C6C5)C)(C)C.O=S(=O)(O)C1=CC=C(C=C1)C,
Cimaterol,CL 263780,54239-37-1,N#CC1=CC(=CC=C1N)C(O)CNC(C)C,
YKL-06-062,,2172617-16-0,O=C1N(C=2C(=CC=CC2C)C)CC3=CN=C(N=C3N1C4CCCCC4)NC5=CC=C(C=C5)N6CCN(C)CC6,
PCLX-001,,1215011-08-7,O=S(=O)(NC=1C(=NN(C1C)C)CC(C)C)C=2C(Cl)=CC(=CC2Cl)C=3C=CN=C(C3)N4CCNCC4,
KR-32568,,852146-73-7,O=C(NC(=N)N)C=1OC(=CC1)C=2C=C(F)C=CC2C,
9-Isopropylolomoucine,N9-Isopropylolomoucine,158982-15-1,OCCNC=1N=C(NCC=2C=CC=CC2)C=3N=CN(C3N1)C(C)C,
SCFSkp2-IN-2,,1375060-02-8,N(CC)(CC)C1=CC(O)=C(/C=N/NC(=O)C=2C=CC=NC2)C=C1,
BMS-599626 2HCL,BMS-599626 2HCL(714971-09-2 Free base);AC480 2HCl,1781932-33-9,O=C(OC[C@@H]1COCCN1)NC2=CN3C(C(NC4=CC=C(N(N=C5)CC6=CC(F)=CC=C6)C5=C4)=NC=N3)=C2C.Cl.Cl,
Endoxifen hydrochloride,,1197194-41-4,Cl.OC1=CC=C(C=C1)C(C2=CC=C(OCCNC)C=C2)=C(C=3C=CC=CC3)CC,
RS1-PDK1 inhibitor,,1643958-85-3,O=S(=O)(NC1=NC=2C=CC(Cl)=CC2S1)C3=CSC=4C=CC=CC43,
ABBV-318,,1802848-94-7,O(C1=CC2=C(N=C(C(=O)N3CC[C@@H](F)C3)C=C2)C=C1)C4=CC=C(C(F)(F)F)C=N4,
Daunomycinone,,21794-55-8,O=C1C=2C(=C(O)C3=C(C2O)[C@@H](O)C[C@@](C(C)=O)(O)C3)C(=O)C=4C1=C(OC)C=CC4,
CMLD-2,,958843-91-9,O=C1OC2=C(C(OC)=CC(OC)=C2C(C3=CC=C(OC)C=C3)CC(=O)N4CCCC4)C(=C1)C=5C=CC=CC5,
Apricitabine,AVX754;SPD754,160707-69-7,O=C1N([C@@H]2S[C@H](CO)OC2)C=CC(N)=N1,
CP-547632,,252003-65-9,O=C(N)C=1C(=NSC1NC(=O)NCCCCN2CCCC2)OCC3=C(F)C=C(Br)C=C3F,
RIPK1-IN-9,,2682889-57-0,O=C1C=2C=C(C=NC2CCN1CC3=CC(F)=CC=C3OC4CCCC4)C=5C=CN6N=C(N=C6C5)N,
TGX-115,,351071-62-0,O=C1C=C(NC=2C(OC=3C=CC=CC3C)=CC=CC12)N4CCOCC4,
(-)-Anonaine,,1862-41-5,C=12C3=C4C(=CC1CCN[C@@]2(CC=5C3=CC=CC5)[H])OCO4,
BRD4097,,1550053-19-4,O=C(NC1=CC=C(C=C1N)C)C2=CC=C(C=C2)NC(=O)C,
NM-3,Isocoumarin NM-3,181427-78-1,O=C1OC(=CC=2C=C(OC)C=C(O)C12)C(C(=O)O)C,
Tubulin inhibitor 8,,1309925-39-0,N#CC1=CC=C2C(OC=3C=CC=CC3N2C(=O)C4=CC=C(OC)C=C4)=C1,
cemadotin free base,LU103793 free base,159776-69-9,C([C@@H](N(C([C@@H](NC([C@H](C(C)C)N(C)C)=O)C(C)C)=O)C)[C@@H](C)C)(=O)N1[C@H](C(=O)N2[C@H](C(NCC3=CC=CC=C3)=O)CCC2)CCC1,
MRT-2359,,2803881-11-8,O=C(OCC1=CC=C2C(=C1)C(=O)N(C2)C3C(=O)NC(=O)CC3)NC4=CC(OC(F)(F)F)=CC=C4F,
CDK8-IN-13,,918523-75-8,O=C(N)C1=CC=CC(=C1)C2=CN=C3NC=CC3=C2,
HDAC-IN-52,,2075787-77-6,O=C(NC=1C=CC=CC1N)C2=NC=C(C=C2)NC(=O)CC=3C=CC=4C=CC=CC4C3,
Mitoquidone,,91753-07-0,O=C1C=2C=CC=CC2C(=O)C=3C1=CN4C3CC=5C=CC=CC5C4,
Talmetacin,,67489-39-8,O=C1OC(OC(=O)CC=2C=3C=C(OC)C=CC3N(C(=O)C4=CC=C(Cl)C=C4)C2C)C=5C=CC=CC15,
Selurampanel,BGG492,912574-69-7,O=C1NC2=CC(=C(C=C2C(=O)N1NS(=O)(=O)C)C3=CC=NN3C)C(C)C,
Ciglitazone,ADD 3878;U-63287,74772-77-3,O=C1SC(C(=O)N1)CC2=CC=C(OCC3(C)CCCCC3)C=C2,
CSF1R-IN-3,,2760584-90-3,C(=C\1/C=2C(=CC(NC(NC=3C=C(C(C)(C)C)ON3)=O)=CC2)NC1=O)\C4=C(C)C(NC(CN5CCN(C)CC5)=O)=C(C)N4,
GSK-3Î² inhibitor 11,,536731-65-4,O=C1C=2C=CC=CC2C(=O)N1CC(=O)NC3=NC(=CS3)C=4C=CC=C(OC)C4,
AZ31,AZ 31,2088113-98-6,N([C@@H](C)C1CCOCC1)C=2C3=C(N=CC2C(N)=O)C=CC(=C3)C=4C=CC(COC)=NC4,
Cdk1/2 Inhibitor III,,443798-55-8,O=S(=O)(N)C1=CC=C(C=C1)NC2=NC(=NN2C(=S)NC=3C(F)=CC=CC3F)N,
Norethindrone acetate,19-Norethindroneacetate,51-98-9,C[C@@]12[C@](OC(C)=O)(C#C)CC[C@]1([C@]3([C@](CC2)([C@@]4(C(CC3)=CC(=O)CC4)[H])[H])[H])[H],
P22074,P-22074,90680-28-7,O=C(C=1SC(SC=2C=CC=CC2)=C(C1)N(=O)=O)C,
Mepivacaine,Carbocaine,96-88-8,O=C(NC=1C(=CC=CC1C)C)C2N(C)CCCC2,
Aluminum potassium sulfate,APS;Potassium Aluminium Sulfate,10043-67-1,[Al].[K].O=S(=O)(O)O,
CDK8-IN-12,,2613307-67-6,O=C1NCCC12CCN(C=3C(Cl)=CN=CC3C=4OC=5C=CC=CC5C4)CC2,
(R)-1-(2-((2-methoxy-4-(piperazin-1-yl)phenyl)amino)pyridin-4-yl)-N-(4-(trifluoromethoxy)benzyl)piperidine-3-carboxamide hydrochloride,(R)-1-(2-((2-methoxy-4-(piperazin-1-yl)phenyl)amino)pyridin-4-yl)-N-(4-(trifluoromethoxy)benzyl)piperidine-3-carboxamide hydrochloride(2365497-12-5 Free base),T67699L,O=C([C@H]1CN(C2=CC(NC3=CC=C(N4CCNCC4)C=C3OC)=NC=C2)CCC1)NCC5=CC=C(OC(F)(F)F)C=C5.[H]Cl,
Terflavoxate,,86433-40-1,O=C(OC(C)(C)CN1CCCCC1)C2=CC=CC=3C(=O)C(=C(OC23)C=4C=CC=CC4)C,
Cholesteryl Hemisuccinate,Cholesterol hydrogen succinate,1510-21-0,C[C@@]12[C@@]3([C@]([C@]4([C@](C)(CC3)[C@@]([C@@H](CCCC(C)C)C)(CC4)[H])[H])(CC=C1C[C@@H](OC(CCC(O)=O)=O)CC2)[H])[H],
Setrobuvir,ANA-598;RG-7790,1071517-39-9,C(N1[C@@]2([C@@]([C@@]3(C[C@]2(CC3)[H])[H])(C(O)=C(C1=O)C=4NC=5C(S(=O)(=O)N4)=CC(NS(C)(=O)=O)=CC5)[H])[H])C6=CC=C(F)C=C6,
LCS3,,109844-92-0,O=C(NC1=CC=C(Cl)C=C1)C=2OC(=CC2)N(=O)=O,
Anticancer agent 46,,2426686-17-9,C(=N\NC(NC1=CC=CC=C1)=S)(\C)/C2=C(O)C=CC(Cl)=C2,
NFATc1-IN-1,,1912422-56-0,O=C(NC1=CC=C(I)C=C1F)C2=CC(F)=CC=C2O,
Ascamycin,,91432-48-3,NC1=C2C(N(C=N2)[C@@H]3O[C@H](COS(NC([C@H](C)N)=O)(=O)=O)[C@@H](O)[C@H]3O)=NC(Cl)=N1,
Ralitoline,,1089085-40-4,O=C(C=C1SCC(=O)N1C)NC=2C(Cl)=CC=CC2C,
LDCA,,349106-80-5,O=C(NC1=CC=C(F)C(Cl)=C1)C(Cl)Cl,
rac-CCT-250863 HCl,rac-CCT-250863 HCl(1364269-06-6 Free base),T28498L,NC1=C(C=C(C=N1)C2=CC(CN(C)C)=CS2)C3=CC(OC(/C=C\C(F)(F)F)C)=C(C(N)=O)C=C3.Cl,
H2-Gamendazole,,877768-84-8,O=C(O)CCC1=NN(C=2C=C(C=CC12)C(F)(F)F)CC3=CC=C(Cl)C=C3Cl,
Protonstatin-1,,521972-99-6,C(=C/1\SC(=S)NC1=O)\C2=CC=CO2,
TT-10,TAZ-K,2230640-94-3,O=C(C=1SC(F)=CC1)C=2SC(=NC2N)NCC=C,
Glutathione arsenoxide hydrochloride,Glutathione arsenoxide hydrochloride(1271726-51-2 Free base);GSAO HCl,T27417L,OC([C@H](CCC(N[C@@H](CSCC(NC1=CC=C([As](O)O)C=C1)=O)C(NCC(O)=O)=O)=O)N)=O.Cl,
"1,1-Dimethylethyl N-[1-[6-[4-(methylsulfonyl)phenoxy]-4-pyrimidinyl]-4-piperidinyl]carbamate",,2697145-21-2,O=C(OC(C)(C)C)NC1CCN(C=2N=CN=C(OC3=CC=C(C=C3)S(=O)(=O)C)C2)CC1,
JHU395,,2079938-92-2,C(OC(C(C)(C)C)=O)(OC(N[C@H](C(OC(C)C)=O)CCC(C=[N+]=[N-])=O)=O)C1=CC=CC=C1,
Evixapodlin,PD-1/PD-L1-IN 7;GS-4224,2374856-75-2,ClC1=C(C=CC=C1C2=NC(OC)=C(CNC[C@H]3NC(=O)CC3)N=C2)C4=C(Cl)C(=CC=C4)C5=NC(OC)=C(CNC[C@H]6NC(=O)CC6)N=C5,
HTH-01-091,HTH 01-091,2000209-42-5,O=C1N(C2=C3C(=NC=C2CN1)C=CC(=C3)C4=CC(Cl)=C(O)C(Cl)=C4)[C@@H]5CC[C@@H](CN(C)C)CC5,
Cis-22a,,1819366-84-1,C(C(O)=O)(F)(F)F.CC=1C=C([C@H]2CC[C@H](CC2)N3CCN(CC3)C=4C=CC=NC4)C=CC1,
Alethine,Î²-Alethine,646-08-2,O=C(NCCSSCCNC(=O)CCN)CCN,
Amlodipine maleate,Amlodipine (+-)-form maleate;Amvaz,88150-47-4,C(=C\C(O)=O)\C(O)=O.C(OCC)(=O)C=1C(C(C(OC)=O)=C(C)NC1COCCN)C2=C(Cl)C=CC=C2,
(-)-Catechin,(-)-Cianidanol;(-)-Catechuic acid,18829-70-4,O[C@H]1[C@@H](OC=2C(C1)=C(O)C=C(O)C2)C3=CC(O)=C(O)C=C3,
WAY-332062,,1015859-04-7,O=C(NC1CCCCC1)CS(=O)CC=2N=C(OC2C)C=3C=CC(Cl)=CC3,
Torbafylline,,105102-21-4,O=C1C2=C(N=CN2COCC)N(C(=O)N1CCCCC(O)(C)C)C,
"5-Hexenoic acid, 6-[4-[2-[[(4-chlorophenyl)sulfonyl]amino]ethyl]phenyl]-6-(3-pyridinyl)-",,133276-52-5,O=C(O)CCCC=C(C=1C=NC=CC1)C2=CC=C(C=C2)CCNS(=O)(=O)C3=CC=C(Cl)C=C3,
Tetrazolast,,95104-27-1,N1=NNC(=N1)C2=CC3=CC=CC=C3N4N=NN=C24,
SFI003,,2361332-90-1,C(=N\NC1=NC(=CS1)C2=CC=C(OC)C=C2)(\C)/C=3NC=4C(N3)=CC=CC4,
Nonabine,,16985-03-8,OC1=CC(=CC=2OC(C=C(C=3C=CN=CC3)C12)(C)C)C(C)C(C)CCCCC,
DN401,DN-401,2135749-60-7,N=1N=C(C)CC=2C=C(OC)C(OC)=CC2C1C=3C=CC(N)=CC3,
I-OMe-Tyrphostin AG 538,I-OMe-AG 538,1094048-77-7,NC1=C2C(N(N=C2C3=CC=C(OC4=CC=CC=C4)C=C3)[C@H]5CN(C(CN(C)C)=O)CCC5)=NC=N1,
PI5P4Ks-IN-2,,2766854-03-7,OCCOCCOCCN1CCC(=C(C=2C=CC=CC2)C=3C=CC=CC3)CC1,
TASK-1-IN-1,,600125-11-9,O=C(NC=1C(=CC=CC1C)C)NCCCNC(C)C,
BMT-124110 Formate,BMT-124110 Formateï¼1679371-59-5 Free baseï¼,T10572L,O=C(NC1=CC=CC(=C1)C(=O)NC=2C=CC=CC2CC)C=3C=CC=CC3,
Saterinone,,102669-89-6,C([C@H](NC(=O)C1=CC(Cl)=CC(Cl)=C1)CCC(O)=O)(=O)N2CCC3(CC2)CCCC3,
OT-551 HCl,OT-551 HClï¼627085-11-4 Free baseï¼,627085-15-8,N#CC1=CC(C2=CC=C(OCC(O)CN3CCN(C=4C=CC=CC4OC)CC3)C=C2)=C(NC1=O)C,
L82,,329227-30-7,O=C1NN=CC(NN=CC2=CC=C(O)C(=C2)N(=O)=O)=C1Cl,
MLS000544460,,352336-36-8,O=C(NN=CC=1OC(SC2=NC=CC=C2)=CC1)C=3C=CC=C(F)C3,
"1-(2-hydroxyethyl)-3-{4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)thieno[3,2-d]pyrimidin-2-yl]phenyl}urea",,1144075-38-6,O=C(NC1=CC=C(C=C1)C2=NC=3C=CSC3C(=N2)N4CC5OC(C4)CC5)NCCO,
USP22-IN-1,,309735-96-4,N#CC=1C2=NC=3C=CC=CC3N2C(NC=4C=CC=CC4)=C5C1CCCC5,
BAY-0069,,420826-65-9,O=C(NC1=CC=C2OC(=NC2=C1)C3=CC=C(C=C3)CC)C4=CC(=CC=C4Br)N(=O)=O,
Elinafide,,162706-37-8,O=C1C=2C=CC=C3C=CC=C(C(=O)N1CCNCCCNCCN4C(=O)C=5C=CC=C6C=CC=C(C4=O)C65)C32,
XR-11576 HCl,XR-11576 HCl(346689-77-8 Free base),T26339L,COC1=CC=CC2=C3C(N=C4C(C(C(N[C@H](C)CN(C)C)=O)=CC=C4)=N3)=CC=C12.Cl,
2-aminobenzo[d]thiazol-6-ol,,26278-79-5,OC=1C=CC=2N=C(SC2C1)N,
"3-Amino-1,2,4-triazole","Amitrole;3-AT;1H-1,2,4-Triazol-5-amine;Trapidil impurity B",61-82-5,N=1N=C(N)NC1,
Isoproterenol,Norisodrine,7683-59-2,OC1=CC=C(C=C1O)C(O)CNC(C)C,
6-Hydroxyflavanone,,4250-77-5,O=C1C2=CC(O)=CC=C2OC(C=3C=CC=CC3)C1,
IPN60090,GLS1-IN-1,1853164-83-6,O(C=1C=C(CC(NC2=CC=C(CC[C@H](CN3C=C(C(NC)=O)N=N3)F)N=N2)=O)N=C(C)C1)C4CC(F)(F)C4,
Rosabulin,STA 5312,501948-05-6,N#CC1=CC=C(C=C1)CC2=CC(C(=O)C(=O)NC=3SN=C(C3)C)=C4C=CC=CN42,
AU-15330,,2380274-50-8,C([C@@H](NC(CN1CCN(CC1)C=2C=C(N=NC2N)C3=C(O)C=CC=C3)=O)C(C)(C)C)(=O)N4[C@H](C(N[C@@H](C)C5=CC=C(C=C5)C6=C(C)N=CS6)=O)C[C@@H](O)C4,
CAY10746,,2247240-76-0,O=C1C=COC2=CC(OCC(=O)NC=3C=CC=C(C3)NC(=O)C4=CC=C(C=C4)N(C)C)=CC=C12,
Diaziquone,NSC 182986,57998-68-2,O=C(OCC)NC=1C(=O)C(=C(NC(=O)OCC)C(=O)C1N2CC2)N3CC3,
GSK2008607,,1244644-50-5,O=S(=O)(NC=1C=CC=C(C1F)C=2N=C(SC2C=3N=C(N=CC3)NC4=CN=C(C=C4)N5CCOCC5)C(C)C)C=6C(F)=CC=CC6F,
ARN25068,,2649882-80-2,N=1NC(=CC1NC2=NC(=NC=3C=CSC32)NCC=4C=CC=CC4)C5CC5,
Tolnapersine TFA,Tolnapersine TFA(70312-00-4 Free base),T68023L,OC1=CC=C2C(CCC(C2)N3CCN(CC3)C4=C(C)C=CC=C4)=C1.OC(C(F)(F)F)=O,
CPI-360,CPI 360;CPI360,1802175-06-9,[C@H](C)(N1C=2C(C(C(NCC3=C(OC)C=C(C)NC3=O)=O)=C1C)=CC=CC2)C4CCOCC4,
"4,6-Benzilidine-D-Glucose",,30688-66-5,[C@H]([C@H](C=O)O)(O)[C@@]1(OC(OC[C@H]1O)C2=CC=CC=C2)[H],
2-Hydroxy-3-methoxy chalcone,,7146-86-3,O=C(C=CC=1C=CC=C(OC)C1)C=2C=CC=CC2O,
"N-Ethyl-Nâ²-[4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)thieno[3,2-d]pyrimidin-2-yl]phenyl]urea",,1144075-34-2,O=C(NC1=CC=C(C=C1)C2=NC=3C=CSC3C(=N2)N4CC5OC(C4)CC5)NCC,
GKI-1 HCl,GKI-1 HClï¼ 2444764-03-6 Free baseï¼,T11402L,ClC1=CC=C(NC2=CC=CC(C3=CNN=C3)=C2)C=C1.Cl,
PDS-0330,,2904682-19-3,O=C(NC(=S)NC1=CC=C(C=C1)C2=NC=3C=CC=CC3O2)C=4C=CC=5C=CC=CC5C4,
"1-methyl-3-{4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)thieno[3,2-d]pyrimidin-2-yl]phenyl}urea",,1144075-32-0,O=C(NC1=CC=C(C=C1)C2=NC=3C=CSC3C(=N2)N4CC5OC(C4)CC5)NC,
Minamestane,,105051-87-4,C[C@@]12[C@@]3([C@]([C@]4([C@](C)(CC3)C(=O)CC4)[H])(C=CC1=C(N)C(=O)C=C2)[H])[H],
Pafenolol,,75949-61-0,O=C(NCCC1=CC=C(OCC(O)CNC(C)C)C=C1)NC(C)C,
MSU-42011,,2456434-36-7,O=C(O)C1=CN=C(C=C1)N(C=2C=C(C=C(C2)C(C)(C)C)C(C)(C)C)CC(C)C,
CGP-20712,CGP 20712,137888-49-4,O=C(N)C1=CC(OCCNCC(O)COC=2C=CC(=CC2)C3=NC(=CN3C)C(F)(F)F)=CC=C1O,
6'-GNTI dihydrochloride,,2410327-94-3,O[C@]12[C@]34[C@](OC5=C(O)C=CC(C[C@@]2([H])N(CC4)CC6CC6)=C53)([H])C7=C(C8=CC=C(NC(N)=N)C=C8N7)C1.Cl.Cl,
Polyphyllin H,,81917-50-2,O[C@@]12[C@]3(C)[C@@](C[C@@]1(O[C@@]4([C@H]2C)CC[C@@H](C)CO4)[H])([C@]5([C@](CC3)([C@]6(C)C(=CC5)C[C@@H](O[C@H]7[C@H](O[C@H]8[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O8)[C@@H](O)[C@H](O[C@@H]9O[C@@H](CO)[C@H](O)[C@H]9O)[C@@H](CO)O7)CC6)[H])[H])[H],
Tuvusertib,ATR inhibitor 1; M1774,1613200-51-3,O=C(NC=1C=NC=C(F)C1C2=CN=CN2C)C=3C(=NN4C=C(F)C=NC34)N,
CP-312,Cardioprotectant 312,895470-67-4,O=C(NC1=NC(=CS1)C=2N=CC=CC2)CSC3=CC=C(Cl)C=C3,
Rhodblock 6,Rhodblock-6,886625-06-5,O=C(NC=1C=CC=2NN=CC2C1)C3CCC3,
Palatrigine,BW-A 256C,98410-36-7,ClC=1C=CC=C(C1Cl)C2=NN(C(=N)N=C2N)C(C)C,
Milveterol HCl,GSK159797,804518-03-4,[C@@H](CNCCC1=CC=C(NC[C@H](O)C2=CC=CC=C2)C=C1)(O)C3=CC(NC=O)=C(O)C=C3.Cl,
Dabelotine,UNII-6RY56RB98P,118976-38-8,O(C1=CC=CC2=C1N(C)CCC2)CC3OCCNC3,
PrNMI,,1541244-33-0,C(=C\1/C=2C(C(CCN3CCOCC3)=C1)=CC=CC2)\C=4C5=C(C(CCC)=CC4)C=CC=C5,
Valencene,,4630-07-3,C[C@]12C(CC[C@@H](C(C)=C)C1)=CCC[C@H]2C,
BMS-641988,,T67818,C[C@@]12[C@@]3([C@]([C@@](C)(O1)[C@H](NS(CC)(=O)=O)C2)(C(=O)N(C3=O)C4=CC(C(F)(F)F)=C(C#N)C=C4)[H])[H],
TAO Kinase inhibitor 2,,850467-77-5,O=C(NCC(=O)NC1C=2C=CC=CC2CCC1)C3=CC=C(OC=4C=CC=CC4)C=C3,
1-vinylpyrene,1-Ethenylpyrene,17088-21-0,C=CC1=CC=C2C=CC3=CC=CC=4C=CC1=C2C34,
Larotinib,,1438072-11-7,N(C=1C2=C(C=C(OC)C(OCCCN3C[C@@]4([C@](C3)(OCCO4)[H])[H])=C2)N=CN1)C5=CC(Cl)=C(F)C=C5,
PHGDH-IN-3,,2893778-31-7,O=C(NC1=NC(=CS1)C=2C=CC=C(F)C2)C3=CC=C(C=C3)S(=O)(=O)NC4=CC=CC(=C4)C(=O)C,
Lobuprofen,,98207-12-6,O=C(OCCN1CCN(C=2C=CC=C(Cl)C2)CC1)C(C3=CC=C(C=C3)CC(C)C)C,
"2,4-Dichlorothieno[3,2-d]pyrimidine",,16234-14-3,ClC=1N=C(Cl)C=2SC=CC2N1,
DSS30,,883027-32-5,O=S(=O)(NC=1C=CC=CC1OC)C=2SC=3C=CC(Cl)=CC3C2C,
Chamaejasmenin B,,89595-71-1,O=C1[C@]([C@H](OC=2C1=C(O)C=C(O)C2)C3=CC=C(OC)C=C3)([C@]4([C@H](OC=5C(C4=O)=C(O)C=C(O)C5)C6=CC=C(OC)C=C6)[H])[H],
Sarmustine,SarCNU; NSC-364432; Sarcosinamide,81965-43-7,O=NN(C(=O)N(C)CC(=O)N)CCCl,
5-LOX-IN-1,,55040-82-9,O=C(C=1C=CC=CC1)C=2SC(=NC2C=3C=CC=CC3)N4CCOCC4,
GSK-3Î² inhibitor 3,,1448990-73-5,O=C(C=C)N1C(=O)CC(SC=2C=CC=CC21)C3=CC=C(F)C=C3,
Orphenadrine,Orphenadrine (free base),83-98-7,O(CCN(C)C)C(C=1C=CC=CC1)C=2C=CC=CC2C,
Miclxin,DS37262926,2494198-61-5,N=1C=CC=C(C1)C2CN(C=3N=C4C=C(OC)C=CC4=C(N3)NCC=5C=CC=C(OC)C5)CC2,
Cyclo(L-Pro-L-Val),,2854-40-2,O=C1N2[C@](C(=O)N[C@H]1[C@@H](C)C)(CCC2)[H],
Carboxylesterase-IN-2,,2764748-88-9,O=C1NN=C2C=CC(=NN21)SC3=CC=C(C(=C3)C)C,
AOH1996,,2089314-64-5,O=C(NCC(=O)NC=1C=CC=CC1OC2=CC=CC(OC)=C2)C3=CC=CC=4C=CC=CC43,
WDR5-IN-6,,326901-92-2,O=S(=O)(C1=CC(Cl)=CC=C1Cl)N2C=NC=3C=CC=CC32,
Trapencaine,,76629-91-9,O=C(OC1CCCCC1N2CCCC2)NC=3C=CC=C(OCCCCC)C3,
Soquinolol,Soquinolol mucate,61563-18-6,O=CN1CC=2C=CC=C(OCC(O)CNC(C)(C)C)C2CC1,
GSK2593074A,,1337531-06-2,O=C(N1C2=CC=C(C=C2CC1)C3=CSC=4C(=CN=C(N)C43)C=5C=NN(C5)C)CC=6C=CC=CC6,
N-Deshydroxyethyl Dasatinib,N-Deshydroxyethyl BMS-354825,910297-51-7,O=C(NC=1C(Cl)=CC=CC1C)C=2SC(=NC2)NC3=NC(=NC(=C3)N4CCNCC4)C,
NLRP3/AIM2-IN-2,,791840-86-3,O=C(NC=1C=CC=C(O)C1)CC2=CC=C(OC)C=C2,
NLRP3/AIM2-IN-3,,1787787-60-3,O=C(NC=1C=CC=C(O)C1)CC=2C=CC=3C=CNC3C2,
ANO1-IN-1,,407587-01-3,O=C(N)C1=C(SC2=C1CCC(C2)C(C)(C)C)NC(=O)C(C)(C)C,
PKM2 activator 2,,1186660-06-9,O=S(=O)(C=1C=CC=2C=CC=CC2C1)N3CCN(CC3)S(=O)(=O)C=4C(F)=CC=CC4F,
KSQ-4279,USP1-IN-1,2446480-97-1,FC(F)(F)C=1N=C(C=2C=CC(=CC2)CN3N=CC=4C=NC(=NC43)C=5C(=NC=NC5C6CC6)OC)N(C1)C(C)C,
Anticancer agent 73,,124811-87-6,O=C(OCC)C=1N=C(OC1C)C=2C=CC(OC)=CC2,
Tilomisole,Wy 18251,58433-11-7,O=C(O)CC=1SC2=NC=3C=CC=CC3N2C1C=4C=CC(Cl)=CC4,
5-Methyl-2-thiophenecarboxaldehyde,,13679-70-4,O=CC=1SC(=CC1)C,
Diphenyl disulfide,Phenyl disulfide,882-33-7,S(SC=1C=CC=CC1)C=2C=CC=CC2,
Lactic acid,2-hydroxypropanoic acid,50-21-5,O=C(O)C(O)C,
L-Aspartic aicd sodium,Sodium L-aspartate,3792-50-5,[C@H](CC(O)=O)(C(O)=O)N.[Na],
Cyclamic acid sodium,Cyclohexylsulfamicacidsodium; Sodiumcyclamate,139-05-9,[Na].O=S(=O)(O)NC1CCCCC1,
"1H-Benzimidazole-6-carboxamide, N-[3-(aminocarbonyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]-",,941185-83-7,O=C(N)C1=C(SC2=C1CCCC2)NC(=O)C=3C=CC=4N=CNC4C3,
2â-Deoxy-2â-fluoro-beta-D-arabinocytidine hydrochloride,,25183-22-6,F[C@@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(=O)N=C(N)C=C2.Cl,
Bcl-B inhibitor 1,,79220-88-5,O=C(NC1=CC=C(C=C1)N2C=C(NC2=S)C=3C=CC=CC3)C,
JG-231,,1627126-59-3,CN1/C(/SC=2C1=CC=C(Cl)C2)=C/3\S/C(=C\C4=[N+](CC5=CC=C(Br)S5)C=CS4)/N(CC)C3=O.[Cl-],
Tallimustine HCl,Tallimustine HCl(115308-98-0 Free base),118438-45-2,Cl.O=C(NC=1C=C(C(=O)NC=2C=C(C(=O)NC=3C=C(C(=O)NCCC(=N)N)N(C3)C)N(C2)C)N(C1)C)C4=CC=C(C=C4)N(CCCl)CCCl,
EG01377 2HCl,EG01377 2HCl(2227996-00-9 Free base),2749438-61-5,N=C(N)NCCC[C@@H](C(O)=O)NC(C(SC=C1)=C1NS(=O)(C2=C3C(CCO3)=CC(C4=CC=C(C=C4)CN)=C2)=O)=O.Cl.Cl,
6'-hydroxydihydrocinchonidine,,5962-19-6,[C@H](O)([C@]1([N@@]2C[C@H](CC)[C@](C1)(CC2)[H])[H])C=3C4=C(N=CC3)C=CC(O)=C4,
"1,4-Dideoxy-1,4-epithio-D-ribitol",,190315-43-6,C(O)[C@@H]1[C@@H](O)[C@@H](O)CS1,
Fluparoxan hydrochloride,,105227-44-9,FC1=C2C(O[C@@]3([C@@](O2)(CNC3)[H])[H])=CC=C1.Cl,
"(3aR,9aR)-Fluparoxan",,105182-47-6,FC1=C2C(O[C@]3([C@](O2)(CNC3)[H])[H])=CC=C1,
2-Acetyl-3-ethylpyrazine,,32974-92-8,O=C(C1=NC=CN=C1CC)C,
2-Thiocytidine,,13239-97-9,O[C@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(=S)N=C(N)C=C2,
4-(2-Bromoacetyl)benzonitrile,4-Cyanophenacyl bromide,20099-89-2,N#CC1=CC=C(C=C1)C(=O)CBr,
Tyrphostin A25,AG-82;RG-50875;Tyrphostin AG 82,118409-58-8,N#CC(C#N)=CC1=CC(O)=C(O)C(O)=C1,
ABT-510 acetate,ABT 510 acetate,442526-87-6,C(C)(O)=O.C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](NC([C@@H](NC(CNC(CN(C(C)=O)C)=O)=O)[C@H](C)C)=O)[C@H](CC)C)=O)[C@@H](C)O)=O)CCC)=O)[C@H](CC)C)=O)CCCNC(=N)N)(=O)N1[C@H](C(NCC)=O)CCC1,
Haspin-IN-3,,2416569-95-2,C(\C=1C=2C(NC1)=NC=CC2)=C/3\OC=4C(C3=O)=CC=C(O)C4,
Crebinostat,,1092061-61-4,O=C(NO)CCCCCC(=O)NN=CC=1C=CC(=CC1)C=2C=CC=CC2,
Glucocorticoid receptor agonist-1,,2166375-82-0,C(CO)(=O)[C@]12[C@]3(C)[C@@](C[C@]1(O[C@H](O2)C4=CC=C(CC5=CC(N)=CC=C5)C=C4)[H])([C@]6([C@]([C@@H](O)C3)([C@]7(C)C(CC6)=CC(=O)C=C7)[H])[H])[H],
DB04760,MMP-13 Inhibitor,544678-85-5,O=C(NCC1=CC=C(F)C(=C1)C)C2=NC=NC(=C2)C(=O)NCC3=CC=C(F)C(=C3)C,
VT107,,2417718-63-7,C(N[C@@H](C)C=1N=C(N)C=CC1)(=O)C2=CC3=C(C(=CC=C3)C4=CC=C(C(F)(F)F)C=C4)C=C2,
BAY 2965501,,2732902-08-6,N([C@@H](C(N)=O)C)(C=1SC(C(=O)C2=CC=C(OC)C=C2)=C(N)N1)C3=CC=C(F)C=C3,
IK-930,compound I-32,2563892-44-2,O=S(=O)(NC)C=1C=CC(NCC2=CC=C(C=C2)C(F)(F)F)=C(C1)C=3N=CN(C3)C,
Coumarin343,,55804-65-4,O=C(O)C1=CC=2C=C3C4=C(C2OC1=O)CCCN4CCC3,
KM02894,,116850-74-9,O=C(NNC(=S)NC)C=1SC=CC1,
DP-1 hydrochloride,DP-1 hydrochloride(1472616-61-7 Free base),1472616-35-5,Cl.O=C1NN=C(C=2C=C(C(O)=CC2O)C(C)C)N1C=3C=CC4=C(C=CN4CCC5CCNCC5)C3,
2â-O-Methyl-5-iodouridine,5-Iodo-2'-O-methyluridine,34218-84-3,O(C)[C@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(=O)NC(=O)C(I)=C2,
Luciferase-IN-1,,10205-56-8,N1=C(SC=2C=CC=CC12)C3=CC=C(C=C3)N(C)C,
Robenacoxib,Onsior,220991-32-2,O=C(O)CC1=CC(=CC=C1NC=2C(F)=C(F)C=C(F)C2F)CC,
ALDH1A3-IN-2,,886502-08-5,O=CC1=CC=C(C(=C1)C)N2CCCCC2,
MMRi64,,430458-66-5,ClC1=CC=CC(=C1Cl)C(NC2=NC=CC(=C2)C)C=3C=CC4=CC=CN=C4C3O,
Avotaciclib,BEY1107,1983983-41-0,OC1=CC=C(N=C1C=2N=C(N=CC2)N)C3=NC(=NC=C3)N,
CP 461,,227619-96-7,C(C(NCC1=CC=CC=C1)=O)C=2C=3C(/C(=C\C=4C=CN=CC4)/C2C)=CC=C(F)C3.Cl,
1-(2-Amino-4-pyrimidinyl)-3-(3-phenylpropyl)-3-piperidinemethanol,,1332084-64-6,OCC1(CN(C2=NC(=NC=C2)N)CCC1)CCCC=3C=CC=CC3,
Luxdegalutamide,ARV-766,2750830-09-0,O([C@H]1C(C)(C)[C@H](NC(=O)C2=CC=C(C=C2)N3CCC(CN4CCN(CC4)C5=CC(F)=C(C(N[C@@H]6C(=O)NC(=O)CC6)=O)C=C5)CC3)C1(C)C)C7=CC(OC)=C(C#N)C=C7,
CIA-1 (Free base),CIA-1(Free baseï¼,452087-38-6,N=1C=NC(NCCC2=CC=C(OC)C(OC)=C2)=C3C=C(SC13)C,
PG-11047 2HCl,PG-11047 2HCl(949933-50-0 Free base);CGC-11047 2HCl,T73400L,CCNCCCNCC=CCNCCCNCC.Cl.Cl,
HDAC-IN-57,,2716217-79-5,O=C(NO)C1=CC=C(C=C1)CNC(=O)C=2C=CN=C(C2)C=3C=CC(OC)=CC3,
"3-Piperidinemethanol, 1-(1-isoquinolinyl)-3-(3-phenylpropyl)-",,2525206-41-9,OCC1(CN(C2=NC=CC=3C=CC=CC32)CCC1)CCCC=4C=CC=CC4,
Brefonalol HCl,Brefonalol HCl(103880-26-8 Free base),T30586L,O=C1NC2=CC=C(C(CNC(C)(CCC3=CC=CC=C3)C)O)C=C2CC1.Cl,
Lifarizine FA,Lifarizine FA(119514-66-8 Free base),T27830L,CC1=C(CN2CCN(C(C3=CC=CC=C3)C4=CC=CC=C4)CC2)NC(C5=CC=C(C)C=C5)=N1.OC=O,
Antroquinonol,,1010081-09-0,C(/C=C(/CC/C=C(/CCC=C(C)C)\C)\C)[C@H]1[C@@H](O)C(OC)=C(OC)C(=O)[C@@H]1C,
Rilmakalim,,132014-21-2,O[C@H]1[C@@H](C=2C(=CC=C(S(=O)(=O)C3=CC=CC=C3)C2)OC1(C)C)N4C(=O)CCC4,
Schinifoline,,80554-58-1,O=C1C=C(N(C=2C=CC=CC12)C)CCCCCCC,
Taurocholic acid,N-Choloyltaurine,81-24-3,O[C@H]1[C@]2([C@]3([C@@](C)([C@@]([C@@H](CCC(NCCS(=O)(=O)O)=O)C)(CC3)[H])[C@@H](O)C[C@@]2([C@]4(C)[C@](C1)(C[C@H](O)CC4)[H])[H])[H])[H],
Nesuparib,JPI-547/OCN-201,2055357-64-5,N#CC1=CN=C(C=C1)N2CCN(CC=3C=CC4=C(C3)NC(=O)C5=C4NCCC5)CC2,
Pinostrobin chalcone,,18956-15-5,C(/C=C/C1=CC=CC=C1)(=O)C2=C(O)C=C(OC)C=C2O,
SIRT2-IN-9,,522650-91-5,O=C(NC1=NC2=C(S1)CCCC2)CSC=3N=NC4=C(N3)N(C5=CC=CC=C45)CCC,
ABBV-CLS-484,Osunprotafib; AC 484,2489404-97-7,FC=1C(=C(O)C=C2C1C[C@H](NCCC(C)C)CC2)N3CC(=O)NS3(=O)=O,
CDK9-IN-15,,852678-17-2,OC1=CC=CC=2C(=CC=CC12)NC=3N=CN=C4SC=CC43,
MicroRNA-21-IN-2,,303018-40-8,N#CC1=C(N=C(C=C1C)C)SCC(=O)NC2=CC=C3OCOC3=C2,
Talotrexin ammonium,,648420-92-2,NC=1C2=C(N=CC(CNC3=CC=C(C(N[C@@H](CCCNC(=O)C4=C(C(O)=O)C=CC=C4)C(O)=O)=O)C=C3)=N2)N=C(N)N1.N,
Mefenidil,McN-2378,58261-91-9,N#CCC=1NC(=NC1C)C=2C=CC=CC2,
CG 428,,2412055-93-5,O=C1C=2C(C(=O)N1C3C(=O)NC(=O)CC3)=CC=CC2NCCOCCC(=O)N4CCN(CC4)C=5N=C(C=CC5)C=6N7C(=NC6)C=CC(=N7)N8[C@H](CCC8)C9=CC(F)=CC=C9,
Edralbrutinib,TG-1701,1858206-58-2,O=C1C2=C(C(=CN2[C@H]3CN(C(C#CC)=O)CC3)C4=CC=C(OC5=C(F)C=CC=C5F)C=C4)C(N)=NN1,
T521,T 521,891020-54-5,O=S(=O)(C=1C=CC=CC1)C=2N=C(OC2S(=O)(=O)CC)C=3C=CC(F)=CC3,
AMPK activator 4,,2493239-46-4,N#CC1=CC=C(C=C1)COC2=CC=C(C=C2)NC(=O)C(OC3=CC=C(Cl)C=C3)(C)C,
icFSP1,,1115910-36-5,O=C1C=2C=CC=CC2N=C(N1C3=CC=C(C=C3)NC(=O)CC4=CC(OC)=C(OC)C(OC)=C4)C,
Foxy-5 Ammonium Salt,Foxy-5 Ammonium Saltï¼881188-51-8 Free base),TP1565L1,CSCC[C@H](NC=O)C(N[C@@H](CC(O)=O)C(NCC(N[C@@H](CS)C(N[C@@H](CCC(O)=O)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O)=O)=O.[NH4+],
GSK3-IN-3,,331963-27-0,O=C(NNC(=O)CCCCCCCCCCC)C=1C(=O)N(C=2C=CC=CC2C1O)CC,
SNX7,WAY-323879,685097-43-2,N=1C=2C=CC=CC2N(C1C=CC=3OC=CC3)CC,
Neratinib maleate,HKI-272 maleate,915942-22-2,C(=C\C(O)=O)\C(O)=O.N(C=1C2=C(C=C(OCC)C(NC(/C=C/CN(C)C)=O)=C2)N=CC1C#N)C3=CC(Cl)=C(OCC4=CC=CC=N4)C=C3,
DAPK-IN-2,WAY-380496,304000-05-3,O=C1OC(=NC1=CC=2C=NC=CC2)C=3C=CC(OC)=C(OC)C3,
WAY-656935,,852902-81-9,O=C(NC1=CC(=CC=C1Cl)S(=O)(=O)N(C)C)CNC23CC4CC(CC(C4)C2)C3,
Methyl-4-oxoretinoate,,38030-58-9,C(=C/C(=C/C=C/C(=C/C(OC)=O)/C)/C)\C=1C(C)(C)CCC(=O)C1C,
DpC,,1382469-39-7,S=C(NN=C(C1=NC=CC=C1)C2=NC=CC=C2)N(C)C3CCCCC3,
PRMT6-IN-3,,2890765-10-1,O=S(=O)(NC1=CC=C(C=C1)C=2C=NC=C(C2)CN(C)CCNC)C3CC3,
HDAC-IN-51,,T73181,O=C(NC1=CC=C(C(NC2=CC=CC=C2N)=O)N=C1)C(C3=CC=CC=C3)CC4=CC=CC=C4,
Flurocitabine HCl,Flurocitabine HCl(37717-21-8 Free base),40505-45-1,O[C@H]1[C@]2([C@](N3C(O2)=NC(=N)C(F)=C3)(O[C@@H]1CO)[H])[H].Cl,
Turosteride,,137099-09-3,C[C@@]12[C@]([C@]3([C@@]([C@]4(C)[C@@](CC3)(N(C)C(=O)CC4)[H])(CC1)[H])[H])(CC[C@@H]2C(N(C(NC(C)C)=O)C(C)C)=O)[H],
AXL-IN-13,,2376928-82-2,O=C(NC1CCCCC1)C2=CN(N=C2NC3=CC=C(OC=4C=CN=C5C=C(OCCCN6CCOCC6)C(OC)=CC54)C(F)=C3)C,
Zanoterone,,107000-34-0,C[C@@]12[C@@]3([C@]([C@]4([C@](C)(CC3)[C@@](C#C)(O)CC4)[H])(CC[C@]1(CC=5C(C2)=CN(S(C)(=O)=O)N5)[H])[H])[H],
CCG-257081,CCG 257081; CCG257081; MRTF/SRF-IN-1,1922098-90-5,O=C(C1=CC(F)=CC(=C1)C=2C=CN=CC2)N3CC(C(=O)NC4=CC=C(Cl)C=C4)CC(F)(F)C3,
CQ211,,2648986-65-4,O=C1NC2=CC=C(C=C2C3=C1N=NN3C4=CC=C(C(=C4)C(F)(F)F)N5CCNCC5)C=6C=NC(OC)=CC6,
AZD9567,Mizacorat,1893415-00-3,O([C@@H]([C@@H](NC(C(C)(F)F)=O)[C@@H](C)C)C1=CC=CC=C1)C=2C=C3C(N(N=C3)C4=CN(C)C(=O)C=C4)=CC2,
Izonsteride,LY320236; LY-320236,176975-26-1,C[C@@]12C=3C(=CC(SC4=NC=5C(S4)=CC=CC5CC)=CC3)CC[C@]1(N(C)C(=O)CC2)[H],
Carboxylesterase-IN-3,,2764748-92-5,O=C1NN=C2C=CC(=NN12)SC3=CC=C(Cl)C(Cl)=C3,
Chlorin E6,CE6,19660-77-6,C(C(O)=O)C1=C2[C@@H](CCC(O)=O)[C@H](C)C(=N2)C=C3NC(C(C=C)=C3C)=CC4=NC(=CC=5NC1=C(C(O)=O)C5C)C(CC)=C4C,
NAMI-A,,201653-76-1,[H+].O=[S](C)(C)[Ru+3]([Cl-])([Cl-])([Cl-])([Cl-])[N]=1C=CNC1.N=1C=CNC1,
Tetrac,"Tetraiodothyroacetic acid; 3,3',5,5'-Tetraiodothyroacetic acid",67-30-1,O=C(O)CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1,
Rofleponide,,144459-70-1,C(CO)(=O)[C@]12[C@]3(C)[C@@](C[C@]1(O[C@@H](CCC)O2)[H])([C@]4([C@](F)([C@@H](O)C3)[C@]5(C)C([C@@H](F)C4)=CC(=O)CC5)[H])[H],
TAS-119,TAS 119; TAS119; TAS-2104; TAS 2104; TAS2104,1453099-83-6,O=C(O)C1(CC2=NC(NC3=NNC(=C3)C)=C(F)C=C2)CCN(C(=O)C=4C=CC=C(Cl)C4Cl)CC1,
Talviraline,Bay-10-8979; Bay 10-8979; Bay10-8979; Bay-108979; Bay 108979; Bay108979; HBY 097,163451-80-7,C(OC(C)C)(=O)N1C=2C(NC(=S)[C@@H]1CSC)=CC=C(OC)C2,
ZNL 02-096,Pomalidomide-C3-adavosertib ,2414418-49-6,O=C1C=2C=CC=C(NCCCN3CCN(C4=CC=C(C=C4)NC5=NC=C6C(=O)N(N(C=7N=C(C=CC7)C(O)(C)C)C6=N5)CC=C)CC3)C2C(=O)N1C8C(=O)NC(=O)CC8,
Tienoxolol FA,Tienoxolol FA (90055-97-3 Free base),T68161L,O=C(C1=CC(NC(C2=CC=CS2)=O)=CC=C1OCC(CNC(C)(C)C)O)OCC.[H]C(O)=O,
Isomer-Turosteride,Isomer-Turosteride(Isomer-137099-09-3),T71703L,C[C@@]12[C@](CC[C@@H]2C(N(C(C)C)C(NC(C)C)=O)=O)([H])[C@@]3([H])[C@@](CC1)([H])[C@@]4([C@](N(C(CC4)=O)C)([H])CC3)C,
MAT2A-IN-9,,2439277-80-0,O=C1N=C(N)C=2C=CC(=NC2N1C=3C=CC=CC3Cl)C(F)(F)F,
"5-Bromoimidazo[1,2-A]Pyrazine",,87597-26-0,BrC1=CN=CC2=NC=CN12,
MyD88-IN-1,,2911609-80-6,O=N(=O)C1=CC=CC(=C1)CN2CCN(C3=CC=C(C=C3N(=O)=O)S(=O)(=O)NC4=CN=C(OC)C=C4)CC2,
MMP-9-IN-6,,2241964-36-1,O1C(=CC(=C1C=2C=CC=CC2)C3=CNC=4C=CC=C(OC)C43)C=5C=CC=CC5,
Pemedolac,Dexpemedolac,114716-16-4,C(C(O)=O)[C@@]1(CC)C2=C(C=3C(N2)=CC=CC3)[C@@H](CC4=CC=CC=C4)CO1,
Mofarotene,Ro 40-8757; Ro-40-8757,125533-88-2,CC1(C)C=2C(C(C)(C)CC1)=CC=C(\C(=C\C3=CC=C(OCCN4CCOCC4)C=C3)\C)C2,
5-Hydroxydopamine hydrochloride,,5720-26-3,Cl.OC=1C=C(C=C(O)C1O)CCN,
Asundexian,BAY-2433334; BAY 2433334; BAY2433334,2064121-65-7,O(C)C=1C(C2=C(C=CC(Cl)=C2)N3C=C(C(F)(F)F)N=N3)=CC(=O)N([C@H](C(NC4=CC(F)=C(C(N)=O)C=C4)=O)CC)C1,
Funapide,TV 45070; XEN402,1259933-16-8,O=C1[C@]2(C=3C(OC2)=CC4=C(C3)OCO4)C=5C(N1CC=6OC(C(F)(F)F)=CC6)=CC=CC5,
CM037,CM-037; CM 037; A37; A-37; A 37,896795-60-1,O=C(OCC)CSC1=NC2=C(SC=3C=CC=CC32)C(=O)N1CCCN4CCCC4,
VT103,VT 103; VT-103,2290608-13-6,O=S(=O)(NC)C=1C=CC(NC2=CC=C(C=C2)C(F)(F)F)=C(C1)C=3N=CN(C3)C,
LDHA-IN-3,PSTMB; 1-(phenylseleno)-4-(trifluoromethyl) benzene,227010-33-5,FC(F)(F)C1=CC=C([Se]C=2C=CC=CC2)C=C1,
Cytembena,,21739-91-3,COC1=CC=C(C(/C(Br)=C\C([O-])=O)=O)C=C1.[Na+],
AK301,AK-301; AK 301,314022-97-4,O=C(C=1C=CC=CC1OCC)N2CCN(C=3C=CC=C(Cl)C3)CC2,
Antifolate C2,AGF154; AGF-154; AGF 154,1286279-90-0,O=C1C2=C(NC(CCCC3=CC(C(N[C@@H](CCC(O)=O)C(O)=O)=O)=CS3)=C2)NC(N)=N1,
Aloisine B,AloisineB,496864-14-3,ClC1=CC=C(C=C1)C=2NC=3N=CC=NC3C2C(C)C,
GNE-900,GNE 900; GNE900,1200126-26-6,N#CC1=NC=C2NC3=NC=C(C=C3C2=C1)C=4C=CC(=CC4)CN5CCCCC5,
2'-Deoxy-2'-fluoro-beta-D-arabinoguanosine,,103884-98-6,O=C1C2=C(N(C=N2)[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)NC(N)=N1,
4-Thiothymidine,,7236-57-9,O=C1N([C@@H]2O[C@H](CO)[C@@H](O)C2)C=C(C)C(=S)N1,
FMAU,2'-Deoxy-2'-fluoro-5-methyl-beta-D-arabinouridine,69256-17-3,F[C@@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(=O)NC(=O)C(C)=C2,
Enpp/CarbonicÂ anhydrase-IN-2,,2883495-39-2,O=C(NC1=CC=C(OS(=O)(=O)C2=CC=C(F)C=C2)C=C1)C34CC5CC(CC(C5)C3)C4,
Nebularine,9-(beta-D-Ribofuranosyl)-9H-purine,550-33-4,O[C@H]1[C@H](N2C=3C(N=C2)=CN=CN3)O[C@H](CO)[C@H]1O,
GSK3-IN-2,,380450-97-5,O=C1C2=C(NC=3NN=C(C3C2C4=CSC=C4)C)CC(C)(C)C1,
1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil,,69123-94-0,F[C@@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(=O)NC(=O)C=C2,
6-Azauridine,6-Azuridine,54-25-1,O[C@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(=O)NC(=O)C=N2,
1-beta-D-Arabinofuranosylthymine,Thymine 1-Î²-D-arabinofuranoside ; Spongothymidine,605-23-2,O[C@@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(=O)NC(=O)C(C)=C2,
5-Methoxyuridine,Mo5U,35542-01-9,O[C@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C=C(OC)C(=O)NC2=O,
MDL-800,MDL800; MDL 800,2275619-53-7,O=C(OC)C1=CC(=CC=C1S(=O)(=O)NC2=CC(Br)=C(F)C=C2C)NS(=O)(=O)C=3C=C(Cl)C=C(Cl)C3,
Naluzotan hydrochloride, PRX 00023 hydrochloride,740873-82-9,Cl.O=C(NC1=CC=CC(=C1)N2CCN(CC2)CCCCNS(=O)(=O)CC3CCCCC3)C,
CYP1B1-IN-4,,2685779-55-7,N#CC=1C=CC(=CC1)C=2N=C(SC2)C=3C=CC(OC)=CC3OC,
Ly-295501,Ly 295501; Ly295501; ILX-295501,150869-74-2,O=C(NC1=CC=C(Cl)C(Cl)=C1)NS(=O)(=O)C2=CC=C3OCCC3=C2,
JP1302,,80259-18-3,N=1C=2C=CC=CC2C(NC3=CC=C(C=C3)N4CCN(C)CC4)=C5C=CC=CC15,
Rafabegron,TAK-677; TAK677; AD-9677; AD9677,244081-42-3,O(CC(O)=O)C1=C2C(C(C[C@H](NC[C@H](O)C3=CC(Cl)=CC=C3)C)=CN2)=CC=C1,
Dmt-2'fluoro-da(bz) amidite,,136834-22-5,C(OC[C@@H]1[C@@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](F)[C@@H](O1)N2C=3C(N=C2)=C(NC(=O)C4=CC=CC=C4)N=CN3)(C5=CC=C(OC)C=C5)(C6=CC=C(OC)C=C6)C7=CC=CC=C7,
MMP-3 Inhibitor,,158841-76-0,C([C@@H](NC(CNC([C@@H](NC([C@H](CCCNC(=N)N)NC(C)=O)=O)CS)=O)=O)[C@H](C)C)(=O)N1[C@H](C(N[C@@H](CC(O)=O)C(N)=O)=O)CCC1,
N-decanoyl-L-Homoserine lactone,C10-HSL,177315-87-6,N(C(CCCCCCCCC)=O)[C@@H]1C(=O)OCC1,
PU-H71 HCl,PU-H71 HCl(873436-91-0 Free base); Zelavespib HCl,2095432-24-7,Cl.IC=1C=C2OCOC2=CC1SC3=NC=4C(=NC=NC4N3CCCNC(C)C)N,
NG-497,NG497,2598242-66-9,O=C(OC(C)C)C=1N=C(C=C(OC)C1)C=2C=CC(OCC)=CC2,
SLU-PP-1072,,2285432-57-5,O=C(NC=1C=CC=2N=CSC2C1)C=3OC(=CC3)C=4C=CC(O)=CC4,
COX-2-IN-34,,2788578-71-0,O=C(NC=1C=CC=CC1O)C=2C=CC=C(O)C2O,
Topoisomerase II inhibitor 14,,305343-00-4,ClC1=CC=C(C(Cl)=C1)C2N=C(N=C3NC=4C=CC=CC4N32)N,
3'-Deoxy-3'-fluoroadenosine,,75059-22-2,O[C@H]1[C@H](N2C=3C(N=C2)=C(N)N=CN3)O[C@H](CO)[C@H]1F,
2'-Deoxy-2'-fluoroarabinoadenosine,,20227-41-2,F[C@@H]1[C@H](N2C=3C(N=C2)=C(N)N=CN3)O[C@H](CO)[C@H]1O,
3'-Deoxy-3'-fluoroguanosine,,123402-21-1,O=C1C2=C(N(C=N2)[C@@H]3O[C@H](CO)[C@@H](F)[C@H]3O)NC(N)=N1,
9-(Î²-D-Xylofuranosyl)adenine,Xylosyladenine; Adenine xyloside,524-69-6,O[C@H]1[C@H](N2C=3C(N=C2)=C(N)N=CN3)O[C@H](CO)[C@@H]1O,
N6-Methyl-2'-O-methyladenosine,"N6,2â²-O-Dimethyladenosine",57817-83-1,O(C)[C@H]1[C@H](N2C=3C(N=C2)=C(NC)N=CN3)O[C@H](CO)[C@H]1O,
8-Azaguanosine,,2133-80-4,O=C1C2=C(N(N=N2)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)NC(N)=N1,
6-Methoxy-9-(2-C-methyl-beta-D-ribofuranosyl)purine,2â²-C-Methyl-6-O-methylinosine,565450-78-4,C[C@]1(O)[C@@H](O[C@H](CO)[C@H]1O)N2C=3C(N=C2)=C(OC)N=CN3,
Refametinib R enantiomer,BAY 869766 R enantiomer; RDEA119 R enantiomer,923032-38-6,S(NC1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1OC)(=O)(=O)C3(C[C@H](CO)O)CC3,
Itasetron,DAU 6215CL; DAU6215CL; U 98079A; U-98079A,123258-84-4,C(N[C@H]1C[C@@]2(N(C)[C@](C1)(CC2)[H])[H])(=O)N3C=4C(NC3=O)=CC=CC4,
PI3KÎ´-IN-3,TC KHNS 11,1431540-99-6,N#CC=1C=C(C=NC1OC)C2=CC=C3N=CN=C(C=4C=CC=C(C4)C(=O)N5CCN(C(=O)C)CC5)C3=C2,
Vorozole,(+)-Vorozole; R83842,129731-10-8,[C@@H](C=1C=C2C(=CC1)N=NN2C)(C3=CC=C(Cl)C=C3)N4C=NC=N4,
ZEN-3694,ZEN 3694; ZEN3694,1643947-30-1,N=1OC(=C(C=2C=NC=3N=C(NC)N(C3C2)CC=4C=CC=CC4)C1C)C,
Sovleplenib,HMPL-523; HMPL 523; HMPL523,1415792-84-5,N(C[C@@H]1CNCCO1)C=2C3=C(C=C(N2)C4=CC=C(C=C4)C5CCN(S(C)(=O)=O)CC5)N=CC=N3,
Deoxyguanosine triphosphate trisodium salt,Deoxyguanosine 5-triphosphate; dGTP trisodium salt; 2'-Deoxyguanosine-5'-triphosphate trisodium salt,93919-41-6,O=C1C2=C(N(C=N2)[C@@H]3O[C@H](COP(OP(OP(=O)(O)O)(=O)O)(=O)O)[C@@H](O)C3)NC(N)=N1.[Na],
Taletrectinib free base,DS-6051b free base; AB-106freebase; IBI-344 free base,1505514-27-1,N([C@H](C)C1=CC(F)=CC=C1)C2=NN3C(=CN=C3C=C2)C4=CC=C(OC[C@@H](C)N)C=C4,
PI3K/Akt/mTOR-IN-2,,2757804-89-8,FC=1C=C(F)C=C(C1)C2OCCC=3C=4C=CC=CC4NC32,
Laprafylline,,90749-32-9,O=C1C=2NC(=NC2N(C(=O)N1C)CC(C)C)CCN3CCN(CC3)C(C=4C=CC=CC4)C=5C=CC=CC5,
RU-SKI 43,RUSKI 43,1043797-53-0,O=C(N1CCC=2SC=CC2C1COC3=CC=CC(=C3)C)CNCC(C)CC,
Tafetinib,SIM-010603; SIM010603; SIM 010603,1032265-57-8,O=C1/C(=C/2\C3=C(C(C(NCCN(CC)CC)=O)=C(C)N3)CCC2)/C=4C(N1)=CC=C(F)C4,
KRAS G12C inhibitor 19,,2649788-46-3,C(#N)C=1C2=C(C=CC(F)=C2SC1N)C=3C(Cl)=C4C(=CC3F)C(=O)N5[C@@](CCO4)(CN(C(C=C)=O)CC5)[H],
BAY-179,,2764880-87-5,N1=CC=CC=2NC(=NC12)CN3CCC(C4=NC(=CS4)C=5OC=6C=CC=CC6C5)CC3,
PI3K-IN-38,,1382979-64-7,N=1C(=NC(=C2N=C3N(C12)CCOC3(C)C)N4CCOCC4)C=5C=CC(N)=CC5,
COX-2-IN-6,,2756347-91-6,O=S(=O)(C=1C=CC(=CC1)C2=CC(=C(N=C2OCC(O)(C)C)OCCC)CO)C,
Crobenetine,Crobenetine Free Base; BIII 890 CL,221019-25-6,C[C@]12C=3C(C[C@](C1(C)C)(N(C[C@@H](OCC4=CC=CC=C4)C)CC2)[H])=C(O)C=CC3,
ITF3756,,2247608-27-9,O=C(NO)C1=CC=C(C=C1)CN2N=NN=C2C=3SC=CC3,
"(1R,2R)-(-)-1,2-Diaminocyclohexane","(1R,2R)-Cyclohexane-1,2-diamin",20439-47-8,N[C@H]1[C@H](N)CCCC1,
7-FluorotryptaMine HCl,,159730-09-3,Cl.FC1=CC=CC=2C(=CNC12)CCN,
"2',5-Difluoro-2'-deoxy-1-arabinosyluracil",2'-Deoxy-2'-fluoro-5-fluoro-arabinouridine,69123-95-1,F[C@@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(=O)NC(=O)C(F)=C2,
4-(2-Aminoethyl)amino-7-chloroquinoline,"N1-(7-Chloroquinolin-4-yl)ethane-1,2-diamine",5407-57-8,ClC=1C=CC=2C(=NC=CC2NCCN)C1,
3-Methoxy-9H-Carbazole,,18992-85-3,O(C=1C=CC=2NC=3C=CC=CC3C2C1)C,
"6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile",,1207836-10-9,N#CC=1C=NN2C=C(Br)C=C(OC)C12,
Tubulin polymerization-IN-43,,2773345-90-5,FC=1C=CC=2N=C(N=C(C2C1)N(C3=CC=C(OC)C=C3)C)C(F)(F)F,
"3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one",,545445-44-1,O=C1C(=CCCN1C2=CC=C(C=C2)N3C(=O)CCCC3)N4CCOCC4,
Berberine chloride hydrate,Natural Yellow 18 chloride hydrate,68030-18-2,[Cl-].O.O(C=1C=CC2=CC=3C4=CC=5OCOC5C=C4CC[N+]3C=C2C1OC)C,
AKT Kinase Inhibitor,,842148-40-7,OCC#CC=1N=CC(OCCCN)=C2C1N=C(C3=NON=C3N)N2CC,
ZK-90055 hydrochloride,ZK90055 hydrochloride; ZK 90055 hydrochloride,84638-81-3,Cl.O=C(OC)C1=CC=2C(N1)=C(O)C=CC2C(O)CNC(C)(C)C,
SYM2206,SYM 2206; SYM-2206,173952-44-8,O=C(NCCC)N1N=C(C=2C=CC(N)=CC2)C=3C=C4OCOC4=CC3C1C,
GSK9027,GSK 9027; GSK-9027; GR agonist 23a,1229096-88-1,O=S(=O)(NC=1C=CC(C2=CC=C3C(C=NN3C4=CC=C(F)C=C4)=C2)=C(C1)C(F)(F)F)CC=5C=CC=CC5,
Angstrom6,A-6 peptide; A6 peptide; A 6 peptide,220334-14-5,C(=O)([C@H]1N(C([C@@H](NC([C@@H](NC(=O)[C@H]2N(C([C@H](CCCCN)NC(C)=O)=O)CCC2)CO)=O)CO)=O)CCC1)N3[C@H](C(N[C@H](C(N[C@@H](CCC(O)=O)C(N)=O)=O)CCC(O)=O)=O)CCC3,
T-0509,T 0509; T0509,96843-99-1,C(CNC[C@H](O)C1=CC(O)=C(O)C=C1)C2=CC(OC)=C(OC)C=C2,
L-Uridine,,26287-69-4,O[C@@H]1[C@H](O[C@@H](CO)[C@@H]1O)N2C(=O)NC(=O)C=C2,
PERK-IN-4,,1337531-89-1,O=C(N1C=2C=CC(=CC2CC1)C3=CN(C=4N=CN=C(N)C34)C)CC5=CC(F)=CC(=C5)C(F)(F)F,
Exarafenib,RAF/KIN_2787,2639957-39-2,CC=1C(C=2C=C(N=C(N[C@@H](CO)C)C2)N3CCOCC3)=CC(NC(=O)N4C[C@H](CC(F)(F)F)CC4)=CC1,
Tolamolol,,38103-61-6,O=C(N)C1=CC=C(OCCNCC(O)COC=2C=CC=CC2C)C=C1,
NX-2127,NX2127; NX 2127,2416131-46-7,O=C1C=2C(C(=O)N1C3C(=O)NC(=O)CC3)=CC=C(C2)N4C[C@H](CN5CCC(CC5)C6=CC=C(NC=7C(C(N)=O)=NC=C(N7)N8CCCCC8)C=C6)CC4,
VEGFR-3-IN-1,,2756668-73-0,O=C(NC1=CC=C(Cl)C(=C1)C(F)(F)F)N2CCN(C=3N=CN=C4SC(=CC43)C5=CC=C(C=C5)N6CCN(C)CC6)CC2,
Tubulin polymerization-IN-47,,2834087-62-4,N=1C=CN2C=C(N=C2C1C=3C=C(OC)C(OC)=C(OC)C3)C=4C=CC(=CC4)C,
5-LOX-IN-2,,179691-97-5,C(=C/C(OCCC1=CC=CC=C1)=O)\C2=C(O)C=CC(O)=C2,
Imatinib Mesylate (STI571),,220127-57-1,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,123596.0
Lapatinib (GW-572016) Ditosylate,,388082-77-7,CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,9941095.0
Pazopanib HCl (GW786034 HCl),,635702-64-6,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl,11525740.0
"Temsirolimus (CCI-779, NSC 683864)",,162635-04-3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,6918289.0
Brivanib (BMS-540215),,649735-46-6,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)O)C,11234052.0
Quisinostat (JNJ-26481585) 2HCl,,875320-31-3,CN1C=C(C2=CC=CC=C21)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO.Cl.Cl,122129987.0
"Roscovitine (Seliciclib,CYC202)",,186692-46-6 ,CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3,160355.0
Bleomycin sulfate,,9041-93-4,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.OS(=O)(=O)[O-],72466.0
Flavopiridol (Alvocidib),,146426-40-6,CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,5287969.0
Ondansetron HCl,,99614-01-4,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl,68647.0
Ziprasidone HCl,,122883-93-6,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.Cl,219099.0
Tipifarnib ,,192185-72-1,CN1C=NC=C1C(C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N,159324.0
Zibotentan (ZD4054),,186497-07-4,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,9910224.0
Daclatasvir (BMS-790052),,1009119-64-5,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,25154714.0
HMN-214,,173529-46-9 ,CC(=O)N(C1=CC=CC=C1C=CC2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC,9888590.0
Pralatrexate ,,146464-95-1,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,148121.0
Cyclosporine ,,79217-60-0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,6435893.0
R406 (free base),,841290-80-0,CC1(C(=O)NC2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)C,11213558.0
Saxagliptin,,361442-04-8,C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N,11243969.0
Naproxen Sodium,,26159-34-2,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+],23681059.0
Allopurinol Sodium ,,17795-21-0,C1=NNC2=C1C(=NC=N2)[O-].[Na+],23662349.0
Betamethasone Valerate,,2152-44-5 ,CCCCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CO,16533.0
Emtricitabine ,,143491-57-0 ,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,60877.0
Gemcitabine ,,95058-81-4 ,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,60750.0
Glyburide (Glibenclamide),,10238-21-8 ,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,3488.0
Fomepizole ,,7554-65-6 ,CC1=CNN=C1,3406.0
Terbinafine ,,91161-71-6 ,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,1549008.0
NEXIUM (esomeprazole magnesium),,161973-10-0 ,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Mg+2],130564.0
Octocrylene,,6197-30-4 ,CCCCC(CC)COC(=O)C(=C(C1=CC=CC=C1)C2=CC=CC=C2)C#N,22571.0
Tetrabenazine (Xenazine),,58-46-8 ,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,6018.0
Proparacaine HCl,,5875-06-9,CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N.Cl,517321.0
Diltiazem HCl ,,33286-22-5 ,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl,62920.0
Diphenhydramine HCl ,,147-24-0 ,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl,8980.0
Valaciclovir HCl,,124832-27-5 ,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N.Cl,135398741.0
Potassium Iodide,,7681-11-0,[K+].[I-],4875.0
Tropisetron HCl,,105826-92-4 ,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43.Cl,656664.0
Nystatin (Fungicidin),,62997-67-5,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1OC3CC(C(C(O3)C)O)O)C)C)O)O)O)O)O)O)O)C(=O)O)OC4C(C(C(C(O4)C)O)N)O,11953998.0
Rimantadine ,,13392-28-4,CC(C12CC3CC(C1)CC(C3)C2)N,5071.0
Adenine HCl,,2922-28-3 ,C1=NC2=NC=NC(=C2N1)N.Cl,76219.0
Capsaicin(Vanilloid),,404-86-4,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,1548943.0
Pramipexole 2HCl Monohydrate ,,191217-81-9,CCCNC1CCC2=C(C1)SC(=N2)N.O.Cl.Cl,166589.0
ENMD-2076 L-(+)-Tartaric acid ,,1291074-87-7,CC1=CC(=NN1)NC2=CC(=NC(=N2)C=CC3=CC=CC=C3)N4CCN(CC4)C.C(C(C(=O)O)O)(C(=O)O)O,66576993.0
Cyproheptadine HCl ,,969-33-5,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1.Cl,13770.0
Orphenadrine Citrate ,,4682-36-4,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,83823.0
Terazosin HCl Dihydrate,,70024-40-7,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.O.O.Cl,63016.0
Tiopronin ,,1953-02-2,CC(C(=O)NCC(=O)O)S,5483.0
Rosiglitazone HCl,,302543-62-0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.Cl,9865387.0
Moexipril HCl,,82586-52-5,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC.Cl,54889.0
Procaterol HCl,,62929-91-3,CCC(C(C1=C2C=CC(=O)NC2=C(C=C1)O)O)NC(C)C.Cl,43091.0
Duloxetine HCl,,136434-34-9 ,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl,60834.0
Detomidine HCl,,90038-01-0,CC1=C(C(=CC=C1)CC2=CN=CN2)C.Cl,56031.0
Pantoprazole ,,102625-70-7,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,4679.0
S- (+)-Rolipram,,85416-73-5,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,158758.0
Bazedoxifene HCl,,198480-56-7,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O.Cl,9936012.0
Rosuvastatin Calcium,, 147098-20-2,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Ca+2],5282455.0
DL-Carnitine HCl,,461-05-2,C[N+](C)(C)CC(CC(=O)O)O.[Cl-],5970.0
Morin Hydrate,,6202-27-3,C1=CC(=C(C=C1O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O.O,16219651.0
Neohesperidin Dihydrochalcone (Nhdc),,20702-77-6 ,CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C(C(=C3)O)C(=O)CCC4=CC(=C(C=C4)OC)O)O)CO)O)O)O)O)O,30231.0
Rotenone (Barbasco),,83-79-4 ,CC(=C)C1CC2=C(O1)C=CC3=C2OC4COC5=CC(=C(C=C5C4C3=O)OC)OC,6758.0
Yohimbine HCl,,65-19-0 ,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O.Cl,6169.0
Sorbitol,,50-70-4 ,C(C(C(C(C(CO)O)O)O)O)O,5780.0
Quinine HCl Dihydrate,,6119-47-7 ,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.O.O.Cl,16211283.0
Scopolamine HBr,,114-49-8,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4.Br,6603108.0
Xylazine HCl,,23076-35-9,CC1=C(C(=CC=C1)C)NC2=NCCCS2.Cl,68554.0
Tiotropium Bromide hydrate,,139404-48-1,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.O.[Br-],11431811.0
Sulbactam sodium ,,69388-84-7,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)[O-])C.[Na+],23663973.0
5-Aminolevulinic acid HCl,,5451-09-2,C(CC(=O)O)C(=O)CN.Cl,123608.0
Amoxicillin Sodium,,34642-77-8,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)[O-])C.[Na+],23663126.0
Clindamycin palmitate HCl,,25507-04-4 ,CCCCCCCCCCCCCCCC(=O)OC1C(C(C(OC1SC)C(C(C)Cl)NC(=O)C2CC(CN2C)CCC)O)O.Cl,16052038.0
PF-04929113 (SNX-5422),,908115-27-5,CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)OC(=O)CN)C(F)(F)F)C,44195571.0
Resminostat,,864814-88-0,CN(C)CC1=CC=C(C=C1)S(=O)(=O)N2C=CC(=C2)C=CC(=O)NO,11609955.0
GSK1070916,,942918-07-2,CCN1C=C(C(=N1)C2=CC=C(C=C2)NC(=O)N(C)C)C3=C4C=C(NC4=NC=C3)C5=CC=CC(=C5)CN(C)C,46885626.0
Milciclib (PHA-848125),,802539-81-7,CC1(CC2=CN=C(N=C2C3=C1C(=NN3C)C(=O)NC)NC4=CC=C(C=C4)N5CCN(CC5)C)C,16718576.0
CUDC-907,,1339928-25-4,CN(CC1=CC2=C(S1)C(=NC(=N2)C3=CN=C(C=C3)OC)N4CCOCC4)C5=NC=C(C=N5)C(=O)NO,54575456.0
MK-2048,,869901-69-9,CCN1CC(N2C3=C(C(=C2C1=O)O)C(=O)N(N=C3C(=O)NC)CC4=CC(=C(C=C4)F)Cl)C,54698642.0
MPEP,,96206-92-7,CC1=NC(=CC=C1)C#CC2=CC=CC=C2,3025961.0
AT101,,866541-93-7,CC1=CC2=C(C(=C(C(=C2C(C)C)O)O)C=O)C(=C1C3=C(C4=C(C=C3C)C(=C(C(=C4C=O)O)O)C(C)C)O)O.CC(=O)O,227456.0
OC000459,,"851723-84-7, 950688-14-9 (sodium salt)",CC1=C(C2=C(N1CC(=O)O)C=CC(=C2)F)CC3=NC4=CC=CC=C4C=C3,11462174.0
GW5074,,220904-83-6,C1=CC2=C(C=C1I)C(=CC3=CC(=C(C(=C3)Br)O)Br)C(=O)N2,5924208.0
Acesulfame Potassium,,55589-62-3,CC1=CC(=O)[N-]S(=O)(=O)O1.[K+],11074431.0
S-Ruxolitinib (INCB018424),,941685-37-6,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,50878566.0
Fenoprofen calcium hydrate,,71720-56-4,CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].O.O.[Ca+2],64747.0
Fosaprepitant dimeglumine salt,,265121-04-8,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NN(C(=O)N3)P(=O)(O)O)C4=CC=C(C=C4)F.CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O,135564864.0
Bosentan Hydrate,,157212-55-0,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC.O,185462.0
Medetomidine HCl,,86347-15-1,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.Cl,68601.0
Epinephrine HCl,,55-31-2,CNCC(C1=CC(=C(C=C1)O)O)O.Cl,441411.0
Chlorhexidine?2HCl,,3697-42-5,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl.Cl.Cl,9571016.0
Fexofenadine HCl,,153439-40-8,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl,63002.0
(+)-Fangchinoline,,436-77-1,CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)O)OC)OC,73481.0
Ceftibuten dihydrate,,118081-34-8,C1C=C(N2C(S1)C(C2=O)NC(=O)C(=CCC(=O)O)C3=CSC(=N3)N)C(=O)O.O.O,5282241.0
Kitasamycin,,1392-21-8,CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)O,5282189.0
Mafenide Acetate,,13009-99-9,CC(=O)O.C1=CC(=CC=C1CN)S(=O)(=O)N,25590.0
Promestriene,,39219-28-8,CCCOC1=CC2=C(C=C1)C3CCC4(C(C3CC2)CCC4OC)C,9883915.0
Ilaprazole,,172152-36-2,CC1=C(C=CN=C1CS(=O)C2=NC3=C(N2)C=C(C=C3)N4C=CC=C4)OC,214351.0
Ethidium bromide,,1239-45-8,CC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N)N.[Br-],14710.0
N-Ethylmaleimide (NEM),,128-53-0,CCN1C(=O)C=CC1=O,4362.0
4-Methylbenzylidene camphor,,36861-47-9,CC1=CC=C(C=C1)C=C2C3CCC(C2=O)(C3(C)C)C,6440721.0
Ethopabate,,59-06-3,CCOC1=C(C=CC(=C1)NC(=O)C)C(=O)OC,6034.0
Carbasalate Calcium,,5749-67-7,CC(=O)OC1=CC=CC=C1C(=O)[O-].CC(=O)OC1=CC=CC=C1C(=O)[O-].C(=O)(N)N.[Ca+2],21975.0
Testosterone Enanthate,,315-37-7,CCCCCCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,9416.0
Leuprolide Acetate,,74381-53-6,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O,657180.0
Vilanterol Trifenate,,503070-58-4,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl,44482554.0
Travoprost,,157283-68-6,CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O,5282226.0
Levothyroxine sodium,,55-03-8,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+],23666112.0
Sodium benzoate,,532-32-1,C1=CC=C(C=C1)C(=O)[O-].[Na+],517055.0
Quinidine sulfate,,6591-63-5,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.O.O.OS(=O)(=O)O,656862.0
Eucalyptol,,470-82-6,CC1(C2CCC(O1)(CC2)C)C,2758.0
Hederacoside C,,14216-03-6,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(CC4C6=CCC7C8(CCC(C(C8CCC7(C6(CC5)C)C)(C)CO)OC9C(C(C(CO9)O)O)OC1C(C(C(C(O1)C)O)O)O)C)(C)C)O)O)O)CO)O)O)O,11491905.0
Mesterolone,,1424-00-6,CC1CC(=O)CC2C1(C3CCC4(C(C3CC2)CCC4O)C)C,15020.0
Gamma-Oryzanol,,11042-64-1,CC(CCC=C(C)C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)OC(=O)C=CC6=CC(=C(C=C6)O)OC)C)C,5282164.0
Vanillyl Butyl Ether,,82654-98-6 ,CCCCOCC1=CC(=C(C=C1)O)OC,5084146.0
(-)-Borneol,,464-45-9,CC1(C2CCC1(C(C2)O)C)C,1201518.0
Oxaceprol,,33996-33-7,CC(=O)N1CC(CC1C(=O)O)O,65784.0
(+)-Î±-Lipoic acid,,1200-22-2,C1CSSC1CCCCC(=O)O,6112.0
Sitagliptin phosphate monohydrate,,654671-77-9,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.O.OP(=O)(O)O,11591741.0
Ouabain,,630-60-4,CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O,439501.0
Doxapram HCl,,7081-53-0,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4.O.Cl,64648.0
Methyclothiazide,,135-07-9 ,CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl,4121.0
Ropivacaine HCl,, 132112-35-7,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.O.Cl,6918111.0
Sodium Nitroprusside Dihydrate,,13755-38-9,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.O.O.[Na+].[Na+].[Fe+4],11953895.0
Erythromycin Ethylsuccinate,,1264-62-6,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O,443953.0
Sodium Nitrite,,7632-00-0,N(=O)[O-].[Na+],23668193.0
Levobetaxolol HCl,,116209-55-3,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl,60656.0
Fenspiride HCl,,5053-08-7,C1CN(CCC12CNC(=O)O2)CCC3=CC=CC=C3.Cl,68626.0
Difluprednate,,23674-86-4,CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)COC(=O)C,443936.0
Closantel Sodium,,61438-64-0,CC1=CC(=C(C=C1NC(=O)C2=C(C(=CC(=C2)I)I)[O-])Cl)C(C#N)C3=CC=C(C=C3)Cl.[Na+],23683671.0
Estradiol Benzoate,,50-50-0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)OC(=O)C5=CC=CC=C5,222757.0
Dicloxacillin Sodium,,343-55-5,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+],23667628.0
Desvenlafaxine Succinate,,386750-22-7,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O.C(CC(=O)O)C(=O)O.O,6918664.0
Pefloxacin Mesylate Dihydrate,,149676-40-4,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O.CS(=O)(=O)O.O.O,6917670.0
Tilmicosin,,108050-54-0,CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)O)N(C)C)O)CCN3CC(CC(C3)C)C)C)C)COC4C(C(C(C(O4)C)O)OC)OC,5282521.0
Cetylpyridinium Chloride,,123-03-5,CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1.[Cl-],31239.0
Mezlocillin Sodium,,42057-22-7,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)[O-])C.[Na+],23685177.0
Isosorbide,,652-67-5 ,C1C(C2C(O1)C(CO2)O)O,12597.0
Chlorocresol,,59-50-7,CC1=C(C=CC(=C1)O)Cl,1732.0
Montelukast Sodium,,151767-02-1,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)[O-])O.[Na+],23663996.0
Valnemulin HCl,,133868-46-9,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC(C)(C)CNC(=O)C(C(C)C)N)C.Cl,60195218.0
Mexiletine HCl,,5370-01-4,CC1=C(C(=CC=C1)C)OCC(C)N.Cl,21467.0
Epinastine HCl,,108929-04-0,C1C2C3=CC=CC=C3CC4=CC=CC=C4N2C(=N1)N.Cl,157313.0
Chloroprocaine HCl,,3858-89-7,CCN(CC)CCOC(=O)C1=C(C=C(C=C1)N)Cl.Cl,441348.0
Promethazine HCl,,58-33-3 ,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl,6014.0
Disopyramide Phosphate ,,22059-60-5,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C.OP(=O)(O)O,30928.0
Ractopamine HCl,,90274-24-1,CC(CCC1=CC=C(C=C1)O)NCC(C2=CC=C(C=C2)O)O.Cl,14010333.0
Bentiromide ,,37106-97-1,C1=CC=C(C=C1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC3=CC=C(C=C3)C(=O)O,6957673.0
Brucine sulfate salt hydrate,,652154-10-4,COC1=C(C=C2C(=C1)C34CCN5C3CC6C7C4N2C(=O)CC7OCC=C6C5)OC.COC1=C(C=C2C(=C1)C34CCN5C3CC6C7C4N2C(=O)CC7OCC=C6C5)OC.O.OS(=O)(=O)O,16211422.0
6-Mercaptopurine (6-MP) Monohydrate,,6112-76-1,C1=NC2=C(N1)C(=S)N=CN2.O,2724350.0
Ademetionine disulfate tosylate,,97540-22-2,CC1=CC=C(C=C1)S(=O)(=O)O.C[S+](CCC(C(=O)[O-])N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O.OS(=O)(=O)O.OS(=O)(=O)O,45072193.0
2-Aminoheptane,,123-82-0,CCCCCC(C)N,5603.0
Trihexyphenidyl hydrochloride,,52-49-3,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O.Cl,66007.0
Bronopol,,52-51-7,C(C(CO)([N+](=O)[O-])Br)O,2450.0
Carzenide,,138-41-0,C1=CC(=CC=C1C(=O)O)S(=O)(=O)N,8739.0
Diatrizoic acid,,117-96-4,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I,2140.0
Terpin hydrate,,2451-01-6,CC1(CCC(CC1)C(C)(C)O)O.O,17141.0
Methylbenactyzine Bromide,,3166-62-9,CC[N+](C)(CC)CCOC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O.[Br-],18493.0
Sodium sulfadiazine,,547-32-0,C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Na+],15899898.0
Teneligliptin hydrobromide,,906093-29-6,CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5.CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5.Br.Br.Br.Br.Br,11996485.0
Desogestrel,,54024-22-5,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34,40973.0
Tedizolid Phosphate,,856867-55-5,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)COP(=O)(O)O)F,11476460.0
Sulisobenzone,,4065-45-6,COC1=C(C=C(C(=C1)O)C(=O)C2=CC=CC=C2)S(=O)(=O)O,19988.0
Sivelestat sodium tetrahydrate,,201677-61-4,CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)[O-].O.O.O.O.[Na+],23663985.0
Benzocaine hydrochloride,,23239-88-5,CCOC(=O)C1=CC=C(C=C1)N.Cl,10214462.0
Sildenafil Mesylate,,1308285-21-3,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C.CS(=O)(=O)O,135425271.0
Escin,,6805-41-0,CC=C(C)C(=O)OC1C(C2(C(CC1(C)C)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)CO)OC6C(C(C(C(O6)C(=O)O)OC7C(C(C(C(O7)CO)O)O)O)O)OC8C(C(C(C(O8)CO)O)O)O)C)CO)OC(=O)C,16211024.0
Acetylcholine iodide,,2260-50-6,CC(=O)OCC[N+](C)(C)C.[I-],75271.0
Benzenesulfonamide,,98-10-2,C1=CC=C(C=C1)S(=O)(=O)N,7370.0
Retigabine,,150812-12-7,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,121892.0
Retigabine 2HCl,,150812-13-8,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N.Cl.Cl,6918229.0
Cisapride hydrate,,260779-88-2,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F.O,13677778.0
p-Coumaric Acid,,501-98-4,C1=CC(=CC=C1C=CC(=O)O)O,637542.0
Harmaline,,304-21-2,CC1=NCCC2=C1NC3=C2C=CC(=C3)OC,3564.0
Drostanolone Propionate,,521-12-0,CCC(=O)OC1CCC2C1(CCC3C2CCC4C3(CC(C(=O)C4)C)C)C,224004.0
Daminozide,,1596-84-5,CN(C)NC(=O)CCC(=O)O,15331.0
L-Cysteine HCl,,52-89-1,C(C(C(=O)O)N)S.Cl,60960.0
Diatrizoate sodium,,737-31-5,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+],23672589.0
Saccharin,,81-07-2,C1=CC=C2C(=C1)C(=O)NS2(=O)=O,5143.0
Potassium acetate,,127-08-2,CC(=O)[O-].[K+],517044.0
Meropenem Trihydrate,,119478-56-7,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O.O.O.O,441129.0
Faropenem Sodium,,122547-49-3,CC(C1C2N(C1=O)C(=C(S2)C3CCCO3)C(=O)[O-])O.[Na+],23663972.0
Dalbavancin,,171500-79-1,CC(C)CCCCCCCCC(=O)NC1C(C(C(OC1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)C(C6C(=O)NC(C7=C(C(=CC(=C7)O)OC8C(C(C(C(O8)CO)O)O)O)C9=C(C=CC(=C9)C(C(=O)N6)NC(=O)C4NC(=O)C1C2=C(C(=CC(=C2)OC2=C(C=CC(=C2)C(C(=O)NC(CC2=CC=C(O3)C=C2)C(=O)N1)NC)O)O)Cl)O)C(=O)NCCCN(C)C)O)Cl)C(=O)O)O)O,16134627.0
Levocetirizine Dihydrochloride,,130018-87-0,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl,9955977.0
Gadopentetate Dimeglumine,,86050-77-3,CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O.C(CN(CC(=O)O)CC(=O)[O-])N(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-].[Gd+3],55466.0
Bedaquiline fumarate,,845533-86-0,CN(C)CCC(C1=CC=CC2=CC=CC=C21)(C(C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O.C(=CC(=O)O)C(=O)O,24812732.0
Iproniazid,,54-92-2,CC(C)NNC(=O)C1=CC=NC=C1,3748.0
Cefetamet pivoxil hydrochloride,,111696-23-2,CC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)OCOC(=O)C(C)(C)C.Cl,5489410.0
Xanthinol Nicotinate,,437-74-1,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CN(C)CCO)O.C1=CC(=CN=C1)C(=O)O,9912.0
Sulfamethoxazole sodium,,4563-84-2,CC1=CC(=NO1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Na+],15899900.0
Cefodizime Sodium,,86329-79-5,CC1=C(SC(=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-])CC(=O)[O-].[Na+].[Na+],9852176.0
Pyridoxal 5-phosphate monohydrate,, 41468-25-1,CC1=NC=C(C(=C1O)C=O)COP(=O)(O)O.O,38882.0
Cefazedone,,56187-47-4,CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=C(C(=O)C(=C4)Cl)Cl)SC2)C(=O)O,71736.0
Cephapirin Benzathine,,97468-37-6,CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)O.CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)O.C1=CC=C(C=C1)CNCCNCC2=CC=CC=C2,167441.0
Robenidine Hydrochoride,,25875-50-7,C1=CC(=CC=C1C=NNC(=NN=CC2=CC=C(C=C2)Cl)N)Cl.Cl,16212175.0
Cefathiamidine,,33075-00-2,CC(C)NC(=NC(C)C)SCC(=O)NC1C2N(C1=O)C(=C(CS2)COC(=O)C)C(=O)O,15942748.0
Calcium Dobesilate,,20123-80-2,C1=CC(=C(C=C1O)S(=O)(=O)[O-])O.C1=CC(=C(C=C1O)S(=O)(=O)[O-])O.[Ca+2],29963.0
Menbutone,,3562-99-0,COC1=CC=C(C2=CC=CC=C21)C(=O)CCC(=O)O,71818.0
Elagolix Sodium,,832720-36-2,CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)[O-])C4=C(C(=CC=C4)OC)F.[Na+],24785956.0
Lithium carbonate,,554-13-2,[Li+].[Li+].C(=O)([O-])[O-],11125.0
cis-Aconitic acid,,585-84-2,C(C(=CC(=O)O)C(=O)O)C(=O)O,643757.0
Lactobionic acid,,96-82-2,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(C(=O)O)O)O)O)O)O)O,7314.0
Buparvaquone,,88426-33-9,CC(C)(C)C1CCC(CC1)CC2=C(C3=CC=CC=C3C(=O)C2=O)O,71768.0
Iminostilbene,,256-96-2,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2,9212.0
Sorbic acid,,110-44-1,CC=CC=CC(=O)O,643460.0
Tiamulin fumarate,,55297-96-6,CCN(CC)CCSCC(=O)OC1CC(C(C(C23CCC(C1(C2C(=O)CC3)C)C)C)O)(C)C=C.C(=CC(=O)O)C(=O)O,23725049.0
Indometacin Sodium,,1330-43-4  ,B1(OB2OB(OB(O1)O2)[O-])[O-].[Na+].[Na+],10219853.0
Disodium Phosphate,,7558-79-4,OP(=O)([O-])[O-].[Na+].[Na+],24203.0
Oxyclozanide,,2277-92-1,C1=C(C=C(C(=C1NC(=O)C2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl)Cl,16779.0
Phenazine methosulfate,,299-11-6,C[N+]1=C2C=CC=CC2=NC3=CC=CC=C31.COS(=O)(=O)[O-],9285.0
Tiamulin,,55297-95-5,CCN(CC)CCSCC(=O)OC1CC(C(C(C23CCC(C1(C2C(=O)CC3)C)C)C)O)(C)C=C,656958.0
Difloxacin hydrochloride,,91296-86-5,CN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F.Cl,56205.0
Mupirocin calcium,,115074-43-6,CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)[O-])C)C(C)O.CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)[O-])C)C(C)O.O.O.[Ca+2],5282317.0
Duloxetine,,116539-59-4,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,60835.0
Argatroban Monohydrate,,141396-28-3,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C.O,92721.0
Acotiamide,,185106-16-5,CC(C)N(CCNC(=O)C1=CSC(=N1)NC(=O)C2=CC(=C(C=C2O)OC)OC)C(C)C,5282338.0
Xipamide,,14293-44-8,CC1=C(C(=CC=C1)C)NC(=O)C2=CC(=C(C=C2O)Cl)S(=O)(=O)N,26618.0
Regorafenib Monohydrate,,1019206-88-2,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F.O,24768591.0
Vitamin K2,,863-61-6,CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,5282367.0
Azamethiphos,,35575-96-3,COP(=O)(OC)SCN1C2=C(C=C(C=N2)Cl)OC1=O,71482.0
p-Anisaldehyde,,123-11-5,COC1=CC=C(C=C1)C=O,31244.0
Tianeptine,,72797-41-2,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O,68870.0
Febantel,,58306-30-2,COCC(=O)NC1=C(C=CC(=C1)SC2=CC=CC=C2)N=C(NC(=O)OC)NC(=O)OC,135449328.0
SulfadiMethoxine sodium,,1037-50-9,COC1=NC(=NC(=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N)OC.[Na+],13384041.0
Gefitinib hydrochloride,,184475-55-6,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4.Cl,19077490.0
Pralidoxime Iodide,,94-63-3,C[N+]1=CC=CC=C1C=NO.[I-],135410029.0
Lanolin,,8006-54-0,CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC,75778.0
Ademetionine,,29908-03-0,C[S+](CCC(C(=O)[O-])N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O,34755.0
D(-)-Arabinose,,28697-53-2,C1C(C(C(C(O1)O)O)O)O,6902.0
Benzyl cinnamate,,103-41-3,C1=CC=C(C=C1)COC(=O)C=CC2=CC=CC=C2,5273469.0
Ropivacaine Mesilate,,854056-07-8,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.CS(=O)(=O)O,24784155.0
Sulbutiamine,, 3286-46-2,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCOC(=O)C(C)C)SSC(=C(C)N(CC2=CN=C(N=C2N)C)C=O)CCOC(=O)C(C)C)C,20055424.0
Nilotinib hydrochloride,,923288-95-3,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.Cl,16006490.0
Ciprofloxacin hydrochloride hydrate,,86393-32-0,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.O.Cl,62998.0
Piroctone Olamine,,68890-66-4,CC1=CC(=O)N(C(=C1)CC(C)CC(C)(C)C)O.C(CO)N,50258.0
Imidocarb dipropionate,,55750-06-6,CCC(=O)O.CCC(=O)O.C1CN=C(N1)C2=CC(=CC=C2)NC(=O)NC3=CC=CC(=C3)C4=NCCN4,9983292.0
Phenylpiracetam,,77472-70-9,C1C(CN(C1=O)CC(=O)N)C2=CC=CC=C2,132441.0
Adrafinil,,63547-13-7,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)NO,3033226.0
Boldenone,,846-48-0,CC12CCC3C(C1CCC2O)CCC4=CC(=O)C=CC34C,13308.0
Erythromycin thiocyanate,,7704-67-8,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O.C(#N)S,83938.0
Solifenacin,,242478-37-1,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,154059.0
Paroxetine mesylate,,217797-14-3,CS(=O)(=O)O.C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,9845306.0
lenvatinib Mesylate,,857890-39-2,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl.CS(=O)(=O)O,11237762.0
Cediranib Maleate,,857036-77-2,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5.C(=CC(=O)O)C(=O)O,11226834.0
Doxapram,,309-29-5,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4,3156.0
Revefenacin,,864750-70-9,CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N,11753673.0
Tedizolid,, 856866-72-3,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)CO)F,11234049.0
Diazolidinyl urea,,78491-02-8,C(NC(=O)N(CO)C1C(=O)N(C(=O)N1CO)CO)O,62277.0
Vidarabine monohydrate,,24356-66-9,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N.O,32326.0
Amoxicillin trihydrate,, 61336-70-7,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.O.O.O,62883.0
Tosufloxacin p-Toluenesulfonate Hydrate,,1400591-39-0,CC1=CC=C(C=C1)S(=O)(=O)O.C1CN(CC1N)C2=C(C=C3C(=O)C(=CN(C3=N2)C4=C(C=C(C=C4)F)F)C(=O)O)F.O,5282468.0
Octinoxate,,5466-77-3,CCCCC(CC)COC(=O)C=CC1=CC=C(C=C1)OC,5355130.0
Sodium gualenate,,6223-35-4,CC1=C2C(=CC(=C2C=C(C=C1)C(C)C)C)S(=O)(=O)[O-].[Na+],23669592.0
Ceftezole sodium,,41136-22-5,C1C(=C(N2C(S1)C(C2=O)NC(=O)CN3C=NN=N3)C(=O)[O-])CSC4=NN=CS4.[Na+],23688977.0
Cefpiramide sodium,,74849-93-7,CC1=CC(=O)C(=CN1)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)[O-].[Na+],23663969.0
Ceftiofur,,80370-57-6,CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)CSC(=O)C4=CC=CO4)C(=O)O,6328657.0
Butoconazole,,64872-76-0,C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl,47472.0
Alogliptin,,850649-61-5,CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N,11450633.0
Ethyl Oleate,,111-62-6,CCCCCCCCC=CCCCCCCCC(=O)OCC,5363269.0
Lactitol,,585-86-4,C(C1C(C(C(C(O1)OC(C(CO)O)C(C(CO)O)O)O)O)O)O,157355.0
Dibutyl phthalate,,84-74-2,CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC,3026.0
Formate,,64-18-6,C(=O)O,284.0
Betrixaban,,330942-05-7,CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl,10275777.0
Betrixaban maleate,,936539-80-9,CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl.C(=CC(=O)O)C(=O)O,16069304.0
Ombitasvir (ABT-267),,1258226-87-7,CC(C)C(C(=O)N1CCCC1C(=O)NC2=CC=C(C=C2)C3CCC(N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,54767916.0
Paritaprevir (ABT-450),,1216941-48-8,CC1=CN=C(C=N1)C(=O)NC2CCCCCC=CC3CC3(NC(=O)C4CC(CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8,45110509.0
Isoprene,,78-79-5,CC(=C)C=C,6557.0
Chloramphenicol sodium succinate,,982-57-0,C1=CC(=CC=C1C(C(COC(=O)CCC(=O)[O-])NC(=O)C(Cl)Cl)O)[N+](=O)[O-].[Na+],656833.0
Sultamicillin,,76497-13-7,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)OCOC(=O)C4C(S(=O)(=O)C5N4C(=O)C5)(C)C)C,444022.0
Diflucortolone valerate,,59198-70-8,CCCCC(=O)OCC(=O)C1C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C,91670.0
Enoxaparin sodium,,679809-58-6,CC1C(C(OC(C1OC2CC(C(C(C2O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C=C(O4)C(=O)[O-])O)O)O)NC(=O)C)C(=O)[O-])CO)OC5C(C(C(OC5C(=O)[O-])OC6C7COC(O7)C(C6O)NS(=O)(=O)[O-])O)O)NC(=O)C.[Na+].[Na+].[Na+].[Na+],72679307.0
Parecoxib Sodium,,198470-85-8,CCC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C.[Na+],15895902.0
Clindamycin alcoholate,,58207-19-5,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl.O.Cl,53302336.0
Carbaryl,,63-25-2,CNC(=O)OC1=CC=CC2=CC=CC=C21,6129.0
Metoprolol,,51384-51-1,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,4171.0
Quinacrine Dihydrochloride Dihydrate,,6151-30-0,CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC.O.O.Cl.Cl,2725002.0
Gefarnate,,51-77-4,CC(=CCCC(=CCCC(=CCCC(=O)OCC=C(C)CCC=C(C)C)C)C)C,5282182.0
Cefoperazone sodium,,62893-20-3,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)[O-].[Na+],23663974.0
4-Aminophenol,,123-30-8,C1=CC(=CC=C1N)O,403.0
Penicillin G Procaine,,6130-64-9,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C.O,22502.0
Acetophenone,,98-86-2,CC(=O)C1=CC=CC=C1,7410.0
Doripenem,,148016-81-3,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,73303.0
Erythromycin estolate,,3521-62-8 ,CCCCCCCCCCCCOS(=O)(=O)O.CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CC)(C)O)C)C)O)(C)O,441371.0
"1, 10-Phenanthroline monohydrate",,5144-89-8,C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1.O,21226.0
Sulfacetamide,, 144-80-9,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N,5320.0
Hydroxylammonium chloride,,5470-11-1,NO.Cl,443297.0
(-)-Sparteine Sulfate,,6160-12-9,C1CCN2CC3CC(C2C1)CN4C3CCCC4.O.O.O.O.O.OS(=O)(=O)O,20055553.0
Tocofersolan,,9002-96-4,CC1=C(C(=C(C2=C1OC(CC2)(C)CCCC(C)CCCC(C)CCCC(C)C)C)OC(=O)CCC(=O)OCCOCCOCCO)C,66524795.0
Anisole,,100-66-3,COC1=CC=CC=C1,7519.0
Tilmicosin phosphate,,137330-13-3,CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)O)N(C)C)O)CCN3CC(CC(C3)C)C)C)C)COC4C(C(C(C(O4)C)O)OC)OC.OP(=O)(O)O,5282522.0
Arabic gum,,9000-01-5,CC.CC.CC.CC.CC.CC,91333377.0
Citronellal,,106-23-0,CC(CCC=C(C)C)CC=O,7794.0
Camphene,,79-92-5,CC1(C2CCC(C2)C1=C)C,6616.0
Î±-Terpineol,,10482-56-1,CC1=CCC(CC1)C(C)(C)O,443162.0
(1S)-(-)-Î±-Pinene,,7785-26-4,CC1=CCC2CC1C2(C)C,440968.0
(1R)-(-)-Menthyl acetate,,2623-23-6,CC1CCC(C(C1)OC(=O)C)C(C)C,220674.0
p-Cymene,,99-87-6,CC1=CC=C(C=C1)C(C)C,7463.0
Sodium cholate,,361-09-1,CC(CCC(=O)[O-])C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C.[Na+],23668194.0
Diphenylamine Hydrochloride,,537-67-7,C1=CC=C(C=C1)NC2=CC=CC=C2.Cl,68311.0
(+)-Longifolene,,475-20-7,CC1(CCCC2(C3C1C(C2=C)CC3)C)C,1796220.0
Ammonium lactate,,515-98-0,CC(C(=O)[O-])O.[NH4+],62358.0
Benzalkonium chloride,,63449-41-2,CCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1.[Cl-],13762.0
Indigo carmine,,860-22-0,C1=CC2=C(C=C1S(=O)(=O)[O-])C(=C(N2)C3=NC4=C(C3=O)C=C(C=C4)S(=O)(=O)[O-])O.[Na+].[Na+],2723854.0
Mivacurium chloride,,106861-44-3,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C.[Cl-].[Cl-],5281080.0
Methyl linolenate,,301-00-8,CCC=CCC=CCC=CCCCCCCCC(=O)OC,5319706.0
Isoproterenol sulfate dihydrate,,299-95-6,CC(C)NCC(C1=CC(=C(C=C1)O)O)O.CC(C)NCC(C1=CC(=C(C=C1)O)O)O.OS(=O)(=O)O,8239.0
Tropic acid,,529-64-6,C1=CC=C(C=C1)C(CO)C(=O)O,10726.0
Levomilnacipran Hydrochloride,,175131-60-9,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2.Cl,6917778.0
Alvimopan dihydrate,,170098-38-1,CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O.O.O,5488547.0
lurasidone,,367514-87-2,C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O,213046.0
Ceftizoxime sodium,,68401-82-1,CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=CCS3)C(=O)[O-].[Na+],23663938.0
Triiodothyronine,, 6893-02-3,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,5920.0
Benzathine penicilline,,1538-09-6 ,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C.C1=CC=C(C=C1)CNCCNCC2=CC=CC=C2,15232.0
Nebivolol,,118457-14-0,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O,9844194.0
Palonosetron,,135729-61-2 ,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,6337614.0
Chlorpromazine,,50-53-3,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,2726.0
Dihydroergotamine Mesylate ,,6190-39-2,CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O,71171.0
Alfuzosin,,81403-80-7,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,2092.0
Aliskiren,,173334-57-1,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,5493444.0
Fenoterol,,13392-18-2 ,CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O,3343.0
sulforaphane,,4478-93-7,CS(=O)CCCCN=C=S,5350.0
Esmolol,,81147-92-4,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,59768.0
Trimetazidine,,5011-34-7,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC,21109.0
Raloxifene,,84449-90-1,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,5035.0
Linoleic acid,,60-33-3,CCCCCC=CCC=CCCCCCCCC(=O)O,5280450.0
Cinitapride Hydrogen Tartrate,,1207859-16-2,CCOC1=CC(=C(C=C1C(=O)NC2CCN(CC2)CC3CCC=CC3)[N+](=O)[O-])N.C(C(C(=O)O)O)(C(=O)O)O,6917844.0
Metronidazole Benzoate,,13182-89-3,CC1=NC=C(N1CCOC(=O)C2=CC=CC=C2)[N+](=O)[O-],83213.0
Trans-Tranilast,,70806-55-2,COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC,5282230.0
Suberohydroxamic acid,,38937-66-5,C(CCCC(=O)NO)CCC(=O)NO,5173.0
Anagliptin,,739366-20-2,CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N,44513473.0
Olanexidine Hydrochloride semihydrate,,218282-71-4,CCCCCCCCN=C(N)NC(=NCC1=CC(=C(C=C1)Cl)Cl)N.CCCCCCCCN=C(N)NC(=NCC1=CC(=C(C=C1)Cl)Cl)N.O.Cl.Cl,636390.0
Proguanil,,500-92-5,CC(C)N=C(N)N=C(N)NC1=CC=C(C=C1)Cl,6178111.0
Imidazole,,288-32-4,C1=CN=CN1,795.0
Bisphenol A,,80-05-7,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,6623.0
Sodium L-lactate,,867-56-1,CC(C(=O)[O-])O.[Na+],23664767.0
Isonicotinic acid,,55-22-1,C1=CN=CC=C1C(=O)O,5922.0
p-Cresol,,106-44-5,CC1=CC=C(C=C1)O,2879.0
p-Benzoquinone,,106-51-4,C1=CC(=O)C=CC1=O,4650.0
2-Naphthol,,135-19-3,C1=CC=C2C=C(C=CC2=C1)O,8663.0
Dibutyl sebacate,,109-43-3,CCCCOC(=O)CCCCCCCCC(=O)OCCCC,7986.0
Saccharin sodium salt hydrate,,82385-42-0,C1=CC=C2C(=C1)C(=O)[N-]S2(=O)=O.O.[Na+],443755.0
Phenylglyoxylic acid,,611-73-4,C1=CC=C(C=C1)C(=O)C(=O)O,11915.0
(S)-(â)-Limonene,,5989-54-8,CC1=CCC(CC1)C(=C)C,439250.0
"2,4-dichlorobenzyl alcohol",,1777-82-8,C1=CC(=C(C=C1Cl)Cl)CO,15684.0
Doxycycline monohydrate,,17086-28-1,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O,54684461.0
2-Methylhexanoic acid,,4536-23-6,CCCCC(C)C(=O)O,20653.0
Terpinen-4-ol,,562-74-3,CC1=CCC(CC1)(C(C)C)O,11230.0
Brucine sulfate heptahydrate,,60583-39-3,COC1=C(C=C2C(=C1)C34CCN5C3CC6C7C4N2C(=O)CC7OCC=C6C5)OC.COC1=C(C=C2C(=C1)C34CCN5C3CC6C7C4N2C(=O)CC7OCC=C6C5)OC.O.O.O.O.O.O.O.OS(=O)(=O)O,16211665.0
p-Toluenesulfonic acid monohydrate,,6192-52-5,CC1=CC=C(C=C1)S(=O)(=O)O.O,521998.0
4-Nitrophenol,,100-02-7,C1=CC(=CC=C1[N+](=O)[O-])O,980.0
o-Cresol,,95-48-7,CC1=CC=CC=C1O,335.0
Butylated hydroxytoluene,,128-37-0,CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C,31404.0
Ethanolamine hydrochloride,,2002-24-6,C(CO)N.Cl,74819.0
Furfural,,98-01-1,C1=COC(=C1)C=O,7362.0
o-Toluic acid,,118-90-1,CC1=CC=CC=C1C(=O)O,8373.0
Sodium lauryl sulfate,,151-21-3,CCCCCCCCCCCCOS(=O)(=O)[O-].[Na+],3423265.0
Triethyl citrate,,77-93-0,CCOC(=O)CC(CC(=O)OCC)(C(=O)OCC)O,6506.0
4-Methyl-2-pentanone,,108-10-1,CC(C)CC(=O)C,7909.0
Pentadecanoic acid,,1002-84-2,CCCCCCCCCCCCCCC(=O)O,13849.0
Sodium dehydroacetate,,4418-26-2,CC1=CC(=C(C(=O)O1)C(=O)C)[O-].[Na+],23681141.0
Pyrrolidine,,123-75-1,C1CCNC1,31268.0
Terephthalic acid,,100-21-0,C1=CC(=CC=C1C(=O)O)C(=O)O,7489.0
"1,2-Propanediol",,57-55-6,CC(CO)O,1030.0
Rutin hydrate,,207671-50-9,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O.O.O.O,16218542.0
(â)-Î²-Pinene,,18172-67-3,CC1(C2CCC(=C)C1C2)C,440967.0
Catechol,,120-80-9,C1=CC=C(C(=C1)O)O,289.0
m-Cresol,,108-39-4,CC1=CC(=CC=C1)O,342.0
Nonadecanoic acid,,646-30-0,CCCCCCCCCCCCCCCCCCC(=O)O,12591.0
L-(+)-Arabinose,,5328-37-0,C(C(C(C(C=O)O)O)O)O,5460291.0
Cilengitide?trifluoroacetate,,199807-35-7,CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N.C(=O)(C(F)(F)F)O,129626550.0
Zotarolimus(ABT-578),,221877-54-9,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)N5C=NN=N5)C)C)O)OC)C)C)C)OC,9876378.0
Marimastat (BB-2516),,154039-60-8,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,119031.0
Glasdegib (PF-04449913),,1095173-27-5,CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,25166913.0
Crenigacestat (LY3039478),,1421438-81-4 ,CC(C(=O)NC1C2=CC=CC=C2C3=C(N=CC=C3)N(C1=O)CCO)NC(=O)CCC(F)(F)F,71236992.0
Abscisic Acid (Dorminï¼,,21293-29-8,CC1=CC(=O)CC(C1(C=CC(=CC(=O)O)C)O)(C)C,5280896.0
UM171,,1448724-09-1,CN1N=C(N=N1)C2=CC3=C(C=C2)C4=C(N3)N=C(N=C4NC5CCC(CC5)N)CC6=CC=CC=C6,71714981.0
Lomitapide Mesylate,,202914-84-9,CS(=O)(=O)O.C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F,11274333.0
"Cerdulatinib (PRT062070, PRT2070)",,1369761-01-2,CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N.Cl,56960607.0
"Peficitinib (ASP015K, JNJ-54781532)",,944118-01-8,C1C2CC3CC(C2)(CC1C3NC4=C5C=CNC5=NC=C4C(=O)N)O,57928403.0
Omaveloxolone (RTA-408),,1474034-05-3,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)NC(=O)C(C)(F)F)C,71811910.0
"Savolitinib(AZD6094, HMPL-504)",,1313725-88-0,CC(C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C,68289010.0
TRx0237 (LMTX) mesylate,,1236208-20-0,CN(C)C1=CC2=C(C=C1)NC3=C(S2)C=C(C=C3)N(C)C.CS(=O)(=O)O.CS(=O)(=O)O,60150609.0
Dasatinib Monohydrate,,863127-77-9,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO.O,11540687.0
Fumagillin,,23110-15-8,CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)C=CC=CC=CC=CC(=O)O)OC)C,6917655.0
GSK2879552 2HCl,,1401966-69-5 (free base),C1CN(CCC1CNC2CC2C3=CC=CC=C3)CC4=CC=C(C=C4)C(=O)O.Cl.Cl,121272425.0
Cyclo (-RGDfK),,161552-03-0(free base),C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCCCN)CC2=CC=CC=C2)CC(=O)O.C(=O)(C(F)(F)F)O,91759592.0
Endoxifen HCl,,1032008-74-4,CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCNC)C3=CC=CC=C3.Cl,54613017.0
Cyclo(RGDyK),,250612-42-1,C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCCCN)CC2=CC=C(C=C2)O)CC(=O)O.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O,129896716.0
Y-39983 HCl,,173897-44-4,CC(C1=CC=C(C=C1)C(=O)NC2=C3C=CNC3=NC=C2)N.Cl.Cl,20601328.0
Nemiralisib (GSK2269557),,1254036-71-9,CC(C)N1CCN(CC1)CC2=CN=C(O2)C3=C4C=NNC4=CC(=C3)C5=C6C=CNC6=CC=C5,49784002.0
CP21R7 (CP21),,125314-13-8,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CC(=CC=C4)N,5327711.0
Ripasudil (K-115) hydrochloride dihydrate,,887375-67-9,CC1CNCCCN1S(=O)(=O)C2=CC=CC3=CN=CC(=C32)F.O.O.Cl,11625386.0
"Nirogacestat (PF-03084014, PF-3084014)",,1290543-63-3,CCCC(C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C)NC2CCC3=C(C2)C(=CC(=C3)F)F,46224413.0
Vortioxetine (Lu AA21004) HBr,,960203-27-4,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Br,56843850.0
Pacritinib (SB1518),,937272-79-2 ,C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2,46216796.0
ONO-4059 (GS-4059) hydrochloride,,1439901-97-9,CC#CC(=O)N1CCC(C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N.Cl,71571562.0
Verubecestat (MK-8931) Trifluoroacetat,,1286770-55-5(free base),CC1(CS(=O)(=O)N(C(=N1)N)C)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)F)F.C(=O)(C(F)(F)F)O,129896720.0
"Lanabecestatï¼AZD3293, LY3314814ï¼",,1383982-64-6,CC#CC1=CC(=CN=C1)C2=CC3=C(CC4(C35N=C(C(=N5)N)C)CCC(CC4)OC)C=C2,67979346.0
Oclacitinib?maleate,,1640292-55-2,CNS(=O)(=O)CC1CCC(CC1)N(C)C2=NC=NC3=C2C=CN3.C(=CC(=O)O)C(=O)O,44631937.0
AS101,,106566-58-9,C1CO[Te](O1)(Cl)(Cl)Cl.[NH4+],9839786.0
MLR-1023,,41964-07-2,CC1=CC(=CC=C1)OC2=CNC(=O)N=C2,39065.0
Miransertib (ARQ 092) HCl,,1313883-00-9,C1CC(C1)(C2=CC=C(C=C2)N3C4=C(C=CC(=N4)C5=CC=CC=C5)N=C3C6=C(N=CC=C6)N)N.Cl,67305743.0
CPI-1205,,1621862-70-1,CC1=CC(=C(C(=O)N1)CNC(=O)C2=C(N(C3=CC=CC=C32)C(C)C4CCN(CC4)CC(F)(F)F)C)OC,78320408.0
Eltanexor (KPT-8602),,1642300-52-4,C1=C(C=C(C=C1C(F)(F)F)C(F)(F)F)C2=NN(C=N2)C=C(C3=CN=CN=C3)C(=O)N,86345880.0
RRx-001,,925206-65-1,C1C(CN1C(=O)CBr)([N+](=O)[O-])[N+](=O)[O-],15950826.0
"Voxelotor(GBT440, GTx011)",,1446321-46-5,CC(C)N1C(=CC=N1)C2=C(C=CC=N2)COC3=CC=CC(=C3C=O)O,71602803.0
Tofogliflozin(CSG 452),,1201913-82-7,CCC1=CC=C(C=C1)CC2=CC3=C(COC34C(C(C(C(O4)CO)O)O)O)C=C2.O,46908928.0
Seletalisib (UCB-5857),,1362850-20-1,C1=CC2=CC(=C(N=C2C(=C1)Cl)C3=C[N+](=CC=C3)[O-])C(C(F)(F)F)NC4=NC=NC5=C4N=CC=C5,56928390.0
Pamiparib (BGB-290),,1446261-44-4,CC12CCCN1CC3=NNC(=O)C4=C5C3=C2NC5=CC(=C4)F,135565554.0
Derazantinib(ARQ-087),,1234356-69-4,COCCNCCC1=CC(=CC=C1)NC2=NC=C3CC(C4=CC=CC=C4C3=N2)C5=CC=CC=C5F,46834118.0
Tenalisib (RP6530),,1639417-53-0,CCC(C1=C(C(=O)C2=CC=CC=C2O1)C3=CC(=CC=C3)F)NC4=NC=NC5=C4NC=N5,86291103.0
Ripretinib (DCC-2618),,1442472-39-0,CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC,71584930.0
Adavivint (SM04690),,1467093-03-3,CC(C)CC(=O)NC1=CN=CC(=C1)C2=CC3=C(C=C2)NN=C3C4=NC5=C(N4)C=NC=C5C6=CC(=CC=C6)F,135565709.0
PF-04965842,,1622902-68-4,CCCS(=O)(=O)NC1CC(C1)N(C)C2=NC=NC3=C2C=CN3,78323835.0
Lanifibranor(IVA-337),,927961-18-0,C1=CC2=C(C=C1S(=O)(=O)N3C4=C(C=C(C=C4)Cl)C=C3CCCC(=O)O)SC=N2,68677842.0
Sparteine,,492-08-0,C1CCN2CC3CC(C2C1)CN4C3CCCC4,7014.0
Ammonium Glycyrrhizate,,53956-04-0,CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C.N,62074.0
Melamine,,108-78-1,C1(=NC(=NC(=N1)N)N)N,7955.0
Sinensetin ,,2306-27-6,COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)OC)OC)OC,145659.0
Securinine,,5610-40-2,C1CCN2C(C1)C34CC2C=CC3=CC(=O)O4,442872.0
Scopolamine,,51-34-3,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4,3000322.0
1-Indanone,,83-33-0,C1CC(=O)C2=CC=CC=C21,6735.0
Ligustilide,,4431-01-0,CCCC=C1C2=C(C=CCC2)C(=O)O1,5319022.0
Methysergide Maleate,,129-49-7,CCC(CO)NC(=O)C1CN(C2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C.C(=CC(=O)O)C(=O)O,5281073.0
Methenamine Hippurate,,5714-73-8,C1N2CN3CN1CN(C2)C3.C1=CC=C(C=C1)C(=O)NCC(=O)O,21945.0
Thiothixene,,3313-26-6,CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C,941651.0
Haloperidol Decanoate,,74050-97-8,CCCCCCCCCC(=O)OC1(CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)Cl,52919.0
Oxtriphylline,,4499-40-5,CN1C(=C2C(=NC=N2)N(C1=O)C)[O-].C[N+](C)(C)CCO,656652.0
Valbenazine tosylate,, 1639208-54-0,CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C(C(C)C)N)OC)OC,92042922.0
Glucagon HCl,,16941-32-5,CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N,16132283.0
Gemcitabine HCl,,122111-03-9,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F.Cl,60749.0
Polymyxin B sulphate,,"1405-20-5, 4135-11-9 (free base)",CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O,5702105.0
Teicoplanin,,61036-62-2,CCCCCCCCCC(=O)NC1C(C(C(OC1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)C(C6C(=O)NC(C7=C(C(=CC(=C7)O)OC8C(C(C(C(O8)CO)O)O)O)C9=C(C=CC(=C9)C(C(=O)N6)NC(=O)C4NC(=O)C1C2=CC(=CC(=C2)OC2=C(C=CC(=C2)C(C(=O)NC(CC2=CC(=C(O3)C=C2)Cl)C(=O)N1)N)O)O)O)C(=O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)Cl)CO)O)O,16170201.0
Ibuprofen Lysine ,,57469-77-9,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O.C(CCN)CC(C(=O)O)N,9841440.0
Palbociclib (PD0332991) Isethionate,,827022-33-3,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C.C(CS(=O)(=O)O)O,11478676.0
Gadodiamide Hydrate,,122795-43-1,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3],60754.0
Sodium butyrate,,156-54-7,CCCC(=O)[O-].[Na+],5222465.0
Chondroitin sulfate,,9007-28-7,CC(=O)NC1C(C(C(OC1O)OS(=O)(=O)O)O)OC2C(C(C(C(O2)C(=O)O)O)O)O,24766.0
Oxacillin sodium monohydrate,,7240-38-2,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+],23694213.0
Vancomycin HCl ,,1404-93-9 ,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O.Cl,6420023.0
L-NAME HCl,,51298-62-5,COC(=O)C(CCCN=C(N)N[N+](=O)[O-])N.Cl,135193.0
Amikacin disulfate,,39831-55-5,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N.OS(=O)(=O)O.OS(=O)(=O)O,38351.0
Caspofungin Acetate,,179463-17-3,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O.CC(=O)O.CC(=O)O,6850808.0
Ceftazidime,,72558-82-8,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],5481173.0
Fondaparinux Sodium,,114870-03-0,COC1C(C(C(C(O1)COS(=O)(=O)[O-])OC2C(C(C(C(O2)C(=O)[O-])OC3C(C(C(C(O3)COS(=O)(=O)[O-])OC4C(C(C(C(O4)C(=O)[O-])OC5C(C(C(C(O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],636380.0
Cangrelor Tetrasodium,,163706-36-3,CSCCNC1=C2C(=NC(=N1)SCCC(F)(F)F)N(C=N2)C3C(C(C(O3)COP(=O)([O-])OP(=O)(C(P(=O)([O-])[O-])(Cl)Cl)[O-])O)O.[Na+].[Na+].[Na+].[Na+],10260031.0
L-Lysine hydrochloride,,657-27-2,C(CCN)CC(C(=O)O)N.Cl,69568.0
Bismuth Subcitrate Potassium,,880149-29-1,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+].[K+].[K+].[Bi+3],53297469.0
Cefradine,,38821-53-3,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O,38103.0
VitaMin U,,3493-12-7,C[S+](C)CCC(C(=O)O)N.[Cl-],14220.0
Manganese chloride,,7773-01-5,O.O.O.O.Cl[Mn]Cl,643989.0
Sodium carbonate,,497-19-8,C(=O)([O-])[O-].[Na+].[Na+],10340.0
L(+)-Asparagine monohydrate,,5794-13-8,C(C(C(=O)O)N)C(=O)N.O,170358.0
Fosfomycin Disodium,,26016-99-9,CC1C(O1)P(=O)([O-])[O-].[Na+].[Na+],73491.0
Ozagrel sodium,,189224-26-8,C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)[O-].[Na+],23663942.0
"UTP, Trisodium Salt",,19817-92-6,C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)([O-])OP(=O)([O-])OP(=O)(O)[O-])O)O.[Na+].[Na+].[Na+],88265.0
Loxoprofen Sodium,,80382-23-6,CC(C1=CC=C(C=C1)CC2CCCC2=O)C(=O)[O-].[Na+],23663407.0
Sodium succinate,,150-90-3,C(CC(=O)[O-])C(=O)[O-].[Na+].[Na+],9020.0
Spermine Tetrahydrochloride,,306-67-2,C(CCNCCCN)CNCCCN.Cl.Cl.Cl.Cl,9384.0
Tobramycin sulfate,,79645-27-5,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N.OS(=O)(=O)O,54413.0
DL-Serine,,302-84-1,C(C(C(=O)O)N)O,617.0
DL-Arginine,,7200-25-1,C(CC(C(=O)O)N)CN=C(N)N,232.0
Lodoxamide Tromethamine,,63610-09-3,C1=C(C=C(C(=C1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N.C(C(CO)(CO)N)O.C(C(CO)(CO)N)O,11192129.0
Edetate Trisodium,,150-38-9,C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)O)CC(=O)[O-].[Na+].[Na+].[Na+],9008.0
edetate calcium disodium,,62-33-9,C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Ca+2],6093170.0
pentetate calcium trisodium hydrate,,207226-35-5,C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Na+].[Na+].[Na+].[Ca+2],17749130.0
Creatine monohydrate,,6020-87-7,CN(CC(=O)O)C(=N)N.O,80116.0
scyllo-Inositol,,488-59-5,C1(C(C(C(C(C1O)O)O)O)O)O,892.0
Malachite green,,2437-29-8,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=CC=C3.CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=CC=C3.C(=O)(C(=O)O)O.C(=O)(C(=O)[O-])O.C(=O)(C(=O)[O-])O,2724411.0
(R)-Serine,,312-84-5,C(C(C(=O)O)N)O,71077.0
Aprotinin,,9087-70-1,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C(=O)NC(C(=O)NCC(=O)N6CCCC6C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)N)C(C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)C)CCCCN)C(C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)NC(=O)C1CCCN1C(=O)C(CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)NC(C)C(=O)O)C(C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)C(C)CC,22833874.0
Pemetrexed Disodium Hydrate,,357166-30-4,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].O.O.O.O.O.[Na+].[Na+].[Na+].[Na+],135564527.0
Mangafodipir Trisodium,,140678-14-4,[H+].[H+].[H+].CC1=NC=C(C(=C1[O-])CN(CCN(CC2=C(C(=NC=C2COP(=O)([O-])[O-])C)[O-])CC(=O)[O-])CC(=O)[O-])COP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Mn+2],160036.0
Gadoversetamide,,131069-91-5,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],444013.0
Bivalirudin Trifluoroacetate,,128270-60-0,CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C5CCCN5C(=O)C(CC6=CC=CC=C6)N,16129704.0
Eptifibatide Acetate,,148031-34-9,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N,123610.0
Lypressin Acetate,,50-57-7,C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCCN)C(=O)NCC(=O)N,644076.0
Octreotide Acetate,,79517-01-4,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,448601.0
Alarelin Acetate,,79561-22-1,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O.CC(=O)O,12821051.0
Atosiban Acetate,,90779-69-4,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(=O)N)CC(=O)N)C(C)O,5311010.0
Gonadorelin Acetate,,71447-49-9,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O.CC(=O)O,56841073.0
GHRP-2 ,,158861-67-7,CC(C(=O)NC(CC1=CC2=CC=CC=C2C=C1)C(=O)NC(C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCCN)C(=O)N)N,6918245.0
Nafarelin Acetate,,76932-56-4,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,25077405.0
Carperitide Acetate,,89213-87-6,CCC(C)C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CO)N)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)CC(C)C)CO)CCC(=O)N)C,16129708.0
Camptothecin,,7689-03-4,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O,24360.0
Cefoselis Sulfate,,122841-12-7,CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)CN4C=CC(=N)N4CCO)C(=O)O.OS(=O)(=O)O,9830519.0
Marbofloxacin,,115550-35-1,CN1CCN(CC1)C2=C(C=C3C4=C2OCN(N4C=C(C3=O)C(=O)O)C)F,60651.0
Irsogladine,,57381-26-7,C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl,3752.0
Retinyl (Vitamin A) Palmitate,,79-81-2 ,CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C,5280531.0
Chlortetracycline HCl,,64-72-2 ,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O.Cl,54682468.0
6-Aminopenicillanic acid,,551-16-6,CC1(C(N2C(S1)C(C2=O)N)C(=O)O)C,11082.0
Amantadine,,768-94-5,C1C2CC3CC1CC(C2)(C3)N,2130.0
Balofloxacin Dihydrate,,151060-21-8,CNC1CCCN(C1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F.O.O,6918202.0
Xanthopterin Hydrate,,5979-01-1,C1=NC2=C(C(=O)NC(=N2)N)NC1=O.O,135465063.0
Garenoxacin,,194804-75-6,CC1C2=C(CN1)C=C(C=C2)C3=C(C4=C(C=C3)C(=O)C(=CN4C5CC5)C(=O)O)OC(F)F,124093.0
Voreloxin (SNS-595) hydrochloride,,175519-16-1,CNC1CN(CC1OC)C2=NC3=C(C=C2)C(=O)C(=CN3C4=NC=CS4)C(=O)O.Cl,10343042.0
Cefadroxil hydrate,,66592-87-8,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O.O,47964.0
Zofenopril calcium,,81938-43-4 ,CC(CSC(=O)C1=CC=CC=C1)C(=O)N2CC(CC2C(=O)[O-])SC3=CC=CC=C3.CC(CSC(=O)C1=CC=CC=C1)C(=O)N2CC(CC2C(=O)[O-])SC3=CC=CC=C3.[Ca+2],3033690.0
Heparin sodium,,9041-08-1,C1N(CN(CN1CCO)CC[O-])CCO.[Na+],118989588.0
Piperaquine phosphate,,85547-56-4,C1CN(CCN1CCCN2CCN(CC2)C3=C4C=CC(=CC4=NC=C3)Cl)C5=C6C=CC(=CC6=NC=C5)Cl.OP(=O)(O)O,174478.0
